Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.8521987790554194,-2.048875302182094,0.0,0.0,0.0,61/102,9.87%,RPS13;RPS4X;RPL28;RPS27A;RPS8;RPL38;RPS21;RPL31;RPL37A;RPS14;RPL12;RPLP1;RPL3;RPL23A;RPL39;RPL32;RPS11;RPL5;RPS15;RPS12;RPS25;RPS23;RPS27;RPS20;RPL29;RPLP2;RPL19;RPS24;RPL13A;RPL41;RPL7A;RPL35;RPL37;RPS18;RPL10;RPL10A;RPL11;RPS3;RPL23;RPS3A;RPL4;RPS26;RPL30;RPL36;RPL24;RPL14;RPL18A;RPS6;RPS2;RPS7;RPL34;RPL15;PNRC2;RPL21;RPS5;EIF4A3;RPL27A;RPL6;RPL27;RPL18;NCBP2
prerank,GO_Biological_Process_2021__cytoplasmic translation (GO:0002181),-0.8514037296000116,-2.0290727984754535,0.0,0.0,0.0,58/84,9.60%,RPS13;RPS4X;RPL28;RPS27A;RPS8;RPL38;RPS21;RPL31;RPL37A;RPS14;RPL12;RPLP1;RPL3;RPL23A;RPL39;RPL32;RPS11;RPL5;RPS15;RPS12;RPS25;RPS23;RPS27;RPS20;RPL29;RPL19;RPS24;RPL13A;RPL41;RPL7A;RPL35;RPL37;RPS18;RPL10;RPL10A;RPL11;RPS3;RPL23;TMA7;RPS3A;RPL4;RPS26;RPL30;RPL36;RPL24;RPL14;RPL18A;RPS6;RPS2;RPS7;RPL34;RPL15;RPL21;RPS5;RPL27A;RPL6;RPL27;RPL18
prerank,GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.8607490484488086,-2.0135820388982535,0.0,0.0,0.0,59/84,9.60%,RPS13;RPS4X;RPL28;RPS27A;RPS8;RPL38;RPS21;RPL31;RPL37A;RPS14;RPL12;RPLP1;RPL3;RPL23A;RPL39;RPL32;RPS11;RPL5;RPS15;RPS12;RPS25;RPS23;RPS27;SRP14;RPS20;RPL29;RPLP2;RPL19;RPS24;RPL13A;RPL41;RPL7A;RPL35;RPL37;RPS18;RPL10;RPL10A;RPL11;RPS3;RPL23;RPS3A;RPL4;RPS26;RPL30;RPL36;RPL24;RPL14;RPL18A;RPS6;RPS2;RPS7;RPL34;RPL15;RPL21;RPS5;RPL27A;RPL6;RPL27;RPL18
prerank,GO_Biological_Process_2021__cotranslational protein targeting to membrane (GO:0006613),-0.8536435050347304,-1.9837027023813634,0.0,0.0,0.0,59/87,9.60%,RPS13;RPS4X;RPL28;RPS27A;RPS8;RPL38;RPS21;RPL31;RPL37A;RPS14;RPL12;RPLP1;RPL3;RPL23A;RPL39;RPL32;RPS11;RPL5;RPS15;RPS12;RPS25;RPS23;RPS27;SRP14;RPS20;RPL29;RPLP2;RPL19;RPS24;RPL13A;RPL41;RPL7A;RPL35;RPL37;RPS18;RPL10;RPL10A;RPL11;RPS3;RPL23;RPS3A;RPL4;RPS26;RPL30;RPL36;RPL24;RPL14;RPL18A;RPS6;RPS2;RPS7;RPL34;RPL15;RPL21;RPS5;RPL27A;RPL6;RPL27;RPL18
prerank,GO_Biological_Process_2021__protein targeting to ER (GO:0045047),-0.8428719524279192,-1.9740704914414282,0.0,0.0,0.0,59/95,9.60%,RPS13;RPS4X;RPL28;RPS27A;RPS8;RPL38;RPS21;RPL31;RPL37A;RPS14;RPL12;RPLP1;RPL3;RPL23A;RPL39;RPL32;RPS11;RPL5;RPS15;RPS12;RPS25;RPS23;RPS27;SRP14;RPS20;RPL29;RPLP2;RPL19;RPS24;RPL13A;RPL41;RPL7A;RPL35;RPL37;RPS18;RPL10;RPL10A;RPL11;RPS3;RPL23;RPS3A;RPL4;RPS26;RPL30;RPL36;RPL24;RPL14;RPL18A;RPS6;RPS2;RPS7;RPL34;RPL15;RPL21;RPS5;RPL27A;RPL6;RPL27;RPL18
prerank,PanglaoDB_Augmented_2021__T Cells,-0.8592439501978547,-1.9357828204761383,0.0,0.0,0.0,30/85,5.75%,CCL4;ITK;GNLY;JAML;NKG7;SKAP1;THEMIS;CCL3;MYO1G;CD96;CD2;CXCR4;CCL5;JUNB;PYHIN1;IL7R;CD69;GRAP2;IFIT3;PSTPIP1;SELL;RORA;GZMB;PRF1;CD247;SLAMF6;SNX20;LSP1;IL10RA;TXK
prerank,GO_Biological_Process_2021__peptide biosynthetic process (GO:0043043),-0.7839573143359321,-1.9308703394354565,0.0,0.0,0.0,64/128,9.60%,RPS13;RPS4X;HARS2;RPL28;RPS27A;RPS8;RPL38;RPS21;RPL31;WARS1;RPL37A;RPS14;RPL12;RPLP1;RPL3;RPL23A;RPL39;RPL32;RPS11;RPL5;RPS15;RPS12;RPS25;RPS23;RPS27;RPS20;RPL29;RPLP2;RPL19;RPS24;RPL13A;RPL41;RPL7A;RPL35;RPL37;RPS18;RPL10;RPL10A;RPL11;RPS3;RPL23;ABCF1;RPS3A;RPL4;RPS26;RPL30;MRPS7;RPL36;MRPL51;RPL24;RPL14;RPL18A;RPS6;RPS2;RPS7;RPL34;RPL15;RPL21;RPS5;RPL27A;MRPL52;RPL6;RPL27;RPL18
prerank,PanglaoDB_Augmented_2021__NK Cells,-0.8547246653866328,-1.8885762236408106,0.0,0.0,0.0,28/83,5.75%,CCL4;ITK;GNLY;TRGC2;JAML;SPON2;SAMD3;NKG7;THEMIS;CCL3;MYO1G;CD96;CD2;CXCR4;CCL5;PYHIN1;CD69;VNN2;GRAP2;PSTPIP1;SELL;GZMB;PRF1;CD247;SLAMF6;SNX20;IL10RA;TXK
prerank,GO_Biological_Process_2021__protein localization to cilium (GO:0061512),0.867458913949777,1.8781091872757842,0.0,0.30272666062273684,0.18,4/24,5.34%,TULP2;BBS9;TULP3;INVS
prerank,GO_Biological_Process_2021__translation (GO:0006412),-0.7468622355757343,-1.8759718242335917,0.0,0.0,0.0,76/175,12.11%,RPS13;RPS4X;HARS2;RPL28;RPS27A;RPS8;RPL38;RPS21;RPL31;WARS1;RPL37A;RPS14;RPL12;RPLP1;RPL3;RPL23A;RPL39;RPL32;RPS11;RPL5;RPS15;RPS12;RPS25;RPS23;RPS27;RPS20;RPL29;RPLP2;RPL19;RPS24;NARS1;RPL13A;RPL41;RPL7A;RPL35;RPL37;RPS18;RPL10;RPL10A;RPL11;RPS3;RPL23;TMA7;ABCF1;MRPL57;RPS3A;RPL4;RPS26;RPL30;MRPS7;RPL36;MRPL51;RPL24;RPL14;RPL18A;RPS6;RPS2;RPS7;RPL34;RPL15;RPL21;RPS5;RPL27A;MRPL52;RPL6;RPL27;RPL18;LARS1;RPLP0;RPS9;KARS1;MRPS11;GTPBP2;MRPS15;MRPL16;MRPL32
prerank,GO_Biological_Process_2021__regulation of lipid biosynthetic process (GO:0046890),0.8585591910337167,1.8673951705600815,0.0,0.15136333031136842,0.18,4/22,2.30%,PRKAB2;AVIL;ADIPOR2;PDK4
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process (GO:0000956),-0.7697505427186387,-1.8640710530863014,0.0,0.0008667664720796032,0.01,64/153,9.87%,RPS13;RPS4X;RPL28;RPS27A;RPS8;RPL38;ZFP36;RPS21;RPL31;RPL37A;RPS14;RPL12;RPLP1;RPL3;RPL23A;RPL39;RPL32;RPS11;RPL5;RPS15;RPS12;RPS25;RPS23;RPS27;RPS20;RPL29;RPLP2;RPL19;RPS24;RPL13A;RPL41;RPL7A;RPL35;RPL37;RPS18;RPL10;RPL10A;RPL11;RPS3;RPL23;RPS3A;RPL4;RPS26;RPL30;RPL36;RPL24;RPL14;EXOSC10;RPL18A;POLR2G;RPS6;RPS2;RPS7;RPL34;RPL15;PNRC2;RPL21;RPS5;EIF4A3;RPL27A;RPL6;RPL27;RPL18;NCBP2
prerank,PanglaoDB_Augmented_2021__Thymocytes,-0.8320679497192157,-1.8579172303417226,0.0,0.001575939040144733,0.02,21/75,5.34%,CCL4;GNLY;JAML;NKG7;MYO1G;CD37;CD2;CXCR4;CD69;VNN2;PSTPIP1;SELL;GZMB;PRF1;CD247;SLAMF6;SNX20;NCF4;LSP1;PLEK;IL10RA
prerank,PanglaoDB_Augmented_2021__T Memory Cells,-0.848316437409118,-1.8470883455941796,0.0,0.0014446107867993388,0.02,24/75,5.34%,ITK;GNLY;JAML;NKG7;SKAP1;THEMIS;MYO1G;ACAP1;CD96;CD2;PYHIN1;IL7R;CD69;GRAP2;PSTPIP1;SELL;GZMB;PRF1;CD247;SLAMF6;SNX20;LSP1;ARHGEF1;IL10RA
prerank,PanglaoDB_Augmented_2021__T Helper Cells,-0.8584364122162916,-1.8467560350815153,0.0,0.0013334868801224665,0.02,20/58,4.22%,CCL4;ITK;GNLY;JAML;NKG7;THEMIS;MYO1G;CD96;CD2;CXCR4;CCL5;PYHIN1;CD69;SELL;RORA;GZMB;PRF1;CD247;SLAMF6;SNX20
prerank,GO_Biological_Process_2021__cellular macromolecule biosynthetic process (GO:0034645),-0.7148733089923823,-1.8459806975386728,0.0,0.001238237817256576,0.02,84/233,13.60%,RPS13;RPS4X;HARS2;RPL28;RPS27A;RPS8;RPL38;RPS21;RPL31;WARS1;RPL37A;RPS14;GCNT1;RPL12;RPLP1;RPL3;RPL23A;RPL39;RPL32;RPS11;RPL5;RPS15;RPS12;RPS25;RPS23;RPS27;POLE3;RPS20;RPL29;RPLP2;RPL19;RPS24;RPL13A;RPL41;RPL7A;RPL35;RPL37;RPS18;PTMA;HUS1;ING5;RPL10;RPL10A;RPL11;RPS3;RPL23;ABCF1;TIPIN;RPS3A;RPL4;RPS26;RPL30;MRPS7;RPL36;MRPL51;RPL24;RPL14;RPL18A;POLR2G;RPS6;RPS2;RPS7;RPL34;RPL15;RPL21;RPS5;RPL27A;MRPL52;RPL6;RPL27;RPL18;RPLP0;RPS9;MRPS11;ING4;GTPBP2;MRPS15;MRPL32;KAT5;RPS28;MCM7;EEF1B2;RAD9A;RPL9
prerank,PanglaoDB_Augmented_2021__Monocytes,-0.7675193513771499,-1.8434379963039966,0.0,0.0011556886294394708,0.02,43/127,11.39%,CCL4;JAML;CD36;CCL3;ADGRE1;MX1;CXCR4;MNDA;VNN2;CLEC12A;RGS2;IFIT3;AIF1;IFIT1;CD14;SELL;FCER1G;RGS1;IFITM3;SNX20;NCF4;LSP1;TNFSF10;PLEK;IL10RA;CD300LF;PECAM1;C5AR1;SIRPB2;PLSCR1;TNFRSF1B;TYMP;OAS1;LY6E;CD44;NCF2;MS4A6A;ITGB2;CSF2RB;HLA-DRA;TYROBP;ITGAL;CSF3R
prerank,PanglaoDB_Augmented_2021__T Cells Naive,-0.8371770819399701,-1.8224847169101974,0.0,0.002166916180199008,0.03,19/58,5.34%,GNLY;JAML;NKG7;MYO1G;CD37;CD96;CD2;PYHIN1;VNN2;GRAP2;PSTPIP1;SELL;GZMB;PRF1;CD247;SLAMF6;SNX20;LSP1;IL10RA
prerank,PanglaoDB_Augmented_2021__T Follicular Helper Cells,-0.8270820715727423,-1.82049225958764,0.0,0.002039450522540243,0.03,21/72,5.34%,CCL4;GNLY;JAML;NKG7;MYO1G;CD37;CD2;PYHIN1;GPR183;VNN2;PSTPIP1;SELL;GZMB;PRF1;CD247;SLAMF6;SNX20;NCF4;LSP1;PLEK;IL10RA
prerank,PanglaoDB_Augmented_2021__T Regulatory Cells,-0.834381822984159,-1.8152859847899327,0.0,0.002889221573598677,0.05,24/64,8.06%,CCL4;ITK;GNLY;JAML;CD96;CD2;CCL5;PYHIN1;GPR183;CD69;PSTPIP1;SELL;GZMB;PRF1;CD247;SLAMF6;SNX20;LSP1;PLEK;IL10RA;SP140;HLA-F;CYTIP;TNFRSF1B
prerank,PanglaoDB_Augmented_2021__Bergmann Glia,0.6372569589313989,1.8100634039105135,0.0,0.32290843799758595,0.48,30/100,12.47%,NPAS3;SLC39A12;GRIN3A;CNTN2;NCAN;GFAP;HEPACAM;SLC1A3;CDH20;KCND3;PLPPR4;LRRC4C;SLC1A2;TNR;GRIA3;GRIA4;CA10;CTNNA2;SLC4A4;CADM2;GRIA1;LRRTM2;PSD2;GRM5;PTPN5;PTCH1;METRN;GRIN2B;RBFOX1;NTRK2
prerank,PanglaoDB_Augmented_2021__Gamma Delta T Cells,-0.9124933539357152,-1.791151423190539,0.0,0.00638670032058655,0.11,10/25,3.81%,GNLY;TRGC2;SPON2;NKG7;CD96;CD2;CCL5;GZMB;PRF1;CD247
prerank,GO_Biological_Process_2021__neutrophil chemotaxis (GO:0030593),-0.9137401385667896,-1.7881855927632075,0.0,0.007367515012676627,0.11,5/21,3.26%,CCL4;JAML;CCL3;CCL5;FCER1G
prerank,PanglaoDB_Augmented_2021__Nuocytes,-0.9145597480539381,-1.7838973088734438,0.0,0.008667664720796033,0.14,17/29,4.14%,ITK;GNLY;JAML;THEMIS;BCL11B;CD96;CD2;PYHIN1;IL7R;CD69;ZNF831;SELL;RORA;GZMB;PRF1;CD247;SLAMF6
prerank,PanglaoDB_Augmented_2021__Megakaryocytes,-0.7685410223048812,-1.7807421831529215,0.0,0.009061649480832216,0.16,29/91,11.96%,GNLY;JAML;SPON2;NKG7;CXCR4;MNDA;VNN2;CLEC12A;AIF1;PSTPIP1;FCER1G;SNX20;NCF4;TSPAN32;PLEK;F13A1;CD300LF;PECAM1;C5AR1;TNFRSF1B;FERMT3;LILRB3;SLC11A1;ITGB2;CSF2RB;VEGFA;TYROBP;CSF3R;TSPAN9
prerank,GO_Biological_Process_2021__regulation of axonogenesis (GO:0050770),0.752196962642853,1.7763219672118375,0.0,0.4783081237839242,0.68,23/44,18.25%,PLXNB1;LRP4;PLXNA2;CHODL;LRRC4C;PLXNA3;PLXNB2;ROBO1;PLXNC1;BRSK1;METRN;LINGO1;PTEN;RTN4;NTRK2;PLXNA1;ROBO2;GSK3B;TIAM2;KIF13B;BRSK2;MARK2;MAP6
prerank,GO_Biological_Process_2021__regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.8490494695855052,1.7652082186482427,0.0,0.4770972171414332,0.78,5/19,6.06%,KLF4;ANXA1;FGF2;HDAC9;CIB1
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type I Cells,0.7554851794983074,1.7641602323469774,0.0,0.4036355474969825,0.78,5/39,1.36%,SHROOM3;COL16A1;PLXNB1;PDPN;FKBP9
prerank,GO_Biological_Process_2021__positive regulation of ion transport (GO:0043270),-0.8898066480779268,-1.763230785505965,0.0,0.012813069587263698,0.24,4/32,1.49%,CCL4;CCL3;MYLK;CCL5
prerank,PanglaoDB_Augmented_2021__Neutrophils,-0.7531881819554709,-1.7519993203010689,0.0,0.016974176744892232,0.3,26/83,11.39%,JAML;CCL3;MYLK;OAS3;MNDA;VNN2;CLEC12A;AIF1;PSTPIP1;CD14;SELL;FCER1G;SNX20;NCF4;PLEK;CD300LF;PECAM1;C5AR1;SIRPB2;LILRB3;NCF2;SLC11A1;ITGB2;CSF2RB;TYROBP;CSF3R
prerank,GO_Biological_Process_2021__cellular response to nitrogen compound (GO:1901699),-0.8889883709690973,-1.7444092560417113,0.0,0.018028742619255748,0.32,1/15,0.51%,DDX11
prerank,PanglaoDB_Augmented_2021__Eosinophils,-0.7413002957500358,-1.7429676851008944,0.0,0.019335559761775763,0.36,25/86,11.39%,JAML;NKG7;MYO1G;CCL5;MNDA;CD69;VNN2;CLEC12A;AIF1;PSTPIP1;FCER1G;SNX20;NCF4;PLEK;IL10RA;CD300LF;C5AR1;CYTIP;TNFRSF1B;ITGB2;CSF2RB;NCKAP1L;TYROBP;ITGAL;CSF3R
prerank,GO_Biological_Process_2021__icosanoid metabolic process (GO:0006690),0.7960190284954214,1.7427197173944229,0.0,0.5051210565819381,0.85,3/27,0.68%,CPA1;FAAH;PLA2G4C
prerank,PanglaoDB_Augmented_2021__Gamma (PP) Cells,0.6520206873911637,1.7403152460559637,0.0,0.46317179075278736,0.85,37/81,21.03%,ESRRG;PPARGC1A;PDZRN4;PLPPR1;NOL4;SNAP91;PBX1;PLPPR4;PCDH17;MAGI1;SHC2;NFIB;ASXL3;GUCY1A2;PTPRD;THSD7A;NTRK2;ABCC8;ERBB4;GRIA2;CNTN4;NFASC;CSRNP3;PPFIA2;KALRN;MAPK4;SORBS2;CNTN3;MAP6;PCLO;MAP2;CNTN1;PHYHIPL;SYT4;FAM149A;GAREM1;NOVA1
prerank,GO_Biological_Process_2021__modulation by host of symbiont process (GO:0051851),-0.8466980429658798,-1.738704266222666,0.0,0.023434797208078156,0.44,4/27,4.48%,CCL4;CCL3;CCL5;CTDP1
prerank,GO_Biological_Process_2021__cellular response to chemokine (GO:1990869),-0.9046906203147265,-1.7378982371306726,0.0,0.02290739961924666,0.44,5/17,1.54%,CCL4;CCL3;RIPOR2;CCL5;DUSP1
prerank,PanglaoDB_Augmented_2021__Pyramidal Cells,0.6301095433982363,1.7353017863805944,0.0,0.4278536803468014,0.86,43/89,21.61%,KCNQ2;CNTN2;NCAN;GFAP;CDH20;KCND3;SNAP91;NGB;GRIA3;GRIA4;CA10;OLFM3;CTNNA2;KCNC2;CADM2;GRIA1;SATB2;SORCS3;PSD2;GRM5;SNCB;PTPN5;GRIN2B;RTN4;RBFOX1;GRIA2;DAB1;GRIN2A;ADGRB3;NXPH1;KCNB1;MAP2;KCND2;SYT4;GRM3;AGER;AMER2;CACNG3;CACNA1B;GRM1;KCNB2;SYNPR;NRXN1
prerank,PanglaoDB_Augmented_2021__T Cytotoxic Cells,-0.9073357903089944,-1.735175762067223,0.0,0.023014144258665322,0.46,16/30,4.14%,ITK;GNLY;JAML;NKG7;THEMIS;CD96;CD2;PYHIN1;CD69;GRAP2;ZNF831;SELL;GZMB;PRF1;CD247;SLAMF6
prerank,GO_Biological_Process_2021__neutrophil migration (GO:1990266),-0.8859097891338132,-1.7345312924160847,0.0,0.02282485043142955,0.47,6/23,5.65%,CCL4;JAML;CCL3;CCL5;FCER1G;PECAM1
prerank,GO_Biological_Process_2021__regulation of fatty acid biosynthetic process (GO:0042304),0.7594749561204251,1.7328177149914676,0.06896551724137931,0.40081009866450357,0.86,3/20,2.30%,PRKAB2;ADIPOR2;PDK4
prerank,GO_Biological_Process_2021__cellular nitrogen compound biosynthetic process (GO:0044271),0.8200840778420606,1.7279550427751802,0.02040816326530612,0.3907925982584421,0.87,4/15,10.57%,ACER2;ABCA2;SPTLC2;GCH1
prerank,GO_Biological_Process_2021__antigen receptor-mediated signaling pathway (GO:0050851),-0.7328101248114944,-1.726447287467838,0.0,0.026282596250155714,0.5,33/138,12.85%,ITK;BTN3A1;SKAP1;THEMIS;THEMIS2;MNDA;PRKCQ;NFKBID;GRAP2;VAV3;PSMB3;BTK;EIF2B1;CD247;BTN3A3;HLA-DRB5;TXK;BTN3A2;BTN2A1;PSMB6;PSMA7;FYN;BTN2A2;PRKD2;PSMB9;SPG21;NCKAP1L;HLA-DRA;PSMD12;PLEKHA1;PTPRC;PSMD8;PSMA5
prerank,PanglaoDB_Augmented_2021__Decidual Cells,-0.9333027859319812,-1.7261009524338156,0.0,0.02573212963986322,0.5,17/24,4.14%,CCL4;GNLY;TRGC2;JAML;NKG7;SKAP1;CD96;CD2;KLRC4-KLRK1;CCL5;PYHIN1;GRAP2;SELL;GZMB;PRF1;CD247;SLAMF6
prerank,GO_Biological_Process_2021__response to hydroxyurea (GO:0072710),-0.9291860062288055,-1.7220818504790403,0.0,0.02731627669584204,0.54,1/9,0.51%,DDX11
prerank,GO_Biological_Process_2021__regulation of fatty acid metabolic process (GO:0019217),0.9129894656034138,1.7208714294223961,0.0,0.40565372523446735,0.9,4/11,5.17%,PRKAB2;ADIPOR2;PDK4;PPARG
prerank,PanglaoDB_Augmented_2021__Peri-islet Schwann Cells,0.6411268780183962,1.720632773085214,0.03225806451612903,0.3744495925241237,0.9,22/65,15.62%,COL16A1;LRP4;ARNT2;GULP1;PHLDB1;PBX1;SEMA3B;MAGI1;NUAK1;NTM;CDH11;PTPRG;ENAH;RUNX1T1;GPC6;TJP1;FBXL7;ADCY6;FERMT2;NFASC;CSRNP3;ANTXR1
prerank,GO_Biological_Process_2021__cellular protein metabolic process (GO:0044267),-0.6692655978594209,-1.7187245688920012,0.0,0.028552307315563397,0.56,78/275,11.44%,RPS13;USP6;RPS4X;HARS2;RPL28;RPS27A;RPS8;RPL38;RPS21;RPL31;WARS1;RPL37A;RPS14;RPL12;RPLP1;RPL3;RPL23A;RPL39;RPL32;RPS11;RPL5;RPS15;RPS12;RPS25;YES1;RPS23;RPS27;RPS20;RPL29;RPLP2;RPL19;RPS24;RPL13A;RPL41;RPL7A;RPL35;RPL37;RPS18;RPL10;RPL10A;RPL11;ERO1A;RPS3;RPL23;IGF1;ABCF1;RPS3A;RPL4;RPS26;RPL30;MRPS7;RPL36;MRPL51;RPL24;RPL14;RPL18A;RPS6;RPS2;RPS7;RPL34;RPL15;CSF2RA;RPL21;RPS5;RPL27A;MRPL52;GPC3;RPL6;RPL27;RPL18;GGCX;CSF2RB;ADPRH;CCDC59;RPLP0;RPS9;SPARCL1;MRPS11
prerank,GO_Biological_Process_2021__leukotriene metabolic process (GO:0006691),0.9344795146321028,1.7177176479156595,0.0,0.3554875929026996,0.9,1/14,0.01%,CPA1
prerank,GO_Biological_Process_2021__branching morphogenesis of an epithelial tube (GO:0048754),0.8580171656503306,1.715217511680918,0.0,0.345512028657417,0.9,6/13,7.23%,NRP1;PKD2;TGFBR2;FGF2;PKD1;SALL1
prerank,PanglaoDB_Augmented_2021__Embryonic Stem Cells,0.6231765692304033,1.7087460528812377,0.0,0.3564606428832726,0.92,26/83,16.64%,SHROOM3;KLF4;LRP4;SMAD1;FRAS1;GULP1;SMAD2;SMAD3;MAGI1;KITLG;PTPRG;ENAH;ANO6;FNBP1L;ARHGAP42;DCBLD2;TJP1;PTK2;FERMT2;CD276;ANTXR1;PARD3;NACC1;COL4A5;WWC2;RAI14
prerank,GO_Biological_Process_2021__rRNA metabolic process (GO:0016072),-0.6884621394835703,-1.7085144058287869,0.0,0.035413601573538074,0.63,54/137,12.02%,RPL28;RPL38;RPL31;RPL37A;RPS14;RPL12;RPLP1;RPL3;RPL23A;RPL39;RPL32;RPL5;RPS15;RPS25;RPS27;RPL29;RPLP2;RPL19;RPS24;RPL13A;RPL41;RPL7A;RPL35;RPL37;UTP3;RPL10;RPL10A;RPL11;RPL23;RPL4;RPL30;RPL36;RPL24;RPL14;EXOSC10;RPL18A;RPS6;RPS2;RPS7;RPL34;RPL15;RPL21;RPL27A;RPL6;RPL27;RPL18;WDR46;EXOSC1;DDX27;RPLP0;RPS9;NOB1;NOP53;WDR55
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport (GO:0051928),-0.9349713089814815,-1.7052538788018912,0.0,0.03731911199231625,0.63,4/22,1.49%,CCL4;CCL3;MYLK;CCL5
prerank,GO_Biological_Process_2021__T cell receptor signaling pathway (GO:0050852),-0.7249737549861031,-1.7018896743052954,0.0,0.03771605459589625,0.64,22/123,9.00%,ITK;BTN3A1;SKAP1;THEMIS;THEMIS2;PRKCQ;NFKBID;GRAP2;PSMB3;EIF2B1;CD247;BTN3A3;HLA-DRB5;TXK;BTN3A2;BTN2A1;PSMB6;PSMA7;FYN;BTN2A2;PRKD2;PSMB9
prerank,GO_Biological_Process_2021__regulation of BMP signaling pathway (GO:0030510),0.7249617994596633,1.700255536085515,0.0,0.37538105917219367,0.94,16/40,14.65%,UBE2D1;ACVR2A;SMAD1;SMAD7;UBE2O;PPARG;SMAD2;SPART;LEMD3;BMPR1B;SORL1;BMPR1A;TWSG1;PCSK6;SMURF1;XIAP
prerank,PanglaoDB_Augmented_2021__Basophils,-0.7222472947536306,-1.6993809227435126,0.0,0.03854829836354025,0.66,32/109,11.39%,CCL4;JAML;OSBPL5;H1-3;PLEKHG5;CCL3;MNDA;GPR183;CD69;H2AC6;CLEC12A;MS4A4A;AIF1;SIGLEC1;CD14;FCER1G;CD93;NCF4;IL3RA;PLEK;F13A1;CD300LF;SIRPB2;ENPP3;CD44;LILRB3;NCF2;MS4A6A;CSF2RB;TYROBP;ITGAL;CSF3R
prerank,PanglaoDB_Augmented_2021__Alveolar Macrophages,-0.7159523494852792,-1.6963178686378368,0.0,0.04244933235056518,0.72,30/90,11.39%,CCL4;CD36;CCL3;MNDA;CLEC12A;MS4A4A;MARCO;AIF1;SIGLEC1;CD14;FCER1G;PLET1;NCF4;PLEK;LILRB4;CD300LF;C5AR1;SIRPB2;TNFRSF1B;OLR1;TYMP;TNFAIP2;LILRB3;NCF2;SLC11A1;MS4A6A;ITGB2;CSF2RB;TYROBP;CSF3R
prerank,GO_Biological_Process_2021__negative regulation of viral genome replication (GO:0045071),-0.7926575330360516,-1.6958163457814388,0.0,0.042254865513880656,0.72,15/37,8.67%,OAS3;MX1;RSAD2;CCL5;IFIT1;OAS2;IFITM3;SHFL;ILF3;EIF2AK2;PLSCR1;SRPK1;OAS1;RNASEL;APOBEC3G
prerank,GO_Biological_Process_2021__negative regulation of cellular response to growth factor stimulus (GO:0090288),0.6655440524933125,1.6912451216480333,0.0,0.4016173697594975,0.96,12/48,12.30%,UBE2D1;ACVR2A;SPRY2;SMAD1;FGF2;SMAD7;PPARG;SPART;LEMD3;BMPR1B;SORL1;BMPR1A
prerank,GO_Biological_Process_2021__rRNA processing (GO:0006364),-0.6759760529180733,-1.690662832734253,0.0,0.045240981713423195,0.74,55/148,12.02%,RPL28;RPL38;RPL31;RPL37A;RPS14;RPL12;RPLP1;RPL3;RPL23A;RPL39;RPL32;RPL5;RPS15;RPS25;RPS27;RPL29;RPLP2;RPL19;RPS24;RPL13A;RPL41;RPL7A;RPL35;RPL37;UTP3;RPL10;RPL10A;RPL11;RPL23;RPL4;RPL30;RPL36;RPL24;RPL14;EXOSC10;RPL18A;RPS6;RPS2;RPS7;RPL34;RPL15;RPL21;RPL27A;RPL6;RPL27;RPL18;WDR46;NSA2;EXOSC1;DDX27;RPLP0;RPS9;NOB1;NOP53;WDR55
prerank,PanglaoDB_Augmented_2021__Cardiac Stem And Precursor Cells,0.6526524959273862,1.689808632962352,0.0,0.38749012559710316,0.96,18/51,18.51%,LRP4;FKBP9;WNT5A;MAGI1;NUAK1;KITLG;TANC1;PTPRG;GNA11;ENAH;TJP1;ADCY6;FERMT2;CD276;ANTXR1;RAI14;RBFOX2;SNX7
prerank,PanglaoDB_Augmented_2021__Plasmacytoid Dendritic Cells,-0.7287842053795669,-1.6890939738131105,0.0,0.046227545177578835,0.75,24/111,5.48%,CCL4;JAML;NKG7;MYO1G;CD37;MCTP2;CXCR4;MNDA;GPR183;VNN2;AIF1;PSTPIP1;SELL;FCER1G;GZMB;BTK;SLAMF6;SNX20;NCF4;LSP1;IL3RA;PLEK;IL10RA;CD300LF
prerank,GO_Biological_Process_2021__ncRNA processing (GO:0034470),-0.6506961146562678,-1.6878464994755014,0.0,0.04616035397819282,0.75,57/170,12.02%,RPL28;RPL38;RPL31;RPL37A;RPS14;RPL12;RPLP1;RPL3;RPL23A;RPL39;RPL32;RPL5;RPS15;RPS25;RPS27;RPL29;SSB;RPLP2;RPL19;RPS24;RPL13A;RPL41;RPL7A;RPL35;RPL37;UTP3;RPL10;RPL10A;RPL11;RPL23;RPL4;RPL30;RPL36;RPL24;RPL14;EXOSC10;RPL18A;RPS6;RPS2;RPS7;RPL34;RPL15;RPL21;RPL27A;RPL6;RPL27;RPL18;WDR46;EXOSC1;ZCCHC8;DDX27;RPLP0;RPS9;KARS1;NOB1;NOP53;WDR55
prerank,PanglaoDB_Augmented_2021__Delta Cells,0.6388792187701202,1.6863015283920577,0.0,0.3862792189546122,0.96,29/77,20.32%,LEPR;PPARGC1A;PLPPR1;NOL4;SNAP91;PLPPR4;PCDH17;BAIAP3;GRIA3;SHC2;UNC5B;ASXL3;LCORL;PTPRD;ABCC8;GRIA2;CNTN4;NFASC;CSRNP3;KALRN;MAPK4;SORBS2;UCP2;MAP6;CNTN1;PHYHIPL;SYT4;UNC5D;FAM149A
prerank,PanglaoDB_Augmented_2021__Glutaminergic Neurons,0.5960623250101684,1.6837209846054226,0.0,0.3794174146471635,0.97,41/81,22.69%,CNTN2;NCAN;NOL4;SNAP91;SCN3B;SLC1A2;KCTD16;TNR;GRIA4;CA10;OLFM3;CTNNA2;KCNC2;FUT9;GRIA1;PSD2;GRM5;PTPN5;GRIN2B;RBFOX1;GRIA2;CSRNP3;PPFIA2;GRIN2A;NXPH1;PHYHIPL;GRM3;TMEM132B;CELF5;AMER2;CACNG3;CACNA1B;GRM1;SYNPR;NRXN1;GABRA2;GRIN1;LSAMP;DLG2;GLS;OPCML
prerank,PanglaoDB_Augmented_2021__Enterocytes,-0.7608921343458697,-1.6834340993818886,0.0,0.05082403404466764,0.79,7/43,4.37%,SPON2;CD36;COL18A1;DEGS2;CD55;SLC51A;AQP11
prerank,GO_Biological_Process_2021__lymphocyte chemotaxis (GO:0048247),-0.9686199658844805,-1.6787657320991083,0.0,0.05431736558365514,0.82,5/12,1.61%,CCL4;CCL3;CH25H;CCL5;GPR183
prerank,GO_Biological_Process_2021__negative regulation of blood vessel endothelial cell migration (GO:0043537),0.7408898427697169,1.6782231367844391,0.0,0.38418765293576423,0.97,4/22,7.30%,KLF4;FGF2;PPARG;TNF
prerank,PanglaoDB_Augmented_2021__Natural Killer T Cells,-0.7698544932690244,-1.6751308029365273,0.0,0.05935466058805978,0.85,25/70,5.81%,CCL4;ITK;GNLY;JAML;NKG7;THEMIS;MYO1G;CD96;CD2;CXCR4;PYHIN1;CD69;GRAP2;ZNF831;PSTPIP1;SELL;RORA;GZMB;PRF1;CD247;SLAMF6;SNX20;LSP1;IL10RA;IL12RB2
prerank,GO_Biological_Process_2021__cellular response to tumor necrosis factor (GO:0071356),-0.7080691255547252,-1.6726632364749907,0.0,0.06288667382534993,0.85,21/114,10.01%,CCL4;CCL3;TNFRSF11B;ZFP36;CCL5;CARD14;PID1;TNFRSF25;PSMB3;AIM2;RPS3;GBP3;PSMB6;PSMA7;TNFRSF1B;TMSB4X;GBP2;PSMB9;CHI3L1;STAT1;EIF5A
prerank,GO_Biological_Process_2021__cellular response to interferon-gamma (GO:0071346),-0.7492665526862646,-1.672595582937464,0.014705882352941176,0.061757111135671734,0.85,23/75,10.77%,CCL4;MT2A;CCL3;OAS3;HLA-B;GAPDH;CCL5;TRIM5;AIF1;B2M;OAS2;RPL13A;HLA-C;HLA-DRB5;GBP3;TRIM22;HLA-F;OAS1;CD44;GBP2;STAT1;IRF1;HLA-DRA
prerank,PanglaoDB_Augmented_2021__Oligodendrocyte Progenitor Cells,0.5803771508260911,1.6720618077377392,0.0,0.3922284559372851,0.98,30/83,17.15%,CNTN2;NCAN;PCDH15;GFAP;ZNF536;ARNT2;SNAP91;PLPPR4;CSPG5;LRRC4C;HAPLN2;CHST1;LHFPL3;TNR;NTM;CA10;PSD2;SNCB;OLIG1;PTPN5;NRXN2;SLC35F1;LINGO1;GRIA2;NFASC;LRRC4B;ADGRB3;MAPK4;ETV5;NXPH1
prerank,GO_Biological_Process_2021__response to laminar fluid shear stress (GO:0034616),0.9260712968698066,1.6719472579388246,0.0,0.3763901480409361,0.98,2/8,2.59%,KLF4;SMAD7
prerank,GO_Biological_Process_2021__cellular response to hydroxyurea (GO:0072711),-0.9293662592042198,-1.6716122965115496,0.0,0.06138121751257597,0.86,1/8,0.51%,DDX11
prerank,GO_Biological_Process_2021__DNA packaging (GO:0006323),-0.8943019368980464,-1.6663481483344247,0.03225806451612903,0.0663943117612976,0.9,4/15,3.75%,H1-4;H1-3;H1-2;H1-0
prerank,PanglaoDB_Augmented_2021__Platelets,-0.6853502038557368,-1.6660377418585843,0.0,0.06543237093149946,0.9,35/143,11.39%,JAML;CD36;SLC2A3;SRGN;THEMIS2;CXCR4;CCL5;MNDA;CARD16;CD69;VNN2;CLEC12A;GRAP2;AIF1;SELL;FCER1G;OST4;CD93;NCF4;LSP1;PLEK;ERO1A;F13A1;CD300LF;PECAM1;SIRPB2;TNFRSF1B;FERMT3;CD226;NCF2;ITGB2;CSF2RB;VEGFA;TYROBP;CSF3R
prerank,MSigDB_Hallmark_2020__Interferon Gamma Response,-0.6901921841218651,-1.6657708171852832,0.0,0.06450742782592431,0.9,46/150,11.51%,MT2A;MX2;STAT4;OAS3;HLA-B;MX1;RSAD2;IFI44L;CMPK2;CCL5;XAF1;WARS1;CD69;HERC6;IFIT3;DHX58;PARP14;B2M;IFIT1;OAS2;RNF213;IFITM3;TNFSF10;SAMD9L;OGFR;SP110;IL10RA;SRI;NLRC5;EIF2AK2;PLSCR1;IFIT2;NAMPT;TNFAIP3;LY6E;IFI44;TNFAIP2;PSMB9;STAT1;BANK1;IRF1;CSF2RB;EPSTI1;TAP1;HIF1A;BTG1
prerank,GO_Biological_Process_2021__cellular response to laminar fluid shear stress (GO:0071499),0.9460424188773426,1.6640877716009408,0.0,0.40395845593498003,1.0,1/5,0.08%,KLF4
prerank,PanglaoDB_Augmented_2021__Radial Glia Cells,0.6123801107986538,1.663385028354886,0.0,0.39214745883745294,1.0,36/80,19.89%,NPAS3;LRP4;CNTN2;NCAN;GFAP;SLC1A3;ZNF536;NLGN1;ARNT2;SNAP91;PLPPR4;LRRC4C;PCDH17;PURG;NTM;ASXL3;GUCY1A2;PTPN5;PTPRD;SLC35F1;RUNX1T1;NTRK2;FBXL7;MARK1;GRIA2;NFASC;CSRNP3;PPFIA2;ADGRB3;MAPK4;CDH4;MAP6;CRMP1;MAP2;DCLK1;PHYHIPL
prerank,GO_Biological_Process_2021__ribosome biogenesis (GO:0042254),-0.6762034027711166,-1.6614084010243648,0.0,0.07032256282909989,0.92,59/162,12.02%,RBIS;RPL28;RPL38;RPL31;RPL37A;RPS14;RPL12;RPLP1;RPL3;RPL23A;RPL39;RPL32;RPL5;RPS15;RPS25;RPS27;RPL29;RPLP2;RPL19;RPS24;RPL13A;RPL41;RPL7A;RPL35;RPL37;UTP3;METTL17;RPL10;RPL10A;RPL11;GLUL;RPL23;RPL4;RPL30;RPL36;RPL24;RPL14;EXOSC10;RPL18A;RPS6;RPS2;RPS7;RPL34;RPL15;RPL21;RPL27A;RPL6;RPL27;RPL18;WDR46;EXOSC1;NPM1;DDX27;RPLP0;RPS9;EIF2A;NOB1;NOP53;WDR55
prerank,GO_Biological_Process_2021__chemokine-mediated signaling pathway (GO:0070098),-0.9040673327195818,-1.6584235070821998,0.0,0.07271207626890004,0.93,3/13,1.49%,CCL4;CCL3;CCL5
prerank,GO_Biological_Process_2021__regulation of hemoglobin biosynthetic process (GO:0046984),0.9832708746927131,1.655004340698675,0.0,0.42292035698850494,1.0,1/6,0.08%,KLF4
prerank,MSigDB_Hallmark_2020__Interferon Alpha Response,-0.7592346317802832,-1.6497211350501853,0.0,0.08541589597584452,0.96,31/78,11.24%,PROCR;MX1;RSAD2;IFI44L;CMPK2;WARS1;HERC6;TRIM5;IFIT3;DHX58;PARP14;B2M;SELL;IFITM3;SAMD9L;OGFR;HLA-C;SP110;PARP9;EIF2AK2;PLSCR1;IFIT2;OAS1;LY6E;IFI44;GBP2;PSMB9;SAMD9;IRF1;EPSTI1;TAP1
prerank,GO_Biological_Process_2021__sympathetic ganglion development (GO:0061549),0.8992516352272256,1.6484463948959287,0.038461538461538464,0.44327832448329324,1.0,2/5,5.40%,NRP1;FZD3
prerank,GO_Biological_Process_2021__cellular response to fluid shear stress (GO:0071498),0.9189288084645045,1.6481944583722015,0.0,0.42924552706230823,1.0,2/9,1.00%,KLF4;PKD2
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.7364861298859124,-1.646826846536011,0.0,0.08776010529805982,0.96,18/65,12.85%,CD36;HLA-B;B2M;PSMB3;FCER1G;NCF4;HLA-C;PSMB6;PSMA7;MFSD6;HLA-F;PSMB9;NCF2;TAP1;PSMD12;CYBA;PSMD8;PSMA5
prerank,MSigDB_Hallmark_2020__Allograft Rejection,-0.7054467514310707,-1.646007276074438,0.0,0.08774109726139141,0.96,32/119,11.78%,CCL4;ITK;FLNA;STAT4;TPD52;SRGN;CD96;CD2;CCL5;WARS1;GCNT1;RPL39;B2M;GZMB;PRF1;CD247;ETS1;NCF4;RPS3A;KLRD1;GBP2;STAT1;GLMN;EIF5A;ITGB2;NPM1;HLA-DRA;RPS9;TAP1;ITGAL;HIF1A;IFNGR2
prerank,GO_Biological_Process_2021__negative regulation of viral process (GO:0048525),-0.7632141758024235,-1.643412727577268,0.014084507042253521,0.09056215208279991,0.96,19/48,9.65%,OAS3;MX1;RSAD2;ZFP36;CCL5;TRIM5;IFIT1;OAS2;IFITM3;SHFL;ILF3;EIF2AK2;PLSCR1;SRPK1;OAS1;RNASEL;APOBEC3G;STAT1;TRIM13
prerank,GO_Biological_Process_2021__negative regulation by host of viral transcription (GO:0043922),-0.9347289885771677,-1.6426341497803487,0.0,0.09005556735335538,0.96,3/11,1.49%,CCL4;CCL3;CCL5
prerank,GO_Biological_Process_2021__insulin secretion (GO:0030073),0.7960816249809357,1.6415285664284818,0.0,0.4553008975765962,1.0,1/11,0.34%,ANXA1
prerank,GO_Biological_Process_2021__granulocyte chemotaxis (GO:0071621),-0.8310922141674433,-1.6377650641503432,0.015625,0.09823353350235503,0.96,5/24,3.26%,CCL4;JAML;CCL3;CCL5;FCER1G
prerank,GO_Biological_Process_2021__response to interferon-beta (GO:0035456),-0.8613214185888862,-1.6367295286095072,0.0,0.09832826207853859,0.96,10/17,10.38%,MNDA;PYHIN1;XAF1;IFITM3;AIM2;SHFL;PLSCR1;OAS1;STAT1;IRF1
prerank,GO_Biological_Process_2021__polarized epithelial cell differentiation (GO:0030859),0.8308389663766116,1.6352433690499666,0.02040816326530612,0.4749878958932232,1.0,3/10,5.14%,SCRIB;MSN;RAB10
prerank,GO_Biological_Process_2021__positive regulation of hemoglobin biosynthetic process (GO:0046985),0.987023273238011,1.6344776774124736,0.0,0.4669558740105716,1.0,1/5,0.08%,KLF4
prerank,GO_Biological_Process_2021__regulation of immune response (GO:0050776),-0.7148816942149534,-1.6328227703081037,0.012048192771084338,0.10429157873731999,0.97,26/92,11.83%,JAML;IL4I1;HLA-B;RSAD2;CD96;DHX58;B2M;CD200R1;SELL;CD247;SLAMF6;HLA-C;CD300LF;PLSCR1;HLA-F;ITGA4;KLRD1;OSCAR;CD226;IRF1;ITGB2;HLA-DRA;ERAP1;TYROBP;ITGAL;APPL1
prerank,GO_Biological_Process_2021__activation of adenylate cyclase activity (GO:0007190),-0.8494401336102313,-1.6292432824105163,0.031746031746031744,0.1099280017764449,0.99,1/17,0.10%,CALCR
prerank,GO_Biological_Process_2021__response to tumor necrosis factor (GO:0034612),-0.771355875483509,-1.6283065347600145,0.0,0.11037729292888697,0.99,7/56,5.67%,CCL4;CCL3;ZFP36;CCL5;PID1;RPS3;GBP3
prerank,GO_Biological_Process_2021__regulation of calcium ion transport (GO:0051924),-0.8336793963300692,-1.6265594085133088,0.014084507042253521,0.11107945711420145,0.99,5/39,1.49%,CCL4;CCL3;MYLK;PLN;CCL5
prerank,GO_Biological_Process_2021__regulation of protein sumoylation (GO:0033233),0.8577891537696407,1.6250888746089196,0.04081632653061224,0.5115163211007214,1.0,3/11,7.49%,EGR1;SAE1;GNL3L
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.8740752990001864,1.6249855124885817,0.027777777777777776,0.4971840214462831,1.0,6/11,7.75%,PLXNB1;NRP1;PLXNA2;PLXNA3;PLXNB2;PLXNC1
prerank,PanglaoDB_Augmented_2021__Retinal Progenitor Cells,0.635389678089175,1.618678264747308,0.0,0.5161922030275695,1.0,28/60,21.09%,KCNQ2;LRP4;DPYSL5;NCAN;ZNF536;GALNT13;NOL4;SNAP91;CSPG5;LRRC4C;PURG;CADM2;SNCB;SLC35F1;LINGO1;CAMKV;GRIA2;CSRNP3;MAPK4;BRSK2;MAP6;PCLO;PHYHIPL;GRIK3;UNC5D;CELF5;MEGF10;CACNA1B
prerank,GO_Biological_Process_2021__response to estradiol (GO:0032355),0.7918092831444313,1.618568705745742,0.025,0.5028626195899906,1.0,4/20,4.06%,ANXA1;RUVBL2;NCOA3;NRIP1
prerank,PanglaoDB_Augmented_2021__Immature Neurons,0.6189212664139878,1.6174594716549775,0.0,0.49778081168344085,1.0,49/96,22.69%,NPAS3;KCNQ2;CNTN2;DPYSL5;NCAN;ZNF536;NOL4;SNAP91;SCN3B;LRRC4C;ROBO1;PURG;GRIA4;OLFM3;CTNNA2;FUT9;CADM2;SOX5;PTPN5;SLC35F1;CAMKV;NF1;RBFOX1;SLC12A5;GRIA2;CSRNP3;ROBO2;PPFIA2;ADGRB3;MAPK4;ATRNL1;CLASP2;NXPH1;PCLO;HIVEP2;DCLK1;PHYHIPL;SYT4;GRM3;GRIK3;CELF5;AMER2;NOVA1;CACNA1B;SYNPR;NRXN1;LSAMP;RAB3C;OPCML
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-lysine acetylation (GO:2000758),0.7657927247878078,1.616134710097528,0.05405405405405406,0.4929664673509199,1.0,5/18,8.29%,PPARGC1A;RUVBL2;RPS6KA4;DIP2B;SOX4
prerank,PanglaoDB_Augmented_2021__Schwann Cells,0.6168203479704659,1.6152961483372488,0.0,0.485294123644449,1.0,19/82,10.47%,COL16A1;BAG3;LGI4;LRP4;RGS11;CNTN2;GFAP;ASPA;ARNT2;PHLDB1;PLPPR4;SEMA3B;HAPLN2;CHST1;NTM;SHC2;CD82;PSD2;OLIG1
prerank,GO_Biological_Process_2021__negative regulation of BMP signaling pathway (GO:0030514),0.7604922949013028,1.614280255652332,0.0,0.4783081237839242,1.0,10/31,12.30%,UBE2D1;ACVR2A;SMAD1;SMAD7;PPARG;SPART;LEMD3;BMPR1B;SORL1;BMPR1A
prerank,GO_Biological_Process_2021__regulation of glucose transmembrane transport (GO:0010827),-0.8631284880801451,-1.6125249958054384,0.0,0.14183451361302596,1.0,1/14,0.08%,NR4A3
prerank,PanglaoDB_Augmented_2021__Melanocytes,0.6368872180384967,1.611730512472636,0.0,0.4814092261610352,1.0,25/71,16.66%,COL16A1;EPS8;RASSF8;FKBP9;COL5A2;MITF;BNC2;PHLDB1;RASAL2;PPARG;TIMP3;TANC1;SASH1;LOXL2;EPAS1;ITGAV;FAM114A1;COL6A1;GPNMB;MMP14;ENPP1;ANTXR1;STARD13;RAI14;TNC
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.7231487034076759,-1.6085085866150444,0.0,0.15097260789804434,1.0,17/62,14.31%,CD36;HLA-B;B2M;PSMB3;NCF4;HLA-C;PSMB6;PSMA7;HLA-F;PSMB9;NCF2;TAP1;PSMD12;CYBA;PSMD8;PSMA5;HLA-E
prerank,GO_Biological_Process_2021__negative regulation of wound healing (GO:0061045),0.7933762752990288,1.6084201092245345,0.0,0.4898405679981237,1.0,9/15,16.96%,SERPINE1;FGF2;SERPINE2;TNF;CRK;PTEN;CLASP1;SLC12A2;CLASP2
prerank,GO_Biological_Process_2021__negative regulation of interleukin-8 production (GO:0032717),0.8601702738804811,1.6070675915280532,0.0,0.48746032515158844,1.0,2/11,0.34%,KLF4;ANXA1
prerank,GO_Biological_Process_2021__negative regulation of response to wounding (GO:1903035),0.8523369661735423,1.6026356435577318,0.0,0.5052783171848589,1.0,4/13,8.31%,SERPINE1;FGF2;CRK;GIT1
prerank,GO_Biological_Process_2021__sphingosine metabolic process (GO:0006670),0.8508356693659509,1.6021413232958204,0.02127659574468085,0.4967408137862865,1.0,4/13,6.65%,ACER2;ABCA2;PLPP1;SPTLC2
prerank,PanglaoDB_Augmented_2021__Neuroendocrine Cells,0.55814815197613,1.6014583413953634,0.0,0.4901539496343791,1.0,38/87,22.69%,CNTN2;NCAN;GFAP;ZNF536;SNAP91;SCN3B;PLPPR4;LRRC4C;PDE10A;GRIA4;CA10;OLFM3;KCNC2;CADM2;PSD2;GRM5;SNCB;PTPN5;RBFOX1;NEGR1;CXCL14;GRIA2;NFASC;FXYD7;CSRNP3;PPFIA2;ADGRB3;CLASP2;NXPH1;PHYHIPL;SYT4;GRM3;AMER2;SYNPR;NRXN1;LSAMP;RAB3C;OPCML
prerank,GO_Biological_Process_2021__cellular response to organonitrogen compound (GO:0071417),0.6139109256672769,1.601388357731068,0.0,0.4799827819065181,1.0,7/72,6.73%,EGR1;RRAGD;PKD2;AANAT;RAP1A;GLRA1;CPEB4
prerank,GO_Biological_Process_2021__cardiac muscle cell membrane repolarization (GO:0099622),0.828191215283721,1.6010018768332515,0.022222222222222223,0.47326267944021194,1.0,4/10,5.43%,KCNJ2;KCNIP2;KCND3;KCNJ5
prerank,GO_Biological_Process_2021__regulation of lamellipodium assembly (GO:0010591),0.7494991206646962,1.5990058736365569,0.0,0.4781845618816292,1.0,5/25,8.34%,AVIL;FER;AKIRIN1;WASF2;AUTS2
prerank,GO_Biological_Process_2021__negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),-0.8401983603520264,-1.598082697810943,0.0,0.180746302560129,1.0,4/14,5.33%,RPGRIP1L;CCL5;RGS2;PLEK
prerank,PanglaoDB_Augmented_2021__Acinar Cells,0.9607259327829603,1.596343155327156,0.0,0.4848470196533753,1.0,1/8,0.01%,CPA1
prerank,GO_Biological_Process_2021__positive regulation of glucose metabolic process (GO:0010907),0.8959872057896676,1.5963354094696485,0.024390243902439025,0.4753402153464464,1.0,2/8,2.51%,PPARGC1A;SIRT1
prerank,GO_Biological_Process_2021__positive regulation of cell projection organization (GO:0031346),0.6084427502115479,1.5935412991079658,0.0,0.48506125698243135,1.0,31/88,18.87%,AVIL;PLXNB1;PLXNA2;RAP1A;CHODL;WNT5A;RELN;PLXNA3;SCARB2;PLXNB2;ROBO1;DVL3;PLXNC1;FUT9;NPTN;ZNF804A;PTPRD;METRN;NTRK2;PRKCI;PLXNA1;MAP3K13;CAPRIN2;ROBO2;TIAM2;IL1RAPL1;CX3CL1;RAPGEF2;MARK2;MAP6;SCN1B
prerank,GO_Biological_Process_2021__establishment of apical/basal cell polarity (GO:0035089),0.8694226359282315,1.5930324633047308,0.025,0.47865083321104435,1.0,2/10,1.49%,SCRIB;MSN
prerank,GO_Biological_Process_2021__negative regulation of DNA metabolic process (GO:0051053),-0.8016882721048166,-1.5923800965266457,0.0,0.19269851712610309,1.0,6/24,8.56%,H1-4;H1-3;H1-2;H1-0;RPS3;H1-10
prerank,GO_Biological_Process_2021__sympathetic nervous system development (GO:0048485),0.8399835949691457,1.591530391029126,0.0975609756097561,0.4783081237839242,1.0,4/7,12.21%,NRP1;FZD3;SOX4;NF1
prerank,PanglaoDB_Augmented_2021__Macrophages,-0.6833840107866629,-1.5911444968647515,0.0,0.19291745192857457,1.0,45/152,11.39%,CCL4;NR4A3;JAML;CD36;CCL3;ADGRE1;MYO1G;RUNX3;CCL5;MNDA;CLEC12A;MS4A4A;CHIT1;AIF1;PARP14;SIGLEC1;CD14;CD200R1;FCER1G;RGS1;PLTP;SNX20;NCF4;LSP1;PLEK;IL10RA;F13A1;LILRB4;CD300LF;SELENOP;C5AR1;CYTIP;TNFRSF1B;RBPJ;EGLN3;SAMSN1;NCF2;SLC11A1;MS4A6A;ITGB2;CSF2RB;HLA-DRA;TYROBP;ITGAL;CSF3R
prerank,GO_Biological_Process_2021__negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.9228498758609321,1.591041290430212,0.0,0.472693920259648,1.0,1/9,0.08%,KLF4
prerank,PanglaoDB_Augmented_2021__Purkinje Neurons,0.571082647774859,1.590745668901446,0.0,0.46598282402999847,1.0,47/104,23.08%,KCNQ2;CNTN2;GRID2;NCAN;PKP4;SLC22A15;SNAP91;GRIA3;GRIA4;CA10;OLFM3;MRPS35;CTNNA2;CADM2;SHANK2;PSD2;GRM5;SNCB;CLSTN3;PTPN5;NRXN2;RBFOX1;SLC12A5;GRIA2;SLC24A2;CACNG2;GAD1;ADGRB3;NXPH1;DLGAP1;HIVEP2;PPM1E;SYT4;GRM3;GRIK3;CELF5;CNTNAP2;AMER2;PRKG1;CACNA1B;CERK;SYNPR;NRXN1;GRIN1;RAB3C;OPCML;SYP
prerank,GO_Biological_Process_2021__central nervous system neuron differentiation (GO:0021953),0.7289966920462991,1.5895680260790088,0.027777777777777776,0.46609283747809455,1.0,8/22,12.47%,GRID2;CHD5;MDGA2;RYK;ZC4H2;SOX4;KNDC1;NTRK2
prerank,GO_Biological_Process_2021__fatty-acyl-CoA biosynthetic process (GO:0046949),0.6784643846529046,1.589172147989221,0.0,0.45993574713923396,1.0,7/20,20.80%,PPT1;HACD2;ELOVL6;GCDH;FASN;ACACA;SCD5
prerank,PanglaoDB_Augmented_2021__Myeloid-derived Suppressor Cells,-0.7378700500072303,-1.5876864693613446,0.014084507042253521,0.2020420438439075,1.0,36/73,19.56%,JAML;ADGRE1;MNDA;VNN2;CLEC12A;AIF1;PSTPIP1;FCER1G;SNX20;NCF4;PLEK;CD300LF;C5AR1;SIRPB2;CYTIP;TNFRSF1B;LILRB3;NCF2;ITGB2;CSF2RB;TYROBP;ITGAL;CSF3R;PTPRC;MYO1F;LY86;FPR1;IGSF6;S100A4;FCGR3A;LST1;EVI2B;PARVG;RNASE6;ARHGAP30;MPEG1
prerank,GO_Biological_Process_2021__branching involved in ureteric bud morphogenesis (GO:0001658),0.9230046826032259,1.5874710894151987,0.0,0.4617864314584122,1.0,3/5,7.23%,PKD2;FGF2;SALL1
prerank,GO_Biological_Process_2021__response to interferon-alpha (GO:0035455),-0.8766323813907229,-1.5860934338501602,0.0,0.20597742135113903,1.0,4/13,6.90%,MX2;PYHIN1;IFITM3;EIF2AK2
prerank,GO_Biological_Process_2021__lipid oxidation (GO:0034440),0.9244506519306628,1.5855578439282767,0.0,0.46680451068026024,1.0,3/8,1.59%,PPARGC1A;ADIPOR2;PLA2G7
prerank,GO_Biological_Process_2021__positive regulation of sprouting angiogenesis (GO:1903672),0.8691679469659126,1.5851350246821616,0.02040816326530612,0.46193110771744833,1.0,3/11,2.26%,KLF4;SMAD1;FGF2
prerank,GO_Biological_Process_2021__keratan sulfate metabolic process (GO:0042339),0.8310344525248728,1.5849169661072688,0.0,0.45584775864094695,1.0,4/17,6.57%,B3GNT2;GLB1;B4GALT4;CHST1
prerank,PanglaoDB_Augmented_2021__Langerhans Cells,-0.6825396278965722,-1.5813272165896057,0.01282051282051282,0.21574173695460808,1.0,35/91,15.96%,CCL4;JAML;MNDA;MS4A4A;AIF1;SIGLEC1;FCER1G;SNX20;NCF4;LSP1;PLEK;IL10RA;LILRB4;CD300LF;HLA-DRB5;HLA-F;CYTIP;NCF2;MS4A6A;ITGB2;CSF2RB;NCKAP1L;HLA-DRA;TYROBP;ITGAL;PTPRC;HAVCR2;MYO1F;HLA-DRB6;LY86;HLA-DPA1;CIITA;HLA-DMB;CD74;IGSF6
prerank,GO_Biological_Process_2021__protein export from nucleus (GO:0006611),0.6745857916937925,1.5809028680712471,0.05555555555555555,0.4695626869214896,1.0,5/24,7.82%,NUTF2;PKD1;NUP42;XPO1;RANBP3L
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein catabolic process (GO:1902991),0.8636344414231207,1.5796996018644403,0.046511627906976744,0.47073995726835577,1.0,3/10,6.50%,ABCA2;PICALM;TMED10
prerank,GO_Biological_Process_2021__organelle fission (GO:0048285),-0.7500003506867181,-1.5783060668709747,0.08771929824561403,0.22137684219330406,1.0,3/19,5.76%,MX2;MX1;FIS1
prerank,GO_Biological_Process_2021__regulation of DNA recombination (GO:0000018),-0.7956034000334686,-1.5778891170533895,0.030303030303030304,0.21946527073055555,1.0,5/28,3.75%,H1-4;H1-3;H1-2;IL7R;H1-0
prerank,PanglaoDB_Augmented_2021__Taste Receptor Cells,0.595918091125476,1.5772992335617073,0.0,0.47430281719722345,1.0,25/82,14.91%,CACNA1A;KCNT1;CNTN2;AP3B2;SGSM1;FAM135B;ASPA;OTUD7A;SCN3B;SLC1A2;RUNDC3A;TNR;GRIA4;CTNNA2;KCNC2;CYP46A1;MOBP;SV2B;ZNF493;UNC80;CACNA1E;GRIA2;SLC24A2;CACNG2;CACNB4
prerank,GO_Biological_Process_2021__keratan sulfate biosynthetic process (GO:0018146),0.8656126637001187,1.5769420199843514,0.02564102564102564,0.46986847142716914,1.0,3/13,6.57%,B3GNT2;B4GALT4;CHST1
prerank,GO_Biological_Process_2021__membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.7818623933479405,1.5761951640354321,0.04878048780487805,0.46647015586106494,1.0,5/11,10.99%,KCNJ2;KCNIP2;KCND3;KCNJ5;KCNN2
prerank,GO_Biological_Process_2021__regulation of long-term neuronal synaptic plasticity (GO:0048169),0.8714282234950235,1.5733683254948245,0.0,0.4772396767464322,1.0,4/10,8.88%,SYNGR1;NETO1;SHANK3;NPTN
prerank,GO_Biological_Process_2021__potassium ion export across plasma membrane (GO:0097623),0.9220087033475663,1.5723194024246523,0.03333333333333333,0.4754124774649241,1.0,2/6,4.38%,KCNIP2;KCND3
prerank,GO_Biological_Process_2021__regulation of plasminogen activation (GO:0010755),0.8855309361026575,1.5712523358433954,0.029411764705882353,0.4743294305300254,1.0,4/9,6.90%,SERPINE1;SERPINE2;HPN;RUNX1
prerank,GO_Biological_Process_2021__error-prone translesion synthesis (GO:0042276),-0.8259551763566216,-1.5706597484075313,0.03125,0.24155412998218415,1.0,2/18,1.30%,UBC;RPS27A
prerank,GO_Biological_Process_2021__neuron projection extension (GO:1990138),0.7222512281195926,1.5700886219182646,0.029411764705882353,0.47327689195949,1.0,5/27,9.71%,NRP1;SEMA5A;AUTS2;FLRT1;ALCAM
prerank,GO_Biological_Process_2021__regulation of megakaryocyte differentiation (GO:0045652),-0.7182592257764792,-1.5700836745441806,0.0,0.24179407558792046,1.0,2/41,1.65%,NR4A3;PRKCQ
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell proliferation (GO:0048660),-0.776344019742663,-1.568951310510328,0.0,0.24325023171567325,1.0,7/29,9.56%,NR4A3;CCL5;AIF1;APOD;IGF1;TNFAIP3;STAT1
prerank,GO_Biological_Process_2021__negative regulation of protein processing (GO:0010955),0.8643862879460276,1.5686385606260798,0.05714285714285714,0.47494449422144935,1.0,4/9,8.81%,SERPINE1;SERPINE2;LRRK2;SNX12
prerank,GO_Biological_Process_2021__aerobic electron transport chain (GO:0019646),-0.7073682223943581,-1.5685629303036603,0.028169014084507043,0.24137800488292746,1.0,24/50,18.32%,CYCS;COX7C;UQCRB;NDUFC1;NDUFA2;UQCRH;NDUFA1;NDUFB9;NDUFA12;NDUFB4;UQCR10;COX4I1;COX5B;NDUFB1;NDUFS8;NDUFS5;COX6C;NDUFS6;NDUFB7;UQCRC1;NDUFB3;UQCRQ;NDUFS7;NDUFA3
prerank,GO_Biological_Process_2021__phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.8517540451911962,1.5674940814100975,0.0,0.47324885630502367,1.0,1/11,0.68%,PLA2G4C
prerank,GO_Biological_Process_2021__chromatin assembly (GO:0031497),-0.7611007226507864,-1.5662343489861266,0.0,0.2463783696886272,1.0,11/40,10.59%,H1-4;H1-3;H1-2;POLE3;H1-0;H2BC18;H2BC21;H2BC5;H1-10;H2BC9;NPM1
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.7096614909758029,-1.5653531815202812,0.028169014084507043,0.2457978501687467,1.0,25/51,18.32%,CYCS;COX7C;UQCRB;NDUFC1;NDUFA2;UQCRH;NDUFA1;NDUFB9;NDUFA12;NDUFB4;UQCR10;COX4I1;COX5B;NDUFB1;NDUFS8;NDUFS5;COA6;COX6C;NDUFS6;NDUFB7;UQCRC1;NDUFB3;UQCRQ;NDUFS7;NDUFA3
prerank,PanglaoDB_Augmented_2021__Parietal Cells,0.6159517626611024,1.565339775187605,0.037037037037037035,0.4789626679150004,1.0,20/70,11.74%,HID1;PLXNB1;FAAH;SRCIN1;HIP1R;RAP1GAP;KIAA1671;NEO1;NDRG2;MTUS1;PLPPR1;TPPP;BAIAP3;PIK3C2B;SLC12A6;SHC2;SHANK2;PTCH1;COBL;ZDHHC11B
prerank,GO_Biological_Process_2021__positive regulation of neurogenesis (GO:0050769),0.6105921107204682,1.5653166933235674,0.05555555555555555,0.4725764990094671,1.0,22/52,18.25%,PLXNB1;PLXNA2;CHODL;FZD3;PLXNA3;PLXNB2;LIG4;ROBO1;PLXNC1;SHANK3;NPTN;NUMBL;PTPRD;METRN;NTRK2;PLXNA1;CAPRIN2;ROBO2;TIAM2;IL1RAPL1;CX3CL1;MAP6
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),-0.7036623804730214,-1.5645442580800888,0.0,0.24533719288984865,1.0,16/62,12.85%,UBC;RPS27A;PSMB3;ELOB;PSMB6;PSMA7;RBPJ;EGLN3;PSMB9;CITED2;RBX1;VEGFA;HIF1A;PSMD12;PSMD8;PSMA5
prerank,GO_Biological_Process_2021__gene expression (GO:0010467),-0.6036261398730153,-1.5643764120753434,0.0,0.24259018248685763,1.0,73/291,9.87%,RPS13;RPS4X;HARS2;RPL28;RPS27A;RPS8;RPL38;RPS21;RPL31;WARS1;RPL37A;RPS14;RPL12;RPLP1;RPL3;DHX38;RPL23A;RPL39;RPL32;RPS11;RPL5;RPS15;RPS12;RPS25;RPS23;RPS27;RPS20;RPL29;RPLP2;RPL19;RPS24;RPL13A;RPL41;RPL7A;RPL35;RPL37;RPS18;PTMA;TSPAN32;RPL10;RPL10A;RPL11;RPS3;RPL23;ABCF1;RPS3A;RPL4;RPS26;RPL30;MRPS7;RPL36;MRPL51;RPL24;RPL14;RPL18A;POLR2G;RPS6;RPS2;RPS7;RPL34;RPL15;RPL21;RNASEL;RPS5;EIF4A3;RPL27A;MRPL52;RPL6;RPL27;CHTOP;RPL18;U2AF2;NCBP2
prerank,GO_Biological_Process_2021__potassium ion transport (GO:0006813),0.5903433117963102,1.5639604360504793,0.0,0.47400621860665376,1.0,20/56,14.30%,KCNQ2;PKD2;SLC9C2;KCNJ2;SLC1A3;KCNIP2;KCND3;KCNJ5;HPN;KCNC2;SLC9A1;KCNMB4;KCNK6;KCNK13;KCNN2;SLC9A9;ABCC8;KCNH5;KCNMB3;SLC24A2
prerank,GO_Biological_Process_2021__ribosomal small subunit assembly (GO:0000028),-0.8043062129564301,-1.5629010377472754,0.03773584905660377,0.24517108781680208,1.0,11/14,18.57%,RPS14;RPS15;RPS27;MRPS7;RPS5;MRPS11;LOC102724159;RPS28;RPS27L;RRP7A;RPS19
prerank,GO_Biological_Process_2021__phosphatidylinositol acyl-chain remodeling (GO:0036149),0.868178027912268,1.5628306579958375,0.022727272727272728,0.47508428142404563,1.0,1/8,0.68%,PLA2G4C
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium assembly (GO:0010592),0.7483875630036605,1.5625606386721276,0.02564102564102564,0.46992492395129465,1.0,4/18,8.34%,AVIL;AKIRIN1;WASF2;AUTS2
prerank,GO_Biological_Process_2021__positive regulation of gluconeogenesis (GO:0045722),0.9464114126209546,1.5622302260506828,0.02564102564102564,0.46474290380158895,1.0,2/5,2.51%,PPARGC1A;SIRT1
prerank,PanglaoDB_Augmented_2021__Meningeal Cells,0.6295800746419928,1.5620241928105512,0.03571428571428571,0.4599931608162487,1.0,15/50,15.62%,COL16A1;LRP4;SVEP1;COL5A2;PHLDB1;TIMP3;MAGI1;CDH11;GUCY1A2;RUNX1T1;COL6A1;TJP1;FBXL7;FERMT2;ANTXR1
prerank,GO_Biological_Process_2021__regulation of dendritic spine morphogenesis (GO:0061001),0.6780813490585212,1.5616908685581792,0.0,0.4553606954354846,1.0,11/27,15.82%,CDK5R1;SRCIN1;NLGN1;LRRK2;RELN;SHANK3;PDLIM5;TANC2;PTEN;CAPRIN2;PPFIA2
prerank,GO_Biological_Process_2021__cellular response to heat (GO:0034605),0.6538167677290375,1.56162842040466,0.0,0.449955187764624,1.0,2/31,0.68%,BAG3;POLR2D
prerank,GO_Biological_Process_2021__macromolecule depalmitoylation (GO:0098734),0.9193009175797138,1.560928865216307,0.0,0.44299001337793825,1.0,3/6,6.49%,LYPLAL1;PPT1;ABHD17B
prerank,GO_Biological_Process_2021__protein depalmitoylation (GO:0002084),0.9193009175797138,1.560928865216307,0.0,0.44299001337793825,1.0,3/6,6.49%,LYPLAL1;PPT1;ABHD17B
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion assembly (GO:0051894),0.7997294015626946,1.5605910721455694,0.02702702702702703,0.43920296221171656,1.0,2/13,0.61%,COL16A1;NRP1
prerank,GO_Biological_Process_2021__positive regulation of nitrogen compound metabolic process (GO:0051173),0.8363224287013215,1.5602242907269497,0.02857142857142857,0.4347999665130286,1.0,3/13,7.30%,KLF4;HPN;TNF
prerank,GO_Biological_Process_2021__regulation of cellular catabolic process (GO:0031329),0.6277838854026316,1.5592486852710148,0.0,0.4341169905665822,1.0,8/52,7.92%,ACER2;RRAGD;DAPK2;DEPP1;LRRK2;DDIT3;SCARB2;BOK
prerank,GO_Biological_Process_2021__negative regulation of blood vessel morphogenesis (GO:2000181),0.7134101980387749,1.558992245217305,0.0,0.4301470641393979,1.0,7/36,5.26%,KLF4;YJEFN3;SPRY2;AMOT;SPRED1;PPARG;PTPRM
prerank,GO_Biological_Process_2021__regulation of gluconeogenesis (GO:0006111),0.736059672184733,1.558203767794474,0.046511627906976744,0.42885143113836693,1.0,2/17,2.51%,PPARGC1A;SIRT1
prerank,GO_Biological_Process_2021__epithelial cell morphogenesis (GO:0003382),-0.9198981223334328,-1.5574009933262312,0.0,0.26196741962029424,1.0,2/6,0.86%,COL18A1;CCDC88C
prerank,PanglaoDB_Augmented_2021__Trophoblast Progenitor Cells,-0.730526264264649,-1.5572216271315433,0.0,0.25962679442756487,1.0,23/66,17.04%,TC2N;SIGIRR;ZFP36;JUNB;CD55;CTDSP1;HLA-C;NBEAL2;HLA-F;TYMP;PRKD2;KIAA0040;LITAF;IRF1;TAP1;PIM3;OSTF1;NOD2;HLA-E;IFI35;DEDD2;PARP12;IRF7
prerank,GO_Biological_Process_2021__ribosomal small subunit biogenesis (GO:0042274),-0.7189493977958911,-1.5571656765231283,0.05,0.2567422067297859,1.0,20/36,17.31%,RPS14;RPS15;RPS25;RPS27;RPS24;METTL17;MRPS7;RPS6;RPS7;RPS5;NPM1;MRPS11;LOC102724159;NOB1;RPS28;SURF6;RPS27L;RRP7A;RPS16;EMG1
prerank,GO_Biological_Process_2021__Fc-epsilon receptor signaling pathway (GO:0038095),-0.6700646098976707,-1.556226552026052,0.013333333333333334,0.2570750559236096,1.0,13/97,9.00%,NR4A3;ITK;FOS;PRKCQ;GRAP2;VAV3;PSMB3;FCER1G;BTK;PSMB6;PSMA7;CALM1;PSMB9
prerank,GO_Biological_Process_2021__interleukin-23-mediated signaling pathway (GO:0038155),-0.9433990241583114,-1.555453662229419,0.015873015873015872,0.25671869892155436,1.0,1/6,0.41%,STAT4
prerank,GO_Biological_Process_2021__diol biosynthetic process (GO:0034312),0.8269845510155825,1.5548898290560489,0.061224489795918366,0.4417118341441978,1.0,4/12,10.57%,ACER2;ABCA2;SPTLC2;GCH1
prerank,GO_Biological_Process_2021__positive regulation of isotype switching (GO:0045830),-0.8936090844612484,-1.5547081357812835,0.0,0.2571407200502823,1.0,1/11,1.44%,TFRC
prerank,PanglaoDB_Augmented_2021__Kupffer Cells,-0.6510892386943881,-1.5529779584190984,0.013333333333333334,0.2595536963095515,1.0,40/100,17.07%,JAML;ADGRE1;MNDA;CLEC12A;MS4A4A;MARCO;CHIT1;AIF1;SIGLEC1;CD14;FCER1G;PLTP;NCF4;PLEK;IL10RA;LILRB4;CD300LF;C5AR1;SIRPB2;TNFRSF1B;TYMP;LILRB3;NCF2;SLC11A1;MS4A6A;ITGB2;CSF2RB;HLA-DRA;TYROBP;CSF3R;FTL;HAVCR2;MYO1F;LY86;FPR1;SLC15A3;IGSF6;FCGR3A;IRF7;LST1
prerank,GO_Biological_Process_2021__error-free translesion synthesis (GO:0070987),-0.8053671513012545,-1.552335859709902,0.07936507936507936,0.25927623164815955,1.0,2/19,1.30%,UBC;RPS27A
prerank,GO_Biological_Process_2021__B cell receptor signaling pathway (GO:0050853),-0.8491233208987206,-1.5512383985105362,0.016666666666666666,0.2606823464953387,1.0,4/21,3.54%,ITK;MNDA;VAV3;BTK
prerank,GO_Biological_Process_2021__negative regulation of mononuclear cell migration (GO:0071676),-0.8746554408225489,-1.5509181420043532,0.05,0.2594766864289365,1.0,1/8,1.54%,DUSP1
prerank,GO_Biological_Process_2021__cellular polysaccharide biosynthetic process (GO:0033692),0.8588025366724791,1.549818161471924,0.022222222222222223,0.46333812408279984,1.0,5/11,10.88%,B3GNT2;CSGALNACT1;HS2ST1;FUT9;EXT1
prerank,GO_Biological_Process_2021__fatty-acyl-CoA metabolic process (GO:0035337),0.7268699906723439,1.5495747200287717,0.0,0.4597496632848782,1.0,5/15,20.80%,PPT1;GCDH;FASN;ACACA;SCD5
prerank,PanglaoDB_Augmented_2021__Dopaminergic Neurons,0.605254940937585,1.5494894271392239,0.04,0.45545714359498213,1.0,28/71,21.61%,KCNQ2;CNTN2;SRCIN1;DPYSL5;NCAN;CHD5;NOL4;SNAP91;SMAD3;OLFM3;SNCB;PTPN5;LINGO1;CAMKV;ABCC8;GRIA2;CSRNP3;MAPK4;ATRNL1;NXPH1;BRSK2;PHYHIPL;SYT4;GRIK3;CELF5;CACNA1B;KCNB2;NRXN1
prerank,GO_Biological_Process_2021__phosphatidylethanolamine metabolic process (GO:0046337),0.818471631482198,1.5491550369843545,0.04878048780487805,0.45280179237826385,1.0,4/15,10.72%,ETNPPL;NAPEPLD;CHKA;SELENOI
prerank,GO_Biological_Process_2021__urogenital system development (GO:0001655),0.9228907261073039,1.5489567152630552,0.020833333333333332,0.4489277047213807,1.0,1/5,0.34%,ANXA1
prerank,GO_Biological_Process_2021__regulation of calcium-mediated signaling (GO:0050848),-0.8570830559179755,-1.548719538776619,0.0,0.2644093932722832,1.0,2/16,0.62%,CCL4;CCL3
prerank,GO_Biological_Process_2021__acidic amino acid transport (GO:0015800),0.8317585976885499,1.5481000530798574,0.022727272727272728,0.45055817989350666,1.0,3/11,6.03%,SLC1A3;SLC25A18;SLC1A2
prerank,GO_Biological_Process_2021__regulation of lymphocyte differentiation (GO:0045619),-0.8781475684776777,-1.5480410726044684,0.0,0.2645443503326289,1.0,4/13,2.84%,IL4I1;CD2;IKZF3;PRELID1
prerank,GO_Biological_Process_2021__embryonic limb morphogenesis (GO:0030326),0.7066848124896522,1.5477258554670272,0.0,0.447785786248972,1.0,6/19,13.48%,SALL1;WDPCP;HDAC1;PTCH1;MEGF8;NIPBL
prerank,GO_Biological_Process_2021__response to interferon-gamma (GO:0034341),-0.7462176002105348,-1.5464325010005602,0.015384615384615385,0.2679827473986319,1.0,9/42,6.14%,CCL4;CCL3;GAPDH;CCL5;AIF1;RPL13A;IFITM3;GBP3;SHFL
prerank,PanglaoDB_Augmented_2021__B Cells Memory,-0.6911543624183256,-1.545304609442476,0.012987012987012988,0.2689629430198034,1.0,24/89,9.60%,JAML;NKG7;MYO1G;CD37;ACAP1;MNDA;PYHIN1;CD69;VNN2;IKZF3;SELL;BTK;SLAMF6;AIM2;SNX20;NCF4;LSP1;PLEK;IL10RA;SP140;CYTIP;CD72;P2RY8;BANK1
prerank,GO_Biological_Process_2021__fatty acid oxidation (GO:0019395),0.6490618019676966,1.543690559055122,0.047619047619047616,0.46138014316951,1.0,3/39,1.69%,PPARGC1A;ADIPOR2;ACADS
prerank,GO_Biological_Process_2021__positive regulation of axonogenesis (GO:0050772),0.7103782728068032,1.542261877277518,0.07407407407407407,0.4636916244124426,1.0,18/31,20.63%,PLXNB1;PLXNA2;CHODL;PLXNA3;PLXNB2;ROBO1;PLXNC1;METRN;NTRK2;PLXNA1;MAP3K13;ROBO2;TIAM2;SHTN1;MAP6;SEMA4D;TIAM1;ZFYVE27
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte apoptotic process (GO:0070229),-0.9639277210846349,-1.5419886948093946,0.01818181818181818,0.2790287622745147,1.0,2/6,1.65%,CCL5;PRKCQ
prerank,GO_Biological_Process_2021__ventricular cardiac muscle cell membrane repolarization (GO:0099625),0.9060294408323627,1.5417087184690987,0.025,0.4618397934460473,1.0,2/5,5.43%,KCND3;KCNJ5
prerank,GO_Biological_Process_2021__activin receptor signaling pathway (GO:0032924),0.836181352567026,1.5414299394400923,0.09523809523809523,0.458466039691622,1.0,3/7,5.98%,ACVR2A;SMAD2;SMAD3
prerank,GO_Biological_Process_2021__positive regulation of histone acetylation (GO:0035066),0.7605141407679294,1.540653236952686,0.04878048780487805,0.4571766157090822,1.0,3/19,5.00%,PPARGC1A;RUVBL2;RPS6KA4
prerank,GO_Biological_Process_2021__ribosome assembly (GO:0042255),-0.7206549390855426,-1.5385755072451008,0.017543859649122806,0.2897600316162114,1.0,20/37,13.26%,RPS14;RPL3;RPL23A;RPL5;RPS15;RPS27;RPL10;RPL11;MRPS7;RPL24;RPS5;RPL6;NPM1;RPLP0;EIF2A;MRPS11;LOC102724159;NOP53;TRAF7;RPS28
prerank,GO_Biological_Process_2021__lipid import into cell (GO:0140354),-0.9662525732425922,-1.5383846398463052,0.0,0.28783512350049395,1.0,1/6,0.52%,CD36
prerank,GO_Biological_Process_2021__regulation of cellular biosynthetic process (GO:0031326),0.703280167979087,1.537593070346547,0.07317073170731707,0.46602271173146753,1.0,7/22,4.05%,PRKAB2;AVIL;ADIPOR2;PDK4;SIRT1;MITF;SIRPA
prerank,GO_Biological_Process_2021__negative regulation of B cell receptor signaling pathway (GO:0050859),0.9562860130538936,1.5370434156134616,0.0,0.4637539574078311,1.0,1/5,1.61%,CD22
prerank,GO_Biological_Process_2021__protein deacylation (GO:0035601),0.7663767728413933,1.5367984350389747,0.045454545454545456,0.460259848588702,1.0,6/20,9.84%,SIRT1;LYPLAL1;PPT1;ABHD17B;SIRT6;HDAC1
prerank,GO_Biological_Process_2021__antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),-0.8615398270578436,-1.5365577056218658,0.0,0.29223626445899564,1.0,5/11,7.02%,GNLY;GAPDH;RPL39;RPL30;H2BC21
prerank,GO_Biological_Process_2021__receptor internalization (GO:0031623),-0.7559886634946,-1.5349842109858913,0.03125,0.2962153380310877,1.0,6/37,5.46%,MX2;CD36;MX1;TFRC;FCER1G;LILRB4
prerank,GO_Biological_Process_2021__defense response to virus (GO:0051607),-0.6708443161578291,-1.5349685588969384,0.013157894736842105,0.2934504565569503,1.0,26/82,11.93%,FLNA;MX2;OAS3;MX1;RSAD2;IFI44L;DDIT4;TRIM5;IFIT3;IFIT1;OAS2;PRF1;IFITM3;SHFL;PHB2;NLRC5;EIF2AK2;PLSCR1;IFIT2;OAS1;RNASEL;APOBEC3G;STAT1;IRF1;STING1;MLKL
prerank,PanglaoDB_Augmented_2021__Chromaffin Cells,0.5685103090828916,1.5338969757730472,0.0,0.46962615163021554,1.0,39/91,22.69%,LRP4;CNTN2;SERPINE1;ARNT2;SNAP91;PLPPR4;PCDH17;KCTD16;GRIA4;STX1A;ASXL3;GUCY1A2;PTPRD;TTLL7;RBFOX1;GRIA2;NFASC;CSRNP3;SLC12A2;KALRN;FAM171B;ADGRB3;MAPK4;RAPGEF2;MAP6;PCLO;CRMP1;MAP2;DCLK1;CNTN1;PHYHIPL;SYT4;UNC5D;CACNA1B;SYNPR;NRXN1;LSAMP;RAB3C;OPCML
prerank,MSigDB_Hallmark_2020__TNF-alpha Signaling via NF-kB,-0.6366022640138995,-1.533187983051605,0.0,0.29717707614157823,1.0,41/133,11.78%,CCL4;NR4A3;BCL2A1;CEBPD;SAT1;SLC2A3;FOSL2;PPP1R15A;FOS;ZFP36;CCL5;JUNB;DUSP1;GPR183;IL7R;CD69;GADD45B;BTG2;IER3;SPSB1;BHLHE40;PLEK;EIF1;TNFAIP8;IER2;IFIT2;SGK1;NAMPT;TNFAIP3;OLR1;PFKFB3;CD44;TNFAIP2;CFLAR;LITAF;IRF1;KDM6B;VEGFA;TAP1;BTG1;IFNGR2
prerank,GO_Biological_Process_2021__antiviral innate immune response (GO:0140374),-0.8411229617144065,-1.5331723133817796,0.06666666666666667,0.2944552892413822,1.0,4/9,8.28%,MX1;IFIT1;PHB2;OAS1
prerank,PanglaoDB_Augmented_2021__Glomus Cells,0.5813669939487985,1.5330728696389009,0.03571428571428571,0.46908486290887635,1.0,34/70,24.52%,COL16A1;LRP4;ARNT2;PHLDB1;PLPPR4;MAGI1;CHST1;NUAK1;NTM;SHC2;GUCY1A2;EPAS1;GPC6;COL6A1;FBXL7;ABCC8;FERMT2;NFASC;ANTXR1;TNFRSF1A;MAP6;RBFOX2;CRMP1;DCLK1;PRICKLE2;HTRA1;NR2F1;LIMCH1;PLPP3;DAB2IP;SEMA6D;GPC1;ARHGEF17;LIFR
prerank,GO_Biological_Process_2021__regulation of cellular amine metabolic process (GO:0033238),-0.7305234294114014,-1.5325611246169002,0.0,0.29461959429472123,1.0,16/40,22.96%,PSMB3;ODC1;PSMB6;PSMA7;PSMB9;AZIN1;PSMD12;PSMD8;PSMA5;PSMA3;PSMC4;PSME2;PSME1;PSMB5;PSMC3;PSME3
prerank,GO_Biological_Process_2021__axon extension (GO:0048675),0.7265998795970054,1.5317747799984722,0.0,0.470571775790232,1.0,4/21,9.71%,NRP1;SEMA5A;AUTS2;ALCAM
prerank,GO_Biological_Process_2021__interferon-gamma-mediated signaling pathway (GO:0060333),-0.7316398741910978,-1.5302242294829775,0.01694915254237288,0.30264595983446146,1.0,17/51,11.78%,MT2A;OAS3;HLA-B;TRIM5;B2M;OAS2;HLA-C;HLA-DRB5;TRIM22;HLA-F;OAS1;CD44;GBP2;STAT1;IRF1;HLA-DRA;IFNGR2
prerank,GO_Biological_Process_2021__lipoprotein catabolic process (GO:0042159),0.9122114161178295,1.530075756140799,0.0,0.473919975859301,1.0,3/7,6.49%,LYPLAL1;PPT1;ABHD17B
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in mitochondrial fission (GO:0003374),-0.9260617413735617,-1.529927978893858,0.0,0.2989556359154559,1.0,2/7,1.19%,MX2;MX1
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in membrane fission (GO:0003373),-0.9260617413735617,-1.529927978893858,0.0,0.2989556359154559,1.0,2/7,1.19%,MX2;MX1
prerank,GO_Biological_Process_2021__regulation of neuronal synaptic plasticity (GO:0048168),0.722250328937875,1.5293318301230088,0.07317073170731707,0.4733544147919158,1.0,4/22,7.28%,SYNGR1;NETO1;GRIK2;SHISA9
prerank,PanglaoDB_Augmented_2021__Astrocytes,0.5821884326920463,1.5288517745611239,0.0,0.4711626836863425,1.0,26/100,12.47%,PLXNB1;LGI4;SLC39A12;CNTN2;NCAN;AANAT;PLA2G7;LUZP2;GFAP;SLC1A3;CDH20;PLPPR4;GSTA4;SLC1A2;NTM;GRIA3;CA10;SLC4A4;CADM2;PSD2;GRM5;PTPN5;LCAT;SLC25A46;RBFOX1;NTRK2
prerank,PanglaoDB_Augmented_2021__Dendritic Cells,-0.6362212435018134,-1.5280630319437811,0.0,0.30383678764520144,1.0,22/140,5.49%,CCL4;NR4A3;JAML;ADGRE1;HLA-B;CXCR4;MNDA;VNN2;CLEC12A;AIF1;CD14;FCER1G;SNX20;NCF4;LSP1;HLA-C;PLEK;IL10RA;KMO;LILRB4;CD300LF;HLA-DRB5
prerank,GO_Biological_Process_2021__intracellular lipid transport (GO:0032365),0.8019529311493967,1.52551948572375,0.020833333333333332,0.4845788903253952,1.0,3/15,7.76%,PRKAB2;CPT1A;ACACB
prerank,GO_Biological_Process_2021__response to cadmium ion (GO:0046686),-0.8325639315393079,-1.5254192631455332,0.0,0.31288721844802103,1.0,2/16,1.22%,MT2A;FOS
prerank,GO_Biological_Process_2021__positive regulation of biosynthetic process (GO:0009891),-0.7272958492144388,-1.5251243739845668,0.0,0.31157569996348217,1.0,2/24,1.49%,CD36;CCL5
prerank,GO_Biological_Process_2021__cellular response to epidermal growth factor stimulus (GO:0071364),-0.8071800348770183,-1.5247252982555748,0.029850746268656716,0.31150370492194157,1.0,2/22,1.48%,SYAP1;ZFP36
prerank,GO_Biological_Process_2021__pre-replicative complex assembly (GO:0036388),-0.7223339821280668,-1.5245323874644432,0.0,0.3093225740360601,1.0,20/51,22.96%,UBC;RPS27A;PSMB3;PSMB6;PSMA7;PSMB9;PSMD12;PSMD8;PSMA5;MCM7;UBA52;PSMA3;PSMC4;PSME2;PSME1;MCM6;PSMB5;PSMC3;MCM5;PSME3
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.7747117899430565,-1.5244187778912106,0.046153846153846156,0.3071043276075146,1.0,2/19,1.30%,UBC;RPS27A
prerank,GO_Biological_Process_2021__sphingoid biosynthetic process (GO:0046520),0.8640158001925071,1.522355443801285,0.041666666666666664,0.4912669492561958,1.0,3/9,6.65%,ACER2;ABCA2;SPTLC2
prerank,GO_Biological_Process_2021__sphingosine biosynthetic process (GO:0046512),0.8640158001925071,1.522355443801285,0.041666666666666664,0.4912669492561958,1.0,3/9,6.65%,ACER2;ABCA2;SPTLC2
prerank,GO_Biological_Process_2021__chondroitin sulfate metabolic process (GO:0030204),0.7607178265440793,1.5220785058155133,0.03333333333333333,0.4875215438898336,1.0,6/18,9.98%,NCAN;CHST7;CSGALNACT1;UGDH;CSPG5;CHST15
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase I (GO:0006356),-0.8804234797510081,-1.521600013766757,0.0,0.3165549688201833,1.0,1/12,0.28%,FLNA
prerank,GO_Biological_Process_2021__chromosome condensation (GO:0030261),-0.7477316540553504,-1.5204140416309218,0.05970149253731343,0.31879377023944727,1.0,6/29,8.56%,H1-4;H1-3;H1-2;H1-0;TTN;H1-10
prerank,"GO_Biological_Process_2021__chemical synaptic transmission, postsynaptic (GO:0099565)",0.7835718194559942,1.5187914671739875,0.023809523809523808,0.5005428750641459,1.0,7/14,16.68%,GRID2;INSYN2A;LRRK2;GLRA1;GRIN2B;GSK3B;GRIN2A
prerank,GO_Biological_Process_2021__positive regulation of T-helper 17 type immune response (GO:2000318),-0.9171195747688475,-1.5186428512055596,0.01639344262295082,0.3227430451919934,1.0,2/7,1.70%,PRKCQ;NFKBID
prerank,GO_Biological_Process_2021__positive regulation of glucose transmembrane transport (GO:0010828),-0.7764537165114519,-1.5184661964031063,0.03389830508474576,0.32084805574813313,1.0,2/21,5.56%,NR4A3;IGF1
prerank,GO_Biological_Process_2021__glycolipid metabolic process (GO:0006664),0.6530297720262691,1.51824490404829,0.0,0.49885213818857826,1.0,5/35,5.16%,ARSA;PGAP1;ABCA2;GLB1;ST6GALNAC3
prerank,GO_Biological_Process_2021__negative regulation of reproductive process (GO:2000242),-0.9069978729572409,-1.5181531246429714,0.017241379310344827,0.31948582359297767,1.0,2/6,5.56%,DUSP1;IGF1
prerank,GO_Biological_Process_2021__mammary gland epithelium development (GO:0061180),0.7880281527613142,1.5173306304405492,0.05405405405405406,0.4984214883541128,1.0,4/9,15.47%,SCRIB;ZNF703;ERBB4;AKT2
prerank,GO_Biological_Process_2021__histone H2A-K119 monoubiquitination (GO:0036353),0.9107077778966084,1.5172749963522052,0.05,0.4943348293463044,1.0,1/6,1.33%,RNF2
prerank,GO_Biological_Process_2021__glucose homeostasis (GO:0042593),0.6244128314658833,1.5171839906907632,0.034482758620689655,0.49112355241695343,1.0,9/52,5.72%,LEPR;PPARGC1A;IGF1R;ADIPOR2;PDK4;SIRT1;MCU;PPARG;BACE2
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy (GO:0010611),-0.7836968214903223,-1.5166039950860892,0.015873015873015872,0.32418486984419914,1.0,3/20,5.56%,NR4A3;RGS2;IGF1
prerank,PanglaoDB_Augmented_2021__Glycinergic Neurons,0.6229646885332097,1.5164107656600914,0.029411764705882353,0.48996685302774196,1.0,19/61,14.85%,KCNQ2;CNTN2;NCAN;B4GALNT4;ADGRB2;SNAP91;CSPG5;NGB;BRSK1;PSD2;GRM5;SNCB;CELSR2;PPFIA3;LINGO1;CAMKV;GRIA2;GAD1;LRRC4B
prerank,GO_Biological_Process_2021__autonomic nervous system development (GO:0048483),0.8768494106358478,1.5162139720691181,0.05,0.4872410416383656,1.0,4/6,12.21%,NRP1;SOX4;PHACTR4;NF1
prerank,GO_Biological_Process_2021__B cell proliferation (GO:0042100),0.8188439813250642,1.515915859368055,0.0,0.48554402933051644,1.0,1/9,0.44%,CD180
prerank,GO_Biological_Process_2021__defense response to symbiont (GO:0140546),-0.6737180816204186,-1.5158729315717303,0.0,0.3247907861638123,1.0,25/77,11.93%,FLNA;MX2;OAS3;MX1;RSAD2;IFI44L;DDIT4;TRIM5;IFIT3;IFIT1;OAS2;PRF1;IFITM3;SHFL;NLRC5;EIF2AK2;PLSCR1;IFIT2;OAS1;RNASEL;APOBEC3G;STAT1;IRF1;STING1;MLKL
prerank,GO_Biological_Process_2021__NADH dehydrogenase complex assembly (GO:0010257),-0.7090099427031425,-1.51461370318445,0.046153846153846156,0.3245173671466034,1.0,21/48,18.32%,DMAC1;NDUFC1;NDUFA2;NDUFA1;TMEM126B;NDUFB9;NDUFA12;NDUFB4;TIMM21;NDUFB1;NDUFS8;NDUFS5;BCS1L;OXA1L;NDUFS6;NDUFB7;NUBPL;TMEM126A;NDUFB3;NDUFS7;NDUFA3
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex I assembly (GO:0032981),-0.7090099427031425,-1.51461370318445,0.046153846153846156,0.3245173671466034,1.0,21/48,18.32%,DMAC1;NDUFC1;NDUFA2;NDUFA1;TMEM126B;NDUFB9;NDUFA12;NDUFB4;TIMM21;NDUFB1;NDUFS8;NDUFS5;BCS1L;OXA1L;NDUFS6;NDUFB7;NUBPL;TMEM126A;NDUFB3;NDUFS7;NDUFA3
prerank,GO_Biological_Process_2021__transport along microtubule (GO:0010970),0.82988117940216,1.5144060756310287,0.02702702702702703,0.48797584617155354,1.0,2/12,7.65%,BAG3;COPG1
prerank,GO_Biological_Process_2021__cellular response to interferon-beta (GO:0035458),-0.859972103044158,-1.5136103939538719,0.0,0.3254501729689367,1.0,6/11,10.38%,MNDA;PYHIN1;AIM2;OAS1;STAT1;IRF1
prerank,GO_Biological_Process_2021__regulation of telomere capping (GO:1904353),-0.8293235173345721,-1.5134322648131244,0.017543859649122806,0.32350181713837156,1.0,2/17,1.65%,PKIB;PRKCQ
prerank,GO_Biological_Process_2021__regulation of T-helper 2 cell differentiation (GO:0045628),0.9108969724527892,1.5129203190857887,0.0425531914893617,0.49153122431992535,1.0,1/5,0.34%,ANXA1
prerank,GO_Biological_Process_2021__regulation of cellular amino acid metabolic process (GO:0006521),-0.7209135863847815,-1.5127873533660898,0.0,0.32361538828659564,1.0,16/41,22.96%,PSMB3;ODC1;PSMB6;PSMA7;PSMB9;AZIN1;PSMD12;PSMD8;PSMA5;PSMA3;PSMC4;PSME2;PSME1;PSMB5;PSMC3;PSME3
prerank,GO_Biological_Process_2021__positive regulation of calcium-mediated signaling (GO:0050850),-0.9801223425990324,-1.5124126023654028,0.0,0.32204741865717346,1.0,2/7,0.62%,CCL4;CCL3
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion involved in gastrulation (GO:0070587),0.8838921954283704,1.5112732149548698,0.045454545454545456,0.49170437443510356,1.0,3/5,10.86%,KLF4;MYADM;WNK1
prerank,GO_Biological_Process_2021__negative regulation of heterotypic cell-cell adhesion (GO:0034115),0.8838921954283704,1.5112732149548698,0.045454545454545456,0.49170437443510356,1.0,3/5,10.86%,KLF4;MYADM;WNK1
prerank,GO_Biological_Process_2021__regulation of hydrolase activity (GO:0051336),0.5526289464784775,1.5111672813429442,0.0,0.48814674025416316,1.0,19/55,13.77%,PLXNB1;PLXNA2;RAP1GAP;FGD4;PLXNA3;SCARB2;TBC1D10B;PLXNB2;CRK;PLXNC1;TDG;ARHGAP15;FBXW11;NF1;NTRK2;RABGAP1;PLXNA1;VAV1;PTK2
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),-0.8392539901894828,-1.5092706533474143,0.07272727272727272,0.33277165093456146,1.0,4/13,4.24%,PPP1R15A;DNAJB9;DDRGK1;RACK1
prerank,GO_Biological_Process_2021__melanosome localization (GO:0032400),-0.8502324449958056,-1.5085122030013745,0.03508771929824561,0.32613705613622085,1.0,2/11,5.18%,BBS2;RAB11A
prerank,GO_Biological_Process_2021__pigment granule transport (GO:0051904),-0.8502324449958056,-1.5085122030013745,0.03508771929824561,0.32613705613622085,1.0,2/11,5.18%,BBS2;RAB11A
prerank,GO_Biological_Process_2021__melanosome transport (GO:0032402),-0.8502324449958056,-1.5085122030013745,0.03508771929824561,0.32613705613622085,1.0,2/11,5.18%,BBS2;RAB11A
prerank,GO_Biological_Process_2021__establishment of melanosome localization (GO:0032401),-0.8502324449958056,-1.5085122030013745,0.03508771929824561,0.32613705613622085,1.0,2/11,5.18%,BBS2;RAB11A
prerank,GO_Biological_Process_2021__platelet activating factor metabolic process (GO:0046469),0.8789372597542189,1.508398188265744,0.04,0.4993816541125457,1.0,2/7,1.59%,PLA2G4C;PLA2G7
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species biosynthetic process (GO:1903426),-0.7887066524064912,-1.5081047069851636,0.07407407407407407,0.3251337344156378,1.0,1/15,0.52%,CD36
prerank,GO_Biological_Process_2021__peptide hormone secretion (GO:0030072),0.7881868561888667,1.5080848547089762,0.027777777777777776,0.4972168967397444,1.0,1/12,0.34%,ANXA1
prerank,GO_Biological_Process_2021__regulation of protein modification by small protein conjugation or removal (GO:1903320),0.747754570475778,1.5072201728047137,0.06521739130434782,0.4981355646094439,1.0,1/19,0.03%,EGR1
prerank,GO_Biological_Process_2021__regulation of cytoskeleton organization (GO:0051493),0.5933833313869801,1.5066586931523227,0.03225806451612903,0.4975725476417347,1.0,19/77,18.65%,PLXNB1;PDGFA;HIP1R;CDK10;PHLDB1;TPPP;CRK;MAPK1;TJP1;PTK2;CLASP1;RHOBTB1;GSK3B;IQCJ-SCHIP1;PRKAA1;P2RX7;MARK2;MAP6;TAOK2
prerank,PanglaoDB_Augmented_2021__B Cells Naive,-0.665819773341546,-1.5060425430209,0.0,0.3326216336605477,1.0,26/99,11.27%,JAML;NKG7;MYO1G;CD37;ACAP1;CD2;MNDA;PYHIN1;CD69;VNN2;IKZF3;STAG3;PSTPIP1;SELL;SLAMF6;SNX20;NCF4;PLEK;IL10RA;SP140;CYTIP;CD72;BANK1;ABCB4;NCKAP1L;ITGAL
prerank,GO_Biological_Process_2021__MyD88-dependent toll-like receptor signaling pathway (GO:0002755),-0.7724478740323583,-1.5053946150402575,0.015873015873015872,0.3334836550606998,1.0,5/26,3.54%,CD36;UBC;RPS27A;CD14;BTK
prerank,GO_Biological_Process_2021__positive regulation of chromatin binding (GO:0035563),-0.9006534731447617,-1.5047798149944767,0.01694915254237288,0.3337050917506472,1.0,4/7,6.59%,DDX11;DTX3L;MED25;PARP9
prerank,PanglaoDB_Augmented_2021__Trigeminal Neurons,0.534311782998157,1.50456703172682,0.0,0.5044837372964165,1.0,48/104,22.69%,AVIL;VAMP1;CNTN2;NCAN;ZNF536;GDAP1;SNAP91;SCN3B;PLPPR4;PARM1;DHCR24;KCTD16;GRIA4;CA10;OLFM3;CADM2;GRM5;ASXL3;PTPN5;PTPRD;CCDC92;RBFOX1;GRIA2;NFASC;CSRNP3;PPFIA2;NKAIN2;ADGRB3;MAPK4;GCNT2;PRKX;MAP6;CRMP1;MAP2;DCLK1;PHYHIPL;SYT4;AMER2;NOVA1;CACNA1B;LRFN5;SYNPR;NRXN1;CPNE3;LSAMP;DLG2;RAB3C;OPCML
prerank,PanglaoDB_Augmented_2021__Red Pulp Macrophages,-0.6460072517543282,-1.5042901461576395,0.0273972602739726,0.3336115558004228,1.0,33/81,17.23%,JAML;ADGRE1;MNDA;CLEC12A;MS4A4A;MARCO;AIF1;SIGLEC1;CD14;FCER1G;NCF4;PLEK;LILRB4;CD300LF;C5AR1;SIRPB2;LILRB3;NCF2;SLC11A1;MS4A6A;CSF2RB;TYROBP;CSF3R;FCGR1CP;HAVCR2;CASP5;MYO1F;LY86;FPR1;IGSF6;FCGR3A;LST1;GIMAP4
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.8702535020650093,-1.503935952617142,0.0,0.33283832527856766,1.0,2/10,4.24%,NR4A3;RACK1
prerank,GO_Biological_Process_2021__axon extension involved in axon guidance (GO:0048846),0.7852310059059914,1.5029380901287213,0.075,0.5058001894078854,1.0,2/7,9.71%,NRP1;ALCAM
prerank,GO_Biological_Process_2021__neuron projection extension involved in neuron projection guidance (GO:1902284),0.7852310059059914,1.5029380901287213,0.075,0.5058001894078854,1.0,2/7,9.71%,NRP1;ALCAM
prerank,GO_Biological_Process_2021__midbrain dopaminergic neuron differentiation (GO:1904948),0.897544191108796,1.5013298710956662,0.022222222222222223,0.5121422799711712,1.0,2/5,7.29%,WNT5A;RYK
prerank,PanglaoDB_Augmented_2021__B Cells,-0.6741110102470038,-1.5011531809739864,0.012658227848101266,0.3427723296677921,1.0,29/106,11.27%,JAML;NKG7;MYO1G;CD37;ACAP1;CD2;CXCR4;CD55;CD69;VNN2;IFIT3;PSTPIP1;CD14;SELL;SLAMF6;SNX20;NCF4;LSP1;PLEK;IL10RA;SP140;CYTIP;CD72;P2RY8;BANK1;CSF2RB;NCKAP1L;HLA-DRA;ITGAL
prerank,GO_Biological_Process_2021__positive regulation of telomere capping (GO:1904355),-0.8672797877292732,-1.5008181671384082,0.01818181818181818,0.3421285969018434,1.0,2/12,1.65%,PKIB;PRKCQ
prerank,GO_Biological_Process_2021__positive regulation of osteoblast differentiation (GO:0045669),0.6841865300289919,1.5005455295059125,0.0,0.5129117698083917,1.0,10/25,14.29%,ATRAID;ACVR2A;CTNNBIP1;TMEM119;FBN2;BMPR1B;HGF;BMPR1A;NELL1;FERMT2
prerank,GO_Biological_Process_2021__pyroptosis (GO:0070269),-0.8706744144616566,-1.4993008739048836,0.0,0.3464035236318134,1.0,4/14,4.19%,APIP;NAIP;GZMB;AIM2
prerank,PanglaoDB_Augmented_2021__Choroid Plexus Cells,0.622272552366832,1.49760836085529,0.038461538461538464,0.523673249448259,1.0,14/62,14.09%,SHROOM3;PLXNB1;NEO1;SLC31A1;SCARB2;MAGI1;UNC13B;SHC2;SHANK2;COBL;GPC6;TJP1;ADCY6;CHMP1A
prerank,GO_Biological_Process_2021__quinone biosynthetic process (GO:1901663),0.8084935717909176,1.497150136726357,0.023809523809523808,0.51766258966488,1.0,2/10,4.98%,UBIAD1;COQ9
prerank,GO_Biological_Process_2021__ubiquinone biosynthetic process (GO:0006744),0.8084935717909176,1.497150136726357,0.023809523809523808,0.51766258966488,1.0,2/10,4.98%,UBIAD1;COQ9
prerank,GO_Biological_Process_2021__defense response to bacterium (GO:0042742),-0.6822969451972906,-1.4960885338923238,0.0,0.35874501205516907,1.0,16/54,14.41%,GNLY;OAS3;HAMP;RPL39;NAIP;FCER1G;OAS2;RPL30;H2BC21;OAS1;GBP2;SLC11A1;H2BC11;NOD2;HLA-E;COLEC12
prerank,GO_Biological_Process_2021__epithelial tube morphogenesis (GO:0060562),0.6989030739630757,1.4959389740069815,0.05555555555555555,0.5199169371376026,1.0,3/16,3.46%,SCRIB;PKD2;PKD1
prerank,GO_Biological_Process_2021__dicarboxylic acid transport (GO:0006835),0.8399095136152984,1.4957952729998505,0.05263157894736842,0.5171083014130357,1.0,4/14,6.03%,PDPN;SLC1A3;SLC25A18;SLC1A2
prerank,GO_Biological_Process_2021__cellular response to cadmium ion (GO:0071276),-0.8341220583996787,-1.4956051329734534,0.0,0.3586619884467324,1.0,2/15,1.22%,MT2A;FOS
prerank,GO_Biological_Process_2021__development of primary male sexual characteristics (GO:0046546),0.8504756615530543,1.4953700434019908,0.02564102564102564,0.5152704139550639,1.0,5/10,11.17%,LHFPL2;WNT5A;WNT2B;KITLG;NCOA4
prerank,GO_Biological_Process_2021__mast cell degranulation (GO:0043303),-0.9895586570984931,-1.4949331476323147,0.0,0.3576738380703995,1.0,1/5,0.08%,NR4A3
prerank,GO_Biological_Process_2021__mast cell activation involved in immune response (GO:0002279),-0.9895586570984931,-1.4949331476323147,0.0,0.3576738380703995,1.0,1/5,0.08%,NR4A3
prerank,GO_Biological_Process_2021__negative regulation of biomineral tissue development (GO:0070168),-0.8518907596355328,-1.4945305638877873,0.0,0.3571312126176635,1.0,2/13,0.93%,CCL3;SRGN
prerank,GO_Biological_Process_2021__regulation of response to biotic stimulus (GO:0002831),-0.7742611816096565,-1.4939894814728591,0.029850746268656716,0.35630500949581,1.0,7/26,11.83%,CD36;CD55;TRIM5;DHX58;IRF1;ERAP1;APPL1
prerank,GO_Biological_Process_2021__regulation of dendritic spine development (GO:0060998),0.7406654042296053,1.4935897532717166,0.03333333333333333,0.5213625821836023,1.0,7/19,15.82%,GRIN3A;DLG5;NLGN1;SHANK3;TANC2;ARF6;PPFIA2
prerank,PanglaoDB_Augmented_2021__Trophoblast Stem Cells,0.763763472946952,1.4934724198471574,0.045454545454545456,0.5183515537890558,1.0,1/14,0.04%,SHROOM3
prerank,GO_Biological_Process_2021__regulation of relaxation of cardiac muscle (GO:1901897),-0.9628233671963041,-1.4925449779484175,0.0,0.36074820567953086,1.0,1/5,0.73%,PLN
prerank,GO_Biological_Process_2021__inclusion body assembly (GO:0070841),0.9686063647234302,1.4925361205941443,0.0,0.5196116517264237,1.0,1/5,0.35%,BAG3
prerank,GO_Biological_Process_2021__positive regulation of mitophagy in response to mitochondrial depolarization (GO:0098779),-0.8667470373849347,-1.4923713948476334,0.10638297872340426,0.35887576049282643,1.0,1/7,0.92%,TOMM7
prerank,GO_Biological_Process_2021__ribosomal large subunit assembly (GO:0000027),-0.8232085207516747,-1.492268341216485,0.018867924528301886,0.35685688041277347,1.0,10/17,12.56%,RPL3;RPL23A;RPL5;RPL10;RPL11;RPL24;RPL6;RPLP0;NOP53;TRAF7
prerank,PanglaoDB_Augmented_2021__Osteoclast Precursor Cells,-0.6426630346350285,-1.4909594837771516,0.0,0.3603029256487762,1.0,25/93,11.20%,CCL4;BCL2A1;CCL3;SRGN;MNDA;GPR183;MS4A4A;FCER1G;NCF4;SAMD9L;PLEK;LILRB4;C5AR1;CSF2RA;TNFRSF1B;TNFAIP3;TYMP;GBP2;NCF2;CFLAR;MS4A6A;IRF1;ITGB2;CSF2RB;TYROBP
prerank,PanglaoDB_Augmented_2021__Erythroid-like And Erythroid Precursor Cells,-0.6975567490118257,-1.490827024281289,0.02702702702702703,0.35846984809577875,1.0,22/66,15.33%,NKG7;CD36;RSAD2;MNDA;CD55;VNN2;CLEC12A;GRAP2;BTK;NCF4;TSPAN32;CD300LF;ITGA4;CD44;CSF2RB;CSF3R;CD47;UROS;MYO1F;C19ORF38;FPR1;KLRF1
prerank,GO_Biological_Process_2021__monocarboxylic acid transport (GO:0015718),-0.7558714458608282,-1.4904254496008313,0.0410958904109589,0.3580025131776529,1.0,8/25,14.37%,CD36;SLC51A;ABCC3;SLC16A3;SLC16A7;ABCB4;SLC16A6;ATP8B1
prerank,GO_Biological_Process_2021__pyruvate metabolic process (GO:0006090),-0.7034506902908879,-1.4900305814409782,0.014925373134328358,0.35759673168617473,1.0,7/34,9.55%,NR4A3;ME1;GAPDH;PDHX;SLC16A3;HK2;LDHA
prerank,GO_Biological_Process_2021__xenobiotic transport (GO:0042908),-0.838470700499027,-1.4899582421949666,0.03389830508474576,0.35553987771927675,1.0,4/11,11.64%,SLC7A5;ABCC3;ABCB1;ABCA8
prerank,GO_Biological_Process_2021__actin filament capping (GO:0051693),0.7636490527575821,1.4898825492759398,0.1,0.5255989372541788,1.0,3/16,1.66%,AVIL;EPS8;GSN
prerank,GO_Biological_Process_2021__barbed-end actin filament capping (GO:0051016),0.7636490527575821,1.4898825492759398,0.1,0.5255989372541788,1.0,3/16,1.66%,AVIL;EPS8;GSN
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell membrane repolarization (GO:0099623),-0.8740614550465895,-1.4886997513403293,0.0,0.3591594995383014,1.0,1/12,0.28%,FLNA
prerank,GO_Biological_Process_2021__cellular response to catecholamine stimulus (GO:0071870),-0.7788775426713935,-1.4873642921518997,0.043478260869565216,0.3630606732107017,1.0,1/20,0.08%,NR4A3
prerank,GO_Biological_Process_2021__interleukin-27-mediated signaling pathway (GO:0070106),-0.8428190486643321,-1.4870012541187037,0.05454545454545454,0.3624709040427891,1.0,4/12,9.56%,MX1;OAS2;OAS1;STAT1
prerank,GO_Biological_Process_2021__regulation of B cell differentiation (GO:0045577),-0.8445537356163336,-1.4862222522372357,0.04081632653061224,0.3640419182734333,1.0,3/12,3.54%,IL4I1;IKZF3;BTK
prerank,GO_Biological_Process_2021__phosphatidylserine metabolic process (GO:0006658),-0.7952208454364966,-1.484978894074735,0.03125,0.3675196849823947,1.0,2/19,7.40%,OSBPL5;PLSCR1
prerank,GO_Biological_Process_2021__mast cell mediated immunity (GO:0002448),-0.989555245081956,-1.4835339527140963,0.0,0.37308181399450896,1.0,1/6,0.08%,NR4A3
prerank,GO_Biological_Process_2021__spinal cord development (GO:0021510),0.8508481570655148,1.4834408321401282,0.05128205128205128,0.556366904328391,1.0,5/7,12.21%,PKD2;PKD1;RELN;SOX4;NF1
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor production (GO:0032680),-0.6563629797711157,-1.4833779322435632,0.04285714285714286,0.3714411442546007,1.0,21/76,14.31%,CCL3;OAS3;CD2;ZFP36;NLRC3;CD14;OAS2;CLU;IGF1;GSTP1;TNFAIP3;OAS1;SELENOS;TYROBP;C5AR2;CD47;CYBA;PTPRC;HAVCR2;NOD2;HLA-E
prerank,GO_Biological_Process_2021__chondroitin sulfate biosynthetic process (GO:0030206),0.790898685001578,1.4833442918346587,0.0,0.5529807000708661,1.0,6/14,9.98%,NCAN;CHST7;CSGALNACT1;UGDH;CSPG5;CHST15
prerank,GO_Biological_Process_2021__glucosamine-containing compound metabolic process (GO:1901071),0.8444302584193261,1.4829832724387106,0.025,0.5506016561154201,1.0,5/8,12.99%,CHST7;LARGE1;EXTL2;CHST1;RENBP
prerank,GO_Biological_Process_2021__positive regulation of organelle organization (GO:0010638),0.648584743555934,1.4827099841326965,0.08108108108108109,0.5486522399233654,1.0,2/27,0.34%,PPARGC1A;ANXA1
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion (GO:0022408),0.7050737564622114,1.4826874900392943,0.034482758620689655,0.5455411429209216,1.0,8/23,13.77%,KLF4;MYADM;JAG1;WNK1;FXYD5;GTPBP4;ZNF703;PTK2
prerank,GO_Biological_Process_2021__RIG-I signaling pathway (GO:0039529),-0.9092812798521189,-1.4823716785565149,0.03571428571428571,0.37428552203437415,1.0,2/5,6.40%,OAS3;PHB2
prerank,GO_Biological_Process_2021__secondary alcohol metabolic process (GO:1902652),-0.7499998517257479,-1.4822569353813824,0.09090909090909091,0.37229186421250426,1.0,2/25,0.88%,OSBPL5;CH25H
prerank,GO_Biological_Process_2021__artery development (GO:0060840),0.7663640208078434,1.4816303430402191,0.02702702702702703,0.546952376958898,1.0,7/13,15.51%,NRP1;PKD2;SMAD7;ROBO1;NF1;TGFBR1;ROBO2
prerank,GO_Biological_Process_2021__positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.8361968284238409,1.48154833721745,0.044444444444444446,0.5436580209738389,1.0,4/10,6.06%,ANXA1;FGF2;HDAC9;CIB1
prerank,GO_Biological_Process_2021__regulation of osteoblast differentiation (GO:0045667),0.5811208603904383,1.4815446966168089,0.0,0.5401730336599041,1.0,16/50,14.29%,ATRAID;ACVR2A;CTNNBIP1;PPARG;RANBP3L;TMEM119;FBN2;BMPR1B;TWIST2;HGF;PTCH1;CDK6;BMPR1A;PTK2;NELL1;FERMT2
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.8445270996497117,1.4796073047405978,0.044444444444444446,0.5472218234696351,1.0,2/8,5.72%,ABCA2;BACE2
prerank,GO_Biological_Process_2021__cellular response to nutrient levels (GO:0031669),0.6277183623045932,1.4787526301243894,0.0,0.5488166118277009,1.0,5/44,3.81%,RRAGD;PDK4;MAP1LC3A;SIRT1;LRRK2
prerank,GO_Biological_Process_2021__cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),-0.9519144727756967,-1.4774544034645045,0.0,0.3941451849684135,1.0,1/6,0.52%,CD36
prerank,GO_Biological_Process_2021__negative regulation of plasminogen activation (GO:0010757),0.9060297463083147,1.4772072069167033,0.08571428571428572,0.5551131142840575,1.0,2/5,2.96%,SERPINE1;SERPINE2
prerank,GO_Biological_Process_2021__negative regulation of protein maturation (GO:1903318),0.9040642831271484,1.475844236180259,0.041666666666666664,0.557925235527704,1.0,3/5,8.81%,SERPINE2;LRRK2;SNX12
prerank,GO_Biological_Process_2021__Golgi localization (GO:0051645),0.7756321186146213,1.4753839452719906,0.023809523809523808,0.5570170555458358,1.0,4/11,11.51%,STK25;TBCCD1;COPG1;RIPOR1
prerank,GO_Biological_Process_2021__regulation of podosome assembly (GO:0071801),0.8615033528802555,1.4751010992953695,0.024390243902439025,0.5548493831611297,1.0,3/7,7.30%,GSN;LCP1;TNF
prerank,GO_Biological_Process_2021__positive regulation of signaling receptor activity (GO:2000273),0.6799464217426161,1.4747885186695973,0.05405405405405406,0.5524111529793058,1.0,7/21,10.80%,NRP1;TGFA;NCOA3;RELN;SHANK3;HDAC1;FBXW7
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G1/S phase transition (GO:1902807),0.7274741328070662,1.4747457775371402,0.043478260869565216,0.5491904638321748,1.0,2/21,1.00%,KLF4;PKD2
prerank,GO_Biological_Process_2021__synaptic vesicle membrane organization (GO:0048499),0.7208322739655949,1.474692804917619,0.0851063829787234,0.546302366466825,1.0,5/15,10.74%,SYNGR1;STX11;STX1A;STX2;SNAP23
prerank,GO_Biological_Process_2021__G-quadruplex DNA unwinding (GO:0044806),-0.8820651867467011,-1.4746250716999978,0.03508771929824561,0.40583244460584283,1.0,1/7,0.51%,DDX11
prerank,GO_Biological_Process_2021__regulation of Notch signaling pathway (GO:0008593),0.6115566652738503,1.474588058528743,0.0,0.5435220116385572,1.0,11/50,14.07%,MFNG;MAML2;YJEFN3;RFNG;TSPAN15;JAG1;MAML3;POGLUT1;FBXW7;PRKCI;MMP14
prerank,GO_Biological_Process_2021__modification-dependent macromolecule catabolic process (GO:0043632),-0.8934022653750957,-1.474493342129487,0.03389830508474576,0.40420038854789064,1.0,2/8,1.30%,UBC;RPS27A
prerank,GO_Biological_Process_2021__respiratory electron transport chain (GO:0022904),0.6975981724364684,1.4744692945136744,0.024390243902439025,0.5405574263335337,1.0,2/12,3.49%,PPARGC1A;SLC25A18
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (GO:0002480)",-0.8583850772689339,-1.474359362607871,0.05454545454545454,0.40238358809718994,1.0,4/7,7.77%,HLA-B;B2M;HLA-C;HLA-F
prerank,GO_Biological_Process_2021__inflammatory response (GO:0006954),-0.647758639624571,-1.4743169659965654,0.0,0.4002332200900905,1.0,21/100,11.47%,CCL4;CCL3;FOS;CD96;CXCR4;CCL5;MGLL;AIF1;SIGLEC1;NAIP;CD14;ABCF1;TACR1;C5AR1;OLR1;CD44;CHI3L1;SLC11A1;ITGB2;ITGAL;C5AR2
prerank,GO_Biological_Process_2021__monocyte chemotaxis (GO:0002548),-0.82905439729967,-1.4739010920209823,0.016666666666666666,0.39951887154924964,1.0,3/12,1.49%,CCL4;CCL3;CCL5
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor production (GO:0032760),-0.6931215893277441,-1.4737878923523688,0.03125,0.3977105349923636,1.0,13/50,14.31%,CCL3;OAS3;CD2;CD14;OAS2;CLU;OAS1;TYROBP;CYBA;PTPRC;HAVCR2;NOD2;HLA-E
prerank,GO_Biological_Process_2021__water-soluble vitamin metabolic process (GO:0006767),-0.6683458301231725,-1.4730781031084998,0.06451612903225806,0.39846350633130717,1.0,12/45,20.15%,SLC2A3;VNN2;MTHFD1;CYB5A;FLAD1;SLC25A19;SHMT1;MCCC2;SLC2A1;FOLR2;MMAA;MMAB
prerank,GO_Biological_Process_2021__ganglion development (GO:0061548),0.8390841831595464,1.472602153339713,0.044444444444444446,0.5467820113057337,1.0,2/6,5.40%,NRP1;FZD3
prerank,GO_Biological_Process_2021__membrane repolarization during action potential (GO:0086011),0.815366973803718,1.4725867443807796,0.075,0.5436899173503733,1.0,3/9,4.38%,KCNJ2;KCNIP2;KCND3
prerank,GO_Biological_Process_2021__histone H2A monoubiquitination (GO:0035518),0.791263776026339,1.4718900050332056,0.05263157894736842,0.5442669208984311,1.0,2/15,5.39%,RNF2;RYBP
prerank,PanglaoDB_Augmented_2021__Crypt Cells,0.6393019660472252,1.4716360169885965,0.08571428571428572,0.541933832455159,1.0,11/46,11.62%,HID1;SPON1;AMOT;NEO1;NDRG2;AHCYL2;PBX1;PARM1;SHC2;ASXL3;COBL
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001269),0.8340519237358601,1.4711390038035654,0.043478260869565216,0.5415287147697888,1.0,2/7,10.07%,GSN;LGALS9
prerank,PanglaoDB_Augmented_2021__Alpha Cells,0.5471457734749648,1.4705992090428082,0.05714285714285714,0.5409882913186435,1.0,29/69,23.74%,DEPP1;PLPPR1;NOL4;PLPPR4;PCDH17;MAGI1;GRIA3;SHC2;ASXL3;PTPRD;FXYD5;RUNX1T1;GPC6;ABCC8;CNTN4;NFASC;CSRNP3;SORBS2;PEMT;CNTN3;UCP2;MAP6;PHYHIPL;SYT4;KCNB2;GLS;RAB3C;SEMA6D;FGF14
prerank,GO_Biological_Process_2021__intracellular cholesterol transport (GO:0032367),0.7587555361007818,1.469869348905255,0.075,0.5410108183175072,1.0,2/13,4.97%,LDLR;STARD4
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in axon guidance (GO:1902287),0.8731540798447229,1.4692190755186396,0.05,0.5408946985343849,1.0,5/8,7.75%,PLXNB1;PLXNA2;PLXNA3;PLXNB2;PLXNC1
prerank,GO_Biological_Process_2021__L-glutamate transmembrane transport (GO:0015813),0.8950609061669645,1.4686896060856938,0.041666666666666664,0.5413303104044758,1.0,3/6,6.03%,SLC1A3;SLC25A18;SLC1A2
prerank,GO_Biological_Process_2021__TRAIL-activated apoptotic signaling pathway (GO:0036462),0.9290445573446169,1.4686223105731553,0.04081632653061224,0.5383403598735178,1.0,2/5,4.66%,ZDHHC3;TNFRSF10A
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.7066486142547532,1.4673776269446177,0.07894736842105263,0.541574594430923,1.0,5/23,7.87%,BAG3;ZDHHC3;TNFRSF10A;TNF;SORT1
prerank,PanglaoDB_Augmented_2021__Podocytes,0.5704449247230581,1.4673417361597203,0.047619047619047616,0.5387519832847991,1.0,43/105,24.52%,COL16A1;RASSF8;FKBP9;MYO1D;PHLDB1;RASAL2;DACH1;MAGI1;UNC13B;NUAK1;KITLG;TANC1;KANK1;NFIB;LOXL2;PTPRG;MERTK;ENAH;THSD7A;GOLIM4;TJP1;ADCY6;FERMT2;ANTXR1;COL4A5;STARD13;RAI14;MYO1E;RBFOX2;SNX7;PTPRO;NTN4;PRICKLE2;HTRA1;CTTN;CD2AP;LIMCH1;PLPP3;DAB2IP;MAGI2;CADPS2;ARHGEF17;LIFR
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Blood Brain Barrier),0.5545946671545933,1.4670942630269805,0.027777777777777776,0.5373061863097331,1.0,11/74,7.23%,PLXNB1;LRP4;ZNRF3;MTCL1;GFAP;ARNT2;ADGRB2;SEMA3B;TBC1D16;NUAK1;SALL1
prerank,GO_Biological_Process_2021__striated muscle cell development (GO:0055002),0.8886950033672356,1.4669988142627692,0.11363636363636363,0.5350735539581545,1.0,3/5,8.30%,PGM5;TMOD2;TMOD3
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell action potential (GO:0086014),0.8290067810211239,1.4669820423133149,0.05263157894736842,0.5322666560399769,1.0,3/9,10.99%,SCN3B;KCNJ5;KCNN2
prerank,GO_Biological_Process_2021__regulation of myeloid cell differentiation (GO:0045637),-0.6702570233235463,-1.4669355957439074,0.016129032258064516,0.43051052430376635,1.0,2/48,1.65%,NR4A3;PRKCQ
prerank,GO_Biological_Process_2021__positive regulation of ossification (GO:0045778),0.7248477287214775,1.4668000257999294,0.05555555555555555,0.530085962458742,1.0,13/25,17.67%,ATRAID;ACVR2A;ZBTB16;WNT5A;TMEM119;FBN2;BMPR1B;ANO6;BMPR1A;SLC8A1;NELL1;ADGRV1;P2RX7
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),-0.6861258160855761,-1.4665723894205982,0.03076923076923077,0.43013286176950305,1.0,13/52,14.31%,CCL3;OAS3;CD2;CD14;OAS2;CLU;OAS1;TYROBP;CYBA;PTPRC;HAVCR2;NOD2;HLA-E
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte chemotaxis (GO:0140131),-0.9085070640062743,-1.4641841627940517,0.03773584905660377,0.43960240790161564,1.0,3/10,1.49%,CCL4;CCL3;CCL5
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance (GO:0032206),-0.7177914440764892,-1.463629703033164,0.03389830508474576,0.4396648582250976,1.0,2/25,1.65%,PKIB;PRKCQ
prerank,GO_Biological_Process_2021__regulation of response to cytokine stimulus (GO:0060759),0.7399864937565824,1.4633240154954927,0.027777777777777776,0.5424072036636081,1.0,4/15,8.84%,KLF4;WNT5A;RUNX1;IRAK1
prerank,GO_Biological_Process_2021__gamma-delta T cell activation (GO:0046629),-0.9905347553538908,-1.4632984550889925,0.0,0.43933922911610274,1.0,2/5,0.19%,ITK;JAML
prerank,GO_Biological_Process_2021__long-chain fatty acid import into cell (GO:0044539),-0.9038796960815969,-1.4630724213636335,0.04285714285714286,0.4378615294788796,1.0,1/8,0.52%,CD36
prerank,PanglaoDB_Augmented_2021__Transient Cells,0.5543432710779409,1.462291264617078,0.0,0.5449079891209263,1.0,21/65,13.87%,HID1;PLXNB1;FKBP9;GCLC;RAP1GAP;TSPAN15;MYO1D;MTUS1;DAG1;PARM1;SCARB2;UNC13B;PLXNB2;UNC5B;EPAS1;ITGAV;GNA11;COBL;RTKN;ADCY6;GPR107
prerank,GO_Biological_Process_2021__glycosaminoglycan biosynthetic process (GO:0006024),0.5757874906831134,1.462116041663872,0.07692307692307693,0.5424991963374766,1.0,11/53,6.57%,B3GNT2;HS3ST5;NCAN;CHST7;CSGALNACT1;HS2ST1;B4GALT4;UGDH;CSPG5;B4GALT7;CHST1
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),-0.7490083268473565,-1.4618385105518266,0.017857142857142856,0.44310442906920267,1.0,2/15,5.56%,NR4A3;IGF1
prerank,GO_Biological_Process_2021__mitochondrial fission (GO:0000266),-0.7570880096260371,-1.4618027065329733,0.08771929824561403,0.44086028747477407,1.0,3/15,5.76%,MX2;MX1;FIS1
prerank,GO_Biological_Process_2021__cellular response to hormone stimulus (GO:0032870),-0.671241982034202,-1.4612160379916777,0.014492753623188406,0.44119834357494553,1.0,2/43,3.91%,NR4A3;CTSB
prerank,GO_Biological_Process_2021__positive regulation of cellular protein localization (GO:1903829),-0.6797914354656049,-1.4611054976821274,0.0,0.43936580897209015,1.0,12/48,11.20%,RIC3;TFRC;PYHIN1;DDRGK1;DTX3L;LAMTOR5;PARP9;FYN;ENTR1;GPR137B;VPS28;TYROBP
prerank,GO_Biological_Process_2021__regulation of chromatin binding (GO:0035561),-0.8717782903439719,-1.4610182387136894,0.04918032786885246,0.4374593810706625,1.0,5/9,8.76%,DDX11;DTX3L;MED25;PARP9;BTAF1
prerank,GO_Biological_Process_2021__SMAD protein complex assembly (GO:0007183),0.9078072962272409,1.4601705771657465,0.041666666666666664,0.5499588296617977,1.0,3/5,5.98%,SMAD1;SMAD2;SMAD3
prerank,GO_Biological_Process_2021__positive regulation of ERK1 and ERK2 cascade (GO:0070374),-0.6344524604941897,-1.4596502879873612,0.0,0.44223730215244267,1.0,15/94,9.28%,CCL4;CALCR;CD36;CCL3;CCL5;GPR183;PDGFD;MARCO;GLIPR2;PHB2;C5AR1;MAP3K12;PRKD2;CD44;CHI3L1
prerank,GO_Biological_Process_2021__carnitine shuttle (GO:0006853),0.8663662737679794,1.4594718474980501,0.02127659574468085,0.5508981124055891,1.0,3/8,7.76%,PRKAB2;CPT1A;ACACB
prerank,GO_Biological_Process_2021__apical protein localization (GO:0045176),0.8892168636733261,1.4594224076510671,0.058823529411764705,0.5484317915197094,1.0,1/6,0.04%,SHROOM3
prerank,GO_Biological_Process_2021__regulation of nucleocytoplasmic transport (GO:0046822),-0.8549369352471738,-1.4590364617045861,0.01694915254237288,0.44260711453947227,1.0,1/11,0.35%,MX2
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin protein ligase activity (GO:1904667),-0.926190806504404,-1.458133388148546,0.019230769230769232,0.4456470595277364,1.0,4/5,7.39%,RPL5;RPL11;RPL23;RPS7
prerank,GO_Biological_Process_2021__artery morphogenesis (GO:0048844),0.7709624379296565,1.45695962100745,0.027777777777777776,0.5595026007593699,1.0,7/14,15.21%,NRP1;PKD2;SMAD7;JAG1;NF1;BMPR1A;TGFBR1
prerank,GO_Biological_Process_2021__maintenance of synapse structure (GO:0099558),-0.9058564687985962,-1.4569562431819554,0.01639344262295082,0.44989307360322256,1.0,2/6,6.19%,CHCHD10;RAB3A
prerank,GO_Biological_Process_2021__negative regulation of platelet activation (GO:0010544),0.7705069880521234,1.455973463869927,0.02564102564102564,0.5615183315467183,1.0,2/11,2.96%,PDGFA;SERPINE2
prerank,GO_Biological_Process_2021__zinc ion transmembrane transport (GO:0071577),0.7699288051001276,1.4556800309779636,0.05263157894736842,0.559855117989174,1.0,3/14,5.71%,SLC39A12;SLC39A14;SLC39A8
prerank,GO_Biological_Process_2021__regulation of integrin activation (GO:0033623),-0.8749821808241935,-1.454901101540268,0.014925373134328358,0.4575614586820221,1.0,2/9,5.33%,SKAP1;PLEK
prerank,PanglaoDB_Augmented_2021__His Bundle Cells,0.5931389963870053,1.4537427134287655,0.03571428571428571,0.5664282470677863,1.0,26/64,20.68%,RASSF8;FGF2;PHLDB1;GPR161;PDE10A;MAGI1;NTM;CDH11;PTPRG;GUCY1A2;TACC2;ENAH;RUNX1T1;BMPR1A;FLRT2;TJP1;FBXL7;FERMT2;TYRO3;NFASC;ANTXR1;FARP1;PPFIBP1;SLIT3;ZNF462;NAV1
prerank,GO_Biological_Process_2021__protein heterooligomerization (GO:0051291),0.7089251457686153,1.4536130348307268,0.045454545454545456,0.5640702746490047,1.0,6/15,12.14%,PKD2;PKD1;TMEM120B;KCNC2;GRIN2B;CPSF7
prerank,GO_Biological_Process_2021__positive regulation of T-helper 2 cell cytokine production (GO:2000553),-0.9620083658228654,-1.4535713797276786,0.03225806451612903,0.4605599764664641,1.0,1/5,1.20%,RSAD2
prerank,GO_Biological_Process_2021__regulation of T-helper 2 cell cytokine production (GO:2000551),-0.9620083658228654,-1.4535713797276786,0.03225806451612903,0.4605599764664641,1.0,1/5,1.20%,RSAD2
prerank,GO_Biological_Process_2021__regulation of T cell migration (GO:2000404),-0.8234034106776194,-1.4532115994015236,0.037037037037037035,0.45974551164139366,1.0,5/13,4.08%,RIPOR2;CCL5;AIF1;CD200R1;APOD
prerank,GO_Biological_Process_2021__N-terminal protein amino acid acetylation (GO:0006474),0.7182352740721578,1.453201312952582,0.06060606060606061,0.5632268331996355,1.0,3/12,13.59%,AANAT;NAA20;NAA35
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.8425888364804934,-1.4526295449374387,0.08771929824561403,0.46019044651649027,1.0,2/11,9.70%,TFRC;CD226
prerank,GO_Biological_Process_2021__ganglioside metabolic process (GO:0001573),0.7982117420455617,1.4513509878802862,0.04878048780487805,0.5701146171891052,1.0,4/11,15.06%,ABCA2;ST6GALNAC3;ST6GALNAC5;ST8SIA4
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.6860645818235734,-1.4508629846047374,0.027777777777777776,0.46747605060826597,1.0,16/47,22.96%,ATF5;PSMB3;PSMB6;PSMA7;PSMB9;RBX1;PSMD12;PSMD8;PSMA5;PSMA3;PSMC4;PSME2;PSME1;PSMB5;PSMC3;PSME3
prerank,GO_Biological_Process_2021__negative regulation of erythrocyte differentiation (GO:0045647),-0.966468262676778,-1.4502829812957074,0.0,0.4686287910524262,1.0,1/5,1.48%,ZFP36
prerank,GO_Biological_Process_2021__nucleosome organization (GO:0034728),-0.690414024150877,-1.4497587473693256,0.015873015873015872,0.468977859182563,1.0,12/55,10.59%,H1-4;H1-3;H1-2;POLE3;H1-0;H2BC18;H2BC21;H2BC5;H1-10;H2BC9;SMARCD1;NPM1
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.7178523912257112,-1.4496939371497861,0.0,0.4669157167273257,1.0,12/28,15.88%,HLA-B;B2M;FCER1G;HLA-C;MFSD6;HLA-F;ERAP1;ABCB9;TAP1;HLA-E;ERAP2;SEC13
prerank,GO_Biological_Process_2021__T cell chemotaxis (GO:0010818),-0.938590125250686,-1.4494384899280224,0.017857142857142856,0.4663987629662509,1.0,2/6,1.61%,CCL3;GPR183
prerank,GO_Biological_Process_2021__regulation of trans-synaptic signaling (GO:0099177),0.6667156503463159,1.4492097260071914,0.0,0.5769324744375651,1.0,8/28,5.73%,CACNA1A;GRID2;EIF4EBP2;NLGN1;GRID1;GRIK2;RELN;LRRC4C
prerank,GO_Biological_Process_2021__keratinocyte differentiation (GO:0030216),0.7512356244742027,1.448916202812459,0.030303030303030304,0.5754864396888796,1.0,3/16,6.62%,ANXA1;WNT5A;JAG1
prerank,GO_Biological_Process_2021__magnesium ion transport (GO:0015693),0.8124758865426592,1.4488026597740427,0.0425531914893617,0.5731421942523734,1.0,4/10,8.80%,NIPA2;NIPAL2;NIPA1;SLC41A1
prerank,GO_Biological_Process_2021__insulin receptor signaling pathway (GO:0008286),0.5679834673075246,1.4485716439853686,0.0,0.5719112072484744,1.0,6/48,2.61%,GRB10;FER;IGF1R;PDK4;SLC39A14;GAB1
prerank,GO_Biological_Process_2021__regulation of release of cytochrome c from mitochondria (GO:0090199),-0.6880495779700564,-1.4484152208269654,0.07462686567164178,0.4698307661907489,1.0,9/28,18.04%,PRELID1;TNFSF10;CLU;IGF1;PDCD5;BMF;GPX1;PINK1;FAM162A
prerank,GO_Biological_Process_2021__regulation of histamine secretion by mast cell (GO:1903593),-0.9480977140145039,-1.4483502062554838,0.0,0.46779515866266347,1.0,1/5,2.43%,SNX6
prerank,GO_Biological_Process_2021__N-acetylglucosamine metabolic process (GO:0006044),0.819010635380856,1.4482527375853775,0.05263157894736842,0.570451492425213,1.0,5/10,12.99%,CHST7;LARGE1;EXTL2;CHST1;RENBP
prerank,GO_Biological_Process_2021__negative regulation of leukocyte chemotaxis (GO:0002689),-0.8604854244086773,-1.4482444255304636,0.03278688524590164,0.4659084333584323,1.0,2/7,4.71%,DUSP1;PADI2
prerank,GO_Biological_Process_2021__aromatic amino acid family metabolic process (GO:0009072),-0.909411503313021,-1.4478481000184455,0.13559322033898305,0.465065045019263,1.0,1/5,0.34%,IL4I1
prerank,GO_Biological_Process_2021__regulation of protein deacetylation (GO:0090311),0.8757200945840129,1.447791609278163,0.08888888888888889,0.5696056889578703,1.0,3/5,10.28%,SPRED1;SPRED2;DYRK1A
prerank,GO_Biological_Process_2021__cellular defense response (GO:0006968),-0.7700991840629384,-1.4477303062512106,0.03076923076923077,0.46321019993195267,1.0,6/23,6.88%,ITK;GNLY;MNDA;PRF1;LSP1;C5AR1
prerank,GO_Biological_Process_2021__regulation of Golgi organization (GO:1903358),0.6997761521125545,1.4470248473178984,0.025,0.570259482867658,1.0,5/15,11.38%,RAB33B;MAP2K1;PDE4DIP;RBSN;MAPK1
prerank,GO_Biological_Process_2021__aggrephagy (GO:0035973),-0.6871577615939355,-1.4457983726183927,0.03333333333333333,0.47109814789809457,1.0,6/26,14.82%,UBC;RPS27A;ACBD5;CFTR;DYNC1LI2;UBA52
prerank,GO_Biological_Process_2021__N-terminal peptidyl-methionine acetylation (GO:0017196),0.8183874142961319,1.445472014919026,0.05263157894736842,0.5760710277144434,1.0,1/5,5.00%,NAA20
prerank,GO_Biological_Process_2021__phosphatidylserine acyl-chain remodeling (GO:0036150),-0.8887638419036165,-1.445138117394226,0.046875,0.472093194987046,1.0,1/10,0.49%,OSBPL5
prerank,GO_Biological_Process_2021__establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.6624817783843513,1.444647175553796,0.02702702702702703,0.5772775910762941,1.0,4/24,5.96%,SCRIB;MSN;MTCL1;LIN7A
prerank,GO_Biological_Process_2021__receptor metabolic process (GO:0043112),-0.7254680338298843,-1.4446107629462246,0.046153846153846156,0.4734973558587514,1.0,6/44,5.46%,MX2;CD36;MX1;TFRC;FCER1G;LILRB4
prerank,GO_Biological_Process_2021__pantothenate metabolic process (GO:0015939),-0.9025255355130548,-1.443896395640209,0.07547169811320754,0.4751380439736363,1.0,1/5,1.92%,VNN2
prerank,GO_Biological_Process_2021__cGMP-mediated signaling (GO:0019934),-0.8307547809235868,-1.4436701684266495,0.08771929824561403,0.4739429302835266,1.0,1/8,0.52%,CD36
prerank,GO_Biological_Process_2021__postsynaptic endocytosis (GO:0140239),-0.9296033624991988,-1.44342838860139,0.023255813953488372,0.470272159827834,1.0,2/5,1.19%,MX2;MX1
prerank,GO_Biological_Process_2021__postsynaptic neurotransmitter receptor internalization (GO:0098884),-0.9296033624991988,-1.44342838860139,0.023255813953488372,0.470272159827834,1.0,2/5,1.19%,MX2;MX1
prerank,GO_Biological_Process_2021__positive regulation of actin cytoskeleton reorganization (GO:2000251),0.7197917948143567,1.4433403367571493,0.16666666666666666,0.5811176246439567,1.0,1/12,0.61%,NRP1
prerank,GO_Biological_Process_2021__nucleosome positioning (GO:0016584),-0.9144550660019918,-1.4427959624789608,0.05660377358490566,0.471651793486335,1.0,4/9,3.75%,H1-4;H1-3;H1-2;H1-0
prerank,GO_Biological_Process_2021__regulation of activin receptor signaling pathway (GO:0032925),0.8396787199435106,1.4426122194672886,0.045454545454545456,0.5819371632608669,1.0,3/8,9.38%,ACVR2A;SMAD7;LEMD3
prerank,GO_Biological_Process_2021__NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),-0.8782506532356871,-1.4424962781255704,0.01818181818181818,0.47090242323498444,1.0,3/8,8.03%,NUDT12;PARP9;NAMPT
prerank,PanglaoDB_Augmented_2021__Endothelial Cells,-0.6175643138038505,-1.4423918219340963,0.02631578947368421,0.4691069756834563,1.0,19/77,12.34%,CD36;MYLK;PROCR;SRGN;SLC7A5;CD55;F8;MGLL;CD93;ETS1;PECAM1;SGK1;PCDH12;PTPRB;USHBP1;SPARCL1;ABCA8;A2M;FLT1
prerank,GO_Biological_Process_2021__amino sugar metabolic process (GO:0006040),0.9097565675854434,1.4419843142225577,0.022727272727272728,0.5822830883747334,1.0,3/6,6.70%,CSGALNACT1;EXTL2;GFPT1
prerank,GO_Biological_Process_2021__lipid transport (GO:0006869),-0.6530352481883458,-1.441939086940618,0.038461538461538464,0.4695455395493553,1.0,8/65,4.96%,ABCA9;OSBPL5;CD36;SLC51A;ABCA6;PRELID1;PLTP;ABCC3
prerank,GO_Biological_Process_2021__SREBP signaling pathway (GO:0032933),-0.8963441756237416,-1.4414917122769808,0.07142857142857142,0.46697542972731065,1.0,1/8,0.72%,INSIG1
prerank,GO_Biological_Process_2021__cellular response to sterol depletion (GO:0071501),-0.8963441756237416,-1.4414917122769808,0.07142857142857142,0.46697542972731065,1.0,1/8,0.72%,INSIG1
prerank,GO_Biological_Process_2021__protein-DNA complex assembly (GO:0065004),-0.6248058528623225,-1.4414561009531324,0.014492753623188406,0.46499238031976875,1.0,22/98,14.82%,UBC;RPS27A;XPA;PSMB3;GTF2H5;H2BC18;CENPV;H2BC21;PSMB6;PSMA7;H2BC5;PSMB9;H2BC9;NPM1;RBX1;PSMD12;H2BC11;PSMD8;PSMA5;MCM7;RPA3;UBA52
prerank,GO_Biological_Process_2021__regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.7116494391550712,1.4409245569434863,0.03225806451612903,0.5839582798883377,1.0,6/22,15.21%,ACVR2A;SMAD7;GDF11;BMPR1A;TWSG1;TGFBR1
prerank,GO_Biological_Process_2021__negative regulation of osteoclast differentiation (GO:0045671),-0.7834851851864788,-1.4408801648058647,0.03571428571428571,0.4656000355043129,1.0,4/13,9.06%,CCL3;LILRB4;GPR137B;LILRB3
prerank,PanglaoDB_Augmented_2021__Intercalated Cells,0.6187779692163138,1.4405478930721003,0.030303030303030304,0.5837723261227785,1.0,9/29,17.71%,ESRRG;NPHP1;JAG1;TACC2;CCDC40;ERBB4;MAP3K13;CX3CL1;RSPH3
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.6959130132927762,1.4404464745726888,0.05263157894736842,0.5815795220380693,1.0,2/15,8.59%,HACD2;ELOVL6
prerank,PanglaoDB_Augmented_2021__Microfold Cells,-0.6254853179393668,-1.4402117278823423,0.04054054054054054,0.4664385574068373,1.0,21/80,9.97%,CEBPD;SAT1;OAS3;FOSL2;ZFP36;JUNB;ZMYND15;CD14;CTSB;IER3;TNFSF10;ANKRD22;BHLHE40;ABCC3;HLA-C;GBP3;DTX3L;TYMP;OAS1;TNFAIP2;SSH3
prerank,GO_Biological_Process_2021__positive regulation of B cell proliferation (GO:0030890),-0.7688696905081683,-1.4399482678452273,0.08955223880597014,0.46593600399573243,1.0,7/18,15.77%,TFRC;GPR183;VAV3;NCKAP1L;TNFSF13B;PTPRC;CD74
prerank,PanglaoDB_Augmented_2021__Neuroblasts,0.5732607577745515,1.439861349326962,0.037037037037037035,0.5815778978227749,1.0,31/71,20.28%,KCNQ2;DPYSL5;GRID2;NCAN;SIRT1;B4GALNT4;ADGRB2;NOL4;SNAP91;CNR1;PBX1;CSPG5;ELAVL2;PURG;POU6F2;BRSK1;GRM5;SLC35F1;LINGO1;CAMKV;ERBB4;LRRC4B;CSRNP3;DAB1;MAPK4;BRSK2;MARK2;CRMP1;PPM1E;SYT4;UNC5D
prerank,GO_Biological_Process_2021__establishment or maintenance of apical/basal cell polarity (GO:0035088),0.7306552145277262,1.439570400309785,0.08695652173913043,0.5805529874703077,1.0,6/14,18.36%,SCRIB;MTCL1;PRKCI;PARD3;MARK2;ERBIN
prerank,GO_Biological_Process_2021__regulation of B cell receptor signaling pathway (GO:0050855),0.6863729448346534,1.4395221815297823,0.05405405405405406,0.5778967074654227,1.0,2/17,6.90%,CD22;RUNX1
prerank,GO_Biological_Process_2021__regulation of nucleobase-containing compound metabolic process (GO:0019219),0.857621139597536,1.438684311544663,0.022222222222222223,0.5796018724592715,1.0,1/8,0.47%,PCBP4
prerank,GO_Biological_Process_2021__second-messenger-mediated signaling (GO:0019932),-0.6703765797237379,-1.4384132173859585,0.05970149253731343,0.4719192048660434,1.0,6/44,6.11%,CD36;CCL3;MCTP2;CXCR4;BTK;ACKR4
prerank,GO_Biological_Process_2021__sulfur compound biosynthetic process (GO:0044272),0.5329398588439763,1.4383710435104522,0.0,0.5776473168623483,1.0,11/60,7.66%,B3GNT2;GCLC;NCAN;CHST7;CSGALNACT1;B4GALT4;UGDH;CSPG5;GSTA4;CHST1;HPGDS
prerank,GO_Biological_Process_2021__membrane fusion involved in viral entry into host cell (GO:0039663),-0.909170631948327,-1.4377864706599819,0.018518518518518517,0.47103340467075944,1.0,1/6,1.43%,CXCR4
prerank,GO_Biological_Process_2021__fusion of virus membrane with host plasma membrane (GO:0019064),-0.909170631948327,-1.4377864706599819,0.018518518518518517,0.47103340467075944,1.0,1/6,1.43%,CXCR4
prerank,GO_Biological_Process_2021__negative regulation of receptor binding (GO:1900121),-0.9101419789037193,-1.4375487706090349,0.1016949152542373,0.46797718992545656,1.0,1/5,2.81%,B2M
prerank,GO_Biological_Process_2021__regulation of receptor binding (GO:1900120),-0.9101419789037193,-1.4375487706090349,0.1016949152542373,0.46797718992545656,1.0,1/5,2.81%,B2M
prerank,GO_Biological_Process_2021__carboxylic acid catabolic process (GO:0046395),-0.8904692826408689,-1.4371961632165546,0.04918032786885246,0.46767205947273044,1.0,1/8,0.34%,IL4I1
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell migration (GO:1904754),-0.9745144249563783,-1.436422527502908,0.0,0.4690042967564063,1.0,1/5,0.08%,NR4A3
prerank,GO_Biological_Process_2021__negative regulation of lipid biosynthetic process (GO:0051055),0.6965850189633658,1.436140812486995,0.15625,0.5850297345564559,1.0,4/13,11.26%,ABCA2;ASXL3;FBXW7;ACADVL
prerank,GO_Biological_Process_2021__GPI anchor metabolic process (GO:0006505),0.7087075319504855,1.436084816927676,0.07317073170731707,0.582623842802181,1.0,3/18,1.13%,PIGQ;PIGU;PGAP1
prerank,GO_Biological_Process_2021__positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.8269403865584891,-1.4354077908709362,0.09433962264150944,0.4719146014798469,1.0,4/10,5.78%,H1-0;DDRGK1;IGF1;LAMTOR5
prerank,GO_Biological_Process_2021__negative regulation of response to biotic stimulus (GO:0002832),-0.7948005974009555,-1.435156116016977,0.05,0.4711817913222295,1.0,5/21,8.14%,SIGIRR;CARD16;NLRC3;DHX58;TNFAIP3
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.7099123153441608,-1.4350626590198983,0.08196721311475409,0.46947974453073577,1.0,17/30,22.44%,NDUFC1;NDUFA2;NDUFA1;NDUFB9;NDUFA12;NDUFB4;NDUFB1;NDUFS8;NDUFS5;NDUFS6;NDUFB7;NDUFB3;NDUFS7;NDUFA3;NDUFS2;NDUFA10;NDUFAB1
prerank,GO_Biological_Process_2021__regulation of Cdc42 protein signal transduction (GO:0032489),0.9372096601061302,1.4345479054870343,0.0,0.5871514902562269,1.0,1/6,0.61%,NRP1
prerank,GO_Biological_Process_2021__positive regulation of integrin-mediated signaling pathway (GO:2001046),-0.8895873249111061,-1.434423426438066,0.05555555555555555,0.47066913858874315,1.0,2/6,5.63%,FLNA;CD63
prerank,GO_Biological_Process_2021__canonical Wnt signaling pathway (GO:0060070),0.6708759143794094,1.4341726122798144,0.08571428571428572,0.5867943507089086,1.0,13/30,15.80%,TCF7L1;LRRK2;WNT5A;FZD3;WNT2B;RYK;DVL3;BCL9L;TCF7L2;PTEN;CSNK1E;GSK3B;BCL9
prerank,GO_Biological_Process_2021__monocarboxylic acid biosynthetic process (GO:0072330),-0.6567911993250727,-1.4339168512694933,0.06451612903225806,0.47102991714471826,1.0,4/36,4.89%,CH25H;LIPG;PER2;GATM
prerank,GO_Biological_Process_2021__regulation of chromatin silencing (GO:0031935),-0.8849666193037085,-1.4334725635192558,0.017857142857142856,0.47164690123887126,1.0,4/11,3.75%,H1-4;H1-3;H1-2;H1-0
prerank,GO_Biological_Process_2021__regulation of synapse organization (GO:0050807),0.6972682413765617,1.43322960553448,0.0,0.589125258826365,1.0,8/18,18.25%,WNT5A;ABHD17B;TNF;CTNNA2;PDLIM5;SETD5;IL1RAPL1;NEDD4
prerank,PanglaoDB_Augmented_2021__Microglia,-0.5844091919451385,-1.4330576972701434,0.011627906976744186,0.47118900769433747,1.0,30/134,11.42%,CCL4;JAML;CCL3;FOS;MNDA;GPR183;CLEC12A;MS4A4A;AIF1;SIGLEC1;CD14;FCER1G;CD93;NCF4;LSP1;PLEK;IL10RA;LILRB4;CD300LF;PECAM1;C5AR1;TNFRSF1B;NCF2;MS4A6A;ITGB2;CSF2RB;HLA-DRA;TYROBP;CSF3R;STING1
prerank,GO_Biological_Process_2021__cellular response to copper ion (GO:0071280),-0.9252960170951927,-1.4328633134804323,0.0,0.4702575384960695,1.0,1/6,0.25%,MT2A
prerank,GO_Biological_Process_2021__regulation of mesenchymal cell proliferation (GO:0010464),0.8383998585866301,1.4327280092857608,0.02702702702702703,0.5888715365915436,1.0,4/6,4.48%,PDGFA;TGFBR2;CTNNBIP1;WNT5A
prerank,GO_Biological_Process_2021__glycerophospholipid metabolic process (GO:0006650),0.5714428031283646,1.4326995540718699,0.06060606060606061,0.5863394585478586,1.0,3/47,1.59%,PIGQ;PLA2G4C;PLA2G7
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),-0.8219238773367431,-1.4325596491351809,0.13846153846153847,0.4694070746473294,1.0,3/10,12.68%,CARD16;GSTP1;H2BC11
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion mediated by integrin (GO:0033629),0.8768449795833395,1.4322274987844814,0.02040816326530612,0.5861544966307742,1.0,4/6,10.95%,ACER2;SERPINE1;WNK1;PDE3B
prerank,GO_Biological_Process_2021__electron transport chain (GO:0022900),0.6978731312089588,1.4320688103984665,0.08108108108108109,0.5844642727756306,1.0,1/13,0.24%,PPARGC1A
prerank,GO_Biological_Process_2021__regulation of interleukin-1 production (GO:0032652),0.801036226360826,1.4314181789701934,0.06976744186046512,0.5843428249117819,1.0,3/8,6.50%,ANXA1;SIRPA;TMED10
prerank,GO_Biological_Process_2021__lymphocyte migration (GO:0072676),-0.9297031116358431,-1.4312929390143465,0.03571428571428571,0.4738808964159578,1.0,4/6,1.49%,CCL4;CCL3;MYO1G;CCL5
prerank,GO_Biological_Process_2021__positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.7006839834581782,1.430221410283527,0.05,0.5871030179407651,1.0,6/23,7.30%,EGR1;KLF4;FGF2;PPARG;SMAD3;TNF
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell proliferation (GO:0048661),-0.716697639920848,-1.4302061721121768,0.03636363636363636,0.47683035878253655,1.0,4/29,5.56%,NR4A3;CCL5;AIF1;IGF1
prerank,GO_Biological_Process_2021__potassium ion transmembrane transport (GO:0071805),0.5747556767431337,1.4300841397031263,0.0,0.5855902035133854,1.0,22/63,15.56%,KCNQ2;PKD2;SLC9C2;KCNJ2;SLC1A3;KCNIP2;KCND3;KCNJ5;HPN;SLC12A6;KCNC2;SLC9A1;KCNK6;KCNK13;KCNN2;SLC9A9;SLC12A5;ABCC8;KCNH5;SLC24A2;SLC12A2;ABCB8
prerank,GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),-0.7610808870757895,-1.4289430477820835,0.03076923076923077,0.4808025851164899,1.0,3/15,7.16%,ZFP36;BTG2;POLR2G
prerank,GO_Biological_Process_2021__regulation of T cell apoptotic process (GO:0070232),-0.9441074505711622,-1.428639158267074,0.03773584905660377,0.48035406643548473,1.0,3/5,2.84%,CCL5;PRKCQ;PRELID1
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle hypertrophy (GO:0010613),-0.7912846514228141,-1.4282712814021463,0.04918032786885246,0.48005252170590584,1.0,2/14,5.56%,NR4A3;IGF1
prerank,GO_Biological_Process_2021__regulation of histone acetylation (GO:0035065),0.6609198197041348,1.4282519499514292,0.11428571428571428,0.5923395724534319,1.0,3/26,5.00%,PPARGC1A;RUVBL2;RPS6KA4
prerank,GO_Biological_Process_2021__positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.5639249090715913,1.4282101453332758,0.037037037037037035,0.5898168311228732,1.0,12/54,14.94%,UBE2D1;SMAD7;SAE1;LRRK2;DCUN1D4;LAPTM5;UBE2L3;FBXW7;DCUN1D1;UBA2;XIAP;TRAF6
prerank,GO_Biological_Process_2021__branching involved in blood vessel morphogenesis (GO:0001569),0.8639899312030035,1.4281784249042175,0.13513513513513514,0.5875780327134644,1.0,2/5,1.95%,NRP1;TGFBR2
prerank,GO_Biological_Process_2021__glutamate receptor signaling pathway (GO:0007215),0.6578248893869673,1.427924827733851,0.0,0.5861936423196479,1.0,18/28,21.96%,GRIN3A;CDK5R1;GRID2;GNAQ;GRIK2;CPEB4;GRIA3;GRIA4;GRM5;GRIN2B;GRIA2;GRIN2A;KCNB1;HOMER1;GRM3;GRIK3;GRM1;GRIN1
prerank,GO_Biological_Process_2021__regulation of neuron differentiation (GO:0045664),0.5617165295108498,1.4275626610549526,0.05714285714285714,0.5846132541365093,1.0,13/42,20.12%,CDK5R1;NLGN1;LRRK2;ZC4H2;BRINP3;YWHAG;CNTN4;MMD;MOSMO;BIN1;TIAM1;FGFR1;ZFHX2
prerank,GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),-0.7841416533881325,-1.4273158389056009,0.03225806451612903,0.4825356721931224,1.0,3/13,7.16%,ZFP36;BTG2;POLR2G
prerank,GO_Biological_Process_2021__limb development (GO:0060173),0.6792862778535688,1.4272315179936361,0.09090909090909091,0.5839778401927496,1.0,7/17,13.38%,LRP4;ZNRF3;SALL1;BMPR1B;PTCH1;KAT2A;MEGF8
prerank,GO_Biological_Process_2021__positive regulation of cold-induced thermogenesis (GO:0120162),0.5759520032806524,1.4266015992350312,0.034482758620689655,0.5844814487563752,1.0,7/62,1.53%,PRKAB2;LEPR;ESRRG;PPARGC1A;GRB10;IGF1R;ADIPOR2
prerank,GO_Biological_Process_2021__microtubule bundle formation (GO:0001578),0.6668621336843245,1.4264567137303783,0.05405405405405406,0.58262054769003,1.0,10/23,20.68%,MAP1S;MTCL1;TPPP;TOGARAM1;ZNF207;CCDC40;CLASP1;NCKAP5L;CHP1;NAV1
prerank,GO_Biological_Process_2021__regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.6372809789793461,1.4259981489524427,0.07142857142857142,0.5822059574339385,1.0,6/31,7.30%,EGR1;KLF4;FGF2;PPARG;SMAD3;TNF
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleus (GO:1900180),-0.7325596518114075,-1.4259386236422713,0.03333333333333333,0.4881245120018782,1.0,7/29,6.59%,TFRC;PYHIN1;GLUL;LILRB4;DTX3L;LAMTOR5;PARP9
prerank,MSigDB_Hallmark_2020__Hedgehog Signaling,0.6211253895522716,1.4249035539346429,0.12121212121212122,0.5847966785206281,1.0,6/26,12.21%,NRP1;CDK5R1;AMOT;PTCH1;CDK6;NF1
prerank,GO_Biological_Process_2021__positive chemotaxis (GO:0050918),0.8425409202587648,1.424875127679378,0.06382978723404255,0.5824511615931351,1.0,4/10,4.14%,NRP1;SCRIB;SEMA5A;TSC2
prerank,GO_Biological_Process_2021__axonal fasciculation (GO:0007413),0.7538958886265507,1.4248510146252518,0.038461538461538464,0.580125190640038,1.0,5/11,14.50%,CDK5R1;SEMA5A;RTN4;MEGF8;CNTN4
prerank,GO_Biological_Process_2021__regulation of ketone biosynthetic process (GO:0010566),0.9513987049056633,1.4247801937743005,0.044444444444444446,0.5780697477949522,1.0,1/5,0.03%,EGR1
prerank,GO_Biological_Process_2021__embryonic digit morphogenesis (GO:0042733),0.8192702519458558,1.4246099332172635,0.14583333333333334,0.5762814794036463,1.0,3/8,9.84%,SALL1;WDPCP;HDAC1
prerank,GO_Biological_Process_2021__cellular response to light stimulus (GO:0071482),0.6084795617952743,1.4243220197152153,0.038461538461538464,0.5749564132123683,1.0,7/37,10.90%,ZBTB1;RUVBL2;CASP9;PARP1;EIF2S1;PTPRK;ERCC4
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision (GO:0033683)",-0.7219709663406999,-1.4242923349596799,0.03333333333333333,0.4947290753290273,1.0,5/30,4.34%,UBC;RPS27A;XPA;OGG1;GTF2H5
prerank,GO_Biological_Process_2021__regulation of G protein-coupled receptor signaling pathway (GO:0008277),-0.6684488570023664,-1.424096703666173,0.030303030303030304,0.49359884176273017,1.0,10/51,8.36%,CALCR;DYNLT1;RPGRIP1L;CCL5;MGLL;RGS2;RGS16;PLEK;RGS4;CALM1
prerank,GO_Biological_Process_2021__regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.8593355402075511,-1.4238617332492476,0.06666666666666667,0.49272340220525135,1.0,1/10,0.72%,INSIG1
prerank,GO_Biological_Process_2021__regulation of sister chromatid cohesion (GO:0007063),-0.9249599693916394,-1.423193082337932,0.0784313725490196,0.49395203830246104,1.0,1/6,0.51%,DDX11
prerank,GO_Biological_Process_2021__male gonad development (GO:0008584),0.8178497188352523,1.4231614277865579,0.025,0.5788034496463902,1.0,4/9,11.17%,WNT5A;WNT2B;KITLG;NCOA4
prerank,GO_Biological_Process_2021__regulation of neuron projection development (GO:0010975),0.5222700874097118,1.4231447506173522,0.05555555555555555,0.576539836108445,1.0,43/128,18.96%,AVIL;PTPN9;CDK5R1;SRCIN1;LRRK2;RAP1A;WNT5A;RELN;LRRC4C;CIB1;SCARB2;PLXNB2;KANK1;CTNNA2;BRSK1;SHANK3;FUT9;PDLIM5;NPTN;ZNF804A;TANC2;KNDC1;CSMD3;PTEN;NTRK2;PRKCI;MARK1;DCC;ADCY6;BAG5;FKBP4;GSK3B;PPFIA2;IL1RAPL1;KIF13B;CX3CL1;RAPGEF2;CAMSAP2;BRSK2;MYLIP;MARK2;SCN1B;CRMP1
prerank,GO_Biological_Process_2021__ribonucleoprotein complex assembly (GO:0022618),-0.5928618007236399,-1.4229457272096553,0.05405405405405406,0.4932562614204007,1.0,33/103,17.48%,RPL38;RPS14;RPL3;RPL23A;RPL5;RPS15;RPS27;SNRPD2;RPL10;RPL11;EIF2D;MRPS7;RPL24;SRPK1;RPS5;RPL6;CRNKL1;ZRSR2;RPLP0;MRPS11;LOC102724159;NOP53;GCFC2;TRAF7;DDX23;RPS28;RPS27L;EIF2S2;RRP7A;LSM4;SNRNP200;LUC7L3;PRPF18
prerank,PanglaoDB_Augmented_2021__Mammary Epithelial Cells,-0.7615357271710714,-1.4229333873921048,0.0847457627118644,0.4913179070336023,1.0,6/21,8.80%,BTN3A1;CLDN7;PADI2;PRLR;BTN2A2;OVOL2
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell contraction (GO:0086004),-0.7611979289850921,-1.422852882492709,0.07692307692307693,0.48956766034551935,1.0,8/18,18.55%,PLN;JUP;SRI;FGF13;TRPM4;DSC2;PKP2;AKAP9
prerank,GO_Biological_Process_2021__eosinophil migration (GO:0072677),-0.9779715183764376,-1.4228169711092586,0.018518518518518517,0.48586885798549145,1.0,3/5,1.49%,CCL4;CCL3;CCL5
prerank,GO_Biological_Process_2021__eosinophil chemotaxis (GO:0048245),-0.9779715183764376,-1.4228169711092586,0.018518518518518517,0.48586885798549145,1.0,3/5,1.49%,CCL4;CCL3;CCL5
prerank,GO_Biological_Process_2021__negative regulation of cytokine-mediated signaling pathway (GO:0001960),-0.7209201024609491,-1.4224695468180777,0.10526315789473684,0.48600346832116964,1.0,9/33,8.28%,SIGIRR;OAS3;CARD16;PARP14;PADI2;NR1H2;NLRC5;GSTP1;OAS1
prerank,GO_Biological_Process_2021__proteolysis (GO:0006508),0.49181185442927344,1.421910027270661,0.038461538461538464,0.579364682199937,1.0,12/144,7.06%,CPA1;MMP17;CTSF;DESI2;CTSC;CPM;ATG4C;BACE2;CTSK;HPN;BMP1;FOLH1
prerank,GO_Biological_Process_2021__positive regulation of posttranscriptional gene silencing (GO:0060148),-0.8549479064245447,-1.421719750760368,0.06666666666666667,0.48780257414958367,1.0,1/9,1.48%,ZFP36
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex assembly (GO:0031334),-0.6172280744801516,-1.4203318455767757,0.0125,0.493176579387168,1.0,12/86,6.39%,SKAP1;CD36;TFRC;XPA;WARS1;MPP7;RACK1;GTF2H5;CLU;PLEK;RPS3;MED25
prerank,GO_Biological_Process_2021__positive regulation of muscle hypertrophy (GO:0014742),-0.7922550572625491,-1.420018008722057,0.06451612903225806,0.4928427414980249,1.0,2/13,5.56%,NR4A3;IGF1
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response to antigenic stimulus (GO:0002862),-0.6623026539007827,-1.4195812082443824,0.04477611940298507,0.4926458738982675,1.0,6/52,9.83%,CALCR;YES1;CD247;PRKAR1B;FYN;SELENOS
prerank,GO_Biological_Process_2021__peptidyl-lysine methylation (GO:0018022),0.6804552762879665,1.4194506038905363,0.08571428571428572,0.5886378970197896,1.0,5/17,15.35%,SETD7;VCPKMT;SETD3;SETD2;SETD4
prerank,GO_Biological_Process_2021__regulation of mitochondrial fusion (GO:0010635),-0.9314542043597311,-1.41914241291446,0.015151515151515152,0.49258439005944704,1.0,2/7,1.81%,TFRC;PID1
prerank,GO_Biological_Process_2021__regulation of bicellular tight junction assembly (GO:2000810),0.7196219272479646,1.418993421485039,0.10810810810810811,0.5880709517000391,1.0,4/13,12.87%,NPHP1;RUNX1;TNF;TJP1
prerank,GO_Biological_Process_2021__cellular response to bacterial lipopeptide (GO:0071221),-0.9298794533477873,-1.4186731362692682,0.017241379310344827,0.49299009958127576,1.0,2/5,3.07%,CD36;CD14
prerank,GO_Biological_Process_2021__cellular response to cholesterol (GO:0071397),0.8583999944432714,1.4184502957775964,0.05,0.5891133761901741,1.0,3/6,10.96%,GRAMD1A;GRAMD1C;PTCH1
prerank,GO_Biological_Process_2021__T cell differentiation (GO:0030217),0.702977404045602,1.4184083466012087,0.10810810810810811,0.5870475402796113,1.0,4/23,8.29%,LEPR;ANXA1;LIG4;SOX4
prerank,GO_Biological_Process_2021__skin development (GO:0043588),0.6366118935295945,1.4183470180575912,0.0,0.5848534353353687,1.0,9/30,6.63%,COL5A3;ANXA1;PDGFA;COL5A2;PKD1;WNT5A;FA2H;JAG1;DHCR24
prerank,GO_Biological_Process_2021__regulation of viral genome replication (GO:0045069),-0.6594014024943156,-1.4182010865358121,0.06153846153846154,0.49312702467088226,1.0,16/50,8.67%,PPIE;OAS3;MX1;RSAD2;CCL5;IFIT1;OAS2;IFITM3;SHFL;ILF3;EIF2AK2;PLSCR1;SRPK1;OAS1;RNASEL;APOBEC3G
prerank,GO_Biological_Process_2021__regulation of nuclear division (GO:0051783),0.7716455235749757,1.418029335682454,0.0975609756097561,0.5837338846420647,1.0,3/9,10.82%,BORA;RCC1;CDK13
prerank,GO_Biological_Process_2021__myoblast migration (GO:0051451),0.8842262126370087,1.417516357214641,0.0,0.5843940752891094,1.0,2/6,4.73%,ANXA1;AKIRIN1
prerank,PanglaoDB_Augmented_2021__Hepatic Stellate Cells,0.576684823500899,1.4166412779979316,0.07142857142857142,0.5859548638919778,1.0,13/46,9.97%,COL16A1;TPM2;SVEP1;COL5A2;GFAP;ACTA2;PHLDB1;PPARG;TIMP3;RELN;VCL;CDH11;HGF
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.8170068408192421,1.4166148398650629,0.044444444444444446,0.579303391806467,1.0,2/10,4.53%,PANK3;PANK1
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.8170068408192421,1.4166148398650629,0.044444444444444446,0.579303391806467,1.0,2/10,4.53%,PANK3;PANK1
prerank,GO_Biological_Process_2021__coenzyme A biosynthetic process (GO:0015937),0.8170068408192421,1.4166148398650629,0.044444444444444446,0.579303391806467,1.0,2/10,4.53%,PANK3;PANK1
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell apoptotic process (GO:0033034),0.8922303150354491,1.4165287099311876,0.06976744186046512,0.5775743078485891,1.0,2/6,2.51%,ANXA1;SIRT1
prerank,GO_Biological_Process_2021__positive regulation of cartilage development (GO:0061036),0.8495261076351635,1.4165162303519594,0.06976744186046512,0.5753910443681888,1.0,5/9,9.95%,ZBTB16;BMP1;SOX5;BMPR1B;LOXL2
prerank,GO_Biological_Process_2021__purine ribonucleoside triphosphate metabolic process (GO:0009205),0.7804942204740896,1.4164796921367457,0.05555555555555555,0.5733177218870601,1.0,4/10,13.57%,EFL1;LRRK2;MFN1;AK3
prerank,GO_Biological_Process_2021__negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.7276281824080694,1.415969987979547,0.047619047619047616,0.5728377132120968,1.0,7/23,13.76%,KLF4;PKD2;NACC2;SLFN11;PTEN;CDK6;GPNMB
prerank,GO_Biological_Process_2021__epidermal cell differentiation (GO:0009913),0.6334758868051468,1.4158905359892349,0.07692307692307693,0.5712059234559397,1.0,4/21,9.84%,ANXA1;WNT5A;JAG1;HDAC1
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell migration (GO:1904752),-0.945533971872607,-1.4156274433595966,0.0,0.5037831998789388,1.0,1/8,0.08%,NR4A3
prerank,GO_Biological_Process_2021__chondroitin sulfate catabolic process (GO:0030207),0.8103231956187783,1.4140257585483667,0.045454545454545456,0.5769993172508194,1.0,2/7,5.57%,NCAN;CSPG5
prerank,GO_Biological_Process_2021__response to dsRNA (GO:0043331),0.8060660332577916,1.4138390050303915,0.10869565217391304,0.5755017289141634,1.0,2/7,10.79%,SLC3A2;IRAK3
prerank,GO_Biological_Process_2021__ubiquinone metabolic process (GO:0006743),0.7639642375827598,1.4137926432511256,0.07692307692307693,0.573558497228165,1.0,2/11,4.98%,UBIAD1;COQ9
prerank,GO_Biological_Process_2021__cellular response to interferon-alpha (GO:0035457),-0.9012614642666087,-1.4125187121329597,0.03278688524590164,0.5166982794396966,1.0,1/7,1.60%,PYHIN1
prerank,GO_Biological_Process_2021__positive regulation of calcium ion import (GO:0090280),-0.9703881437956519,-1.4124844796744036,0.0,0.5148395851772825,1.0,2/5,0.62%,CALCR;CCL3
prerank,GO_Biological_Process_2021__dendritic cell chemotaxis (GO:0002407),-0.8887919951891409,-1.4124547765805515,0.01639344262295082,0.5129949187960943,1.0,3/8,1.61%,CXCR4;CCL5;GPR183
prerank,GO_Biological_Process_2021__regulation of T cell mediated immune response to tumor cell (GO:0002840),-0.9207193731233441,-1.4118435081145193,0.05454545454545454,0.5139338645729136,1.0,1/5,0.34%,IL4I1
prerank,GO_Biological_Process_2021__stress-activated protein kinase signaling cascade (GO:0031098),-0.7171091793241632,-1.4116004054121674,0.07246376811594203,0.5133075451881155,1.0,3/27,1.30%,UBC;CCDC88C;RPS27A
prerank,GO_Biological_Process_2021__cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.644596434070724,1.4114025629749516,0.09090909090909091,0.5825098269666978,1.0,4/23,2.61%,ANXA1;NRP1;SPRY2;GAB1
prerank,GO_Biological_Process_2021__tryptophan catabolic process (GO:0006569),-0.8961046993653886,-1.4111834546825472,0.018867924528301886,0.5133650825119233,1.0,2/5,5.45%,IL4I1;KMO
prerank,GO_Biological_Process_2021__negative regulation of T-helper cell differentiation (GO:0045623),0.9441285324151715,1.410455023134516,0.024390243902439025,0.5849540777096719,1.0,2/5,2.59%,ANXA1;SMAD7
prerank,MSigDB_Hallmark_2020__Angiogenesis,0.6366489899623783,1.4103323995806962,0.12121212121212122,0.5834943425794065,1.0,4/19,6.62%,NRP1;PDGFA;COL5A2;JAG1
prerank,GO_Biological_Process_2021__response to organonitrogen compound (GO:0010243),0.670626224759117,1.4101934959773983,0.08823529411764706,0.581865400031152,1.0,9/26,18.00%,RNF139;RCN3;GLRA1;SEL1L;UBXN6;IRAK3;RNF185;IRF5;BRSK2
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex assembly (GO:0033108),-0.6376890405894873,-1.4100980326278942,0.057971014492753624,0.516483263232861,1.0,30/68,22.44%,DMAC1;NDUFC1;NDUFA2;NDUFA1;TMEM126B;NDUFB9;NDUFA12;NDUFB4;TIMM21;NDUFB1;NDUFS8;NDUFS5;BCS1L;COX18;TTC19;OXA1L;NDUFS6;NDUFB7;NUBPL;TMEM126A;NDUFB3;NDUFS7;NDUFA3;SURF1;COX20;UQCC2;NDUFAF6;NDUFS2;NDUFA10;NDUFAB1
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex disassembly (GO:0043243),0.7828868970645644,1.4099751471717117,0.08695652173913043,0.5805624624831597,1.0,2/10,7.30%,IGF1R;TNF
prerank,"GO_Biological_Process_2021__maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.6762728420569106,-1.4098174667132866,0.0967741935483871,0.5160149730447238,1.0,7/24,11.56%,RPS8;RPS21;RPS14;UTP3;WDR46;MRPS11;LOC102724159
prerank,GO_Biological_Process_2021__regulation of integrin-mediated signaling pathway (GO:2001044),-0.8379871238823522,-1.4096073125361923,0.11538461538461539,0.5153582348567766,1.0,2/9,5.63%,FLNA;CD63
prerank,GO_Biological_Process_2021__positive regulation of metabolic process (GO:0009893),0.548591692438537,1.4093867544082777,0.038461538461538464,0.5809670909840331,1.0,7/72,1.53%,PRKAB2;LEPR;ESRRG;PPARGC1A;GRB10;IGF1R;ADIPOR2
prerank,GO_Biological_Process_2021__regulation of protein processing (GO:0070613),0.8267309915908001,1.4079997176059553,0.10256410256410256,0.586087718690931,1.0,5/10,8.81%,RNF139;SERPINE2;LRRK2;RUNX1;SNX12
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),-0.8082469820485965,-1.4079604401310408,0.10526315789473684,0.5229915933739135,1.0,2/8,9.58%,DUSP1;XRCC3
prerank,PanglaoDB_Augmented_2021__Leydig Cells,0.5619778211882055,1.4075431620986092,0.03125,0.5866909216200645,1.0,13/47,13.72%,ESRRG;COL16A1;FKBP9;SVEP1;TIMP3;CDH11;SASH1;TACC2;EPAS1;PTCH1;FAM114A1;TJP1;CXCL14
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.7620216753846041,-1.4072982741344646,0.03278688524590164,0.5241555929509952,1.0,4/19,4.34%,UBC;RPS27A;XPA;GTF2H5
prerank,GO_Biological_Process_2021__negative regulation of transcription by competitive promoter binding (GO:0010944),0.8577122699073725,1.407027474360508,0.05660377358490566,0.5872013342619423,1.0,2/6,6.26%,SMAD7;DACH1
prerank,GO_Biological_Process_2021__lysosome localization (GO:0032418),-0.7623204031202612,-1.4067921369362273,0.06451612903225806,0.5245202508595584,1.0,4/25,10.75%,NR4A3;RAB3A;KXD1;BLOC1S2
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition (GO:0010717),0.6211379853958512,1.4064384395050025,0.03225806451612903,0.5879281996559684,1.0,19/45,15.21%,PDPN;SPRY2;TGFBR2;SMAD7;SPRED1;SPRED2;PHLDB1;USF3;DAG1;SMAD2;SMAD3;HPN;LOXL2;BCL9L;PTEN;ZNF703;FERMT2;CLASP1;TGFBR1
prerank,PanglaoDB_Augmented_2021__Adrenergic Neurons,0.6529898125446126,1.4062460786533064,0.05555555555555555,0.5867193670301246,1.0,5/31,4.25%,HID1;FAAH;RAP1GAP;RNF208;PLPPR1
prerank,GO_Biological_Process_2021__positive regulation of transporter activity (GO:0032411),-0.8814442728006735,-1.4060610410990155,0.038461538461538464,0.5259538952579033,1.0,2/7,7.98%,STK39;SGK1
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine development (GO:0060999),0.682749837499435,1.4058022255778715,0.10256410256410256,0.5866121384688094,1.0,4/18,8.67%,DLG5;NLGN1;RELN;SHANK3
prerank,GO_Biological_Process_2021__positive regulation of biomineral tissue development (GO:0070169),0.7084598933176397,1.4049053164464864,0.0975609756097561,0.5885964553949703,1.0,11/22,17.67%,ATRAID;ACVR2A;TMEM119;FBN2;BMPR1B;ANO6;BMPR1A;SLC8A1;NELL1;ADGRV1;P2RX7
prerank,GO_Biological_Process_2021__positive regulation of hormone metabolic process (GO:0032352),0.9036379888389278,1.4048561474703496,0.0425531914893617,0.5865301923520667,1.0,1/5,0.03%,EGR1
prerank,GO_Biological_Process_2021__regulation of homotypic cell-cell adhesion (GO:0034110),-0.8497706453664791,-1.40482788433537,0.05,0.5302663725023224,1.0,2/10,1.65%,CCL5;PRKCQ
prerank,GO_Biological_Process_2021__regulation of innate immune response (GO:0045088),-0.6553738419350094,-1.4047445470131008,0.028985507246376812,0.5290717512607195,1.0,15/48,16.01%,CCL5;NLRC3;DHX58;CDC37;PARP9;PLSCR1;TNFAIP3;RNASEL;IRF1;TASL;ERAP1;APPL1;HLA-E;IFI35;POLR3C
prerank,GO_Biological_Process_2021__outflow tract septum morphogenesis (GO:0003148),0.7151330266033147,1.4045660302683476,0.10810810810810811,0.585473361644373,1.0,5/16,15.51%,NRP1;TGFBR2;ROBO1;BMPR1A;ROBO2
prerank,GO_Biological_Process_2021__response to prostaglandin E (GO:0034695),-0.8904832473451054,-1.4045497406785048,0.047619047619047616,0.5286340120183335,1.0,1/5,1.03%,TGFBR3
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.8400078721337932,-1.4040602626922678,0.06779661016949153,0.5288207486644805,1.0,4/9,7.47%,CYCS;UQCRB;UQCRH;UQCR10
prerank,GO_Biological_Process_2021__sterol metabolic process (GO:0016125),-0.7219724109520929,-1.4035758007711503,0.05084745762711865,0.5295633584952062,1.0,3/36,0.88%,OSBPL5;INSIG1;CH25H
prerank,GO_Biological_Process_2021__folic acid transport (GO:0015884),0.8785979296985921,1.4035095206104582,0.09523809523809523,0.5878283811465841,1.0,1/5,0.66%,PDPN
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte migration (GO:2000403),-0.7869787034135549,-1.4034628995958505,0.08333333333333333,0.5282031696758407,1.0,2/9,2.67%,CCL5;AIF1
prerank,GO_Biological_Process_2021__response to zinc ion (GO:0010043),-0.763968203952769,-1.4022418746905365,0.08333333333333333,0.5331228531283942,1.0,1/11,0.25%,MT2A
prerank,GO_Biological_Process_2021__inositol phosphate-mediated signaling (GO:0048016),0.7783237539532006,1.4020907400364317,0.13636363636363635,0.5918842964572772,1.0,7/11,18.52%,ADGRB2;NFAT5;PPP3CA;NFATC3;INPP5A;PPP3CB;NFATC2
prerank,GO_Biological_Process_2021__regulation of establishment or maintenance of cell polarity (GO:0032878),-0.7604097564323116,-1.4016627198792675,0.04918032786885246,0.5342099224739377,1.0,3/14,9.33%,RIPOR2;RACK1;LLGL2
prerank,GO_Biological_Process_2021__negative regulation of interleukin-1 production (GO:0032692),-0.758025669135493,-1.4014792796106337,0.015384615384615385,0.5333665797909558,1.0,6/17,8.14%,CARD16;LILRB4;IGF1;GSTP1;NLRP12;TNFAIP3
prerank,GO_Biological_Process_2021__cytokine-mediated signaling pathway (GO:0019221),-0.5494522180791488,-1.4013111511185325,0.0,0.5322554395742153,1.0,72/368,11.39%,CCL4;MT2A;MX2;STAT4;CD36;CCL3;UBC;CEBPD;OAS3;TNFRSF11B;HLA-B;MX1;RSAD2;FOS;RPS27A;CCL5;JUNB;CARD14;XAF1;IL7R;GRAP2;TRIM5;IFIT3;B2M;IFIT1;TNFRSF25;PSMB3;FCER1G;RORA;OAS2;ANXA2;DUOX1;IFITM3;AIM2;HLA-C;IL3RA;IL10RA;F13A1;LILRB4;CD300LF;HLA-DRB5;IL12RB2;TRIM22;RHOU;OSMR;PRLR;PSMB6;PSMA7;FYN;HLA-F;IFIT2;CSF2RA;TNFRSF1B;OAS1;RNASEL;CFL1;TMSB4X;CD44;GBP2;PSMB9;STAT1;EIF5A;IRF1;ITGB2;CSF2RB;HLA-DRA;RPLP0;TNFSF13B;RBX1;VEGFA;HIF1A;CSF3R
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.7152846775391235,1.400901991123221,0.17142857142857143,0.5952269365262038,1.0,2/11,8.59%,HACD2;ELOVL6
prerank,GO_Biological_Process_2021__positive regulation of mast cell activation (GO:0033005),-0.937140949010405,-1.4008970412089754,0.03571428571428571,0.5323946368888948,1.0,1/5,0.08%,NR4A3
prerank,GO_Biological_Process_2021__positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.746447692089646,-1.400873027449954,0.09523809523809523,0.5306906079227452,1.0,4/21,4.35%,NR4A3;SKAP1;PRKCQ;ETS1
prerank,GO_Biological_Process_2021__negative regulation of signaling receptor activity (GO:2000272),-0.7824924863930469,-1.4003080373728751,0.06451612903225806,0.5316468656002149,1.0,4/17,5.46%,CALCR;SNX6;CBLB;LILRB4
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential (GO:0086001),0.6647274770391993,1.4001374274635852,0.08823529411764706,0.5967126218894651,1.0,4/20,5.10%,KCNJ2;KCNIP2;KCND3;SCN3B
prerank,GO_Biological_Process_2021__regulation of tissue remodeling (GO:0034103),0.7915727934664191,1.3985520356472918,0.0,0.6014594537228719,1.0,2/11,6.90%,LEPR;RUNX1
prerank,GO_Biological_Process_2021__protein-DNA covalent cross-linking repair (GO:0106300),0.8797956363967333,1.3984478867878831,0.02040816326530612,0.5995681456053953,1.0,1/5,4.47%,TEX264
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway in response to virus (GO:0039528),-0.8212135097847454,-1.398319005191101,0.07246376811594203,0.539884542003631,1.0,2/8,6.40%,OAS3;PHB2
prerank,GO_Biological_Process_2021__regulation of nuclease activity (GO:0032069),-0.8921741614813026,-1.3977772745697583,0.03773584905660377,0.5403840625930768,1.0,3/5,8.28%,OAS3;OAS2;OAS1
prerank,GO_Biological_Process_2021__intracellular distribution of mitochondria (GO:0048312),0.8167800976484823,1.3974354882280426,0.11904761904761904,0.6027108497555116,1.0,2/5,13.10%,LRRK2;CLUH
prerank,GO_Biological_Process_2021__aorta development (GO:0035904),0.8303858898185276,1.3973717557638763,0.045454545454545456,0.6009965120751946,1.0,3/7,7.38%,PKD2;JAG1;ROBO1
prerank,"GO_Biological_Process_2021__wound healing, spreading of epidermal cells (GO:0035313)",-0.9279980275930128,-1.39726414248716,0.0196078431372549,0.541237579524346,1.0,2/5,3.99%,COL5A1;PLET1
prerank,GO_Biological_Process_2021__positive regulation of smoothened signaling pathway (GO:0045880),0.734706570226348,1.3971544376979572,0.044444444444444446,0.600467235070511,1.0,2/9,4.51%,DLG5;STK36
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomere lengthening (GO:1904358),-0.7128877008009835,-1.3971225649892873,0.029850746268656716,0.5400073856189089,1.0,2/30,1.65%,PKIB;PRKCQ
prerank,GO_Biological_Process_2021__regulation of inflammatory response to antigenic stimulus (GO:0002861),-0.6624000323795547,-1.3970922216135562,0.029850746268656716,0.5382531044193987,1.0,5/52,7.36%,CALCR;YES1;CD247;PRKAR1B;FYN
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase I (GO:0016479),-0.9092063411509524,-1.39657304583311,0.06382978723404255,0.5391641238568634,1.0,1/5,0.28%,FLNA
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),-0.8197553957433042,-1.3963605991755355,0.05172413793103448,0.5380709967184331,1.0,1/12,2.68%,PARP14
prerank,GO_Biological_Process_2021__negative regulation of hydrogen peroxide-induced cell death (GO:1903206),-0.8247226548204222,-1.3962684652630466,0.10526315789473684,0.5366924290633435,1.0,2/9,4.24%,NR4A3;RACK1
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte migration (GO:2000402),-0.8281568261764043,-1.396014370172878,0.06557377049180328,0.5364905069440857,1.0,4/9,4.71%,RIPOR2;CD200R1;APOD;PADI2
prerank,GO_Biological_Process_2021__negative regulation of gene silencing (GO:0060969),-0.8870483066965674,-1.3960137230122265,0.017857142857142856,0.5311256018746449,1.0,4/9,3.75%,H1-4;H1-3;H1-2;H1-0
prerank,GO_Biological_Process_2021__negative regulation of chromatin silencing (GO:0031936),-0.8870483066965674,-1.3960137230122265,0.017857142857142856,0.5311256018746449,1.0,4/9,3.75%,H1-4;H1-3;H1-2;H1-0
prerank,GO_Biological_Process_2021__negative regulation of chromatin organization (GO:1905268),-0.8870483066965674,-1.3960137230122265,0.017857142857142856,0.5311256018746449,1.0,4/9,3.75%,H1-4;H1-3;H1-2;H1-0
prerank,GO_Biological_Process_2021__positive regulation of release of cytochrome c from mitochondria (GO:0090200),-0.7107421055941878,-1.3951471464594514,0.10606060606060606,0.5344579974019081,1.0,5/18,18.04%,TNFSF10;PDCD5;BMF;PINK1;FAM162A
prerank,GO_Biological_Process_2021__regulation of B cell proliferation (GO:0030888),-0.6960073364201373,-1.3949901958247632,0.06944444444444445,0.533434491724222,1.0,9/28,12.82%,TFRC;MNDA;GPR183;VAV3;IKZF3;NCKAP1L;TNFSF13B;TYROBP;PTPRC
prerank,GO_Biological_Process_2021__axon regeneration (GO:0031103),-0.8985566564703911,-1.394787144664293,0.03636363636363636,0.5327324095557244,1.0,1/7,4.08%,APOD
prerank,GO_Biological_Process_2021__response to interleukin-1 (GO:0070555),-0.6842234743668126,-1.394740783787836,0.04477611940298507,0.5313506570287989,1.0,3/40,1.49%,CCL4;CCL3;CCL5
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.7018353607609173,-1.3947072829426526,0.046153846153846156,0.5298642908827607,1.0,4/25,4.34%,UBC;RPS27A;XPA;GTF2H5
prerank,GO_Biological_Process_2021__macromolecule biosynthetic process (GO:0009059),-0.8883623045688486,-1.3944419343109369,0.09259259259259259,0.5295773190196165,1.0,3/5,10.20%,COL5A1;RPS23;SLC11A1
prerank,GO_Biological_Process_2021__positive regulation of T cell cytokine production (GO:0002726),-0.795128350904293,-1.393842255989515,0.07407407407407407,0.5310144562499406,1.0,3/15,2.81%,RSAD2;CD55;B2M
prerank,GO_Biological_Process_2021__response to X-ray (GO:0010165),0.7515019138389553,1.3937676962674113,0.09523809523809523,0.6131780705165366,1.0,5/13,18.27%,ANXA1;LIG4;NIPBL;BLM;IKBIP
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix organization (GO:1903055),0.7389412298023168,1.3937467034902036,0.06666666666666667,0.6113206008534194,1.0,3/11,6.90%,PDPN;SMAD3;RUNX1
prerank,GO_Biological_Process_2021__positive regulation of bone mineralization (GO:0030501),0.7112817914850669,1.3926903771272836,0.09523809523809523,0.6132495694916482,1.0,11/21,17.67%,ATRAID;ACVR2A;TMEM119;FBN2;BMPR1B;ANO6;BMPR1A;SLC8A1;NELL1;ADGRV1;P2RX7
prerank,GO_Biological_Process_2021__negative regulation of proteolysis (GO:0045861),0.684316577505164,1.3924920542591166,0.075,0.6121484364701677,1.0,5/18,13.44%,SERPINE2;LRRK2;TIMP3;SNX12;BAG6
prerank,GO_Biological_Process_2021__regulation of ERK1 and ERK2 cascade (GO:0070372),-0.5796431580979199,-1.3924858561149198,0.05063291139240506,0.5357911318806352,1.0,20/136,9.28%,CCL4;CALCR;CD36;CCL3;APIP;TGFBR3;CCL5;GPR183;PDGFD;MARCO;EPHB1;GLIPR2;SEMA6A;PHB2;GSTP1;C5AR1;MAP3K12;PRKD2;CD44;CHI3L1
prerank,GO_Biological_Process_2021__glutamine metabolic process (GO:0006541),-0.8555021637830689,-1.3922345367578262,0.03225806451612903,0.5353194612675453,1.0,2/7,5.41%,NIT2;GLUL
prerank,GO_Biological_Process_2021__negative regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034128),-0.9108214404093116,-1.3921788679989724,0.02040816326530612,0.533760385548375,1.0,1/5,3.07%,CD14
prerank,GO_Biological_Process_2021__response to growth factor (GO:0070848),0.6369853657988239,1.391612206437713,0.07894736842105263,0.6147616512183632,1.0,4/26,6.06%,KLF4;ACVR2A;TGFBR2;CIB1
prerank,GO_Biological_Process_2021__DNA methylation (GO:0006306),-0.7576383593566326,-1.3906508774440614,0.09836065573770492,0.5395969667502635,1.0,3/16,14.27%,FOS;DNMT1;PICK1
prerank,GO_Biological_Process_2021__negative regulation of mitochondrion organization (GO:0010823),-0.7279464158337865,-1.3905886724464886,0.04918032786885246,0.5381730800360921,1.0,5/20,5.57%,TFRC;PRELID1;CLU;IGF1;SLC25A5
prerank,GO_Biological_Process_2021__regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.5987207202336788,1.3904424035467777,0.03225806451612903,0.6180960075467351,1.0,5/48,5.15%,KLF4;ANXA1;PKD2;PKD1;UBE2E2
prerank,GO_Biological_Process_2021__cell differentiation in hindbrain (GO:0021533),0.8152102903426954,1.3898071414826447,0.023255813953488372,0.6188305669243434,1.0,2/7,9.53%,GRID2;KNDC1
prerank,GO_Biological_Process_2021__membrane fusion (GO:0061025),-0.7571392234263133,-1.3896380506147756,0.034482758620689655,0.5414382767444217,1.0,4/28,6.51%,MX2;MX1;RIMS1;NAPA
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication (GO:0006261),-0.5788623849426862,-1.3895289102109452,0.0375,0.5402384275499973,1.0,29/99,22.17%,UBC;RPS27A;PSMB3;POLE3;PSMB6;PSMA7;PSMB9;PSMD12;PSMD8;PSMA5;DDX23;MCM7;RPA3;UBA52;RECQL5;RFC1;PSMA3;MGME1;PSMC4;WRN;PSME2;PSME1;PRIM1;MCM6;PSMB5;POLG;PSMC3;CDC7;MCM5
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.6466179523046878,1.3894725791858302,0.03125,0.6186632118908294,1.0,6/19,9.98%,NCAN;CHST7;CSGALNACT1;UGDH;CSPG5;CHST15
prerank,GO_Biological_Process_2021__positive regulation of cellular extravasation (GO:0002693),-0.8694610671414429,-1.3890853088427053,0.125,0.5409998605573676,1.0,1/7,0.96%,RIPOR2
prerank,GO_Biological_Process_2021__regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.8383400550408058,-1.388798959937696,0.078125,0.5405221550253373,1.0,2/8,4.08%,CBLB;APOD
prerank,GO_Biological_Process_2021__regulation of protein kinase A signaling (GO:0010738),-0.7805889197771205,-1.3885283031482307,0.10204081632653061,0.5399927778265011,1.0,2/12,6.63%,CALCR;PRKAR1B
prerank,GO_Biological_Process_2021__DNA alkylation (GO:0006305),-0.7739737243212567,-1.3884694371463673,0.0967741935483871,0.5370691563362205,1.0,1/14,1.22%,FOS
prerank,GO_Biological_Process_2021__DNA methylation or demethylation (GO:0044728),-0.7739737243212567,-1.3884694371463673,0.0967741935483871,0.5370691563362205,1.0,1/14,1.22%,FOS
prerank,GO_Biological_Process_2021__regulation of transcription regulatory region DNA binding (GO:2000677),-0.7855253689602372,-1.3878337078308973,0.10344827586206896,0.5385057572317059,1.0,3/12,5.56%,PER2;H1-0;IGF1
prerank,GO_Biological_Process_2021__positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.7262557648621488,1.3877826769722572,0.08823529411764706,0.6253642022797208,1.0,5/15,15.21%,ACVR2A;GDF11;BMPR1A;TWSG1;TGFBR1
prerank,GO_Biological_Process_2021__organophosphate catabolic process (GO:0046434),-0.8972639746237188,-1.3872199464747035,0.017857142857142856,0.5398524011304519,1.0,2/5,8.11%,LIPG;ENPP2
prerank,GO_Biological_Process_2021__mesonephric tubule development (GO:0072164),0.8087705823486071,1.3871017997056452,0.08333333333333333,0.6262290773524254,1.0,3/6,7.23%,PKD2;PKD1;SALL1
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.7485831210900629,-1.3865982887076544,0.13725490196078433,0.5409214986471934,1.0,2/11,6.59%,DTX3L;PARP9
prerank,GO_Biological_Process_2021__regulation of calcium ion-dependent exocytosis (GO:0017158),0.7176310964796989,1.3865491971478832,0.06666666666666667,0.626280915496318,1.0,5/15,19.97%,DOC2A;STX1A;SYT17;KCNB1;SYT4
prerank,PanglaoDB_Augmented_2021__GABAergic Neurons,0.531343733251855,1.3863852141526658,0.047619047619047616,0.6246427720251476,1.0,27/80,17.15%,CNTN2;NCAN;GFAP;ZNF536;SNAP91;PLPPR4;PARM1;CHST1;KCTD16;CA10;OLFM3;KCNC2;CADM2;PSD2;GRM5;SNCB;PTPN5;RBFOX1;NTRK2;ABCC8;GRIA2;GAD1;PPFIA2;NKAIN2;ADGRB3;MAPK4;NXPH1
prerank,GO_Biological_Process_2021__response to unfolded protein (GO:0006986),0.5605779236226921,1.385999564057069,0.0975609756097561,0.6246193270438403,1.0,9/38,17.42%,BAG3;DNAJB2;DDIT3;STT3B;HSPA14;ERP44;HSPD1;TM7SF3;HSPH1
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),-0.7960039963748571,-1.3859763036691253,0.1111111111111111,0.5424133343698149,1.0,2/8,3.88%,SNX6;CBLB
prerank,GO_Biological_Process_2021__granulocyte differentiation (GO:0030851),0.759958405303036,1.3856645914373968,0.08333333333333333,0.6241963976589474,1.0,1/11,3.96%,CBFA2T3
prerank,GO_Biological_Process_2021__sensory perception of chemical stimulus (GO:0007606),-0.8231268850067781,-1.385606571357363,0.11864406779661017,0.5425851107011886,1.0,2/10,6.88%,CD36;C5AR1
prerank,GO_Biological_Process_2021__aromatic amino acid family catabolic process (GO:0009074),-0.8680639635191718,-1.3853595131166507,0.12727272727272726,0.5419824075569752,1.0,2/6,5.45%,IL4I1;KMO
prerank,GO_Biological_Process_2021__positive regulation of B cell activation (GO:0050871),-0.708905385795707,-1.3847488452895123,0.08064516129032258,0.5428723259791821,1.0,9/34,15.77%,TFRC;GPR183;VAV3;BTK;NCKAP1L;TNFSF13B;PTPRC;NOD2;CD74
prerank,PanglaoDB_Augmented_2021__Purkinje Fiber Cells,0.5117664371179674,1.384254418763331,0.030303030303030304,0.6284366479795946,1.0,38/79,22.69%,KCNQ2;CPT1C;CNTN2;GRID2;NCAN;SNAP91;SCN3B;PCDH17;PURG;NTM;GRIA4;CTNNA2;GRIA1;ASXL3;GUCY1A2;PTPN5;PTPRD;SLC35F1;RUNX1T1;RBFOX1;GRIA2;NFASC;CSRNP3;ROBO2;ADGRB3;MAPK4;PNMA2;CRMP1;DCLK1;CNTN1;UNC5D;TMEM132B;NOVA1;CACNA1B;NRXN1;LSAMP;RAB3C;OPCML
prerank,GO_Biological_Process_2021__GTP metabolic process (GO:0046039),0.7192097955110845,1.3842216523347541,0.07894736842105263,0.6265350073819554,1.0,4/12,13.57%,EFL1;LRRK2;MFN1;AK3
prerank,GO_Biological_Process_2021__phosphatidylethanolamine biosynthetic process (GO:0006646),0.8505538071372474,1.3841727476979542,0.06976744186046512,0.62468536792033,1.0,3/9,10.72%,ETNPPL;CHKA;SELENOI
prerank,GO_Biological_Process_2021__neuron projection fasciculation (GO:0106030),0.7474851157715636,1.383837269635142,0.13333333333333333,0.6238338585549453,1.0,4/9,14.50%,CDK5R1;SEMA5A;RTN4;CNTN4
prerank,GO_Biological_Process_2021__regulation of osteoclast differentiation (GO:0045670),-0.7256410870469714,-1.383708361472342,0.03333333333333333,0.5461158906500324,1.0,4/19,9.06%,CCL3;LILRB4;GPR137B;LILRB3
prerank,GO_Biological_Process_2021__homologous chromosome pairing at meiosis (GO:0007129),-0.7980548092343088,-1.3835166333462419,0.09836065573770492,0.5456929161110916,1.0,4/11,9.53%,SYCE2;STAG3;MEI4;IHO1
prerank,GO_Biological_Process_2021__adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),-0.6771680240010653,-1.3832924439647176,0.11428571428571428,0.5452461673604702,1.0,3/42,1.54%,CALCR;ADGRE1;ADGRD1
prerank,GO_Biological_Process_2021__embryonic hemopoiesis (GO:0035162),0.7995245733609658,1.382963355168822,0.1,0.6260151450773817,1.0,2/8,7.17%,TGFBR2;KITLG
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transport (GO:1903170),-0.9109825736497689,-1.382695426578491,0.0784313725490196,0.5458527522047973,1.0,1/6,0.73%,PLN
prerank,GO_Biological_Process_2021__negative regulation of bone mineralization (GO:0030502),-0.8864648559444156,-1.3825150473604058,0.061224489795918366,0.5449630528836441,1.0,2/7,0.93%,CCL3;SRGN
prerank,GO_Biological_Process_2021__regulation of cell cycle checkpoint (GO:1901976),0.787865084658266,1.3817582679384088,0.14285714285714285,0.6301025211848524,1.0,2/6,18.66%,FEM1B;RFWD3
prerank,GO_Biological_Process_2021__Fc receptor signaling pathway (GO:0038093),-0.6025248330850042,-1.381573473654648,0.027777777777777776,0.5476815376893348,1.0,12/96,9.00%,ITK;FOS;PRKCQ;GRAP2;VAV3;PSMB3;FCER1G;BTK;PSMB6;PSMA7;CALM1;PSMB9
prerank,GO_Biological_Process_2021__histone H3-K36 methylation (GO:0010452),0.8200563652129532,1.3815246663083516,0.1111111111111111,0.629046470021749,1.0,3/5,14.78%,SETD3;SETD2;SETD5
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin protein ligase activity (GO:1904668),0.7829124209308309,1.3815170664949168,0.13333333333333333,0.6270238125618719,1.0,4/8,11.81%,FZR1;CDC14B;BTRC;PTEN
prerank,GO_Biological_Process_2021__phospholipid dephosphorylation (GO:0046839),0.5997535594560817,1.3811186028760574,0.06451612903225806,0.6271099208131004,1.0,7/28,17.59%,PLPPR1;PLPP1;PLPP5;PLPPR4;PTEN;MTMR9;PIP4P2
prerank,GO_Biological_Process_2021__acute-phase response (GO:0006953),-0.9087783510677667,-1.3809783096926693,0.03571428571428571,0.5488479828910064,1.0,2/5,7.40%,SIGIRR;PLSCR1
prerank,GO_Biological_Process_2021__positive regulation of growth (GO:0045927),0.5447658424400782,1.3807027959805747,0.13043478260869565,0.6267312334937171,1.0,12/48,22.55%,CDKN2AIP;CIB1;HPN;TAF9B;MMP14;TGFBR1;MTPN;DDX3X;PPM1F;CSNK2A1;MFSD2A;ADAM10
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomerase (GO:0032212),-0.720137230855054,-1.3802396344262333,0.03125,0.5513569001737498,1.0,2/28,1.65%,PKIB;PRKCQ
prerank,GO_Biological_Process_2021__peptidyl-lysine monomethylation (GO:0018026),0.7478125533807212,1.3800015144653168,0.075,0.6284759730151264,1.0,4/9,15.35%,SETD7;SETD3;SETD2;SETD4
prerank,GO_Biological_Process_2021__vascular endothelial growth factor signaling pathway (GO:0038084),0.7625608474791765,1.3799703102559338,0.061224489795918366,0.6265961356381727,1.0,2/8,2.61%,NRP1;GAB1
prerank,GO_Biological_Process_2021__interstrand cross-link repair (GO:0036297),-0.6827485617651845,-1.3794519042891822,0.1095890410958904,0.5535662289594958,1.0,9/35,14.82%,UBC;RPS27A;XPA;MUS81;XRCC3;WDR48;RPA3;FANCB;UBA52
prerank,GO_Biological_Process_2021__regulation of lens fiber cell differentiation (GO:1902746),0.8954066112815677,1.3793747809211727,0.07017543859649122,0.6276405030809882,1.0,4/5,3.94%,SPRY2;FGF2;SPRED1;SPRED2
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA destabilization (GO:0061158),-0.8481292143110679,-1.3791103723751,0.08196721311475409,0.5534923043136895,1.0,1/11,1.48%,ZFP36
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species biosynthetic process (GO:1903428),-0.890564205372392,-1.3788763366237333,0.03571428571428571,0.5527758165559298,1.0,1/5,0.52%,CD36
prerank,GO_Biological_Process_2021__positive regulation of interleukin-17 production (GO:0032740),-0.8138101185387543,-1.3786947335429163,0.09836065573770492,0.5521917882630205,1.0,3/12,4.14%,SLC7A5;PRKCQ;SLAMF6
prerank,GO_Biological_Process_2021__response to iron ion (GO:0010039),-0.8060765152174668,-1.3783198093722342,0.0967741935483871,0.5523782555400515,1.0,3/9,11.34%,HAMP;B2M;HIF1A
prerank,GO_Biological_Process_2021__regulation of fertilization (GO:0080154),0.8801590244473875,1.3781760879628682,0.06521739130434782,0.6314668046377871,1.0,1/5,0.84%,LHFPL2
prerank,GO_Biological_Process_2021__coenzyme A metabolic process (GO:0015936),0.7973486796731362,1.3780574836155661,0.06666666666666667,0.6298618482214704,1.0,2/12,4.53%,PANK3;PANK1
prerank,GO_Biological_Process_2021__global genome nucleotide-excision repair (GO:0070911),-0.7233533448843719,-1.3770565173800953,0.078125,0.5577897179147565,1.0,4/23,4.34%,UBC;RPS27A;XPA;GTF2H5
prerank,GO_Biological_Process_2021__negative regulation of fibroblast proliferation (GO:0048147),-0.8075011628324278,-1.3766453825650582,0.03773584905660377,0.5579078385828508,1.0,5/15,6.85%,FTH1;NLRC3;EMD;MED25;GSTP1
prerank,GO_Biological_Process_2021__T cell migration (GO:0072678),-0.8127237987810458,-1.3762368428158518,0.12903225806451613,0.5583547411223899,1.0,3/9,1.61%,CCL3;MYO1G;GPR183
prerank,GO_Biological_Process_2021__muscle tissue development (GO:0060537),0.8166373532848521,1.3761885502070248,0.07692307692307693,0.6369596696237648,1.0,4/6,12.21%,PGM5;POGLUT1;PTCH1;NF1
prerank,GO_Biological_Process_2021__regulation of neurotransmitter transport (GO:0051588),-0.8075927557145852,-1.3757153892756646,0.12162162162162163,0.5598351143571875,1.0,2/12,1.34%,MCTP2;RIMS1
prerank,GO_Biological_Process_2021__positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.7132143041482284,-1.3755799723000735,0.09230769230769231,0.558661227295028,1.0,5/17,18.97%,RPS3;PRKD2;CD226;PTPRC;TESPA1
prerank,GO_Biological_Process_2021__regulation of cholesterol esterification (GO:0010872),0.8266889871185555,1.3754500364043871,0.027777777777777776,0.6377693922669508,1.0,2/7,4.97%,ABCA2;STARD4
prerank,GO_Biological_Process_2021__negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.60360227451897,1.3750546214720802,0.05263157894736842,0.6374046585099545,1.0,6/31,5.20%,DUSP6;SPRY2;SPRED1;SPRED2;SIRPA;TIMP3
prerank,GO_Biological_Process_2021__nucleotide-sugar biosynthetic process (GO:0009226),0.6971769913741003,1.3740911730890684,0.09523809523809523,0.6402010770734748,1.0,6/16,13.68%,GNPNAT1;UGDH;GFPT1;SLC35D1;RENBP;NANS
prerank,GO_Biological_Process_2021__regulation of adaptive immune response (GO:0002819),-0.7900793846028988,-1.3736627347766204,0.0625,0.5669908910693473,1.0,2/13,0.40%,IL4I1;SKAP1
prerank,GO_Biological_Process_2021__platelet aggregation (GO:0070527),-0.684641835098914,-1.3726627719100464,0.07692307692307693,0.5705377572720509,1.0,8/27,14.58%,FLNA;PLEK;ACTG1;FERMT3;MYL12A;ACTB;PIK3CB;TLN1
prerank,GO_Biological_Process_2021__adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),-0.611898955043755,-1.3724665128834377,0.06756756756756757,0.5699426683988562,1.0,6/67,3.46%,CALCR;ADGRE1;CHRM2;ADGRD1;MARCO;RGS1
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via nonhomologous end joining (GO:2001032),-0.6961196263748688,-1.3723057173877915,0.08771929824561403,0.5690770216688152,1.0,3/21,8.09%,DTX3L;PARP9;CYREN
prerank,GO_Biological_Process_2021__negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.6405155461879583,-1.372233185678367,0.041666666666666664,0.5677444570699063,1.0,17/50,22.96%,PSMB3;PSMB6;PSMA7;PSMB9;RBX1;NABP1;PSMD12;PSMD8;PSMA5;CHFR;PSMA3;PSMC4;PSME2;PSME1;PSMB5;PSMC3;PSME3
prerank,GO_Biological_Process_2021__regulation of NLRP3 inflammasome complex assembly (GO:1900225),-0.8270679476158781,-1.371416079306866,0.13846153846153847,0.5698370435014762,1.0,3/9,6.90%,CD36;NLRC3;EIF2AK2
prerank,GO_Biological_Process_2021__pharyngeal system development (GO:0060037),0.8384280531397542,1.3709399725257962,0.11627906976744186,0.6517526928701275,1.0,3/5,15.21%,PTCH1;BMPR1A;TGFBR1
prerank,GO_Biological_Process_2021__negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.6245730030907917,1.3708528487964724,0.16279069767441862,0.6500774734409733,1.0,3/18,7.80%,RAP1GAP;CDK10;KANK1
prerank,GO_Biological_Process_2021__cellular response to inorganic substance (GO:0071241),-0.7508601180681602,-1.3707216780667142,0.07142857142857142,0.5715472933413793,1.0,1/14,0.51%,DDX11
prerank,GO_Biological_Process_2021__regulation by virus of viral protein levels in host cell (GO:0046719),-0.8505645347119697,-1.370100226656236,0.10714285714285714,0.5730754575201308,1.0,4/7,12.16%,DYNLT1;IFIT1;STAT1;TBC1D20
prerank,GO_Biological_Process_2021__aspartate family amino acid biosynthetic process (GO:0009067),-0.8905318685888883,-1.3686129867370174,0.01694915254237288,0.5782044443209772,1.0,1/6,3.80%,MTHFD1
prerank,GO_Biological_Process_2021__positive regulation of vasculogenesis (GO:2001214),0.7917493174750095,1.368170676805757,0.15217391304347827,0.6611922854659801,1.0,2/5,6.25%,RAP1A;RIN2
prerank,GO_Biological_Process_2021__negative regulation of intracellular protein transport (GO:0090317),-0.7052763068057099,-1.3680027688832572,0.08823529411764706,0.5796072295782024,1.0,3/19,4.08%,INSIG1;MDFIC;APOD
prerank,GO_Biological_Process_2021__negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665),-0.9610073872176066,-1.3676614761236334,0.03636363636363636,0.5792197469618149,1.0,2/5,1.78%,SIGIRR;CARD16
prerank,GO_Biological_Process_2021__cell morphogenesis involved in neuron differentiation (GO:0048667),0.5314415574602592,1.367417149514711,0.09375,0.6626185151961966,1.0,22/57,19.59%,LRP4;SLITRK5;MAP1S;RAB10;PLPPR4;TMEM106B;RYK;CTNNA2;BRSK1;BTBD3;KLF7;CELSR2;DCC;CNTN4;PARD3;SHTN1;FARP1;BRSK2;MAP6;TAOK2;MAP2;FGFR2
prerank,GO_Biological_Process_2021__activation of phospholipase C activity (GO:0007202),-0.7436261981662735,-1.367387553120907,0.09836065573770492,0.57866400960438,1.0,4/19,6.88%,ITK;TXK;PHB2;C5AR1
prerank,GO_Biological_Process_2021__interleukin-35-mediated signaling pathway (GO:0070757),-0.8561516245132452,-1.3666324296462575,0.13725490196078433,0.5805150237373478,1.0,3/9,9.56%,STAT4;IL12RB2;STAT1
prerank,GO_Biological_Process_2021__membrane invagination (GO:0010324),0.8080894550850605,1.36610070945673,0.11363636363636363,0.6663689612117614,1.0,2/6,14.49%,FNBP1L;SMURF1
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase III (GO:0042796),-0.8191493973720695,-1.366076015569867,0.06557377049180328,0.5818472585758945,1.0,1/8,2.61%,SNAPC1
prerank,PanglaoDB_Augmented_2021__Ionocytes,0.6126450691627434,1.3660408083304578,0.10869565217391304,0.6646326916086746,1.0,1/21,0.04%,SHROOM3
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.7053515750730218,-1.3659149954569132,0.06451612903225806,0.5809266875963045,1.0,4/28,4.34%,UBC;RPS27A;XPA;GTF2H5
prerank,GO_Biological_Process_2021__replicative senescence (GO:0090399),0.9030628631890222,1.3657916800232635,0.09090909090909091,0.6636062846234584,1.0,1/6,1.65%,SERPINE1
prerank,GO_Biological_Process_2021__response to chemokine (GO:1990868),-0.7132164760213063,-1.3655289122309493,0.16,0.5814558416867339,1.0,3/11,7.09%,RIPOR2;DUSP1;STK39
prerank,GO_Biological_Process_2021__negative regulation of androgen receptor signaling pathway (GO:0060766),0.8113406535660788,1.3651819697713632,0.0625,0.6635768400850391,1.0,2/9,9.84%,SIRT1;HDAC1
prerank,GO_Biological_Process_2021__regulation of tau-protein kinase activity (GO:1902947),0.7960532364487379,1.364500636060445,0.11538461538461539,0.6643889889509998,1.0,1/8,0.03%,EGR1
prerank,PanglaoDB_Augmented_2021__Cajal-Retzius Cells,0.4714271298092364,1.3638750222610478,0.045454545454545456,0.6653786108121191,1.0,36/119,11.99%,KCNQ2;SLITRK5;CNTN2;DPYSL5;GRID2;NCAN;SMAD1;INSYN2A;ZNF536;NBEA;NLGN1;GALNT13;NOL4;SNAP91;CNR1;RELN;TMEM170B;CNRIP1;NRG1;DACH1;ELAVL2;GNL3L;PURG;DNM3;OLFM3;FUT9;CADM2;ZDBF2;CLSTN2;SNCB;RGMB;PTPN5;SLC35F1;LINGO1;CAMKV;SLC25A46
prerank,GO_Biological_Process_2021__endoplasmic reticulum membrane organization (GO:0090158),0.7641559656291468,1.3636208696030363,0.07142857142857142,0.6644713837308432,1.0,1/9,0.24%,VAPB
prerank,GO_Biological_Process_2021__regulation of response to endoplasmic reticulum stress (GO:1905897),-0.7659860715484041,-1.3631657316894548,0.09259259259259259,0.5912739928374601,1.0,3/12,5.38%,AQP11;CLU;NR1H2
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.7241717812430499,1.3631496631303155,0.06521739130434782,0.6645484657742236,1.0,3/9,15.49%,STK25;MAP3K5;ZNF622
prerank,GO_Biological_Process_2021__regulation of lipid storage (GO:0010883),0.6567984729464472,1.3630694627595457,0.075,0.6629623501470587,1.0,4/12,10.85%,SIRT1;TNF;FBXW7;ITGAV
prerank,GO_Biological_Process_2021__sarcoplasmic reticulum calcium ion transport (GO:0070296),-0.9217814852590607,-1.3629541284418145,0.09615384615384616,0.5909336058266467,1.0,1/5,0.62%,CCL3
prerank,GO_Biological_Process_2021__synaptic vesicle budding (GO:0070142),-0.7734825517097799,-1.3629042501325708,0.12244897959183673,0.5895444681995979,1.0,2/8,1.19%,MX2;MX1
prerank,GO_Biological_Process_2021__regulation of lymphocyte activation (GO:0051249),-0.8325568113748385,-1.3623999800421729,0.10204081632653061,0.5901393812513409,1.0,4/8,8.90%,THEMIS2;CCL5;IKZF3;DCAF15
prerank,GO_Biological_Process_2021__regulation of humoral immune response (GO:0002920),-0.6854700906383323,-1.3623574680309407,0.11475409836065574,0.5886887902151605,1.0,7/21,14.85%,CD55;CLU;PHB2;C5AR1;C5AR2;SERPING1;C3
prerank,GO_Biological_Process_2021__response to type I interferon (GO:0034340),-0.878924636211174,-1.3621814724780694,0.05084745762711865,0.5879565902273309,1.0,3/6,6.14%,MX1;IFIT1;SHFL
prerank,GO_Biological_Process_2021__regulation of prostaglandin biosynthetic process (GO:0031392),0.9060459717167239,1.3620358850145478,0.07692307692307693,0.6651697589421255,1.0,2/5,2.51%,ANXA1;SIRT1
prerank,GO_Biological_Process_2021__regulation of sensory perception of pain (GO:0051930),-0.9467168512465454,-1.3616649573956219,0.0,0.5886218197177099,1.0,2/5,2.02%,CCL3;MGLL
prerank,GO_Biological_Process_2021__ionotropic glutamate receptor signaling pathway (GO:0035235),0.8276003842011304,1.361652879041271,0.10204081632653061,0.6654237422044467,1.0,3/7,6.73%,GRIN3A;CDK5R1;CPEB4
prerank,GO_Biological_Process_2021__membrane repolarization (GO:0086009),0.7427115853338206,1.3614007266702937,0.125,0.6648522328800888,1.0,3/11,4.38%,KCNJ2;KCNIP2;KCND3
prerank,GO_Biological_Process_2021__L-ascorbic acid metabolic process (GO:0019852),-0.8924944753551127,-1.3608045220002372,0.07272727272727272,0.5911912622064684,1.0,2/6,4.51%,SLC2A3;CYB5A
prerank,GO_Biological_Process_2021__granulocyte activation (GO:0036230),-0.9016783475706897,-1.360761566559354,0.05454545454545454,0.5898475035336291,1.0,1/5,1.49%,CCL5
prerank,GO_Biological_Process_2021__response to copper ion (GO:0046688),-0.8440931827450684,-1.3603035845530709,0.1,0.5904553764531459,1.0,1/9,0.25%,MT2A
prerank,GO_Biological_Process_2021__regulation of cell projection organization (GO:0031344),0.7564559080641381,1.3594209400564596,0.06818181818181818,0.67217820644232,1.0,1/10,1.76%,SPRY2
prerank,GO_Biological_Process_2021__muscle tissue morphogenesis (GO:0060415),-0.8861384930102606,-1.359415797436205,0.1509433962264151,0.5941205225063155,1.0,3/6,7.37%,MYLK;TGFBR3;TTN
prerank,GO_Biological_Process_2021__positive regulation of tau-protein kinase activity (GO:1902949),0.881463224428281,1.3593178196066489,0.058823529411764705,0.6705929756312367,1.0,1/5,0.03%,EGR1
prerank,GO_Biological_Process_2021__protein localization to cell surface (GO:0034394),-0.6708868219291294,-1.3585280168483684,0.10909090909090909,0.596298052512398,1.0,2/19,0.78%,FLNA;RIC3
prerank,GO_Biological_Process_2021__regulation of endothelial cell proliferation (GO:0001936),0.5320909099017719,1.3583993137749322,0.0,0.6726035986926989,1.0,6/46,5.26%,NRP1;SEMA5A;FGF2;SIRT1;WNT5A;PTPRM
prerank,GO_Biological_Process_2021__regulation of pH (GO:0006885),0.811396487130752,1.3581160636302037,0.13157894736842105,0.6716283070587947,1.0,4/5,18.83%,PDK4;SLC9A1;SLC9A7;CLCN3
prerank,GO_Biological_Process_2021__regulation of epithelial cell proliferation (GO:0050678),-0.6504398668277894,-1.3580802401985397,0.07692307692307693,0.5975343984733221,1.0,9/42,6.88%,NR4A3;TGFBR3;RUNX3;ZFP36;NLRC3;B2M;AQP11;IGF1;C5AR1
prerank,GO_Biological_Process_2021__regulation of T cell activation (GO:0050863),-0.7102205638515235,-1.358015258621657,0.07692307692307693,0.5961684686571047,1.0,5/27,2.84%,IL4I1;CD2;CCL5;PRKCQ;PRELID1
prerank,GO_Biological_Process_2021__nucleic acid transport (GO:0050657),-0.8218554032255765,-1.3578760124333433,0.12244897959183673,0.5953183267968603,1.0,2/8,2.95%,SIDT2;SIDT1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte apoptotic process (GO:2000108),0.779783462671014,1.357680471012472,0.13157894736842105,0.6717531076769022,1.0,2/9,2.51%,ANXA1;SIRT1
prerank,MSigDB_Hallmark_2020__Oxidative Phosphorylation,-0.5482929637059847,-1.3576269265567946,0.01282051282051282,0.5949337529635744,1.0,48/167,18.86%,CYCS;MDH2;COX7C;UQCRB;NDUFC1;PDHX;NDUFA2;UQCRH;NDUFA1;CYB5A;ATP6V1F;SLC25A5;ISCA1;PHB2;ATP5PD;ATP5F1E;NDUFB4;UQCR10;ACAA1;COX4I1;COX5B;ETFB;LDHA;NDUFB1;IDH3B;NDUFS8;ATP5ME;MTRF1;MRPS11;GPX4;MRPS15;COX7A2;COX6C;OXA1L;NDUFS6;NDUFB7;ETFDH;UQCRC1;NDUFB3;UQCRQ;ATP5F1C;GOT2;DLST;NDUFS7;NDUFA3;SURF1;ATP5F1D;RHOT2
prerank,GO_Biological_Process_2021__single strand break repair (GO:0000012),0.7248754866684075,1.357548964593685,0.14285714285714285,0.6703635494069071,1.0,2/7,7.13%,SIRT1;LIG4
prerank,PanglaoDB_Augmented_2021__Enteric Neurons,0.4795218361318198,1.357358518141666,0.047619047619047616,0.6690873427769545,1.0,49/114,22.00%,CNTN2;NCAN;NMNAT2;ZNF536;SCN3A;SNAP91;PLPPR4;LRRC4C;PCDH17;AHDC1;PLEKHA5;TAFA5;KCTD16;CA10;OLFM3;CADM2;ASXL3;RGMB;GUCY1A2;RBFOX1;NTRK2;CACNA1E;GRIA2;NFASC;CSRNP3;STXBP5;EML5;PPFIA2;KALRN;ADGRB3;MAPK4;ATRNL1;PIK3CA;GCNT2;MAP6;PCLO;CRMP1;FSTL5;MAP2;DCLK1;CNTN1;PHYHIPL;SYT4;TUB;NOVA1;CACNA1B;FBXO7;NRXN1;LSAMP
prerank,GO_Biological_Process_2021__excitatory synapse assembly (GO:1904861),0.8195375027724897,1.3569851518113756,0.0784313725490196,0.6689384267217332,1.0,6/7,11.81%,GRID2;NLGN1;WNT5A;PLXNB2;SHANK3;PTEN
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.7379072992298478,-1.3568943324167557,0.109375,0.5971952019169149,1.0,4/22,2.80%,UBC;RPS27A;XPA;COPS6
prerank,GO_Biological_Process_2021__lung development (GO:0030324),0.6530625343338041,1.3563457957089207,0.1111111111111111,0.670186226773448,1.0,4/16,4.19%,PDPN;FGF2;PKD1;RCN3
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.7699503837468722,-1.3560613938584418,0.1111111111111111,0.5999032921308618,1.0,1/13,0.08%,NR4A3
prerank,GO_Biological_Process_2021__cellular response to hypoxia (GO:0071456),-0.5719156809652275,-1.35579228677641,0.0547945205479452,0.5992352269506533,1.0,24/90,18.04%,UBC;RPS27A;CARD16;PSMB3;RORA;ELOB;PSMB6;PSMA7;EGLN3;PSMB9;RBX1;VEGFA;HIF1A;NOP53;PSMD12;PSMD8;PSMA5;PGK1;UBA52;MT3;PSMA3;PINK1;PSMC4;FAM162A
prerank,GO_Biological_Process_2021__neural crest cell migration (GO:0001755),0.6464785040568285,1.355748730110845,0.10526315789473684,0.670661339866969,1.0,5/18,14.14%,NRP1;SEMA5A;SEMA3B;PHACTR4;ERBB4
prerank,GO_Biological_Process_2021__peptidyl-threonine modification (GO:0018210),0.5345164797701881,1.3556817867466067,0.027777777777777776,0.6689478529290964,1.0,16/52,15.67%,CDK5R1;TGFBR2;CDK10;GALNT13;LRRK2;GALNTL6;MAP2K1;NLK;MAP3K10;DYRK1A;WNK1;MAPK1;GALNT1;TGFBR1;GALNT2;GSK3B
prerank,GO_Biological_Process_2021__positive regulation of behavior (GO:0048520),-0.8947147178112443,-1.3556665342701897,0.10416666666666667,0.5982057235989389,1.0,1/5,0.08%,NR4A3
prerank,GO_Biological_Process_2021__regulation of axon guidance (GO:1902667),0.7857172521681117,1.3553601187539748,0.1111111111111111,0.6683858693223602,1.0,2/8,2.84%,NRP1;ZSWIM4
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell differentiation (GO:0030857),0.8688238528395881,1.354449579422421,0.07272727272727272,0.6701040063744775,1.0,3/5,3.94%,SPRY2;SPRED1;SPRED2
prerank,GO_Biological_Process_2021__negative regulation of leukocyte cell-cell adhesion (GO:1903038),-0.7938092502756575,-1.3542265165156182,0.09523809523809523,0.6038700586582937,1.0,1/12,0.34%,IL4I1
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle (GO:0045931),0.683514593022093,1.3542128329434966,0.09375,0.6694043283020269,1.0,3/20,9.60%,KLHL18;PPP1R10;MDM2
prerank,GO_Biological_Process_2021__positive regulation of glial cell migration (GO:1903977),-0.8636538482576301,-1.3539151584570959,0.1076923076923077,0.6035372091844337,1.0,1/6,0.62%,CCL3
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen (GO:0002483),-0.7627755775740891,-1.3528024425321392,0.08955223880597014,0.6084338538344682,1.0,8/11,14.74%,B2M;HLA-F;HLA-DRA;ERAP1;ABCB9;TAP1;HLA-E;ERAP2
prerank,GO_Biological_Process_2021__positive regulation of chondrocyte differentiation (GO:0032332),0.8436053603729541,1.3525240246047974,0.11627906976744186,0.6758093984055001,1.0,4/6,9.95%,ZBTB16;SOX5;BMPR1B;LOXL2
prerank,GO_Biological_Process_2021__negative regulation of RNA metabolic process (GO:0051253),-0.6718647995025844,-1.3524931419480544,0.13793103448275862,0.6080682810248029,1.0,2/15,6.24%,RPS13;RPS26
prerank,MSigDB_Hallmark_2020__Spermatogenesis,0.56022455393611,1.3523680143735382,0.12121212121212122,0.674379221940933,1.0,5/65,6.63%,TULP2;SIRT1;NPHP1;SNAP91;MAST2
prerank,GO_Biological_Process_2021__polyphosphate metabolic process (GO:0006797),-0.8703269207282811,-1.3523363789347354,0.12,0.6071867987529065,1.0,2/5,9.75%,BNIP2;PRUNE1
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination (GO:0045910),-0.6836833970229086,-1.3520601344252807,0.05970149253731343,0.607163177164777,1.0,6/39,8.56%,H1-4;H1-3;H1-2;H1-0;POLR2G;H1-10
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate junction organization (GO:0150117),0.6750314801592828,1.3520097316464708,0.09090909090909091,0.6741850644741851,1.0,2/18,0.61%,COL16A1;NRP1
prerank,GO_Biological_Process_2021__negative regulation of appetite (GO:0032099),-0.8584957395796629,-1.3519890229740055,0.11320754716981132,0.60593023606309,1.0,1/5,3.44%,BBS2
prerank,GO_Biological_Process_2021__regulation of monocyte chemotactic protein-1 production (GO:0071637),-0.807141543274285,-1.3518514774368486,0.18518518518518517,0.6051504371691847,1.0,4/8,8.28%,OAS3;APOD;GSTP1;OAS1
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration (GO:0007204),-0.6307520474733808,-1.351798150195274,0.04477611940298507,0.6038175996628578,1.0,12/56,11.47%,CALCR;CD36;CXCR4;CD55;FIS1;ACKR4;TACR1;C5AR1;TRPV4;P2RY8;TRPM4;C5AR2
prerank,GO_Biological_Process_2021__regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.7509313188900841,-1.3516644632405665,0.11940298507462686,0.6029583176287086,1.0,5/15,2.49%,CD36;SIGIRR;CD55;CARD16;TRIM5
prerank,GO_Biological_Process_2021__digestive system development (GO:0055123),0.7880316365217735,1.3515614998414274,0.13157894736842105,0.6745022112526822,1.0,4/7,19.59%,PKD1;COBL;NIPBL;FGFR2
prerank,MSigDB_Hallmark_2020__Hypoxia,-0.5587577101724186,-1.3511297111858136,0.075,0.6037216905528366,1.0,36/129,12.19%,MT2A;TPD52;COL5A1;SLC2A3;FOSL2;PPP1R15A;FOS;GAPDH;CXCR4;ZFP36;DUSP1;DDIT4;RORA;HS3ST1;ANKZF1;PHKG1;ANXA2;IER3;ETS1;BHLHE40;ERO1A;JMJD6;HK2;TNFAIP3;RBPJ;PFKFB3;GPC3;LDHA;CITED2;VEGFA;FBP1;MXI1;BTG1;SDC3;ATF3;AKAP12
prerank,GO_Biological_Process_2021__response to calcium ion (GO:0051592),0.5458807064326654,1.3510460303312026,0.045454545454545456,0.6749532571128113,1.0,24/67,23.01%,TRPC1;PKD2;KCNIP2;NLGN1;WNT5A;ANXA11;PPP3CA;KCNMB4;ALOX5AP;SYT17;KCNMB3;AHCYL1;PRKAA1;SEC31A;ADGRV1;NEDD4;CPNE2;SYT4;HOMER1;ADD1;RYR1;CPNE3;ITPKB;RYR2
prerank,GO_Biological_Process_2021__protein localization to nuclear envelope (GO:0090435),0.9049091065944981,1.3510060301346416,0.047619047619047616,0.6731693854428724,1.0,2/5,4.41%,NUTF2;TOR1AIP2
prerank,GO_Biological_Process_2021__transcription-coupled nucleotide-excision repair (GO:0006283),-0.6025202213389395,-1.3509778087158357,0.09090909090909091,0.6028891486663892,1.0,8/61,7.16%,UBC;PPIE;RPS27A;XPA;COPS6;UVSSA;GTF2H5;POLR2G
prerank,GO_Biological_Process_2021__fatty acid elongation (GO:0030497),0.798555999207688,1.3502792063165416,0.10526315789473684,0.6723222769474738,1.0,2/8,8.59%,HACD2;ELOVL6
prerank,GO_Biological_Process_2021__very long-chain fatty acid biosynthetic process (GO:0042761),0.798555999207688,1.3502792063165416,0.10526315789473684,0.6723222769474738,1.0,2/8,8.59%,HACD2;ELOVL6
prerank,GO_Biological_Process_2021__regulation of postsynapse organization (GO:0099175),0.6228436776854237,1.3500682246298794,0.02857142857142857,0.6711642938947747,1.0,8/25,9.17%,CDK5R1;SRCIN1;LRRK2;WNT5A;ABHD17B;SHANK3;PDLIM5;TANC2
prerank,GO_Biological_Process_2021__negative regulation of dendritic spine development (GO:0061000),0.8326221637851337,1.3499231569175578,0.09259259259259259,0.6699458076190247,1.0,3/6,11.81%,GRIN3A;NLGN1;PTEN
prerank,GO_Biological_Process_2021__primary miRNA processing (GO:0031053),0.7816920825754912,1.34972593305878,0.075,0.668834109695413,1.0,4/10,13.55%,SMAD1;SMAD2;SMAD3;DROSHA
prerank,PanglaoDB_Augmented_2021__Fibroblasts,0.5109623165127025,1.3497034236340104,0.0,0.6670964533481035,1.0,16/92,7.07%,EGR1;KLF4;COL5A3;COL16A1;PKD2;SVEP1;GSN;COL5A2;FGF2;KLF6;ACTA2;PBX1;TIMP3;CTSK;RUNX1;NFAT5
prerank,GO_Biological_Process_2021__negative regulation of heart contraction (GO:0045822),-0.8698016021310593,-1.3495787064181013,0.10714285714285714,0.6088097123482281,1.0,2/8,6.56%,PLN;SRI
prerank,GO_Biological_Process_2021__long-term synaptic potentiation (GO:0060291),0.6881201827314608,1.349520941832751,0.1956521739130435,0.6659986533700211,1.0,6/12,16.68%,NPTN;SHANK2;PLK2;GRIN2B;SLC24A2;GRIN2A
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin production (GO:0002639),-0.7447991811439554,-1.349284176583513,0.13333333333333333,0.6085404606768017,1.0,5/20,14.31%,TFRC;DNAJB9;PHB2;PTPRC;HLA-E
prerank,GO_Biological_Process_2021__cholesterol transport (GO:0030301),-0.645402699264427,-1.3489688233835153,0.11864406779661017,0.6086675544947856,1.0,4/30,4.82%,OSBPL5;CD36;LIPG;CLU
prerank,GO_Biological_Process_2021__negative regulation of nitrogen compound metabolic process (GO:0051172),0.8694806413006057,1.3487513613299142,0.07317073170731707,0.6677190671790245,1.0,2/7,3.01%,ABCA2;LDLR
prerank,GO_Biological_Process_2021__negative regulation of neuron projection development (GO:0010977),0.5270673605213995,1.3485742451735672,0.08,0.6664275848782603,1.0,14/45,15.36%,PTPN9;LRP4;NLGN1;CIB1;BCL11A;KANK1;LINGO1;PTEN;RTN4;DCC;ADCY6;BAG5;FKBP4;KIAA0319
prerank,PanglaoDB_Augmented_2021__Airway Epithelial Cells,-0.8453828552817829,-1.3485342056555376,0.09090909090909091,0.6093412074804059,1.0,3/7,10.61%,DUOX1;CLCA4;CFTR
prerank,GO_Biological_Process_2021__regulation of microglial cell migration (GO:1904139),-0.8636562208762271,-1.3484267263603313,0.0967741935483871,0.6082648340588852,1.0,1/6,0.62%,CCL3
prerank,GO_Biological_Process_2021__melanocyte differentiation (GO:0030318),0.8056014138695268,1.3481420802032922,0.13636363636363635,0.6668541852369984,1.0,2/5,14.62%,MITF;ENPP1
prerank,GO_Biological_Process_2021__cellular senescence (GO:0090398),0.6868906818441902,1.348134794739195,0.05,0.665112624119418,1.0,4/19,13.79%,SIRT1;MAP2K1;HMGA1;NSMCE2
prerank,GO_Biological_Process_2021__positive regulation of MAPK cascade (GO:0043410),-0.5626874211953696,-1.3479775314729798,0.012195121951219513,0.6090014478702017,1.0,18/146,9.28%,CCL4;CALCR;CD36;CCL3;CCL5;GPR183;PDGFD;MARCO;TRIM5;GLIPR2;IGF1;PHB2;C5AR1;EIF2AK2;MAP3K12;PRKD2;CD44;CHI3L1
prerank,GO_Biological_Process_2021__positive regulation of macrophage cytokine production (GO:0060907),0.7336412974656203,1.3472026667172898,0.17307692307692307,0.6678313769370344,1.0,3/8,10.29%,SIRT1;WNT5A;LAPTM5
prerank,GO_Biological_Process_2021__tumor necrosis factor-mediated signaling pathway (GO:0033209),-0.6041746691291969,-1.3471454855959075,0.08974358974358974,0.6114722470199667,1.0,16/82,12.85%,TNFRSF11B;CARD14;TNFRSF25;PSMB3;AIM2;PSMB6;PSMA7;TNFRSF1B;TMSB4X;PSMB9;STAT1;EIF5A;TNFSF13B;PSMD12;PSMD8;PSMA5
prerank,GO_Biological_Process_2021__associative learning (GO:0008306),0.8040194214238062,1.3470964666158818,0.14,0.6664882382659069,1.0,1/5,8.58%,BRSK1
prerank,GO_Biological_Process_2021__regulation of cell adhesion mediated by integrin (GO:0033628),0.6255737577260071,1.3470018422489174,0.12195121951219512,0.6650546670089394,1.0,6/18,13.77%,ACER2;SERPINE1;CIB1;PDE3B;P2RY12;PTK2
prerank,PanglaoDB_Augmented_2021__Distal Tubule Cells,0.5393449482148421,1.3468491950054047,0.1,0.6640832782518719,1.0,21/52,18.86%,ESRRG;PPARGC1A;FGD4;LPP;JAG1;CPEB4;PLEKHA5;LARP1B;WNK1;MAP7;CMYA5;COBL;SLC8A1;CXCL14;STON2;BAZ2B;RSPH3;NIPSNAP2;SPTLC3;TSC22D2;ACOT11
prerank,GO_Biological_Process_2021__box C/D snoRNP assembly (GO:0000492),0.8812305253715784,1.345902121710548,0.12244897959183673,0.6672613635052389,1.0,2/6,1.43%,NUFIP1;RUVBL2
prerank,GO_Biological_Process_2021__manganese ion transport (GO:0006828),0.7423917061797392,1.3455812704990007,0.15555555555555556,0.6670642512154131,1.0,3/10,5.71%,TRPC1;SLC39A14;SLC39A8
prerank,GO_Biological_Process_2021__positive regulation of cell junction assembly (GO:1901890),0.6001982971634796,1.3453902005404095,0.07692307692307693,0.6660308583339172,1.0,6/37,3.53%,COL16A1;NRP1;GRID2;DLG5;NPHP1;NLGN1
prerank,GO_Biological_Process_2021__regulation of protein metabolic process (GO:0051246),0.5761663595321086,1.3453032888655971,0.05263157894736842,0.6648423499448307,1.0,5/34,9.60%,KLF4;LDLR;SPOPL;NEDD4L;MDM2
prerank,GO_Biological_Process_2021__modified amino acid transport (GO:0072337),0.7979893335317023,1.3452440035300532,0.08163265306122448,0.6633397842873029,1.0,1/8,0.66%,PDPN
prerank,GO_Biological_Process_2021__negative regulation of viral transcription (GO:0032897),-0.8090204115393373,-1.3452072074648567,0.16666666666666666,0.6194779975952924,1.0,3/10,9.65%,ZFP36;IFITM3;TRIM13
prerank,PanglaoDB_Augmented_2021__Neural Stem/Precursor Cells,0.5598444470352733,1.3449726480345632,0.07142857142857142,0.6625799987329094,1.0,12/69,5.57%,NPAS3;KCNQ2;CNTN2;IGF1R;DPYSL5;NCAN;GFAP;SLC1A3;ZNF536;ARNT2;SNAP91;CSPG5
prerank,GO_Biological_Process_2021__regulation of cartilage development (GO:0061035),0.7829043635379163,1.3445277143745307,0.11627906976744186,0.6622703355497199,1.0,5/11,11.55%,ZBTB16;BMP1;SOX5;BMPR1B;KAT2A
prerank,GO_Biological_Process_2021__inositol phosphate catabolic process (GO:0071545),0.7001319942985584,1.3440943613111156,0.11363636363636363,0.6627250737328408,1.0,5/11,16.55%,INPP1;IMPA1;NUDT3;PTEN;INPP5A
prerank,GO_Biological_Process_2021__positive regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901838),-0.7840362482233708,-1.3434628773164228,0.1875,0.6263630630404674,1.0,1/10,0.51%,DDX11
prerank,GO_Biological_Process_2021__excitatory postsynaptic potential (GO:0060079),0.7566308826518846,1.3431292507416817,0.15384615384615385,0.665428069088219,1.0,5/11,16.68%,GRID2;LRRK2;GRIN2B;GSK3B;GRIN2A
prerank,"GO_Biological_Process_2021__protein localization to chromosome, telomeric region (GO:0070198)",-0.8077206184560791,-1.3428526686226825,0.11864406779661017,0.6278019743169603,1.0,3/10,12.59%,TPP1;BRCA2;TERF2IP
prerank,GO_Biological_Process_2021__positive regulation of leukocyte mediated cytotoxicity (GO:0001912),-0.7059173410457844,-1.3427241866413917,0.07575757575757576,0.6268678807749904,1.0,8/20,14.31%,HLA-B;SLAMF6;HLA-F;KLRD1;CD226;HLA-DRA;TYROBP;HLA-E
prerank,GO_Biological_Process_2021__cellular response to estradiol stimulus (GO:0071392),0.752057252636692,1.34271407293141,0.13953488372093023,0.66587218792433,1.0,3/11,4.06%,RUVBL2;NCOA3;NRIP1
prerank,GO_Biological_Process_2021__regulation of B cell activation (GO:0050864),-0.7175010906279952,-1.34270055647347,0.06666666666666667,0.6255736829925017,1.0,6/16,9.60%,IL4I1;THEMIS2;IKZF3;TNFAIP3;SAMSN1;BANK1
prerank,GO_Biological_Process_2021__positive regulation of DNA-directed DNA polymerase activity (GO:1900264),-0.8588047018150571,-1.3426324279321502,0.09259259259259259,0.6228549710079414,1.0,1/5,6.55%,CHTF18
prerank,GO_Biological_Process_2021__regulation of DNA-directed DNA polymerase activity (GO:1900262),-0.8588047018150571,-1.3426324279321502,0.09259259259259259,0.6228549710079414,1.0,1/5,6.55%,CHTF18
prerank,GO_Biological_Process_2021__negative regulation of angiogenesis (GO:0016525),0.5781772044424024,1.3424765200551965,0.0,0.6651472346370196,1.0,9/43,7.30%,KLF4;SERPINE1;YJEFN3;SPRY2;AMOT;SPRED1;PPARG;PTPRM;TNF
prerank,GO_Biological_Process_2021__negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),-0.8644313399964116,-1.3424636300999198,0.05357142857142857,0.6220699913868601,1.0,1/8,2.68%,PARP14
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential (GO:0098901),-0.7118928612119912,-1.3424225416459812,0.1076923076923077,0.6207789970744629,1.0,8/18,18.55%,JUP;FGF13;CALM1;TRPM4;DSC2;NOS1AP;PKP2;AKAP9
prerank,GO_Biological_Process_2021__regulation of immune effector process (GO:0002697),-0.6970450948579129,-1.341670814648522,0.04838709677419355,0.6231605895232453,1.0,12/22,21.85%,CD55;CLU;PHB2;C5AR1;HLA-DRA;C5AR2;SERPING1;C3;HLA-DRB1;C1QBP;C1QB;C1QC
prerank,GO_Biological_Process_2021__regulation of postsynaptic membrane potential (GO:0060078),0.6660430432017505,1.3415600574595545,0.1282051282051282,0.6674769030374775,1.0,11/20,21.96%,GRID2;INSYN2A;LRRK2;GLRA1;GRIN2B;GSK3B;GRIN2A;GABRG3;GABRA4;GABRA2;GRIN1
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial fusion (GO:0010637),-0.9077869828569882,-1.3414064358304316,0.03278688524590164,0.6227822805120251,1.0,1/5,1.44%,TFRC
prerank,GO_Biological_Process_2021__inorganic cation transmembrane transport (GO:0098662),0.4575465101895608,1.3413928915539846,0.05263157894736842,0.6662809891156796,1.0,35/128,15.77%,CACNA1A;TRPC1;KCNQ2;PKD2;SLC39A14;SLC9C2;KCNJ2;SLC1A3;SCN3A;PKD1;KCND3;SCN3B;SLC39A8;HPN;SLC4A4;KCNC2;SLC41A1;SLC9A1;SCN8A;KCNK6;KCNK13;ITGAV;KCNN2;ANO6;SLC9A9;ABCC8;KCNH5;SLC8A1;SLC40A1;SLC25A14;HVCN1;SLC24A2;SLC12A2;ABCB8;TRPC4
prerank,GO_Biological_Process_2021__organic hydroxy compound biosynthetic process (GO:1901617),-0.6634707125350162,-1.341289917784504,0.0967741935483871,0.6218996714149737,1.0,3/31,3.13%,INSIG1;CH25H;PER2
prerank,GO_Biological_Process_2021__B cell activation (GO:0042113),-0.6066328760964863,-1.3410026919323577,0.15384615384615385,0.6218628676747813,1.0,10/45,12.82%,TPD52;GPR183;DNAJB9;BTK;SLC25A5;PHB2;ITGA4;BANK1;TCF3;PTPRC
prerank,GO_Biological_Process_2021__positive regulation of oligodendrocyte differentiation (GO:0048714),-0.8869106613816775,-1.3406293314382816,0.14583333333333334,0.6224138804470893,1.0,3/5,10.30%,CXCR4;TNFRSF1B;PTN
prerank,GO_Biological_Process_2021__regulation of lamellipodium organization (GO:1902743),0.7462931680537959,1.3403723009630626,0.0975609756097561,0.6694092172984838,1.0,2/10,1.04%,PDPN;FER
prerank,GO_Biological_Process_2021__establishment of epithelial cell apical/basal polarity (GO:0045198),0.7571738305006928,1.339927775287967,0.1346153846153846,0.669774934394284,1.0,1/7,1.49%,MSN
prerank,GO_Biological_Process_2021__regulation of T cell mediated cytotoxicity (GO:0001914),-0.754719047243937,-1.3398314196371912,0.04054054054054054,0.6244277784969605,1.0,6/14,14.31%,HLA-B;HLA-F;KLRD1;HLA-DRA;PTPRC;HLA-E
prerank,GO_Biological_Process_2021__positive regulation of immune response (GO:0050778),-0.6428235736456632,-1.3390190301155858,0.05714285714285714,0.6265364007094923,1.0,16/47,16.01%,SKAP1;RSAD2;CCL5;PLSCR1;CD226;ITGB2;TASL;HLA-DRA;KARS1;CYBA;PTPRC;NOD2;IFI35;HLA-DMB;CD74;POLR3C
prerank,GO_Biological_Process_2021__homotypic cell-cell adhesion (GO:0034109),-0.6453835819827567,-1.3387477300740405,0.11940298507462686,0.6265721477975439,1.0,9/32,14.58%,FLNA;PLEK;ACTG1;FERMT3;MYL12A;ACTB;DSC2;PIK3CB;TLN1
prerank,GO_Biological_Process_2021__xenobiotic catabolic process (GO:0042178),-0.87229037129976,-1.338666466756686,0.1702127659574468,0.6253605774337396,1.0,3/5,8.97%,GSTM4;ACAA1;GSTM3
prerank,GO_Biological_Process_2021__regulation of membrane depolarization (GO:0003254),0.7943559719294011,1.3385428191195485,0.10526315789473684,0.6745279186667439,1.0,4/9,8.52%,SMAD7;LRRK2;SCN3B;NEDD4L
prerank,GO_Biological_Process_2021__response to corticosteroid (GO:0031960),-0.8923589158736602,-1.3384348275090592,0.12244897959183673,0.6250257177374019,1.0,1/5,0.10%,CALCR
prerank,GO_Biological_Process_2021__cellular response to calcium ion (GO:0071277),0.5631582310762133,1.3382717544119658,0.06896551724137931,0.6738540221020777,1.0,13/44,22.43%,PKD2;NLGN1;WNT5A;ALOX5AP;SYT17;PRKAA1;ADGRV1;CPNE2;SYT4;ADD1;RYR1;CPNE3;ITPKB
prerank,GO_Biological_Process_2021__synaptic vesicle localization (GO:0097479),0.756334262674998,1.3380210962302077,0.06976744186046512,0.6733693894547486,1.0,2/11,6.03%,NLGN1;TMEM230
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via nonhomologous end joining (GO:2001033),-0.8548525720540208,-1.3377591578988712,0.10204081632653061,0.6270920962916727,1.0,1/5,8.09%,CYREN
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton organization (GO:0032956),0.5309366046987538,1.3375494832650139,0.034482758620689655,0.6739683960680483,1.0,5/62,7.54%,PDGFA;EPS8;HIP1R;CDK10;CRK
prerank,GO_Biological_Process_2021__positive regulation of interleukin-4 production (GO:0032753),-0.786401285657579,-1.3365958915277245,0.10344827586206896,0.6308202560013626,1.0,3/12,3.26%,SLC7A5;PRKCQ;FCER1G
prerank,GO_Biological_Process_2021__protein kinase B signaling (GO:0043491),-0.6965327301747968,-1.3365957854492179,0.10344827586206896,0.6293218705951836,1.0,4/17,7.56%,CCL3;CCL5;IGF1;THEM4
prerank,GO_Biological_Process_2021__positive regulation of actin filament polymerization (GO:0030838),0.5607823301179183,1.3365518045331637,0.05714285714285714,0.6769060567145959,1.0,6/31,4.43%,FER;GSN;CDC42EP3;NCK2;VASP;SPIRE2
prerank,GO_Biological_Process_2021__nuclear pore organization (GO:0006999),0.6929768459998055,1.336414748896474,0.15789473684210525,0.6758026944602397,1.0,7/13,25.66%,NUP153;RTN4;NDC1;NUP133;NUP205;NUP98;TPR
prerank,GO_Biological_Process_2021__zinc ion import across plasma membrane (GO:0071578),0.9273935266096578,1.3362469045121539,0.023255813953488372,0.6746436071214754,1.0,3/5,5.71%,SLC39A12;SLC39A14;SLC39A8
prerank,GO_Biological_Process_2021__response to UV-C (GO:0010225),-0.824242203969269,-1.3356554837974373,0.15789473684210525,0.6320822609425997,1.0,1/7,1.78%,CARD16
prerank,GO_Biological_Process_2021__cellular response to peptide hormone stimulus (GO:0071375),-0.592034052480291,-1.3354483276803621,0.075,0.6315510504956371,1.0,4/74,2.94%,NR4A3;SYAP1;INSIG1;USF1
prerank,GO_Biological_Process_2021__TORC2 signaling (GO:0038203),-0.8715765231971819,-1.33483881647134,0.1836734693877551,0.6332914749658969,1.0,1/6,0.46%,SYAP1
prerank,GO_Biological_Process_2021__copper ion homeostasis (GO:0055070),-0.8073888797569648,-1.3348037236375891,0.07352941176470588,0.6319645334195451,1.0,1/11,0.25%,MT2A
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by integrin (GO:0033632),-0.8621874813692276,-1.3344693890475026,0.11290322580645161,0.6321901655865106,1.0,3/5,8.42%,SKAP1;CCL5;FERMT3
prerank,GO_Biological_Process_2021__negative regulation of PERK-mediated unfolded protein response (GO:1903898),-0.843500151405257,-1.3341681412944015,0.10416666666666667,0.6321508541803982,1.0,1/5,1.16%,PPP1R15A
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-serine phosphorylation (GO:0033138),-0.6126053134402032,-1.334165919795809,0.11428571428571428,0.6306738662033412,1.0,8/49,14.13%,CALCR;TFRC;PRKD2;CD44;VEGFA;MTCP1;TERF2IP;CAMK1
prerank,GO_Biological_Process_2021__positive regulation of cytoskeleton organization (GO:0051495),0.5309011165036162,1.3341314409734235,0.041666666666666664,0.6807374665437745,1.0,6/47,4.28%,NRP1;FER;SEMA5A;CDC42EP3;NCK2;VASP
prerank,GO_Biological_Process_2021__cation homeostasis (GO:0055080),0.8204301434030172,1.3340532449354878,0.07692307692307693,0.6792667740119244,1.0,3/6,15.12%,SLC7A8;UNC80;ATP13A2
prerank,GO_Biological_Process_2021__transcription by RNA polymerase III (GO:0006383),-0.6546932519240801,-1.3340160051210235,0.14705882352941177,0.6300725508578654,1.0,2/23,3.40%,SNAPC1;GTF3C6
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte activation (GO:0051250),-0.7597584220275323,-1.333968544637165,0.140625,0.6289297836129233,1.0,4/14,9.60%,IL4I1;TNFAIP3;SAMSN1;BANK1
prerank,GO_Biological_Process_2021__protein localization to chromatin (GO:0071168),0.6640956722924384,1.3334690998542411,0.11627906976744186,0.6797202336655842,1.0,8/15,26.93%,RUVBL2;CHMP7;NIPBL;MACROH2A1;LEMD2;ESR1;WAPL;MCM9
prerank,GO_Biological_Process_2021__alpha-amino acid catabolic process (GO:1901606),-0.7924444635180402,-1.3331828117487081,0.14545454545454545,0.6311910091111468,1.0,2/10,5.45%,IL4I1;KMO
prerank,GO_Biological_Process_2021__regulation of lymphocyte migration (GO:2000401),0.793311131020006,1.3330767197293563,0.1568627450980392,0.6797161922774373,1.0,3/7,14.99%,MSN;JAM2;STK10
prerank,GO_Biological_Process_2021__iron ion transmembrane transport (GO:0034755),0.7627926518141012,1.3330266239274422,0.15555555555555556,0.6782288104591796,1.0,3/8,13.82%,SLC39A14;SLC39A8;SLC40A1
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic transport (GO:1903651),0.7005647931975524,1.3327693048397535,0.20454545454545456,0.6776547621979888,1.0,3/11,11.83%,MSN;PTPN23;SORL1
prerank,GO_Biological_Process_2021__negative regulation of interleukin-1 beta production (GO:0032691),-0.7443320714375443,-1.3327445108835378,0.0967741935483871,0.6320774113408273,1.0,5/14,8.14%,CARD16;LILRB4;IGF1;GSTP1;TNFAIP3
prerank,GO_Biological_Process_2021__synaptonemal complex assembly (GO:0007130),-0.9106092458804799,-1.3327247207979778,0.08064516129032258,0.6292245269433175,1.0,2/5,2.73%,SYCE2;STAG3
prerank,GO_Biological_Process_2021__synaptonemal complex organization (GO:0070193),-0.9106092458804799,-1.3327247207979778,0.08064516129032258,0.6292245269433175,1.0,2/5,2.73%,SYCE2;STAG3
prerank,GO_Biological_Process_2021__mitochondrion morphogenesis (GO:0070584),-0.7730300460662887,-1.3325569488250997,0.11475409836065574,0.6288938710753205,1.0,5/11,18.39%,PID1;FIS1;NUBPL;SLIRP;PNPT1
prerank,GO_Biological_Process_2021__cellular glucose homeostasis (GO:0001678),0.5723766992463805,1.3325081278855015,0.11764705882352941,0.6772040581214299,1.0,7/31,10.70%,PPARGC1A;IGF1R;SLC39A14;SIRT1;UNC13B;SOX4;PCK2
prerank,"GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent (GO:0002486)",-0.8382078487211133,-1.3319616624451664,0.1,0.6291891539430017,1.0,4/5,14.31%,HLA-B;HLA-C;HLA-F;HLA-E
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway (GO:0002484),-0.8382078487211133,-1.3319616624451664,0.1,0.6291891539430017,1.0,4/5,14.31%,HLA-B;HLA-C;HLA-F;HLA-E
prerank,GO_Biological_Process_2021__regulation of cell junction assembly (GO:1901888),0.624943438904132,1.331908037139513,0.047619047619047616,0.6785884767745796,1.0,7/17,19.15%,RAP1A;RUNX1;PDLIM5;TJP1;SETD5;RAPGEF2;CBFB
prerank,GO_Biological_Process_2021__positive regulation of integrin activation (GO:0033625),-0.8439642839650674,-1.3313428131536453,0.1746031746031746,0.6304439787103197,1.0,2/7,5.33%,SKAP1;PLEK
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell proliferation (GO:0050680),-0.5866788960194023,-1.3311983216963763,0.08333333333333333,0.6296989315269883,1.0,8/42,10.09%,TGFBR3;RUNX3;NLRC3;B2M;AQP11;BRCA2;STAT1;ATP5IF1
prerank,GO_Biological_Process_2021__negative regulation of exocytosis (GO:0045920),0.8044133877953367,1.3309938368195302,0.125,0.6805055547305562,1.0,2/9,0.57%,ANXA1;RAB33B
prerank,GO_Biological_Process_2021__positive regulation of NLRP3 inflammasome complex assembly (GO:1900227),-0.8488944093784228,-1.3309041247459057,0.10606060606060606,0.6295285488238155,1.0,1/6,0.52%,CD36
prerank,PanglaoDB_Augmented_2021__Ciliated Cells,-0.7334360692824058,-1.330398122990855,0.12307692307692308,0.6303023581206529,1.0,6/16,17.34%,ANKUB1;ATP5MK;CCDC39;DNAH12;TUBB4B;DNAH9
prerank,GO_Biological_Process_2021__neuropeptide signaling pathway (GO:0007218),0.6654315919629082,1.3298664504243631,0.20689655172413793,0.6839380110365536,1.0,7/15,17.63%,GLRA1;SORT1;SORCS3;SORL1;SORCS2;MCHR2;RAPGEF2
prerank,GO_Biological_Process_2021__synaptic vesicle budding from presynaptic endocytic zone membrane (GO:0016185),-0.7737030504551895,-1.3293024923131278,0.14285714285714285,0.6333670478558151,1.0,2/7,1.19%,MX2;MX1
prerank,GO_Biological_Process_2021__negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394),0.8558582381011512,1.3292553871315194,0.0851063829787234,0.6848184093161243,1.0,1/5,2.59%,SMAD7
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.7750415636034175,-1.3290539236168493,0.08955223880597014,0.6332678021518834,1.0,4/11,14.31%,HLA-B;HLA-F;HLA-DRA;HLA-E
prerank,GO_Biological_Process_2021__pyrimidine deoxyribonucleotide catabolic process (GO:0009223),-0.7571442022242844,-1.3286948271370578,0.15254237288135594,0.6335594388484559,1.0,3/10,4.95%,SMUG1;OGG1;NT5C
prerank,GO_Biological_Process_2021__lymphocyte mediated immunity (GO:0002449),-0.8070332355753334,-1.3284351022394139,0.07936507936507936,0.6332069941760858,1.0,5/9,8.19%,MYO1G;CD55;BTN3A3;BTN3A2;KLRD1
prerank,GO_Biological_Process_2021__negative regulation of protein transport (GO:0051224),-0.7223020617845657,-1.3279375940399403,0.14516129032258066,0.6341776573296325,1.0,1/14,1.20%,RSAD2
prerank,GO_Biological_Process_2021__bone resorption (GO:0045453),-0.8609790990670093,-1.3278215609311366,0.13043478260869565,0.6335927175660186,1.0,2/6,7.73%,TPP1;RAB3D
prerank,PanglaoDB_Augmented_2021__Osteocytes,0.5441452720724931,1.3277987066101076,0.07142857142857142,0.6898002581364279,1.0,14/40,16.66%,PDPN;TCF7L1;WNT5A;GPR161;CDH11;P3H2;ENAH;FBXL7;CXCL14;FERMT2;CD276;ANTXR1;RAI14;TNC
prerank,GO_Biological_Process_2021__regulation of early endosome to late endosome transport (GO:2000641),0.635145056610949,1.3277907033661402,0.09523809523809523,0.6882579666511046,1.0,5/17,11.38%,MSN;MAP2K1;PTPN23;SNX12;MAPK1
prerank,GO_Biological_Process_2021__defense response to fungus (GO:0050832),-0.8424212062150452,-1.3276177717153792,0.13793103448275862,0.6332425587313709,1.0,1/8,1.38%,GAPDH
prerank,GO_Biological_Process_2021__vasculature development (GO:0001944),0.7789317249501073,1.3273388450051402,0.23214285714285715,0.6886476406928956,1.0,2/6,17.35%,FBXW7;PIK3CA
prerank,GO_Biological_Process_2021__proteasomal ubiquitin-independent protein catabolic process (GO:0010499),-0.747091295270789,-1.3272190329291722,0.08823529411764706,0.6339750046673998,1.0,8/17,21.50%,PSMB3;PSMB6;PSMA7;PSMB9;PSMA5;PSMA3;PSMB5;NFE2L2
prerank,GO_Biological_Process_2021__negative regulation of execution phase of apoptosis (GO:1900118),0.7929164961798925,1.3271688195815643,0.09090909090909091,0.6877063700097977,1.0,1/6,5.40%,FZD3
prerank,GO_Biological_Process_2021__regulation of extracellular matrix disassembly (GO:0010715),0.8050559955165482,1.3270289670609499,0.1,0.6867696797193182,1.0,1/9,0.66%,PDPN
prerank,GO_Biological_Process_2021__negative regulation of synaptic transmission (GO:0050805),0.6364268229694843,1.3267780147696573,0.13953488372093023,0.6863665733517256,1.0,9/18,20.60%,LRRK2;SHANK2;PLK2;PTEN;PRRT1;SLC24A2;ATAD1;GRIK3;SLC30A1
prerank,"GO_Biological_Process_2021__positive regulation of gene expression, epigenetic (GO:0045815)",-0.637775617581952,-1.3267704747636813,0.1044776119402985,0.6345501034708988,1.0,6/45,4.71%,H1-4;H1-3;H1-2;TAF1D;H1-0;PADI2
prerank,GO_Biological_Process_2021__neutrophil activation (GO:0042119),-0.809215763245946,-1.3265461917423158,0.1746031746031746,0.6342385885831261,1.0,3/10,11.20%,CCL5;FCER1G;TYROBP
prerank,GO_Biological_Process_2021__oligosaccharide biosynthetic process (GO:0009312),0.7890817075251715,1.3262593858643827,0.09302325581395349,0.6853614600687893,1.0,3/8,11.79%,MPDU1;FUT9;ST6GALNAC5
prerank,GO_Biological_Process_2021__carbohydrate biosynthetic process (GO:0016051),0.7890817075251715,1.3262593858643827,0.09302325581395349,0.6853614600687893,1.0,3/8,11.79%,MPDU1;FUT9;ST6GALNAC5
prerank,GO_Biological_Process_2021__regulation of chondrocyte differentiation (GO:0032330),0.7429979868686474,1.3262423688424694,0.17142857142857143,0.6838267005642853,1.0,7/11,21.47%,ZBTB16;SOX5;BMPR1B;LOXL2;TGFBR1;SCIN;SOX6
prerank,GO_Biological_Process_2021__cellular copper ion homeostasis (GO:0006878),-0.8574548771308691,-1.3261796497804381,0.03076923076923077,0.6344462108131343,1.0,1/8,0.25%,MT2A
prerank,GO_Biological_Process_2021__negative regulation of B cell activation (GO:0050869),-0.7680950105717869,-1.3261213248782984,0.09090909090909091,0.6333518099847008,1.0,5/13,11.20%,MNDA;TNFAIP3;SAMSN1;BANK1;TYROBP
prerank,GO_Biological_Process_2021__digestive tract development (GO:0048565),0.6454724798975446,1.3260417524188417,0.17142857142857143,0.6828523780335368,1.0,8/17,13.48%,PKD1;SALL1;TNF;COBL;CCDC40;RARB;MEGF8;NIPBL
prerank,GO_Biological_Process_2021__negative regulation of myeloid leukocyte differentiation (GO:0002762),-0.7426442899305146,-1.3258340361314294,0.10344827586206896,0.6335986543811849,1.0,4/16,9.06%,CCL3;LILRB4;GPR137B;LILRB3
prerank,GO_Biological_Process_2021__regulation of histone methylation (GO:0031060),-0.7633313842195698,-1.3254899773487112,0.1,0.6335396167461839,1.0,3/9,13.98%,ZNF335;CHTOP;TET1
prerank,GO_Biological_Process_2021__carbohydrate homeostasis (GO:0033500),0.6198849795726811,1.3254028326381382,0.125,0.6841767722716837,1.0,11/41,11.06%,LEPR;IGF1R;ADIPOR2;PDK4;MCU;PPARG;BACE2;VGF;SOX4;KLF7;TCF7L2
prerank,GO_Biological_Process_2021__pattern recognition receptor signaling pathway (GO:0002221),-0.6219662891586869,-1.3252837982173795,0.07575757575757576,0.6330436532048048,1.0,5/42,3.91%,CD36;UBC;RPS27A;CD14;CTSB
prerank,GO_Biological_Process_2021__dense core granule cytoskeletal transport (GO:0099519),0.7054138381552143,1.3252442889016949,0.18604651162790697,0.683206274079103,1.0,3/7,19.97%,TANC2;PPFIA2;SYT4
prerank,GO_Biological_Process_2021__establishment of Golgi localization (GO:0051683),0.7959630151081702,1.324941307779383,0.10810810810810811,0.6823849079354714,1.0,3/7,11.51%,STK25;COPG1;RIPOR1
prerank,GO_Biological_Process_2021__production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.5961970896245276,1.3246935887552478,0.09302325581395349,0.6817404397224033,1.0,3/24,5.98%,SMAD1;SMAD2;SMAD3
prerank,GO_Biological_Process_2021__calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.8721529920069369,-1.3243136985733184,0.16326530612244897,0.6358120884797492,1.0,1/5,3.74%,CLDN7
prerank,GO_Biological_Process_2021__negative regulation of immune response (GO:0050777),-0.6040104462849656,-1.3241178176932422,0.05405405405405406,0.6353322540214925,1.0,10/77,9.21%,CALCR;NLRC3;DHX58;YES1;CD247;PRKAR1B;FYN;TNFAIP3;ENPP3;SAMSN1
prerank,GO_Biological_Process_2021__negative regulation of gene silencing by miRNA (GO:0060965),0.7807933075144339,1.3241157125187968,0.14583333333333334,0.6825659271485196,1.0,2/8,7.30%,PPARG;TNF
prerank,GO_Biological_Process_2021__cellular response to dsRNA (GO:0071359),-0.723615308319097,-1.3238318767613935,0.1111111111111111,0.6351755349644778,1.0,5/14,16.49%,IFIT1;NPM1;STING1;COLEC12;FLOT1
prerank,GO_Biological_Process_2021__regulation of embryonic development (GO:0045995),0.6438222932113522,1.323523914809412,0.06060606060606061,0.6840187806563793,1.0,13/24,18.85%,PHLDB1;DAG1;TDG;WDPCP;POGLUT1;RPS6KA6;BAG6;NIPBL;CLASP1;TRIP12;RAB14;CLASP2;B4GALT5
prerank,GO_Biological_Process_2021__peptidyl-lysine deacetylation (GO:0034983),0.7861823951798099,1.3229992002528614,0.12195121951219512,0.6848922321890287,1.0,2/8,3.65%,SIRT1;HDAC9
prerank,GO_Biological_Process_2021__regulation of organ growth (GO:0046620),0.7546345565428944,1.3226790275072238,0.175,0.6846191989102121,1.0,1/7,0.35%,DUSP6
prerank,GO_Biological_Process_2021__lipopolysaccharide-mediated signaling pathway (GO:0031663),-0.761706006202211,-1.3223331569083647,0.1864406779661017,0.6407853786089363,1.0,3/15,3.07%,CCL3;CCL5;CD14
prerank,GO_Biological_Process_2021__negative regulation of cell motility (GO:2000146),0.4956618599065521,1.3222834899950178,0.05555555555555555,0.685002764676879,1.0,23/72,14.68%,SERPINE1;SRGAP2B;DLG5;SMAD7;MITF;DAG1;DACH1;TMEFF2;JAG1;RECK;VCL;ROBO1;CRK;KANK1;PTPRK;RNF20;CCDC125;PTEN;NF1;GTPBP4;AFDN;FRMD5;SRGAP2
prerank,GO_Biological_Process_2021__regulation of mast cell activation (GO:0033003),-0.7898147961730669,-1.3220603059691647,0.10909090909090909,0.640767925563403,1.0,3/8,9.70%,CD300LF;PLSCR1;CD226
prerank,GO_Biological_Process_2021__entrainment of circadian clock by photoperiod (GO:0043153),-0.698660311186746,-1.322017308660372,0.14492753623188406,0.6395310714339723,1.0,7/20,18.38%,PER3;PER2;BHLHE40;PPP1CB;RBM4B;CRTC1;RBM4
prerank,GO_Biological_Process_2021__negative regulation of cell migration (GO:0030336),0.49696837594436005,1.321978035519711,0.03225806451612903,0.6847307537785078,1.0,29/91,17.58%,SERPINE1;SRGAP2B;FGF2;DLG5;SMAD7;MITF;PTPN23;DAG1;DACH1;TMEFF2;JAG1;RECK;VCL;ROBO1;KANK1;PTPRG;PTPRK;RNF20;PTEN;NF1;BMPR1A;GTPBP4;AFDN;CLASP1;SRGAP2;PTPRR;CLASP2;RAP2C;CX3CL1
prerank,GO_Biological_Process_2021__purine-containing compound metabolic process (GO:0072521),0.7786159878905593,1.3216334244919825,0.21428571428571427,0.6844032999971084,1.0,1/6,12.09%,FHIT
prerank,GO_Biological_Process_2021__regulation of platelet-derived growth factor receptor-beta signaling pathway (GO:2000586),0.7971011503586527,1.3215227020984381,0.10638297872340426,0.683539824359376,1.0,1/5,2.09%,HIP1R
prerank,GO_Biological_Process_2021__apoptotic mitochondrial changes (GO:0008637),-0.6686221049407027,-1.3212818714019003,0.14754098360655737,0.6413323067063292,1.0,6/22,7.84%,CLU;FIS1;VPS35;THEM4;HK2;IFIT2
prerank,GO_Biological_Process_2021__negative regulation of neurotransmitter secretion (GO:0046929),0.7792333274556108,1.3209886632035492,0.13636363636363635,0.6841199136142913,1.0,1/7,3.84%,RAP1A
prerank,GO_Biological_Process_2021__modulation by symbiont of host process (GO:0044003),-0.8039849352198813,-1.3209537846680375,0.12727272727272726,0.6413324680913133,1.0,3/10,2.81%,UBC;RPS27A;B2M
prerank,GO_Biological_Process_2021__pyrimidine deoxyribonucleotide biosynthetic process (GO:0009221),-0.8724194809438266,-1.3206303998191262,0.12,0.641724071705043,1.0,1/5,1.39%,CMPK2
prerank,GO_Biological_Process_2021__forebrain neuron differentiation (GO:0021879),0.8056765140916722,1.320346023578265,0.13043478260869565,0.6849789109755767,1.0,4/5,17.63%,SALL1;SHANK3;ERBB4;RAPGEF2
prerank,GO_Biological_Process_2021__regulation of low-density lipoprotein particle clearance (GO:0010988),-0.859161469221631,-1.3185699463182994,0.08771929824561403,0.6500748540597023,1.0,1/5,3.81%,ANXA2
prerank,GO_Biological_Process_2021__positive regulation of transmembrane transport (GO:0034764),-0.813248007118564,-1.3180197626157688,0.12,0.6514668773018002,1.0,1/12,0.08%,NR4A3
prerank,GO_Biological_Process_2021__regulation of AMPA receptor activity (GO:2000311),0.6080169711501077,1.3179759576540733,0.14634146341463414,0.6934758389003259,1.0,7/16,14.74%,NLGN1;RELN;SHISA9;SHANK3;PRRT1;CACNG8;CACNG2
prerank,GO_Biological_Process_2021__lipid modification (GO:0030258),0.6154918347841474,1.3176883823063508,0.1891891891891892,0.6929076898698198,1.0,5/25,5.54%,PLA2G7;PLPPR1;PLPP1;PLPP5;PLPPR4
prerank,GO_Biological_Process_2021__amyloid fibril formation (GO:1990000),-0.6324009347652503,-1.3173729180230203,0.13114754098360656,0.6530937201910908,1.0,4/35,2.81%,CD36;UBC;RPS27A;B2M
prerank,GO_Biological_Process_2021__regulation of oligodendrocyte differentiation (GO:0048713),-0.7660166343325285,-1.3170903964141742,0.12962962962962962,0.6529024717617958,1.0,3/10,10.30%,CXCR4;TNFRSF1B;PTN
prerank,GO_Biological_Process_2021__regulation of response to interferon-gamma (GO:0060330),-0.7691447784850223,-1.3158712587391057,0.09615384615384616,0.6575437991914521,1.0,4/12,11.78%,CDC37;PARP9;STAT1;IFNGR2
prerank,GO_Biological_Process_2021__regulation of long-term synaptic depression (GO:1900452),0.7381933999007301,1.3156773407277755,0.15555555555555556,0.6999767496893399,1.0,4/8,20.52%,GRID2;SHANK3;KCNB1;AGER
prerank,GO_Biological_Process_2021__negative regulation of cell activation (GO:0050866),0.783729590502662,1.3150821365426542,0.1346153846153846,0.7008191946103137,1.0,2/8,3.01%,PDGFA;LDLR
prerank,GO_Biological_Process_2021__negative regulation of RIG-I signaling pathway (GO:0039536),-0.8546148392240025,-1.3147739421969926,0.08771929824561403,0.6606379953542606,1.0,1/5,2.65%,DHX58
prerank,GO_Biological_Process_2021__positive regulation of angiogenesis (GO:0045766),0.5522816595063171,1.3137902780760384,0.1111111111111111,0.7045806443238706,1.0,12/62,9.91%,KLF4;SEMA5A;SERPINE1;SMAD1;FGF2;SIRT1;GAB1;WNT5A;RUNX1;SIRT6;TMIGD2;SASH1
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.7313948263390043,-1.3137040566294895,0.14285714285714285,0.6643985372847467,1.0,2/16,8.36%,PLN;CALM1
prerank,GO_Biological_Process_2021__regulation of sterol biosynthetic process (GO:0106118),0.7441174810117004,1.3136239970987915,0.1702127659574468,0.703992237932581,1.0,1/8,1.57%,ABCA2
prerank,GO_Biological_Process_2021__regulation of cell activation (GO:0050865),-0.8215756784536126,-1.3134750314895198,0.22950819672131148,0.6640200820777272,1.0,2/6,5.75%,FCER1G;TXK
prerank,GO_Biological_Process_2021__nucleic acid phosphodiester bond hydrolysis (GO:0090305),-0.6263920141250695,-1.31312329547952,0.11290322580645161,0.6641552376778731,1.0,11/53,11.16%,UBC;RPS27A;XPA;OGG1;GTF2H5;MUS81;MEI4;PNRC2;IHO1;REXO4;RBX1
prerank,GO_Biological_Process_2021__cellular response to cytokine stimulus (GO:0071345),-0.5186369136496921,-1.3127476225997774,0.023809523809523808,0.6648737510882615,1.0,42/277,8.28%,CCL4;MT2A;STAT4;CD36;CCL3;UBC;SIGIRR;CEBPD;RIPOR2;FOS;RPS27A;GAPDH;CXCR4;ZFP36;CCL5;JUNB;DUSP1;MNDA;PYHIN1;PID1;GRAP2;AIF1;IFIT1;RORA;RPL13A;DUOX1;AIM2;IL3RA;IL10RA;F13A1;RPS3;GBP3;IL12RB2;RHOU;OSMR;PRLR;STK39;FYN;NLRP12;CSF2RA;TNFRSF1B;OAS1
prerank,GO_Biological_Process_2021__axon guidance (GO:0007411),0.4506470911959067,1.3125895469511906,0.05263157894736842,0.7067593781092472,1.0,36/133,13.77%,PLXNB1;NRP1;GRB10;CDK5R1;CNTN2;SEMA5A;PLXNA2;RAP1GAP;GAB1;VASP;WNT5A;PTPRM;DAG1;RELN;PLXNA3;SEMA3B;PLXNB2;RYK;ROBO1;PLXNC1;TNR;SHANK3;NPTN;SPTAN1;UNC5B;ALCAM;NFIB;KLF7;EPHA6;ENAH;MAPK1;PDLIM7;GAB2;PLXNA1;DCC;PTK2
prerank,GO_Biological_Process_2021__response to host defenses (GO:0052200),-0.8372641041811761,-1.3120590808263324,0.125,0.6655203781952929,1.0,3/7,2.81%,UBC;RPS27A;B2M
prerank,GO_Biological_Process_2021__modulation by symbiont of host defense response (GO:0052031),-0.8372641041811761,-1.3120590808263324,0.125,0.6655203781952929,1.0,3/7,2.81%,UBC;RPS27A;B2M
prerank,GO_Biological_Process_2021__small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.8019857317802714,1.3120513090033685,0.13636363636363635,0.7076615828274151,1.0,2/8,1.43%,NUFIP1;RUVBL2
prerank,PanglaoDB_Augmented_2021__Plasma Cells,-0.6218083796183963,-1.311798595378883,0.136986301369863,0.6652704671057842,1.0,10/48,5.33%,H2AC8;CD37;CYCS;CXCR4;MS4A4A;GZMB;SLAMF6;CD93;NCF4;PLEK
prerank,GO_Biological_Process_2021__monosaccharide transmembrane transport (GO:0015749),-0.8474240167523907,-1.3117441077889531,0.21153846153846154,0.6641349281475073,1.0,2/5,10.34%,SLC5A9;SLC2A8
prerank,GO_Biological_Process_2021__negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.6583770759053811,-1.311699221813669,0.1774193548387097,0.6629499476970514,1.0,5/20,9.32%,RPL5;RPL11;RPL23;RPS7;GABARAPL2
prerank,GO_Biological_Process_2021__GPI anchor biosynthetic process (GO:0006506),0.6697385637489919,1.3116377178560632,0.09090909090909091,0.7078700949030794,1.0,3/22,1.13%,PIGQ;PIGU;PGAP1
prerank,GO_Biological_Process_2021__regulation of leukocyte cell-cell adhesion (GO:1903037),-0.855831892910106,-1.31141794360202,0.1,0.6630493210014345,1.0,1/6,0.40%,SKAP1
prerank,GO_Biological_Process_2021__cardiac muscle cell contraction (GO:0086003),0.6742616604199331,1.3113274747673966,0.1590909090909091,0.7078574943524922,1.0,3/14,5.10%,GSN;KCNJ2;SCN3B
prerank,GO_Biological_Process_2021__regulation of natural killer cell activation (GO:0032814),-0.8081062655621052,-1.3112727618777702,0.19642857142857142,0.662393008279091,1.0,4/6,19.00%,DCAF15;TYROBP;PRDM1;PTPN22
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885),-0.7768589903497704,-1.310843439311583,0.13114754098360656,0.6628520326957412,1.0,5/7,14.74%,B2M;ERAP1;ABCB9;TAP1;ERAP2
prerank,GO_Biological_Process_2021__ribosomal large subunit biogenesis (GO:0042273),-0.6138022923009121,-1.3104549078408991,0.08695652173913043,0.6630405343445295,1.0,22/45,19.85%,RPL3;RPL23A;RPL5;RPL7A;RPL10;RPL10A;RPL11;RPL24;RPL14;RPL6;NSA2;NPM1;RPLP0;NOP53;TRAF7;NHP2;SURF6;RPL35A;LAS1L;GTF3A;HEATR3;BRIX1
prerank,GO_Biological_Process_2021__neuron projection morphogenesis (GO:0048812),0.4661503187032942,1.3102363567074868,0.08695652173913043,0.710782978401829,1.0,35/106,19.71%,PLXNB1;LRP4;SLITRK5;MAP1S;NLGN1;NYAP2;LRRK2;RAB10;PLPPR4;TMEM106B;RYK;DOCK10;FLRT1;CTNNA2;BRSK1;SHANK3;GPM6A;ALCAM;BTBD3;KLF7;CELSR2;PTEN;DCC;CNTN4;SRGAP2;CNTNAP1;PARD3;SHTN1;FARP1;BRSK2;MAP6;TAOK2;MAP2;FGFR2;DCLK1
prerank,GO_Biological_Process_2021__regulation of vesicle-mediated transport (GO:0060627),0.46520071531847457,1.3102104113738289,0.07142857142857142,0.709366644661043,1.0,10/75,5.14%,RAB33B;NRP1;CD22;HIP1R;RNF139;PICALM;LRRK2;MAP2K1;TSC2;RAB10
prerank,GO_Biological_Process_2021__positive regulation of regulatory T cell differentiation (GO:0045591),-0.796170616918815,-1.309826739652505,0.06153846153846154,0.6646043621380677,1.0,3/10,10.77%,IL4I1;LILRB4;HLA-DRA
prerank,GO_Biological_Process_2021__substrate-dependent cell migration (GO:0006929),0.6823125176043454,1.3096820185264006,0.19047619047619047,0.7100887755898382,1.0,4/10,12.55%,NRP1;P2RY12;ANKS1A;ITGA2
prerank,GO_Biological_Process_2021__synapse assembly (GO:0007416),0.5555397339847816,1.309677471801921,0.10869565217391304,0.7084894765457169,1.0,12/39,11.81%,PLXNB1;GRID2;NLGN1;WNT5A;PLXNB2;RYK;DNM3;SHANK3;SHANK2;GPM6A;NRXN2;PTEN
prerank,GO_Biological_Process_2021__extracellular matrix organization (GO:0030198),0.460841540562739,1.3095564257609509,0.045454545454545456,0.7073055361408359,1.0,34/139,13.53%,COL5A3;MMP17;COL16A1;PDGFA;NCAN;SERPINE1;GSN;COL5A2;FGF2;EXOC8;COL24A1;LCP1;DAG1;SLC39A8;CTSK;BMP1;ADAMTSL2;RECK;TNR;ADAMTS17;FBN2;ADAMTSL3;MMP16;LOXL2;ITGAV;P3H2;COL11A1;NF1;ITGA2;COL6A1;FLRT2;COL25A1;JAM2;COL15A1
prerank,GO_Biological_Process_2021__glial cell migration (GO:0008347),-0.892873080441901,-1.3090742558938955,0.08196721311475409,0.6667146301595023,1.0,1/5,0.62%,CCL3
prerank,GO_Biological_Process_2021__regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.7551347524724409,-1.3088230289893314,0.09259259259259259,0.6666092699233974,1.0,8/18,11.78%,PARP14;CDC37;NR1H2;TXK;NLRC5;PARP9;STAT1;IFNGR2
prerank,GO_Biological_Process_2021__superoxide anion generation (GO:0042554),-0.7856815784944444,-1.3088172188843856,0.16363636363636364,0.6652432673210954,1.0,5/7,14.59%,DUOX1;NCF4;NCF2;CYBA;ALOX12
prerank,GO_Biological_Process_2021__regulation of DNA damage checkpoint (GO:2000001),0.6996781543551405,1.3086438859737293,0.17391304347826086,0.7093577992906048,1.0,2/9,18.66%,FEM1B;RFWD3
prerank,GO_Biological_Process_2021__response to amyloid-beta (GO:1904645),-0.6441707816669753,-1.3085499897791208,0.09836065573770492,0.6650527204995238,1.0,6/30,8.15%,CALCR;CD36;SNX6;IGF1;FYN;ITGA4
prerank,GO_Biological_Process_2021__positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),-0.7528664922412163,-1.3081233009397115,0.18181818181818182,0.6657297178921605,1.0,4/9,16.49%,RIPOR2;TYROBP;CAMK1;FLOT1
prerank,GO_Biological_Process_2021__calcineurin-mediated signaling (GO:0097720),0.7765654706940638,1.3073130098233778,0.23404255319148937,0.7108130108086369,1.0,6/8,18.52%,ADGRB2;NFAT5;PPP3CA;NFATC3;PPP3CB;NFATC2
prerank,GO_Biological_Process_2021__calcineurin-NFAT signaling cascade (GO:0033173),0.7765654706940638,1.3073130098233778,0.23404255319148937,0.7108130108086369,1.0,6/8,18.52%,ADGRB2;NFAT5;PPP3CA;NFATC3;PPP3CB;NFATC2
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.652113528770841,1.3073105973327523,0.07894736842105263,0.7092568773022144,1.0,10/22,12.35%,ARRDC3;FZR1;DCUN1D4;CDC14B;BTRC;UBE2L3;FBXW7;PTEN;UBE2N;DCUN1D1
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate adhesion (GO:0010811),-0.6192216542938463,-1.3073085074063342,0.1111111111111111,0.668310490834819,1.0,3/43,0.52%,FLNA;SKAP1;CD36
prerank,GO_Biological_Process_2021__activation of Janus kinase activity (GO:0042976),-0.8445738886373495,-1.307003949460741,0.16326530612244897,0.6683086609418648,1.0,1/5,6.83%,PRLR
prerank,GO_Biological_Process_2021__negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.7462515365637371,-1.3058454494765497,0.1267605633802817,0.6729483465581926,1.0,3/10,8.28%,OAS3;NLRC5;OAS1
prerank,GO_Biological_Process_2021__positive regulation of lipopolysaccharide-mediated signaling pathway (GO:0031666),0.8060582342194402,1.305655163096105,0.08695652173913043,0.7140581925586618,1.0,2/6,9.91%,CD180;SASH1
prerank,GO_Biological_Process_2021__peptidyl-serine modification (GO:0018209),0.45195540582467403,1.3054016442861376,0.047619047619047616,0.7137099860464381,1.0,35/138,16.08%,CDK5R1;POGLUT3;TGFBR2;CSNK1G1;STK32B;PKD1;GALNT13;LRRK2;RPS6KA4;TLK1;PARP1;MAST2;CAB39;MAP3K10;STK38L;BRSK1;POGLUT1;MAST3;PLK2;DYRK1A;WNK1;RPS6KA6;MAPK1;CAMKV;MAPKAPK2;CSNK1E;PRKCI;MARK1;GALNT1;MAP3K13;TGFBR1;AKT2;GALNT2;GSK3B;RPS6KB2
prerank,GO_Biological_Process_2021__nucleoside catabolic process (GO:0009164),-0.7423436402232021,-1.3053123064732224,0.1935483870967742,0.6742355308219212,1.0,3/9,10.19%,NT5C;TYMP;DPYS
prerank,GO_Biological_Process_2021__regulation of Fc-gamma receptor signaling pathway involved in phagocytosis (GO:1905449),-0.872069341313063,-1.3050140228318017,0.14285714285714285,0.6740466379036817,1.0,3/5,12.82%,APPL1;CD47;PTPRC
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell proliferation (GO:1904705),-0.6270358221599565,-1.3049494750720645,0.14754098360655737,0.6730197003871323,1.0,2/25,5.56%,NR4A3;IGF1
prerank,GO_Biological_Process_2021__response to ketone (GO:1901654),-0.7713271340842691,-1.3047763237204855,0.09090909090909091,0.6723108148625493,1.0,2/13,10.11%,TGFBR3;ABCB4
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type II Cells,-0.6051027134160748,-1.3047118082111184,0.0945945945945946,0.6711696525368205,1.0,11/50,4.85%,CD36;CEBPD;SAT1;RUNX3;MS4A4A;MARCO;ZMYND15;SIGLEC1;CD14;TNFSF10;LPCAT1
prerank,GO_Biological_Process_2021__positive regulation of macrophage migration (GO:1905523),-0.737235369169866,-1.3046857949634032,0.1774193548387097,0.6699114735209231,1.0,2/13,1.49%,CCL3;CCL5
prerank,GO_Biological_Process_2021__hexose transmembrane transport (GO:0008645),-0.8105882547841678,-1.3045923978681804,0.10344827586206896,0.6691090457865704,1.0,3/8,10.34%,SLC2A3;SLC5A9;SLC2A8
prerank,GO_Biological_Process_2021__inositol metabolic process (GO:0006020),0.8019114804734586,1.304591171688431,0.09523809523809523,0.7154261479584236,1.0,4/7,13.98%,IPPK;IMPA1;ISYNA1;PPIP5K1
prerank,GO_Biological_Process_2021__fatty acid transport (GO:0015908),-0.7812896962076228,-1.3045040074032879,0.14705882352941177,0.6680503104367623,1.0,1/10,0.52%,CD36
prerank,GO_Biological_Process_2021__positive regulation of type 2 immune response (GO:0002830),-0.7793071969075658,-1.3044871776610325,0.1875,0.6667713317190844,1.0,4/9,17.61%,RSAD2;NOD2;CD74;IL18
prerank,GO_Biological_Process_2021__signal complex assembly (GO:0007172),0.841999029953147,1.3039156396544131,0.12195121951219512,0.7161456922511031,1.0,1/5,4.13%,NCK2
prerank,GO_Biological_Process_2021__positive regulation of embryonic development (GO:0040019),-0.7983075239035752,-1.3032962811530069,0.24561403508771928,0.6715113847011941,1.0,2/7,8.34%,RACK1;CFL1
prerank,GO_Biological_Process_2021__intestinal absorption (GO:0050892),-0.9126098688317981,-1.3029630041325402,0.10909090909090909,0.6719159933363114,1.0,1/6,0.52%,CD36
prerank,PanglaoDB_Augmented_2021__Germ Cells,0.5622905519437843,1.302888023869625,0.13333333333333333,0.718435711941325,1.0,5/42,7.46%,TULP2;MYO1D;GCNA;UBE3D;STX11
prerank,GO_Biological_Process_2021__negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),-0.8405731518366824,-1.302843114969344,0.12962962962962962,0.6711003773923264,1.0,1/6,2.65%,DHX58
prerank,GO_Biological_Process_2021__positive regulation of NF-kappaB transcription factor activity (GO:0051092),-0.5512102897468636,-1.3026455832690684,0.0375,0.6709389165694446,1.0,23/117,12.59%,CD36;UBC;RPS27A;TFRC;CARD14;PRKCQ;CARD16;TRIM5;BTK;DDRGK1;AIM2;CLU;RPS3;LAMTOR5;TRIM22;EIF2AK2;PRKD2;TRIM13;CFLAR;NPM1;IL18R1;HSPA1B;TERF2IP
prerank,GO_Biological_Process_2021__positive regulation of microglial cell migration (GO:1904141),-0.8636645719625977,-1.3022056279861478,0.14285714285714285,0.6712909722421636,1.0,1/5,0.62%,CCL3
prerank,GO_Biological_Process_2021__negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.7230166718051744,-1.3021541521219653,0.15517241379310345,0.6701230943095751,1.0,3/11,5.56%,PRELID1;CLU;IGF1
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell surface (GO:2000009),0.7672248839970388,1.3021330278790424,0.15217391304347827,0.7202366256204947,1.0,3/8,13.94%,PICALM;NEDD4L;LEPROTL1
prerank,GO_Biological_Process_2021__interleukin-21-mediated signaling pathway (GO:0038114),-0.8283422724837721,-1.3020177957513173,0.14035087719298245,0.6681919728682681,1.0,2/6,9.56%,STAT4;STAT1
prerank,GO_Biological_Process_2021__cellular response to interleukin-21 (GO:0098757),-0.8283422724837721,-1.3020177957513173,0.14035087719298245,0.6681919728682681,1.0,2/6,9.56%,STAT4;STAT1
prerank,GO_Biological_Process_2021__neutrophil degranulation (GO:0043312),-0.5003668154140103,-1.301800589455943,0.043478260869565216,0.6677663889007792,1.0,71/346,15.24%,CD36;SLC2A3;PPIE;FTH1;NIT2;HLA-B;DYNLT1;MNDA;CD55;RNASET2;ENPP4;CLEC12A;CHIT1;RAB37;B2M;CD14;FCAR;SRP14;SELL;FCER1G;ANXA2;CTSB;CD93;PADI2;LPCAT1;HLA-C;GLA;JUP;NBEAL2;CD63;PECAM1;RAB3A;GSTP1;C5AR1;RAB3D;CYSTM1;AGA;TNFRSF1B;OLR1;ACAA1;OSCAR;CD44;COMMD9;LILRB3;CHI3L1;SLC11A1;ITGB2;NCKAP1L;PTGES2;PTPRB;PRDX4;TYROBP;ITGAL;STING1;CD47;PSMD12;HSPA1B;CYBA;PTPRC;PSMA5;FTL;OSTF1;TUBB4B;CRACR2A;HSPA1A;IGF2R;TIMP2;C3;TMEM179B;FPR1;GUSB
prerank,GO_Biological_Process_2021__lipoprotein transport (GO:0042953),-0.8461783737607935,-1.3015349650572003,0.10638297872340426,0.6677656931871084,1.0,1/7,0.52%,CD36
prerank,GO_Biological_Process_2021__mitochondrial cytochrome c oxidase assembly (GO:0033617),-0.7638496590645056,-1.300890033073405,0.12727272727272726,0.6690490986629265,1.0,6/13,18.82%,TIMM21;BCS1L;COX18;OXA1L;SURF1;COX20
prerank,GO_Biological_Process_2021__positive regulation of early endosome to late endosome transport (GO:2000643),0.7634641048150654,1.3008320021393398,0.20454545454545456,0.7238353785311019,1.0,2/8,4.44%,MSN;PTPN23
prerank,GO_Biological_Process_2021__protein retention in ER lumen (GO:0006621),0.8235898260039289,1.3005677491026026,0.19444444444444445,0.7236028336933321,1.0,1/6,1.27%,PDIA2
prerank,GO_Biological_Process_2021__hepatocyte growth factor receptor signaling pathway (GO:0048012),0.7364178580102139,1.3004652777181895,0.18421052631578946,0.7223930609777326,1.0,3/7,9.97%,NRP1;HPN;HGF
prerank,GO_Biological_Process_2021__regulation of cellular response to growth factor stimulus (GO:0090287),0.7468629837442604,1.3003397776946088,0.21153846153846154,0.7214787550946063,1.0,3/6,14.65%,TWSG1;PCSK6;XIAP
prerank,GO_Biological_Process_2021__nuclear pore complex assembly (GO:0051292),0.7425968396778049,1.2999646511483178,0.15384615384615385,0.7216740348671591,1.0,6/9,25.66%,NUP153;RTN4;NDC1;NUP205;NUP98;TPR
prerank,GO_Biological_Process_2021__positive regulation of hydrolase activity (GO:0051345),-0.5511975422249684,-1.2998518528454894,0.05263157894736842,0.6720812790804004,1.0,8/90,5.49%,CCL4;CCL3;CCL5;RGS1;RGS16;RACK1;GNB5;RPS3
prerank,GO_Biological_Process_2021__cellular response to interleukin-1 (GO:0071347),-0.5457186058369321,-1.2998123353127309,0.0875,0.6708604189726792,1.0,17/102,12.85%,CCL4;CCL3;UBC;RPS27A;CCL5;PSMB3;GBP3;PSMB6;PSMA7;GBP2;PSMB9;RBX1;HIF1A;CD47;PSMD12;PSMD8;PSMA5
prerank,GO_Biological_Process_2021__ribonucleoprotein complex biogenesis (GO:0022613),-0.6262846461096742,-1.2997468318805927,0.09230769230769231,0.669761875479805,1.0,12/50,7.39%,RBIS;RPL38;RPL5;RPS15;RPS25;RPS24;METTL17;RPL11;GLUL;RPL14;RPS6;RPS7
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell proliferation (GO:0001938),0.55487156394036,1.2995289630162603,0.03333333333333333,0.7219998022158063,1.0,5/41,4.48%,NRP1;SEMA5A;FGF2;SIRT1;WNT5A
prerank,GO_Biological_Process_2021__regulation of complement activation (GO:0030449),-0.6898668004527424,-1.299143972391401,0.1,0.6711823780122792,1.0,7/20,14.85%,CD55;CLU;PHB2;C5AR1;C5AR2;SERPING1;C3
prerank,GO_Biological_Process_2021__axon development (GO:0061564),0.5573941164866612,1.2988435438954378,0.10344827586206896,0.7235822441395581,1.0,20/58,19.59%,SLITRK5;CDK5R1;SEMA5A;MAP1S;RAB10;PLPPR4;RYK;CTNNA2;BRSK1;KLF7;RTN4;DCC;CNTN4;PARD3;SHTN1;CAMSAP2;BRSK2;MARK2;TAOK2;FGFR2
prerank,GO_Biological_Process_2021__neutrophil activation involved in immune response (GO:0002283),-0.49952000751718895,-1.2988275998276495,0.06382978723404255,0.671308959331305,1.0,71/349,15.24%,CD36;SLC2A3;PPIE;FTH1;NIT2;HLA-B;DYNLT1;MNDA;CD55;RNASET2;ENPP4;CLEC12A;CHIT1;RAB37;B2M;CD14;FCAR;SRP14;SELL;FCER1G;ANXA2;CTSB;CD93;PADI2;LPCAT1;HLA-C;GLA;JUP;NBEAL2;CD63;PECAM1;RAB3A;GSTP1;C5AR1;RAB3D;CYSTM1;AGA;TNFRSF1B;OLR1;ACAA1;OSCAR;CD44;COMMD9;LILRB3;CHI3L1;SLC11A1;ITGB2;NCKAP1L;PTGES2;PTPRB;PRDX4;TYROBP;ITGAL;STING1;CD47;PSMD12;HSPA1B;CYBA;PTPRC;PSMA5;FTL;OSTF1;TUBB4B;CRACR2A;HSPA1A;IGF2R;TIMP2;C3;TMEM179B;FPR1;GUSB
prerank,GO_Biological_Process_2021__rRNA 3'-end processing (GO:0031125),-0.7636977202328346,-1.298239993180204,0.21052631578947367,0.6726542041608897,1.0,2/9,7.08%,RPS21;EXOSC10
prerank,PanglaoDB_Augmented_2021__Oxyphil Cells,0.5742749523782753,1.298190279295186,0.16129032258064516,0.7248178550754668,1.0,14/38,14.24%,WIPF3;L2HGDH;ADRA1A;SYCP2L;ACACB;DTNA;CADM2;LDB3;PREX2;HIF3A;CMYA5;SLC35F1;RBFOX1;HFM1
prerank,GO_Biological_Process_2021__positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization (GO:1904925),-0.8235636562974606,-1.2981866164269558,0.10416666666666667,0.6716106671736801,1.0,3/6,10.09%,TOMM7;HK2;ATP5IF1
prerank,GO_Biological_Process_2021__regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.6946415938185692,-1.2978937289043369,0.09090909090909091,0.6714861486771007,1.0,5/20,8.32%,OAS3;CDC37;NLRC5;OAS1;RNASEL
prerank,GO_Biological_Process_2021__muscle cell differentiation (GO:0042692),-0.7513909005960342,-1.2976310459198268,0.15151515151515152,0.6713288978195087,1.0,3/16,9.67%,RORA;SYNE1;GLMN
prerank,GO_Biological_Process_2021__neutrophil mediated immunity (GO:0002446),-0.4984605980442514,-1.2972775473180582,0.043478260869565216,0.6717357293753438,1.0,71/350,15.24%,CD36;SLC2A3;PPIE;FTH1;NIT2;HLA-B;DYNLT1;MNDA;CD55;RNASET2;ENPP4;CLEC12A;CHIT1;RAB37;B2M;CD14;FCAR;SRP14;SELL;FCER1G;ANXA2;CTSB;CD93;PADI2;LPCAT1;HLA-C;GLA;JUP;NBEAL2;CD63;PECAM1;RAB3A;GSTP1;C5AR1;RAB3D;CYSTM1;AGA;TNFRSF1B;OLR1;ACAA1;OSCAR;CD44;COMMD9;LILRB3;CHI3L1;SLC11A1;ITGB2;NCKAP1L;PTGES2;PTPRB;PRDX4;TYROBP;ITGAL;STING1;CD47;PSMD12;HSPA1B;CYBA;PTPRC;PSMA5;FTL;OSTF1;TUBB4B;CRACR2A;HSPA1A;IGF2R;TIMP2;C3;TMEM179B;FPR1;GUSB
prerank,GO_Biological_Process_2021__piRNA metabolic process (GO:0034587),-0.8468047729760847,-1.2972471393933993,0.16129032258064516,0.6706522870991495,1.0,3/6,10.44%,MYBL1;MOV10L1;TDRKH
prerank,GO_Biological_Process_2021__regulation of dendritic cell antigen processing and presentation (GO:0002604),-0.844680147193542,-1.297103808407905,0.1875,0.6701343066992589,1.0,2/5,14.09%,SLC11A1;NOD2
prerank,GO_Biological_Process_2021__T-helper cell differentiation (GO:0042093),-0.8347359398164224,-1.2970896724348275,0.10714285714285714,0.6689262009049318,1.0,1/6,1.61%,GPR183
prerank,PanglaoDB_Augmented_2021__Pinealocytes,0.5215068641533993,1.2968678370291145,0.07692307692307693,0.7280837159235979,1.0,8/39,9.76%,CACNA1A;AANAT;AP3B2;SCN3B;MGAT4C;PDE10A;TNR;SV2B
prerank,GO_Biological_Process_2021__DNA duplex unwinding (GO:0032508),-0.5868063614378132,-1.2968454157684777,0.140625,0.6686108277605318,1.0,5/40,4.34%,DDX11;UBC;RPS27A;XPA;GTF2H5
prerank,GO_Biological_Process_2021__RNA metabolic process (GO:0016070),0.45562522104782294,1.2967735132255005,0.11538461538461539,0.7267783545221473,1.0,8/111,2.70%,ADARB2;POLR2D;NUFIP1;SYNCRIP;RNASEH2C;TBRG4;NOL9;WDR74
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix disassembly (GO:0090091),0.8327052060487363,1.2965960718741065,0.10638297872340426,0.7258683723463975,1.0,1/5,0.66%,PDPN
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion mediated by integrin (GO:0033630),-0.8054613382898885,-1.296595334882325,0.16071428571428573,0.6685593057180667,1.0,2/9,1.49%,SKAP1;CCL5
prerank,GO_Biological_Process_2021__myeloid dendritic cell activation (GO:0001773),0.7363352743866347,1.2965264178501335,0.20454545454545456,0.7245474156557717,1.0,1/7,1.95%,TGFBR2
prerank,GO_Biological_Process_2021__negative regulation of IRE1-mediated unfolded protein response (GO:1903895),-0.8513223396143772,-1.296236341654435,0.16666666666666666,0.6690159134495705,1.0,2/5,4.19%,DNAJB9;DDRGK1
prerank,GO_Biological_Process_2021__regulation of muscle contraction (GO:0006937),-0.794607086533029,-1.295975232966445,0.12903225806451613,0.669111008276696,1.0,3/11,7.44%,CHRM2;SRI;MYBPC3
prerank,GO_Biological_Process_2021__regulation of neurotransmitter receptor activity (GO:0099601),0.5344580212429481,1.295688104268864,0.09090909090909091,0.7268286003037009,1.0,22/42,22.89%,NETO1;NLGN1;RELN;NPTXR;SHISA9;GRIA3;GRIA4;GRIA1;GRIN2B;NPTX1;PRRT1;GRIA2;CACNG8;CACNG2;GRIN2A;DLGAP4;DLGAP1;CACNG3;CNIH3;GRIN1;DLG2;DLGAP2
prerank,GO_Biological_Process_2021__interleukin-7-mediated signaling pathway (GO:0038111),-0.7783829486921116,-1.2956509567959358,0.1206896551724138,0.667931546792771,1.0,1/10,1.80%,IL7R
prerank,GO_Biological_Process_2021__cellular response to interleukin-7 (GO:0098761),-0.7783829486921116,-1.2956509567959358,0.1206896551724138,0.667931546792771,1.0,1/10,1.80%,IL7R
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),-0.632892463630905,-1.2956247475673186,0.18461538461538463,0.6667759641314801,1.0,4/30,3.46%,FLNA;CHRM2;MARCO;RGS1
prerank,GO_Biological_Process_2021__adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.7838869668178058,1.2941642588832887,0.20930232558139536,0.7310881127670291,1.0,3/5,17.63%,ADRA1A;ADCY9;RAPGEF2
prerank,GO_Biological_Process_2021__chemokine (C-X-C motif) ligand 12 signaling pathway (GO:0038146),-0.8545066431701019,-1.2940242486519151,0.13725490196078433,0.6730263108297503,1.0,2/5,7.09%,CXCR4;STK39
prerank,GO_Biological_Process_2021__heterotypic cell-cell adhesion (GO:0034113),-0.7062615776267561,-1.293828373574523,0.14285714285714285,0.6727727947584599,1.0,9/20,18.52%,CD2;CD200R1;JUP;ITGA4;ITGB2;DSC2;CD200;PKP2;ITGB1
prerank,GO_Biological_Process_2021__regulation of ruffle assembly (GO:1900027),0.6624377029105295,1.2936324042147769,0.2,0.7314906679489995,1.0,4/14,11.03%,EPS8;NLGN1;KANK1;P2RY12
prerank,PanglaoDB_Augmented_2021__Cholinergic Neurons,0.5276718246926937,1.2935955090091287,0.08823529411764706,0.7300147370176316,1.0,9/36,11.82%,KCNQ2;DPYSL5;NCAN;SNAP91;CSPG5;VGF;PURG;LINGO1;CAMKV
prerank,GO_Biological_Process_2021__positive regulation of DNA binding (GO:0043388),-0.7438136126856394,-1.2927871502997421,0.08064516129032258,0.6764821236288441,1.0,4/17,5.56%,PYHIN1;EDF1;H1-0;IGF1
prerank,GO_Biological_Process_2021__regulation of DNA biosynthetic process (GO:2000278),0.6367349574345555,1.292343112426681,0.14285714285714285,0.7335220915699401,1.0,4/18,9.97%,PDGFA;FGF2;DACH1;HGF
prerank,GO_Biological_Process_2021__B cell mediated immunity (GO:0019724),-0.7775714469284815,-1.2922702031115212,0.1864406779661017,0.6776112339734417,1.0,2/5,15.77%,FCER1G;CD74
prerank,GO_Biological_Process_2021__positive regulation of protein ubiquitination (GO:0031398),0.5317255473459278,1.2921303298740008,0.043478260869565216,0.7329185257478505,1.0,12/56,14.94%,UBE2D1;SMAD7;LRRK2;ARRDC3;DCUN1D4;LAPTM5;UBE2L3;FBXW7;UBE2N;DCUN1D1;XIAP;TRAF6
prerank,GO_Biological_Process_2021__negative regulation of protein import into nucleus (GO:0042308),-0.8153764839963448,-1.292123248032963,0.10714285714285714,0.6759652811477944,1.0,2/6,4.08%,MDFIC;APOD
prerank,GO_Biological_Process_2021__negative regulation of protein import (GO:1904590),-0.8153764839963448,-1.292123248032963,0.10714285714285714,0.6759652811477944,1.0,2/6,4.08%,MDFIC;APOD
prerank,GO_Biological_Process_2021__sensory perception of light stimulus (GO:0050953),0.523779355679939,1.2909981011528588,0.12903225806451613,0.7362005827701292,1.0,4/38,3.93%,TULP2;PCDH15;CRYGS;RP2
prerank,GO_Biological_Process_2021__glycerophospholipid catabolic process (GO:0046475),0.6224171758475437,1.2904615142099625,0.16981132075471697,0.7368685579200175,1.0,3/17,5.79%,PLA2G4C;PLA2G7;PRDX6
prerank,GO_Biological_Process_2021__inositol phosphate dephosphorylation (GO:0046855),0.6846268232982311,1.2903148854374824,0.16666666666666666,0.7344136093765851,1.0,4/10,16.55%,INPP1;IMPA1;PTEN;INPP5A
prerank,GO_Biological_Process_2021__phosphorylated carbohydrate dephosphorylation (GO:0046838),0.6846268232982311,1.2903148854374824,0.16666666666666666,0.7344136093765851,1.0,4/10,16.55%,INPP1;IMPA1;PTEN;INPP5A
prerank,GO_Biological_Process_2021__dorsal/ventral pattern formation (GO:0009953),0.7641725270391171,1.2899018150335957,0.15217391304347827,0.7342451490786113,1.0,4/8,14.04%,BMPR1B;PTCH1;BMPR1A;AIDA
prerank,GO_Biological_Process_2021__presynaptic membrane organization (GO:0097090),0.7006172785588768,1.289611427500968,0.22727272727272727,0.7340521122757753,1.0,7/10,17.29%,LRP4;CNTN2;NLGN1;PTPRD;PTEN;NLGN4Y;IL1RAPL1
prerank,GO_Biological_Process_2021__negative regulation of p38MAPK cascade (GO:1903753),-0.79422291166811,-1.289482054906088,0.18181818181818182,0.6869445315850145,1.0,1/7,1.54%,DUSP1
prerank,GO_Biological_Process_2021__glycerolipid biosynthetic process (GO:0045017),0.7453786319758489,1.2894351854422996,0.2553191489361702,0.7333553353585799,1.0,2/5,21.64%,HDHD5;CPNE3
prerank,GO_Biological_Process_2021__cholesterol metabolic process (GO:0008203),-0.6192974744617927,-1.2894005241464224,0.11666666666666667,0.6859951947325762,1.0,3/42,0.88%,OSBPL5;INSIG1;CH25H
prerank,GO_Biological_Process_2021__chromatin maintenance (GO:0070827),0.79080184800116,1.288817986310189,0.25,0.7348013114558373,1.0,1/5,2.51%,SIRT1
prerank,GO_Biological_Process_2021__regulation of protein ADP-ribosylation (GO:0010835),-0.805262573437982,-1.2886723939094307,0.08928571428571429,0.6879599052101928,1.0,1/6,1.84%,WARS1
prerank,GO_Biological_Process_2021__androgen receptor signaling pathway (GO:0030521),0.706003824013307,1.2883127791011868,0.15384615384615385,0.7354122436854255,1.0,2/10,5.23%,ARID1A;PLPP1
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase I (GO:0045943),-0.6974878338356022,-1.288221989684289,0.16129032258064516,0.688847888326394,1.0,1/19,0.51%,DDX11
prerank,GO_Biological_Process_2021__macrophage activation (GO:0042116),-0.6326769871895919,-1.2875998528764954,0.203125,0.6899875381141032,1.0,6/27,10.55%,AIF1;CD93;CLU;C5AR1;SLC11A1;ITGB2
prerank,GO_Biological_Process_2021__depyrimidination (GO:0045008),-0.7622783474409678,-1.2874551317484213,0.2222222222222222,0.6894053767285622,1.0,2/6,4.21%,SMUG1;OGG1
prerank,GO_Biological_Process_2021__sphingolipid metabolic process (GO:0006665),0.4934992339797222,1.2872487328540487,0.07692307692307693,0.7390291098829843,1.0,12/78,6.69%,VAPB;ACER2;ARSA;ABCA2;PPM1L;GLB1;ST6GALNAC3;PLPP1;FA2H;PPT1;SPTLC2;HACD2
prerank,PanglaoDB_Augmented_2021__Spermatocytes,0.8242538699470102,1.2866258330138174,0.2894736842105263,0.7395537262816612,1.0,2/6,5.60%,SYCP3;GCNA
prerank,GO_Biological_Process_2021__necroptotic process (GO:0070266),-0.7350119706173204,-1.286572734392528,0.15789473684210525,0.6920003165645051,1.0,3/11,14.98%,CD14;MLKL;IPMK
prerank,GO_Biological_Process_2021__organic hydroxy compound transport (GO:0015850),-0.6559794622922529,-1.2865668858609236,0.14285714285714285,0.6907669253631836,1.0,2/18,4.96%,SLC51A;ABCC3
prerank,GO_Biological_Process_2021__female gonad development (GO:0008585),-0.7800531466878442,-1.2865216798071755,0.11290322580645161,0.6897278384667018,1.0,4/9,19.59%,VEGFA;SOD1;EIF2B2;CYP19A1
prerank,GO_Biological_Process_2021__glycosphingolipid metabolic process (GO:0006687),0.5535574279354964,1.2864020738159845,0.15151515151515152,0.7384533147413351,1.0,5/34,5.16%,ARSA;ABCA2;GLB1;LARGE1;ST6GALNAC3
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transport (GO:1904427),-0.7181690637293141,-1.2857996533978155,0.21052631578947367,0.6914870299479502,1.0,2/11,3.66%,CALCR;CEMIP
prerank,GO_Biological_Process_2021__tight junction assembly (GO:0120192),-0.6903782258673725,-1.2856534014165355,0.125,0.6910019909322612,1.0,4/22,7.76%,MPP7;CLDN7;PECAM1;ACTG1
prerank,GO_Biological_Process_2021__regulation of ER to Golgi vesicle-mediated transport (GO:0060628),0.7563503447450985,1.2852895606247903,0.24444444444444444,0.7415931133148262,1.0,3/8,3.81%,PGAP1;RNF139;LRRK2
prerank,GO_Biological_Process_2021__negative regulation of T cell migration (GO:2000405),-0.8262749156678947,-1.2849796382070924,0.1864406779661017,0.6925165226925657,1.0,3/5,4.08%,RIPOR2;CD200R1;APOD
prerank,GO_Biological_Process_2021__regulation of hematopoietic stem cell differentiation (GO:1902036),-0.5763758890489342,-1.28449626544176,0.1625,0.6933346662078782,1.0,17/55,22.96%,PSMB3;EIF2AK2;PSMB6;PSMA7;PSMB9;TCF3;PSMD12;PSMD8;PSMA5;SETD1A;PSMA3;PSMC4;PSME2;PSME1;PSMB5;PSMC3;PSME3
prerank,GO_Biological_Process_2021__negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.7168803422404548,1.284437302427325,0.17073170731707318,0.7430540883819194,1.0,1/10,0.35%,BAG3
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.6990871529365843,1.2841576190088995,0.15789473684210525,0.7424743556683223,1.0,4/15,4.71%,HS3ST5;CSGALNACT1;HS2ST1;UGDH
prerank,GO_Biological_Process_2021__response to retinoic acid (GO:0032526),0.5782570621094684,1.284019700256421,0.15555555555555556,0.7416988907134735,1.0,3/27,8.25%,ACER2;WNT5A;BRINP3
prerank,GO_Biological_Process_2021__proteasome assembly (GO:0043248),-0.7673649353861356,-1.2839227289250936,0.18867924528301888,0.6946670893773601,1.0,3/9,19.33%,ADRM1;OTUD6B;PSMG1
prerank,GO_Biological_Process_2021__glutamine transport (GO:0006868),-0.7993700319012087,-1.2838694896825453,0.21052631578947367,0.6936791529348982,1.0,3/5,17.98%,SLC38A1;SLC38A6;SLC1A4
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),-0.8424473012416323,-1.2838410074268454,0.07407407407407407,0.6926010721402927,1.0,2/5,8.36%,SRI;CALM1
prerank,GO_Biological_Process_2021__aminophospholipid transport (GO:0015917),0.8178743874097543,1.2837074272891147,0.3090909090909091,0.7413961261504267,1.0,1/5,6.28%,SCARB2
prerank,GO_Biological_Process_2021__regulation of cGMP-mediated signaling (GO:0010752),0.8181306442898413,1.2836382689971022,0.17777777777777778,0.7402314231031728,1.0,3/5,13.04%,RUNDC3A;PDE10A;CGAS
prerank,GO_Biological_Process_2021__positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.6645684484237475,-1.2832839589818164,0.16666666666666666,0.6943485371659268,1.0,10/26,15.77%,CXCR4;PARP14;CD300LF;TXK;NLRC5;PARP9;HIF1A;HSPA1B;HSPA1A;CD74
prerank,PanglaoDB_Augmented_2021__Trichocytes,-0.8273642243823378,-1.2832577361777169,0.20408163265306123,0.6932420029564497,1.0,1/5,12.31%,ADGRG6
prerank,GO_Biological_Process_2021__positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.6245618471670844,1.2831836822705096,0.16279069767441862,0.7407204535042184,1.0,4/14,13.44%,DDIT3;BOK;RNF185;BAG6
prerank,GO_Biological_Process_2021__nuclear transport (GO:0051169),0.7226389355633904,1.2829854965279077,0.21052631578947367,0.7399302759642961,1.0,3/11,7.27%,NUTF2;XPO1;HMGA1
prerank,GO_Biological_Process_2021__malate metabolic process (GO:0006108),-0.8318149920170714,-1.282708811712663,0.1875,0.6946403201599959,1.0,2/6,2.23%,ME1;MDH2
prerank,GO_Biological_Process_2021__cellular response to hepatocyte growth factor stimulus (GO:0035729),0.7573516254064665,1.282480531217284,0.17777777777777778,0.7385552008776605,1.0,2/6,9.97%,NRP1;HGF
prerank,GO_Biological_Process_2021__response to hepatocyte growth factor (GO:0035728),0.7573516254064665,1.282480531217284,0.17777777777777778,0.7385552008776605,1.0,2/6,9.97%,NRP1;HGF
prerank,GO_Biological_Process_2021__positive regulation of histone modification (GO:0031058),0.5904604307097094,1.2820723988105167,0.0975609756097561,0.7388727728828332,1.0,3/26,5.00%,PPARGC1A;RUVBL2;RPS6KA4
prerank,"GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",-0.7282001762062562,-1.2820710876238248,0.09615384615384616,0.695084798716979,1.0,1/12,1.48%,ZFP36
prerank,"GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",-0.7282001762062562,-1.2820710876238248,0.09615384615384616,0.695084798716979,1.0,1/12,1.48%,ZFP36
prerank,GO_Biological_Process_2021__negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.6883921729224498,-1.281608709736889,0.2153846153846154,0.6959779411996043,1.0,4/15,15.37%,NLRC3;NLRP12;TMSB4X;IFI35
prerank,GO_Biological_Process_2021__phosphatidylglycerol metabolic process (GO:0046471),-0.6893521407015116,-1.2815157442899192,0.21818181818181817,0.6953101932520418,1.0,1/13,4.85%,LPCAT1
prerank,GO_Biological_Process_2021__actin filament-based transport (GO:0099515),-0.7096252706549528,-1.2815030470695092,0.1864406779661017,0.6941829525056716,1.0,2/14,1.88%,MYO1G;SYNE2
prerank,PanglaoDB_Augmented_2021__Enteric Glia Cells,0.4937999820026568,1.2813667779629556,0.15384615384615385,0.7405047401454198,1.0,25/65,20.67%,LGI4;CNTN2;GFAP;ZNF536;NDRG2;INTS6;PLPPR4;PCDH17;CHST1;NTM;SHC2;PTPN5;PTPRD;LINGO1;NTRK2;CXCL14;NFASC;MAPK4;TMEM132C;CX3CL1;DCLK1;CNTN1;PHYHIPL;GRIK3;MEGF10
prerank,GO_Biological_Process_2021__isoprenoid biosynthetic process (GO:0008299),0.7828692579214648,1.2811503386561105,0.15555555555555556,0.7396986138798617,1.0,2/6,11.61%,IDI1;MVD
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905005),0.737142384841235,1.280935671060077,0.225,0.7389199852474819,1.0,1/6,1.95%,TGFBR2
prerank,GO_Biological_Process_2021__eye photoreceptor cell development (GO:0042462),-0.7938271996515839,-1.2808464534234556,0.14814814814814814,0.6957491440423369,1.0,3/9,13.29%,RPGRIP1L;VEGFA;NRL
prerank,GO_Biological_Process_2021__dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.7477003596516743,1.2805541581610973,0.2,0.7390163239122252,1.0,4/10,11.46%,NCAN;CSGALNACT1;CSPG5;UST
prerank,GO_Biological_Process_2021__positive regulation of ligase activity (GO:0051351),-0.787685457433269,-1.2805532257815466,0.1702127659574468,0.6958830785841218,1.0,2/8,8.69%,GCLM;TMSB4X
prerank,GO_Biological_Process_2021__cardiac muscle cell-cardiac muscle cell adhesion (GO:0086042),-0.8184714059696193,-1.2802429018387214,0.16129032258064516,0.6959399703826425,1.0,3/5,16.41%,JUP;DSC2;PKP2
prerank,GO_Biological_Process_2021__purine ribonucleotide biosynthetic process (GO:0009152),0.5528921380473408,1.2802241742055063,0.1388888888888889,0.7391364477847436,1.0,7/34,15.24%,PANK3;PANK1;ADCY9;GUCY1A1;NPR2;ADCY6;GUCY1B1
prerank,GO_Biological_Process_2021__detection of bacterium (GO:0016045),-0.8017315208024789,-1.279809206228511,0.16666666666666666,0.6970514566822883,1.0,2/7,3.02%,HLA-B;NAIP
prerank,GO_Biological_Process_2021__cellular response to glucose stimulus (GO:0071333),0.5127701179900209,1.2790823639451887,0.2413793103448276,0.7422230555666623,1.0,11/25,20.52%,IGF1R;SLC39A14;UNC13B;SOX4;PCK2;PTPRN;PRKAA1;TRA2B;ZBTB20;KCNB1;AGER
prerank,GO_Biological_Process_2021__actin filament reorganization (GO:0090527),0.8617927649948982,1.2786911252283306,0.2,0.742191884453199,1.0,2/6,3.12%,GSN;MCU
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation (GO:0035335),0.5673232378835283,1.278558632641421,0.12121212121212122,0.7411757740913341,1.0,3/25,2.07%,DUSP6;PTPN9;DUSP18
prerank,GO_Biological_Process_2021__serine family amino acid biosynthetic process (GO:0009070),-0.7675851738869326,-1.2783667739587854,0.18181818181818182,0.7025386415774784,1.0,2/7,13.89%,MTHFD1;SEPHS1
prerank,GO_Biological_Process_2021__peptidyl-lysine hydroxylation (GO:0017185),-0.7934416285932095,-1.2783045397401582,0.27906976744186046,0.7016238477594805,1.0,2/5,16.10%,JMJD6;VIPAS39
prerank,GO_Biological_Process_2021__DNA replication checkpoint signaling (GO:0000076),-0.7236808169299797,-1.2779464458925784,0.17857142857142858,0.7018831588031271,1.0,4/10,18.89%,HUS1;TIPIN;RAD9A;NAE1
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.6889913265436843,-1.2778255228658868,0.2,0.7011093353054401,1.0,5/11,7.39%,RPL5;RPL11;RPL23;DTX3L;RPS7
prerank,GO_Biological_Process_2021__actin filament organization (GO:0007015),0.4727473194587662,1.277703257893267,0.10526315789473684,0.7432089382971666,1.0,12/98,4.81%,SHROOM3;AVIL;TPM2;CORO6;EPS8;GSN;HIP1R;GAS2;MCU;MYO1D;SPIRE2;LCP1
prerank,GO_Biological_Process_2021__positive regulation of neuron projection development (GO:0010976),0.5252757080400509,1.2770507554156587,0.16129032258064516,0.7443725516735359,1.0,17/64,18.87%,AVIL;RAP1A;WNT5A;RELN;SCARB2;PLXNB2;FUT9;NPTN;ZNF804A;COBL;NTRK2;PRKCI;CAPRIN2;CX3CL1;RAPGEF2;MARK2;SCN1B
prerank,GO_Biological_Process_2021__positive regulation of podosome assembly (GO:0071803),0.7950001064841461,1.2768434519573804,0.2926829268292683,0.7436925253231385,1.0,2/5,7.30%,LCP1;TNF
prerank,GO_Biological_Process_2021__positive regulation of ruffle assembly (GO:1900029),0.7286138773975933,1.2765904662929126,0.28205128205128205,0.7431105232215607,1.0,3/8,11.03%,EPS8;NLGN1;P2RY12
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity (GO:2000116),-0.6672934903660317,-1.2764949565102384,0.1875,0.7057782378248181,1.0,4/14,9.00%,AIM2;FYN;NLRP12;PSMB9
prerank,GO_Biological_Process_2021__entry into host (GO:0044409),-0.7659662345346361,-1.2764698466310673,0.2,0.7046524008531266,1.0,1/9,1.43%,CXCR4
prerank,GO_Biological_Process_2021__ovarian follicle development (GO:0001541),-0.8026656058714119,-1.2763714891228424,0.18333333333333332,0.7038324958820611,1.0,3/7,16.91%,VEGFA;SOD1;EIF2B2
prerank,"GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0015014)",0.8340719154163958,1.2761964492878166,0.20833333333333334,0.743387244883244,1.0,3/6,10.88%,CSGALNACT1;HS2ST1;EXT1
prerank,GO_Biological_Process_2021__mRNA catabolic process (GO:0006402),-0.6211101981372725,-1.2758671134633806,0.16417910447761194,0.7048997176936765,1.0,7/39,14.43%,ZFP36;NUDT12;EXOSC10;HSPA1B;DDX5;NUDT16;HSPA1A
prerank,GO_Biological_Process_2021__platelet degranulation (GO:0002576),-0.5474153779876199,-1.275602701050318,0.12857142857142856,0.7049098718419606,1.0,18/81,11.68%,FLNA;CD36;SRGN;F8;CLU;PLEK;F13A1;IGF1;CD63;PECAM1;SELENOP;TTN;CALM1;FERMT3;TMSB4X;VEGFA;A2M;GTPBP2
prerank,GO_Biological_Process_2021__positive regulation of BMP signaling pathway (GO:0030513),0.6855814107840411,1.2754824521687997,0.17073170731707318,0.7448500447369315,1.0,5/14,12.30%,ACVR2A;UBE2O;SMAD2;BMPR1B;BMPR1A
prerank,GO_Biological_Process_2021__basement membrane organization (GO:0071711),0.7846566607555735,1.2752462250907368,0.12962962962962962,0.7444113750921842,1.0,3/7,20.19%,HPN;FLRT2;NTN4
prerank,GO_Biological_Process_2021__ruffle organization (GO:0031529),-0.7199812827936513,-1.2749686266432807,0.23809523809523808,0.70655738326281,1.0,8/13,20.20%,AIF1;PLEK;CORO1B;PLEKHA1;RAC1;INPP5K;CARMIL1;TPM1
prerank,GO_Biological_Process_2021__response to glucocorticoid (GO:0051384),-0.665420459393008,-1.27481532554691,0.19642857142857142,0.7061447474698345,1.0,2/16,1.48%,CALCR;ZFP36
prerank,GO_Biological_Process_2021__ornithine metabolic process (GO:0006591),-0.8213024496785613,-1.2744214544616215,0.29411764705882354,0.7064670699547605,1.0,3/6,11.99%,ODC1;AZIN2;AZIN1
prerank,GO_Biological_Process_2021__nucleotide-excision repair (GO:0006289),-0.5375880451583734,-1.2742554688651155,0.14102564102564102,0.7059663472593183,1.0,11/88,7.58%,UBC;PPIE;RPS27A;XPA;COPS6;UVSSA;OGG1;GTF2H5;HUS1;POLR2G;BRCA2
prerank,GO_Biological_Process_2021__negative regulation of cytoskeleton organization (GO:0051494),0.6103142858501878,1.274077880308267,0.15217391304347827,0.7477112012177988,1.0,10/24,17.35%,HIP1R;MYADM;KANK1;SHANK3;TJP1;SSH2;CLASP1;FKBP4;IQCJ-SCHIP1;PIK3CA
prerank,GO_Biological_Process_2021__cellular response to unfolded protein (GO:0034620),0.5986346763943668,1.2740773920744235,0.14285714285714285,0.746253674509772,1.0,1/23,0.35%,BAG3
prerank,GO_Biological_Process_2021__commissural neuron axon guidance (GO:0071679),0.7422736610236994,1.2740533285502844,0.13636363636363635,0.7448724945968633,1.0,3/6,9.90%,NRP1;RYK;NFIB
prerank,PanglaoDB_Augmented_2021__Airway Goblet Cells,-0.7378594128092206,-1.2738413368055588,0.24,0.7065116451763485,1.0,2/8,8.80%,CLDN7;OVOL2
prerank,GO_Biological_Process_2021__regulation of peptidyl-serine phosphorylation (GO:0033135),-0.5739282414848089,-1.2737203102767947,0.13846153846153847,0.7057742802723779,1.0,10/66,12.59%,CALCR;TFRC;DDIT4;PAQR3;RACK1;PRKD2;CD44;VEGFA;MTCP1;TERF2IP
prerank,GO_Biological_Process_2021__regulation of actin filament-based process (GO:0032970),0.5492568534510607,1.2736531330924112,0.1724137931034483,0.7449074435098194,1.0,4/47,7.54%,PDGFA;HIP1R;CDK10;CRK
prerank,GO_Biological_Process_2021__visual perception (GO:0007601),0.5019460594354662,1.2736097455296744,0.15625,0.7436046275312141,1.0,3/39,3.93%,TULP2;CRYGS;RP2
prerank,GO_Biological_Process_2021__regulation of translational termination (GO:0006449),-0.7979084158185641,-1.2734809875733804,0.21666666666666667,0.7052921898625093,1.0,2/7,11.36%,SHFL;MTRF1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-12 production (GO:0032735),0.5978234820450969,1.2733355103147774,0.14285714285714285,0.7434545192639778,1.0,7/19,21.93%,MAPK11;LGALS9;LAPTM5;IRF5;HSPD1;AGER;SYK
prerank,GO_Biological_Process_2021__toll-like receptor 2 signaling pathway (GO:0034134),0.7995256723148279,1.2731621085938116,0.2222222222222222,0.7426270698581547,1.0,3/5,13.17%,IRAK1;LGALS9;PIK3AP1
prerank,GO_Biological_Process_2021__RNA catabolic process (GO:0006401),-0.5796182272207816,-1.2731095729890474,0.16417910447761194,0.7058803666456495,1.0,4/39,2.90%,ZFP36;RNASET2;SIDT2;NUDT12
prerank,GO_Biological_Process_2021__protein processing involved in protein targeting to mitochondrion (GO:0006627),0.7831842358291601,1.2729667918967917,0.19148936170212766,0.7418961352201763,1.0,2/5,15.45%,IMMP2L;IMMP1L
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport into cytosol (GO:0010524),-0.7000369707683856,-1.2725903478651805,0.16666666666666666,0.7066591473395657,1.0,2/12,3.66%,CALCR;CEMIP
prerank,GO_Biological_Process_2021__leptin-mediated signaling pathway (GO:0033210),0.7002054900114284,1.2724417883297767,0.23076923076923078,0.7424022051779595,1.0,2/9,2.51%,LEPR;SIRT1
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transport (GO:1902305),0.6580140544613405,1.2724078536669832,0.11428571428571428,0.7412561525712819,1.0,6/16,18.87%,SCN3B;NEDD4L;SLMAP;FXYD5;FXYD7;SCN1B
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transport (GO:0034765),0.6090312009577914,1.2722651241751848,0.21875,0.740578439875929,1.0,11/19,22.92%,KCNJ2;KCNJ5;NEDD4L;WNK1;ANO6;AHCYL1;P2RX7;NEDD4;CHRM3;YWHAE;KCNJ6
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell periphery (GO:1904377),0.5429057081947316,1.271874908463198,0.11428571428571428,0.7406210646271592,1.0,16/38,28.07%,PTPN9;EPB41;CIB1;TNF;ARF6;PRKCI;DPP10;PLS1;SPTBN1;STX3;PIK3R1;PRKCE;SORBS1;EFCAB7;CLIP3;EPB41L2
prerank,GO_Biological_Process_2021__positive regulation of actin nucleation (GO:0051127),0.7280016204078004,1.2718696280966113,0.175,0.739207665648863,1.0,2/11,5.63%,GSN;WASF2
prerank,GO_Biological_Process_2021__monocyte differentiation (GO:0030224),0.713336696519973,1.2712291356550676,0.15,0.7404751781053215,1.0,2/8,5.17%,PIR;PPARG
prerank,GO_Biological_Process_2021__gastrulation (GO:0007369),-0.8106755022196608,-1.2711458063621484,0.15,0.7122720044879401,1.0,1/8,0.08%,NR4A3
prerank,GO_Biological_Process_2021__positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.6489166592519546,1.2704997423816862,0.15384615384615385,0.7421982918993942,1.0,2/14,1.00%,TRPC1;PKD2
prerank,GO_Biological_Process_2021__regulation of regulatory T cell differentiation (GO:0045589),-0.6942658996764169,-1.2702969978685634,0.19696969696969696,0.7146024432077069,1.0,3/14,10.38%,IL4I1;LILRB4;IRF1
prerank,GO_Biological_Process_2021__calcium-mediated signaling (GO:0019722),-0.5770189872228204,-1.2700040820846417,0.15714285714285714,0.7147580390849625,1.0,6/54,6.11%,CCL3;MCTP2;CXCR4;BTK;FIS1;ACKR4
prerank,GO_Biological_Process_2021__epithelial cell apoptotic process (GO:1904019),0.8399581713319102,1.269959523648671,0.16666666666666666,0.742857908002511,1.0,1/6,1.66%,GSN
prerank,GO_Biological_Process_2021__negative regulation of B cell proliferation (GO:0030889),-0.8089478473923919,-1.2698049586720774,0.13333333333333333,0.7141184480578422,1.0,2/8,11.20%,MNDA;TYROBP
prerank,GO_Biological_Process_2021__regulation of short-term neuronal synaptic plasticity (GO:0048172),0.742133110517422,1.269680078980944,0.17391304347826086,0.7425747382048179,1.0,4/10,11.06%,SYNGR1;GRIK2;SHISA9;PPFIA3
prerank,GO_Biological_Process_2021__protein heterotetramerization (GO:0051290),0.671608049337954,1.2695951933524052,0.18181818181818182,0.7414228005724345,1.0,4/11,12.14%,PKD2;PKD1;GRIN2B;CPSF7
prerank,GO_Biological_Process_2021__sprouting angiogenesis (GO:0002040),0.5723453538491298,1.2693119660704126,0.1794871794871795,0.7411434070898839,1.0,7/25,9.95%,NRP1;SEMA5A;YJEFN3;FGF2;RECK;ROBO1;LOXL2
prerank,"GO_Biological_Process_2021__substrate-dependent cell migration, cell extension (GO:0006930)",0.758194611671903,1.2693022928283704,0.275,0.7398160695987065,1.0,1/6,0.61%,NRP1
prerank,GO_Biological_Process_2021__nitric oxide biosynthetic process (GO:0006809),0.764219105610822,1.2692386612449718,0.2,0.737289929995473,1.0,1/6,10.57%,GCH1
prerank,GO_Biological_Process_2021__nitric oxide metabolic process (GO:0046209),0.764219105610822,1.2692386612449718,0.2,0.737289929995473,1.0,1/6,10.57%,GCH1
prerank,GO_Biological_Process_2021__skeletal muscle tissue regeneration (GO:0043403),0.786303107004014,1.2691900303744594,0.14893617021276595,0.736067970323149,1.0,4/6,9.28%,ANXA1;LARGE1;AKIRIN1;PPP3CA
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),-0.7221040308565916,-1.2690565912489848,0.20689655172413793,0.7159637968949061,1.0,3/12,6.83%,CCL5;IL10RA;PRLR
prerank,GO_Biological_Process_2021__regulation of acute inflammatory response (GO:0002673),-0.8499563447058648,-1.2689075430715213,0.12280701754385964,0.7151483369127853,1.0,2/6,6.85%,OSMR;GSTP1
prerank,GO_Biological_Process_2021__sterol transport (GO:0015918),-0.7042774310638855,-1.268528354560255,0.18032786885245902,0.7155508618830129,1.0,2/13,0.52%,OSBPL5;CD36
prerank,GO_Biological_Process_2021__carnitine metabolic process (GO:0009437),0.7861521947426993,1.2683540187287896,0.16,0.738223010308126,1.0,2/7,5.35%,CPT1C;CPT1A
prerank,GO_Biological_Process_2021__positive regulation of interferon-gamma production (GO:0032729),-0.6402790660452011,-1.2680290680185637,0.15625,0.7164782281348734,1.0,10/36,10.20%,BTN3A1;CD2;SLC7A5;CD14;SLAMF6;TXK;IL12RB2;BTN3A2;CD226;SLC11A1
prerank,GO_Biological_Process_2021__negative regulation of axonogenesis (GO:0050771),0.5675208790429057,1.2679490440134396,0.16216216216216217,0.7384045449592652,1.0,8/22,15.36%,LRP4;DIP2B;LINGO1;PTEN;RTN4;DCC;RNF6;KIAA0319
prerank,GO_Biological_Process_2021__circulatory system development (GO:0072359),0.47185018213577185,1.2678948913906494,0.05714285714285714,0.7372324351880639,1.0,21/67,15.68%,PKD2;TGFBR2;PKD1;HDAC9;TSC2;SALL1;ALPK3;SOX4;PDLIM5;TAB2;LDB3;HEG1;FBXW7;KAT2A;PTEN;SMYD4;NF1;PDLIM7;ERBB4;TGFBR1;CACYBP
prerank,GO_Biological_Process_2021__ESCRT complex disassembly (GO:1904896),0.680794861821171,1.2678512090946927,0.14285714285714285,0.7347440026468727,1.0,3/9,19.81%,CHMP7;CHMP1A;VTA1
prerank,GO_Biological_Process_2021__ESCRT III complex disassembly (GO:1904903),0.680794861821171,1.2678512090946927,0.14285714285714285,0.7347440026468727,1.0,3/9,19.81%,CHMP7;CHMP1A;VTA1
prerank,GO_Biological_Process_2021__monocarboxylic acid metabolic process (GO:0032787),-0.547027939919706,-1.2672153522298046,0.07246376811594203,0.7188470827282406,1.0,12/80,9.55%,CD36;ME1;VNN2;PER2;PDHX;GATM;SLC16A3;IGF1;GNPAT;THEM4;ACAA1;LDHA
prerank,GO_Biological_Process_2021__regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034127),-0.7821305716697047,-1.2671290535840982,0.19607843137254902,0.7179302864453627,1.0,1/6,3.07%,CD14
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion (GO:0022407),0.533039078949184,1.266930955336341,0.11764705882352941,0.7373300242915711,1.0,11/27,16.79%,SMAD7;MAGI1;JAG1;FUT9;PTPRG;CELSR2;GTPBP4;AFDN;PTK2;PTPRR;RNASE10
prerank,GO_Biological_Process_2021__positive regulation of axon extension (GO:0045773),0.6466024537651751,1.2669213457793784,0.11428571428571428,0.7359895049609488,1.0,2/16,1.58%,NRP1;SEMA5A
prerank,GO_Biological_Process_2021__gliogenesis (GO:0042063),0.6516048562629817,1.266909074025323,0.1388888888888889,0.7346762736470905,1.0,5/12,11.88%,ANXA1;RELN;NFIB;METRN;CDK6
prerank,PanglaoDB_Augmented_2021__Peritubular Myoid Cells,0.5180792078484454,1.2667529750314739,0.030303030303030304,0.7340591887822193,1.0,10/42,6.44%,COL16A1;TPM2;FKBP9;SVEP1;COL5A2;ACTA2;PHLDB1;INTS6;TIMP3;WNT2B
prerank,GO_Biological_Process_2021__neuromuscular process (GO:0050905),-0.7631013075465369,-1.266716599606157,0.1746031746031746,0.7183399852667772,1.0,1/8,1.79%,TPP1
prerank,GO_Biological_Process_2021__membrane lipid biosynthetic process (GO:0046467),0.5405658419160818,1.266300152426572,0.12903225806451613,0.7341789299499801,1.0,8/42,8.59%,VAPB;ACER2;PPM1L;PLPP1;FA2H;SPTLC2;HACD2;ELOVL6
prerank,GO_Biological_Process_2021__positive regulation of axon extension involved in axon guidance (GO:0048842),0.8191974305710419,1.2662314820812635,0.1891891891891892,0.7329429049998416,1.0,2/5,1.58%,NRP1;SEMA5A
prerank,GO_Biological_Process_2021__high-density lipoprotein particle remodeling (GO:0034375),-0.7423351814090562,-1.2658125929683497,0.2459016393442623,0.7209696728731815,1.0,2/9,4.17%,LIPG;PLTP
prerank,GO_Biological_Process_2021__inorganic cation import across plasma membrane (GO:0098659),0.5530616974075442,1.2657875505861171,0.13333333333333333,0.7332416742497381,1.0,13/39,15.33%,SLC39A12;SLC39A14;SLC9C2;KCNJ2;KCNJ5;SLC39A8;SLC12A6;SLC9A1;SLC9A9;SLC12A5;SLC8A1;SLC24A2;SLC12A2
prerank,GO_Biological_Process_2021__response to granulocyte macrophage colony-stimulating factor (GO:0097012),-0.8306697774945351,-1.2653531554269724,0.1276595744680851,0.7202843853206412,1.0,1/5,1.48%,ZFP36
prerank,GO_Biological_Process_2021__cellular response to granulocyte macrophage colony-stimulating factor stimulus (GO:0097011),-0.8306697774945351,-1.2653531554269724,0.1276595744680851,0.7202843853206412,1.0,1/5,1.48%,ZFP36
prerank,GO_Biological_Process_2021__carboxylic acid metabolic process (GO:0019752),-0.648539111701389,-1.2649499381582407,0.1774193548387097,0.720831890397134,1.0,2/18,4.51%,SLC2A3;CYB5A
prerank,GO_Biological_Process_2021__bile acid and bile salt transport (GO:0015721),-0.7047956346963952,-1.2649260806436622,0.2318840579710145,0.7196325028923135,1.0,2/13,4.96%,SLC51A;ABCC3
prerank,GO_Biological_Process_2021__histone arginine methylation (GO:0034969),0.7700241124249336,1.2646679215241123,0.1875,0.7361294073629154,1.0,2/5,17.32%,COPRS;PRMT7
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transport (GO:0051926),-0.7739664418255567,-1.2646169464064156,0.18333333333333332,0.7198193190223867,1.0,1/10,0.73%,PLN
prerank,GO_Biological_Process_2021__negative regulation of T cell mediated cytotoxicity (GO:0001915),-0.7967057824441091,-1.2644904809924007,0.17543859649122806,0.7191143128556947,1.0,3/6,12.82%,KLRD1;NCKAP1L;PTPRC
prerank,PanglaoDB_Augmented_2021__Pancreatic Progenitor Cells,0.5331167840622283,1.2643236277364116,0.15789473684210525,0.7361782062267956,1.0,4/41,0.92%,SHROOM3;PLXNB1;MFNG;LRP4
prerank,GO_Biological_Process_2021__positive regulation of neuroinflammatory response (GO:0150078),-0.8240588092481981,-1.263967808435128,0.19607843137254902,0.7200475911103671,1.0,1/5,0.62%,CCL3
prerank,GO_Biological_Process_2021__preassembly of GPI anchor in ER membrane (GO:0016254),0.7117913510216004,1.2639651117886785,0.21052631578947367,0.7367120722375252,1.0,1/12,0.08%,PIGQ
prerank,GO_Biological_Process_2021__aminoglycan biosynthetic process (GO:0006023),0.6068768297793079,1.2636357303613788,0.15,0.7370458485576262,1.0,5/24,6.07%,B3GNT2;HS3ST5;HS2ST1;UGDH;B4GALT7
prerank,GO_Biological_Process_2021__endothelial cell proliferation (GO:0001935),0.7146546762089075,1.2633062186254405,0.175,0.7368070236441742,1.0,3/9,17.57%,SEMA5A;LOXL2;PRKX
prerank,GO_Biological_Process_2021__regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),-0.7158458182178388,-1.2624563182538697,0.2033898305084746,0.7249892653407642,1.0,1/14,0.51%,DDX11
prerank,GO_Biological_Process_2021__negative regulation of cell development (GO:0010721),-0.670721172110144,-1.2624244877570105,0.25925925925925924,0.723907338034536,1.0,3/16,5.56%,DYNLT1;B2M;IGF1
prerank,GO_Biological_Process_2021__fat-soluble vitamin metabolic process (GO:0006775),0.7650796565329515,1.2624212812246034,0.1568627450980392,0.7383240012014097,1.0,1/8,1.92%,UBIAD1
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, GABAergic (GO:0032228)",0.7075205020650361,1.262156874906593,0.18181818181818182,0.7380399346321407,1.0,4/8,6.34%,NLGN1;ZDHHC3;ADRA1A;BAIAP3
prerank,GO_Biological_Process_2021__pyrimidine nucleoside catabolic process (GO:0046135),-0.7425251560143205,-1.2618683747772945,0.23728813559322035,0.7247281508641862,1.0,3/8,10.19%,NT5C;TYMP;DPYS
prerank,GO_Biological_Process_2021__positive regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904261),0.7991644755767338,1.2617091698769693,0.2708333333333333,0.7372566911065153,1.0,4/5,16.96%,PHLDB1;DAG1;CLASP1;CLASP2
prerank,GO_Biological_Process_2021__regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904259),0.7991644755767338,1.2617091698769693,0.2708333333333333,0.7372566911065153,1.0,4/5,16.96%,PHLDB1;DAG1;CLASP1;CLASP2
prerank,GO_Biological_Process_2021__negative regulation of epithelial to mesenchymal transition (GO:0010719),0.6935550104347107,1.2610089952639436,0.19047619047619047,0.7384134840585534,1.0,6/14,6.57%,SPRY2;SMAD7;SPRED1;SPRED2;USF3;HPN
prerank,GO_Biological_Process_2021__apoptotic cell clearance (GO:0043277),0.5928848871485727,1.2607842439902055,0.2222222222222222,0.7379791182405333,1.0,5/20,17.07%,ANXA1;ITGAV;TYRO3;RHOBTB1;XKR6
prerank,GO_Biological_Process_2021__negative regulation of transposition (GO:0010529),-0.7559827222207033,-1.2607416676261514,0.15254237288135594,0.7283404450418903,1.0,2/12,8.67%,MYBL1;APOBEC3G
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte differentiation (GO:0045618),0.7352846725665144,1.2605056965676766,0.16666666666666666,0.7363352163068386,1.0,1/7,3.26%,NCOA3
prerank,GO_Biological_Process_2021__positive regulation of epidermal cell differentiation (GO:0045606),0.7352846725665144,1.2605056965676766,0.16666666666666666,0.7363352163068386,1.0,1/7,3.26%,NCOA3
prerank,GO_Biological_Process_2021__regulation of defense response to virus (GO:0050688),0.7124932915354124,1.2604400884118037,0.2727272727272727,0.7351933186552181,1.0,1/13,0.25%,IFNLR1
prerank,GO_Biological_Process_2021__regulation of neurogenesis (GO:0050767),-0.6332346047127003,-1.2603267938159015,0.1791044776119403,0.7288666305692703,1.0,5/31,4.86%,DYNLT1;B2M;PER2;ZNF335;BHLHE40
prerank,GO_Biological_Process_2021__purine nucleotide catabolic process (GO:0006195),-0.7780896680063933,-1.2601327431995666,0.2033898305084746,0.7286095801446855,1.0,3/7,14.09%,NT5C;HINT1;GPX1
prerank,"GO_Biological_Process_2021__negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.6492224476104906,1.260099077780904,0.23684210526315788,0.7348757139081425,1.0,1/13,0.47%,PCBP4
prerank,GO_Biological_Process_2021__negative regulation of cytokine production involved in inflammatory response (GO:1900016),-0.693740533438537,-1.2600223093037848,0.20967741935483872,0.7279703483017499,1.0,3/13,5.46%,NLRC3;APOD;LILRB4
prerank,GO_Biological_Process_2021__positive regulation of cation channel activity (GO:2001259),0.5864275069279167,1.259890861568948,0.11904761904761904,0.734343775611681,1.0,4/21,8.67%,PKD2;KCNIP2;RELN;SHANK3
prerank,GO_Biological_Process_2021__antibacterial humoral response (GO:0019731),-0.7768082939806643,-1.2596143140390197,0.15517241379310345,0.7287353276860115,1.0,5/8,18.84%,RPL39;H2BC21;H2BC11;HLA-E;RNASE6
prerank,GO_Biological_Process_2021__positive regulation of phospholipase C activity (GO:0010863),-0.6432716303776714,-1.2589691766589584,0.22727272727272727,0.7303886152572904,1.0,4/25,6.88%,ITK;TXK;PHB2;C5AR1
prerank,GO_Biological_Process_2021__regulation of T cell receptor signaling pathway (GO:0050856),-0.6429317385891204,-1.2588199664464694,0.20588235294117646,0.729721375810079,1.0,7/25,19.00%,LILRB4;RPS3;PRKD2;CD226;EZR;TESPA1;PTPN22
prerank,GO_Biological_Process_2021__regulation of endocytosis (GO:0030100),0.5237461654417351,1.2585629001157925,0.07142857142857142,0.7380938410366223,1.0,6/49,8.81%,CD22;HIP1R;PICALM;TSC2;NEDD4L;SNX12
prerank,GO_Biological_Process_2021__folic acid metabolic process (GO:0046655),-0.7111041840810782,-1.2585370731239733,0.22950819672131148,0.7298737445461204,1.0,3/14,18.15%,MTHFD1;SHMT1;FOLR2
prerank,GO_Biological_Process_2021__regulation of focal adhesion assembly (GO:0051893),0.5045071901548145,1.2582086207211411,0.16216216216216217,0.7383739422323788,1.0,8/45,14.39%,COL16A1;NRP1;VCL;SLC9A1;PTEN;PTK2;FERMT2;CLASP1
prerank,GO_Biological_Process_2021__regulation of cytokine production (GO:0001817),-0.5660520417576579,-1.257372163452546,0.12162162162162163,0.7338528991045393,1.0,21/86,13.37%,ITK;BTN3A1;SRGN;HLA-B;GAPDH;BTN3A3;TXK;EIF2AK2;BTN3A2;BTN2A1;NLRP12;LURAP1;TNFRSF1B;BTN2A2;GLMN;SLC11A1;STING1;C5AR2;CD47;PTPRC;SOD1
prerank,GO_Biological_Process_2021__fructose 6-phosphate metabolic process (GO:0006002),0.765385670258848,1.2570757901290344,0.23404255319148937,0.7411605931083529,1.0,3/7,6.70%,PFKP;PFKM;GFPT1
prerank,GO_Biological_Process_2021__phosphatidylglycerol acyl-chain remodeling (GO:0036148),-0.8236096844272511,-1.2570222029115297,0.14583333333333334,0.7344476163175646,1.0,1/6,4.85%,LPCAT1
prerank,GO_Biological_Process_2021__negative regulation of ERAD pathway (GO:1904293),-0.843471344768141,-1.2569203421297073,0.16363636363636364,0.7337921529568407,1.0,2/6,4.37%,UBXN1;AQP11
prerank,"GO_Biological_Process_2021__negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.7825120970728386,-1.256816644072767,0.12727272727272726,0.7318305045229526,1.0,1/8,1.48%,ZFP36
prerank,GO_Biological_Process_2021__miRNA mediated inhibition of translation (GO:0035278),-0.7825120970728386,-1.256816644072767,0.12727272727272726,0.7318305045229526,1.0,1/8,1.48%,ZFP36
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.7186937648437366,1.2566498912349373,0.1951219512195122,0.7413059215956064,1.0,2/9,10.07%,GSN;LGALS9
prerank,GO_Biological_Process_2021__vesicle tethering to Golgi (GO:0099041),0.8205311076646398,1.2566061746271868,0.21153846153846154,0.7401693547698633,1.0,1/5,3.83%,C17ORF75
prerank,GO_Biological_Process_2021__attachment of GPI anchor to protein (GO:0016255),0.8388648131364081,1.2558783861664264,0.19230769230769232,0.7414671307365344,1.0,3/5,8.91%,PIGU;PGAP1;PIGT
prerank,GO_Biological_Process_2021__positive regulation of fatty acid biosynthetic process (GO:0045723),-0.8032277230384579,-1.2551265462993213,0.18181818181818182,0.7377704054941009,1.0,1/6,5.38%,NR1H2
prerank,GO_Biological_Process_2021__positive regulation of cellular biosynthetic process (GO:0031328),0.43551191010659407,1.2547791580020309,0.1,0.7449310389060303,1.0,12/119,7.30%,EGR1;KLF4;PPARGC1A;PKD2;FGF2;SIRT1;LDLR;SAMD4A;STARD4;SMAD3;PLXNB2;TNF
prerank,GO_Biological_Process_2021__peptidyl-threonine phosphorylation (GO:0018107),0.4995136134364535,1.254463875455861,0.15151515151515152,0.7448987809175891,1.0,10/47,11.38%,CDK5R1;TGFBR2;CDK10;LRRK2;MAP2K1;NLK;MAP3K10;DYRK1A;WNK1;MAPK1
prerank,GO_Biological_Process_2021__regulation of DNA-templated transcription in response to stress (GO:0043620),0.7338095369707527,1.2542244615150582,0.30612244897959184,0.7443788801764404,1.0,1/6,5.85%,DDIT3
prerank,GO_Biological_Process_2021__regulation of organelle organization (GO:0033043),0.4751969393017892,1.2537296101620095,0.09090909090909091,0.7448769427043089,1.0,10/61,15.12%,PLXNB1;RAB33B;MSN;PDE4DIP;SCARB2;RBSN;MAPK1;TJP1;PTK2;ATP13A2
prerank,GO_Biological_Process_2021__rDNA heterochromatin assembly (GO:0000183),0.799278539340767,1.2531144847002054,0.16279069767441862,0.7460283820805484,1.0,1/6,2.51%,SIRT1
prerank,GO_Biological_Process_2021__negative regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002924),-0.8031315782687996,-1.2527448746657304,0.2,0.7471610600239885,1.0,1/5,1.64%,CD55
prerank,GO_Biological_Process_2021__protein hexamerization (GO:0034214),0.7712898033892417,1.25264449332864,0.2558139534883721,0.746374163960448,1.0,1/7,4.71%,UGDH
prerank,GO_Biological_Process_2021__ATP synthesis coupled proton transport (GO:0015986),-0.6978254364513514,-1.252599410814226,0.21875,0.7465461015300068,1.0,8/15,20.98%,ATP5PD;ATP5F1E;VPS9D1;ATP5ME;STOML2;ATP5F1C;ATP5F1D;ATP5MC2
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell migration (GO:0014911),-0.7860904854860215,-1.252529211417623,0.10909090909090909,0.7456275233134779,1.0,4/10,5.56%,NR4A3;CCL5;AIF1;IGF1
prerank,GO_Biological_Process_2021__cellular response to exogenous dsRNA (GO:0071360),-0.7164505017689147,-1.252435419733284,0.19230769230769232,0.7448366989192211,1.0,4/11,16.49%,IFIT1;STING1;COLEC12;FLOT1
prerank,GO_Biological_Process_2021__PML body organization (GO:0030578),-0.8103248266622747,-1.251924869553191,0.23214285714285715,0.7457930109524548,1.0,1/5,4.35%,ETS1
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905007),0.7761480173237274,1.2516417348232267,0.225,0.748887845454271,1.0,2/5,15.21%,TGFBR2;TGFBR1
prerank,GO_Biological_Process_2021__aerobic respiration (GO:0009060),-0.6664218123309466,-1.2514996513931156,0.15,0.7462900796685388,1.0,10/18,18.76%,MDH2;UQCRB;UQCRH;UQCR10;NDUFS8;OXA1L;UQCRC1;NDUFS7;SURF1;ATP5F1D
prerank,GO_Biological_Process_2021__vesicle transport along microtubule (GO:0047496),0.5604813445054542,1.2512471189700696,0.21052631578947367,0.7488700767154952,1.0,7/20,25.09%,BICDL1;FBXW11;DYNC1H1;NDE1;TRAK2;PAFAH1B1;TRAK1
prerank,GO_Biological_Process_2021__response to fatty acid (GO:0070542),-0.7803136742318921,-1.2511780444509077,0.2222222222222222,0.7463715049466355,1.0,2/9,1.81%,CD36;PID1
prerank,GO_Biological_Process_2021__regulation of Golgi to plasma membrane protein transport (GO:0042996),-0.7951815406741174,-1.2509786248513004,0.21568627450980393,0.7463148706098446,1.0,1/6,4.24%,RACK1
prerank,GO_Biological_Process_2021__programmed necrotic cell death (GO:0097300),-0.7261964845537041,-1.2506825006663027,0.15517241379310345,0.7464235144402335,1.0,3/12,14.98%,CD14;MLKL;IPMK
prerank,GO_Biological_Process_2021__protein mono-ADP-ribosylation (GO:0140289),-0.750022888256869,-1.2505434063757046,0.2,0.7459136761785516,1.0,6/11,16.67%,PARP14;PARP15;PARP9;PARP4;PARP11;PARP12
prerank,"GO_Biological_Process_2021__protein alpha-1,2-demannosylation (GO:0036508)",-0.6376010542844344,-1.2502419913305274,0.21311475409836064,0.7461460429349811,1.0,2/22,1.30%,UBC;RPS27A
prerank,GO_Biological_Process_2021__regulation of macrophage cytokine production (GO:0010935),0.674361249007692,1.2502243904417663,0.23404255319148937,0.7509719808474187,1.0,4/12,10.79%,SIRT1;WNT5A;LAPTM5;IRAK3
prerank,GO_Biological_Process_2021__regulation of IRE1-mediated unfolded protein response (GO:1903894),-0.7562135700079196,-1.2496514581365408,0.16071428571428573,0.7476648168797867,1.0,2/11,4.19%,DNAJB9;DDRGK1
prerank,GO_Biological_Process_2021__regulation of cellular localization (GO:0060341),0.5744868177619792,1.2496101451503094,0.21428571428571427,0.7518934152076142,1.0,14/32,21.44%,FER;GSN;LRRK2;PARP1;DVL3;BRSK1;CSNK1E;STXBP2;DYNC1H1;BRSK2;PPM1F;MAP2;UNC13D;EPHA5
prerank,GO_Biological_Process_2021__negative regulation of muscle hypertrophy (GO:0014741),-0.7700081182674129,-1.2495648659740743,0.22641509433962265,0.7468956766979951,1.0,1/7,2.19%,RGS2
prerank,GO_Biological_Process_2021__negative regulation of catalytic activity (GO:0043086),-0.6363482597046974,-1.2495572899085923,0.22580645161290322,0.7457604126310098,1.0,6/17,16.40%,PLN;IFIT1;PARP9;ATP5IF1;OXA1L;MT3
prerank,GO_Biological_Process_2021__negative regulation of developmental process (GO:0051093),0.5435845626719805,1.2492120511995328,0.13333333333333333,0.752226081470024,1.0,15/40,15.36%,GRIN3A;ZNF706;MARCHF5;ANP32B;BCL11A;KANK1;SFMBT1;NFIB;LOXL2;KLF7;RPS6KA6;CDK6;DCC;RAPGEF3;KIAA0319
prerank,GO_Biological_Process_2021__glycolipid biosynthetic process (GO:0009247),0.587934358284087,1.2490520682679633,0.16129032258064516,0.7515972263736915,1.0,3/27,3.31%,PIGQ;PIGU;LARGE1
prerank,GO_Biological_Process_2021__myeloid cell activation involved in immune response (GO:0002275),-0.7342726249823627,-1.248849333161113,0.22413793103448276,0.7479813058744802,1.0,5/14,15.37%,FCER1G;ENPP3;TYROBP;KARS1;IFI35
prerank,GO_Biological_Process_2021__regulation of interleukin-17 production (GO:0032660),-0.6957182601654844,-1.248700596818217,0.2459016393442623,0.7475010383625275,1.0,3/16,4.14%,SLC7A5;PRKCQ;SLAMF6
prerank,GO_Biological_Process_2021__Fc receptor mediated stimulatory signaling pathway (GO:0002431),-0.5741244741153504,-1.248387944560564,0.17647058823529413,0.7474977752396842,1.0,10/66,10.76%,NR4A3;MYO1G;VAV3;YES1;FCER1G;CD247;FYN;ACTG1;ACTB;NCKAP1L
prerank,GO_Biological_Process_2021__superoxide metabolic process (GO:0006801),-0.669420167528939,-1.2482889967414035,0.21875,0.7467620436212581,1.0,7/16,16.40%,DUOX1;NCF4;NCF2;CYBA;SOD1;ALOX12;MT3
prerank,GO_Biological_Process_2021__neurotransmitter receptor diffusion trapping (GO:0099628),0.7500865784687096,1.248188904586102,0.14,0.7522601471804586,1.0,4/5,20.94%,GPHN;CACNG8;CACNG2;CACNG3
prerank,GO_Biological_Process_2021__postsynaptic neurotransmitter receptor diffusion trapping (GO:0098970),0.7500865784687096,1.248188904586102,0.14,0.7522601471804586,1.0,4/5,20.94%,GPHN;CACNG8;CACNG2;CACNG3
prerank,GO_Biological_Process_2021__chromatin remodeling at centromere (GO:0031055),-0.6578758814592527,-1.248135453936349,0.23809523809523808,0.7465703402091894,1.0,4/20,10.59%,CENPV;CENPU;ITGB3BP;NPM1
prerank,GO_Biological_Process_2021__endoplasmic reticulum mannose trimming (GO:1904380),-0.6575726785584698,-1.2478372136997526,0.20634920634920634,0.7466361547948108,1.0,2/17,1.30%,UBC;RPS27A
prerank,GO_Biological_Process_2021__cellular response to zinc ion (GO:0071294),-0.8019585818511998,-1.2478099855647564,0.1864406779661017,0.7455946794485371,1.0,1/6,0.25%,MT2A
prerank,GO_Biological_Process_2021__bicellular tight junction assembly (GO:0070830),-0.6840690706732511,-1.2477631186633957,0.16981132075471697,0.744623843720143,1.0,3/20,5.65%,MPP7;CLDN7;PECAM1
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.6092241804548072,1.2476261053817455,0.17777777777777778,0.7529637667852801,1.0,5/16,15.55%,PKD2;PKD1;SPDYA;CCNYL1;CCND3
prerank,GO_Biological_Process_2021__cellular response to type I interferon (GO:0071357),-0.5864527776683877,-1.2475126062235788,0.13559322033898305,0.7434706212062644,1.0,18/41,10.38%,MX2;OAS3;HLA-B;MX1;RSAD2;XAF1;IFIT3;IFIT1;OAS2;IFITM3;HLA-C;HLA-F;IFIT2;OAS1;RNASEL;GBP2;STAT1;IRF1
prerank,GO_Biological_Process_2021__type I interferon signaling pathway (GO:0060337),-0.5864527776683877,-1.2475126062235788,0.13559322033898305,0.7434706212062644,1.0,18/41,10.38%,MX2;OAS3;HLA-B;MX1;RSAD2;XAF1;IFIT3;IFIT1;OAS2;IFITM3;HLA-C;HLA-F;IFIT2;OAS1;RNASEL;GBP2;STAT1;IRF1
prerank,GO_Biological_Process_2021__response to manganese ion (GO:0010042),0.8222211126108159,1.2474613442280698,0.22448979591836735,0.752275751647501,1.0,2/5,15.12%,LRRK2;ATP13A2
prerank,GO_Biological_Process_2021__DNA catabolic process (GO:0006308),-0.7599663194969031,-1.2474361725941756,0.23728813559322035,0.7427759307717454,1.0,3/9,15.97%,MUS81;REXO4;DFFB
prerank,GO_Biological_Process_2021__anoikis (GO:0043276),0.725733687429889,1.2474201309276265,0.1702127659574468,0.7511761035213074,1.0,2/9,4.14%,DAPK2;TSC2
prerank,GO_Biological_Process_2021__negative regulation of protein secretion (GO:0050709),-0.6686225132737291,-1.247358069231754,0.203125,0.7419762141596418,1.0,1/18,1.20%,RSAD2
prerank,GO_Biological_Process_2021__gland morphogenesis (GO:0022612),0.7523513364700041,1.2473271384022373,0.1875,0.7501422002680268,1.0,1/5,1.49%,MSN
prerank,GO_Biological_Process_2021__cellular respiration (GO:0045333),-0.5901106162012306,-1.2470535749161846,0.14084507042253522,0.741954775305301,1.0,8/35,10.31%,NR4A3;CYCS;MDH2;UQCRB;UQCRH;UQCR10;ETFB;NDUFS8
prerank,GO_Biological_Process_2021__regulation of cytosolic calcium ion concentration (GO:0051480),-0.5916141581345643,-1.247047025348831,0.13432835820895522,0.7408115476083746,1.0,10/61,6.88%,CALCR;CD36;PLN;CXCR4;CD55;CDH23;FIS1;ACKR4;TACR1;C5AR1
prerank,GO_Biological_Process_2021__positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.5171954851956582,1.2468708083673568,0.125,0.7503495436791435,1.0,11/56,12.11%,AVIL;NRP1;EPS8;CDC42EP3;NLGN1;AKIRIN1;WASF2;AUTS2;GPM6A;P2RY12;FNBP1L
prerank,"GO_Biological_Process_2021__nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-0.6358731959086525,-1.2466962258950074,0.1774193548387097,0.7410586638904583,1.0,2/23,1.30%,UBC;RPS27A
prerank,GO_Biological_Process_2021__negative regulation of sprouting angiogenesis (GO:1903671),-0.7961110776692004,-1.2466403733359672,0.22,0.7401200407060058,1.0,2/7,5.83%,EPN1;SEMA6A
prerank,GO_Biological_Process_2021__interleukin-6-mediated signaling pathway (GO:0070102),0.6212067411626637,1.2465822732856886,0.24390243902439024,0.7504944008894149,1.0,1/16,1.04%,FER
prerank,GO_Biological_Process_2021__forebrain neuron development (GO:0021884),0.7910627082896184,1.246161011032315,0.24,0.7509471465240548,1.0,4/5,19.59%,WNT5A;ROBO2;RAPGEF2;FGFR2
prerank,GO_Biological_Process_2021__defense response to Gram-positive bacterium (GO:0050830),-0.6689360216841562,-1.2460208915001203,0.2,0.7415772103070016,1.0,10/21,20.38%,RPL39;H2BC21;GBP2;H2BC11;HLA-E;RNASE6;TNFRSF14;MPEG1;PPP1R11;TLR2
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix assembly (GO:1901203),0.7214826678114242,1.2458706393762249,0.17391304347826086,0.7507621183443874,1.0,5/8,16.96%,PHLDB1;DAG1;SMAD3;CLASP1;CLASP2
prerank,GO_Biological_Process_2021__oogenesis (GO:0048477),-0.8119059305704617,-1.2458674371485619,0.18,0.7411716120670885,1.0,3/7,10.30%,MEI4;IHO1;PTN
prerank,GO_Biological_Process_2021__calcium-ion regulated exocytosis (GO:0017156),-0.6591594857884442,-1.2457888844346021,0.1896551724137931,0.7403564015796756,1.0,1/16,1.34%,RIMS1
prerank,GO_Biological_Process_2021__protein poly-ADP-ribosylation (GO:0070212),-0.7484365727100134,-1.2456432170802818,0.20967741935483872,0.7399274394859697,1.0,4/9,9.48%,PARP14;PARP15;PARP9;PARP2
prerank,GO_Biological_Process_2021__positive regulation of T cell apoptotic process (GO:0070234),-0.8469661741802343,-1.2451420582727868,0.14545454545454545,0.7406493078113134,1.0,2/6,2.84%,CCL5;PRELID1
prerank,GO_Biological_Process_2021__regulation of ossification (GO:0030278),0.5898619743541558,1.245096459440386,0.16216216216216217,0.7523192910149341,1.0,3/20,4.48%,LRP4;ZBTB16;WNT5A
prerank,GO_Biological_Process_2021__mitochondrial transcription (GO:0006390),0.6812927436984149,1.2449433057709245,0.24324324324324326,0.7518257525573863,1.0,1/9,5.52%,TFB1M
prerank,GO_Biological_Process_2021__cellular response to nerve growth factor stimulus (GO:1990090),0.6282700344480197,1.244910502154295,0.18181818181818182,0.750680438301049,1.0,10/16,28.85%,RAP1A;CIB1;NTRK2;RAPGEF2;TMEM108;MAGI2;ACAP2;NTRK3;KIDINS220;WASF1
prerank,GO_Biological_Process_2021__protein polyglutamylation (GO:0018095),0.7202460788420997,1.244629831611068,0.3076923076923077,0.7504359482049957,1.0,4/7,11.84%,TTLL11;TTLL1;CEP41;TTLL7
prerank,GO_Biological_Process_2021__regulation of smooth muscle contraction (GO:0006940),-0.7090435176153559,-1.2443797794636606,0.1896551724137931,0.742912535399492,1.0,1/11,1.41%,CHRM2
prerank,GO_Biological_Process_2021__negative regulation of protein localization to nucleus (GO:1900181),-0.6687357333844104,-1.243518481696767,0.09259259259259259,0.7453401295320381,1.0,3/16,5.46%,MDFIC;APOD;LILRB4
prerank,GO_Biological_Process_2021__regulation of cellular response to heat (GO:1900034),0.48330173392952464,1.24344150169082,0.13333333333333333,0.7533874453507964,1.0,15/73,17.93%,BAG3;SIRT1;NUP153;NUP188;NUP42;MAPK1;MAPKAPK2;IER5;BAG5;FKBP4;GSK3B;NDC1;NUP133;HSPH1;NUP205
prerank,GO_Biological_Process_2021__negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.4803914583727623,1.2430576939828801,0.16666666666666666,0.7535862126951632,1.0,17/68,10.09%,UBE2D1;ACVR2A;SPRY2;SMAD1;TGFBR2;SIRT1;SMAD7;SPRED1;SPRED2;PPARG;SMAD2;SMAD3;SPART;ADAMTSL2;LEMD3;BMPR1B;BCL9L
prerank,MSigDB_Hallmark_2020__Inflammatory Response,-0.526321890543954,-1.2426545302901633,0.11594202898550725,0.7479181892008278,1.0,33/120,11.78%,ADGRE1;CCL5;GPR183;CD55;IL7R;CD69;MARCO;BTG2;CD14;SELL;RGS1;RGS16;TNFSF10;ADRM1;IL10RA;RNF144B;SRI;TACR1;OSMR;C5AR1;EIF2AK2;EMP3;NAMPT;TNFRSF1B;OLR1;LY6E;GPC3;SELENOS;BEST1;IRF1;HIF1A;CSF3R;IFNGR2
prerank,GO_Biological_Process_2021__stress-induced premature senescence (GO:0090400),0.8293709060484795,1.2424760070432153,0.24,0.7546970578526495,1.0,1/5,2.51%,SIRT1
prerank,GO_Biological_Process_2021__inhibitory synapse assembly (GO:1904862),0.7248560579895942,1.2421209771430357,0.21052631578947367,0.7547107269612057,1.0,2/8,4.48%,PLXNB1;WNT5A
prerank,GO_Biological_Process_2021__regulation of cell death (GO:0010941),-0.5459020593590223,-1.2418640240543295,0.11428571428571428,0.7502389128862348,1.0,8/66,9.65%,CALCR;CD36;CCL5;EPHB1;CLU;VPS35;TNFRSF1B;TRIM13
prerank,GO_Biological_Process_2021__dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.6469579096854475,1.2417907103281942,0.2558139534883721,0.7548456432489478,1.0,6/13,18.95%,MPDU1;MVD;ALG12;ALG8;ALG3;NUS1
prerank,GO_Biological_Process_2021__positive regulation of chromosome organization (GO:2001252),-0.6995512446052923,-1.2416934098924348,0.2,0.749746441870248,1.0,1/11,0.51%,DDX11
prerank,GO_Biological_Process_2021__positive regulation of isomerase activity (GO:0010912),-0.7447805764914324,-1.241683661645199,0.17543859649122806,0.7486269875241007,1.0,4/8,15.71%,PLSCR1;ITGB2;NOD2;UHRF1
prerank,GO_Biological_Process_2021__regulation of protein transport (GO:0051223),0.5612718768870738,1.2416082186370714,0.15789473684210525,0.7545562924908591,1.0,11/24,22.99%,LCP1;TNF;SNX12;DISP1;ATP13A2;STXBP5;ARFIP1;CHP1;PPM1F;DNAJA1;STXBP5L
prerank,GO_Biological_Process_2021__negative regulation of mRNA processing (GO:0050686),0.6114259772698061,1.241402703349724,0.1951219512195122,0.7542679046304677,1.0,1/14,0.47%,PCBP4
prerank,GO_Biological_Process_2021__negative regulation of binding (GO:0051100),-0.5613506829561622,-1.2413013953629164,0.15584415584415584,0.7489228373989766,1.0,9/62,10.71%,DDX11;PLN;CARD16;IFIT1;RACK1;IFIT2;BTAF1;DVL1;ACTB
prerank,GO_Biological_Process_2021__mitotic spindle assembly (GO:0090307),-0.6104919186344959,-1.2412844925110436,0.18181818181818182,0.7479124249668805,1.0,4/29,8.95%,FLNA;RAB11A;WRAP73;ABRAXAS1
prerank,GO_Biological_Process_2021__regulation of DNA binding (GO:0051101),-0.6201311427305488,-1.2412593846703885,0.18055555555555555,0.7468659491223058,1.0,3/30,5.56%,PYHIN1;EDF1;IGF1
prerank,GO_Biological_Process_2021__regulation of B cell apoptotic process (GO:0002902),-0.8135857150209362,-1.2409328453419122,0.16666666666666666,0.7470720089607427,1.0,1/6,3.54%,BTK
prerank,GO_Biological_Process_2021__epithelial cell-cell adhesion (GO:0090136),-0.7764632227666716,-1.2409168636195673,0.2413793103448276,0.7459779509704592,1.0,2/7,5.44%,PLEKHA7;JUP
prerank,GO_Biological_Process_2021__histone H3-K27 demethylation (GO:0071557),-0.7857941074677994,-1.2405053251524454,0.22641509433962265,0.7468205249552939,1.0,2/5,10.85%,KDM7A;KDM6B
prerank,GO_Biological_Process_2021__regulation of vasculogenesis (GO:2001212),0.7215969748677764,1.2402726498980445,0.23809523809523808,0.757158601937612,1.0,2/6,6.25%,RAP1A;RIN2
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-0.7962399393491706,-1.2400811877415003,0.23076923076923078,0.7472978078188256,1.0,5/6,20.38%,GSTP1;NAMPT;SELENOS;NOD2;TLR2
prerank,GO_Biological_Process_2021__nicotinamide nucleotide biosynthetic process (GO:0019359),0.7257142058859669,1.2399489583735892,0.24489795918367346,0.7570275059473256,1.0,1/7,1.71%,NMNAT2
prerank,GO_Biological_Process_2021__negative regulation of protein binding (GO:0032091),-0.5639524670696909,-1.2398905087837726,0.14864864864864866,0.7468680890462635,1.0,9/56,10.71%,DDX11;CARD16;B2M;IFIT1;RACK1;IFIT2;ITGA4;DVL1;ACTB
prerank,GO_Biological_Process_2021__regulation of glucan biosynthetic process (GO:0010962),-0.7585798183078318,-1.2392255282381293,0.16176470588235295,0.7486356317343279,1.0,2/5,17.44%,PPP1R3B;INPP5K
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein biosynthetic process (GO:0042985),0.7779053747423228,1.2391382218510538,0.2708333333333333,0.7589417526181672,1.0,1/5,5.72%,BACE2
prerank,GO_Biological_Process_2021__dicarboxylic acid biosynthetic process (GO:0043650),-0.7493943201619258,-1.2390793225854528,0.21428571428571427,0.7481665061454968,1.0,1/7,3.80%,MTHFD1
prerank,GO_Biological_Process_2021__negative regulation of cellular catabolic process (GO:0031330),0.5252137071322609,1.2390139052553997,0.09090909090909091,0.758087603156812,1.0,8/48,13.96%,LEPR;ATRAID;TIMP3;TAB2;HGF;SORL1;MTMR9;NELL1
prerank,GO_Biological_Process_2021__cellular response to alkaloid (GO:0071312),0.6945046646558892,1.2388944225942657,0.21153846153846154,0.7572562546283734,1.0,5/10,24.83%,SLC8A1;BLM;RYR1;RYR2;CASP3
prerank,GO_Biological_Process_2021__immunoglobulin mediated immune response (GO:0016064),-0.7144966562200172,-1.238321843442503,0.25,0.7499397459542825,1.0,2/7,15.77%,FCER1G;CD74
prerank,GO_Biological_Process_2021__positive regulation of adaptive immune response (GO:0002821),-0.7928669554781931,-1.238202527130003,0.20689655172413793,0.7492643169551028,1.0,1/7,0.40%,SKAP1
prerank,GO_Biological_Process_2021__negative regulation of regulated secretory pathway (GO:1903306),0.7383992003969628,1.2379607048209265,0.23255813953488372,0.7588215299352662,1.0,1/6,3.84%,RAP1A
prerank,GO_Biological_Process_2021__positive regulation of binding (GO:0051099),-0.5626988574996169,-1.2377886062896146,0.1794871794871795,0.7497851008107856,1.0,9/61,6.59%,DDX11;PYHIN1;B2M;EDF1;RPL11;IGF1;DTX3L;MED25;PARP9
prerank,GO_Biological_Process_2021__beta-catenin-TCF complex assembly (GO:1904837),0.6009815827324726,1.2375463855047983,0.19607843137254902,0.7588281905517694,1.0,8/23,18.19%,TCF7L1;TLE2;HDAC1;BCL9L;TCF7L2;TLE1;BCL9;RBBP5
prerank,GO_Biological_Process_2021__nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),-0.6307228524207986,-1.2375340637955088,0.19672131147540983,0.749701710391929,1.0,2/24,1.30%,UBC;RPS27A
prerank,GO_Biological_Process_2021__poly(A)+ mRNA export from nucleus (GO:0016973),0.6885583387424196,1.2372466446390264,0.21621621621621623,0.7585962270002401,1.0,3/10,17.17%,NXF1;NUP133;IWS1
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell apoptotic process (GO:2000352),0.7272811512625985,1.2363300347490045,0.34146341463414637,0.7601913094129644,1.0,2/10,1.65%,SEMA5A;SERPINE1
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.6094629872613002,1.2360065219216125,0.18604651162790697,0.7602551507789727,1.0,5/15,15.55%,PKD2;PKD1;SPDYA;CCNYL1;CCND3
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),-0.6544816042207735,-1.2358969604527477,0.2,0.7552903173913151,1.0,1/16,0.27%,BCL2A1
prerank,GO_Biological_Process_2021__regulation of type B pancreatic cell development (GO:2000074),0.7423821799017468,1.2358459272013802,0.25,0.7595669133755717,1.0,4/6,22.15%,RFX3;CLOCK;GSK3B;FOXO1
prerank,GO_Biological_Process_2021__Schwann cell development (GO:0014044),0.6941905756891666,1.235481163839358,0.3111111111111111,0.7582760504419288,1.0,4/7,15.71%,LGI4;NF1;CNTNAP1;PARD3
prerank,GO_Biological_Process_2021__peripheral nervous system axon ensheathment (GO:0032292),0.6941905756891666,1.235481163839358,0.3111111111111111,0.7582760504419288,1.0,4/7,15.71%,LGI4;NF1;CNTNAP1;PARD3
prerank,GO_Biological_Process_2021__defense response to tumor cell (GO:0002357),0.7636949582874777,1.2354212182847264,0.20930232558139536,0.7572990452599483,1.0,1/8,0.08%,KLF4
prerank,GO_Biological_Process_2021__positive regulation of T cell receptor signaling pathway (GO:0050862),-0.7507976679383261,-1.2351982246422168,0.12962962962962962,0.7570655414466375,1.0,3/11,9.70%,RPS3;PRKD2;CD226
prerank,PanglaoDB_Augmented_2021__Anterior Pituitary Gland Cells,0.4622325920667844,1.2351881145869714,0.14814814814814814,0.7569149394336676,1.0,44/86,24.55%,PDZRN4;ZNF536;SCN3A;RCN3;SNAP91;PLPPR4;CPEB4;KCTD16;NTM;GRIA3;GRIA4;CDH11;OLFM3;CADM2;GRIA1;ASXL3;PTPRD;COL11A1;RUNX1T1;PTPRN;RBFOX1;GRIA2;HFM1;SGIP1;CNTN4;NFASC;CSRNP3;ROBO2;ADGRB3;MAP6;SYT4;UNC5D;INTS6L;PRKG1;NOVA1;NRXN1;LSAMP;RAB3C;OPCML;SEMA6D;FGF14;MAGI2;COL14A1;CADPS
prerank,GO_Biological_Process_2021__response to lipoteichoic acid (GO:0070391),-0.789499313103805,-1.2351499800990613,0.19230769230769232,0.7549790903128661,1.0,1/5,3.07%,CD14
prerank,GO_Biological_Process_2021__cellular response to lipoteichoic acid (GO:0071223),-0.789499313103805,-1.2351499800990613,0.19230769230769232,0.7549790903128661,1.0,1/5,3.07%,CD14
prerank,GO_Biological_Process_2021__heme biosynthetic process (GO:0006783),0.6145982850798115,1.235050359313715,0.17391304347826086,0.7562769443823122,1.0,2/15,4.35%,FLVCR1;COX10
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomerase (GO:0032210),-0.592484672978099,-1.2346904769306493,0.17142857142857143,0.7558432737804293,1.0,3/43,7.08%,PKIB;PRKCQ;EXOSC10
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),-0.5409532276312273,-1.2343526902596975,0.14925373134328357,0.7561838463675118,1.0,17/70,14.82%,UBC;RPS27A;PSMB3;ELOB;PSMB6;PSMA7;EGLN3;PSMB9;RBX1;VEGFA;HIF1A;ATF3;PSMD12;PSMD8;PSMA5;HSPA1A;UBA52
prerank,PanglaoDB_Augmented_2021__Mast Cells,0.43924290517451436,1.2342625047665947,0.038461538461538464,0.7582470105358362,1.0,22/124,8.62%,CPA1;GSN;FPR3;PDK4;MITF;TCF7L1;STK32B;NEO1;HS2ST1;SPRED1;MRC1;KCTD12;NCEH1;GRIK2;VSIG4;ST6GALNAC3;RIN2;CHST1;UNC13B;HPGDS;DNM3;SLC4A4
prerank,GO_Biological_Process_2021__positive regulation of cardiac epithelial to mesenchymal transition (GO:0062043),0.7627227342964397,1.2339376026609308,0.2571428571428571,0.758313167843604,1.0,3/7,15.21%,TGFBR2;JAG1;TGFBR1
prerank,GO_Biological_Process_2021__linoleic acid metabolic process (GO:0043651),-0.7172232707020851,-1.2338288559801676,0.23529411764705882,0.7573736903910794,1.0,3/10,17.64%,GSTP1;ALOX12;FADS2
prerank,GO_Biological_Process_2021__positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.5731398439764581,1.2336022675858658,0.16216216216216217,0.7582228657223156,1.0,2/18,2.15%,HIP1R;TGFA
prerank,GO_Biological_Process_2021__protein secretion (GO:0009306),0.5317890659054328,1.233400683256871,0.17857142857142858,0.7577623676946973,1.0,5/40,7.65%,ANXA1;RCN3;RAB10;SEL1L;COPG1
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via STAT (GO:1904894),-0.7579814507902348,-1.233389284876404,0.1320754716981132,0.7579264541162741,1.0,3/10,5.34%,CCL5;IL7R;IL10RA
prerank,PanglaoDB_Augmented_2021__Loop Of Henle Cells,0.4876588053285974,1.233382519510992,0.14705882352941177,0.756621972032326,1.0,14/58,11.39%,COL16A1;KCNT1;PLA2G7;GSN;PLXNA2;PHLDB1;TIMP3;RIN2;DACH1;JAG1;CDH11;SASH1;EPAS1;FAM114A1
prerank,GO_Biological_Process_2021__regulation of pattern recognition receptor signaling pathway (GO:0062207),-0.8212878455758652,-1.2333384119513415,0.20689655172413793,0.7570857161673987,1.0,1/6,0.52%,CD36
prerank,GO_Biological_Process_2021__central nervous system neuron development (GO:0021954),0.6456877506307303,1.233262081472135,0.19047619047619047,0.7560877751668997,1.0,8/11,27.08%,PTEN;NTRK2;RAPGEF2;B4GALT5;MAP2;ARHGAP35;B4GALT6;GBA2
prerank,GO_Biological_Process_2021__aortic valve morphogenesis (GO:0003180),0.6428518310557394,1.2332466484689533,0.2571428571428571,0.7549343127055341,1.0,7/12,26.68%,JAG1;ROBO1;ROBO2;SLIT3;TGFB1;NOTCH1;SLIT2
prerank,GO_Biological_Process_2021__integrin activation (GO:0033622),0.7431883848489095,1.2329943367289657,0.2553191489361702,0.7545013980563994,1.0,1/7,0.32%,COL16A1
prerank,"GO_Biological_Process_2021__DNA catabolic process, endonucleolytic (GO:0000737)",-0.6488037410969727,-1.2328318221509267,0.19047619047619047,0.7579531651182396,1.0,6/18,23.00%,H1-0;MUS81;REXO4;DFFB;DICER1;DNASE2
prerank,GO_Biological_Process_2021__positive regulation of deacetylase activity (GO:0090045),-0.7985972893819488,-1.232450325158405,0.2,0.7583638879732283,1.0,2/6,11.19%,PRKD2;VEGFA
prerank,GO_Biological_Process_2021__glycogen catabolic process (GO:0005980),-0.6809796831523414,-1.232355485996328,0.1774193548387097,0.7577529505257542,1.0,2/12,8.36%,PHKG1;CALM1
prerank,GO_Biological_Process_2021__ribosome disassembly (GO:0032790),-0.750875470016081,-1.232091325371062,0.23529411764705882,0.7576973093375109,1.0,2/7,11.14%,EIF2D;MTIF3
prerank,GO_Biological_Process_2021__regulation of metallopeptidase activity (GO:1905048),-0.8173429274693785,-1.2318932925705595,0.19298245614035087,0.7572021652755698,1.0,2/5,14.68%,DDRGK1;TIMP2
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition (GO:0010718),0.5947803777016799,1.2318475430210432,0.21428571428571427,0.7572808969149856,1.0,11/27,15.21%,PDPN;TGFBR2;SMAD2;SMAD3;JAG1;LOXL2;BCL9L;TCF7L2;ZNF703;FERMT2;TGFBR1
prerank,GO_Biological_Process_2021__negative regulation of T cell mediated immunity (GO:0002710),-0.7466981546761909,-1.2316611844336398,0.1896551724137931,0.75707222029471,1.0,4/9,8.19%,IL4I1;LILRB4;HLA-F;KLRD1
prerank,GO_Biological_Process_2021__nuclear body organization (GO:0030575),-0.7848735076680853,-1.2313269767381148,0.17543859649122806,0.7574311464324521,1.0,1/8,4.35%,ETS1
prerank,GO_Biological_Process_2021__late endosome to Golgi transport (GO:0034499),0.7980431941149768,1.2309557599032002,0.22807017543859648,0.7596266502248236,1.0,2/5,8.81%,SGSM2;SNX12
prerank,GO_Biological_Process_2021__regulation of cell aging (GO:0090342),0.7134202362098723,1.2308431797952042,0.2708333333333333,0.758706282941621,1.0,2/7,7.01%,MARCHF5;NUAK1
prerank,GO_Biological_Process_2021__spindle assembly (GO:0051225),-0.5682141477526784,-1.2307572692895778,0.1791044776119403,0.7586145285864959,1.0,11/55,16.54%,FLNA;GOLGA8A;RAB11A;RPS3;WRAP73;ABRAXAS1;TUBGCP2;CSNK1D;SMC1A;GOLGA8N;TUBGCP5
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium organization (GO:1902745),0.5519230599437642,1.2301909762173806,0.2,0.7600027413713454,1.0,4/25,8.34%,AVIL;AKIRIN1;WASF2;AUTS2
prerank,GO_Biological_Process_2021__establishment of mitotic spindle orientation (GO:0000132),-0.6894920384013172,-1.229932694942213,0.22413793103448276,0.7612932320693403,1.0,1/15,1.29%,DYNLT1
prerank,GO_Biological_Process_2021__endocardial cushion morphogenesis (GO:0003203),0.7523014186982139,1.2298694066105982,0.22727272727272727,0.759834307792891,1.0,2/7,12.30%,TGFBR2;BMPR1A
prerank,GO_Biological_Process_2021__central nervous system development (GO:0007417),0.4424432784758509,1.2295391238927085,0.047619047619047616,0.7598966914319577,1.0,35/160,12.41%,IL1RAPL2;PKD2;QARS1;CDK5R1;NCAN;GSN;MAP1S;AATK;TGFBR2;ZBTB16;MYRF;PKD1;ARNT2;PBX1;TPPP;RELN;PPT1;HAPLN2;PDGFC;PLXNB2;LIG4;SH3GL3;ALDH5A1;SOX4;CA10;POU6F2;NFIB;PTCH1;RPS6KA6;PTEN;GRIN2B;NF1;ELP3;NPTX1;SH3GL1
prerank,GO_Biological_Process_2021__snoRNA localization (GO:0048254),-0.7715346124923614,-1.2291136153488473,0.20833333333333334,0.763864455372714,1.0,3/6,22.62%,ZNHIT6;FBL;PIH1D1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110),0.712853998876532,1.229098427488296,0.2619047619047619,0.7599971974849038,1.0,1/8,0.75%,STPG1
prerank,GO_Biological_Process_2021__positive regulation of protein tyrosine kinase activity (GO:0061098),0.569195113310412,1.229023955520381,0.275,0.7589687368219326,1.0,6/24,12.47%,SRCIN1;TGFA;RELN;GRM5;FBXW7;NTRK2
prerank,GO_Biological_Process_2021__innate immune response activating cell surface receptor signaling pathway (GO:0002220),-0.5358694042413364,-1.228584922235839,0.15,0.7647719691150636,1.0,20/80,22.96%,PSMB3;FCER1G;PSMB6;PSMA7;FYN;KLRD1;PSMB9;TYROBP;PSMD12;PSMD8;PSMA5;PSMA3;PSMC4;PSME2;PSME1;CLEC7A;PSMB5;PSMC3;LYN;PSME3
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' (GO:0034427)",0.7649100168247024,1.228510008384939,0.175,0.7580656969912225,1.0,2/5,17.25%,EXOSC6;EXOSC7
prerank,GO_Biological_Process_2021__U4 snRNA 3'-end processing (GO:0034475),0.7649100168247024,1.228510008384939,0.175,0.7580656969912225,1.0,2/5,17.25%,EXOSC6;EXOSC7
prerank,GO_Biological_Process_2021__RNA polymerase II preinitiation complex assembly (GO:0051123),0.6950963044392546,1.228347908579576,0.20930232558139536,0.7573687945227577,1.0,1/8,2.38%,DR1
prerank,GO_Biological_Process_2021__regulation of glial cell migration (GO:1903975),-0.8553297207562232,-1.2283074821864628,0.16981132075471697,0.7648934313439345,1.0,1/5,1.61%,GPR183
prerank,GO_Biological_Process_2021__dendrite extension (GO:0097484),0.7503230456271022,1.2281504417073668,0.16666666666666666,0.7569782325059972,1.0,2/5,22.09%,AUTS2;TMEM108
prerank,GO_Biological_Process_2021__negative regulation of ion transport (GO:0043271),-0.6755123057651746,-1.2278777306552118,0.26229508196721313,0.7655609312852082,1.0,1/16,0.73%,PLN
prerank,GO_Biological_Process_2021__smooth muscle tissue development (GO:0048745),-0.8513292980562429,-1.227713616526825,0.208955223880597,0.7649741120037596,1.0,1/5,0.62%,MYLK
prerank,GO_Biological_Process_2021__long-chain fatty acid biosynthetic process (GO:0042759),-0.6937784087859604,-1.2275271903607585,0.19672131147540983,0.7646489992904534,1.0,4/11,14.59%,GSTM4;GSTP1;GPX4;ALOX12
prerank,GO_Biological_Process_2021__regulation of GTPase activity (GO:0043087),-0.5019255637460945,-1.227184476288116,0.11538461538461539,0.7650419675746261,1.0,9/124,4.88%,CCL4;CCL3;CCL5;VAV3;RGS1;GMIP;RGS16;RACK1;GNB5
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell migration (GO:0010596),0.5658017536630681,1.2271081699525948,0.1111111111111111,0.7595117729241417,1.0,5/21,9.92%,FGF2;PPARG;PTPRM;TNF;DNAJA4
prerank,GO_Biological_Process_2021__ER-associated misfolded protein catabolic process (GO:0071712),0.662108578518102,1.2270992957896099,0.20930232558139536,0.7583231786003168,1.0,3/10,13.44%,AUP1;RNF185;BAG6
prerank,GO_Biological_Process_2021__B cell differentiation (GO:0030183),-0.629726608370447,-1.2269665405121908,0.16666666666666666,0.7647300315487507,1.0,6/28,12.82%,TPD52;DNAJB9;SLC25A5;ITGA4;TCF3;PTPRC
prerank,GO_Biological_Process_2021__regulation of myeloid leukocyte mediated immunity (GO:0002886),0.7200370677729805,1.2269533027604729,0.22857142857142856,0.757800513203866,1.0,1/8,1.04%,FER
prerank,GO_Biological_Process_2021__negative regulation of natural killer cell mediated cytotoxicity (GO:0045953),-0.7322852681682535,-1.2262948239772091,0.1896551724137931,0.7663547203211922,1.0,4/10,14.31%,HLA-B;HLA-F;KLRD1;HLA-E
prerank,PanglaoDB_Augmented_2021__Stromal Cells,0.5251505693322415,1.2261122591051363,0.10810810810810811,0.7592252412123427,1.0,6/44,5.20%,COL5A3;COL16A1;SVEP1;COL5A2;ACTA2;TIMP3
prerank,GO_Biological_Process_2021__fibroblast growth factor receptor signaling pathway (GO:0008543),0.5176535542349765,1.2259996405496496,0.23529411764705882,0.7584764612848671,1.0,20/44,24.36%,POLR2D;FGF2;SPRED1;SPRED2;FLRT1;MAPK1;FLRT2;SHOC2;POLR2H;RAB14;RBFOX2;FGFR2;FGFR1;CBL;FRS2;ANOS1;HNRNPH1;FGFR3;POLR2F;POLR2A
prerank,GO_Biological_Process_2021__tRNA metabolic process (GO:0006399),-0.7221466501691114,-1.2253352227484675,0.22807017543859648,0.7692798680181501,1.0,3/12,12.52%,SSB;KARS1;DARS2
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.4817344456543107,1.2252809584003488,0.12,0.7598203779872823,1.0,9/57,11.20%,PCBP4;ACER2;ZNF385A;SOX4;CNOT7;PLK2;MDM2;CNOT2;RPS6KA6
prerank,GO_Biological_Process_2021__peptide catabolic process (GO:0043171),-0.702725141059356,-1.225202037120328,0.2,0.7686804732959,1.0,4/13,15.21%,TPP1;ERAP1;ERAP2;TRHDE
prerank,GO_Biological_Process_2021__cristae formation (GO:0042407),-0.6227998551481604,-1.224892652029598,0.1774193548387097,0.7686966338505399,1.0,13/24,28.12%,ATP5PD;ATP5F1E;ATP5ME;MICOS13;APOO;SPG7;ATP5F1C;ATP5F1D;ATP5MC2;AFG3L2;DNAJC11;ATP5F1A;ATP5MC3
prerank,GO_Biological_Process_2021__eye photoreceptor cell differentiation (GO:0001754),-0.7616850834158504,-1.2247349100872968,0.2708333333333333,0.7683449552782587,1.0,2/8,11.19%,NKD1;VEGFA
prerank,GO_Biological_Process_2021__positive regulation of gliogenesis (GO:0014015),0.8018069931757942,1.2246728554827266,0.2391304347826087,0.7605020195992059,1.0,2/5,12.90%,TNF;PRKCI
prerank,GO_Biological_Process_2021__regulation of interleukin-4 production (GO:0032673),-0.6861807813672653,-1.2239167500207628,0.2459016393442623,0.7708834917218708,1.0,3/15,3.26%,SLC7A5;PRKCQ;FCER1G
prerank,GO_Biological_Process_2021__positive regulation of alcohol biosynthetic process (GO:1902932),0.7592674066854024,1.2237638785698903,0.30612244897959184,0.7627022210517399,1.0,3/5,22.61%,PRKAA1;SNCA;SCAP
prerank,GO_Biological_Process_2021__cellular response to lectin (GO:1990858),-0.5374572305886535,-1.2237496270152295,0.11538461538461539,0.7693345958307677,1.0,20/79,22.96%,PSMB3;FCER1G;PSMB6;PSMA7;FYN;KLRD1;PSMB9;TYROBP;PSMD12;PSMD8;PSMA5;PSMA3;PSMC4;PSME2;PSME1;CLEC7A;PSMB5;PSMC3;LYN;PSME3
prerank,GO_Biological_Process_2021__stimulatory C-type lectin receptor signaling pathway (GO:0002223),-0.5374572305886535,-1.2237496270152295,0.11538461538461539,0.7693345958307677,1.0,20/79,22.96%,PSMB3;FCER1G;PSMB6;PSMA7;FYN;KLRD1;PSMB9;TYROBP;PSMD12;PSMD8;PSMA5;PSMA3;PSMC4;PSME2;PSME1;CLEC7A;PSMB5;PSMC3;LYN;PSME3
prerank,GO_Biological_Process_2021__adenosine to inosine editing (GO:0006382),0.7769976388532236,1.2236344294511319,0.16981132075471697,0.761952695210751,1.0,1/6,0.51%,ADARB2
prerank,GO_Biological_Process_2021__negative regulation of production of molecular mediator of immune response (GO:0002701),0.8004371607881822,1.2234030391601967,0.23404255319148937,0.7614300748547405,1.0,3/5,15.40%,CD22;TNF;CR1
prerank,GO_Biological_Process_2021__retina homeostasis (GO:0001895),-0.7336184005113273,-1.2233311038434003,0.2037037037037037,0.7699714539598839,1.0,4/11,13.37%,B2M;ACTG1;ACTB;SOD1
prerank,GO_Biological_Process_2021__folic acid-containing compound metabolic process (GO:0006760),-0.7128838300811616,-1.2231906291611212,0.2631578947368421,0.7694865440123545,1.0,3/13,18.15%,MTHFD1;SHMT1;FOLR2
prerank,GO_Biological_Process_2021__positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.5687033179164217,1.2231804788948328,0.17073170731707318,0.7611519963262541,1.0,3/20,5.15%,ANXA1;CDK10;UBE2E2
prerank,GO_Biological_Process_2021__epithelial cell development (GO:0002064),0.7149839540115661,1.2230276113451868,0.2708333333333333,0.760744168478943,1.0,2/8,10.18%,ACTA2;TMEM79
prerank,GO_Biological_Process_2021__Roundabout signaling pathway (GO:0035385),0.7087235704070792,1.2230153791001341,0.2826086956521739,0.7596296808340134,1.0,4/5,28.91%,ROBO1;SLIT3;SLIT2;RHOA
prerank,GO_Biological_Process_2021__homologous chromosome segregation (GO:0045143),-0.7088357478263847,-1.2228311781287269,0.25,0.7698661137493574,1.0,4/9,17.43%,MEI4;IHO1;ZCWPW1;SGO2
prerank,PanglaoDB_Augmented_2021__Tuft Cells,-0.5624912271812837,-1.2224863955964094,0.2,0.7702567598522525,1.0,14/53,13.83%,JAML;MNDA;RGS2;AIF1;CD14;FCER1G;NCF4;CD300LF;MS4A6A;CSF2RB;TYROBP;CSF3R;PTPRC;CASP5
prerank,GO_Biological_Process_2021__nervous system development (GO:0007399),0.4314442900926116,1.2224210790974412,0.0625,0.7607135016582531,1.0,55/254,12.41%,IL1RAPL2;AVIL;KCNQ2;PKD2;DPYSL5;NCAN;SEMA5A;GSN;MAP1S;DOC2A;FGF2;ZBTB16;DPF3;PKD1;NLGN1;ARNT2;ADGRB2;CSPG5;RELN;GDF11;PPT1;NRG1;HAPLN2;PDGFC;JAG1;TMOD2;LIG4;RYK;ROBO1;SH3GL3;ZC4H2;ALDH5A1;WDPCP;DNM3;POU6F2;SHANK3;SHANK2;CYP46A1;MOBP;GPM6A;SCN8A;NUMBL;DYRK1A;BTBD3;MERTK;RPS6KA6;NRXN2;PTEN;APAF1;FKTN;NF1;ELP3;NPTX1;RBFOX1;SH3GL1
prerank,GO_Biological_Process_2021__positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),-0.6530130024055476,-1.2223461948606094,0.20967741935483872,0.7698583437187032,1.0,5/24,11.19%,CCL5;PARP14;IGF1;PARP9;VEGFA
prerank,GO_Biological_Process_2021__regulation of toll-like receptor signaling pathway (GO:0034121),-0.6733330582672752,-1.2220195170640198,0.1935483870967742,0.7703205435452707,1.0,5/18,17.04%,CD36;IRF1;APPL1;FLOT1;IRF7
prerank,GO_Biological_Process_2021__cGMP metabolic process (GO:0046068),0.7560676889395582,1.2218838065186544,0.3541666666666667,0.7613854097478355,1.0,3/6,15.24%,GUCY1A1;NPR2;GUCY1B1
prerank,GO_Biological_Process_2021__positive regulation of macroautophagy (GO:0016239),0.5045220101664368,1.221538684429443,0.20930232558139536,0.7613691413077077,1.0,4/44,6.65%,BAG3;SIRT1;TSC2;SPTLC2
prerank,GO_Biological_Process_2021__positive regulation of long-term synaptic potentiation (GO:1900273),0.6276540945287112,1.2214198150631095,0.1951219512195122,0.7605382453663326,1.0,2/10,8.67%,RELN;SHANK3
prerank,GO_Biological_Process_2021__chromatin assembly or disassembly (GO:0006333),0.7101085131635898,1.2212111315288527,0.2,0.7602460131168737,1.0,3/9,16.84%,MTA2;SUPT16H;CHAF1A
prerank,GO_Biological_Process_2021__phagolysosome assembly (GO:0001845),0.6963079455911052,1.2209065797873415,0.2545454545454545,0.7602684738456502,1.0,7/8,30.41%,RAB7A;RAB14;ARL8B;RAB7B;RAB20;PIKFYVE;RAB39A
prerank,GO_Biological_Process_2021__marginal zone B cell differentiation (GO:0002315),0.7785352657680356,1.220611913381122,0.28846153846153844,0.7601802811193169,1.0,2/5,8.17%,MFNG;DOCK10
prerank,GO_Biological_Process_2021__cellular response to cAMP (GO:0071320),0.6178809814152988,1.2205926764546253,0.2222222222222222,0.7591170061208447,1.0,3/20,3.84%,PKD2;AANAT;RAP1A
prerank,GO_Biological_Process_2021__negative regulation of cell cycle phase transition (GO:1901988),-0.7163715775508991,-1.2204100472496626,0.32558139534883723,0.7754598170779681,1.0,1/6,2.73%,ATF5
prerank,GO_Biological_Process_2021__microglial cell activation (GO:0001774),-0.671678853788323,-1.220391345947787,0.2545454545454545,0.7744642931726303,1.0,5/18,11.20%,AIF1;CLU;C5AR1;ITGB2;TYROBP
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell apoptotic process (GO:1905461),0.8357063826801396,1.2201528563649686,0.21428571428571427,0.7597841997019451,1.0,3/5,12.13%,E2F3;PPARG;SOD2
prerank,GO_Biological_Process_2021__mitochondrial fragmentation involved in apoptotic process (GO:0043653),-0.7502753324417291,-1.2199819647910124,0.23076923076923078,0.7751713169355027,1.0,2/9,6.23%,FIS1;VPS35
prerank,GO_Biological_Process_2021__blood vessel endothelial cell migration (GO:0043534),0.6463123640906876,1.2198578310076056,0.15789473684210525,0.7596604474596618,1.0,3/11,7.38%,NRP1;FGF2;ROBO1
prerank,GO_Biological_Process_2021__proteoglycan metabolic process (GO:0006029),0.5803032170683906,1.2198150853610419,0.23529411764705882,0.7586394232804102,1.0,6/16,9.81%,HS3ST4;CSGALNACT1;HPSE;B4GALT7;CANT1;BMPR1B
prerank,GO_Biological_Process_2021__histone H3-K4 trimethylation (GO:0080182),-0.6869507662140686,-1.2195798776825193,0.23529411764705882,0.7757559925112449,1.0,2/10,14.77%,ZNF335;SETD1A
prerank,GO_Biological_Process_2021__positive regulation of synaptic transmission (GO:0050806),0.4590876885815971,1.219335845514487,0.11764705882352941,0.7592494398264992,1.0,17/48,14.74%,NLGN1;ZDHHC3;GRIK2;RELN;ADRA1A;BAIAP3;TNF;SHANK3;NPTN;SHANK2;PLK2;CLSTN2;CLSTN3;GRIN2B;SLC24A2;CACNG8;CACNG2
prerank,GO_Biological_Process_2021__toll-like receptor 9 signaling pathway (GO:0034162),0.6408677464245818,1.2190167287310352,0.17073170731707318,0.7593279586962464,1.0,5/12,14.94%,TLR7;IRAK1;PIK3AP1;IRAK2;TRAF6
prerank,GO_Biological_Process_2021__regulation of myoblast fusion (GO:1901739),-0.8116275922567102,-1.2190024185911938,0.2549019607843137,0.777372914709507,1.0,2/5,9.94%,RIPOR2;CFLAR
prerank,GO_Biological_Process_2021__microtubule anchoring (GO:0034453),0.6834434846158068,1.2188622099247786,0.3023255813953488,0.7588409081429339,1.0,6/9,30.34%,DAG1;CLASP1;CLASP2;PCM1;BICD2;PEX14
prerank,GO_Biological_Process_2021__anterograde trans-synaptic signaling (GO:0098916),0.4295046076457655,1.2180774080216772,0.11538461538461539,0.7603401167496541,1.0,49/124,22.06%,CACNA1A;KCNQ2;DOC2A;SLC1A3;KCNIP2;NLGN1;GRIK2;GLRA1;SLC1A2;UNC13B;PDE7B;GABRR2;DTNA;GRIA3;SLC12A6;GRIA4;GRIA1;KCNMB4;GRM5;SNCB;NRXN2;MAPK1;GRIN2B;NPTX1;SLC12A5;CACNA1E;GRIA2;GAD1;CACNB4;NLGN4Y;HTR7;GRIN2A;GABRD;DLGAP1;SNCA;KCND2;GABRB2;HOMER1;GRM3;GABRG3;NOVA1;CACNA1B;GABRA4;GRM1;CHRM3;NRXN1;GABRA2;GRIN1;DLG2
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in immune response (GO:0002720),-0.6436542864480581,-1.2179651061103143,0.2535211267605634,0.780762109115915,1.0,7/19,14.31%,SLC7A5;CD55;B2M;HLA-F;CD226;NOD2;HLA-E
prerank,GO_Biological_Process_2021__positive regulation of type I interferon production (GO:0032481),-0.5522530097334604,-1.2179298473254836,0.2028985507246377,0.7797901130901492,1.0,9/65,11.42%,OAS3;GAPDH;DHX58;CD14;OAS2;OAS1;STAT1;IRF1;STING1
prerank,GO_Biological_Process_2021__adherens junction organization (GO:0034332),0.518582482022329,1.2178663563246426,0.1794871794871795,0.7599075543980353,1.0,12/32,15.66%,SMAD7;CDH20;CADM1;VCL;CDH11;CADM2;AFDN;TJP1;CDH19;ZNF703;FERMT2;CDH8
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum (GO:0070972),-0.6505758042865144,-1.217661825472176,0.20634920634920634,0.7797665832315027,1.0,3/14,9.32%,PPP1R15A;DDRGK1;GABARAPL2
prerank,GO_Biological_Process_2021__positive regulation of insulin receptor signaling pathway (GO:0046628),0.6956545768316128,1.2173893089046952,0.17073170731707318,0.7603477061590084,1.0,2/8,11.83%,SIRT1;SORL1
prerank,GO_Biological_Process_2021__regulation of phospholipid metabolic process (GO:1903725),-0.7412667531754832,-1.2164528532811707,0.22413793103448276,0.7834253813641975,1.0,2/9,6.40%,DNAJC19;PHB2
prerank,GO_Biological_Process_2021__membrane lipid metabolic process (GO:0006643),0.6651110061700306,1.2164158835541197,0.2702702702702703,0.7623817464557151,1.0,6/12,27.72%,B4GALT4;ARV1;CERK;SERINC1;TEX2;MGST2
prerank,GO_Biological_Process_2021__regulation of peptidyl-lysine acetylation (GO:2000756),0.7284255484824081,1.2162921191776677,0.2978723404255319,0.7614955658630291,1.0,4/7,16.79%,SIRT1;DIP2B;SETD5;PRKAA1
prerank,GO_Biological_Process_2021__cellular response to leucine starvation (GO:1990253),0.6889653176505937,1.2161795289303423,0.25,0.7607204699863651,1.0,1/10,0.78%,RRAGD
prerank,GO_Biological_Process_2021__bleb assembly (GO:0032060),-0.80880416616754,-1.2159163715185846,0.2826086956521739,0.7845191686890194,1.0,2/6,7.32%,MYLK;EMP3
prerank,GO_Biological_Process_2021__regulation of lysosomal protein catabolic process (GO:1905165),0.7935898222533504,1.2158979153871685,0.2127659574468085,0.7605612585362292,1.0,2/5,15.12%,LDLR;ATP13A2
prerank,GO_Biological_Process_2021__protein O-linked glycosylation via serine (GO:0018242),0.7888885007326448,1.2158183153648363,0.21739130434782608,0.7596276848340532,1.0,5/6,15.60%,POGLUT3;GALNT13;POGLUT1;GALNT1;GALNT2
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium morphogenesis (GO:2000394),-0.7827586626097932,-1.2155224645539568,0.2708333333333333,0.7848588288445705,1.0,2/6,8.11%,CORO1B;ENPP2
prerank,GO_Biological_Process_2021__cell migration involved in sprouting angiogenesis (GO:0002042),0.6846345459571,1.215085780334273,0.225,0.7612878298727261,1.0,3/9,7.38%,NRP1;FGF2;ROBO1
prerank,GO_Biological_Process_2021__sphingoid metabolic process (GO:0046519),-0.7456754878693277,-1.2150553175211016,0.29310344827586204,0.7856738011821558,1.0,1/9,0.87%,DEGS2
prerank,GO_Biological_Process_2021__regulation of leukocyte degranulation (GO:0043300),0.720066343543363,1.2147196524181891,0.2,0.7614518728292853,1.0,1/7,1.04%,FER
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transporter activity (GO:1901020),-0.6449280289669436,-1.214698085000273,0.2698412698412698,0.7859990558266986,1.0,4/13,8.36%,PLN;GNB5;SRI;CALM1
prerank,GO_Biological_Process_2021__sphingolipid biosynthetic process (GO:0030148),0.5001924987774762,1.2145833801367525,0.09375,0.7608081586376456,1.0,12/50,12.86%,VAPB;ACER2;PPM1L;LARGE1;PLPP1;FA2H;SPTLC2;HACD2;ELOVL6;SAMD8;ST6GALNAC5;SGMS1
prerank,GO_Biological_Process_2021__protein O-linked glycosylation (GO:0006493),0.5221574933179948,1.2144377006889209,0.10344827586206896,0.7600946976452422,1.0,15/55,15.60%,B3GNT2;POGLUT3;LARGE1;GALNT13;GALNTL6;TMTC2;FKRP;POGLUT1;C1GALT1;GALNT7;FKTN;GXYLT1;GALNT1;EOGT;GALNT2
prerank,GO_Biological_Process_2021__negative regulation of nervous system development (GO:0051961),-0.6735072201491108,-1.2136833893681795,0.23214285714285715,0.7887812366190712,1.0,2/14,2.81%,DYNLT1;B2M
prerank,GO_Biological_Process_2021__cell morphogenesis involved in differentiation (GO:0000904),0.5319732758497586,1.2136456791964265,0.16666666666666666,0.7619232076341119,1.0,11/48,16.86%,NRP1;FER;SRCIN1;RELN;TMEFF2;ITGAV;FERMT2;TYRO3;SRGAP2;ANTXR1;ATRNL1
prerank,GO_Biological_Process_2021__positive regulation of monocyte chemotactic protein-1 production (GO:0071639),-0.7578648243969558,-1.212783993509353,0.30612244897959184,0.7913068027456143,1.0,2/6,8.28%,OAS3;OAS1
prerank,PanglaoDB_Augmented_2021__Foveolar Cells,-0.8060761945021069,-1.2126575661477734,0.2413793103448276,0.790687584332179,1.0,2/6,14.37%,ABCC3;ATP8B1
prerank,GO_Biological_Process_2021__regulation of metaphase/anaphase transition of cell cycle (GO:1902099),0.780868873699584,1.212634636292824,0.21739130434782608,0.7647286226869819,1.0,2/5,11.55%,CDC23;CENPE
prerank,GO_Biological_Process_2021__phospholipid transport (GO:0015914),-0.5664817065255237,-1.2124868954495722,0.14705882352941177,0.7903065538194842,1.0,7/44,10.11%,OSBPL5;PRELID1;PLTP;ABCB1;ATP10A;PCTP;ABCB4
prerank,PanglaoDB_Augmented_2021__Ductal Cells,-0.7248443640997934,-1.2122828321155898,0.25,0.789961987959634,1.0,6/12,17.39%,CLDN7;CFTR;SERPING1;ATP8B1;C3;GPRC5C
prerank,GO_Biological_Process_2021__negative regulation of adenylate cyclase activity (GO:0007194),0.7581637123704574,1.2119331531963191,0.3125,0.7649368490417814,1.0,2/5,20.06%,ADGRV1;GRM3
prerank,GO_Biological_Process_2021__negative regulation of cyclase activity (GO:0031280),0.7581637123704574,1.2119331531963191,0.3125,0.7649368490417814,1.0,2/5,20.06%,ADGRV1;GRM3
prerank,GO_Biological_Process_2021__regulation of translation (GO:0006417),-0.4976054448848741,-1.21183945591812,0.14285714285714285,0.7903730951254309,1.0,33/151,18.50%,MIF4GD;RPS4X;GAPDH;BTG2;RPL5;GZMB;RPL13A;RACK1;RPL10;RPS3;EIF1;SHFL;ILF3;EIF2AK2;EIF4A3;NCBP2;NPM1;MTRF1;EIF2A;PATL2;RBM4B;PASK;RPS27L;ZCCHC4;PUM3;SHMT1;CNOT8;EIF2B2;EEF2;ZNF540;RBM4;PAIP2;VIM
prerank,GO_Biological_Process_2021__pexophagy (GO:0000425),0.7417452577447599,1.2116235494696141,0.19607843137254902,0.76463153363283,1.0,2/7,12.36%,USP30;PEX5
prerank,GO_Biological_Process_2021__mononuclear cell differentiation (GO:1903131),0.5699297387582659,1.2116000869616248,0.22857142857142856,0.7635458834850543,1.0,3/18,9.31%,PIR;PPARG;IKZF1
prerank,GO_Biological_Process_2021__regulation of myotube differentiation (GO:0010830),0.650601261382187,1.2114858328756641,0.3023255813953488,0.7627470801353666,1.0,9/15,27.24%,HDAC9;TMEM119;HDAC1;MMP14;PIEZO1;HDAC3;MAPK14;NOTCH1;ATP11A
prerank,GO_Biological_Process_2021__regulation of T cell cytokine production (GO:0002724),-0.685654176571984,-1.2114718850068367,0.2033898305084746,0.7909715126461204,1.0,6/13,10.69%,CD55;B2M;LILRB4;HLA-F;TNFRSF1B;TRPM4
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation or removal (GO:0070647),0.618629841993321,1.2114595031811903,0.25,0.7616850627656873,1.0,4/13,12.79%,DESI2;SAE1;UBA1;UBA2
prerank,GO_Biological_Process_2021__ion homeostasis (GO:0050801),0.6371621984935131,1.211208740337863,0.2222222222222222,0.7611918251921196,1.0,8/16,25.84%,NEDD4L;SLC4A4;WNK1;UNC80;SLC12A5;SLC4A8;SLC4A2;CAMK2D
prerank,GO_Biological_Process_2021__porphyrin-containing compound biosynthetic process (GO:0006779),0.5901495034822526,1.2112028275946707,0.19148936170212766,0.760152822918807,1.0,4/17,13.15%,FLVCR1;COX10;RSAD1;ALAD
prerank,GO_Biological_Process_2021__regulation of response to external stimulus (GO:0032101),-0.5421397371012805,-1.2111462763537828,0.175,0.7911684411090784,1.0,14/72,14.09%,CD36;CXCR4;CD55;MGLL;TRIM5;DHX58;CALM1;TMSB4X;IRF1;ERAP1;APPL1;EFNB2;CASP5;NOD2
prerank,GO_Biological_Process_2021__positive regulation of protein localization to nucleus (GO:1900182),-0.5723896612996193,-1.2107408387327963,0.2028985507246377,0.7916467111660376,1.0,8/47,6.59%,FLNA;TFRC;PYHIN1;JUP;DTX3L;LAMTOR5;RBM22;PARP9
prerank,GO_Biological_Process_2021__aromatic amino acid transport (GO:0015801),0.7288401307910612,1.2107317726758662,0.3111111111111111,0.7608441940285914,1.0,2/5,4.23%,SLC7A8;SLC3A2
prerank,GO_Biological_Process_2021__positive regulation of phosphatase activity (GO:0010922),-0.730521417726258,-1.2106126488970024,0.23214285714285715,0.7911032716549006,1.0,3/12,8.36%,PPP1R15A;PLEK;CALM1
prerank,GO_Biological_Process_2021__regulation of protein localization to cell cortex (GO:1904776),0.8072199163300072,1.210423467024615,0.17777777777777778,0.7596725634495094,1.0,1/5,3.48%,EPB41
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell cortex (GO:1904778),0.8072199163300072,1.210423467024615,0.17777777777777778,0.7596725634495094,1.0,1/5,3.48%,EPB41
prerank,GO_Biological_Process_2021__cell chemotaxis (GO:0060326),-0.5936436207690354,-1.2103614454260234,0.16417910447761194,0.7911469539208746,1.0,6/27,6.72%,PLEKHG5;CXCR4;PRKCQ;EPHB1;ACKR4;CORO1B
prerank,GO_Biological_Process_2021__actin filament network formation (GO:0051639),0.6548138089157883,1.2103266302456237,0.21875,0.7589401255241088,1.0,3/10,11.62%,SPIRE2;LCP1;COBL
prerank,GO_Biological_Process_2021__neural crest cell development (GO:0014032),0.5577196892500816,1.2092879640837226,0.2777777777777778,0.7618898421936168,1.0,8/22,18.35%,SEMA5A;SEMA3B;NRG1;PHACTR4;ERBB4;KLHL12;NOLC1;SEMA4D
prerank,GO_Biological_Process_2021__odontogenesis of dentin-containing tooth (GO:0042475),0.7585048837212138,1.2091601642766203,0.3181818181818182,0.761488791347956,1.0,2/5,14.43%,HDAC1;ANKRD11
prerank,GO_Biological_Process_2021__peptidyl-methionine modification (GO:0018206),0.6465169998200216,1.2090637882338857,0.21052631578947367,0.7606870097287288,1.0,1/8,5.00%,NAA20
prerank,GO_Biological_Process_2021__positive regulation of blood vessel endothelial cell migration (GO:0043536),0.5391242969306618,1.2087199293672752,0.21621621621621623,0.7608995356251834,1.0,5/36,6.06%,ANXA1;FGF2;SIRT1;HDAC9;CIB1
prerank,GO_Biological_Process_2021__nucleotide-sugar metabolic process (GO:0009225),0.7059470851022859,1.2087002093386345,0.2857142857142857,0.7599266779695706,1.0,3/7,6.70%,CSGALNACT1;EXTL2;GFPT1
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.4858177379674665,1.2084702100355855,0.1951219512195122,0.7594611603163051,1.0,12/50,16.39%,PKD2;CDK5R1;CCNG2;PKD1;CDK7;CCNG1;SPDYA;PTEN;GTPBP4;CCNYL1;CCND3;BLM
prerank,GO_Biological_Process_2021__negative regulation of cAMP-dependent protein kinase activity (GO:2000480),-0.7035556176295562,-1.2077292016879988,0.21568627450980393,0.8005600182068562,1.0,2/8,6.63%,PKIB;PRKAR1B
prerank,GO_Biological_Process_2021__translesion synthesis (GO:0019985),-0.6185751095306428,-1.207689625586964,0.20967741935483872,0.7996563186820651,1.0,2/33,1.30%,UBC;RPS27A
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.5102235761067038,1.2074842213101937,0.2,0.7619851555186937,1.0,7/40,9.99%,PCBP4;ZNF385A;SOX4;CNOT7;PLK2;MDM2;CNOT2
prerank,GO_Biological_Process_2021__negative regulation of response to endoplasmic reticulum stress (GO:1903573),-0.6342485320842791,-1.207442585521996,0.1694915254237288,0.7995249923344238,1.0,6/22,9.83%,UBXN1;RACK1;AQP11;CLU;NR1H2;SELENOS
prerank,GO_Biological_Process_2021__NIK/NF-kappaB signaling (GO:0038061),-0.533239189074455,-1.2072527054953517,0.21333333333333335,0.7992192677097438,1.0,19/62,22.96%,CARD14;PSMB3;PSMB6;PSMA7;PSMB9;CHI3L1;PSMD12;COPS8;PSMD8;PSMA5;REL;PSMA3;PSMC4;PSME2;PSME1;DICER1;PSMB5;PSMC3;PSME3
prerank,PanglaoDB_Augmented_2021__Oligodendrocytes,0.4538437536199247,1.2068455069676458,0.13043478260869565,0.7631834529579049,1.0,29/118,13.18%,LGI4;SLC39A12;CNTN2;SRCIN1;NCAN;GFAP;TSPAN15;HEPACAM;MYRF;ASPA;MYO1D;NDRG2;DPY19L1;TPPP;FA2H;SLC1A2;HAPLN2;TNR;CA10;MOBP;PSD2;GRM5;SNCB;OLIG1;PTPN5;NTRK2;FASN;KIF6;MPPED1
prerank,GO_Biological_Process_2021__establishment of endothelial intestinal barrier (GO:0090557),0.7057802793585501,1.2068075500671716,0.25,0.7622821886914042,1.0,5/9,17.63%,RAB1B;AFDN;TJP1;RAP2C;RAPGEF2
prerank,GO_Biological_Process_2021__cellular lipid biosynthetic process (GO:0097384),-0.7891569160471041,-1.2067044717223268,0.26229508196721313,0.7990517938050733,1.0,1/5,5.77%,GNPAT
prerank,GO_Biological_Process_2021__glycerol ether biosynthetic process (GO:0046504),-0.7891569160471041,-1.2067044717223268,0.26229508196721313,0.7990517938050733,1.0,1/5,5.77%,GNPAT
prerank,GO_Biological_Process_2021__nucleoside phosphate biosynthetic process (GO:1901293),-0.7103892945901167,-1.2066959056290711,0.3230769230769231,0.7979937159883607,1.0,2/9,1.39%,ME1;CMPK2
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),-0.7156108603092947,-1.206298089870458,0.2545454545454545,0.7985259940839243,1.0,3/9,7.65%,CLU;RPS3;TPT1
prerank,GO_Biological_Process_2021__regulation of microtubule cytoskeleton organization (GO:0070507),0.5649173224790555,1.2061041439497264,0.10810810810810811,0.7636496247537553,1.0,10/28,22.56%,PHLDB1;TPPP;CLASP1;GSK3B;PRKAA1;CLASP2;MARK2;MAP6;MAPRE2;STMN3
prerank,GO_Biological_Process_2021__regulation of isotype switching (GO:0045191),-0.7110729822084916,-1.2060695567717747,0.2631578947368421,0.7983046503329685,1.0,1/11,1.44%,TFRC
prerank,GO_Biological_Process_2021__regulation of mast cell degranulation (GO:0043304),0.6504495692445704,1.2058713299775827,0.2777777777777778,0.7632512125315623,1.0,7/13,24.34%,FER;LGALS9;GAB2;STXBP2;UNC13D;SYK;CD84
prerank,GO_Biological_Process_2021__p38MAPK cascade (GO:0038066),-0.7925375653938714,-1.2056401028586152,0.3111111111111111,0.7988004237822679,1.0,1/5,1.48%,ZFP36
prerank,GO_Biological_Process_2021__lipid droplet organization (GO:0034389),0.6237826692881732,1.2055844483749865,0.1836734693877551,0.7630954267401285,1.0,2/11,8.99%,PLA2G4C;AUP1
prerank,GO_Biological_Process_2021__regulation of dendritic cell differentiation (GO:2001198),-0.7051430506812829,-1.2055661873830144,0.3392857142857143,0.7979676047018867,1.0,1/9,1.11%,HLA-B
prerank,GO_Biological_Process_2021__purine-containing compound catabolic process (GO:0072523),-0.748347264379601,-1.2052700431762555,0.3888888888888889,0.7981051971570208,1.0,2/7,14.09%,NT5C;GPX1
prerank,MSigDB_Hallmark_2020__Androgen Response,-0.5260665454423378,-1.2052343249420752,0.1232876712328767,0.7971719157689353,1.0,12/84,7.98%,TPD52;INSIG1;SAT1;B2M;DNAJB9;H1-0;ADRM1;MAK;TNFAIP8;SELENOP;STK39;SGK1
prerank,GO_Biological_Process_2021__protein O-linked glycosylation via threonine (GO:0018243),0.7498440561445723,1.2052254759199377,0.26666666666666666,0.7632329065259442,1.0,5/7,15.60%,GALNT13;GALNTL6;GALNT1;EOGT;GALNT2
prerank,GO_Biological_Process_2021__high-density lipoprotein particle assembly (GO:0034380),0.7105762695527701,1.2047414775370213,0.24074074074074073,0.7641612131526324,1.0,1/7,6.72%,BMP1
prerank,PanglaoDB_Augmented_2021__Gastric Chief Cells,0.5607015507709421,1.2043873114291936,0.21951219512195122,0.7643311431325838,1.0,4/26,5.87%,HID1;FAAH;AATK;FA2H
prerank,GO_Biological_Process_2021__selective autophagy (GO:0061912),-0.5198084842455986,-1.2043800454271572,0.13114754098360656,0.7990000483009658,1.0,10/55,14.82%,UBC;RPS27A;DDRGK1;PHB2;ACBD5;ATG2A;CFTR;STING1;DYNC1LI2;UBA52
prerank,GO_Biological_Process_2021__gland development (GO:0048732),0.5352748567804236,1.2039965332183649,0.2,0.7646892598982492,1.0,7/30,7.23%,ANXA1;PKD2;ZBTB1;MSN;PRKCSH;NRG1;SALL1
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species metabolic process (GO:2000379),-0.6253071113791787,-1.2039092263602524,0.2463768115942029,0.7996408619835841,1.0,7/29,13.37%,CD36;PID1;GSTP1;ITGB2;TYROBP;CYBA;SOD1
prerank,GO_Biological_Process_2021__regulation of anatomical structure morphogenesis (GO:0022603),0.42919369364509213,1.203796437767136,0.043478260869565216,0.7644126500850562,1.0,31/92,18.35%,CDK5R1;SRCIN1;FGF2;MARCHF5;LRRK2;PHLDB1;DAG1;LRRC4C;NEDD4L;BRSK1;SHANK3;PDLIM5;POGLUT1;TANC2;ZRANB1;KNDC1;BCL9L;NF1;STRIP1;GPNMB;FERMT2;CLASP1;GSK3B;PPFIA2;ADGRB3;CLASP2;KIF13B;BRSK2;MARK2;NEDD4;SEMA4D
prerank,GO_Biological_Process_2021__regulation of angiogenesis (GO:0045765),0.4667975279368473,1.2036974745070788,0.18181818181818182,0.7637263448275532,1.0,13/103,5.26%,KLF4;SEMA5A;SERPINE1;YJEFN3;SPRY2;AMOT;FGF2;SIRT1;GAB1;SPRED1;WNT5A;PPARG;PTPRM
prerank,GO_Biological_Process_2021__regulation of homophilic cell adhesion (GO:1903385),0.8185200728254189,1.2034243557369166,0.22641509433962265,0.7636226642089244,1.0,3/5,16.19%,PTPN23;PTPRG;PTPRR
prerank,GO_Biological_Process_2021__G1/S transition of mitotic cell cycle (GO:0000082),0.4772085888846258,1.2033814077054727,0.14285714285714285,0.7626835795148263,1.0,9/55,12.63%,E2F3;CDK17;CDK18;CDK7;RCC1;SPDYA;PLK2;CDK6;POLA1
prerank,GO_Biological_Process_2021__response to lipid (GO:0033993),0.4891827697659798,1.2033777124034455,0.2,0.7616108881231037,1.0,11/62,10.79%,ANXA1;ACER2;FER;ABCA2;PPARG;IRAK1;TAB2;LGALS9;GCH1;PCK2;IRAK3
prerank,GO_Biological_Process_2021__dermatan sulfate metabolic process (GO:0030205),0.7332615874643466,1.2025046495817626,0.2857142857142857,0.7635514693999097,1.0,3/8,11.46%,NCAN;CSPG5;UST
prerank,GO_Biological_Process_2021__organelle transport along microtubule (GO:0072384),0.5472131482265662,1.2017674762475006,0.2,0.764858226524857,1.0,5/27,12.19%,MAP1S;COPG1;BICDL1;FBXW11;RAB6A
prerank,GO_Biological_Process_2021__establishment of protein localization to mitochondrion (GO:0072655),-0.5788700915106965,-1.201738957976653,0.25396825396825395,0.8069527064071257,1.0,7/31,7.80%,TOMM7;DNAJC19;TIMM44;FIS1;PITRM1;TIMM21;HK2
prerank,GO_Biological_Process_2021__regulation of calcium ion import (GO:0090279),-0.7078689888633983,-1.2012922067275962,0.21818181818181817,0.807535521484256,1.0,3/13,7.36%,CCL3;PLN;FYN
prerank,GO_Biological_Process_2021__negative regulation of cell division (GO:0051782),0.7763607050034286,1.201264439085648,0.24444444444444444,0.7655847010549909,1.0,2/6,16.39%,ZFYVE19;BLM
prerank,GO_Biological_Process_2021__regulation of sprouting angiogenesis (GO:1903670),0.5267868683116054,1.2010825960424092,0.22727272727272727,0.7652252550253282,1.0,3/22,2.26%,KLF4;SMAD1;FGF2
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane permeability (GO:0046902),-0.7089932163721135,-1.2007980868803956,0.16363636363636364,0.8085170207765227,1.0,3/10,13.43%,SLC25A5;THEM4;SPG7
prerank,GO_Biological_Process_2021__regulation of synapse maturation (GO:0090128),0.7084894574642884,1.2006656759587455,0.275,0.7659660997913058,1.0,4/7,25.98%,RELN;NRXN1;DAB2IP;CAMK2B
prerank,GO_Biological_Process_2021__negative regulation of protein serine/threonine kinase activity (GO:0071901),-0.5320233545541825,-1.2005555808255743,0.27419354838709675,0.8082511703281422,1.0,6/56,6.85%,PKIB;DUSP1;RGS2;PAQR3;PRKAR1B;GSTP1
prerank,GO_Biological_Process_2021__regulation of ERAD pathway (GO:1904292),-0.7034743960325583,-1.2004735944007074,0.27586206896551724,0.8074271832081535,1.0,2/10,4.37%,UBXN1;AQP11
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.5845043788095453,1.199836966737908,0.25,0.7676337464594286,1.0,4/17,7.92%,LRRK2;DDIT3;TXNDC12;BOK
prerank,GO_Biological_Process_2021__sodium ion import across plasma membrane (GO:0098719),0.6668445973755228,1.1997201300535192,0.2391304347826087,0.766952513564322,1.0,6/9,17.33%,SLC9C2;SLC9A1;SLC9A9;SLC8A1;SLC12A2;SLC9A7
prerank,GO_Biological_Process_2021__C4-dicarboxylate transport (GO:0015740),0.7290361740489302,1.1995703978108305,0.2222222222222222,0.7662226509981661,1.0,3/8,14.12%,SLC25A18;SLC1A2;SLC25A14
prerank,GO_Biological_Process_2021__positive regulation of GTPase activity (GO:0043547),-0.5154155852377181,-1.199114612648089,0.1794871794871795,0.8117535672156809,1.0,9/135,4.88%,CCL4;CCL3;USP6;CCL5;RGS1;GMIP;RGS16;RACK1;GNB5
prerank,GO_Biological_Process_2021__protein import into peroxisome matrix (GO:0016558),0.6564965215570587,1.1990073700484118,0.22727272727272727,0.7670252672789534,1.0,4/10,17.23%,PEX13;PEX5;PEX16;PEX5L
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion (GO:0007162),0.46089909726965994,1.1988777536313928,0.09375,0.766364507676899,1.0,14/49,13.77%,PLXNB1;ACER2;SEMA5A;SERPINE1;PLXNA2;PLXNA3;JAG1;PLXNB2;PLXNC1;CD164;PDE3B;GTPBP4;PLXNA1;PTK2
prerank,GO_Biological_Process_2021__regulation of osteoblast proliferation (GO:0033688),0.7455707153442102,1.19887224737092,0.2571428571428571,0.7653198325505112,1.0,4/8,8.57%,PLXNB1;ATRAID;HPSE;TMEM119
prerank,GO_Biological_Process_2021__regulation of phospholipase activity (GO:0010517),-0.7342896370339166,-1.1986945713802728,0.26,0.8124741312497352,1.0,1/8,2.19%,RGS2
prerank,GO_Biological_Process_2021__regulation of MHC class I biosynthetic process (GO:0045343),-0.7556781371513738,-1.1984501715653448,0.29310344827586204,0.8123635279801377,1.0,3/5,15.25%,NLRC5;NLRP12;CIITA
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan metabolic process (GO:0030201),0.6601953396097487,1.1984310362073967,0.21212121212121213,0.765584419569899,1.0,5/17,5.59%,HS3ST5;HS3ST4;HS2ST1;UGDH;HPSE
prerank,GO_Biological_Process_2021__negative regulation of type I interferon production (GO:0032480),-0.575946575044016,-1.198166981804605,0.17647058823529413,0.812604912685519,1.0,6/34,14.23%,NLRC3;DHX58;NLRC5;TNFAIP3;HAVCR2;REL
prerank,GO_Biological_Process_2021__tRNA 5'-leader removal (GO:0001682),-0.7979735696904494,-1.198088720778769,0.25,0.8118032804971437,1.0,1/5,3.42%,SSB
prerank,GO_Biological_Process_2021__regulation of tyrosine phosphorylation of STAT protein (GO:0042509),-0.5977329912020181,-1.1976504583295513,0.2537313432835821,0.8124408084705409,1.0,5/30,11.19%,CCL5;PARP14;IGF1;PARP9;VEGFA
prerank,GO_Biological_Process_2021__heart process (GO:0003015),-0.7899580098004133,-1.1974824231341246,0.24528301886792453,0.8120257055769488,1.0,3/6,14.09%,FYN;SOD1;GPX1
prerank,GO_Biological_Process_2021__protein localization to condensed chromosome (GO:1903083),-0.7454340537950221,-1.1974055477850658,0.2777777777777778,0.8112053868966881,1.0,5/8,23.81%,ZWILCH;MIS12;IK;BUB3;CHAMP1
prerank,GO_Biological_Process_2021__protein lipidation (GO:0006497),0.5063696670160766,1.1973084570036412,0.21621621621621623,0.7681563574077932,1.0,4/44,6.37%,PIGQ;PIGU;ZDHHC3;HHAT
prerank,GO_Biological_Process_2021__negative regulation of leukocyte activation (GO:0002695),-0.6997766217867856,-1.197293900712904,0.22641509433962265,0.8105337291770657,1.0,3/10,15.81%,CD300LF;HAVCR2;CD200
prerank,GO_Biological_Process_2021__retinal rod cell development (GO:0046548),-0.8205773588751916,-1.1972855321699671,0.3076923076923077,0.8084536615649871,1.0,2/5,13.29%,RPGRIP1L;NRL
prerank,GO_Biological_Process_2021__retinal rod cell differentiation (GO:0060221),-0.8205773588751916,-1.1972855321699671,0.3076923076923077,0.8084536615649871,1.0,2/5,13.29%,RPGRIP1L;NRL
prerank,GO_Biological_Process_2021__phosphatidylinositol-mediated signaling (GO:0048015),0.4687814648974089,1.1970867712541566,0.2222222222222222,0.7678484286239493,1.0,12/46,18.03%,IGF1R;NYAP2;PLCL1;PLCB4;PIK3C2B;PI4KB;PTEN;NF1;GAB2;TYRO3;PIK3CA;PLCB3
prerank,GO_Biological_Process_2021__regulation of membrane repolarization (GO:0060306),0.6779935769360976,1.1969379008273386,0.3541666666666667,0.7673912357350688,1.0,2/8,8.52%,KCNJ2;NEDD4L
prerank,GO_Biological_Process_2021__negative regulation of cytoplasmic translation (GO:2000766),0.772468648332738,1.1966829352172963,0.23809523809523808,0.7672351124217401,1.0,2/5,18.57%,CPEB4;CPEB2
prerank,GO_Biological_Process_2021__organonitrogen compound catabolic process (GO:1901565),-0.5946951380374081,-1.1966328740182146,0.2698412698412698,0.8099550945054738,1.0,6/36,10.83%,IL4I1;TPP1;PDXDC1;TXN2;ENPP2;ERAP1
prerank,GO_Biological_Process_2021__imitative learning (GO:0098596),0.7449186575727785,1.1960887910330258,0.2608695652173913,0.7670404243751299,1.0,4/5,21.61%,SHANK3;NRXN2;CNTNAP2;NRXN1
prerank,GO_Biological_Process_2021__vocal learning (GO:0042297),0.7449186575727785,1.1960887910330258,0.2608695652173913,0.7670404243751299,1.0,4/5,21.61%,SHANK3;NRXN2;CNTNAP2;NRXN1
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell migration (GO:0010633),0.622749935780723,1.1955270553123745,0.21875,0.7680797421082306,1.0,6/18,16.19%,PTPN23;PTPRM;DNAJA4;PTPRG;PTEN;PTPRR
prerank,GO_Biological_Process_2021__positive regulation of ion transmembrane transporter activity (GO:0032414),-0.6348092304920112,-1.195488633376339,0.3148148148148148,0.813089743724557,1.0,5/18,18.55%,ABCB1;STK39;CFTR;ATP1B3;AKAP9
prerank,GO_Biological_Process_2021__postsynapse assembly (GO:0099068),0.6671718837070622,1.1953455942070916,0.20930232558139536,0.7677247503814698,1.0,5/9,15.11%,LRP4;NLGN1;WNT5A;NRXN2;NLGN4Y
prerank,GO_Biological_Process_2021__external encapsulating structure organization (GO:0045229),0.46492152077801024,1.1953115210875613,0.20833333333333334,0.7667586582800259,1.0,25/91,13.53%,COL5A3;MMP17;COL16A1;PDGFA;NCAN;SERPINE1;COL5A2;FGF2;COL24A1;DAG1;SLC39A8;ADAMTSL2;RECK;TNR;ADAMTS17;FBN2;ADAMTSL3;MMP16;ITGAV;COL11A1;NF1;ITGA2;COL6A1;JAM2;COL15A1
prerank,GO_Biological_Process_2021__cell cycle G1/S phase transition (GO:0044843),0.4841095163992421,1.1951515205414036,0.1891891891891892,0.7664394771946453,1.0,7/44,11.88%,MAP3K11;E2F3;CDK7;RCC1;SPDYA;PLK2;CDK6
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to mitochondrion (GO:1903955),-0.5866727483572943,-1.1948488642893202,0.2459016393442623,0.8143909321582039,1.0,7/25,11.48%,TOMM7;USP36;ARIH2;RHOU;PDCD5;HPS4;ABLIM3
prerank,GO_Biological_Process_2021__protein prenylation (GO:0018342),0.7533087140552497,1.194819182076002,0.22916666666666666,0.7665500973207339,1.0,3/5,12.43%,PTAR1;PGGT1B;CHM
prerank,GO_Biological_Process_2021__amino sugar biosynthetic process (GO:0046349),0.6323201520618504,1.1946435773187463,0.23809523809523808,0.764037729838725,1.0,3/10,12.99%,GNPNAT1;GFPT1;RENBP
prerank,GO_Biological_Process_2021__UDP-N-acetylglucosamine metabolic process (GO:0006047),0.6323201520618504,1.1946435773187463,0.23809523809523808,0.764037729838725,1.0,3/10,12.99%,GNPNAT1;GFPT1;RENBP
prerank,GO_Biological_Process_2021__UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.6323201520618504,1.1946435773187463,0.23809523809523808,0.764037729838725,1.0,3/10,12.99%,GNPNAT1;GFPT1;RENBP
prerank,GO_Biological_Process_2021__peptidyl-tyrosine autophosphorylation (GO:0038083),-0.6564686410841506,-1.1945804080146227,0.24193548387096775,0.8145479861681236,1.0,2/11,5.75%,ITK;TXK
prerank,GO_Biological_Process_2021__IMP biosynthetic process (GO:0006188),-0.7571958686755879,-1.1944445084850375,0.2962962962962963,0.8141684911901333,1.0,1/5,8.61%,AMPD2
prerank,GO_Biological_Process_2021__positive regulation of Notch signaling pathway (GO:0045747),0.5361606512732505,1.1942807930901576,0.14705882352941177,0.7643150842887982,1.0,7/29,15.51%,MAML2;JAG1;ROBO1;MAML3;POGLUT1;PRKCI;ROBO2
prerank,GO_Biological_Process_2021__cellular response to peptide (GO:1901653),-0.5478085373305137,-1.194141669492664,0.17142857142857143,0.8143031166331377,1.0,7/43,8.15%,DDX11;CD36;SNX6;RPL23;IGF1;FYN;ITGA4
prerank,GO_Biological_Process_2021__regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),-0.48196110881113274,-1.194131160186614,0.18518518518518517,0.8133010183583947,1.0,20/168,10.24%,FLNA;PLEKHG5;GAPDH;TFRC;CARD16;TRIM5;NLRC3;RORA;TNFSF10;LILRB4;LAMTOR5;TRIM22;GSTP1;NLRP12;LURAP1;TNFAIP3;STAT1;TRIM13;CFLAR;LITAF
prerank,GO_Biological_Process_2021__steroid biosynthetic process (GO:0006694),-0.5967169629912961,-1.193914638209905,0.20689655172413793,0.8131693720024857,1.0,3/31,6.83%,INSIG1;CH25H;PRLR
prerank,GO_Biological_Process_2021__gamma-aminobutyric acid metabolic process (GO:0009448),0.7996698502342887,1.193496525405472,0.24324324324324326,0.7659025478120685,1.0,2/5,14.77%,ALDH5A1;GAD1
prerank,GO_Biological_Process_2021__glucose import (GO:0046323),-0.7990213650719684,-1.193454245777819,0.30303030303030304,0.8138826048920798,1.0,1/6,0.76%,SLC2A3
prerank,GO_Biological_Process_2021__positive regulation of RIG-I signaling pathway (GO:1900246),-0.7299457116307462,-1.193217923345824,0.23076923076923078,0.8136395693671183,1.0,1/7,2.65%,DHX58
prerank,GO_Biological_Process_2021__sodium ion transmembrane transport (GO:0035725),0.4991431713859202,1.19300689352274,0.2,0.7665529955066005,1.0,12/38,15.33%,PKD2;SLC9C2;SCN3A;SCN3B;SLC4A4;SLC9A1;SCN8A;ANO6;SLC9A9;SLC8A1;SLC24A2;SLC12A2
prerank,GO_Biological_Process_2021__cellular response to topologically incorrect protein (GO:0035967),0.5588599983654049,1.1926573037522739,0.25,0.7667931496032756,1.0,1/27,0.35%,BAG3
prerank,GO_Biological_Process_2021__positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.7025874822514492,-1.1925231627192832,0.2631578947368421,0.8151816746236126,1.0,1/9,0.52%,CD36
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction (GO:0055117),-0.6188539294971,-1.1922040794774134,0.2753623188405797,0.8156017896536527,1.0,4/22,8.36%,PLN;RGS2;SRI;CALM1
prerank,MSigDB_Hallmark_2020__Notch Signaling,0.6071707059267613,1.1921307502883518,0.25,0.7676201582593893,1.0,6/19,11.55%,MAML2;WNT5A;JAG1;FBXW11;TCF7L2;KAT2A
prerank,GO_Biological_Process_2021__regulation of axon extension involved in axon guidance (GO:0048841),0.6357761440601353,1.1920509256276564,0.2,0.7668477826261985,1.0,3/15,6.05%,NRP1;SEMA5A;SEMA3B
prerank,GO_Biological_Process_2021__positive regulation of SMAD protein signal transduction (GO:0060391),0.6638662882167199,1.19177621607184,0.28,0.7665657520790474,1.0,3/9,15.36%,BMPR1A;TGFBR1;KIAA0319
prerank,GO_Biological_Process_2021__atrioventricular valve morphogenesis (GO:0003181),0.605723431247963,1.1915978347994438,0.30434782608695654,0.7662032097587015,1.0,3/13,12.30%,TGFBR2;SOX4;BMPR1A
prerank,GO_Biological_Process_2021__T cell mediated immunity (GO:0002456),-0.7051565038064405,-1.1906411937596975,0.23880597014925373,0.8209516728411098,1.0,4/11,7.06%,MYO1G;CD55;BTN3A3;BTN3A2
prerank,PanglaoDB_Augmented_2021__Granulosa Cells,0.47286183119099146,1.1903797069277364,0.2,0.7691691978696519,1.0,17/45,16.64%,LRP4;FKBP9;COL5A2;MTCL1;DAG1;MAGI1;NUAK1;BOK;GNA11;ENAH;TJP1;ADCY6;FERMT2;CD276;ANTXR1;COL4A5;RAI14
prerank,GO_Biological_Process_2021__positive regulation of synapse maturation (GO:0090129),0.7121381244785996,1.1898945854003742,0.2894736842105263,0.7697605465237635,1.0,4/6,25.98%,RELN;NRXN1;DAB2IP;CAMK2B
prerank,GO_Biological_Process_2021__positive regulation of trophoblast cell migration (GO:1901165),-0.773870154834029,-1.189701005126322,0.3333333333333333,0.823869812919995,1.0,2/5,21.42%,VEGFA;C1QBP
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.4732651903487784,1.1893668864994889,0.2,0.7706578972698068,1.0,13/49,13.77%,PLXNB1;PDGFA;IGF1R;FGF2;SIRT1;GAB1;PDGFC;TNF;UNC5B;HGF;NTRK2;PIK3AP1;PTK2
prerank,GO_Biological_Process_2021__peptide antigen assembly with MHC protein complex (GO:0002501),-0.7360199624001592,-1.1893493502417296,0.28846153846153844,0.8242221330301998,1.0,3/5,18.79%,HLA-DRA;HLA-DMB;HLA-DRB1
prerank,GO_Biological_Process_2021__photoperiodism (GO:0009648),-0.6370840291607704,-1.188615250666699,0.29411764705882354,0.8261815362522419,1.0,7/21,18.38%,PER3;PER2;BHLHE40;PPP1CB;RBM4B;CRTC1;RBM4
prerank,GO_Biological_Process_2021__phosphate-containing compound metabolic process (GO:0006796),0.4380235950424638,1.188345697221639,0.2727272727272727,0.7729432119825393,1.0,34/136,18.14%,PFKP;PLA2G4C;PANK3;PFKM;INPP1;DUSP18;LRRK2;PLPPR1;PLPP1;PLPPR4;PLCB4;GFPT1;PPA2;IPPK;PPP3CA;IMPA1;ACYP1;PTPRD;NUDT3;PTEN;LCAT;PIP4K2A;ISYNA1;PPIP5K1;AGPAT2;ENPP1;PLD4;PPM1A;INPP5A;NUDT4;PIK3CA;PPP3CB;PLCB3;INPP4B
prerank,GO_Biological_Process_2021__nitric oxide mediated signal transduction (GO:0007263),-0.7070854305811695,-1.1883101546300785,0.29310344827586204,0.826585026362512,1.0,1/9,0.52%,CD36
prerank,GO_Biological_Process_2021__transcription preinitiation complex assembly (GO:0070897),0.6429186151810884,1.188070284411867,0.34285714285714286,0.7727198921282232,1.0,1/10,2.38%,DR1
prerank,GO_Biological_Process_2021__negative regulation of cell volume (GO:0045794),0.7222247714882484,1.1878531604191849,0.3333333333333333,0.7722391842271829,1.0,4/5,18.83%,SHANK3;ANO6;P2RX7;CLCN3
prerank,GO_Biological_Process_2021__osteoclast differentiation (GO:0030316),-0.6888219298490504,-1.1876557558588852,0.25396825396825395,0.8278773299862977,1.0,4/16,11.20%,GPR183;ANXA2;OSCAR;TYROBP
prerank,GO_Biological_Process_2021__hippo signaling (GO:0035329),0.5772782538727315,1.187472076623307,0.22448979591836735,0.7724843664922635,1.0,7/17,24.83%,AMOT;MOB1B;TJP1;YWHAE;SAV1;STK3;CASP3
prerank,GO_Biological_Process_2021__positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.7643346370636894,1.1866453457944308,0.23404255319148937,0.7741601152212045,1.0,1/5,2.36%,SLC39A14
prerank,GO_Biological_Process_2021__plasma membrane organization (GO:0007009),-0.5893040017000829,-1.1865070670854494,0.19696969696969696,0.8311851598143607,1.0,5/36,7.98%,COL5A1;CXCR4;RAB3A;PLSCR1;EPB41L3
prerank,GO_Biological_Process_2021__regulation of Rac protein signal transduction (GO:0035020),0.6219918364721306,1.186136468660915,0.25,0.7748678328056461,1.0,3/13,12.17%,KBTBD6;AUTS2;ARF6
prerank,"GO_Biological_Process_2021__regulation of retrograde transport, endosome to Golgi (GO:1905279)",0.7721752730538165,1.1860164576986627,0.32,0.7743226727525887,1.0,3/6,20.25%,LRRK2;ARFIP1;USP7
prerank,GO_Biological_Process_2021__signal transduction in response to DNA damage (GO:0042770),0.4896386438104542,1.185887241190294,0.13513513513513514,0.7736187820855854,1.0,9/39,18.30%,ACER2;CASP9;CLOCK;TIPRL;INTS7;SESN2;HINFP;BATF;NBN
prerank,GO_Biological_Process_2021__bone morphogenesis (GO:0060349),0.7264975072897694,1.1858192355833006,0.2,0.7727567898559469,1.0,3/6,23.98%,BMPR1B;FGFR2;FGFR3
prerank,GO_Biological_Process_2021__mitochondrion localization (GO:0051646),0.614269673948002,1.1853950766741361,0.26666666666666666,0.7733348239623256,1.0,6/12,25.09%,LRRK2;MFN1;MARK1;MARK2;TRAK2;TRAK1
prerank,GO_Biological_Process_2021__negative regulation of histone H4 acetylation (GO:0090241),0.7519431298525739,1.184737185033582,0.2682926829268293,0.7743899541484597,1.0,1/5,2.51%,SIRT1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte migration (GO:0002687),-0.6717917288928933,-1.1844747409314058,0.3,0.8381335922876435,1.0,4/13,11.19%,AIF1;PTN;NCKAP1L;VEGFA
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell apoptotic process (GO:1904036),0.6577364051664251,1.1844386780497942,0.2857142857142857,0.7743747978729609,1.0,2/14,1.65%,SEMA5A;SERPINE1
prerank,GO_Biological_Process_2021__regulation of fibroblast apoptotic process (GO:2000269),-0.7783686171145102,-1.1838369354567442,0.24528301886792453,0.839712851890452,1.0,3/6,19.87%,BTG1;STK17B;PRDM11
prerank,GO_Biological_Process_2021__PERK-mediated unfolded protein response (GO:0036499),0.6925450037877612,1.1838050579367296,0.2765957446808511,0.7755530848227171,1.0,2/8,9.03%,DDIT3;EIF2S1
prerank,GO_Biological_Process_2021__positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),-0.48798750382272826,-1.1835529792262243,0.1875,0.8397578976469586,1.0,20/126,15.77%,FLNA;PLEKHG5;GAPDH;TFRC;CARD16;TRIM5;TNFSF10;LAMTOR5;TRIM22;LURAP1;TRIM13;CFLAR;LITAF;ALPK1;TERF2IP;NOD2;REL;APOL3;LGALS1;CD74
prerank,GO_Biological_Process_2021__regulation of actin filament length (GO:0030832),0.7525196556023682,1.1834056850718784,0.34782608695652173,0.7757589181952833,1.0,1/6,1.05%,EPS8
prerank,GO_Biological_Process_2021__regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.5808015796753787,1.1824556025972024,0.2777777777777778,0.7777099489990351,1.0,4/18,15.98%,CDK17;CDK18;POLA1;HINFP
prerank,GO_Biological_Process_2021__histone mRNA catabolic process (GO:0071044),-0.6906372036837379,-1.1822192569531946,0.2413793103448276,0.8441148293898655,1.0,2/13,7.08%,SSB;EXOSC10
prerank,GO_Biological_Process_2021__positive regulation of protein kinase activity (GO:0045860),0.4234694356256036,1.18218423724927,0.10344827586206896,0.7776271282792322,1.0,13/107,10.03%,EGR1;SRCIN1;TGFBR2;BORA;RAP1A;MAP2K1;RELN;CIB1;CAB39;TNF;TAB2;SPDYA;GRM5
prerank,GO_Biological_Process_2021__regulation of interferon-gamma production (GO:0032649),-0.5636296700478974,-1.1820991454705692,0.18055555555555555,0.8435872831532982,1.0,15/52,14.79%,BTN3A1;CD2;SLC7A5;CD14;SLAMF6;LILRB4;TXK;IL12RB2;BTN3A2;CD226;SLC11A1;CD47;IL18R1;HAVCR2;HLA-DPA1
prerank,GO_Biological_Process_2021__TOR signaling (GO:0031929),-0.6352425981630989,-1.1820779785473985,0.288135593220339,0.8426799464986977,1.0,3/21,11.05%,SYAP1;RPS6;PRR5L
prerank,GO_Biological_Process_2021__regulation of transposition (GO:0010528),-0.7763781882255311,-1.1814792256674818,0.2807017543859649,0.8438847072457828,1.0,2/7,8.67%,MYBL1;APOBEC3G
prerank,GO_Biological_Process_2021__positive regulation of mRNA catabolic process (GO:0061014),-0.5606622516336462,-1.1810995560233033,0.20588235294117646,0.8442392331937247,1.0,4/38,11.05%,ZFP36;BTG2;POLR2G;PRR5L
prerank,GO_Biological_Process_2021__regulation of cAMP-dependent protein kinase activity (GO:2000479),-0.6733522065253533,-1.1809897144429153,0.22641509433962265,0.8435406020330146,1.0,2/12,6.63%,PKIB;PRKAR1B
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum exit site (GO:0070973),0.7219156290818444,1.1808976053425213,0.3269230769230769,0.7809793834491615,1.0,1/5,3.81%,LRRK2
prerank,GO_Biological_Process_2021__dendrite arborization (GO:0140059),0.7392905395536882,1.1808369672340626,0.2765957446808511,0.7801179099254016,1.0,1/5,0.61%,NRP1
prerank,GO_Biological_Process_2021__positive regulation of locomotion (GO:0040017),-0.6521950823822286,-1.1807222575502943,0.3442622950819672,0.843450453980662,1.0,3/15,7.96%,AIF1;DUOX1;SPOCK2
prerank,GO_Biological_Process_2021__chaperone-mediated protein complex assembly (GO:0051131),-0.5771147924778618,-1.1807128381009133,0.2807017543859649,0.8423974571592129,1.0,5/16,22.53%,CLU;HSPA1A;CCT2;PSMG1;PFDN6
prerank,GO_Biological_Process_2021__regulation of protein import into nucleus (GO:0042306),-0.6028888722157519,-1.1804350628864007,0.19047619047619047,0.8424818802745799,1.0,5/27,6.41%,FLNA;MDFIC;APOD;JUP;RBM22
prerank,GO_Biological_Process_2021__cation transport (GO:0006812),0.4335025119196227,1.180132699379866,0.1111111111111111,0.7810584657621205,1.0,20/71,13.70%,KCNJ2;KCNIP2;SCN3A;SLC7A8;SLC3A2;KCND3;ATP10D;SCN3B;KCNJ5;NEDD4L;SLC4A4;SLC41A1;KCNMB4;SCN8A;KCNK6;KCNN2;ANO6;ABCC8;KCNMB3;SLC8A1
prerank,GO_Biological_Process_2021__negative regulation of leukocyte proliferation (GO:0070664),-0.8149319359173196,-1.1799992595235702,0.2765957446808511,0.8435051800829463,1.0,3/5,8.26%,GSTP1;TNFAIP3;ENPP3
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of transcription factor (GO:0042994),0.6708423901657152,1.1799808943188255,0.29545454545454547,0.7804356378908452,1.0,2/9,3.46%,PKD2;PKD1
prerank,GO_Biological_Process_2021__histone mRNA metabolic process (GO:0008334),-0.6103825179332477,-1.179580327494754,0.28125,0.8441054879463776,1.0,3/22,9.87%,SSB;EXOSC10;NCBP2
prerank,GO_Biological_Process_2021__extracellular matrix assembly (GO:0085029),0.6843182937633782,1.179569341345845,0.3023255813953488,0.7806962344350934,1.0,5/10,28.44%,LTBP3;NTN4;QSOX1;TGFB1;GPM6B
prerank,GO_Biological_Process_2021__presynapse assembly (GO:0099054),0.5933778229076397,1.17950352566581,0.25,0.7798396038244622,1.0,8/14,18.31%,LRP4;NLGN1;WNT5A;PTPRD;PTEN;NLGN4Y;IL1RAPL1;PCLO
prerank,GO_Biological_Process_2021__nitrogen compound transport (GO:0071705),0.44472613120784454,1.1791749239828653,0.12,0.7798018898355127,1.0,16/76,11.75%,FLVCR1;PDPN;SLC7A8;SCAMP4;RCN3;SLC3A2;ARRDC3;PPT1;SCARB2;SLC15A4;SLC44A2;RAB7A;RAMP1;LMAN2L;SLC19A2;SLC44A1
prerank,GO_Biological_Process_2021__regulation of sodium ion transport (GO:0002028),0.5126828669487566,1.1791689791584175,0.25,0.7787917837605963,1.0,9/23,18.87%,SCN3B;WNK1;SLMAP;NKAIN3;AHCYL1;NKAIN2;P2RX7;NEDD4;SCN1B
prerank,GO_Biological_Process_2021__protein sumoylation (GO:0016925),0.4864614534815626,1.1791462135323747,0.23076923076923078,0.7778626162940554,1.0,15/47,22.40%,SAE1;NUP153;NUP188;NUP42;BCL11A;STX1A;UBA2;ZNF451;NSMCE2;NDC1;NUP133;NUP205;TRIM28;PIAS1;NUP98
prerank,GO_Biological_Process_2021__regulation of glucocorticoid receptor signaling pathway (GO:2000322),0.7224264491873356,1.178896286166442,0.28846153846153844,0.7777024444215115,1.0,3/5,26.86%,CLOCK;PER1;LMO3
prerank,GO_Biological_Process_2021__regulation of cell-substrate adhesion (GO:0010810),0.47852196793725116,1.1785304883286571,0.22857142857142856,0.7777770549233145,1.0,9/30,19.71%,PDPN;MYADM;NF1;PTK2;GCNT2;CX3CL1;RSU1;PPM1F;PTPRO
prerank,GO_Biological_Process_2021__glycosphingolipid catabolic process (GO:0046479),-0.7701618610956327,-1.1783794842349675,0.35185185185185186,0.8475037985572379,1.0,1/7,5.40%,GLA
prerank,GO_Biological_Process_2021__polyamine metabolic process (GO:0006595),-0.6785170559768633,-1.178345416716709,0.25925925925925924,0.8465705982016194,1.0,3/10,7.79%,SAT1;ODC1;SAT2
prerank,"GO_Biological_Process_2021__positive regulation of CD8-positive, alpha-beta T cell differentiation (GO:0043378)",-0.7417293721200992,-1.1780793442406536,0.3508771929824561,0.8467352518760287,1.0,3/5,10.76%,RUNX3;LILRB4;NCKAP1L
prerank,GO_Biological_Process_2021__mitochondrial outer membrane permeabilization (GO:0097345),-0.6887252011717009,-1.1780432572762387,0.265625,0.8458267672095613,1.0,3/10,18.86%,BLOC1S2;BMF;RHOT2
prerank,GO_Biological_Process_2021__regulation of hippo signaling (GO:0035330),0.6479897092182259,1.177861723457177,0.20930232558139536,0.7788345545536813,1.0,5/13,16.47%,DLG5;SHANK2;MOB3B;WWC2;IQCJ-SCHIP1
prerank,GO_Biological_Process_2021__regulation of posttranscriptional gene silencing (GO:0060147),0.4588406594483777,1.177713936558994,0.10810810810810811,0.7773304684566243,1.0,9/47,17.93%,POLR2D;NUP153;NUP188;NUP42;IPO8;POLR2H;NDC1;NUP133;NUP205
prerank,GO_Biological_Process_2021__regulation of gene silencing by RNA (GO:0060966),0.4588406594483777,1.177713936558994,0.10810810810810811,0.7773304684566243,1.0,9/47,17.93%,POLR2D;NUP153;NUP188;NUP42;IPO8;POLR2H;NDC1;NUP133;NUP205
prerank,GO_Biological_Process_2021__glucose 6-phosphate metabolic process (GO:0051156),-0.6420074153706313,-1.177441286969131,0.3442622950819672,0.8469990537732142,1.0,4/15,15.98%,G6PC3;HK2;TALDO1;H6PD
prerank,GO_Biological_Process_2021__mesenchymal cell development (GO:0014031),0.7169994409704397,1.1767452670755256,0.34210526315789475,0.779643563039486,1.0,5/7,26.65%,NRG1;KLHL12;NOLC1;CDH2;NOTCH1
prerank,GO_Biological_Process_2021__cell projection assembly (GO:0030031),0.5509698325785622,1.1764096789153864,0.225,0.7797307310993631,1.0,2/17,1.66%,PDGFA;GSN
prerank,GO_Biological_Process_2021__membrane depolarization (GO:0051899),0.5616000354721287,1.176194743612167,0.2765957446808511,0.7794610709084173,1.0,9/18,18.87%,CACNA1A;SCN3A;SCN3B;SCN8A;CACNA1E;CACNG2;CACNB4;P2RX7;SCN1B
prerank,GO_Biological_Process_2021__ATF6-mediated unfolded protein response (GO:0036500),0.6693988753594586,1.1760656043227105,0.32653061224489793,0.7788514361126557,1.0,1/9,5.85%,DDIT3
prerank,GO_Biological_Process_2021__regulation of endocytic recycling (GO:2001135),0.6592318068831043,1.176030660502287,0.3269230769230769,0.7779031292967706,1.0,2/7,18.99%,SORL1;ARHGAP1
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell differentiation (GO:0030858),0.7273190292935362,1.175996028428054,0.3541666666666667,0.7770190225820738,1.0,3/6,7.45%,FGF2;VEZF1;RFX3
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair (GO:2000781),-0.5478031273642179,-1.1755873972954418,0.25,0.8533155405314048,1.0,6/31,14.63%,DDX11;DTX3L;PARP9;WDR48;ZCWPW1;FANCB
prerank,GO_Biological_Process_2021__negative regulation of lipid catabolic process (GO:0050995),0.7102626557392234,1.1755005835084558,0.358974358974359,0.7777105757256827,1.0,5/9,21.70%,TNF;PDE3B;SORL1;PRKAA1;MFSD2A
prerank,GO_Biological_Process_2021__substrate adhesion-dependent cell spreading (GO:0034446),0.5815902429924054,1.1754874889906854,0.2647058823529412,0.7767519339408533,1.0,10/31,16.86%,NRP1;FER;SRCIN1;TMEFF2;ITGAV;FERMT2;TYRO3;SRGAP2;ANTXR1;ATRNL1
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response (GO:0050728),-0.5247085442460369,-1.175391923304904,0.2054794520547945,0.8530114973623844,1.0,17/94,9.83%,CALCR;NLRC3;YES1;CD200R1;RORA;CD247;IGF1;VPS35;PRKAR1B;GSTP1;FYN;NLRP12;TNFRSF1B;TNFAIP3;ENPP3;METRNL;SELENOS
prerank,GO_Biological_Process_2021__neural crest cell differentiation (GO:0014033),0.6410201012219522,1.1753242632816416,0.2647058823529412,0.7762727055521382,1.0,5/10,27.82%,NRG1;KLHL12;NOLC1;CDH2;FBXL17
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.6801121035911852,-1.1752653460574944,0.3114754098360656,0.8525267371811525,1.0,7/14,20.98%,ATP5PD;ATP5F1E;ATP5ME;STOML2;ATP5F1C;ATP5F1D;ATP5MC2
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell apoptotic process (GO:0034393),0.8030321849597654,1.1751347561431589,0.3023255813953488,0.7757485929724366,1.0,3/6,12.13%,E2F3;PPARG;SOD2
prerank,GO_Biological_Process_2021__negative regulation of actin filament depolymerization (GO:0030835),0.7730218570121344,1.1751081826292216,0.2916666666666667,0.7748728196796635,1.0,1/5,1.66%,GSN
prerank,GO_Biological_Process_2021__CENP-A containing chromatin organization (GO:0061641),-0.62013971911214,-1.1748396066253977,0.25806451612903225,0.8519867194598675,1.0,3/18,10.59%,CENPU;ITGB3BP;NPM1
prerank,GO_Biological_Process_2021__CENP-A containing nucleosome assembly (GO:0034080),-0.62013971911214,-1.1748396066253977,0.25806451612903225,0.8519867194598675,1.0,3/18,10.59%,CENPU;ITGB3BP;NPM1
prerank,GO_Biological_Process_2021__regulation of interferon-beta production (GO:0032648),-0.5624374315531491,-1.1746367308728811,0.18181818181818182,0.8517177044968715,1.0,11/42,17.04%,OAS3;NLRC3;DHX58;OAS2;OAS1;IRF1;STING1;REL;POLR3C;FLOT1;IRF7
prerank,GO_Biological_Process_2021__adrenergic receptor signaling pathway (GO:0071875),0.7043272112387431,1.174283555188251,0.2926829268292683,0.7763137812941646,1.0,3/8,17.63%,ADRA1A;ADCY9;RAPGEF2
prerank,GO_Biological_Process_2021__peptidyl-lysine acetylation (GO:0018394),0.6538463449299943,1.1742442826940382,0.27906976744186046,0.7754701249307386,1.0,3/9,13.44%,SIRT1;KAT2A;BAG6
prerank,GO_Biological_Process_2021__monovalent inorganic cation homeostasis (GO:0055067),0.6493832607086574,1.1741724612205293,0.3,0.7747509128149467,1.0,7/11,18.83%,PDK4;SLC12A6;SLC9A1;SLC12A5;SLC12A2;SLC9A7;CLCN3
prerank,GO_Biological_Process_2021__negative regulation of locomotion (GO:0040013),0.6241040862493016,1.1737664135147883,0.20512820512820512,0.774735932073401,1.0,4/9,16.45%,CRK;CCDC125;FRMD5;SPOCK3
prerank,GO_Biological_Process_2021__dicarboxylic acid metabolic process (GO:0043648),-0.5646087747860085,-1.1735404119540762,0.21875,0.8547422117071263,1.0,4/38,3.80%,NIT2;ME1;MDH2;MTHFD1
prerank,GO_Biological_Process_2021__dermatan sulfate biosynthetic process (GO:0030208),0.7441980457199149,1.1733200743983623,0.30612244897959184,0.7754682740224143,1.0,3/7,11.46%,NCAN;CSPG5;UST
prerank,PanglaoDB_Augmented_2021__Tanycytes,0.46353950023754925,1.1731258810558223,0.15789473684210525,0.7753153448562793,1.0,28/69,22.83%,LRP4;PBX1;PLPPR4;PRDX6;NTM;CDH11;SHC2;ASXL3;GUCY1A2;PTPRD;COL11A1;RUNX1T1;FBXL7;COL25A1;MARK1;NFASC;CSRNP3;MAPK4;MAP6;CRMP1;MAP2;DCLK1;MEGF10;PRKG1;PRICKLE2;LRFN5;OPCML;PLPP3
prerank,GO_Biological_Process_2021__peptidyl-threonine dephosphorylation (GO:0035970),0.55283913272342,1.1725092860624322,0.30434782608695654,0.7761668180046873,1.0,2/15,2.07%,DUSP6;DUSP18
prerank,GO_Biological_Process_2021__regulation of leukocyte migration (GO:0002685),0.6917856874036626,1.1722844286940945,0.3023255813953488,0.7759374295941678,1.0,1/11,0.34%,ANXA1
prerank,GO_Biological_Process_2021__G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.6779477319161225,1.1720093418830675,0.34782608695652173,0.7758451845102712,1.0,7/9,27.39%,GRM5;HOMER1;GRM3;GRIK3;GRM1;HOMER2;GRM7
prerank,GO_Biological_Process_2021__positive regulation of cellular metabolic process (GO:0031325),0.4552605343728087,1.17155037132249,0.25,0.7762381391957927,1.0,10/64,7.76%,KLF4;IFNLR1;SCRIB;TGFBR2;STARD4;PPARG;RAB1B;TBC1D5;HPN;ACACB
prerank,GO_Biological_Process_2021__carboxylic acid biosynthetic process (GO:0046394),0.7583988124654311,1.171364094009277,0.30434782608695654,0.7758581585100123,1.0,3/6,9.85%,CARNS1;UGDH;SLC35D1
prerank,GO_Biological_Process_2021__gonad development (GO:0008406),0.5604960053038951,1.1712529507867708,0.3333333333333333,0.7751314255565647,1.0,5/14,11.17%,WNT5A;WNT2B;KITLG;SALL1;NCOA4
prerank,GO_Biological_Process_2021__reverse cholesterol transport (GO:0043691),-0.7305716693038696,-1.1712354854241451,0.3409090909090909,0.8622363706894197,1.0,2/9,4.82%,LIPG;CLU
prerank,GO_Biological_Process_2021__ion transport (GO:0006811),0.4854332506137928,1.1709693870259628,0.18181818181818182,0.7752218285792419,1.0,18/59,15.33%,SLC1A3;SLC25A18;ATP10D;GLRA1;SLC1A2;LASP1;SLC15A4;SLC12A6;SLC9A1;WNK1;KCNN2;ANO6;SLC9A9;SLC12A5;SLC8A1;SLC24A2;SLC26A3;SLC12A2
prerank,PanglaoDB_Augmented_2021__Myoblasts,0.5087816182976909,1.1707682743359067,0.25,0.7749651714103646,1.0,7/44,5.20%,COL16A1;TPM2;FKBP9;COL5A2;ZBTB16;PHLDB1;TIMP3
prerank,GO_Biological_Process_2021__regulation of protein localization to Cajal body (GO:1904869),0.668299843125815,1.1705019237538115,0.3,0.7736866117997439,1.0,3/11,13.21%,MEPCE;TCP1;CCT3
prerank,GO_Biological_Process_2021__positive regulation of protein localization to Cajal body (GO:1904871),0.668299843125815,1.1705019237538115,0.3,0.7736866117997439,1.0,3/11,13.21%,MEPCE;TCP1;CCT3
prerank,GO_Biological_Process_2021__nuclear export (GO:0051168),0.4584983025226389,1.1701652123362942,0.20689655172413793,0.7738534770231539,1.0,9/65,7.82%,NUTF2;NXF1;U2AF1;PKD1;NUP153;NUP188;NUP42;XPO1;RANBP3L
prerank,GO_Biological_Process_2021__positive regulation of cellular response to insulin stimulus (GO:1900078),0.6330869857296708,1.1700672219294475,0.35,0.773314691871821,1.0,2/9,11.83%,SIRT1;SORL1
prerank,GO_Biological_Process_2021__mammary gland epithelial cell differentiation (GO:0060644),0.7197874507903483,1.1698698213218526,0.2564102564102564,0.7730469967773581,1.0,3/6,15.47%,ZNF703;ERBB4;AKT2
prerank,GO_Biological_Process_2021__positive regulation of cholesterol metabolic process (GO:0090205),0.6979868010858149,1.1698407530339956,0.3148148148148148,0.7721363418978742,1.0,2/5,22.61%,PRKAA1;SCAP
prerank,GO_Biological_Process_2021__regulation of neural precursor cell proliferation (GO:2000177),0.6664150868534949,1.1697263693196558,0.2926829268292683,0.7715867227022872,1.0,1/10,3.81%,LRRK2
prerank,GO_Biological_Process_2021__apical junction assembly (GO:0043297),-0.5934960241230954,-1.1695913839816863,0.23214285714285715,0.8668618375838663,1.0,3/25,5.65%,MPP7;CLDN7;PECAM1
prerank,GO_Biological_Process_2021__extracellular matrix disassembly (GO:0022617),0.5654503994557846,1.1694908801783999,0.15789473684210525,0.7713520105761384,1.0,7/27,9.60%,GSN;EXOC8;LCP1;CTSK;HPN;BMP1;MMP16
prerank,GO_Biological_Process_2021__limb morphogenesis (GO:0035108),0.622222415416818,1.1693725967804294,0.2222222222222222,0.7708196236910663,1.0,4/12,13.48%,BMPR1B;PTCH1;MEGF8;NIPBL
prerank,GO_Biological_Process_2021__neuron cell-cell adhesion (GO:0007158),0.5765776623774526,1.1691483019081483,0.29545454545454547,0.7705715382030953,1.0,6/14,15.11%,CDK5R1;NLGN1;NRXN2;NCAM2;CNTN4;NLGN4Y
prerank,"GO_Biological_Process_2021__regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.48038547070026244,1.1689183909473033,0.12,0.770502574297526,1.0,22/42,27.66%,KHDRBS2;KHDRBS3;RBFOX1;SRSF12;TRA2B;RBFOX2;THRAP3;HNRNPU;WTAP;CELF2;CELF5;PUF60;NOVA1;KHDRBS1;RNPS1;CELF1;MBNL1;RBM15;RBM5;MBNL3;HNRNPL;RBM8A
prerank,GO_Biological_Process_2021__negative regulation of interleukin-6 production (GO:0032715),-0.6203277922611877,-1.168761925367819,0.31746031746031744,0.8688407850042381,1.0,8/19,11.47%,NLRC3;CD200R1;LILRB4;NLRP12;TNFAIP3;SELENOS;NCKAP1L;C5AR2
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell apoptotic process (GO:0010665),0.7408349832710077,1.1685188952615888,0.3023255813953488,0.7707160768826125,1.0,2/5,12.30%,PPP1R10;BMPR1A
prerank,GO_Biological_Process_2021__positive regulation of T cell migration (GO:2000406),-0.6348855599402724,-1.1672835377328776,0.2641509433962264,0.8729183999668023,1.0,3/14,7.09%,CCL5;AIF1;STK39
prerank,GO_Biological_Process_2021__skeletal system morphogenesis (GO:0048705),0.6116565435208657,1.1668634568830334,0.1891891891891892,0.7747724976035829,1.0,7/15,19.84%,RAB33B;FBN2;MEGF8;ANKRD11;TGFBR1;FGFR2;FGFR1
prerank,GO_Biological_Process_2021__negative regulation of cell aging (GO:0090344),0.6370880776432148,1.166781949167421,0.32608695652173914,0.7741502539851549,1.0,3/10,11.88%,SIRT1;MARCHF5;CDK6
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell surface (GO:2000010),-0.6917824603517326,-1.1666550947662422,0.24561403508771928,0.87412501326157,1.0,1/10,0.78%,RIC3
prerank,GO_Biological_Process_2021__regulation of metal ion transport (GO:0010959),-0.701623703523481,-1.1666117297123626,0.3114754098360656,0.873177591483793,1.0,2/14,6.56%,PLN;SRI
prerank,GO_Biological_Process_2021__negative regulation of ossification (GO:0030279),-0.6577548594151267,-1.1664206947895188,0.31746031746031744,0.8728959749562778,1.0,4/13,10.69%,CCL3;SRGN;RBPJ;TRPM4
prerank,GO_Biological_Process_2021__aorta morphogenesis (GO:0035909),-0.7545959996316146,-1.1662009680762857,0.30158730158730157,0.8726571180063577,1.0,2/7,8.45%,MYLK;RBPJ
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.6069035231204595,1.1661229479864712,0.2702702702702703,0.7749950544538944,1.0,2/13,8.90%,PKD2;SLC9A1
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte activation (GO:0051251),-0.6355603802649173,-1.166095349648022,0.21666666666666667,0.8720301084736867,1.0,8/20,16.72%,PRKCQ;ZNF335;NCKAP1L;TYROBP;CD47;NOD2;HLA-DPA1;HLA-DPB1
prerank,GO_Biological_Process_2021__signal transduction by p53 class mediator (GO:0072331),0.5404431077366825,1.1660557344288156,0.3023255813953488,0.7742114215799264,1.0,7/26,18.30%,ACER2;BOK;FHIT;SESN2;ZNF385B;BATF;NBN
prerank,GO_Biological_Process_2021__peptidyl-serine phosphorylation (GO:0018105),0.4184819119314803,1.1660315941849777,0.21052631578947367,0.7733410970805905,1.0,34/133,18.20%,CDK5R1;TGFBR2;CSNK1G1;STK32B;PKD1;LRRK2;RPS6KA4;TLK1;MAST2;CAB39;NLK;MAP3K10;STK38L;BRSK1;MAST3;PLK2;DYRK1A;WNK1;RPS6KA6;MAPK1;CAMKV;MAPKAPK2;CSNK1E;PRKCI;MARK1;MAP3K13;TGFBR1;AKT2;GSK3B;RPS6KB2;STK32C;PRKX;MAP2K2;MARK2
prerank,GO_Biological_Process_2021__regulation of proteolysis (GO:0030162),0.5335430571406687,1.1656247874768182,0.1935483870967742,0.773431588618548,1.0,6/28,13.44%,RNF139;SERPINE2;SPOPL;BTRC;FBXW11;BAG6
prerank,GO_Biological_Process_2021__negative regulation of innate immune response (GO:0045824),-0.6198720842235479,-1.1656043661399138,0.2459016393442623,0.8731885190640186,1.0,8/29,13.78%,OAS3;NLRC3;DHX58;NLRC5;TNFAIP3;OAS1;A2M;SERPING1
prerank,GO_Biological_Process_2021__acylglycerol homeostasis (GO:0055090),-0.6576624683613703,-1.1655678365928206,0.25862068965517243,0.8723318045665954,1.0,1/10,3.27%,RORA
prerank,GO_Biological_Process_2021__extracellular structure organization (GO:0043062),0.46926667762358004,1.1654413976399265,0.25,0.7730209983541663,1.0,26/93,13.53%,COL5A3;MMP17;COL16A1;PDGFA;NCAN;SERPINE1;COL5A2;FGF2;TEX14;COL24A1;DAG1;SLC39A8;ADAMTSL2;RECK;TNR;ADAMTS17;FBN2;ADAMTSL3;MMP16;ITGAV;COL11A1;NF1;ITGA2;COL6A1;JAM2;COL15A1
prerank,"GO_Biological_Process_2021__regulation of complement activation, classical pathway (GO:0030450)",-0.7926518006073593,-1.1648257971583338,0.2807017543859649,0.8740837397605652,1.0,1/5,1.64%,CD55
prerank,GO_Biological_Process_2021__long-term synaptic depression (GO:0060292),0.6608581437109522,1.1644024304293945,0.3673469387755102,0.7755982108416499,1.0,4/7,14.30%,SHANK2;PLK2;PRRT1;SLC24A2
prerank,GO_Biological_Process_2021__nucleoside diphosphate metabolic process (GO:0009132),-0.7300179761186549,-1.164227827294347,0.2857142857142857,0.8751518365018932,1.0,3/8,11.98%,CMPK2;ENTPD4;ENTPD5
prerank,MSigDB_Hallmark_2020__Apoptosis,-0.4992685987822356,-1.1641442575235974,0.20270270270270271,0.8744420546938021,1.0,29/114,14.68%,SAT1;TGFBR3;CD2;CD69;GADD45B;BTG2;CD14;H1-0;PRF1;IER3;IFITM3;TNFSF10;CLU;RNASEL;CD44;FEZ1;CFLAR;IRF1;TAP1;GPX4;ATF3;BMF;SOD1;GPX1;CCND1;PEA15;BRCA1;IGF2R;TIMP2
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte proliferation (GO:0050672),-0.6234340484027842,-1.1641252105275053,0.26865671641791045,0.8735358034921141,1.0,5/23,11.20%,IL4I1;MNDA;LILRB4;GLMN;TYROBP
prerank,GO_Biological_Process_2021__angiotensin-activated signaling pathway (GO:0038166),0.7809096236601246,1.1637991930476954,0.3333333333333333,0.7761999751180746,1.0,2/5,13.97%,CA2;AHCYL1
prerank,GO_Biological_Process_2021__calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),-0.7423355371980576,-1.163797415843615,0.2545454545454545,0.8737776960664971,1.0,1/7,1.34%,RIMS1
prerank,GO_Biological_Process_2021__positive regulation of protein processing (GO:0010954),0.6583538178665198,1.1637384523132723,0.275,0.7754352585386574,1.0,2/10,6.57%,GSN;HPN
prerank,GO_Biological_Process_2021__cardiac epithelial to mesenchymal transition (GO:0060317),-0.7258472115955146,-1.1633749611728197,0.3137254901960784,0.8741542775439072,1.0,3/9,14.83%,TGFBR3;RBPJ;SPRY1
prerank,GO_Biological_Process_2021__cellular response to hexose stimulus (GO:0071331),0.5261115637158276,1.1631771060097684,0.35294117647058826,0.7765781788459195,1.0,9/19,19.09%,IGF1R;SLC39A14;UNC13B;SOX4;PCK2;PRKAA1;TRA2B;ZBTB20;KCNB1
prerank,GO_Biological_Process_2021__regulation of superoxide anion generation (GO:0032928),-0.688214405925403,-1.1628166250903595,0.265625,0.8752158862498756,1.0,4/11,13.37%,GSTP1;ITGB2;TYROBP;SOD1
prerank,GO_Biological_Process_2021__regulation of type I interferon production (GO:0032479),-0.5114463554314304,-1.1624297284158658,0.25,0.8756521259730181,1.0,7/71,11.42%,GAPDH;DHX58;CD14;NLRC5;TNFAIP3;IRF1;STING1
prerank,GO_Biological_Process_2021__positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.5080276894267013,1.1622860375325557,0.2727272727272727,0.7781283156214802,1.0,9/41,15.36%,ACVR2A;UBE2O;GDF11;SMAD2;BMPR1B;BMPR1A;TWSG1;TGFBR1;KIAA0319
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translation (GO:2000765),0.6373910545159994,1.1621168325849645,0.36363636363636365,0.7776565303678276,1.0,3/11,18.57%,CPEB4;ZNF385A;CPEB2
prerank,GO_Biological_Process_2021__integrated stress response signaling (GO:0140467),0.6358796927030912,1.1621064340314413,0.37209302325581395,0.7768061056008573,1.0,2/11,9.03%,DDIT3;EIF2S1
prerank,GO_Biological_Process_2021__positive regulation of heterotypic cell-cell adhesion (GO:0034116),-0.7474744587233889,-1.1620789972648757,0.39285714285714285,0.8758592256204383,1.0,2/8,8.71%,SKAP1;CD44
prerank,GO_Biological_Process_2021__organophosphate ester transport (GO:0015748),-0.6240657944959183,-1.1620364197072084,0.36363636363636365,0.8750199114851879,1.0,4/21,9.06%,OSBPL5;PRELID1;PLTP;PCTP
prerank,PanglaoDB_Augmented_2021__Pericytes,0.5048647473174184,1.1619765196937955,0.3055555555555556,0.7761619793633842,1.0,7/47,8.39%,COL16A1;SVEP1;COL5A2;ACTA2;TIMP3;LHFPL6;CDH11
prerank,GO_Biological_Process_2021__positive regulation of fibroblast apoptotic process (GO:2000271),-0.7923110375372264,-1.1619193343253202,0.28,0.8744204958187308,1.0,3/5,19.87%,BTG1;STK17B;PRDM11
prerank,GO_Biological_Process_2021__regulation of hematopoietic progenitor cell differentiation (GO:1901532),-0.5246998954437111,-1.1618987693947076,0.28,0.8734092711445279,1.0,17/59,22.96%,PSMB3;EIF2AK2;PSMB6;PSMA7;PSMB9;TCF3;PSMD12;PSMD8;PSMA5;SETD1A;PSMA3;PSMC4;PSME2;PSME1;PSMB5;PSMC3;PSME3
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903377),-0.7377110226469814,-1.1616235604560659,0.2857142857142857,0.8733910444019259,1.0,3/5,22.45%,HIF1A;PINK1;PARK7
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transport (GO:0010766),0.6959857411368223,1.1607999691247013,0.3333333333333333,0.7792206101949869,1.0,4/7,25.84%,NEDD4L;WNK1;NEDD4;CAMK2D
prerank,GO_Biological_Process_2021__peptidyl-serine dephosphorylation (GO:0070262),-0.6312066455875557,-1.1606452775212106,0.3387096774193548,0.8758154728225983,1.0,1/13,1.54%,DUSP1
prerank,"GO_Biological_Process_2021__wound healing, spreading of cells (GO:0044319)",-0.642489521249524,-1.1605260469375345,0.24074074074074073,0.8752591364438036,1.0,3/18,3.99%,FLNA;COL5A1;PLET1
prerank,GO_Biological_Process_2021__negative chemotaxis (GO:0050919),0.5693922972718797,1.1603838584985522,0.22580645161290322,0.7795065969371713,1.0,4/19,10.85%,PDGFA;SEMA3B;ROBO1;ITGAV
prerank,GO_Biological_Process_2021__bile acid biosynthetic process (GO:0006699),-0.6535139616174014,-1.1601082738391393,0.28846153846153844,0.87571174883772,1.0,1/15,0.88%,CH25H
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of protein (GO:0051220),-0.6385374452212957,-1.1599347089061842,0.38333333333333336,0.8754135973105395,1.0,1/10,0.28%,FLNA
prerank,GO_Biological_Process_2021__negative regulation of phagocytosis (GO:0050765),-0.6262933335410442,-1.1597971459261731,0.35714285714285715,0.8748802268655791,1.0,5/14,12.25%,RACK1;CD300LF;PLSCR1;APPL1;CD47
prerank,GO_Biological_Process_2021__regulation of blood circulation (GO:1903522),-0.6344782471013514,-1.1597069512584806,0.35714285714285715,0.8742354172113529,1.0,3/15,6.56%,PLN;PER2;SRI
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization to mitochondrion (GO:1903748),0.7313864984295718,1.1597033595968713,0.2926829268292683,0.7807658555604896,1.0,1/5,3.81%,LRRK2
prerank,MSigDB_Hallmark_2020__Coagulation,0.4616514699240971,1.1594519452130911,0.19444444444444445,0.7805992064777075,1.0,10/66,6.72%,ANXA1;DUSP6;SERPINE1;GSN;CRIP2;CASP9;TIMP3;CTSK;HPN;BMP1
prerank,GO_Biological_Process_2021__lipoprotein localization (GO:0044872),-0.7324013840032841,-1.1593419929561521,0.36,0.8745131334652496,1.0,1/8,0.52%,CD36
prerank,GO_Biological_Process_2021__positive regulation of T-helper 1 type immune response (GO:0002827),-0.773416766320151,-1.1589220368872437,0.37735849056603776,0.8749843994799806,1.0,3/5,17.61%,SLC11A1;IL18R1;IL18
prerank,GO_Biological_Process_2021__regulation of stem cell proliferation (GO:0072091),-0.707050095500911,-1.1588339640510297,0.27586206896551724,0.8743213270777057,1.0,2/8,12.82%,EIF2AK2;PTPRC
prerank,GO_Biological_Process_2021__negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),-0.5596060536830807,-1.158787434751332,0.26153846153846155,0.873466067046148,1.0,7/31,9.56%,NLRC3;RORA;LILRB4;GSTP1;NLRP12;TNFAIP3;STAT1
prerank,GO_Biological_Process_2021__positive regulation of interferon-beta production (GO:0032728),-0.5852673845737758,-1.1586990195904117,0.265625,0.8727554108056056,1.0,9/31,17.04%,OAS3;DHX58;OAS2;OAS1;IRF1;STING1;POLR3C;FLOT1;IRF7
prerank,GO_Biological_Process_2021__negative regulation of telomerase activity (GO:0051974),0.6936113226323544,1.1585022027105576,0.3958333333333333,0.7828112642115129,1.0,1/5,10.90%,ERCC4
prerank,GO_Biological_Process_2021__negative regulation of fatty acid biosynthetic process (GO:0045717),0.6276195447751389,1.1577376742749117,0.2857142857142857,0.7847283393568428,1.0,2/10,11.26%,SIRT1;ACADVL
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.6597287027680018,1.157673713284075,0.3170731707317073,0.7838920611317741,1.0,4/11,22.31%,SLC9A1;WNK1;CHP1;GLRX
prerank,GO_Biological_Process_2021__cyclic-nucleotide-mediated signaling (GO:0019935),-0.606107282705356,-1.1576170646868755,0.26229508196721313,0.8757088163161991,1.0,1/23,0.52%,CD36
prerank,GO_Biological_Process_2021__glycoprotein biosynthetic process (GO:0009101),0.4573216478984352,1.1575819479927676,0.18421052631578946,0.7832311783166684,1.0,7/48,9.81%,B3GNT2;CSGALNACT1;LARGE1;B4GALT7;CANT1;FUT9;BMPR1B
prerank,GO_Biological_Process_2021__protein glycosylation (GO:0006486),0.4592689626233289,1.1574081727970067,0.18518518518518517,0.7828316601753157,1.0,26/86,19.25%,B3GNT2;LARGE1;MGAT4C;SLC39A8;B4GALT7;GFPT1;FUT9;POGLUT1;GALNT7;FKTN;STT3B;MGAT5;GALNT1;EOGT;ST8SIA4;ALG12;GALNT2;COG3;ST8SIA5;GCNT2;TMEM165;ALG8;B4GALT5;ALG3;NUS1;MAGT1
prerank,GO_Biological_Process_2021__regulation of MHC class II biosynthetic process (GO:0045346),0.6988773877541384,1.156608638708161,0.25925925925925924,0.7842638687866369,1.0,1/7,2.51%,SIRT1
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization (GO:1904951),0.6080623992767943,1.1564700423229086,0.2619047619047619,0.7837920807447945,1.0,6/16,18.80%,TCP1;TNF;CCT3;CEP120;CHP1;CEP135
prerank,GO_Biological_Process_2021__apoptotic process (GO:0006915),-0.46597930081557776,-1.1563889015413102,0.22784810126582278,0.8788585248553914,1.0,30/160,13.87%,PPP1R15A;MX1;CD2;GAPDH;CXCR4;DDIT4;CSRNP1;TNFRSF25;CD14;GZMB;PRF1;IER3;BNIP2;SEMA6A;PLSCR1;HK2;IFIT2;EGLN3;CFLAR;BCL2L14;IRF1;ITGB2;ING4;BNIP1;GLRX2;CYFIP2;TRAF7;BMF;CASP5;NOTCH2
prerank,GO_Biological_Process_2021__DNA ligation (GO:0006266),0.6763662017900377,1.1563600709630513,0.35714285714285715,0.783134456257061,1.0,2/7,13.61%,LIG4;MGMT
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte mediated immunity (GO:0002888),-0.713431960774767,-1.156337530347407,0.3404255319148936,0.8780324063185769,1.0,4/8,22.26%,ITGB2;TYROBP;STX4;CAMK4
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253),-0.7050046544595774,-1.1562401332272307,0.38,0.877492073570366,1.0,3/7,10.01%,PTTG1IP;RPS7;EIF5A
prerank,GO_Biological_Process_2021__positive regulation of MAP kinase activity (GO:0043406),0.5114286540265979,1.1561905345767554,0.2647058823529412,0.7828087698200374,1.0,12/43,9.91%,PDGFA;FGF2;MAP3K11;LRRK2;NEK10;PDGFC;TNF;ROBO1;DVL3;MAP3K10;IRAK1;SASH1
prerank,GO_Biological_Process_2021__base-excision repair (GO:0006284),-0.5607867245695212,-1.1559349415900178,0.26153846153846155,0.8776618076398562,1.0,8/34,18.09%,SMUG1;XPA;OGG1;PARG;APEX1;RPA3;RFC1;WRN
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor production (GO:0010575),-0.6281162306316359,-1.1558128037511326,0.25806451612903225,0.8770422566260778,1.0,5/14,14.85%,RORA;SULF2;HIF1A;BRCA1;C3
prerank,GO_Biological_Process_2021__regulation of protein-containing complex assembly (GO:0043254),-0.498930473379869,-1.1557983467588968,0.2625,0.8760604715471233,1.0,13/85,12.96%,CD36;TFRC;WARS1;MPP7;RACK1;CLU;RPS3;NAPA;EIF2AK2;VEGFA;ANKRA2;NOP53;BMF
prerank,GO_Biological_Process_2021__positive regulation of fibroblast proliferation (GO:0048146),0.5383962477032994,1.1556571522919883,0.14634146341463414,0.7833016475525564,1.0,4/18,7.13%,PDGFA;WNT5A;PDGFC;LIG4
prerank,GO_Biological_Process_2021__regulation of voltage-gated calcium channel activity (GO:1901385),-0.6593186711460013,-1.1555539915805928,0.3392857142857143,0.8761202848807417,1.0,5/12,21.19%,GNB5;SRI;NOS1AP;CACNB1;AHNAK
prerank,GO_Biological_Process_2021__histone H4-K12 acetylation (GO:0043983),-0.7558698765381404,-1.155299653150024,0.3076923076923077,0.8760388575948734,1.0,1/6,11.60%,ING4
prerank,MSigDB_Hallmark_2020__mTORC1 Signaling,-0.47539978456239684,-1.155071408883697,0.2345679012345679,0.875967686428973,1.0,18/162,9.55%,INSIG1;SLC2A3;PPP1R15A;ME1;GAPDH;SLC7A5;CXCR4;TFRC;WARS1;DDIT4;BTG2;BHLHE40;ERO1A;GLA;HK2;NAMPT;EGLN3;LDHA
prerank,GO_Biological_Process_2021__nucleoside triphosphate metabolic process (GO:0009141),-0.7608827238919044,-1.1550059421347445,0.28125,0.8752229755949044,1.0,2/7,8.26%,CMPK2;ENPP3
prerank,GO_Biological_Process_2021__regulation of nitric oxide mediated signal transduction (GO:0010749),-0.7370113180924874,-1.154857928981482,0.35714285714285715,0.8747913435881964,1.0,4/5,25.87%,VEGFA;NOS1AP;ATP2B4;EGFR
prerank,GO_Biological_Process_2021__positive regulation of dendrite morphogenesis (GO:0050775),0.5498941991252798,1.154639554840106,0.26,0.7859285668730593,1.0,4/16,17.29%,RELN;PTPRD;CAPRIN2;IL1RAPL1
prerank,GO_Biological_Process_2021__chloride transport (GO:0006821),0.48897712059678494,1.154463121117288,0.25,0.7856007326212546,1.0,20/42,22.93%,SLC1A3;GLRA1;ANO8;ANO4;GABRR2;SLC12A6;ANO6;SLC12A5;ANO3;SLC12A2;GABRD;TTYH1;CLCN3;GABRB2;GABRG3;GABRA4;SLC4A8;GABRA2;TTYH3;GLRB
prerank,GO_Biological_Process_2021__mRNA export from nucleus (GO:0006406),0.4275421842731947,1.1542454358206828,0.2,0.7852593760578543,1.0,9/85,7.20%,POLR2D;NXF1;U2AF1;CPSF4;FYTTD1;NUP153;NUP188;WDR33;NUP42
prerank,GO_Biological_Process_2021__positive regulation of intracellular signal transduction (GO:1902533),-0.45144649106378365,-1.1539777140802587,0.19318181818181818,0.876948971722668,1.0,31/347,8.41%,CCL4;CALCR;FLNA;PLEKHG5;CCL3;GAPDH;TFRC;CCL5;CARD16;PDGFD;TRIM5;DHX58;RPS15;CD14;RPS20;RACK1;RPL37;TNFSF10;RPS3;RPL23;IGF1;FIS1;LAMTOR5;TRIM22;PHB2;EIF2AK2;FYN;THEM4;NLRP12;LURAP1;PRKD2
prerank,GO_Biological_Process_2021__meiosis I (GO:0007127),-0.6753029283693858,-1.1538671665401428,0.3225806451612903,0.8763459951698702,1.0,2/10,5.07%,MYBL1;MOV10L1
prerank,GO_Biological_Process_2021__cellular response to angiotensin (GO:1904385),0.6871664589569444,1.1529605025445733,0.3023255813953488,0.7882316823761828,1.0,2/7,13.97%,CA2;AHCYL1
prerank,GO_Biological_Process_2021__cardiac ventricle development (GO:0003231),0.6515584103833574,1.1528430103194525,0.2978723404255319,0.7877168781876623,1.0,4/7,27.02%,SALL1;TMEM65;NOTCH1;PDE2A
prerank,GO_Biological_Process_2021__negative regulation of T cell activation (GO:0050868),-0.6096876746555228,-1.1528183983153426,0.3230769230769231,0.8792375000728039,1.0,5/26,10.76%,IL4I1;RIPOR2;LILRB4;GLMN;NCKAP1L
prerank,GO_Biological_Process_2021__regulation of cellular protein metabolic process (GO:0032268),0.4780763438459919,1.1527703037163117,0.20588235294117646,0.787046579737616,1.0,1/35,0.08%,KLF4
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor production (GO:0010574),-0.6256631549183451,-1.1525766411639076,0.25757575757575757,0.8790531617472599,1.0,5/15,14.85%,RORA;SULF2;HIF1A;BRCA1;C3
prerank,GO_Biological_Process_2021__male meiosis I (GO:0007141),-0.7379191801042919,-1.1524413095967894,0.3157894736842105,0.8786196034431802,1.0,2/6,5.07%,MYBL1;MOV10L1
prerank,GO_Biological_Process_2021__glycosyl compound catabolic process (GO:1901658),-0.7383417363704986,-1.1517977433850064,0.31746031746031744,0.8790805336829411,1.0,1/6,5.40%,GLA
prerank,GO_Biological_Process_2021__glycoside metabolic process (GO:0016137),-0.7383417363704986,-1.1517977433850064,0.31746031746031744,0.8790805336829411,1.0,1/6,5.40%,GLA
prerank,GO_Biological_Process_2021__presynaptic membrane assembly (GO:0097105),0.6572069790495145,1.1517182568611508,0.34146341463414637,0.7891098668933075,1.0,6/9,17.29%,LRP4;NLGN1;PTPRD;PTEN;NLGN4Y;IL1RAPL1
prerank,GO_Biological_Process_2021__regulation of execution phase of apoptosis (GO:1900117),0.724019121161007,1.151627844808248,0.358974358974359,0.7883826568734195,1.0,2/8,7.92%,FZD3;BOK
prerank,GO_Biological_Process_2021__phosphatidylinositol metabolic process (GO:0046488),0.43315498184495754,1.1514126985937918,0.18181818181818182,0.7879978524974209,1.0,18/86,18.14%,PLA2G4C;PGAP1;FGF2;PIP5K1B;PIK3C2B;PTPN13;PI4KB;IMPA1;PTEN;PIP4K2A;SBF1;MTMR9;RAB14;PIK3CA;PIP4P2;PLEKHA8;PLCB3;INPP4B
prerank,GO_Biological_Process_2021__negative regulation of ion transmembrane transporter activity (GO:0032413),-0.63942275790537,-1.1511865425094086,0.35714285714285715,0.8802008548271057,1.0,2/13,7.09%,PLN;STK39
prerank,GO_Biological_Process_2021__regulation of endodeoxyribonuclease activity (GO:0032071),-0.727060499146833,-1.150964783319804,0.328125,0.8801854484248722,1.0,3/7,10.59%,DDX11;RPS3;NPM1
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),-0.6980913023770106,-1.150798368163001,0.3728813559322034,0.8797133618801966,1.0,2/5,19.00%,IFI35;PTPN22
prerank,GO_Biological_Process_2021__neuron projection regeneration (GO:0031102),-0.6777245581712679,-1.150412959235184,0.3275862068965517,0.8802638309869297,1.0,1/8,10.30%,PTN
prerank,GO_Biological_Process_2021__negative regulation of glycoprotein biosynthetic process (GO:0010561),0.6974493980932094,1.1500170265859877,0.391304347826087,0.7916692104238532,1.0,1/7,5.72%,BACE2
prerank,PanglaoDB_Augmented_2021__Satellite Glial Cells,0.4259457613891686,1.1498438805627151,0.12,0.7914372514114516,1.0,23/80,14.20%,SLC39A12;TGFA;PDK4;GFAP;SLC1A3;CDH20;NDRG2;LRRK2;SIRPA;KCND3;PLXDC2;VSIG4;SLC1A2;TNF;GRIA3;CA10;GRM5;P2RY12;MAPK1;NTRK2;SLC8A1;SLCO2B1;GRIA2
prerank,GO_Biological_Process_2021__positive regulation of glycolytic process (GO:0045821),-0.5740469249343639,-1.1493030274018627,0.25925925925925924,0.8822119339850399,1.0,5/17,11.98%,IGF1;PFKFB3;PFKFB4;HIF1A;ENTPD5
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide metabolic process (GO:1900544),-0.5740469249343639,-1.1493030274018627,0.25925925925925924,0.8822119339850399,1.0,5/17,11.98%,IGF1;PFKFB3;PFKFB4;HIF1A;ENTPD5
prerank,GO_Biological_Process_2021__regulation of dendrite morphogenesis (GO:0048814),0.542962246964119,1.1491696449098143,0.23529411764705882,0.7925638605004709,1.0,12/27,23.21%,NEDD4L;KNDC1;PTPRD;CAPRIN2;GSK3B;ADGRB3;IL1RAPL1;RAPGEF2;NEDD4;SEMA4D;RAP2A;TNIK
prerank,GO_Biological_Process_2021__acyl-CoA biosynthetic process (GO:0071616),0.5674893466836607,1.148760203976159,0.3157894736842105,0.792656379662773,1.0,5/14,20.80%,PPT1;GCDH;FASN;ACACA;SCD5
prerank,GO_Biological_Process_2021__positive regulation of intracellular protein transport (GO:0090316),-0.46696614492676697,-1.1486180154337455,0.22580645161290322,0.8834890361703521,1.0,16/115,11.48%,FLNA;TOMM7;GZMB;USP36;CEMIP;EMD;ARIH2;JUP;FIS1;RHOU;RBM22;FYN;HPS4;ITGB2;PRR5L;ABLIM3
prerank,GO_Biological_Process_2021__regulation of chemotaxis (GO:0050920),-0.6386228979832697,-1.1481824940767213,0.2903225806451613,0.8840129530217793,1.0,3/23,2.67%,CXCR4;GPR183;AIF1
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.5763761678445456,-1.1480735013136345,0.2727272727272727,0.8834805695787492,1.0,6/33,7.39%,UBXN1;RPL5;DDRGK1;RPL11;RPL23;RPS7
prerank,GO_Biological_Process_2021__digestive tract morphogenesis (GO:0048546),0.6675835507625524,1.1480600183398146,0.28888888888888886,0.7936942629417937,1.0,3/5,27.12%,NIPBL;FGFR2;BBS7
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.7174595952929691,-1.1480558718710347,0.24528301886792453,0.8825652609570541,1.0,5/11,13.11%,CYCS;COX7C;COX4I1;COX5B;COX6C
prerank,GO_Biological_Process_2021__nucleotide metabolic process (GO:0009117),-0.6150825661208924,-1.1479745781912039,0.3333333333333333,0.881809445244299,1.0,3/18,8.26%,ME1;CMPK2;ENPP3
prerank,GO_Biological_Process_2021__ether lipid metabolic process (GO:0046485),0.5883680359021486,1.1475335655928978,0.22857142857142856,0.7942927319882994,1.0,2/11,4.94%,PLA2G7;NCEH1
prerank,GO_Biological_Process_2021__T cell activation (GO:0042110),-0.5656400896813806,-1.147507171839017,0.27941176470588236,0.8823918540592696,1.0,4/39,2.57%,ITK;JAML;CD2;NLRC3
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.6305631517715975,1.1473861755921877,0.38461538461538464,0.7938478663213908,1.0,4/10,12.13%,PPARG;TAFA5;PTEN;SOD2
prerank,GO_Biological_Process_2021__regulation of astrocyte differentiation (GO:0048710),0.7120473386799201,1.1472448453691988,0.3,0.7933618421551316,1.0,4/5,26.65%,SERPINE2;BIN1;EPHA4;NOTCH1
prerank,GO_Biological_Process_2021__protein deglycosylation (GO:0006517),-0.695485332491027,-1.147087867018298,0.2698412698412698,0.882972943714976,1.0,5/8,23.24%,AGA;MAN2A1;NGLY1;PARK7;MAN2A2
prerank,GO_Biological_Process_2021__nucleobase-containing small molecule catabolic process (GO:0034656),-0.6949667242560489,-1.1465359714671088,0.39215686274509803,0.8841606318247301,1.0,4/9,13.80%,ADPRM;ENTPD4;ENTPD5;NUDT16
prerank,GO_Biological_Process_2021__actin filament polymerization (GO:0030041),-0.6064808010920428,-1.146390380748251,0.2857142857142857,0.8837883944352456,1.0,3/24,2.79%,CATIP;AIF1;PSTPIP1
prerank,GO_Biological_Process_2021__negative regulation of platelet aggregation (GO:0090331),0.6099758790130563,1.1461806820219405,0.35714285714285715,0.7952088540386025,1.0,1/7,2.96%,SERPINE2
prerank,GO_Biological_Process_2021__neuron apoptotic process (GO:0051402),-0.5958382474773154,-1.1459707382322897,0.3157894736842105,0.8844442036264185,1.0,1/16,1.38%,GAPDH
prerank,GO_Biological_Process_2021__response to peptide (GO:1901652),-0.586278777297014,-1.145835216346361,0.2903225806451613,0.8839161356478074,1.0,3/26,3.63%,CALCR;STAT4;EIF2B1
prerank,GO_Biological_Process_2021__fatty acid alpha-oxidation (GO:0001561),0.7273354242834746,1.1457883616932556,0.3404255319148936,0.7953537905325245,1.0,1/5,10.63%,PEX13
prerank,GO_Biological_Process_2021__negative regulation of axon extension (GO:0030517),0.5385532796494106,1.1453866217743656,0.35555555555555557,0.7955824822643648,1.0,8/19,19.55%,SEMA5A;SEMA3B;DIP2B;RTN4;RNF6;KIAA0319;SEMA4D;MAP2
prerank,GO_Biological_Process_2021__negative regulation of interleukin-2 production (GO:0032703),-0.6189273956935379,-1.1453864667892666,0.3333333333333333,0.8846581718917869,1.0,6/15,13.66%,ZFP36;LILRB4;TNFAIP3;PTPRC;KAT5;HAVCR2
prerank,GO_Biological_Process_2021__negative regulation of circadian rhythm (GO:0042754),-0.7717120773427535,-1.1446094753048153,0.34615384615384615,0.886617276772,1.0,1/6,3.13%,PER2
prerank,GO_Biological_Process_2021__regulation of telomere maintenance (GO:0032204),0.5510623769146388,1.144413559031116,0.30434782608695654,0.7974625178744428,1.0,8/20,22.26%,PPP1R10;YLPM1;SIRT6;ERCC4;NBN;HNRNPD;USP7;ERCC1
prerank,GO_Biological_Process_2021__regulation of synapse assembly (GO:0051963),0.5233010625757963,1.143959852893813,0.26666666666666666,0.7979539187878856,1.0,12/33,15.51%,IL1RAPL2;GRID2;DLG5;NLGN1;PDLIM5;CLSTN2;CLSTN3;PTPRD;GPC6;SETD5;LRRC4B;ROBO2
prerank,PanglaoDB_Augmented_2021__Osteoclasts,-0.4811483108916739,-1.1438885834858783,0.2236842105263158,0.8882700717464769,1.0,20/109,11.34%,CCL3;CEBPD;TNFRSF11B;PID1;MS4A4A;MARCO;ZMYND15;SIGLEC1;CD14;FCER1G;EPHB1;CTSB;CD93;F13A1;OSCAR;TNFAIP2;CHI3L1;OLFML2B;TYROBP;HIF1A
prerank,GO_Biological_Process_2021__cellular response to low-density lipoprotein particle stimulus (GO:0071404),-0.6499389734875464,-1.143864275007906,0.3230769230769231,0.8873995998829796,1.0,2/13,3.26%,CD36;FCER1G
prerank,GO_Biological_Process_2021__secretory granule organization (GO:0033363),-0.7261918655842605,-1.1436876689531905,0.3269230769230769,0.8872015605413006,1.0,2/5,10.75%,SRGN;BLOC1S2
prerank,GO_Biological_Process_2021__regulation of nuclear cell cycle DNA replication (GO:0033262),-0.7440224075657749,-1.1433916724653135,0.3584905660377358,0.8872660329870178,1.0,1/7,5.76%,TIPIN
prerank,GO_Biological_Process_2021__DNA replication (GO:0006260),-0.50938771577892,-1.1432796086315897,0.23943661971830985,0.8867292479857767,1.0,18/76,22.17%,POLE3;HUS1;ING5;TIPIN;ING4;KAT5;MCM7;RAD9A;RPA3;BRCA1;RECQL5;RFC1;WRN;MCM6;POLG;DONSON;CDC7;MCM5
prerank,GO_Biological_Process_2021__phosphatidylinositol biosynthetic process (GO:0006661),0.3959641806834304,1.1432703125912675,0.07407407407407407,0.7990587177646146,1.0,13/98,13.78%,PIGQ;PIGU;FGF2;PIP5K1B;PIK3C2B;PTPN13;PI4KB;IMPA1;PIGC;PTEN;PIP4K2A;SBF1;MTMR9
prerank,GO_Biological_Process_2021__regulation of cell-matrix adhesion (GO:0001952),-0.5420257048381472,-1.1429924490908696,0.27941176470588236,0.8867456813745777,1.0,5/49,7.76%,SKAP1;CD36;PLET1;JUP;ACTG1
prerank,GO_Biological_Process_2021__methionine metabolic process (GO:0006555),-0.6943692071676819,-1.1428364347722704,0.3448275862068966,0.8863364338320254,1.0,2/7,14.52%,MTHFD1;SMS
prerank,GO_Biological_Process_2021__modulation by host of viral process (GO:0044788),-0.7544262460485438,-1.1427071845169496,0.26785714285714285,0.8858411322343984,1.0,2/5,14.49%,CFL1;IGF2R
prerank,GO_Biological_Process_2021__death-inducing signaling complex assembly (GO:0071550),0.679330562124647,1.1423156132977934,0.35714285714285715,0.8008445474520199,1.0,4/6,24.85%,TNF;TNFRSF1A;RIPK1;TRAF2
prerank,GO_Biological_Process_2021__histone H2A ubiquitination (GO:0033522),0.5693499982605605,1.1417441599539075,0.34210526315789475,0.8014557704201304,1.0,2/16,5.39%,RNF2;RYBP
prerank,GO_Biological_Process_2021__fatty acid biosynthetic process (GO:0006633),-0.534511178504208,-1.1416592367522518,0.3181818181818182,0.8885804166998693,1.0,6/36,14.80%,LIPG;GSTM4;FADS3;GPX4;ALOX12;ACSM5
prerank,GO_Biological_Process_2021__positive regulation of protein deubiquitination (GO:1903003),-0.7380442519668962,-1.141643211775432,0.38,0.8876884214056625,1.0,2/6,12.01%,NOP53;WDR48
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to mitochondrion (GO:1903749),-0.5465823650241133,-1.141461052816254,0.22950819672131148,0.8873666218993618,1.0,7/42,11.48%,TOMM7;GZMB;USP36;ARIH2;RHOU;HPS4;ABLIM3
prerank,GO_Biological_Process_2021__regulation of small GTPase mediated signal transduction (GO:0051056),-0.4914478762834419,-1.1412552355974694,0.27848101265822783,0.8872186976028134,1.0,11/109,8.02%,PLEKHG5;ARHGAP4;RASGRF2;VAV3;GMIP;CGNL1;ARHGEF1;RHOU;ARHGEF3;OBSCN;SRGAP3
prerank,GO_Biological_Process_2021__mitotic DNA replication checkpoint signaling (GO:0033314),-0.7127930492357508,-1.141088922693129,0.3620689655172414,0.8868596948414486,1.0,1/6,4.73%,HUS1
prerank,GO_Biological_Process_2021__peptidyl-arginine modification (GO:0018195),-0.7119087141505522,-1.1410804195406918,0.3728813559322034,0.8859159639046177,1.0,1/5,4.71%,PADI2
prerank,GO_Biological_Process_2021__inositol phosphate metabolic process (GO:0043647),0.5145237885191614,1.140701480893366,0.25,0.8037079674022674,1.0,14/36,18.14%,INPP1;FGF2;PLCB4;IPPK;IMPA1;NUDT3;PTEN;ISYNA1;PPIP5K1;PLD4;INPP5A;NUDT4;PLCB3;INPP4B
prerank,GO_Biological_Process_2021__cellular response to ketone (GO:1901655),0.5457120871463875,1.1405424030252747,0.3055555555555556,0.803077177996436,1.0,5/26,13.60%,MSN;TRERF1;PCK2;NCOA4;ADCY6
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061419),-0.7566978346858129,-1.1405345766573263,0.2916666666666667,0.8867481239359516,1.0,3/5,11.34%,RBPJ;VEGFA;HIF1A
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum unfolded protein response (GO:1900101),-0.7031547374017303,-1.1401863661070581,0.2982456140350877,0.8870133706649765,1.0,1/7,4.24%,RACK1
prerank,GO_Biological_Process_2021__cytoplasmic translational initiation (GO:0002183),-0.6320413956426306,-1.140186236584742,0.3225806451612903,0.8860343272094964,1.0,10/17,28.10%,EIF2D;EIF2S2;EIF3I;RBM4;EIF2S3;EIF3D;DENR;EIF4H;MCTS1;EIF4A2
prerank,GO_Biological_Process_2021__regulation of cardiac conduction (GO:1903779),0.5567790492366623,1.1399316560741364,0.20689655172413793,0.8039336955702799,1.0,5/27,14.64%,TRPC1;NPR2;SLC8A1;AHCYL1;FXYD7
prerank,GO_Biological_Process_2021__positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.6876800700803927,1.1396709753995524,0.2978723404255319,0.8036092467280129,1.0,3/6,19.97%,STX1A;KCNB1;SYT4
prerank,MSigDB_Hallmark_2020__Bile Acid Metabolism,-0.507657747606024,-1.1395683792255167,0.3088235294117647,0.8871216273776138,1.0,10/62,11.64%,ABCA9;CH25H;ABCA6;NUDT12;GNPAT;GSTK1;GCLM;EFHC1;DIO2;ABCA8
prerank,GO_Biological_Process_2021__DNA metabolic process (GO:0006259),-0.46053902645337225,-1.1391771855433108,0.2222222222222222,0.8875287746872369,1.0,34/198,16.31%,UBC;RPS27A;SMUG1;XPA;BTG2;POLE3;THAP9;OGG1;HUS1;MUS81;PARP2;XRCC3;NPM1;REXO4;NABP1;PARG;NOP53;GLRX2;TERF2IP;KAT5;DDX23;APEX1;DNMT1;MCM7;RAD9A;RPA3;BRCA1;SMC1A;UBA52;PARP4;ZNF445;UHRF1;DFFB;RECQL5
prerank,GO_Biological_Process_2021__regulation of NMDA receptor activity (GO:2000310),0.5088412127920995,1.1387624243323542,0.2647058823529412,0.8053637553930925,1.0,8/26,16.68%,NLGN1;RELN;GRIA3;GRIA4;GRIA1;GRIN2B;GRIA2;GRIN2A
prerank,GO_Biological_Process_2021__cell projection organization (GO:0030030),0.496435806363659,1.1386945103344823,0.2857142857142857,0.8045817290032137,1.0,6/24,11.54%,PDGFA;GSN;NPHP1;CSPG5;P2RY12;QRICH2
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential involved in contraction (GO:0086002),0.5584925673346024,1.1384932956541858,0.28205128205128205,0.8042991209284905,1.0,3/20,8.52%,KCNJ2;SCN3B;NEDD4L
prerank,GO_Biological_Process_2021__mitochondrion distribution (GO:0048311),0.5680110595558099,1.137820920502683,0.275,0.8053288578098858,1.0,4/10,25.09%,LRRK2;CLUH;TRAK2;TRAK1
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated immunity (GO:0002711),-0.5938250361015631,-1.137443847561099,0.3088235294117647,0.8926645770099464,1.0,5/20,10.77%,HLA-B;CD55;B2M;HLA-F;HLA-DRA
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA stabilization (GO:0070935),-0.6816116563924942,-1.137370927541934,0.3448275862068966,0.8919503243013447,1.0,1/12,1.48%,ZFP36
prerank,GO_Biological_Process_2021__regulation of store-operated calcium entry (GO:2001256),0.6718723933773579,1.136879466969667,0.3695652173913043,0.8071975395411181,1.0,3/6,24.34%,HOMER1;HOMER2;CD84
prerank,GO_Biological_Process_2021__regulation of actin filament polymerization (GO:0030833),0.46998019721721224,1.1367598034707136,0.27586206896551724,0.8067062807466142,1.0,7/47,7.80%,FER;HIP1R;CDC42EP3;NCK2;VASP;MYADM;KANK1
prerank,GO_Biological_Process_2021__post-translational protein modification (GO:0043687),0.3840147817303279,1.1361188760489196,0.10526315789473684,0.8077572923579954,1.0,34/226,13.82%,SPSB2;FBXO30;DCAF16;GOLM1;KBTBD6;FAM20C;FBXL14;ZBTB16;FBXO32;DCAF13;FEM1B;DDA1;RAB1B;PRKCSH;VGF;ANO8;GPS1;KCTD6;BTRC;HIF3A;FBXW11;FBXW7;EPAS1;FEM1C;DCAF5;DCUN1D1;CHM;KLHL42;FBXL12;COP1;FBXL7;STT3B;DNAJC3;FBXO27
prerank,GO_Biological_Process_2021__proteasomal protein catabolic process (GO:0010498),0.39383071911353207,1.1360879911672466,0.13043478260869565,0.8069778750729683,1.0,26/173,11.31%,SPSB2;RNF122;KBTBD6;SIRT1;RNF139;SPOPL;RCN3;FEM1B;UBE3D;DDIT3;SEL1L;UBXN6;CLOCK;NEDD4L;APPBP2;RMND5A;SHARPIN;MDM2;BTRC;FBXO45;KCTD10;TBL1XR1;FBXW11;FBXW7;FEM1C;RNF185
prerank,GO_Biological_Process_2021__regulation of endothelial cell chemotaxis (GO:2001026),0.6157843478411069,1.135924784576542,0.3958333333333333,0.8063924325776449,1.0,2/11,2.26%,SEMA5A;FGF2
prerank,GO_Biological_Process_2021__protein N-linked glycosylation (GO:0006487),0.44681339119873226,1.135704601203362,0.2222222222222222,0.8061511549131408,1.0,17/48,22.36%,UBE2J1;MGAT4C;MPDU1;SLC39A8;B4GALT7;GFPT1;OSTC;STT3B;MGAT5;ALG12;TMEM165;ALG8;ALG3;MAGT1;ALG5;RPN2;MGAT4B
prerank,GO_Biological_Process_2021__action potential (GO:0001508),0.5251905408665664,1.1356065582142858,0.3225806451612903,0.8055953682300351,1.0,8/24,13.35%,KCNJ2;SCN3A;GNAQ;SCN3B;KCNMB4;SCN8A;GNA11;KCNMB3
prerank,GO_Biological_Process_2021__ganglioside biosynthetic process (GO:0001574),0.6651508830784202,1.1355041470251135,0.36585365853658536,0.8049313770745756,1.0,4/10,18.85%,ST6GALNAC3;ST6GALNAC5;ST8SIA4;B4GALT5
prerank,GO_Biological_Process_2021__regulation of myeloid leukocyte differentiation (GO:0002761),-0.6923617941935505,-1.1353313971282268,0.359375,0.8982022176751137,1.0,2/7,22.26%,IRF7;CAMK4
prerank,GO_Biological_Process_2021__tetrahydrofolate metabolic process (GO:0046653),-0.7198599879276617,-1.135322779497522,0.375,0.8972838749507391,1.0,3/8,21.84%,MTHFD1;SHMT1;TYMS
prerank,GO_Biological_Process_2021__non-motile cilium assembly (GO:1905515),-0.59484535837828,-1.1352799691089,0.29310344827586204,0.896424505582086,1.0,3/21,12.71%,RPGRIP1L;TBC1D32;CSNK1D
prerank,GO_Biological_Process_2021__snRNA 3'-end processing (GO:0034472),0.5756741077297599,1.135257432978472,0.25,0.8046105627170097,1.0,5/14,20.54%,INTS6;EXOSC6;INTS7;EXOSC7;INTS6L
prerank,PanglaoDB_Augmented_2021__Parathyroid Chief Cells,0.444112687057923,1.1351810924813082,0.25,0.8039764824078565,1.0,14/41,20.12%,GLIS3;ARNT2;SLC7A8;SPRED2;NOL4;FOXP4;LINGO1;NTRK2;ABCC8;CD276;STARD13;CRMP1;FGFR1;ZFHX2
prerank,GO_Biological_Process_2021__Rap protein signal transduction (GO:0032486),0.6869149639054801,1.1351668164960627,0.3333333333333333,0.8031256488304823,1.0,7/9,25.27%,RAP1A;PLK2;RAPGEF3;RAP2C;RAPGEF2;RAP2A;RAP2B
prerank,GO_Biological_Process_2021__sterol biosynthetic process (GO:0016126),-0.5894422806461519,-1.1350194829076887,0.2857142857142857,0.8961834260882566,1.0,2/23,0.88%,INSIG1;CH25H
prerank,GO_Biological_Process_2021__eye morphogenesis (GO:0048592),-0.6181270640715998,-1.1348034602270145,0.3684210526315789,0.8961039121236526,1.0,2/13,3.23%,COL5A1;NKD1
prerank,GO_Biological_Process_2021__maturation of SSU-rRNA (GO:0030490),-0.5423064083089864,-1.1347542549732763,0.27419354838709675,0.8953054205489491,1.0,8/33,13.26%,RPS8;RPS14;UTP3;WDR46;MRPS11;LOC102724159;NOB1;RPS28
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 3 signaling pathway (GO:0034139),-0.7524982761155332,-1.1342399872287252,0.375,0.8960399264310812,1.0,3/5,19.00%,TNFAIP3;FLOT1;PTPN22
prerank,GO_Biological_Process_2021__regulation of ubiquitin protein ligase activity (GO:1904666),-0.6319610368588854,-1.1339318925871642,0.35,0.8960835733411192,1.0,4/13,7.39%,RPL5;RPL11;RPL23;RPS7
prerank,GO_Biological_Process_2021__lymphocyte proliferation (GO:0046651),0.5807969222821863,1.1333636156514169,0.3611111111111111,0.8069487313958515,1.0,1/13,1.49%,MSN
prerank,GO_Biological_Process_2021__response to dopamine (GO:1903350),0.6863525329516231,1.1331406422097179,0.32608695652173914,0.8058576910566017,1.0,2/7,11.38%,LRRK2;MAPK1
prerank,GO_Biological_Process_2021__cellular response to dopamine (GO:1903351),0.6863525329516231,1.1331406422097179,0.32608695652173914,0.8058576910566017,1.0,2/7,11.38%,LRRK2;MAPK1
prerank,PanglaoDB_Augmented_2021__Reticulocytes,-0.4892047439220657,-1.1327968320140975,0.2777777777777778,0.8993904680200097,1.0,8/90,8.15%,DDX11;CD36;TFRC;DHX16;DHX38;ILF3;HDGF;ITGA4
prerank,GO_Biological_Process_2021__positive regulation of gene expression (GO:0010628),-0.4386028971308281,-1.1326591879240817,0.20930232558139536,0.8988368315465485,1.0,45/291,11.34%,CALCR;ITK;BTN3A1;CD36;CCL3;RPS4X;RIMS1;GAPDH;TFRC;PID1;WARS1;RPL5;TAF1D;DDRGK1;ETS1;CLU;RPL11;RPS3;RPL23;IGF1;TXK;LAMTOR5;VPS35;RBM22;MUSK;EIF2AK2;TTN;RPS7;PLSCR1;SNF8;ACTG1;LURAP1;RBPJ;EIF4A3;OVOL2;PDCD5;GLMN;U2AF2;SLC11A1;NPM1;CITED2;ACTB;VEGFA;TYROBP;HIF1A
prerank,GO_Biological_Process_2021__positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.6340239218711734,-1.1325486204563224,0.35294117647058826,0.8981996970171264,1.0,1/11,2.65%,DHX58
prerank,GO_Biological_Process_2021__negative regulation of cardiac muscle hypertrophy (GO:0010614),-0.7035797658069479,-1.1324441823236693,0.3269230769230769,0.8975733454961419,1.0,1/9,2.19%,RGS2
prerank,GO_Biological_Process_2021__lipoprotein biosynthetic process (GO:0042158),-0.7011418627556527,-1.1324219061319847,0.40350877192982454,0.8966760193555895,1.0,3/8,17.68%,ATG10;WIPI1;UGCG
prerank,GO_Biological_Process_2021__regulation of high voltage-gated calcium channel activity (GO:1901841),-0.6682066073952908,-1.1323912970618906,0.3508771929824561,0.895855680195608,1.0,3/9,16.05%,SRI;CALM1;NOS1AP
prerank,GO_Biological_Process_2021__glucose catabolic process to pyruvate (GO:0061718),0.5929383964433728,1.13197736894569,0.2857142857142857,0.8072801349838304,1.0,2/15,1.17%,PFKP;PFKM
prerank,GO_Biological_Process_2021__canonical glycolysis (GO:0061621),0.5929383964433728,1.13197736894569,0.2857142857142857,0.8072801349838304,1.0,2/15,1.17%,PFKP;PFKM
prerank,GO_Biological_Process_2021__metanephros development (GO:0001656),0.6499204275142536,1.1318198136662732,0.2564102564102564,0.8071085571896037,1.0,7/9,16.14%,PKD2;PKD1;PTCH1;NF1;NIPBL;ROBO2;CTSH
prerank,GO_Biological_Process_2021__clathrin coat assembly (GO:0048268),0.5649167149538967,1.1317538382789631,0.38461538461538464,0.8065720613642215,1.0,2/14,3.41%,HIP1R;PICALM
prerank,MSigDB_Hallmark_2020__Myc Targets V2,0.4984162442792648,1.1314762473536983,0.375,0.8064827443152598,1.0,12/35,17.39%,TBRG4;WDR74;RABEPK;RRP12;RCL1;WDR43;SRM;PUS1;PPRC1;HSPD1;NOLC1;PES1
prerank,GO_Biological_Process_2021__regulation of autophagy (GO:0010506),0.39899235907809355,1.1312632058970011,0.058823529411764705,0.8061236360796759,1.0,10/178,3.81%,PRKAB2;LEPR;ACER2;RRAGD;DAPK2;CDK5R1;GFAP;DEPP1;EXOC8;LRRK2
prerank,GO_Biological_Process_2021__peptidyl-lysine modification (GO:0018205),0.4389355477423346,1.1306448759127068,0.25,0.8069654466951921,1.0,17/80,17.93%,SIRT1;SAE1;HDAC9;NUP153;NUP188;NUP42;BCL11A;VCPKMT;LOXL2;STX1A;UBA2;ZNF451;NSMCE2;HDAC10;NDC1;NUP133;NUP205
prerank,GO_Biological_Process_2021__chromosome organization (GO:0051276),-0.5064043418757378,-1.1306441626166635,0.2777777777777778,0.9011185357189958,1.0,12/75,12.38%,UBC;RPS27A;XPA;COPS6;POLE3;PADI2;CENPV;FAM50A;HMGN3;GATAD1;RBX1;COPS8
prerank,GO_Biological_Process_2021__membrane fission (GO:0090148),0.6530525514878213,1.1306220808261838,0.3333333333333333,0.8061216989966431,1.0,3/7,26.23%,SLC25A46;SH3GLB1;CORO1C
prerank,GO_Biological_Process_2021__actin cytoskeleton reorganization (GO:0031532),0.47299939006444464,1.1305872977229605,0.24242424242424243,0.8053605534024791,1.0,6/46,3.12%,ANXA1;NRP1;FER;GSN;GAB1;MCU
prerank,PanglaoDB_Augmented_2021__Basal Cells,-0.5559024234806557,-1.1304743307189007,0.31746031746031744,0.9007631872695936,1.0,5/37,8.20%,MYLK;CLDN7;ANXA2;SLC16A3;TYMP
prerank,GO_Biological_Process_2021__regulation of macroautophagy (GO:0016241),0.423516025213884,1.1304282303606763,0.23529411764705882,0.8050311640977552,1.0,7/92,4.14%,PRKAB2;RRAGD;CDK5R1;SIRT1;EXOC8;LRRK2;TSC2
prerank,GO_Biological_Process_2021__import into nucleus (GO:0051170),0.4541146512583875,1.130324783188708,0.2222222222222222,0.804447436119568,1.0,9/58,6.86%,NUTF2;BACH2;E2F3;TSC2;IPO13;NUP153;NUP188;GEMIN2;PPP1R10
prerank,GO_Biological_Process_2021__regulation of PERK-mediated unfolded protein response (GO:1903897),-0.6893345865437392,-1.1303195390693717,0.3584905660377358,0.9004740571049211,1.0,1/8,1.16%,PPP1R15A
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial inner membrane (GO:0045039),0.6464921080072852,1.1302494767210647,0.34782608695652173,0.803771132273144,1.0,1/6,4.27%,TOMM70
prerank,GO_Biological_Process_2021__regulation of microtubule-based movement (GO:0060632),0.7270583974392901,1.1296073670321316,0.34545454545454546,0.8046501429322311,1.0,2/5,21.26%,MAP2;LAMP1
prerank,GO_Biological_Process_2021__establishment of protein localization to chromatin (GO:0071169),0.7522751759151819,1.1294701700418655,0.3181818181818182,0.8041356719012536,1.0,2/5,13.48%,RUVBL2;NIPBL
prerank,GO_Biological_Process_2021__autophagosome-lysosome fusion (GO:0061909),0.7187606568272814,1.1291906373561336,0.36538461538461536,0.803969837370397,1.0,4/7,17.89%,RUBCNL;PIP4K2A;ATP13A2;ARL8B
prerank,GO_Biological_Process_2021__ether lipid biosynthetic process (GO:0008611),0.6172298775924588,1.1291313472981432,0.36585365853658536,0.8032703413313433,1.0,1/9,0.68%,PLA2G4C
prerank,GO_Biological_Process_2021__mitral valve development (GO:0003174),0.7450544377929338,1.1289759469394993,0.375,0.8029457933671525,1.0,2/5,12.30%,SOX4;BMPR1A
prerank,GO_Biological_Process_2021__fatty acid homeostasis (GO:0055089),0.7227736150231917,1.128914786729251,0.42592592592592593,0.802235641629151,1.0,1/6,2.51%,SIRT1
prerank,GO_Biological_Process_2021__spliceosomal complex assembly (GO:0000245),-0.5461043826151414,-1.1286074492298328,0.25757575757575757,0.9052292342781356,1.0,14/36,26.45%,SNRPD2;SRPK1;CRNKL1;ZRSR2;GCFC2;DDX23;SNRNP200;LUC7L3;SF3A1;SF3A3;SNRPG;DDX1;YTHDC1;SRSF5
prerank,GO_Biological_Process_2021__protein localization to basolateral plasma membrane (GO:1903361),0.6819302305788769,1.1285516182466835,0.3409090909090909,0.8023786773138641,1.0,2/5,5.96%,RAB10;LIN7A
prerank,GO_Biological_Process_2021__positive regulation of protein dephosphorylation (GO:0035307),-0.6029645544025011,-1.1284008420807174,0.27941176470588236,0.9050758707271688,1.0,3/25,8.91%,PPP1R15A;CALM1;CNEP1R1
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport (GO:1903169),-0.637203015930942,-1.1282432823465127,0.3392857142857143,0.9045686743457846,1.0,3/12,17.23%,FYN;NOS1AP;CACNB1
prerank,GO_Biological_Process_2021__positive regulation of lipid storage (GO:0010884),0.6285843598104173,1.1280692302965916,0.36363636363636365,0.8027606560548658,1.0,1/10,2.42%,MSR1
prerank,GO_Biological_Process_2021__positive regulation of DNA-binding transcription factor activity (GO:0051091),-0.4579890529994828,-1.1280491096825032,0.23809523809523808,0.9041742882430386,1.0,31/179,12.59%,CD36;UBC;RPS27A;TFRC;CARD14;PRKCQ;CARD16;TRIM5;BTK;DDRGK1;AIM2;BEX1;CLU;JUP;RPS3;LAMTOR5;TRIM22;PHB2;EIF2AK2;PRKD2;TRIM13;CFLAR;NPM1;VEGFA;STING1;TCF3;BUD31;FZD2;IL18R1;HSPA1B;TERF2IP
prerank,GO_Biological_Process_2021__regulation of neurotransmitter secretion (GO:0046928),-0.6015063030156379,-1.1279946524083717,0.3142857142857143,0.9033436451985846,1.0,2/22,1.34%,MCTP2;RIMS1
prerank,GO_Biological_Process_2021__leucine metabolic process (GO:0006551),-0.6734527334655807,-1.1277853205968786,0.3870967741935484,0.9030350284247133,1.0,3/7,23.10%,MCCC2;HMGCL;BCAT1
prerank,GO_Biological_Process_2021__tetrahydrofolate interconversion (GO:0035999),-0.7200655392287401,-1.1277381405747307,0.3877551020408163,0.902272344908046,1.0,3/7,21.84%,MTHFD1;SHMT1;TYMS
prerank,GO_Biological_Process_2021__Golgi to lysosome transport (GO:0090160),0.581636228855751,1.1275582957451304,0.3076923076923077,0.8033542368850304,1.0,3/9,10.29%,SORT1;RBSN;LAPTM5
prerank,GO_Biological_Process_2021__mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.44418974679057416,1.1274667164248744,0.26666666666666666,0.8027528526112495,1.0,7/48,9.99%,PCBP4;ZNF385A;SOX4;CNOT7;PLK2;MDM2;CNOT2
prerank,GO_Biological_Process_2021__regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902959),0.6616620909266945,1.1272829858524742,0.36585365853658536,0.8024442497706147,1.0,5/7,24.63%,PICALM;SORL1;BIN1;AGER;EPHA4
prerank,"GO_Biological_Process_2021__negative regulation of retrograde protein transport, ER to cytosol (GO:1904153)",0.6335677404095642,1.1268028054053951,0.3125,0.8029435925667021,1.0,1/8,2.48%,UBE2J1
prerank,GO_Biological_Process_2021__double-strand break repair via break-induced replication (GO:0000727),-0.7078759489622634,-1.1259348318195463,0.3103448275862069,0.9072866458706186,1.0,5/7,22.17%,MUS81;MCM7;MCM6;CDC7;MCM5
prerank,GO_Biological_Process_2021__supramolecular fiber organization (GO:0097435),0.38370802849362506,1.1258547361706563,0.16666666666666666,0.8046712590439298,1.0,21/201,6.81%,SHROOM3;COL5A3;COL16A1;AVIL;TPM2;CORO6;CLIP2;GSN;COL5A2;TSPAN33;HIP1R;GFAP;TSPAN15;MYO1D;COL24A1;PGM5;TPPP;CIB1;B4GALT7;BMP1;TMOD2
prerank,GO_Biological_Process_2021__regulation of protein glycosylation (GO:0060049),0.7075296818208399,1.1257411449387706,0.36363636363636365,0.8040710618093379,1.0,3/7,12.20%,ABCA2;RAMP1;FKTN
prerank,"GO_Biological_Process_2021__regulation of CD8-positive, alpha-beta T cell differentiation (GO:0043376)",-0.722403500948674,-1.1257241160562685,0.34545454545454546,0.9070488882499693,1.0,3/6,10.76%,RUNX3;LILRB4;NCKAP1L
prerank,GO_Biological_Process_2021__regulation of myoblast differentiation (GO:0045661),-0.5965010875018064,-1.1256565633691193,0.3,0.906339865543387,1.0,1/15,0.96%,RIPOR2
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection morphogenesis (GO:0120039),0.4721741684173111,1.1254898941286862,0.2608695652173913,0.8038547026148237,1.0,4/41,3.81%,PLXNB1;MAP1S;NYAP2;LRRK2
prerank,GO_Biological_Process_2021__cell part morphogenesis (GO:0032990),-0.6192454742996205,-1.1251191757029249,0.375,0.9072309750778611,1.0,5/13,18.39%,PID1;FIS1;NUBPL;SLIRP;PNPT1
prerank,GO_Biological_Process_2021__negative regulation of histone H3-K9 methylation (GO:0051573),-0.7307238187250051,-1.124749765437679,0.38461538461538464,0.9075017270453891,1.0,4/5,26.85%,DNMT1;BRCA1;PIH1D1;SMARCB1
prerank,GO_Biological_Process_2021__sensory perception of mechanical stimulus (GO:0050954),-0.5268809310615099,-1.1245521399685008,0.27941176470588236,0.9072555314296196,1.0,9/41,11.02%,RIPOR2;CEMIP;SLC26A5;CDH23;NDUFB9;CRYM;MYO3B;USP53;ZNF354A
prerank,GO_Biological_Process_2021__isotype switching (GO:0045190),0.6717165293017506,1.124548545132045,0.32432432432432434,0.805852441219846,1.0,4/8,18.16%,EXOSC6;LIG4;HSPD1;BATF
prerank,GO_Biological_Process_2021__macrophage differentiation (GO:0030225),0.6042033976359014,1.1244849874861285,0.23809523809523808,0.8051739450841436,1.0,2/9,5.45%,SIRT1;PARP1
prerank,GO_Biological_Process_2021__axonogenesis (GO:0007409),0.3941632236136228,1.1240242188112055,0.16666666666666666,0.8056933664695467,1.0,33/162,12.71%,NRP1;GRB10;SLITRK5;CDK5R1;CNTN2;SEMA5A;MAP1S;RAP1GAP;GAB1;VASP;WNT5A;RAB10;DAG1;PLPPR4;RELN;SEMA3B;RYK;ROBO1;TNR;AUTS2;CTNNA2;BRSK1;SHANK3;NPTN;SPTAN1;UNC5B;KLF7;EPHA6;ENAH;MAPK1;PTEN;PDLIM7;GAB2
prerank,GO_Biological_Process_2021__short-chain fatty acid metabolic process (GO:0046459),-0.7125131068713022,-1.1237022556851182,0.4,0.9094139616197581,1.0,2/5,19.17%,MCEE;MMAA
prerank,GO_Biological_Process_2021__snRNA processing (GO:0016180),0.5651242921073973,1.123428127310364,0.3673469387755102,0.8065793985025926,1.0,3/13,20.54%,INTS6;INTS7;INTS6L
prerank,PanglaoDB_Augmented_2021__Erythroblasts,-0.5111348552649941,-1.1232876614149525,0.2876712328767123,0.9098471580910331,1.0,9/71,10.62%,TFRC;GRAP2;BTK;ETS1;TSPAN32;FERMT3;CD44;P2RY8;CSF2RB
prerank,GO_Biological_Process_2021__hematopoietic stem cell proliferation (GO:0071425),0.6708779317960304,1.123259999466836,0.41304347826086957,0.8062171820259608,1.0,4/7,6.90%,YJEFN3;WNT5A;WNT2B;RUNX1
prerank,GO_Biological_Process_2021__positive regulation of superoxide anion generation (GO:0032930),-0.6902212079413967,-1.1230087442715893,0.3333333333333333,0.9097279406957227,1.0,4/10,13.37%,GSTP1;ITGB2;TYROBP;SOD1
prerank,GO_Biological_Process_2021__regulation of T cell differentiation in thymus (GO:0033081),-0.708105300496455,-1.1230087121664027,0.3333333333333333,0.9087642458432909,1.0,5/7,24.96%,SOD1;TESPA1;TOX;CAMK4;VNN1
prerank,GO_Biological_Process_2021__I-kappaB kinase/NF-kappaB signaling (GO:0007249),-0.5404840521898147,-1.1229618234622776,0.2972972972972973,0.9079310004043996,1.0,4/52,3.07%,UBC;RPS27A;NLRC3;CD14
prerank,GO_Biological_Process_2021__negative regulation of hippo signaling (GO:0035331),0.607787384695237,1.1228348740796585,0.375,0.8066813677330115,1.0,3/10,16.31%,DLG5;SHANK2;WWC2
prerank,GO_Biological_Process_2021__establishment of spindle orientation (GO:0051294),-0.6083799535648173,-1.1227980427721038,0.31666666666666665,0.9074660140349688,1.0,2/18,9.33%,DYNLT1;LLGL2
prerank,GO_Biological_Process_2021__relaxation of cardiac muscle (GO:0055119),-0.5988610596748519,-1.1227608910207525,0.4032258064516129,0.9066267464819968,1.0,2/12,2.19%,PLN;RGS2
prerank,GO_Biological_Process_2021__positive regulation of cellular component biogenesis (GO:0044089),-0.5043593041412568,-1.122720732551301,0.29577464788732394,0.9058715374918864,1.0,11/60,12.96%,TFRC;WARS1;MPP7;RACK1;CLU;PLEK;RPS3;SNF8;VEGFA;PFN1;BMF
prerank,PanglaoDB_Augmented_2021__Epithelial Cells,-0.5524080246385442,-1.1226015480653115,0.3148148148148148,0.9053736573006831,1.0,7/39,14.26%,CD2;NKD1;CLDN7;ITGA4;OVOL2;ITGAL;BRCA1
prerank,GO_Biological_Process_2021__cellular component disassembly (GO:0022411),0.5397954984097317,1.12242821467762,0.2564102564102564,0.8068958230254812,1.0,6/26,9.60%,GSN;EXOC8;LCP1;CTSK;BMP1;MMP16
prerank,GO_Biological_Process_2021__positive regulation of voltage-gated potassium channel activity (GO:1903818),0.6914017311144299,1.122168547990353,0.4222222222222222,0.8065867453076039,1.0,1/5,3.23%,KCNIP2
prerank,GO_Biological_Process_2021__positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000373),-0.6993171556925583,-1.1221641040441426,0.39285714285714285,0.9048185227728981,1.0,2/5,15.71%,PLSCR1;UHRF1
prerank,GO_Biological_Process_2021__regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000371),-0.6993171556925583,-1.1221641040441426,0.39285714285714285,0.9048185227728981,1.0,2/5,15.71%,PLSCR1;UHRF1
prerank,GO_Biological_Process_2021__dendritic cell migration (GO:0036336),-0.7215250024428093,-1.1220937117844256,0.3333333333333333,0.9041321191532868,1.0,3/10,1.61%,CXCR4;CCL5;GPR183
prerank,GO_Biological_Process_2021__hypotonic response (GO:0006971),-0.7828874220154575,-1.1220722547826363,0.36363636363636365,0.9032470630503407,1.0,3/5,9.02%,MYLK;STK39;TRPV4
prerank,GO_Biological_Process_2021__detection of mechanical stimulus involved in sensory perception (GO:0050974),0.6430838384158766,1.1219254509647698,0.44,0.8064873366493106,1.0,3/8,17.05%,HPN;COL11A1;ADGRV1
prerank,GO_Biological_Process_2021__smooth muscle contraction (GO:0006939),-0.6719672178166898,-1.1218218976793521,0.38235294117647056,0.9032451658468946,1.0,1/8,0.62%,MYLK
prerank,GO_Biological_Process_2021__cellular hypotonic response (GO:0071476),-0.7566541262007254,-1.1217034966242077,0.35714285714285715,0.9026896312051642,1.0,3/5,9.02%,MYLK;STK39;TRPV4
prerank,GO_Biological_Process_2021__embryonic appendage morphogenesis (GO:0035113),0.7047052012354269,1.1216941459810126,0.3793103448275862,0.8063359479819837,1.0,2/7,13.38%,PTCH1;MEGF8
prerank,GO_Biological_Process_2021__Golgi ribbon formation (GO:0090161),0.6434326675731379,1.1215982248666936,0.3695652173913043,0.8056113664778847,1.0,3/10,14.60%,TMED5;VTI1A;STX6
prerank,GO_Biological_Process_2021__cAMP biosynthetic process (GO:0006171),0.5912822137670096,1.121420361995503,0.35555555555555557,0.8052268762534156,1.0,4/8,26.69%,ADCY9;ADCY6;ADCY10;ADCY1
prerank,GO_Biological_Process_2021__histone H3-K36 demethylation (GO:0070544),-0.7001664380991146,-1.1209696581692956,0.36666666666666664,0.904456307063232,1.0,1/7,10.73%,KDM7A
prerank,GO_Biological_Process_2021__negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.6471371357352655,1.1207588029082856,0.3018867924528302,0.8061698766366692,1.0,2/7,2.26%,SPRY2;FGF2
prerank,GO_Biological_Process_2021__positive regulation of transcription of Notch receptor target (GO:0007221),0.5794473178854113,1.1206583191644088,0.4358974358974359,0.8055517461489402,1.0,3/12,7.44%,MAML2;PBX1;MAML3
prerank,GO_Biological_Process_2021__negative regulation of cell projection organization (GO:0031345),0.4214414515344347,1.120156973545865,0.23529411764705882,0.8063496119112548,1.0,14/39,19.71%,PTPN9;SPRY2;CIB1;KANK1;PTEN;GRIN2B;DCC;ADCY6;BAG5;FKBP4;RAPGEF2;MYLIP;CRMP1;PTPRO
prerank,GO_Biological_Process_2021__negative regulation of immune system process (GO:0002683),-0.7266942216284172,-1.1201503699362216,0.4,0.9063823189853105,1.0,4/6,26.56%,LILRB4;CD200;LYN;LILRB2
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum tubular network organization (GO:1903371),-0.7024917762666875,-1.119739605430084,0.37037037037037035,0.9067843019961803,1.0,2/5,19.79%,LNPK;TMEM33
prerank,GO_Biological_Process_2021__intraciliary transport involved in cilium assembly (GO:0035735),-0.5702142085457316,-1.119425517959349,0.4,0.9068691085406794,1.0,6/30,16.14%,IFT46;DYNC2I1;IFT27;IFT81;IFT52;IFT43
prerank,GO_Biological_Process_2021__respiratory tube development (GO:0030323),0.5503599191713625,1.1192926169040553,0.2857142857142857,0.8079625477519896,1.0,5/15,13.44%,PDPN;FGF2;HECA;CCDC40;BAG6
prerank,GO_Biological_Process_2021__negative regulation of cell differentiation (GO:0045596),0.4040958964671199,1.1192041383514069,0.21875,0.8073185815289646,1.0,26/96,15.21%,SPRY2;COL5A2;SIRT1;SMAD7;ZBTB16;SPRED1;SPRED2;WNT5A;ANP32B;PPARG;USF3;SMAD3;HPN;JAG1;TNF;RANBP3L;TWIST2;ITGAV;PTCH1;PTEN;CDK6;RUNX1T1;FERMT2;CNTN4;ENPP1;TGFBR1
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleolus (GO:1904749),-0.7263574185830848,-1.1191890553616275,0.32786885245901637,0.90658355689076,1.0,1/5,5.41%,GLUL
prerank,GO_Biological_Process_2021__regulation of biomineral tissue development (GO:0070167),0.5905024288790692,1.1188567683104067,0.3333333333333333,0.8073487172146373,1.0,4/12,26.65%,ANKH;ENPP1;TGFB1;NOTCH1
prerank,GO_Biological_Process_2021__myeloid leukocyte differentiation (GO:0002573),0.44182251196674127,1.1183736976722785,0.2413793103448276,0.8077664854738171,1.0,7/44,6.90%,PIR;TGFBR2;SIRT1;CBFA2T3;PPARG;PARP1;RUNX1
prerank,PanglaoDB_Augmented_2021__Kidney Progenitor Cells,0.4353299604141514,1.118302355782836,0.14285714285714285,0.8070989689609172,1.0,12/45,18.34%,LRP4;GPR161;MAGI1;SALL1;PTPRG;ENAH;GPC6;FERMT2;CD276;ANTXR1;RAI14;RBFOX2
prerank,GO_Biological_Process_2021__nucleosome assembly (GO:0006334),-0.5489163476369103,-1.118207422013116,0.3392857142857143,0.9090405038656293,1.0,7/30,12.68%,H2BC18;H2BC21;H2BC5;H2BC9;NPM1;HIRA;H2BC11
prerank,GO_Biological_Process_2021__pyrimidine nucleobase metabolic process (GO:0006206),0.6223739713526409,1.1181184299086706,0.3409090909090909,0.8067294754094643,1.0,1/9,1.43%,DPYSL5
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.6768915279911321,-1.1178691547470847,0.3559322033898305,0.9091317106629535,1.0,4/9,16.41%,JUP;TRPM4;DSC2;PKP2
prerank,GO_Biological_Process_2021__transforming growth factor beta receptor signaling pathway (GO:0007179),-0.4974022800605607,-1.1178379592412984,0.2647058823529412,0.9082686548704552,1.0,4/57,1.30%,UBC;TGFBR3;FOS;RPS27A
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte proliferation (GO:0050671),-0.5328402421319457,-1.1176516412134383,0.25757575757575757,0.9079019140896052,1.0,15/43,17.61%,TFRC;CCL5;GPR183;VAV3;AIF1;ZNF335;NCKAP1L;TNFSF13B;PTPRC;HLA-E;HLA-DPA1;HLA-DMB;CD74;HLA-DPB1;IL18
prerank,GO_Biological_Process_2021__regulation of cell differentiation (GO:0045595),0.4116794201704916,1.1176137586029538,0.2,0.8073011529602679,1.0,31/99,20.73%,KLF4;CDK5R1;SMAD7;NLGN1;NSUN2;PHLDB1;ANP32B;DAG1;PLEKHB2;RUNX1;TNF;YWHAG;BMPR1B;SMYD5;CDK6;NF1;PTK2;CLASP1;TGFBR1;CLASP2;MOSMO;BIN1;CBFB;FGFR2;TIAM1;FGFR1;ZFHX2;SCIN;CDK9;MEGF10;OCIAD1
prerank,GO_Biological_Process_2021__negative regulation of telomere capping (GO:1904354),0.6811695591409511,1.1176110712865481,0.45098039215686275,0.8064561029214418,1.0,3/6,22.26%,ERCC4;NBN;ERCC1
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),-0.5481041273713156,-1.1176080447247083,0.30666666666666664,0.9070688675223098,1.0,2/41,2.37%,BCL2A1;DDIT4
prerank,GO_Biological_Process_2021__negative regulation of catabolic process (GO:0009895),-0.5303272195952292,-1.1175962859492643,0.2711864406779661,0.9061747365244646,1.0,1/29,0.28%,FLNA
prerank,GO_Biological_Process_2021__metal ion export (GO:0070839),0.5376846040250987,1.1175672664056697,0.35294117647058826,0.8056771202204099,1.0,5/16,13.82%,KCNIP2;KCND3;SLC4A4;SLC9A1;SLC40A1
prerank,GO_Biological_Process_2021__protein mannosylation (GO:0035268),0.5657841604929398,1.11754178666724,0.3076923076923077,0.8048997896566019,1.0,6/18,12.20%,LARGE1;DPY19L1;TMTC2;FKRP;DPY19L3;FKTN
prerank,GO_Biological_Process_2021__positive regulation of myotube differentiation (GO:0010831),0.6965128718634683,1.1169089657284896,0.38461538461538464,0.8057788406923077,1.0,4/5,27.24%,MMP14;PIEZO1;MAPK14;ATP11A
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta formation (GO:1902004),0.5790848958707697,1.116862845070665,0.2631578947368421,0.8051055582470763,1.0,4/14,9.55%,ABCA2;PICALM;TNF;SLC2A13
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex disassembly (GO:0043242),0.6700710700224517,1.1166036459543451,0.38461538461538464,0.8049585107789188,1.0,3/8,10.79%,TMEM39A;TNF;IRAK3
prerank,MSigDB_Hallmark_2020__Fatty Acid Metabolism,-0.46697719678038685,-1.1164048887921267,0.275,0.9092532670915714,1.0,21/106,15.03%,IL4I1;CD36;ME1;MGLL;MDH2;GABARAPL1;BPHL;GLUL;EPHX1;ODC1;ACAA1;PTS;LDHA;IDH3B;MCEE;UROS;APEX1;CBR3;ECI2;SMS;ETFDH
prerank,GO_Biological_Process_2021__response to lead ion (GO:0010288),-0.7652022957539484,-1.1162018697089127,0.4528301886792453,0.9090840169871259,1.0,1/5,7.40%,PLSCR1
prerank,GO_Biological_Process_2021__cellular response to reactive oxygen species (GO:0034614),0.44871851682242087,1.1159354636487002,0.27586206896551724,0.8058602885924707,1.0,5/47,4.05%,ANXA1;PKD2;FER;SIRT1;SIRPA
prerank,GO_Biological_Process_2021__regulation of vesicle size (GO:0097494),0.6767867647930575,1.1156105793274744,0.3617021276595745,0.8061470466338467,1.0,1/6,3.41%,PICALM
prerank,GO_Biological_Process_2021__regulation of microtubule binding (GO:1904526),0.7344647078689631,1.1154315876110845,0.3617021276595745,0.8057186505805151,1.0,5/5,26.58%,MARK2;MAP2;ABL1;PPP2CB;TTBK2
prerank,GO_Biological_Process_2021__rRNA base methylation (GO:0070475),-0.7344075359830959,-1.1149902560232803,0.42424242424242425,0.9122784205826066,1.0,3/5,20.17%,BUD23;EMG1;NSUN5
prerank,GO_Biological_Process_2021__tube closure (GO:0060606),0.48344262386426806,1.1148951642830456,0.26666666666666666,0.8056667391900336,1.0,6/24,11.62%,SCRIB;TSC2;VASP;PLXNB2;PHACTR4;COBL
prerank,GO_Biological_Process_2021__primary neural tube formation (GO:0014020),0.48344262386426806,1.1148951642830456,0.26666666666666666,0.8056667391900336,1.0,6/24,11.62%,SCRIB;TSC2;VASP;PLXNB2;PHACTR4;COBL
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.41489899844739137,1.1144931179561193,0.1875,0.8059397760662963,1.0,20/74,13.77%,PLXNB1;PDGFA;IGF1R;FGF2;SIRT1;GAB1;TSC2;PIP5K1B;PDGFC;TNF;PTPN13;UNC5B;HGF;MAPK1;PTEN;NTRK2;DIPK2A;PIP4K2A;PIK3AP1;PTK2
prerank,GO_Biological_Process_2021__polyol biosynthetic process (GO:0046173),0.6098217324150785,1.1144305992604926,0.3076923076923077,0.805271976647495,1.0,4/13,13.98%,FGF2;IPPK;ISYNA1;PPIP5K1
prerank,GO_Biological_Process_2021__microvillus organization (GO:0032528),0.597061044658707,1.1141589022243583,0.3125,0.8044604390873105,1.0,9/13,27.94%,RAP1A;FXYD5;RAP2C;RAPGEF2;STK26;RAP2A;TNIK;RAP2B;MAP4K4
prerank,GO_Biological_Process_2021__microvillus assembly (GO:0030033),0.597061044658707,1.1141589022243583,0.3125,0.8044604390873105,1.0,9/13,27.94%,RAP1A;FXYD5;RAP2C;RAPGEF2;STK26;RAP2A;TNIK;RAP2B;MAP4K4
prerank,GO_Biological_Process_2021__positive regulation of protein polymerization (GO:0032273),0.4338727601558284,1.1138316109744195,0.2857142857142857,0.8045942651078447,1.0,9/47,12.17%,FER;CDK5R1;CDC42EP3;NCK2;VASP;TPPP;TOGARAM1;SLAIN2;ARF6
prerank,GO_Biological_Process_2021__iron ion transport (GO:0006826),-0.5570012441463985,-1.113651938067688,0.3382352941176471,0.9158862174097226,1.0,3/36,4.87%,FTH1;TFRC;ATP6V1F
prerank,GO_Biological_Process_2021__response to nutrient levels (GO:0031667),0.6416760221601047,1.1135126724022557,0.3333333333333333,0.8044747484109921,1.0,5/10,27.29%,PRKAA1;KCNB1;ULK1;RPS6KB1;PRKAA2
prerank,GO_Biological_Process_2021__glycoside catabolic process (GO:0016139),-0.6826859251938212,-1.1131317193115589,0.3898305084745763,0.9168264759459515,1.0,3/8,23.07%,GLA;GUSB;GBA3
prerank,GO_Biological_Process_2021__regulation of viral transcription (GO:0046782),-0.5570455922622927,-1.1131071155481211,0.296875,0.9159634949856029,1.0,6/32,9.65%,ZFP36;MDFIC;IFITM3;CTDP1;POLR2G;TRIM13
prerank,GO_Biological_Process_2021__protein phosphorylation (GO:0006468),0.3461941296351766,1.1131019769019737,0.0,0.8046209200526746,1.0,75/366,16.08%,DAPK2;FER;CDK5R1;ACVR2A;IGF1R;AATK;FAM20C;TGFBR2;CSNK1G1;PDK4;SMAD7;STK32B;MAP3K11;CDK10;PKD1;LRRK2;NEK10;MAP2K1;STK36;RPS6KA4;CDK17;TLK1;PIM1;RELN;SMAD2;STK25;CDK18;MAST2;CDK7;NUAK1;CAB39;RYK;MAP4K5;NLK;TLR7;MAP3K10;STK38L;BRSK1;IRAK1;MAST3;PLK2;BMPR1B;DYRK1A;MERTK;IRAK3;CDK13;WNK1;RPS6KA6;FNIP2;MAPK1;CAMKV;CDK6;BMPR1A;NTRK2;MAPKAPK2;CILK1;CSNK1E;PRKCI;PRKAB1;MARK1;PRRT1;PTK2;ERBB4;CDKL2;TYRO3;MAP3K13;STK10;MAP3K5;ATP13A2;TGFBR1;AKT2;GSK3B;GTF2H3;ABI1;RPS6KB2
prerank,GO_Biological_Process_2021__positive regulation of fatty acid oxidation (GO:0046321),-0.6960021714023332,-1.1130701406771626,0.40350877192982454,0.9151111960670236,1.0,1/7,0.08%,NR4A3
prerank,GO_Biological_Process_2021__regulation of receptor recycling (GO:0001919),0.548091477986824,1.1126332107473105,0.36363636363636365,0.805107709473491,1.0,2/13,6.95%,SCRIB;TBC1D16
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling (GO:0010649),-0.6904945391044119,-1.1126148706209142,0.39285714285714285,0.9156488974505812,1.0,2/7,8.36%,SRI;CALM1
prerank,GO_Biological_Process_2021__oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.6191100047367154,1.1125886040734578,0.30952380952380953,0.8044834869940639,1.0,4/11,18.89%,MPDU1;ALG12;ALG8;ALG3
prerank,GO_Biological_Process_2021__epidermal growth factor receptor signaling pathway (GO:0007173),0.5292280789986903,1.1121184890691123,0.35294117647058826,0.8050702102188513,1.0,3/31,4.13%,TGFA;GAB1;NCK2
prerank,GO_Biological_Process_2021__atrioventricular valve development (GO:0003171),0.6124854950361318,1.1120535731615728,0.3076923076923077,0.8043592127698183,1.0,2/9,12.30%,TGFBR2;BMPR1A
prerank,GO_Biological_Process_2021__actin crosslink formation (GO:0051764),-0.6139599187843172,-1.1118922754421976,0.36923076923076925,0.9171633862356983,1.0,2/9,2.67%,FLNA;AIF1
prerank,"GO_Biological_Process_2021__positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.5550900657809127,1.1118270945337938,0.3157894736842105,0.8040646443830076,1.0,8/11,22.68%,NLGN1;RELN;SHANK3;CACNG8;CACNG2;CACNG3;NRXN1;TSHZ3
prerank,GO_Biological_Process_2021__peptide metabolic process (GO:0006518),-0.5291771226242981,-1.1117589793836475,0.3088235294117647,0.9166854714603353,1.0,13/45,15.68%,TPP1;GSTM4;GSTP1;GSTK1;GSTM3;ERAP1;ABCB9;GLRX2;SOD1;GPX1;ERAP2;TRHDE;PCSK5
prerank,GO_Biological_Process_2021__sterol import (GO:0035376),-0.7058309188801644,-1.1116612721313959,0.4,0.9150944636159026,1.0,1/5,0.52%,CD36
prerank,GO_Biological_Process_2021__cholesterol import (GO:0070508),-0.7058309188801644,-1.1116612721313959,0.4,0.9150944636159026,1.0,1/5,0.52%,CD36
prerank,GO_Biological_Process_2021__cellular transition metal ion homeostasis (GO:0046916),-0.5139516497580725,-1.1116283596109762,0.33783783783783783,0.9142305686763219,1.0,4/58,2.30%,MT2A;FTH1;TFRC;HAMP
prerank,GO_Biological_Process_2021__positive regulation of autophagosome assembly (GO:2000786),0.664923049864192,1.1112958755880642,0.3181818181818182,0.8049765692675298,1.0,4/8,25.67%,PIP4K2A;SH3GLB1;RAB3GAP2;PIP4K2B
prerank,GO_Biological_Process_2021__COPII-coated vesicle budding (GO:0090114),0.4539382314009295,1.111136193734104,0.2413793103448276,0.804669423382119,1.0,7/57,6.50%,VAPB;TGFA;BET1;CTSC;RAB1B;SEC24B;TMED10
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),-0.6544500648262299,-1.111045329480722,0.42105263157894735,0.9143193482542458,1.0,5/10,14.31%,SLAMF6;HLA-F;KLRD1;CD226;HLA-E
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated immunity (GO:0002717),-0.6544500648262299,-1.111045329480722,0.42105263157894735,0.9143193482542458,1.0,5/10,14.31%,SLAMF6;HLA-F;KLRD1;CD226;HLA-E
prerank,GO_Biological_Process_2021__regulation of respiratory system process (GO:0044065),-0.7198328016577024,-1.1110345162023298,0.3584905660377358,0.9134235756581447,1.0,1/6,7.64%,NLGN2
prerank,GO_Biological_Process_2021__diol metabolic process (GO:0034311),-0.6733417554363681,-1.1106098022745248,0.31746031746031744,0.9139580708443034,1.0,3/12,9.36%,DEGS2;CALM1;PTS
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton reorganization (GO:2000249),0.48056639223717595,1.1105480261348133,0.375,0.8052779877873805,1.0,1/26,0.61%,NRP1
prerank,GO_Biological_Process_2021__embryonic digestive tract development (GO:0048566),0.6459439334638728,1.110468930214208,0.35135135135135137,0.8046455855898739,1.0,5/9,19.59%,SALL1;TNF;RARB;NIPBL;FGFR2
prerank,GO_Biological_Process_2021__neuromuscular synaptic transmission (GO:0007274),0.6051392570007554,1.1104582940301648,0.2830188679245283,0.8038268495163563,1.0,2/9,7.96%,TSPOAP1;DTNA
prerank,PanglaoDB_Augmented_2021__Clara Cells,0.6787404788266413,1.1103602524938794,0.37209302325581395,0.803247235975574,1.0,1/8,0.15%,LEPR
prerank,GO_Biological_Process_2021__cellular protein modification process (GO:0006464),0.35507628639098515,1.1102223574314773,0.0,0.802831103971498,1.0,118/716,13.82%,SPSB2;B3GNT2;ANXA1;DUSP6;FBXO30;HS3ST5;PTPN9;DAPK2;PIGU;FER;PGAP1;ACVR2A;DCAF16;GOLM1;KBTBD6;AATK;FAM20C;TGFBR2;PDK4;SIRT1;FBXL14;ZBTB16;PPM1L;MAP3K11;CDK10;LARGE1;LRRK2;FBXO32;NEK10;DCAF13;MAP2K1;STK36;FEM1B;DDA1;RPS6KA4;CDK17;UBE2E2;PTPRM;TLK1;PIM1;PARP1;RAB1B;PRKCSH;B4GALT7;STK25;CDK18;PPP4R2;MAST2;CDK7;VGF;NUAK1;UBE2D2;ANO8;RYK;PTAR1;NTAQ1;MAP4K5;NLK;PPP2R1B;STK38L;GPS1;PTPN13;BRSK1;ILKAP;FUT9;IRAK1;PIGT;CDC14B;PPP3CA;PLK2;SIRT6;DUSP7;KCTD6;BTRC;BMPR1B;LOXL2;PTPRG;PTPRK;DYRK1A;HIF3A;UBE2L3;PTPN5;MERTK;FBXW11;IRAK3;FBXW7;EPAS1;CDK13;WNK1;PTPRD;FEM1C;FNIP2;PGGT1B;MAPK1;UST;DCAF5;PTEN;CDK6;SETD3;BMPR1A;DCUN1D1;CHM;MAPKAPK2;CILK1;CSNK1E;KLHL42;FBXL12;COP1;FBXL7;PRKCI;STT3B;SBF1;PRKAB1;MARK1;PRRT1;PPP2R5E;DNAJC3;FBXO27
prerank,GO_Biological_Process_2021__negative regulation of Notch signaling pathway (GO:0045746),0.5857698047350774,1.10989907351194,0.3137254901960784,0.802802421321882,1.0,3/14,14.07%,TSPAN15;FBXW7;MMP14
prerank,GO_Biological_Process_2021__telomere maintenance via telomerase (GO:0007004),-0.5725984201013101,-1.1097280447232976,0.3333333333333333,0.9158391958189881,1.0,5/19,17.02%,TERF2IP;NHP2;NOP10;ANKRD28;RFC1
prerank,GO_Biological_Process_2021__regulation of lipid catabolic process (GO:0050994),0.637235219519052,1.1094221947565501,0.37735849056603776,0.8032970289553372,1.0,3/8,16.79%,TNF;PDE3B;PRKAA1
prerank,GO_Biological_Process_2021__protein autoubiquitination (GO:0051865),0.4644442510608715,1.1090523017747222,0.25925925925925924,0.8035168280825079,1.0,13/53,15.70%,RNF122;UHRF2;RNF208;MARCHF5;UBE3D;UBE2D2;MDM2;RNF19B;RNF185;RNF10;SH3RF1;TRAF6;RNF220
prerank,GO_Biological_Process_2021__mitotic DNA integrity checkpoint signaling (GO:0044774),-0.6827484899172513,-1.10873858401748,0.3220338983050847,0.9184292736793935,1.0,1/8,4.73%,HUS1
prerank,GO_Biological_Process_2021__negative regulation of cellular component movement (GO:0051271),-0.6367675381280787,-1.1087382891792725,0.375,0.9174978038277917,1.0,1/11,1.03%,TGFBR3
prerank,GO_Biological_Process_2021__negative regulation of leukocyte migration (GO:0002686),-0.742719269120069,-1.1084970573040631,0.3,0.9174112769882463,1.0,2/6,15.81%,CD200R1;CD200
prerank,PanglaoDB_Augmented_2021__Pancreatic Stellate Cells,-0.5382892194961211,-1.108493381141851,0.32894736842105265,0.9164914960041699,1.0,3/36,1.29%,SPON2;COL5A1;DYNLT1
prerank,GO_Biological_Process_2021__axon ensheathment in central nervous system (GO:0032291),0.6977804348663186,1.1084482253894063,0.3333333333333333,0.8043950881154956,1.0,3/5,18.85%,MYRF;CNTNAP1;B4GALT5
prerank,GO_Biological_Process_2021__negative regulation of receptor-mediated endocytosis (GO:0048261),0.5618130342486076,1.1082890001940806,0.3448275862068966,0.8039550737268358,1.0,4/18,12.17%,ABCA2;PICALM;ITGAV;ARF6
prerank,GO_Biological_Process_2021__mesenchyme morphogenesis (GO:0072132),0.6753195225537193,1.1082733282126704,0.4318181818181818,0.8031685697571104,1.0,4/7,26.65%,SMAD2;BMPR1A;ACVR1;NOTCH1
prerank,GO_Biological_Process_2021__establishment of mitotic spindle localization (GO:0040001),-0.598040752960504,-1.1082211840156717,0.31746031746031744,0.9166427915194922,1.0,1/18,1.29%,DYNLT1
prerank,GO_Biological_Process_2021__renal absorption (GO:0070293),0.6470065661511912,1.108216732631342,0.3333333333333333,0.8024704347463549,1.0,1/7,1.66%,GSN
prerank,GO_Biological_Process_2021__regulation of presynapse organization (GO:0099174),0.64659741427642,1.1080767124029596,0.37209302325581395,0.8012516067473296,1.0,6/10,19.35%,IL1RAPL2;PTPRD;GPC6;LRRC4B;IL1RAPL1;SNCA
prerank,GO_Biological_Process_2021__regulation of presynapse assembly (GO:1905606),0.64659741427642,1.1080767124029596,0.37209302325581395,0.8012516067473296,1.0,6/10,19.35%,IL1RAPL2;PTPRD;GPC6;LRRC4B;IL1RAPL1;SNCA
prerank,GO_Biological_Process_2021__negative regulation of protein metabolic process (GO:0051248),-0.5355140826884108,-1.107588227717023,0.3088235294117647,0.9178093865465131,1.0,2/34,4.82%,FLNA;CLU
prerank,GO_Biological_Process_2021__snRNA metabolic process (GO:0016073),0.591107845947143,1.1075423957189194,0.38095238095238093,0.8020279516065806,1.0,3/14,12.61%,MEPCE;INTS6;INTS7
prerank,GO_Biological_Process_2021__negative regulation of alcohol biosynthetic process (GO:1902931),-0.6824673462123684,-1.10737227435714,0.34615384615384615,0.9177228945451508,1.0,2/9,13.37%,PLEK;SOD1
prerank,GO_Biological_Process_2021__actin-myosin filament sliding (GO:0033275),0.5531109773677839,1.1071073875080344,0.2564102564102564,0.801652257993676,1.0,1/13,0.52%,TPM2
prerank,GO_Biological_Process_2021__muscle filament sliding (GO:0030049),0.5531109773677839,1.1071073875080344,0.2564102564102564,0.801652257993676,1.0,1/13,0.52%,TPM2
prerank,GO_Biological_Process_2021__regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.5290538632461981,-1.1069743868687576,0.3548387096774194,0.9179686044020475,1.0,7/37,9.67%,PYHIN1;RPL5;CLU;RPL11;RPL23;RPS7;GLMN
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization (GO:1904950),0.6193782955380753,1.106807614803418,0.32558139534883723,0.8016251247212451,1.0,6/10,33.13%,SNX12;PPM1F;DNAJA1;CORO2B;NDFIP2;MAPT
prerank,GO_Biological_Process_2021__galactose metabolic process (GO:0006012),0.6791366283799674,1.1067352069741054,0.39622641509433965,0.801056584277929,1.0,3/6,26.42%,CHST1;PGM2L1;GALE
prerank,GO_Biological_Process_2021__phagosome-lysosome fusion (GO:0090385),0.6962762813476314,1.106377316794272,0.33962264150943394,0.8010055239064229,1.0,6/6,30.41%,RAB7A;ARL8B;RAB7B;RAB20;PIKFYVE;RAB39A
prerank,GO_Biological_Process_2021__regulation of cellular protein localization (GO:1903827),0.4327984065235865,1.1052091890951092,0.2222222222222222,0.8034844531944243,1.0,14/37,23.88%,ABCA2;LCP1;PARP1;DVL3;GPC6;CSNK1E;SETD2;ATP13A2;PRKAA1;PPM1F;MAP2;GBF1;TOR1A;GPC1
prerank,GO_Biological_Process_2021__cellular response to muramyl dipeptide (GO:0071225),-0.6867517159955341,-1.1051165485631202,0.38596491228070173,0.9232939612355701,1.0,5/8,25.45%,NOD2;VIM;PTPN22;TRIM41;ARHGEF2
prerank,GO_Biological_Process_2021__negative regulation of cellular amide metabolic process (GO:0034249),-0.4886910356679671,-1.1050492843946544,0.21428571428571427,0.9224871738561491,1.0,12/70,9.50%,GAPDH;BTG2;GZMB;RPL13A;RACK1;CLU;RPS3;IGF1;ILF3;EIF2AK2;EIF4A3;ORMDL1
prerank,GO_Biological_Process_2021__regulation of fat cell proliferation (GO:0070344),-0.7610579270709803,-1.1049648296448111,0.4,0.9218562325764013,1.0,2/5,3.13%,PID1;PER2
prerank,GO_Biological_Process_2021__glycosylceramide catabolic process (GO:0046477),-0.7097617362662598,-1.1049471448598525,0.35,0.9210176988561518,1.0,3/5,23.07%,GLA;GALC;GBA3
prerank,GO_Biological_Process_2021__postreplication repair (GO:0006301),-0.5463382690887737,-1.104931609664963,0.3333333333333333,0.9201199910279735,1.0,2/36,1.30%,UBC;RPS27A
prerank,GO_Biological_Process_2021__negative regulation of histone methylation (GO:0031061),-0.6516133952008545,-1.104555776649669,0.39344262295081966,0.9202836564579049,1.0,3/11,17.91%,DNMT1;BRCA1;SUPT6H
prerank,GO_Biological_Process_2021__regulation of RIG-I signaling pathway (GO:0039535),-0.6379793683092618,-1.1040869854914237,0.37254901960784315,0.9208547822592253,1.0,4/13,21.42%,DHX58;NOP53;DDX60;C1QBP
prerank,GO_Biological_Process_2021__regulation of establishment of cell polarity (GO:2000114),-0.6107083273386498,-1.1039053498561158,0.3898305084745763,0.9205753346663048,1.0,2/14,4.24%,RIPOR2;RACK1
prerank,GO_Biological_Process_2021__release of cytochrome c from mitochondria (GO:0001836),-0.6199910324827562,-1.1036874254505227,0.3076923076923077,0.92044364850739,1.0,2/10,5.76%,CLU;FIS1
prerank,GO_Biological_Process_2021__regulation of RNA splicing (GO:0043484),-0.5052646455385933,-1.1035754930091903,0.3142857142857143,0.9198797069954592,1.0,7/65,9.76%,RPS13;JMJD6;RPS26;RBM22;FAM50A;SRPK1;U2AF2
prerank,GO_Biological_Process_2021__regulation of transport (GO:0051049),0.49964617593956784,1.103472426568016,0.3191489361702128,0.8079949398967711,1.0,4/22,3.81%,LEPR;NRP1;EPB41;LRRK2
prerank,GO_Biological_Process_2021__positive regulation of MHC class II biosynthetic process (GO:0045348),0.7087599895028883,1.1029479427342845,0.41818181818181815,0.8087336610466361,1.0,1/5,2.51%,SIRT1
prerank,GO_Biological_Process_2021__synaptic vesicle endocytosis (GO:0048488),-0.5441943609366517,-1.1029162438442872,0.3484848484848485,0.9212872065995455,1.0,2/29,1.19%,MX2;MX1
prerank,GO_Biological_Process_2021__regulation of microglial cell activation (GO:1903978),-0.6785113776151543,-1.1027968401135628,0.38333333333333336,0.9208357789982741,1.0,1/10,0.62%,CCL3
prerank,GO_Biological_Process_2021__negative regulation of nucleic acid-templated transcription (GO:1903507),0.354475683281688,1.102718771316614,0.21428571428571427,0.8084791447620044,1.0,44/305,11.06%,KLF4;QARS1;CDK5R1;GCLC;ZBTB33;SIRT1;ZBTB16;DPF3;ZNF706;SPINDOC;HDAC9;TLE2;CBFA2T3;WNT5A;SAMD1;FOXN3;ZNF12;PPARG;POU2F1;SMAD2;DDIT3;NRG1;DACH1;SALL1;HMGA1;TNF;RFX3;CLOCK;NACC2;MAP3K10;TRERF1;CNOT7;CTBP2;IKZF1;SFMBT1;MDM2;BTRC;HDAC1;TWIST2;LOXL2;PTPRK;FBXW11;ZBTB38;TCF7L2
prerank,GO_Biological_Process_2021__endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.3891022172235498,1.102669858085486,0.25,0.8077603502030521,1.0,17/137,10.39%,VAPB;PGAP1;TGFA;BET1;HYOU1;CTSC;TMED3;RAB1B;SEC24B;TMED10;TMED5;COPG1;SPTAN1;GRIA1;LMAN2L;VTI1A;COG1
prerank,GO_Biological_Process_2021__inositol lipid-mediated signaling (GO:0048017),0.4309175316923234,1.1025253246300577,0.2777777777777778,0.8072751680065532,1.0,5/36,8.96%,IGF1R;PLCL1;PLCB4;PIK3C2B;PI4KB
prerank,GO_Biological_Process_2021__positive regulation of JUN kinase activity (GO:0043507),0.5556900008965434,1.102419948762615,0.2926829268292683,0.8067543438394073,1.0,8/16,16.34%,MAP3K11;TNF;DVL3;MAP3K10;SASH1;TRAF6;MAP3K5;MAP3K7
prerank,GO_Biological_Process_2021__negative regulation of ATPase activity (GO:0032780),-0.6491204303286574,-1.1020653764187602,0.3333333333333333,0.9225500098050845,1.0,2/11,2.82%,PLN;IFIT1
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.44132204668527986,1.1018946426546832,0.2692307692307692,0.8076003445342191,1.0,9/53,13.99%,FER;TBC1D1;TBC1D5;TBC1D10B;TBC1D16;TBC1D22B;ARF6;RABGAP1;EVI5
prerank,GO_Biological_Process_2021__carboxylic acid transport (GO:0046942),-0.5457705883928973,-1.1016498181898178,0.3387096774193548,0.922727190132854,1.0,8/27,15.72%,SLC7A5;SLC38A1;SLC16A3;SLC16A7;LLGL2;SLC36A4;SLC16A6;SLC38A6
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway (GO:0071526),0.5035065978742675,1.1016378027515732,0.3684210526315789,0.8075187989013826,1.0,7/23,6.97%,PLXNB1;NRP1;SEMA5A;PLXNA2;PLXNA3;SEMA3B;PLXNB2
prerank,GO_Biological_Process_2021__ceramide catabolic process (GO:0046514),0.6463885081072263,1.1016305390832593,0.38095238095238093,0.8067437319670844,1.0,1/10,0.67%,ACER2
prerank,GO_Biological_Process_2021__negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.6284079679328802,1.1012492571984938,0.34545454545454546,0.8062792122543785,1.0,1/8,7.80%,KANK1
prerank,GO_Biological_Process_2021__negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.6284079679328802,1.1012492571984938,0.34545454545454546,0.8062792122543785,1.0,1/8,7.80%,KANK1
prerank,GO_Biological_Process_2021__glycogen metabolic process (GO:0005977),-0.5925170711653258,-1.1010351415973914,0.4032258064516129,0.9239283006901359,1.0,3/20,8.36%,PER2;PHKG1;CALM1
prerank,GO_Biological_Process_2021__regulation of trophoblast cell migration (GO:1901163),-0.6344277007074245,-1.1004196216480606,0.4262295081967213,0.9250410393542408,1.0,2/9,21.42%,VEGFA;C1QBP
prerank,GO_Biological_Process_2021__positive regulation of carbohydrate metabolic process (GO:0045913),-0.5515362643751206,-1.1003351639505385,0.35294117647058826,0.9243647792678464,1.0,5/19,11.98%,IGF1;PFKFB3;PFKFB4;HIF1A;ENTPD5
prerank,GO_Biological_Process_2021__adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),-0.6638545880405826,-1.10026634170351,0.3709677419354839,0.9237241856953687,1.0,4/13,7.06%,MYO1G;CD55;BTN3A3;BTN3A2
prerank,GO_Biological_Process_2021__postsynaptic membrane assembly (GO:0097104),0.6348081398895417,1.1002584446932346,0.3170731707317073,0.808298383862344,1.0,4/8,15.11%,LRP4;NLGN1;NRXN2;NLGN4Y
prerank,GO_Biological_Process_2021__cellular response to hydrogen peroxide (GO:0070301),0.4889323586647909,1.099876611176214,0.42424242424242425,0.8086529103817924,1.0,3/24,4.05%,ANXA1;SIRT1;SIRPA
prerank,GO_Biological_Process_2021__cAMP metabolic process (GO:0046058),0.5912594598928429,1.099798929720475,0.4090909090909091,0.8080137844013594,1.0,4/9,26.69%,ADCY9;ADCY6;ADCY10;ADCY1
prerank,GO_Biological_Process_2021__positive regulation of lipase activity (GO:0060193),0.6882559904840786,1.099742045946806,0.3617021276595745,0.8073517414570013,1.0,4/5,28.91%,FGFR2;FGFR1;FGFR3;RHOA
prerank,GO_Biological_Process_2021__mesoderm development (GO:0007498),-0.6445897374677846,-1.0995969833943262,0.37254901960784315,0.9249195579363385,1.0,3/9,11.19%,IKZF3;BTK;VEGFA
prerank,GO_Biological_Process_2021__RNA-dependent DNA biosynthetic process (GO:0006278),-0.5552848601349705,-1.099397742143588,0.3684210526315789,0.9246308424883957,1.0,5/20,17.02%,TERF2IP;NHP2;NOP10;ANKRD28;RFC1
prerank,GO_Biological_Process_2021__glucose transmembrane transport (GO:1904659),-0.7166708376476663,-1.0992160108649318,0.3793103448275862,0.9243084713366153,1.0,2/7,10.34%,SLC2A3;SLC2A8
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate adhesion (GO:0010812),0.48564983104708925,1.0991393258393136,0.2894736842105263,0.8080082736884954,1.0,3/28,7.80%,ACER2;JAG1;KANK1
prerank,GO_Biological_Process_2021__positive regulation of vesicle fusion (GO:0031340),0.6646262024358967,1.0989198828032982,0.3333333333333333,0.8077580331918427,1.0,1/5,0.34%,ANXA1
prerank,GO_Biological_Process_2021__retinoic acid receptor signaling pathway (GO:0048384),0.6647850025099051,1.0988006460656683,0.37209302325581395,0.8073153180121171,1.0,2/6,13.16%,PPARG;RARB
prerank,GO_Biological_Process_2021__purinergic nucleotide receptor signaling pathway (GO:0035590),-0.5695661116502954,-1.0987786540916822,0.32786885245901637,0.9249612072069989,1.0,4/18,17.61%,PSTPIP1;ENTPD5;C3;IL18
prerank,GO_Biological_Process_2021__tRNA aminoacylation for protein translation (GO:0006418),-0.5348068408186094,-1.098743073240136,0.3333333333333333,0.9241780089445408,1.0,10/38,18.21%,HARS2;WARS1;NARS1;LARS1;KARS1;TARS2;DARS2;GARS1;TARS3;FARSA
prerank,"GO_Biological_Process_2021__positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.5403352110041593,1.0987410618623359,0.35135135135135137,0.8066927515229244,1.0,4/13,22.40%,PRDX6;TRA2B;THRAP3;NUP98
prerank,GO_Biological_Process_2021__chloride transmembrane transport (GO:1902476),0.5184008605884043,1.098737759690743,0.3953488372093023,0.805890870060178,1.0,18/30,24.28%,SLC1A3;GLRA1;ANO4;GABRR2;SLC12A6;ANO6;SLC12A5;ANO3;SLC12A2;GABRD;CLCN3;GABRB2;GABRG3;GABRA4;SLC4A8;GABRA2;GLRB;GABRB1
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome assembly (GO:0006336),-0.5472922653760565,-1.0986080688450928,0.32786885245901637,0.9237546613856242,1.0,5/25,17.45%,CENPU;ITGB3BP;NPM1;HIRA;HAT1
prerank,GO_Biological_Process_2021__sphingomyelin metabolic process (GO:0006684),0.6545166091523095,1.098587920905111,0.3488372093023256,0.8054393030852647,1.0,3/6,12.86%,ABCA2;SAMD8;SGMS1
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.42818657646914887,1.098421056760799,0.26666666666666666,0.8049886320765713,1.0,4/46,2.15%,FER;SPRY2;HIP1R;TGFA
prerank,GO_Biological_Process_2021__regulation of defense response to bacterium (GO:1900424),-0.7280190811392244,-1.0983304504886837,0.39655172413793105,0.923783853576285,1.0,1/5,12.67%,CYBA
prerank,GO_Biological_Process_2021__negative regulation of muscle cell apoptotic process (GO:0010656),0.6821590589930018,1.0982719825717813,0.4666666666666667,0.8045868585978254,1.0,1/5,0.35%,BAG3
prerank,GO_Biological_Process_2021__regulation of glial cell proliferation (GO:0060251),0.7276465623433319,1.0982176186994488,0.3673469387755102,0.803946097216564,1.0,2/5,12.90%,TNF;PRKCI
prerank,GO_Biological_Process_2021__cellular monovalent inorganic cation homeostasis (GO:0030004),0.5958486453628052,1.097994089778913,0.375,0.8038216280005189,1.0,5/12,15.33%,KCNJ2;NEDD4L;SLC9A1;SLC8A1;SLC12A2
prerank,GO_Biological_Process_2021__inositol phosphate biosynthetic process (GO:0032958),0.6095773307061761,1.0978972171754284,0.38095238095238093,0.8033145093900419,1.0,3/9,13.98%,FGF2;IPPK;PPIP5K1
prerank,MSigDB_Hallmark_2020__Myc Targets V1,-0.4438026102949403,-1.0976247333191274,0.27058823529411763,0.9253626102019198,1.0,39/171,16.19%,PSMB3;POLE3;SSB;SNRPD2;RACK1;RPS3;RANBP1;HDGF;PHB2;ODC1;RPL14;PSMA7;RPS6;RPS2;RPL34;SRPK1;RPS5;LSM7;RPL6;LDHA;RPL18;NCBP2;NPM1;XPOT;RPLP0;PRDX4;KARS1;PSMD8;APEX1;SRSF2;PGK1;SRSF7;MCM7;EEF1B2;SNRPA1;CBX3;NHP2;EIF2S2;SNRPA
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),-0.5396600639028457,-1.097581851134721,0.3108108108108108,0.9246331286994024,1.0,8/46,14.43%,CARD16;RACK1;GSTP1;TNFAIP3;CFLAR;HSPA1B;H2BC11;HSPA1A
prerank,GO_Biological_Process_2021__vesicle transport along actin filament (GO:0030050),-0.6139101611813275,-1.0975510952283747,0.4067796610169492,0.9237946073161347,1.0,1/12,0.94%,MYO1G
prerank,GO_Biological_Process_2021__regulation of interleukin-18 production (GO:0032661),-0.7009049815351225,-1.0973738334515564,0.44680851063829785,0.9235434962252289,1.0,3/5,21.31%,NLRP12;TLR2;GBP5
prerank,GO_Biological_Process_2021__positive regulation of myoblast differentiation (GO:0045663),-0.6249754796181233,-1.0973479749915644,0.3541666666666667,0.9227416062843524,1.0,1/9,0.96%,RIPOR2
prerank,GO_Biological_Process_2021__positive regulation of protein metabolic process (GO:0051247),0.4005961868360557,1.0972502875131152,0.14814814814814814,0.8040515735489742,1.0,9/78,9.35%,KLF4;ABCA2;WNT5A;RAB1B;TNF;FZR1;RAB7A;NEDD4L;PLK2
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species metabolic process (GO:2000378),-0.5700057352237196,-1.0972281534511243,0.3508771929824561,0.922212413362975,1.0,4/13,22.45%,BRCA1;MT3;PINK1;PARK7
prerank,GO_Biological_Process_2021__transport across blood-brain barrier (GO:0150104),-0.5084585035433792,-1.0970799591277738,0.36764705882352944,0.9217688991848108,1.0,8/51,6.91%,CD36;SLC2A3;SLC7A5;TFRC;SLC38A1;ABCC3;ABCB1;SLC16A7
prerank,GO_Biological_Process_2021__positive regulation of fatty acid metabolic process (GO:0045923),-0.6309900489303166,-1.0965970886009275,0.3870967741935484,0.9224086514579816,1.0,2/12,5.38%,NR4A3;NR1H2
prerank,GO_Biological_Process_2021__regulation of cytokine-mediated signaling pathway (GO:0001959),-0.5198439663194986,-1.095916520901742,0.3283582089552239,0.9238159261337315,1.0,9/60,12.82%,SIGIRR;CDC37;RACK1;TNFAIP3;RNASEL;STAT1;CFLAR;IFNGR2;PTPRC
prerank,GO_Biological_Process_2021__protein localization to kinetochore (GO:0034501),-0.6383058006055504,-1.0958573471177508,0.42592592592592593,0.9230598739176845,1.0,5/10,23.81%,ZWILCH;MIS12;IK;BUB3;CHAMP1
prerank,GO_Biological_Process_2021__inorganic anion transmembrane transport (GO:0098661),0.4776502242483335,1.095479570777668,0.28205128205128205,0.807736828318,1.0,20/43,21.77%,SLC1A3;XPR1;GLRA1;ANO4;GABRR2;SLC37A2;SLC12A6;SLC37A4;ANO6;SLC12A5;SLC25A14;ANO3;SLC12A2;GABRD;CLCN3;GABRB2;GABRG3;GABRA4;SLC4A8;GABRA2
prerank,GO_Biological_Process_2021__cellular response to sterol (GO:0036315),-0.6991909299447461,-1.0952991822069007,0.36923076923076925,0.9239072929092089,1.0,2/9,3.27%,INSIG1;RORA
prerank,GO_Biological_Process_2021__nucleocytoplasmic transport (GO:0006913),0.5072355542713449,1.094689424761301,0.3055555555555556,0.8092316105103788,1.0,4/27,7.26%,NUTF2;BACH2;GEMIN2;XPO1
prerank,GO_Biological_Process_2021__regulated exocytosis (GO:0045055),-0.45331773912126866,-1.0945354460365375,0.2676056338028169,0.9253932422027716,1.0,17/119,8.69%,FLNA;CD36;SRGN;RIMS1;F8;CLU;PLEK;F13A1;IGF1;CD63;PECAM1;RAB3A;SELENOP;TTN;CALM1;FERMT3;TMSB4X
prerank,GO_Biological_Process_2021__sensory perception of sound (GO:0007605),-0.5073424349362428,-1.0944225662719889,0.3088235294117647,0.9248482409174035,1.0,9/41,11.02%,RIPOR2;CEMIP;SLC26A5;CDH23;NDUFB9;CRYM;MYO3B;USP53;ZNF354A
prerank,GO_Biological_Process_2021__hormone transport (GO:0009914),-0.7153222317107353,-1.0943548839209494,0.3898305084745763,0.9241697841199478,1.0,2/5,6.60%,SLC7A5;CRYM
prerank,GO_Biological_Process_2021__response to interleukin-6 (GO:0070741),-0.6878883336788222,-1.0941387372780345,0.35714285714285715,0.9239545816570259,1.0,2/8,9.28%,PID1;CHI3L1
prerank,GO_Biological_Process_2021__positive regulation by host of viral process (GO:0044794),-0.6650412540944233,-1.0940269950902037,0.4032258064516129,0.9233873835374267,1.0,4/9,21.07%,CFL1;TBC1D20;IGF2R;NUCKS1
prerank,PanglaoDB_Augmented_2021__Photoreceptor Cells,0.42501008675772106,1.0938338781900176,0.23333333333333334,0.8106519399833344,1.0,26/97,14.50%,CNTN2;PCDH15;AP3B2;FAM135B;ZNF536;CDH20;SNAP91;SCN3B;LIN7A;SLC1A2;NLK;TNR;GRIA4;CA10;OLFM3;CTNNA2;CADM2;GRIA1;SV2B;GRM5;PTPN5;RBFOX1;GRIA2;SGIP1;SLC24A2;CNTN4
prerank,GO_Biological_Process_2021__negative regulation of cell growth (GO:0030308),0.41184749720298475,1.0935057028271253,0.3333333333333333,0.8106644911897359,1.0,24/79,19.75%,SERTAD2;CDKN2AIP;SIRT1;DNAJB2;SMAD3;PPT1;DIP2B;NDRG3;NME6;RTN4;DCBLD2;DCC;ENPP1;SESN2;RNF6;CAPRIN2;KIAA0319;OSGIN2;ING1;DDX3X;CGRRF1;SLIT3;MAP2;EI24
prerank,GO_Biological_Process_2021__vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane (GO:1990668),-0.7035057571992819,-1.0934390907019618,0.4482758620689655,0.9244559001342629,1.0,2/5,22.02%,TAP1;STX4
prerank,GO_Biological_Process_2021__negative regulation of programmed cell death (GO:0043069),-0.43433417267421937,-1.0932314476797815,0.27906976744186046,0.9241824231190019,1.0,37/238,12.51%,BCL2A1;FLNA;UBC;APIP;RPS27A;TFRC;CARD14;IFIT3;ATF5;PRELID1;STIL;NAIP;DDRGK1;PTMA;RPL10;BNIP2;IGF1;RPS3A;RNF144B;TNFAIP8;PHB2;PRLR;GSTP1;TPT1;NAA38;CFL1;CD44;KANK2;CFLAR;NPM1;CITED2;NCKAP1L;VEGFA;GPX4;BNIP1;PIM3;HSPA1B
prerank,GO_Biological_Process_2021__toll-like receptor 3 signaling pathway (GO:0034138),-0.6252321524947343,-1.0930443553717746,0.37037037037037035,0.9239513064103375,1.0,2/10,14.41%,OAS1;COLEC12
prerank,GO_Biological_Process_2021__depurination (GO:0045007),-0.7309384408900014,-1.0929509215333013,0.4528301886792453,0.9233612240800949,1.0,2/6,12.59%,OGG1;TERF2IP
prerank,GO_Biological_Process_2021__regulation of transmembrane transport (GO:0034762),0.5395499030172881,1.0927985730434144,0.35294117647058826,0.8117475638851642,1.0,4/18,8.52%,KCNJ2;KCNJ5;PIM1;NEDD4L
prerank,GO_Biological_Process_2021__regulation of glycogen biosynthetic process (GO:0005979),-0.5746142141992557,-1.092652447131948,0.3793103448275862,0.9235989634955355,1.0,5/16,17.44%,IGF1;PPP1R3B;SELENOS;PASK;INPP5K
prerank,GO_Biological_Process_2021__release of sequestered calcium ion into cytosol (GO:0051209),0.5744110505172015,1.0920591306368403,0.3055555555555556,0.8129829935169349,1.0,2/15,2.26%,PKD2;FGF2
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell differentiation (GO:0046639),-0.7421199067896624,-1.0918808972082588,0.4262295081967213,0.9252544387374482,1.0,1/5,1.37%,RUNX3
prerank,GO_Biological_Process_2021__positive regulation of developmental process (GO:0051094),0.39269306513011487,1.091419674123163,0.3076923076923077,0.8135986757826675,1.0,28/114,14.98%,DLG5;SIRT1;ZBTB16;MCU;NCOA3;NLGN1;MARCHF5;PHLDB1;WNT5A;DAG1;RELN;BMP1;TNF;DVL3;TMEM119;SHANK3;DDHD1;SOX5;BMPR1B;TMEM79;COBL;SORL1;RTN4;BMPR1A;ZNF703;CLASP1;RAPGEF3;MAP3K13
prerank,GO_Biological_Process_2021__toll-like receptor signaling pathway (GO:0002224),-0.4941081955826346,-1.0910317930972255,0.3333333333333333,0.9274734622971783,1.0,6/67,3.91%,CD36;UBC;RPS27A;CD14;BTK;CTSB
prerank,GO_Biological_Process_2021__icosanoid transport (GO:0071715),-0.7363155820488956,-1.09102682144182,0.42592592592592593,0.9266158227165695,1.0,2/5,18.23%,ABCC3;SLCO3A1
prerank,GO_Biological_Process_2021__pyrimidine nucleoside metabolic process (GO:0006213),-0.6535509268754315,-1.0909251012402212,0.3389830508474576,0.9262090172761565,1.0,4/12,11.81%,NT5C;TYMP;DPYS;DHODH
prerank,GO_Biological_Process_2021__base conversion or substitution editing (GO:0016553),0.6355162221060712,1.090920606415829,0.38461538461538464,0.814130131966612,1.0,1/7,0.51%,ADARB2
prerank,PanglaoDB_Augmented_2021__Epiblast Cells,0.460481794303647,1.0909199451774945,0.3125,0.8133453755424028,1.0,4/31,2.55%,KCNQ2;DPYSL5;GRID2;FRAS1
prerank,GO_Biological_Process_2021__endothelial tube morphogenesis (GO:0061154),-0.6776851255955383,-1.0908554233680925,0.423728813559322,0.9254955100296182,1.0,2/7,8.45%,PRKD2;RBPJ
prerank,GO_Biological_Process_2021__positive regulation of lipid transport (GO:0032370),-0.6656103899750031,-1.0903552479827732,0.38181818181818183,0.9262030733594679,1.0,2/8,10.11%,PRELID1;ABCB4
prerank,GO_Biological_Process_2021__DNA ligation involved in DNA repair (GO:0051103),0.6891399162811228,1.0900898759531008,0.32653061224489793,0.8148584963413422,1.0,1/5,7.13%,LIG4
prerank,GO_Biological_Process_2021__histone H4 deacetylation (GO:0070933),0.6503833935217638,1.089881611642419,0.3829787234042553,0.8147131254009405,1.0,4/9,22.80%,HDAC9;HDAC1;HDAC3;RCOR1
prerank,GO_Biological_Process_2021__somatic recombination of immunoglobulin genes involved in immune response (GO:0002204),0.6610026083101692,1.0898737864480026,0.34146341463414637,0.81393009705072,1.0,2/7,7.13%,EXOSC6;LIG4
prerank,GO_Biological_Process_2021__telomere maintenance in response to DNA damage (GO:0043247),-0.7406466110911445,-1.0897678069056949,0.4576271186440678,0.9270917596531434,1.0,2/6,12.95%,TERF2IP;APEX1
prerank,GO_Biological_Process_2021__positive regulation of reproductive process (GO:2000243),0.5242762101058414,1.0897395874221898,0.325,0.8134790569233045,1.0,2/16,5.25%,LHFPL2;GLRA1
prerank,GO_Biological_Process_2021__mRNA modification (GO:0016556),0.5805341293973422,1.0897235405813113,0.42857142857142855,0.812722336516636,1.0,7/18,21.50%,NSUN2;TRUB1;PUS1;TRMT10C;PUS7;WTAP;ZC3H13
prerank,GO_Biological_Process_2021__endosome to lysosome transport via multivesicular body sorting pathway (GO:0032510),0.6832652295434468,1.0896990123190506,0.4117647058823529,0.8119906468236475,1.0,2/6,7.89%,LYST;UBXN6
prerank,GO_Biological_Process_2021__polyamine biosynthetic process (GO:0006596),-0.6738381534328646,-1.0896463541816468,0.42592592592592593,0.9266280494629976,1.0,2/6,7.79%,SAT1;SAT2
prerank,"GO_Biological_Process_2021__G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.5421569978093493,1.089353559241046,0.3170731707317073,0.812201803285546,1.0,3/16,4.78%,ANXA1;NPY1R;CNR1
prerank,GO_Biological_Process_2021__regulation of interleukin-6 production (GO:0032675),-0.5060310986340923,-1.0892771760404512,0.36,0.9269930822455927,1.0,16/69,15.81%,HLA-B;NLRC3;AIF1;CD200R1;LILRB4;NLRP12;TNFAIP3;SELENOS;NCKAP1L;TYROBP;C5AR2;CD47;CYBA;NOD2;CD74;CD200
prerank,GO_Biological_Process_2021__alpha-beta T cell differentiation (GO:0046632),-0.7155425834675524,-1.0892382271060193,0.4117647058823529,0.9262243362759798,1.0,2/5,1.20%,ITK;RSAD2
prerank,GO_Biological_Process_2021__negative regulation of cell size (GO:0045792),0.6628863401196478,1.0890882589376005,0.4909090909090909,0.8120363457294631,1.0,2/5,11.81%,DEPTOR;PTEN
prerank,GO_Biological_Process_2021__tRNA 5'-end processing (GO:0099116),-0.7009586451220132,-1.088917610218649,0.4117647058823529,0.9263742254597963,1.0,1/6,3.42%,SSB
prerank,GO_Biological_Process_2021__sulfur amino acid metabolic process (GO:0000096),0.5717005935254266,1.0886402660797632,0.4,0.8124819476973449,1.0,2/12,1.41%,AHCY;GCLC
prerank,GO_Biological_Process_2021__synaptic vesicle transport (GO:0048489),0.6245550665985508,1.0885026115836973,0.40816326530612246,0.812128801873725,1.0,1/9,6.03%,TMEM230
prerank,GO_Biological_Process_2021__dendrite morphogenesis (GO:0048813),0.47337833034302484,1.0880773404968254,0.2222222222222222,0.8126320627690459,1.0,14/29,19.55%,LRP4;TMEM106B;DOCK10;CTNNA2;SHANK3;BTBD3;KLF7;CELSR2;PTEN;FARP1;PHACTR1;MAP6;TAOK2;MAP2
prerank,GO_Biological_Process_2021__protein localization to ciliary membrane (GO:1903441),-0.6544525025418327,-1.0879155756408272,0.36363636363636365,0.928818696561721,1.0,2/6,27.66%,BBIP1;ARL13B
prerank,"GO_Biological_Process_2021__base-excision repair, AP site formation (GO:0006285)",-0.6544967604261578,-1.087585274503588,0.4074074074074074,0.9289575849811472,1.0,2/11,4.21%,SMUG1;OGG1
prerank,GO_Biological_Process_2021__negative regulation of striated muscle cell differentiation (GO:0051154),0.6200695613519314,1.0875152025113093,0.32653061224489793,0.8134622553259786,1.0,6/10,26.65%,TMEM119;HDAC1;SOX6;HDAC3;FRS2;NOTCH1
prerank,GO_Biological_Process_2021__phosphorylation (GO:0016310),0.34465671525413083,1.086987979716176,0.1111111111111111,0.8139866545378277,1.0,53/306,15.21%,DAPK2;PANK3;FER;ACVR2A;AATK;FAM20C;TGFBR2;PDK4;MAP3K11;CDK10;LRRK2;NEK10;MAP2K1;STK36;RPS6KA4;CDK17;TLK1;PIM1;STK25;CDK18;MAST2;CDK7;NUAK1;RYK;MAP4K5;NLK;STK38L;BRSK1;IRAK1;PLK2;FGGY;BMPR1B;DYRK1A;MERTK;IRAK3;CDK13;WNK1;FNIP2;MAPK1;CDK6;BMPR1A;MAPKAPK2;CILK1;CSNK1E;PRKCI;PRKAB1;MARK1;PRRT1;CDKL2;MAP3K13;STK10;MAP3K5;TGFBR1
prerank,GO_Biological_Process_2021__cilium movement (GO:0003341),-0.6215367356675382,-1.0868165079489762,0.3508771929824561,0.9305051168325292,1.0,5/16,12.06%,DNAH11;DNHD1;DNAH17;DNAH1;CCDC39
prerank,GO_Biological_Process_2021__positive regulation of phospholipid transport (GO:2001140),-0.6891604835341449,-1.0867160434248664,0.4583333333333333,0.9299260080745395,1.0,2/7,10.11%,PRELID1;ABCB4
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell proliferation (GO:0050679),-0.4972547966643669,-1.0864478767672667,0.42424242424242425,0.929923649551817,1.0,11/53,14.09%,NR4A3;JAML;IGF1;C5AR1;PRKD2;PTN;VEGFA;HIF1A;NR4A1;NOTCH2;NOD2
prerank,GO_Biological_Process_2021__regulation of cell morphogenesis (GO:0022604),0.518195909913208,1.0863056695387163,0.34210526315789475,0.8152580918315018,1.0,5/25,14.29%,PDPN;ZRANB1;BCL9L;STRIP1;FERMT2
prerank,GO_Biological_Process_2021__mRNA methylation (GO:0080009),0.5844011675767832,1.086101430340056,0.42105263157894735,0.814798878493089,1.0,4/13,21.50%,NSUN2;TRMT10C;WTAP;ZC3H13
prerank,GO_Biological_Process_2021__positive regulation of dendrite extension (GO:1903861),-0.611772301277004,-1.0857053662451965,0.41509433962264153,0.9308218276488193,1.0,1/12,1.34%,RIMS1
prerank,GO_Biological_Process_2021__regulation of dendrite extension (GO:1903859),-0.611772301277004,-1.0857053662451965,0.41509433962264153,0.9308218276488193,1.0,1/12,1.34%,RIMS1
prerank,GO_Biological_Process_2021__negative regulation of sequestering of triglyceride (GO:0010891),0.6359339573781185,1.0854872187716627,0.4166666666666667,0.8154138005475168,1.0,2/6,18.74%,PPARG;OSBPL8
prerank,GO_Biological_Process_2021__insulin-like growth factor receptor signaling pathway (GO:0048009),0.607581226675644,1.0854640356621459,0.4722222222222222,0.814722230509838,1.0,3/10,10.48%,IGF1R;TSC2;GIGYF1
prerank,GO_Biological_Process_2021__sensory perception of smell (GO:0007608),0.6882084821440876,1.0851918030739316,0.46808510638297873,0.8146956604012893,1.0,1/5,8.47%,UBR3
prerank,GO_Biological_Process_2021__positive regulation of multicellular organismal process (GO:0051240),0.3682985357962625,1.085167902009083,0.21428571428571427,0.8139828445877908,1.0,32/190,10.09%,PRKAB2;LEPR;ESRRG;PPARGC1A;PDPN;GRB10;IGF1R;ADIPOR2;SERPINE1;TGFBR2;FGF2;SIRT1;ZBTB16;NCOA3;NLGN1;WNT5A;CADM1;SMAD2;SMAD3;ADRA1A;PDGFC;BMP1;TNF;RFX3;TMEM119;ELOVL6;SIRT6;TMIGD2;SOX5;BMPR1B;LOXL2;BCL9L
prerank,GO_Biological_Process_2021__innate immune response (GO:0045087),-0.45329572450056105,-1.0850808324653753,0.32051282051282054,0.9319666633710405,1.0,35/134,15.77%,MX1;TRIM5;RPL39;DHX58;B2M;IFIT1;YES1;FCER1G;BTK;IFITM3;TRIM22;SHFL;PHB2;NLRC5;H2BC21;FYN;SRPK1;KLRD1;OAS1;APOBEC3G;TRIM13;NCF2;SLC11A1;TYROBP;STING1;ALPK1;CYBA;H2BC11;NOD2;REL;HLA-E;COLEC12;C3;CIITA;CD74
prerank,GO_Biological_Process_2021__regulation of response to stress (GO:0080134),-0.6877703156970197,-1.0850793691699403,0.34545454545454546,0.931102172507213,1.0,1/8,4.97%,ABCB1
prerank,GO_Biological_Process_2021__positive regulation of macrophage activation (GO:0043032),-0.7255137736228353,-1.084940998473816,0.49056603773584906,0.930648552481693,1.0,1/8,0.62%,CCL3
prerank,GO_Biological_Process_2021__regulation of monocyte chemotaxis (GO:0090025),-0.5937162312803064,-1.084848946386873,0.4406779661016949,0.930073132710172,1.0,3/15,2.67%,CCL5;DUSP1;AIF1
prerank,"GO_Biological_Process_2021__positive regulation of CD8-positive, alpha-beta T cell activation (GO:2001187)",-0.6682722317439156,-1.0848347029728245,0.3559322033898305,0.9292292095491663,1.0,4/8,14.31%,RUNX3;LILRB4;NCKAP1L;HLA-E
prerank,GO_Biological_Process_2021__vitamin transport (GO:0051180),0.6175694799226422,1.0843115968918775,0.4473684210526316,0.8154561421327473,1.0,1/10,0.66%,PDPN
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomere lengthening (GO:1904356),0.5445071344702919,1.0838308429813142,0.4473684210526316,0.8159862172659037,1.0,3/14,17.49%,PARP1;ERCC4;NAF1
prerank,GO_Biological_Process_2021__glycolytic process through glucose-6-phosphate (GO:0061620),0.5922589896989231,1.083727047174799,0.38461538461538464,0.8154481944475676,1.0,2/16,1.17%,PFKP;PFKM
prerank,GO_Biological_Process_2021__negative regulation of blood coagulation (GO:0030195),0.5642033131735836,1.0835506733721016,0.37209302325581395,0.8152704176625416,1.0,3/13,2.96%,PDGFA;SERPINE1;SERPINE2
prerank,GO_Biological_Process_2021__positive regulation of protein glycosylation (GO:0060050),0.732220835499892,1.083242677532263,0.38461538461538464,0.8152897820656544,1.0,2/5,18.72%,RAMP1;CHP1
prerank,GO_Biological_Process_2021__regulation of neuroinflammatory response (GO:0150077),-0.6528906458545598,-1.0831310887763548,0.43103448275862066,0.9334307709868179,1.0,6/10,20.54%,CD200R1;IGF1;TNFRSF1B;CD200;IL18;NR1D1
prerank,GO_Biological_Process_2021__negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.6745210768545106,-1.0828828966276196,0.4067796610169492,0.9333272878047755,1.0,1/8,4.08%,APOD
prerank,GO_Biological_Process_2021__ventricular cardiac muscle cell action potential (GO:0086005),0.5715020259028087,1.0827359667195862,0.3076923076923077,0.8158989493903187,1.0,2/11,8.52%,SCN3B;NEDD4L
prerank,"GO_Biological_Process_2021__negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371)",-0.7628715746861774,-1.0825011604380137,0.4126984126984127,0.9338431180486206,1.0,1/5,1.37%,RUNX3
prerank,GO_Biological_Process_2021__regulation of adenylate cyclase activity (GO:0045761),0.5662822617615647,1.082480954070023,0.4,0.8156865880405385,1.0,5/12,27.96%,NF1;ADGRV1;GRM3;ORAI1;CAP1
prerank,GO_Biological_Process_2021__mitochondrion organization (GO:0007005),-0.4513057812116281,-1.082437242319653,0.3246753246753247,0.9331046271398928,1.0,15/134,8.20%,MX2;TOMM7;CYCS;MX1;PID1;DNAJC19;CHCHD2;CHCHD10;TIMM44;FIS1;PHB2;PITRM1;HK2;IFIT2;TYMP
prerank,GO_Biological_Process_2021__regulation of alcohol biosynthetic process (GO:1902930),0.6126548328597505,1.082356348145958,0.325,0.8152206759389483,1.0,1/10,1.57%,ABCA2
prerank,PanglaoDB_Augmented_2021__Follicular Cells,-0.5654120688590918,-1.0819937024504176,0.328125,0.9336766155950165,1.0,5/14,23.15%,SLC5A9;PRLR;CYP3A5;FMO5;TG
prerank,GO_Biological_Process_2021__regulation of clathrin-dependent endocytosis (GO:2000369),0.5987988535561057,1.0819759316910003,0.40540540540540543,0.8154821952744751,1.0,2/13,4.57%,HIP1R;SNAP91
prerank,GO_Biological_Process_2021__positive regulation of immune effector process (GO:0002699),-0.5793473520770682,-1.081941717481853,0.36666666666666664,0.9329802819570244,1.0,7/18,18.79%,DHX58;HLA-DRA;PTPRC;HLA-DMB;DDX60;RPS19;HLA-DRB1
prerank,GO_Biological_Process_2021__alpha-linolenic acid metabolic process (GO:0036109),-0.6968840091324755,-1.0819371184372009,0.3829787234042553,0.9321148207049306,1.0,3/10,22.54%,ACAA1;FADS2;SCP2
prerank,GO_Biological_Process_2021__morphogenesis of an epithelial sheet (GO:0002011),0.6820930104561804,1.0817569044768083,0.41304347826086957,0.8152247507396001,1.0,2/5,26.65%,PHACTR4;NOTCH1
prerank,GO_Biological_Process_2021__negative regulation of proteasomal protein catabolic process (GO:1901799),-0.5560848385434655,-1.081707072125404,0.34328358208955223,0.9320293657537727,1.0,6/31,11.92%,UBXN1;DDRGK1;AQP11;RPL11;GABARAPL2;NOP53
prerank,GO_Biological_Process_2021__cell junction maintenance (GO:0034331),-0.6555610383839154,-1.0815110473045992,0.43859649122807015,0.9317739574855735,1.0,2/6,7.64%,CHCHD10;NLGN2
prerank,GO_Biological_Process_2021__chromatin organization involved in regulation of transcription (GO:0034401),0.6280117568989216,1.081508634120973,0.3902439024390244,0.8151980060313105,1.0,2/8,2.77%,SERTAD2;ARID1A
prerank,GO_Biological_Process_2021__positive regulation of cell motility (GO:2000147),-0.45432897654563964,-1.0813681932523855,0.352112676056338,0.9313895372481897,1.0,18/124,8.60%,CCL3;MYLK;CCL5;SYNE2;PDGFD;AIF1;CEMIP;DUOX1;PLET1;DDRGK1;RACK1;IGF1;PECAM1;SEMA6A;ACTG1;SPOCK2;FERMT3;ITGA6
prerank,GO_Biological_Process_2021__regulation of primary metabolic process (GO:0080090),0.38170846262735175,1.0805384204329387,0.25925925925925924,0.8170342454163279,1.0,16/105,13.43%,PRKAB2;NFYC;IDI1;LDLR;PPARG;PLPP1;FDFT1;ACACB;TM7SF2;ELOVL6;HMGCS1;TBL1XR1;MVD;RUBCNL;FASN;PRKAB1
prerank,GO_Biological_Process_2021__response to leucine (GO:0043201),0.6580606997688888,1.0805012210914446,0.4,0.8155886654229549,1.0,1/10,0.78%,RRAGD
prerank,GO_Biological_Process_2021__cellular response to leucine (GO:0071233),0.6580606997688888,1.0805012210914446,0.4,0.8155886654229549,1.0,1/10,0.78%,RRAGD
prerank,"GO_Biological_Process_2021__regulation of wound healing, spreading of epidermal cells (GO:1903689)",0.7110055885947408,1.0804645423382055,0.4473684210526316,0.8149080630233112,1.0,6/7,28.82%,PTEN;FERMT2;CLASP1;CLASP2;RREB1;PHLDB2
prerank,GO_Biological_Process_2021__negative regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045869),-0.6480615539175701,-1.0803710518456486,0.4117647058823529,0.9337872490112061,1.0,5/8,22.78%,APOBEC3G;INPP5K;RESF1;SETDB1;MORC2
prerank,GO_Biological_Process_2021__CD40 signaling pathway (GO:0023035),-0.6613628838680146,-1.0803039722935142,0.4230769230769231,0.9330866280513976,1.0,3/6,22.77%,PHB2;ITGB1;ITGA5
prerank,GO_Biological_Process_2021__regulation of protein targeting to mitochondrion (GO:1903214),-0.5207373933752051,-1.0801431619386979,0.43548387096774194,0.9326617071310925,1.0,7/31,11.48%,TOMM7;USP36;ARIH2;RHOU;HPS4;ATP5IF1;ABLIM3
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte differentiation (GO:0002763),0.5140773144884463,1.0800293520161632,0.3404255319148936,0.815179602268007,1.0,3/20,7.30%,CTNNBIP1;RUNX1;TNF
prerank,GO_Biological_Process_2021__N-terminal protein amino acid modification (GO:0031365),0.6133279016160914,1.0799441849558187,0.34210526315789475,0.8146036802708004,1.0,1/10,1.55%,AANAT
prerank,GO_Biological_Process_2021__negative regulation of sequestering of calcium ion (GO:0051283),0.5768735703174352,1.0797199019177812,0.3142857142857143,0.8144747889011349,1.0,2/14,2.26%,PKD2;FGF2
prerank,GO_Biological_Process_2021__positive regulation of mitochondrion organization (GO:0010822),0.4568751652002891,1.0797197564512484,0.2647058823529412,0.8137064164587754,1.0,6/41,9.11%,PPARGC1A;HIP1R;MCU;MARCHF5;BOK;DDHD1
prerank,GO_Biological_Process_2021__positive regulation of cell cycle phase transition (GO:1901989),-0.5949825747598734,-1.0794689695478212,0.3582089552238806,0.933793724939117,1.0,6/11,17.56%,DDRGK1;PHB2;NPM1;ZNF16;STXBP4;ATAD5
prerank,GO_Biological_Process_2021__positive regulation of innate immune response (GO:0045089),-0.5393703080014737,-1.078959200710626,0.45614035087719296,0.9344161452443291,1.0,8/23,18.57%,CCL5;NLRC5;PLSCR1;TASL;HLA-E;IFI35;POLR3C;RPS19
prerank,GO_Biological_Process_2021__regulation of protein targeting (GO:1903533),-0.674524254948589,-1.078764819321667,0.4117647058823529,0.9342165166710532,1.0,4/5,29.58%,ATP5IF1;PINK1;SREBF1;HAX1
prerank,GO_Biological_Process_2021__positive regulation of chemokine production (GO:0032722),0.47930150728360166,1.0787582808512461,0.3548387096774194,0.8157242353006406,1.0,4/34,8.03%,EGR1;WNT5A;TNF;TLR7
prerank,GO_Biological_Process_2021__peptidyl-lysine dimethylation (GO:0018027),0.544699238534228,1.078389858835238,0.35,0.8159025105152987,1.0,4/16,15.35%,SETD7;SETD3;SETD2;SETD4
prerank,GO_Biological_Process_2021__positive regulation by symbiont of host autophagy (GO:0075044),-0.6806252549290298,-1.0783266390051776,0.509090909090909,0.9346604988907365,1.0,1/6,6.40%,PHB2
prerank,GO_Biological_Process_2021__positive regulation of striated muscle contraction (GO:0045989),-0.7155599318590656,-1.0781734258602536,0.45454545454545453,0.9343726502911133,1.0,1/5,2.19%,RGS2
prerank,GO_Biological_Process_2021__adiponectin-activated signaling pathway (GO:0033211),0.734985570113088,1.0779639899944162,0.5,0.8163082784656753,1.0,1/5,1.53%,ADIPOR2
prerank,GO_Biological_Process_2021__nucleobase-containing compound catabolic process (GO:0034655),-0.535228333084864,-1.0777216008897912,0.3333333333333333,0.9349280243700853,1.0,10/28,20.23%,ADPRM;RNASET2;SIDT2;ENTPD4;ENTPD5;NUDT16;DFFB;PNPT1;RNASE6;PABPC4
prerank,GO_Biological_Process_2021__regulation of fatty acid oxidation (GO:0046320),-0.6250367702169229,-1.0771943742253436,0.43859649122807015,0.9357549894318039,1.0,1/11,0.08%,NR4A3
prerank,GO_Biological_Process_2021__membrane raft assembly (GO:0001765),-0.7490298368287216,-1.07717495629134,0.4339622641509434,0.9350023021089383,1.0,3/5,21.67%,ANXA2;FLOT1;EMP2
prerank,MSigDB_Hallmark_2020__Estrogen Response Early,-0.4546116390399314,-1.0768913279093137,0.3108108108108108,0.9350593465602611,1.0,11/116,5.40%,CALCR;MYBL1;BCL11B;FOS;SLC7A5;ZNF185;CLDN7;GREB1;BHLHE40;SLC37A1;GLA
prerank,GO_Biological_Process_2021__positive regulation of cation transmembrane transport (GO:1904064),-0.5625917223155981,-1.0768446452037015,0.36923076923076925,0.9343806537023442,1.0,1/23,0.28%,FLNA
prerank,GO_Biological_Process_2021__establishment of endothelial barrier (GO:0061028),0.5314391108213348,1.0768080206944743,0.38,0.8187504292677042,1.0,9/22,17.63%,MSN;RAP1A;RAB1B;MYADM;AFDN;TJP1;RAPGEF3;RAP2C;RAPGEF2
prerank,GO_Biological_Process_2021__neuron projection development (GO:0031175),0.3763967800034124,1.0766899626417408,0.23076923076923078,0.8182431598766294,1.0,40/120,23.37%,PLXNB1;CDK5R1;MAP1S;NLGN1;NYAP2;LRRK2;PTPRM;RYK;DOCK10;BICDL1;SHANK3;GPM6A;PTEN;CNTN4;SRGAP2;CNTNAP1;GSK3B;MANF;ADGRV1;SHTN1;RAPGEF2;CAMSAP2;MARK2;NEDD4;TAOK2;MAP2;DCLK1;AGER;ZFYVE27;CNTNAP2;ULK1;CTTN;TMEM108;DTNBP1;STMN3;TOR1A;UHMK1;TNIK;STX3;DAB2IP
prerank,GO_Biological_Process_2021__maintenance of protein localization in endoplasmic reticulum (GO:0035437),-0.6479948316292773,-1.0765440110324629,0.3484848484848485,0.9346298930963426,1.0,1/10,0.72%,INSIG1
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transport (GO:0043268),-0.5599352440672472,-1.0764126827330576,0.3582089552238806,0.9341763212801956,1.0,1/24,0.28%,FLNA
prerank,GO_Biological_Process_2021__epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.5669306186592991,1.07638413873114,0.4523809523809524,0.8183956844737599,1.0,3/10,12.89%,NEK10;RFX3;CCDC40
prerank,GO_Biological_Process_2021__positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.5404403019944094,1.076209263877109,0.34210526315789475,0.8181507185609876,1.0,4/17,9.55%,ABCA2;PICALM;TNF;SLC2A13
prerank,GO_Biological_Process_2021__negative regulation of signal transduction (GO:0009968),-0.44522011672946765,-1.0761076572662205,0.2727272727272727,0.9343296028793316,1.0,18/144,8.87%,SIGIRR;RPGRIP1L;CCL5;PRKCQ;CARD16;PID1;RGS2;DDIT4;NKD1;APOD;RACK1;PLEK;SEMA6A;SULF2;NLRP12;TNFAIP3;KANK2;GPC3
prerank,GO_Biological_Process_2021__interleukin-12-mediated signaling pathway (GO:0035722),-0.5408898154244453,-1.076086884104066,0.34782608695652173,0.9335664432963998,1.0,8/34,15.40%,STAT4;ANXA2;IL12RB2;CFL1;RPLP0;SOD1;SNRPA1;TALDO1
prerank,GO_Biological_Process_2021__sarcomere organization (GO:0045214),-0.6937455215140726,-1.075904069489244,0.46153846153846156,0.9332583647127806,1.0,2/7,7.37%,OBSCN;TTN
prerank,GO_Biological_Process_2021__transferrin transport (GO:0033572),-0.5747773238775158,-1.0757425953019848,0.4461538461538462,0.9328156676492655,1.0,2/27,4.87%,TFRC;ATP6V1F
prerank,GO_Biological_Process_2021__cell-cell junction organization (GO:0045216),0.45299296913317416,1.0755343460945732,0.35135135135135137,0.818937976408976,1.0,11/40,13.17%,PKP4;CDH20;CADM1;SMAD3;MYADM;CDH11;CADM2;AFDN;TJP1;PRKCI;CDH19
prerank,GO_Biological_Process_2021__SNARE complex assembly (GO:0035493),0.6258199368109736,1.07525089506165,0.4166666666666667,0.8188855285215675,1.0,1/8,1.33%,VAMP1
prerank,GO_Biological_Process_2021__regulation of interleukin-8 production (GO:0032677),0.44903096463452274,1.0752081409778471,0.3333333333333333,0.8182220669040934,1.0,8/48,10.07%,KLF4;ANXA1;SERPINE1;DDIT3;TNF;TLR7;CD33;LGALS9
prerank,PanglaoDB_Augmented_2021__Merkel Cells,-0.5705397931720196,-1.0751647055042812,0.4074074074074074,0.9339309427941858,1.0,3/13,10.61%,OVOL2;TRPV4;CFTR
prerank,GO_Biological_Process_2021__positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.6767875557177547,-1.0751056681589273,0.42592592592592593,0.9333455670228608,1.0,2/7,12.71%,NKD1;CSNK1D
prerank,GO_Biological_Process_2021__protein K48-linked ubiquitination (GO:0070936),0.463024906757174,1.0750881627654008,0.2857142857142857,0.8177068263760298,1.0,5/47,8.52%,UBE2D1;KBTBD6;UBE2E2;UBE2D2;NEDD4L
prerank,GO_Biological_Process_2021__regulation of multicellular organism growth (GO:0040014),-0.6110084121979916,-1.07496581115982,0.39285714285714285,0.9329119354246714,1.0,3/12,13.37%,BBS2;IGF1;SOD1
prerank,GO_Biological_Process_2021__mitophagy (GO:0000423),-0.6492502885756006,-1.0741385059302182,0.4642857142857143,0.9345707450965799,1.0,1/8,6.40%,PHB2
prerank,PanglaoDB_Augmented_2021__Enteroendocrine Cells,0.39407884100820956,1.0740104859977555,0.29411764705882354,0.819824461741679,1.0,15/72,15.06%,NCAN;SCN3A;PLPPR1;NOL4;SNAP91;GRIA4;CA10;OLFM3;ALCAM;ASXL3;PTPRN;ABCC8;GRIA2;NFASC;CSRNP3
prerank,GO_Biological_Process_2021__multivesicular body organization (GO:0036257),-0.5449675008999352,-1.0739762553724572,0.3442622950819672,0.9342476060931066,1.0,5/25,16.16%,RAB11A;SNF8;VPS28;VPS37B;MVB12A
prerank,GO_Biological_Process_2021__modulation of chemical synaptic transmission (GO:0050804),0.42419976368957407,1.0733847791009792,0.24,0.8206516322022294,1.0,19/81,12.34%,CACNA1A;GRID2;EIF4EBP2;NLGN1;LRRK2;GRID1;GRIK2;RELN;LRRC4C;BAIAP3;NPTXR;TNF;CLSTN2;KCNMB4;GRM5;CLSTN3;NRG3;PTEN;NPTX1
prerank,GO_Biological_Process_2021__membrane lipid catabolic process (GO:0046466),-0.671486933607349,-1.0732477800696818,0.4,0.9357123671853512,1.0,2/7,8.11%,PDXDC1;ENPP2
prerank,GO_Biological_Process_2021__regulation of adipose tissue development (GO:1904177),0.6589268831131907,1.0730723846225239,0.4222222222222222,0.8207444044704703,1.0,3/6,11.83%,SIRT1;KLF7;SORL1
prerank,"GO_Biological_Process_2021__phagocytosis, engulfment (GO:0006911)",-0.5376122213346984,-1.0730288722713053,0.35294117647058826,0.9355468015185544,1.0,3/29,2.67%,CD36;MARCO;AIF1
prerank,MSigDB_Hallmark_2020__Xenobiotic Metabolism,-0.44914786753310637,-1.0728563337501216,0.3157894736842105,0.9351920802761969,1.0,19/115,12.39%,MT2A;CD36;GABARAPL1;GSTM4;MTHFD1;CYB5A;ABCC3;BPHL;JUP;IGF1;EPHX1;NFS1;SLC35B1;PTS;COMT;FBP1;KARS1;ENTPD5;CYFIP2
prerank,GO_Biological_Process_2021__heart trabecula morphogenesis (GO:0061384),-0.6464232241187016,-1.0727104570360928,0.3939393939393939,0.9347275884573096,1.0,3/9,12.31%,TGFBR3;RBPJ;ADGRG6
prerank,"GO_Biological_Process_2021__energy coupled proton transport, down electrochemical gradient (GO:0015985)",-0.6766357688811835,-1.0726660761077231,0.4074074074074074,0.9340511893985827,1.0,5/9,20.98%,ATP5PD;VPS9D1;ATP5F1C;ATP5F1D;ATP5MC2
prerank,GO_Biological_Process_2021__relaxation of muscle (GO:0090075),-0.5990433746289738,-1.0723191325323245,0.4098360655737705,0.9341632728740944,1.0,2/11,2.19%,PLN;RGS2
prerank,GO_Biological_Process_2021__bile acid metabolic process (GO:0008206),-0.585542966886549,-1.0721684232919177,0.41818181818181815,0.933748171500927,1.0,2/18,8.24%,CH25H;ACAA1
prerank,GO_Biological_Process_2021__apoptotic nuclear changes (GO:0030262),-0.5907726972744484,-1.072104339592379,0.4107142857142857,0.933168799269745,1.0,8/16,29.88%,H1-0;DFFB;DEDD2;DICER1;DNASE2;CECR2;ACIN1;HMGB2
prerank,GO_Biological_Process_2021__response to peptide hormone (GO:0043434),-0.5472680142837398,-1.0719952894796154,0.3387096774193548,0.9326532857905817,1.0,3/32,3.63%,STAT4;TGFBR3;EIF2B1
prerank,GO_Biological_Process_2021__regulation of histone deacetylase activity (GO:1901725),-0.6706542560317025,-1.0714629529582433,0.3387096774193548,0.9331427425478167,1.0,2/7,11.19%,PRKD2;VEGFA
prerank,GO_Biological_Process_2021__regulation of dendritic spine maintenance (GO:1902950),-0.691092030787779,-1.0714505571233421,0.4222222222222222,0.9323460547049388,1.0,2/7,7.36%,VPS35;FYN
prerank,GO_Biological_Process_2021__regulation of brown fat cell differentiation (GO:0090335),0.6296509255933771,1.0712575158304758,0.375,0.8246893768994393,1.0,3/9,5.93%,SIRT1;PIM1;NAPEPLD
prerank,GO_Biological_Process_2021__response to steroid hormone (GO:0048545),0.559656665723688,1.070838780584331,0.38461538461538464,0.8251158375538454,1.0,4/17,18.31%,ABCA2;UBE2L3;PAQR7;NR3C1
prerank,GO_Biological_Process_2021__oxidative RNA demethylation (GO:0035513),-0.7192622233965311,-1.0702283627180869,0.4339622641509434,0.9352073549382104,1.0,1/5,5.68%,JMJD6
prerank,GO_Biological_Process_2021__response to sterol (GO:0036314),-0.6791372358077027,-1.0701768441107595,0.40298507462686567,0.9344962926144876,1.0,3/9,3.27%,CCL3;INSIG1;RORA
prerank,GO_Biological_Process_2021__RNA destabilization (GO:0050779),0.5535453773231235,1.070006406670247,0.3888888888888889,0.8267220559179143,1.0,8/14,29.84%,YTHDF1;RIDA;YTHDF2;FTO;CELF1;METTL16;YTHDF3;PUM1
prerank,GO_Biological_Process_2021__inner mitochondrial membrane organization (GO:0007007),-0.5228545661087449,-1.0698608663531033,0.3548387096774194,0.9346618764344772,1.0,16/38,24.04%,ATP5PD;ATP5F1E;ATP5ME;MICOS13;APOO;SPG7;MAIP1;ATP5F1C;ATP5F1D;MTX3;TIMM29;ATP5MC2;GHITM;TIMM9;AFG3L2;MICOS10
prerank,GO_Biological_Process_2021__regulation of rRNA processing (GO:2000232),-0.5937986301269971,-1.0697216146957167,0.36538461538461536,0.9343039785392112,1.0,3/13,13.80%,USP36;BUD23;NUDT16
prerank,GO_Biological_Process_2021__regulation of platelet activation (GO:0010543),-0.5920767290898086,-1.0696891655493603,0.41379310344827586,0.9335254342900908,1.0,4/13,5.75%,PRKCQ;FCER1G;PLEK;TXK
prerank,GO_Biological_Process_2021__cardiac conduction system development (GO:0003161),0.6632560613028353,1.0696810293034094,0.4186046511627907,0.8268088527568522,1.0,2/7,12.30%,SMAD1;BMPR1A
prerank,GO_Biological_Process_2021__synapse organization (GO:0050808),0.4403704988026183,1.0696142714337638,0.2222222222222222,0.8262445843072613,1.0,27/82,18.43%,LRP4;CNTN2;NLGN1;LRRK2;LRRC4C;UNC13B;RYK;ZC4H2;DNM3;SHANK3;SHANK2;GPM6A;GRM5;SNCB;PTPRD;PPFIA3;NRXN2;GPHN;PTEN;GPC6;LRRC4B;CACNB4;PPFIA2;FARP1;CX3CL1;NEDD4;PPFIBP1
prerank,MSigDB_Hallmark_2020__Adipogenesis,-0.44085313546038685,-1.069580749234813,0.29333333333333333,0.9330444874761217,1.0,25/149,16.42%,CD36;MYLK;UBC;ME1;MGLL;MDH2;DNAJB9;CHCHD10;UQCR10;ENPP2;PFKFB3;MTCH2;ETFB;SPARCL1;NABP1;GPX4;PIM3;ATP1B3;SOD1;ELMOD3;NDUFB7;C3;TALDO1;UQCRC1;ALDH2
prerank,"GO_Biological_Process_2021__positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.603087918428292,1.069409836223249,0.42857142857142855,0.8258271180802845,1.0,3/11,13.21%,TCP1;GNL3L;CCT3
prerank,GO_Biological_Process_2021__fatty acid catabolic process (GO:0009062),0.43920397114524895,1.0691988389880227,0.375,0.8255448449426256,1.0,7/49,16.90%,FAAH;ACADS;PEX13;ACADVL;ECI1;ECHDC1;AUH
prerank,PanglaoDB_Augmented_2021__Myofibroblasts,0.46241729254371755,1.069158349042209,0.4482758620689655,0.8249049696059634,1.0,10/41,8.39%,COL16A1;TPM2;SVEP1;COL5A2;GFAP;ACTA2;PHLDB1;TIMP3;NTM;CDH11
prerank,GO_Biological_Process_2021__O-glycan processing (GO:0016266),0.5413111640187013,1.069070616070692,0.34210526315789475,0.8243557242619812,1.0,7/22,15.60%,B3GNT2;GALNT13;C1GALT1;GALNT7;GXYLT1;GALNT1;GALNT2
prerank,GO_Biological_Process_2021__regulation of chemokine production (GO:0032642),0.4720614080992699,1.068878488274229,0.375,0.8241314433248351,1.0,4/27,8.03%,EGR1;WNT5A;TNF;TLR7
prerank,GO_Biological_Process_2021__negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.6489095997564542,-1.0684297480049278,0.43333333333333335,0.9355782290184654,1.0,4/10,14.31%,HLA-F;KLRD1;PTPRC;HLA-E
prerank,GO_Biological_Process_2021__positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.5790117328644285,-1.0681817905261763,0.38461538461538464,0.9355631430502303,1.0,7/14,13.17%,RPS15;RPS20;RPL37;RPL23;RPS7;EIF5A;DDX5
prerank,GO_Biological_Process_2021__negative regulation of myeloid leukocyte mediated immunity (GO:0002887),0.7208835274684767,1.06798778366456,0.4583333333333333,0.8256374424409014,1.0,2/5,24.34%,LGALS9;CD84
prerank,GO_Biological_Process_2021__sulfur compound catabolic process (GO:0044273),0.5693461346573779,1.0679485651701406,0.38235294117647056,0.8249998386547439,1.0,3/17,5.57%,NCAN;GLB1;CSPG5
prerank,GO_Biological_Process_2021__heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),-0.5592112333211173,-1.067772474893425,0.375,0.9357890685423368,1.0,1/20,0.19%,JAML
prerank,GO_Biological_Process_2021__response to ionizing radiation (GO:0010212),0.39656467172700316,1.067769244950202,0.3235294117647059,0.8246307655049897,1.0,12/55,19.46%,ANXA1;SIRT1;LIG4;CLOCK;BRSK1;INTS7;COP1;BLM;PRKAA1;IKBIP;RFWD3;EEF1D
prerank,GO_Biological_Process_2021__negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.5144799089006833,1.0677192502519706,0.38461538461538464,0.8240286480090739,1.0,4/21,9.99%,SIRT1;CLOCK;HDAC1;CNOT2
prerank,GO_Biological_Process_2021__axonal transport of mitochondrion (GO:0019896),-0.6405910165726153,-1.0676164474703926,0.38333333333333336,0.9354398515251932,1.0,2/9,11.34%,NEFL;HIF1A
prerank,GO_Biological_Process_2021__calcium ion import (GO:0070509),0.5094938343977274,1.0674349357015087,0.29411764705882354,0.8240280859052032,1.0,6/19,15.77%,CACNA1A;MCU;MICU1;SLC8A1;CACNA1E;TRPC4
prerank,PanglaoDB_Augmented_2021__Luteal Cells,0.39407661069307975,1.0674057204988079,0.21428571428571427,0.8233387522470786,1.0,18/65,14.88%,PLXNB1;FKBP9;SLC39A14;DAG1;MAGI1;DHCR24;UNC13B;TBC1D16;FKBP5;CHKA;BOK;GNA11;RTKN;GPC6;COL6A1;ADCY6;FERMT2;CD276
prerank,GO_Biological_Process_2021__regulation of G2/M transition of mitotic cell cycle (GO:0010389),-0.4575868185860805,-1.0670548924416698,0.379746835443038,0.9363716220756108,1.0,32/115,23.46%,PSMB3;SSNA1;RAB11A;PSMB6;PSMA7;CEP72;PSMB9;CEP164;RBX1;PSMD12;CSNK1D;PSMD8;PSMA5;TUBB4B;CCND1;PSMA3;PRKAR2B;PSMC4;DCTN2;CENPF;AKAP9;PSME2;PSME1;DYNC1I2;NINL;PSMB5;SFI1;PSMC3;CDC7;HAUS5;PSME3;TUBB4A
prerank,"GO_Biological_Process_2021__positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",-0.6241087193492969,-1.0669146308025614,0.453125,0.9359139690785118,1.0,4/9,10.77%,CD55;PRKCQ;NCKAP1L;HLA-DRA
prerank,GO_Biological_Process_2021__organonitrogen compound biosynthetic process (GO:1901566),0.3869820591830508,1.0667396417507562,0.3103448275862069,0.8244154316310044,1.0,24/101,13.67%,VAPB;ACER2;PLA2G4C;PPM1L;LARGE1;PLPP1;GSTA4;FA2H;SPTLC2;HACD2;CHKA;HPGDS;SLC44A2;ELOVL6;GPAT4;GCH1;SAMD8;SLC44A5;GPHN;SLC44A1;LCAT;SGMS1;CHPT1;ESD
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process (GO:0006511),0.36282837096017617,1.066714799301537,0.2222222222222222,0.8237380946652016,1.0,39/288,11.31%,UBE2D1;SPSB2;RNF122;ZNRF3;KBTBD6;SIRT1;FBXL14;SPOPL;OTUD7A;PTPN23;FEM1B;UBE3D;DDIT3;UBE2D2;FZR1;CLOCK;UBR3;NEDD4L;APPBP2;RMND5A;SHARPIN;ZRANB1;CDC23;MDM2;KCTD6;BTRC;FBXO45;RNF19B;KCTD10;UBA1;RNF20;UBE2L3;TBL1XR1;ANAPC16;FBXW11;FBXW7;RNF217;FEM1C;RNF185
prerank,GO_Biological_Process_2021__endosome to pigment granule transport (GO:0043485),-0.6520794604008586,-1.0665265731294065,0.46808510638297873,0.9355892777599953,1.0,1/6,5.63%,CD63
prerank,GO_Biological_Process_2021__endosome to melanosome transport (GO:0035646),-0.6520794604008586,-1.0665265731294065,0.46808510638297873,0.9355892777599953,1.0,1/6,5.63%,CD63
prerank,GO_Biological_Process_2021__regulation of ATP biosynthetic process (GO:2001169),0.532859036302067,1.0665071680051632,0.34210526315789475,0.8235162255835279,1.0,2/12,5.45%,PPARGC1A;PARP1
prerank,GO_Biological_Process_2021__ureteric bud development (GO:0001657),0.6193723419765231,1.0660522770262,0.42857142857142855,0.8239588791011756,1.0,2/6,7.23%,PKD2;SALL1
prerank,GO_Biological_Process_2021__positive regulation of aspartic-type peptidase activity (GO:1905247),0.666739543825553,1.06576354974082,0.44680851063829785,0.8238256816954166,1.0,1/6,3.41%,PICALM
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine morphogenesis (GO:0061003),0.6124807467966671,1.065612721735093,0.44,0.8234496621486569,1.0,4/8,25.98%,RELN;CAPRIN2;CAPRIN1;CAMK2B
prerank,GO_Biological_Process_2021__negative regulation of glial cell apoptotic process (GO:0034351),0.6721414286977755,1.0656080732078455,0.5,0.8226990243527147,1.0,1/6,12.90%,PRKCI
prerank,GO_Biological_Process_2021__positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.5507186419006743,1.0655789664864048,0.30952380952380953,0.8220600367752068,1.0,5/15,18.36%,RUVBL2;TCP1;CCT3;NAF1;SHQ1
prerank,GO_Biological_Process_2021__acetyl-CoA metabolic process (GO:0006084),0.5859741032269998,1.0654333745939462,0.37777777777777777,0.8217417415557312,1.0,4/11,18.18%,ACACB;HMGCS1;MVD;ACACA
prerank,GO_Biological_Process_2021__multivesicular body assembly (GO:0036258),-0.5451097868825544,-1.0653346960908172,0.3389830508474576,0.9383114334190552,1.0,5/24,16.16%,RAB11A;SNF8;VPS28;VPS37B;MVB12A
prerank,GO_Biological_Process_2021__mitotic DNA replication (GO:1902969),0.652513378501824,1.0652093985388953,0.43478260869565216,0.8215891486879033,1.0,3/7,12.91%,GINS3;POLA1;GINS1
prerank,GO_Biological_Process_2021__proton-transporting ATP synthase complex assembly (GO:0043461),-0.7323753293598639,-1.0651324822677228,0.4642857142857143,0.9380777136461522,1.0,3/5,18.76%,TMEM70;OXA1L;ATP5F1D
prerank,GO_Biological_Process_2021__blood circulation (GO:0008015),-0.5391013920604327,-1.0651182343896262,0.4153846153846154,0.9373041282535612,1.0,8/23,14.09%,PLN;OLR1;GCLM;STAT1;TBC1D8;SOD1;SERPING1;GPX1
prerank,GO_Biological_Process_2021__COPI-coated vesicle budding (GO:0035964),0.6569134827677999,1.06497423190618,0.45098039215686275,0.8199363953555883,1.0,2/6,21.27%,TMED10;GBF1
prerank,GO_Biological_Process_2021__COPI coating of Golgi vesicle (GO:0048205),0.6569134827677999,1.06497423190618,0.45098039215686275,0.8199363953555883,1.0,2/6,21.27%,TMED10;GBF1
prerank,GO_Biological_Process_2021__Golgi transport vesicle coating (GO:0048200),0.6569134827677999,1.06497423190618,0.45098039215686275,0.8199363953555883,1.0,2/6,21.27%,TMED10;GBF1
prerank,GO_Biological_Process_2021__negative regulation of gene expression (GO:0010629),-0.4107854019239059,-1.0647858175338178,0.35443037974683544,0.9374341584687268,1.0,37/236,14.43%,RPS13;CCL3;SRGN;GAPDH;SLC7A5;ZFP36;PARP14;BTG2;NUDT12;GZMB;PARP15;RPL13A;DDRGK1;RACK1;RPS3;IGF1;ILF3;RPS26;PARP9;EIF2AK2;CENPV;NLRP12;BTN2A2;EIF4A3;OVOL2;SLC11A1;CITED2;VEGFA;HIF1A;PATL2;HSPA1B;DNMT1;HAVCR2;NUDT16;NOTCH2;REL;HSPA1A
prerank,GO_Biological_Process_2021__neuromuscular junction development (GO:0007528),0.5334155075306298,1.0647035813961025,0.40425531914893614,0.819994389425935,1.0,8/20,18.43%,LRP4;LRRK2;UNC13B;ZC4H2;GPHN;CACNB4;NEDD4;PPFIBP1
prerank,GO_Biological_Process_2021__pyrimidine nucleotide metabolic process (GO:0006220),-0.6787321378180711,-1.064610413593817,0.42857142857142855,0.9370323407495229,1.0,1/5,8.26%,ENPP3
prerank,GO_Biological_Process_2021__positive regulation of protein sumoylation (GO:0033235),0.6822467711081316,1.0645340684102234,0.5333333333333333,0.8197235255950256,1.0,3/6,21.07%,SAE1;UBA2;PIAS1
prerank,GO_Biological_Process_2021__protein polyufmylation (GO:1990564),-0.709996871644522,-1.0643189762981544,0.46511627906976744,0.9355161141513783,1.0,3/5,20.28%,DDRGK1;UFL1;UFC1
prerank,GO_Biological_Process_2021__protein K69-linked ufmylation (GO:1990592),-0.709996871644522,-1.0643189762981544,0.46511627906976744,0.9355161141513783,1.0,3/5,20.28%,DDRGK1;UFL1;UFC1
prerank,GO_Biological_Process_2021__protein ufmylation (GO:0071569),-0.709996871644522,-1.0643189762981544,0.46511627906976744,0.9355161141513783,1.0,3/5,20.28%,DDRGK1;UFL1;UFC1
prerank,GO_Biological_Process_2021__regulation of intracellular protein transport (GO:0033157),0.47770047700633816,1.0642394331510803,0.38636363636363635,0.8195954823709749,1.0,9/27,25.72%,LCP1;CEP131;RIPOR1;ATP13A2;CEP290;UHMK1;PCM1;TPR;TGFB1
prerank,GO_Biological_Process_2021__cellular response to interleukin-2 (GO:0071352),0.6521605326295763,1.0638254857227882,0.4375,0.8191761578930636,1.0,4/6,32.32%,SYK;PTK2B;STAT5A;JAK3
prerank,GO_Biological_Process_2021__interleukin-2-mediated signaling pathway (GO:0038110),0.6521605326295763,1.0638254857227882,0.4375,0.8191761578930636,1.0,4/6,32.32%,SYK;PTK2B;STAT5A;JAK3
prerank,GO_Biological_Process_2021__cellular response to lipopolysaccharide (GO:0071222),-0.4760877023612592,-1.0632639850277954,0.3472222222222222,0.9379119538932584,1.0,9/65,9.83%,CCL3;ZFP36;CCL5;CARD16;CD14;GSTP1;TNFRSF1B;TNFAIP3;SELENOS
prerank,GO_Biological_Process_2021__atrial septum development (GO:0003283),-0.7362110508468245,-1.06289092789847,0.3541666666666667,0.9380791082824711,1.0,2/6,17.77%,NOTCH2;ZFPM1
prerank,GO_Biological_Process_2021__snRNA modification (GO:0040031),0.6427967803923862,1.0628797029050325,0.4318181818181818,0.8207195471851403,1.0,1/6,1.88%,MEPCE
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.5107679896864227,1.062742663755714,0.375,0.8203074322712323,1.0,5/20,18.47%,SCAF8;SUPT16H;CDK13;CDK12;EAPP
prerank,GO_Biological_Process_2021__membrane depolarization during action potential (GO:0086010),0.5494504176316797,1.0627070687323878,0.4,0.8197761674915762,1.0,5/13,13.70%,KCNJ2;SCN3A;SCN3B;SCN8A;SLC8A1
prerank,GO_Biological_Process_2021__replication fork processing (GO:0031297),-0.5437770159430748,-1.0626769383086427,0.4262295081967213,0.9378244626111867,1.0,2/27,7.58%,DDX11;BRCA2
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway (GO:0097193),-0.48714913523382414,-1.062451483921668,0.34177215189873417,0.9377004349536795,1.0,5/77,9.72%,BCL2A1;PPP1R15A;ERO1A;TNFRSF1B;HINT1
prerank,GO_Biological_Process_2021__acute inflammatory response (GO:0002526),-0.6822793801092357,-1.0623117958863189,0.49019607843137253,0.937194116757139,1.0,2/8,7.40%,SIGIRR;PLSCR1
prerank,"GO_Biological_Process_2021__establishment of mitochondrion localization, microtubule-mediated (GO:0034643)",0.6794467838011226,1.0621889518350818,0.5238095238095238,0.82031302415005,1.0,1/6,1.80%,MAP1S
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity (GO:2001056),-0.5203623656304484,-1.0619958163206786,0.3384615384615385,0.9373078104466461,1.0,7/41,12.39%,CYCS;AIM2;TNFSF10;FIS1;FYN;PDCD5;CYFIP2
prerank,GO_Biological_Process_2021__neural tube closure (GO:0001843),0.4650280830680768,1.0619645050208288,0.3076923076923077,0.8200982192661735,1.0,7/27,11.62%,SCRIB;TSC2;VASP;PLXNB2;DVL3;PHACTR4;COBL
prerank,GO_Biological_Process_2021__positive regulation of glial cell differentiation (GO:0045687),-0.5956855722029137,-1.0618917246367847,0.45614035087719296,0.9368103670744412,1.0,3/11,10.30%,CXCR4;TNFRSF1B;PTN
prerank,GO_Biological_Process_2021__positive regulation of DNA repair (GO:0045739),-0.49689460724373935,-1.0618750495543687,0.4375,0.9360391199670215,1.0,7/36,14.47%,DDX11;EYA2;RPS3;ABRAXAS1;BRCA1;ERCC8;ZCWPW1
prerank,GO_Biological_Process_2021__motile cilium assembly (GO:0044458),-0.6702949387781135,-1.0618016345277743,0.4642857142857143,0.9354445648409502,1.0,2/5,12.06%,BBOF1;CCDC39
prerank,GO_Biological_Process_2021__regulation of mRNA catabolic process (GO:0061013),-0.452366712419315,-1.061638641191427,0.3670886075949367,0.9350643187855593,1.0,24/104,20.89%,UBC;RPS27A;ZFP36;PSMB3;PSMB6;PSMA7;PSMB9;EXOSC1;PRR5L;PSMD12;PSMD8;PSMA5;APEX1;HSPA1A;UBA52;CNOT8;PSMA3;PSMC4;PNPT1;VIM;PSME2;PSME1;CARHSP1;PSMB5
prerank,GO_Biological_Process_2021__regulation of multicellular organismal development (GO:2000026),0.5648546186333431,1.061286855345673,0.41379310344827586,0.8211338383038702,1.0,8/17,16.51%,DUSP6;HPSE;TDG;KAT2A;BAG6;NIPBL;TRIP12;RAB14
prerank,GO_Biological_Process_2021__negative regulation of dephosphorylation (GO:0035305),-0.6275176177144618,-1.0605133599778471,0.44642857142857145,0.9379417733382557,1.0,1/15,1.16%,PPP1R15A
prerank,GO_Biological_Process_2021__protein de-ADP-ribosylation (GO:0051725),-0.7269022659150677,-1.0601860025738516,0.5714285714285714,0.9381682610208274,1.0,1/5,10.67%,ADPRH
prerank,GO_Biological_Process_2021__apoptotic DNA fragmentation (GO:0006309),-0.5876413820144071,-1.0598610402838353,0.43859649122807015,0.9383715620517533,1.0,4/12,23.00%,H1-0;DFFB;DICER1;DNASE2
prerank,MSigDB_Hallmark_2020__Complement,-0.4383942664085502,-1.0597841789591922,0.35443037974683544,0.9378231070323986,1.0,29/137,15.30%,CD36;ME1;CCL5;CD55;F8;FCER1G;GZMB;CBLB;CTSB;CLU;PLEK;FYN;PLSCR1;SPOCK2;TNFAIP3;OLR1;CALM1;APOBEC3G;PSMB9;IRF1;PFN1;SERPING1;CASP5;HSPA1A;TIMP2;ERAP2;C3;AKAP10;ZFPM2
prerank,GO_Biological_Process_2021__plasma membrane invagination (GO:0099024),-0.5234549343408835,-1.0591706913374792,0.3484848484848485,0.9389439286085066,1.0,3/25,2.67%,CD36;MARCO;AIF1
prerank,GO_Biological_Process_2021__spermidine metabolic process (GO:0008216),-0.6895786730464977,-1.0591692582788474,0.48936170212765956,0.9381307500561572,1.0,2/6,7.79%,SAT1;SAT2
prerank,GO_Biological_Process_2021__chromatin-mediated maintenance of transcription (GO:0048096),0.6294081606307045,1.0590541247070873,0.42857142857142855,0.8261967151044063,1.0,2/7,2.77%,SERTAD2;ARID1A
prerank,GO_Biological_Process_2021__carbohydrate phosphorylation (GO:0046835),0.6703964156710667,1.0589133537778652,0.4090909090909091,0.8258904121849547,1.0,2/7,9.49%,IPPK;FGGY
prerank,GO_Biological_Process_2021__regulation of miRNA mediated inhibition of translation (GO:1905616),0.6583193993676756,1.058725956536554,0.43902439024390244,0.8248570408960919,1.0,1/7,8.06%,EIF4E2
prerank,GO_Biological_Process_2021__positive regulation of miRNA mediated inhibition of translation (GO:1905618),0.6583193993676756,1.058725956536554,0.43902439024390244,0.8248570408960919,1.0,1/7,8.06%,EIF4E2
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle (GO:0007346),0.38939446741791306,1.0587016238356803,0.3333333333333333,0.8241523672217208,1.0,16/121,10.82%,UBE2D1;SCRIB;BORA;SIRT1;CDK10;SMAD3;RCC1;FZR1;BRINP3;CDC23;MDM2;BTRC;HECA;RNF20;ANAPC16;CDK13
prerank,GO_Biological_Process_2021__ruffle assembly (GO:0097178),-0.7006204826085993,-1.0584907078176777,0.4716981132075472,0.9394764455671542,1.0,3/5,17.44%,AIF1;RAC1;INPP5K
prerank,GO_Biological_Process_2021__regulation of double-strand break repair (GO:2000779),-0.5244878479930059,-1.0580064924571757,0.44776119402985076,0.9399726909562043,1.0,1/30,0.51%,DDX11
prerank,GO_Biological_Process_2021__zinc ion transport (GO:0006829),0.5744647867952188,1.0578715330367718,0.4594594594594595,0.8253950518543428,1.0,2/14,5.71%,SLC39A14;SLC39A8
prerank,GO_Biological_Process_2021__regulation of cellular ketone metabolic process (GO:0010565),-0.49679441781397504,-1.0577310354947367,0.3333333333333333,0.9398861964374257,1.0,16/47,22.96%,PSMB3;ODC1;PSMB6;PSMA7;PSMB9;AZIN1;PSMD12;PSMD8;PSMA5;PSMA3;PSMC4;PSME2;PSME1;PSMB5;PSMC3;PSME3
prerank,GO_Biological_Process_2021__regulation of chromatin assembly or disassembly (GO:0001672),0.5680560232247709,1.0574063155652709,0.4318181818181818,0.8260954182973923,1.0,2/7,5.44%,MAP1S;TLK1
prerank,GO_Biological_Process_2021__regulation of organelle assembly (GO:1902115),0.4033560485123241,1.057097759730562,0.3142857142857143,0.8262441242051867,1.0,12/63,13.99%,MSN;GSN;TBC1D1;RAB1B;TBC1D5;TBC1D10B;TBC1D16;TBC1D12;PLK2;TBC1D22B;RABGAP1;EVI5
prerank,GO_Biological_Process_2021__neuron differentiation (GO:0030182),0.4069495474719924,1.0568209087060771,0.19230769230769232,0.8261769095962278,1.0,24/73,18.00%,CDK5R1;MAP2K1;WNT5A;UGDH;PBX1;FZD3;PPT1;WNT2B;RUNX1;RYK;SOX4;BRSK1;FUT9;OLIG1;WNK1;PTPRD;NTRK2;TGFBR1;MANF;PBX3;MTPN;IL1RAPL1;ERCC2;BRSK2
prerank,GO_Biological_Process_2021__regulation of cellular respiration (GO:0043457),0.6172141682305757,1.0566908881110086,0.44680851063829785,0.825732752909285,1.0,2/9,3.96%,IFNLR1;CBFA2T3
prerank,GO_Biological_Process_2021__protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.4900055191556391,1.0566702316759298,0.30303030303030304,0.8251064043860316,1.0,5/21,22.72%,AUP1;RNF185;BAG6;KLHL15;TOR1A
prerank,GO_Biological_Process_2021__negative regulation of cation transmembrane transport (GO:1904063),-0.5846504814766937,-1.0565681499984239,0.42424242424242425,0.9425028351582662,1.0,2/11,7.09%,HAMP;STK39
prerank,PanglaoDB_Augmented_2021__Airway Smooth Muscle Cells,0.47007359771617174,1.0565637051446741,0.4857142857142857,0.8245994629921923,1.0,7/22,9.95%,TPM2;COL5A2;ACTA2;TIMP3;CDH11;TWIST2;LOXL2
prerank,"GO_Biological_Process_2021__base-excision repair, gap-filling (GO:0006287)",-0.525850466557046,-1.0564363512315504,0.3880597014925373,0.9420748244796961,1.0,8/26,21.41%,SMUG1;OGG1;PARG;APEX1;RPA3;RFC1;POLG;MPG
prerank,GO_Biological_Process_2021__regulation of epidermal cell differentiation (GO:0045604),-0.5754554980839088,-1.056435501831047,0.4406779661016949,0.9412556289801485,1.0,1/12,1.48%,ZFP36
prerank,GO_Biological_Process_2021__negative regulation of response to stimulus (GO:0048585),0.47974373109186913,1.056195095618435,0.3,0.824845537155169,1.0,2/38,2.51%,KLF4;SIRT1
prerank,GO_Biological_Process_2021__metallo-sulfur cluster assembly (GO:0031163),-0.5697263181745569,-1.056188884930066,0.4307692307692308,0.9411457287670945,1.0,4/18,15.50%,ISCA1;NFS1;NUBPL;CIAO2B
prerank,GO_Biological_Process_2021__inorganic anion transport (GO:0015698),0.46815172216629203,1.0561700142994337,0.39285714285714285,0.8241464960754876,1.0,7/26,14.62%,XPR1;GLRA1;ANO8;ANO4;ANO6;SLC25A14;ENPP1
prerank,GO_Biological_Process_2021__negative regulation of mRNA 3'-end processing (GO:0031441),0.5992514166801571,1.0561568170510642,0.46808510638297873,0.8234701442916517,1.0,4/9,20.63%,RNF20;ZC3H14;BARD1;CDK9
prerank,GO_Biological_Process_2021__positive regulation of production of molecular mediator of immune response (GO:0002702),-0.609088640383478,-1.0561062162020924,0.44776119402985076,0.940577054467632,1.0,9/19,19.57%,SLC7A5;DNAJB9;PHB2;PTPRC;NOD2;HLA-E;TNFRSF14;PTPN22;EPHB2
prerank,GO_Biological_Process_2021__protein kinase A signaling (GO:0010737),0.6039514405480282,1.0559805463003593,0.4897959183673469,0.8232021971341112,1.0,2/7,4.81%,MYOM1;LCP1
prerank,GO_Biological_Process_2021__regulation of ubiquitin-protein transferase activity (GO:0051438),0.5357373040871325,1.0557144312339262,0.4,0.8230632019583694,1.0,9/22,13.66%,SMAD7;FEM1B;ARRDC3;DCUN1D4;UBE2L3;FBXW7;UBE2N;DCUN1D1;BAG5
prerank,GO_Biological_Process_2021__hydrogen peroxide metabolic process (GO:0042743),-0.6212490275634694,-1.0554349500520148,0.41509433962264153,0.9418511513782248,1.0,5/12,14.09%,DUOX1;PRDX4;CYBA;SOD1;GPX1
prerank,GO_Biological_Process_2021__positive regulation of defense response to virus by host (GO:0002230),-0.597634964020239,-1.0553500515857142,0.4482758620689655,0.9412452964915733,1.0,6/19,11.42%,AIM2;DTX3L;PARP9;APOBEC3G;STAT1;STING1
prerank,GO_Biological_Process_2021__mitochondrial translational termination (GO:0070126),-0.4943379534039224,-1.0550156150588188,0.425,0.9413008842068293,1.0,20/62,17.46%,MRPL57;AURKAIP1;MRPS7;MRPL51;MRPL19;GADD45GIP1;MRPL52;MRPL50;MTRF1;MRPS11;MRPS10;MRPS15;MRPL16;MRPL32;CHCHD1;OXA1L;MRPL43;MRPS18C;MRPL45;MRPS25
prerank,GO_Biological_Process_2021__mitochondrial translational elongation (GO:0070125),-0.48391670224375094,-1.0548136615020756,0.38372093023255816,0.9410339626154895,1.0,19/61,17.46%,MRPL57;AURKAIP1;MRPS7;MRPL51;MRPL19;GADD45GIP1;MRPL52;MRPL50;MRPS11;MRPS10;MRPS15;MRPL16;MRPL32;CHCHD1;OXA1L;MRPL43;MRPS18C;MRPL45;MRPS25
prerank,GO_Biological_Process_2021__pinocytosis (GO:0006907),0.6439458015175896,1.0544924589483575,0.5,0.8251815309928814,1.0,2/7,12.49%,PPT1;MAPKAPK2
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent rRNA catabolic process (GO:0071035),-0.6856790353530947,-1.0543176588979168,0.40625,0.9392236658706025,1.0,1/5,7.08%,EXOSC10
prerank,GO_Biological_Process_2021__tRNA surveillance (GO:0106354),-0.6856790353530947,-1.0543176588979168,0.40625,0.9392236658706025,1.0,1/5,7.08%,EXOSC10
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent tRNA catabolic process (GO:0071038),-0.6856790353530947,-1.0543176588979168,0.40625,0.9392236658706025,1.0,1/5,7.08%,EXOSC10
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent ncRNA catabolic process (GO:0071046),-0.6856790353530947,-1.0543176588979168,0.40625,0.9392236658706025,1.0,1/5,7.08%,EXOSC10
prerank,GO_Biological_Process_2021__regulation of cholesterol biosynthetic process (GO:0045540),0.5328465557300577,1.054176233936956,0.37209302325581395,0.8250517218038276,1.0,1/16,1.57%,ABCA2
prerank,GO_Biological_Process_2021__positive regulation of morphogenesis of an epithelium (GO:1905332),0.5836161093038367,1.0540929376626722,0.3829787234042553,0.8245163703698282,1.0,2/9,9.36%,FGF2;SIRT6
prerank,GO_Biological_Process_2021__regulation of chaperone-mediated autophagy (GO:1904714),0.6428940202122034,1.0540216096993054,0.43478260869565216,0.8239286183814175,1.0,4/8,19.35%,GFAP;EEF1A2;ATP13A2;SNCA
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.5867194890784624,-1.0539363135305113,0.42857142857142855,0.9394673498152722,1.0,2/23,5.35%,PPP1R15A;ERO1A
prerank,GO_Biological_Process_2021__peroxisome fission (GO:0016559),-0.6684950543052279,-1.053519843761758,0.4528301886792453,0.939800125505863,1.0,1/5,5.76%,FIS1
prerank,GO_Biological_Process_2021__tRNA aminoacylation for mitochondrial protein translation (GO:0070127),-0.6795889820896238,-1.0535066273860383,0.47619047619047616,0.9390516656539805,1.0,3/7,15.79%,TARS2;DARS2;GARS1
prerank,GO_Biological_Process_2021__regulation of protein ubiquitination (GO:0031396),0.39795064877180275,1.0534985989052563,0.3181818181818182,0.8246530060710356,1.0,19/83,15.21%,UBE2D1;SPRY2;SMAD7;SPOPL;LRRK2;DNAJB2;GNL3L;SOX4;SASH1;LAPTM5;UBE2L3;FBXW7;UBE2N;DCUN1D1;GTPBP4;BAG5;XIAP;TRAF6;TGFBR1
prerank,GO_Biological_Process_2021__mitochondrial DNA replication (GO:0006264),-0.6172790078440975,-1.053390226750444,0.45614035087719296,0.9385055458941641,1.0,3/7,25.28%,MGME1;POLG;SSBP1
prerank,GO_Biological_Process_2021__positive regulation of glycogen biosynthetic process (GO:0045725),-0.5945067185886086,-1.0533144066919322,0.43137254901960786,0.9379231634012284,1.0,1/9,5.56%,IGF1
prerank,GO_Biological_Process_2021__response to ethanol (GO:0045471),0.6029546605391194,1.0531921126537844,0.3958333333333333,0.8247797187429106,1.0,4/9,16.68%,GRIN3A;GLRA1;GRIN2B;GRIN2A
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),-0.5591389082554591,-1.0530542854771319,0.421875,0.9377654993080105,1.0,6/23,12.82%,PARP14;LILRB4;SH3BP5;SAMSN1;SH3BP5L;PTPRC
prerank,GO_Biological_Process_2021__metal ion transport (GO:0030001),0.4356720273412499,1.0529322975153268,0.34210526315789475,0.8246401923234264,1.0,11/58,8.80%,CACNA1A;TRPC1;PKD2;GRIN3A;NIPA2;NIPAL2;SLC3A2;SLC39A8;NIPA1;RAMP1;SLC41A1
prerank,GO_Biological_Process_2021__protein localization to cytoplasmic stress granule (GO:1903608),-0.6831390000555698,-1.0527940180313617,0.46153846153846156,0.9378160699537547,1.0,1/6,3.42%,SSB
prerank,GO_Biological_Process_2021__positive regulation of cytokine production (GO:0001819),-0.42406017272668994,-1.0523509062203715,0.3780487804878049,0.9383563364302191,1.0,49/214,16.72%,ITK;BTN3A1;CD2;GAPDH;SLC7A5;PRKCQ;DHX58;AIF1;CD14;FCER1G;RORA;SLAMF6;RPS3;TXK;LAMTOR5;IL12RB2;SULF2;EIF2AK2;BTN3A2;LURAP1;PRKD2;CHI3L1;GLMN;CD226;SLC11A1;IRF1;TYROBP;HIF1A;STING1;APPL1;IL18R1;HSPA1B;CYBA;PTPRC;SOD1;HAVCR2;NOD2;BRCA1;HLA-E;HSPA1A;HLA-DPA1;C3;CD74;CD200;AGT;POLR3C;FLOT1;STOML2;HLA-DPB1
prerank,GO_Biological_Process_2021__positive regulation of cell cycle (GO:0045787),0.4456880983355394,1.0522629751988204,0.3076923076923077,0.8253620473203223,1.0,8/47,15.66%,PKD2;PKD1;CCPG1;SPDYA;MDM2;CCNYL1;CCND3;ANKRD17
prerank,GO_Biological_Process_2021__protein targeting to mitochondrion (GO:0006626),-0.5082781977582939,-1.0519037759491563,0.36923076923076925,0.9389772391590151,1.0,6/36,7.54%,TOMM7;DNAJC19;TIMM44;FIS1;PITRM1;TIMM21
prerank,GO_Biological_Process_2021__icosanoid biosynthetic process (GO:0046456),0.5957223938444426,1.0518048235971544,0.425531914893617,0.8258808181311942,1.0,3/8,27.72%,ALOX5AP;MGST3;MGST2
prerank,GO_Biological_Process_2021__proteolysis involved in cellular protein catabolic process (GO:0051603),-0.49915860105260246,-1.0517439305280352,0.3888888888888889,0.9386858644808748,1.0,4/57,3.91%,UBC;RPS27A;GZMB;CTSB
prerank,GO_Biological_Process_2021__neuronal ion channel clustering (GO:0045161),0.5948801474021098,1.0516918205257817,0.46153846153846156,0.8254117004940923,1.0,2/7,3.23%,CNTN2;KCNIP2
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection organization (GO:0120035),0.49944910209418997,1.0516269488949548,0.3157894736842105,0.8249221976577121,1.0,10/23,21.32%,CTNNA2;BRSK1;ZNF804A;PTEN;MARK1;GSK3B;IL1RAPL1;BRSK2;HOMER1;FBXO7
prerank,GO_Biological_Process_2021__leukocyte tethering or rolling (GO:0050901),-0.621396151687279,-1.0513972131869511,0.4444444444444444,0.9389649363722117,1.0,3/12,8.15%,GCNT1;SELL;ITGA4
prerank,GO_Biological_Process_2021__ISG15-protein conjugation (GO:0032020),0.6944189121609701,1.0513208354677464,0.5,0.8249950391137143,1.0,1/5,5.15%,UBE2E2
prerank,GO_Biological_Process_2021__positive regulation of synapse assembly (GO:0051965),0.4968122273451635,1.0512511607476644,0.5172413793103449,0.8244220774798288,1.0,9/20,18.35%,GRID2;DLG5;NLGN1;CLSTN2;CLSTN3;PTPRD;LRRC4B;IL1RAPL1;SEMA4D
prerank,GO_Biological_Process_2021__peptidyl-tyrosine phosphorylation (GO:0018108),-0.5061980253683522,-1.050714266611015,0.36764705882352944,0.9402123580371333,1.0,5/46,7.36%,ITK;BTK;TXK;PRLR;FYN
prerank,GO_Biological_Process_2021__regulation of endothelial cell apoptotic process (GO:2000351),0.5424003118502656,1.0505399493511842,0.36,0.8254153060242442,1.0,5/19,12.90%,SEMA5A;SERPINE1;TNF;ANO6;PRKCI
prerank,GO_Biological_Process_2021__cellular response to thyroid hormone stimulus (GO:0097067),-0.6109348792832731,-1.0505148767142252,0.4307692307692308,0.9400832405022274,1.0,1/10,3.91%,CTSB
prerank,GO_Biological_Process_2021__neuron development (GO:0048666),0.38071887146753736,1.0503034738497912,0.3333333333333333,0.8252656326219063,1.0,34/96,23.29%,LGI4;CDK5R1;NLGN1;UGDH;PBX1;PTPRM;PPT1;RUNX1;RYK;BICDL1;GPM6A;WNK1;NTRK2;CNTN4;GSK3B;MANF;PBX3;RAPGEF2;NEDD4;B4GALT5;MAP2;HS6ST1;AGER;ZFYVE27;CNTNAP2;ULK1;EPHA5;TMEM108;DTNBP1;STMN3;TOR1A;TENM2;UHMK1;STX3
prerank,GO_Biological_Process_2021__regulation of secretion (GO:0051046),-0.6701283345153414,-1.0502608276376402,0.39344262295081966,0.9399617259484038,1.0,3/8,10.40%,OAS2;SGK1;POFUT2
prerank,GO_Biological_Process_2021__extracellular transport (GO:0006858),0.6671969630410732,1.0500801456257032,0.5348837209302325,0.8251690060189837,1.0,4/7,26.62%,CCDC40;DNAAF2;CABYR;ADCY10
prerank,GO_Biological_Process_2021__positive regulation of cellular respiration (GO:1901857),0.6528522438739367,1.0500789909470303,0.4444444444444444,0.8244502176862145,1.0,1/7,0.25%,IFNLR1
prerank,GO_Biological_Process_2021__pulmonary valve morphogenesis (GO:0003184),0.5580755111656012,1.0499643469711293,0.4444444444444444,0.8240804604837216,1.0,3/9,15.51%,JAG1;ROBO1;ROBO2
prerank,GO_Biological_Process_2021__response to hydrogen peroxide (GO:0042542),0.43144366278714524,1.0497613817209779,0.3142857142857143,0.8239008795508406,1.0,5/37,6.12%,ANXA1;SIRT1;SIRPA;CAT;STK25
prerank,GO_Biological_Process_2021__AMP metabolic process (GO:0046033),-0.680306566273271,-1.0497579385515063,0.5,0.9405043244617965,1.0,2/6,10.32%,AMPD2;AK9
prerank,GO_Biological_Process_2021__positive regulation of nucleic acid-templated transcription (GO:1903508),0.3500288125729599,1.0496158313534263,0.3333333333333333,0.8235112011664977,1.0,45/316,11.93%,EGR1;KLF4;ESRRG;PPARGC1A;NPAS3;FGF2;ZBTB16;ARID1A;MITF;MYRF;KLF6;ACTA2;PICALM;ARNT2;MAP2K1;WNT5A;PPARG;RYBP;PHF5A;SMAD2;DDIT3;SMAD3;RUNX1;SALL1;HMGA1;TNF;RFX3;DVL3;MMS19;CLOCK;SOX4;TRERF1;ZBTB48;BTRC;HDAC1;NFIB;DYRK1A;RNF20;RGMB;TBL1XR1;FBXW11;NSD3;KAT2A;SETD3;RNF10
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),-0.6177849435636774,-1.0490269273620123,0.43636363636363634,0.9416577486340321,1.0,1/10,6.83%,PRLR
prerank,GO_Biological_Process_2021__cellular heat acclimation (GO:0070370),-0.6828076996762761,-1.0482004612056905,0.47368421052631576,0.9423178993742837,1.0,2/5,14.43%,HSPA1B;HSPA1A
prerank,GO_Biological_Process_2021__heat acclimation (GO:0010286),-0.6828076996762761,-1.0482004612056905,0.47368421052631576,0.9423178993742837,1.0,2/5,14.43%,HSPA1B;HSPA1A
prerank,GO_Biological_Process_2021__regulation of protein kinase activity (GO:0045859),0.37258729720582523,1.0479855070553739,0.36,0.8269167939072946,1.0,24/84,19.37%,QARS1;SIRT1;SPRED1;RAP1A;TSC2;GNAQ;CEP85;RELN;TNF;YWHAG;TAB2;SPDYA;DEPTOR;CENPE;NF1;PTK2;MMD;RAP2C;RAPGEF2;CHP1;SMCR8;PPM1F;SNCA;PPM1E
prerank,GO_Biological_Process_2021__receptor recycling (GO:0001881),0.6839615300343644,1.0479251301643613,0.5652173913043478,0.8264306557177374,1.0,2/5,27.92%,SORL1;PLEKHJ1
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",-0.4289006501638174,-1.047780661462114,0.3625,0.9427316795096161,1.0,48/208,19.10%,PPIE;FRG1;RAVER2;DHX16;ZCRB1;DHX38;CSTF2T;SNRNP27;SNRPD2;RNPC3;WDR83;RBM22;POLR2G;PNN;EIF4A3;LSM7;PDCD7;CRNKL1;ZRSR2;U2AF2;NCBP2;ZCCHC8;SMNDC1;PRPF3;BUD31;GCFC2;RBM4B;DDX23;SRSF2;DDX5;SRSF7;CWC25;SNRPA1;CWF19L2;CCAR1;PPWD1;EFTUD2;SLU7;SNRPA;LSM4;IK;SNRNP200;GTF2F1;HNRNPH2;RBM4;BCAS2;SF3A1;PRPF4
prerank,GO_Biological_Process_2021__tRNA aminoacylation (GO:0043039),-0.5130125154960303,-1.0475284330236112,0.4117647058823529,0.9427481024795304,1.0,6/35,12.52%,HARS2;WARS1;NARS1;LARS1;KARS1;DARS2
prerank,GO_Biological_Process_2021__cardiac muscle hypertrophy (GO:0003300),-0.6662318751348238,-1.0474048635519417,0.4727272727272727,0.9422580887757149,1.0,1/6,7.37%,TTN
prerank,GO_Biological_Process_2021__regulation of vesicle fusion (GO:0031338),0.5783229522798309,1.047155145206643,0.35714285714285715,0.8276767257053808,1.0,1/7,0.34%,ANXA1
prerank,GO_Biological_Process_2021__regulation of cytoplasmic transport (GO:1903649),0.5970895637871603,1.0471359108274685,0.4186046511627907,0.8269810905600514,1.0,5/10,20.25%,LRRK2;MAP2K1;MAPK1;MAP2K2;USP7
prerank,PanglaoDB_Augmented_2021__Noradrenergic Neurons,0.7021820491434639,1.0469117872812894,0.5,0.826957057076906,1.0,1/6,4.25%,PLPPR1
prerank,PanglaoDB_Augmented_2021__Smooth Muscle Cells,-0.4980744030684622,-1.0468889751817854,0.358974358974359,0.9429421921469714,1.0,5/63,2.35%,SPON2;MYLK;COL5A1;PLN;PDGFD
prerank,GO_Biological_Process_2021__positive regulation of translation in response to stress (GO:0032056),0.679880509441676,1.04688057706575,0.46153846153846156,0.8263888374337528,1.0,2/5,26.72%,DDX3X;EIF2AK4
prerank,GO_Biological_Process_2021__positive regulation of T cell differentiation (GO:0045582),-0.5526143002336023,-1.0460334357011132,0.41935483870967744,0.9446728786529119,1.0,4/23,10.77%,IL4I1;LILRB4;NCKAP1L;HLA-DRA
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.5458271657865502,-1.045965610110567,0.41935483870967744,0.9433491299924593,1.0,4/18,13.98%,XPA;GTF2H5;RBX1;RPA3
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.5458271657865502,-1.045965610110567,0.41935483870967744,0.9433491299924593,1.0,4/18,13.98%,XPA;GTF2H5;RBX1;RPA3
prerank,GO_Biological_Process_2021__primary alcohol metabolic process (GO:0034308),-0.5976339559147166,-1.0454493962866396,0.43548387096774194,0.9441469392497451,1.0,2/13,5.56%,GDPD1;IGF1
prerank,GO_Biological_Process_2021__translational termination (GO:0006415),-0.4849972069266803,-1.0449530460354435,0.3974358974358974,0.9449141956195856,1.0,20/66,17.46%,MRPL57;AURKAIP1;MRPS7;MRPL51;MRPL19;GADD45GIP1;MRPL52;MRPL50;MTRF1;MRPS11;MRPS10;MRPS15;MRPL16;MRPL32;CHCHD1;OXA1L;MRPL43;MRPS18C;MRPL45;MRPS25
prerank,GO_Biological_Process_2021__regulation of respiratory burst (GO:0060263),-0.6901283873955903,-1.0447504000801313,0.4528301886792453,0.9447462705104686,1.0,4/6,25.96%,RAC1;CLEC7A;RAC2;NOXA1
prerank,GO_Biological_Process_2021__regulation of p38MAPK cascade (GO:1900744),-0.5267185565490731,-1.0447264166343095,0.4406779661016949,0.9440318870297437,1.0,2/29,2.08%,DUSP1;GADD45B
prerank,GO_Biological_Process_2021__centromere complex assembly (GO:0034508),-0.5534287368263743,-1.0445865874446643,0.3709677419354839,0.9435663517569757,1.0,6/24,18.36%,CENPV;CENPU;ITGB3BP;NPM1;MIS12;CENPF
prerank,GO_Biological_Process_2021__positive regulation of DNA-dependent DNA replication (GO:2000105),-0.624996502791727,-1.0443234391101417,0.47368421052631576,0.9433708707790986,1.0,4/9,31.29%,STOML2;CDC7;SSBP1;DBF4B
prerank,GO_Biological_Process_2021__negative regulation of Rho protein signal transduction (GO:0035024),-0.5881252960588279,-1.0442261095019987,0.4426229508196721,0.9427903266567194,1.0,1/13,0.96%,RIPOR2
prerank,GO_Biological_Process_2021__DNA repair (GO:0006281),-0.416614692727225,-1.0441363100054493,0.39759036144578314,0.9422252866564578,1.0,31/218,15.20%,UBC;RPS27A;SMUG1;XPA;UBXN1;BTG2;OGG1;GTF2H5;HUS1;MUS81;DTX3L;PARP9;BRCA2;ABRAXAS1;PARP2;XRCC3;NPM1;REXO4;NABP1;NOP53;WDR48;KAT5;APEX1;RAD9A;RPA3;BRCA1;ERCC8;FANCB;SMC1A;UBA52;PARP4
prerank,GO_Biological_Process_2021__regulation of cellular extravasation (GO:0002691),0.6604223460126409,1.04412434822868,0.6136363636363636,0.8323885194781034,1.0,3/5,29.64%,FUT9;ICAM1;PLVAP
prerank,GO_Biological_Process_2021__BMP signaling pathway (GO:0030509),0.48374688463863,1.0440061589005236,0.34375,0.8312143381174714,1.0,10/30,14.49%,ACVR2A;SMAD1;SMAD7;SMAD2;SMAD3;BMPR1B;RGMB;BMPR1A;MEGF8;SMURF1
prerank,GO_Biological_Process_2021__cellular response to BMP stimulus (GO:0071773),0.48374688463863,1.0440061589005236,0.34375,0.8312143381174714,1.0,10/30,14.49%,ACVR2A;SMAD1;SMAD7;SMAD2;SMAD3;BMPR1B;RGMB;BMPR1A;MEGF8;SMURF1
prerank,GO_Biological_Process_2021__regulation of protein dephosphorylation (GO:0035304),-0.5329380707616025,-1.043792942183071,0.4142857142857143,0.9424814997495384,1.0,3/33,8.91%,PPP1R15A;CALM1;CNEP1R1
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.5943605870142208,-1.043448766535595,0.5254237288135594,0.9426284848953401,1.0,3/15,9.28%,CEMIP;CALM1;CHI3L1
prerank,PanglaoDB_Augmented_2021__Mller Cells,0.4085656513698776,1.043428653646963,0.36666666666666664,0.8319272819263387,1.0,18/79,12.88%,COL16A1;LRP4;SEMA5A;KCNJ2;SLC1A3;TIMP3;PLPPR4;PCDH17;PRDX6;NTM;CDH11;CA2;DBI;PTPRD;COL11A1;NTRK2;COL6A1;FBXL7
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K9 acetylation (GO:2000617),-0.714073240923248,-1.0430547252026736,0.4444444444444444,0.9430651126987842,1.0,4/5,28.16%,BRCA1;PIH1D1;SMARCB1;SPHK2
prerank,GO_Biological_Process_2021__synaptic membrane adhesion (GO:0099560),0.6182221754774139,1.0428549175463186,0.41304347826086957,0.8328265745372979,1.0,5/8,21.43%,LRRC4C;PTPRD;GPC6;LRRC4B;LRFN5
prerank,GO_Biological_Process_2021__positive regulation of intracellular transport (GO:0032388),0.4993527995304974,1.0427829838656615,0.40625,0.8323603587330507,1.0,6/29,18.25%,PGAP1;CEP131;RIPOR1;SORL1;DYNC1H1;NEDD4
prerank,GO_Biological_Process_2021__histone deacetylation (GO:0016575),0.46646143433068316,1.0427817683075982,0.3333333333333333,0.8316452725142078,1.0,11/39,16.09%,SIRT1;HDAC9;MTA2;MIER3;TRERF1;SIRT6;HDAC1;TBL1XR1;BRMS1L;SFPQ;HDAC10
prerank,GO_Biological_Process_2021__positive regulation of B cell differentiation (GO:0045579),-0.6606035801588989,-1.042179040397492,0.38,0.9449275188601148,1.0,2/6,10.76%,BTK;NCKAP1L
prerank,PanglaoDB_Augmented_2021__Hemangioblasts,0.4010564646285037,1.0420718194992071,0.46153846153846156,0.8327919485807699,1.0,6/33,16.08%,MFNG;NOSIP;CNPY3;FAM110A;CCND3;RPS6KB2
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.5170471377022337,1.0420390254240488,0.29545454545454547,0.8321400295841735,1.0,5/14,16.63%,SIRT1;SOD2;BAG5;SFPQ;P4HB
prerank,GO_Biological_Process_2021__positive regulation of autophagy of mitochondrion (GO:1903599),-0.6175469918396358,-1.0418467627804688,0.5161290322580645,0.9451661506393243,1.0,1/9,5.57%,SLC25A5
prerank,GO_Biological_Process_2021__myelination in peripheral nervous system (GO:0022011),0.5667124772122345,1.041839854166629,0.4418604651162791,0.8318939010147962,1.0,4/10,15.71%,LGI4;NF1;CNTNAP1;PARD3
prerank,GO_Biological_Process_2021__mitotic spindle organization (GO:0007052),-0.45367586224733775,-1.0417480040391365,0.3472222222222222,0.9446670183942806,1.0,20/107,18.44%,FLNA;STIL;RPS27;RAB11A;WRAP73;CENPU;ABRAXAS1;EFHC1;ITGB3BP;ZWILCH;DCTN6;MIS12;DYNC1LI2;STMN1;SMC1A;SEC13;SGO2;DCTN2;CENPF;BUB3
prerank,GO_Biological_Process_2021__negative regulation of mast cell activation involved in immune response (GO:0033007),0.6407556689007776,1.041631183206958,0.4827586206896552,0.8317311327095782,1.0,2/5,10.07%,FER;LGALS9
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex assembly (GO:0031333),-0.5192766826865107,-1.0414840240645007,0.3835616438356164,0.9447176701352955,1.0,3/37,4.82%,NLRC3;RPL13A;CLU
prerank,GO_Biological_Process_2021__positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.6206573402855807,-1.0412820928802058,0.43548387096774194,0.9445445092952726,1.0,3/12,12.82%,PPP1R15A;CALM1;PTPRC
prerank,GO_Biological_Process_2021__negative regulation of response to interferon-gamma (GO:0060331),-0.7142288710291482,-1.041089345936902,0.4153846153846154,0.9434425219205935,1.0,2/5,5.38%,PARP14;NR1H2
prerank,GO_Biological_Process_2021__negative regulation of interferon-gamma-mediated signaling pathway (GO:0060336),-0.7142288710291482,-1.041089345936902,0.4153846153846154,0.9434425219205935,1.0,2/5,5.38%,PARP14;NR1H2
prerank,GO_Biological_Process_2021__maintenance of protein location in nucleus (GO:0051457),-0.5918442602558471,-1.041086746025543,0.45161290322580644,0.9426589317861079,1.0,2/18,4.77%,SYNE1;CHCHD10
prerank,GO_Biological_Process_2021__DNA synthesis involved in DNA repair (GO:0000731),-0.5402140652871316,-1.0405178144653995,0.423728813559322,0.9433728034293773,1.0,2/32,1.30%,UBC;RPS27A
prerank,GO_Biological_Process_2021__positive regulation of leukocyte activation (GO:0002696),-0.6297932255859132,-1.0405003492995593,0.4838709677419355,0.9426840031291625,1.0,3/11,11.32%,CD2;CD226;KARS1
prerank,PanglaoDB_Augmented_2021__Adipocyte Progenitor Cells,0.43505017053519734,1.0404524104311133,0.3333333333333333,0.8338164336522779,1.0,6/31,5.20%,FKBP9;SVEP1;COL5A2;TCF7L1;PPARG;TIMP3
prerank,PanglaoDB_Augmented_2021__Retinal Ganglion Cells,0.38161339522776605,1.0403091102025777,0.29411764705882354,0.8334142589164618,1.0,32/96,18.25%,KCNQ2;CNTN2;NCAN;GALNTL6;SNAP91;PURG;TTLL1;CA10;OLFM3;POU6F2;BRSK1;KCTD8;PSD2;SNCB;PTPN5;NKAIN3;GPHN;SLC35F1;LINGO1;CAMKV;RBFOX1;NELL1;GRIA2;FXYD7;LRRC4B;SYT16;DPP10;ADGRB3;MAPK4;NXPH1;BRSK2;MAP6
prerank,GO_Biological_Process_2021__regulation of protein lipidation (GO:1903059),0.638475065070399,1.0402177926540193,0.4634146341463415,0.8328576592046404,1.0,1/5,9.52%,DBI
prerank,GO_Biological_Process_2021__C-terminal protein amino acid modification (GO:0018410),0.5719098528356847,1.039963408216572,0.42,0.8329012634621608,1.0,1/9,7.06%,FOLH1
prerank,GO_Biological_Process_2021__ceramide metabolic process (GO:0006672),0.47879373682151827,1.0399534962978936,0.4,0.832191202708996,1.0,6/27,6.65%,ACER2;ABCA2;ST6GALNAC3;PLPP1;FA2H;SPTLC2
prerank,GO_Biological_Process_2021__membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.5676678420612081,1.0395860800726815,0.40476190476190477,0.8323693871296377,1.0,4/11,18.87%,KCNJ2;SCN3B;SLC8A1;SCN1B
prerank,GO_Biological_Process_2021__regulation of cation channel activity (GO:2001257),0.4082344257854048,1.0394290607637122,0.3548387096774194,0.8320319888353117,1.0,14/57,14.91%,NETO1;NLGN1;RELN;SHISA9;GRIA3;GRIA4;GRIA1;SLMAP;GRIN2B;PRRT1;GRIA2;CACNG8;CACNG2;CACNB4
prerank,GO_Biological_Process_2021__negative regulation of cell-matrix adhesion (GO:0001953),0.48753776854337716,1.0393888792385655,0.4146341463414634,0.8313450722911064,1.0,3/26,6.62%,ACER2;SERPINE1;JAG1
prerank,GO_Biological_Process_2021__positive regulation of kinase activity (GO:0033674),0.3873292968343011,1.0393471213905863,0.375,0.8307519156712108,1.0,21/71,19.84%,IGF1R;RAP1A;RELN;RYK;TNF;TAB2;SPDYA;MERTK;EPHA6;CENPE;EEF1A2;NTRK2;PTK2;ERBB4;TYRO3;ZNF622;MMD;RAPGEF2;NBN;FGFR2;FGFR1
prerank,GO_Biological_Process_2021__regulation of interleukin-1 beta production (GO:0032651),-0.4829904373737979,-1.0392002634367814,0.463768115942029,0.94560128840512,1.0,11/52,8.14%,CD36;CCL3;MNDA;PYHIN1;CARD16;AIM2;LILRB4;IGF1;GSTP1;NLRP12;TNFAIP3
prerank,GO_Biological_Process_2021__regulation of macrophage derived foam cell differentiation (GO:0010743),-0.5757243457634454,-1.0390246822261204,0.38333333333333336,0.9453853481936447,1.0,2/18,5.38%,CD36;NR1H2
prerank,GO_Biological_Process_2021__keratan sulfate catabolic process (GO:0042340),0.6553249740609378,1.0390115119032728,0.4523809523809524,0.8309101581703798,1.0,1/6,3.20%,GLB1
prerank,GO_Biological_Process_2021__formation of translation preinitiation complex (GO:0001731),-0.6273121408579045,-1.0389454540088912,0.4838709677419355,0.9448471474097848,1.0,6/9,28.01%,EIF2D;EIF2S2;EIF2S3;DENR;EIF4H;MCTS1
prerank,GO_Biological_Process_2021__endoderm formation (GO:0001706),-0.5759224316154319,-1.0388247989127488,0.4444444444444444,0.9444244499623716,1.0,3/14,10.55%,DUSP1;ITGA4;ITGB2
prerank,GO_Biological_Process_2021__regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091),-0.5988711551903091,-1.0388039833078238,0.45098039215686275,0.9437304677383314,1.0,5/10,22.78%,APOBEC3G;INPP5K;RESF1;SETDB1;MORC2
prerank,GO_Biological_Process_2021__regulation of oxidative phosphorylation (GO:0002082),-0.6098631877291393,-1.0387881237140908,0.45454545454545453,0.9430090245452851,1.0,3/9,19.90%,COX7A2;PINK1;UQCC2
prerank,GO_Biological_Process_2021__myeloid leukocyte mediated immunity (GO:0002444),-0.6800509632153403,-1.0386407860225157,0.5098039215686274,0.9426460530112875,1.0,2/5,25.08%,IRAK4;CARD9
prerank,GO_Biological_Process_2021__lipid droplet formation (GO:0140042),0.6554653725770014,1.0385967239750145,0.5319148936170213,0.8311708384806183,1.0,2/6,8.99%,PLA2G4C;AUP1
prerank,GO_Biological_Process_2021__ATP synthesis coupled electron transport (GO:0042773),-0.6839349381651365,-1.0381765346736198,0.5,0.9432475466176321,1.0,2/6,11.53%,NDUFA12;COA6
prerank,GO_Biological_Process_2021__serine transport (GO:0032329),-0.7192692643849045,-1.0380588545711986,0.49019607843137253,0.9427565664054627,1.0,2/5,17.98%,SFXN3;SLC1A4
prerank,GO_Biological_Process_2021__membrane assembly (GO:0071709),0.4662544511150166,1.0377932335929039,0.39285714285714285,0.8326214597609153,1.0,11/31,17.29%,LRP4;PICALM;NLGN1;STX2;PTPRD;CHMP7;NRXN2;PTEN;NLGN4Y;UBXN2A;IL1RAPL1
prerank,GO_Biological_Process_2021__regulation of cellular carbohydrate metabolic process (GO:0010675),0.5447638810209043,1.0373630288941709,0.40540540540540543,0.8329622754387982,1.0,3/11,6.28%,PDK4;SIRT1;SCARB2
prerank,GO_Biological_Process_2021__positive regulation of chemotaxis (GO:0050921),0.45939094177488793,1.0373019303960294,0.3684210526315789,0.8324317270917464,1.0,3/26,2.26%,NRP1;SEMA5A;FGF2
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.5870611298535133,-1.0372136110742225,0.43103448275862066,0.9444333099067361,1.0,5/14,22.11%,RAB11A;NPM1;CCND1;ATAD5;CDC7
prerank,GO_Biological_Process_2021__positive regulation of cilium assembly (GO:0045724),-0.5554409725657754,-1.0370294491704397,0.5208333333333334,0.9442270484997984,1.0,2/15,7.65%,WRAP73;ENTR1
prerank,GO_Biological_Process_2021__negative regulation of long-term synaptic potentiation (GO:1900272),-0.6088124279833591,-1.0368533783801899,0.4583333333333333,0.944056707328015,1.0,2/7,11.20%,PTN;TYROBP
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication maintenance of fidelity (GO:0045005),-0.5356863928733618,-1.036740067230341,0.3870967741935484,0.943602226774371,1.0,2/30,5.76%,DDX11;TIPIN
prerank,GO_Biological_Process_2021__cellular response to transforming growth factor beta stimulus (GO:0071560),-0.44333327023046387,-1.0366697847560638,0.3333333333333333,0.9429992937633257,1.0,4/71,1.30%,UBC;TGFBR3;FOS;RPS27A
prerank,GO_Biological_Process_2021__regulation of cholesterol efflux (GO:0010874),0.49226996807378826,1.0365124697697428,0.41935483870967744,0.8338366602755498,1.0,4/24,5.17%,ABCA2;YJEFN3;SIRT1;PPARG
prerank,GO_Biological_Process_2021__negative regulation of lyase activity (GO:0051350),0.6140054278171458,1.0358000315636309,0.4791666666666667,0.8347687666671969,1.0,2/7,20.06%,ADGRV1;GRM3
prerank,GO_Biological_Process_2021__B cell activation involved in immune response (GO:0002312),0.5343865066960525,1.0357062041861975,0.4888888888888889,0.8342789115011682,1.0,3/11,7.13%,CD180;EXOSC6;LIG4
prerank,GO_Biological_Process_2021__dephosphorylation (GO:0016311),0.39586374785489026,1.0356103411913216,0.3333333333333333,0.8338103024086484,1.0,23/107,11.81%,DUSP6;PTPN9;DUSP18;PPM1L;PLPPR1;PLPP1;PTPRM;PLPP5;PLPPR4;PPP4R2;PPP2R1B;PTPN13;ILKAP;CDC14B;PPP3CA;DUSP7;BTRC;PTPRG;PTPRK;PTPN5;FBXW11;PTPRD;PTEN
prerank,GO_Biological_Process_2021__epithelial structure maintenance (GO:0010669),-0.6526637298280358,-1.0355143707836347,0.48214285714285715,0.945385953474211,1.0,3/6,19.95%,CRACD;NOD2;PBLD
prerank,GO_Biological_Process_2021__carboxylic acid transmembrane transport (GO:1905039),-0.5428366329926784,-1.0353262213989056,0.4264705882352941,0.9451088262867982,1.0,6/28,10.63%,SLC7A5;SLC38A4;SLC38A1;ABCB1;SLC16A7;SLC36A4
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation (GO:0032446),0.3342658515870413,1.0351317104890105,0.2857142857142857,0.8342198036200271,1.0,47/300,13.23%,UBE2D1;SPSB2;MKRN3;ZNRF3;MSL2;ZNF598;RNF25;UHRF2;SIRT1;RNF139;KLHL18;SAE1;FBXO32;TRIM26;NUP153;NUP188;UBE2D2;NUP42;BCL11A;DCUN1D4;UBR3;NEDD4L;CDC23;MDM2;BTRC;FBXO45;STX1A;KCTD10;HIF3A;UBA1;RNF20;UBE2L3;PEX13;ANAPC16;FBXW11;FBXW7;EPAS1;TSPAN17;UBE2N;DCUN1D1;PEX5;RNF38;TRIM35;UBA2;FBXL7;BARD1;ZNF451
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell migration (GO:0014910),0.5724711669029976,1.03462278858684,0.5,0.8347713148714108,1.0,3/13,1.65%,NRP1;PDGFA;SERPINE1
prerank,GO_Biological_Process_2021__axon choice point recognition (GO:0016198),0.6638511232806822,1.0346075692244285,0.4634146341463415,0.8341303418551603,1.0,2/5,15.51%,ROBO1;ROBO2
prerank,GO_Biological_Process_2021__intra-Golgi vesicle-mediated transport (GO:0006891),0.4993781940140025,1.0344131828607808,0.4594594594594595,0.8339076492334087,1.0,8/26,17.41%,RAB33B;COPG1;VTI1A;COG1;RAB6A;COG3;COPB1;COPZ1
prerank,GO_Biological_Process_2021__tRNA transcription (GO:0009304),-0.656225033779751,-1.034404490125962,0.5185185185185185,0.9468520087476288,1.0,1/7,3.40%,GTF3C6
prerank,GO_Biological_Process_2021__response to axon injury (GO:0048678),-0.5994577968941939,-1.0343743424226146,0.4576271186440678,0.9461563325247374,1.0,3/14,13.37%,APOD;TYROBP;SOD1
prerank,GO_Biological_Process_2021__positive regulation of dendritic cell cytokine production (GO:0002732),-0.6060060953127622,-1.034068548614906,0.44642857142857145,0.9461552052774249,1.0,2/6,22.26%,CLEC7A;CAMK4
prerank,GO_Biological_Process_2021__negative regulation of protein exit from endoplasmic reticulum (GO:0070862),-0.6791376336572038,-1.0336641836551128,0.5178571428571429,0.9464651542961886,1.0,1/9,0.72%,INSIG1
prerank,GO_Biological_Process_2021__leucine catabolic process (GO:0006552),-0.6864762359872516,-1.0336279533193187,0.4807692307692308,0.9458280071693742,1.0,2/5,22.30%,MCCC2;HMGCL
prerank,GO_Biological_Process_2021__positive regulation of protein import into nucleus (GO:0042307),-0.5499613683516634,-1.0334741898686368,0.45161290322580644,0.945431881943831,1.0,3/21,6.41%,FLNA;JUP;RBM22
prerank,GO_Biological_Process_2021__endosome transport via multivesicular body sorting pathway (GO:0032509),0.4959878626227918,1.0334670552888647,0.4117647058823529,0.8357085918793317,1.0,6/19,14.09%,LYST;SORT1;UBXN6;CHMP7;LEPROTL1;CHMP1A
prerank,GO_Biological_Process_2021__positive regulation of response to cytokine stimulus (GO:0060760),0.532116067092087,1.0333208254318116,0.40816326530612246,0.8354443144165731,1.0,2/11,14.11%,WNT5A;AGPAT2
prerank,GO_Biological_Process_2021__long-chain fatty acid transport (GO:0015909),0.4978522111799581,1.0332787461792106,0.40540540540540543,0.8347846261946812,1.0,4/19,7.76%,PRKAB2;PPARG;CPT1A;ACACB
prerank,GO_Biological_Process_2021__regulation of programmed necrotic cell death (GO:0062098),-0.6130219826944191,-1.0330640896757348,0.5172413793103449,0.9460026097021772,1.0,9/16,28.63%,CDC37;CFLAR;MLKL;FLOT1;SDCBP;OGT;HSP90AA1;ASAH1;BIRC2
prerank,GO_Biological_Process_2021__cellular response to interleukin-12 (GO:0071349),-0.5103264058549724,-1.0330159794933562,0.4142857142857143,0.9453955801728081,1.0,9/36,15.40%,STAT4;ANXA2;IL12RB2;CFL1;RPLP0;CD47;SOD1;SNRPA1;TALDO1
prerank,GO_Biological_Process_2021__protein targeting (GO:0006605),-0.46137421510189053,-1.0329830253849028,0.38571428571428573,0.944726166465187,1.0,13/90,9.39%,TOMM7;SRP14;DNAJC19;CDC37;AQP11;TIMM44;RPL11;FIS1;NACA;PITRM1;ZDHHC4;ZDHHC19;HPS4
prerank,GO_Biological_Process_2021__bicarbonate transport (GO:0015701),0.5333027713280425,1.032958071351236,0.5,0.8348359547451408,1.0,3/12,9.38%,SLC39A8;SLC4A4;CA2
prerank,GO_Biological_Process_2021__lipid translocation (GO:0034204),-0.5382124962070941,-1.0327722687850474,0.41379310344827586,0.9446910292610454,1.0,4/21,14.37%,ABCB1;ATP10A;ABCB4;ATP8B1
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis (GO:0006898),-0.4503903684443834,-1.0322999562434154,0.39473684210526316,0.9450988224314526,1.0,7/101,5.46%,MX2;CD36;MX1;TFRC;MARCO;FCER1G;LILRB4
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 9 signaling pathway (GO:0034165),-0.705427665480451,-1.0322703165054157,0.5263157894736842,0.9443891323952571,1.0,1/5,1.20%,RSAD2
prerank,PanglaoDB_Augmented_2021__Cardiomyocytes,-0.4789993920951964,-1.0321314399877084,0.38235294117647056,0.9440034358466965,1.0,8/49,7.44%,CD36;PLN;CXCR4;HAMP;OBSCN;COL21A1;TTN;MYBPC3
prerank,GO_Biological_Process_2021__regulation of amyloid-beta formation (GO:1902003),0.46670450242318257,1.0318753031546763,0.35714285714285715,0.8367820889561501,1.0,8/29,12.47%,ABCA2;PICALM;TMED10;TNF;SLC2A13;SORL1;RTN4;NTRK2
prerank,PanglaoDB_Augmented_2021__Osteoblasts,0.4358559443218907,1.0314848571456319,0.4375,0.8370746528530439,1.0,14/64,12.56%,COL16A1;LRP4;SVEP1;COL5A2;ACTA2;WNT5A;TNFRSF10A;TIMP3;BMP1;CDH11;COL11A1;FAM114A1;ITGA2;COL6A1
prerank,GO_Biological_Process_2021__protein ubiquitination (GO:0016567),0.34459500134141846,1.031426634326166,0.3333333333333333,0.8365372012322799,1.0,57/390,13.01%,UBE2D1;SPSB2;MKRN3;FBXO30;RNF122;ZNRF3;MSL2;ZNF598;RNF25;UHRF2;UBE2J1;SIRT1;FBXL14;RNF139;UBE2O;RNF208;KLHL18;MARCHF5;FBXO32;TRIM26;DDA1;UBE2E2;UBE3D;UBE2D2;UBR3;NEDD4L;RMND5A;CDC23;MDM2;BTRC;FBXO45;SASH1;RNF19B;KCTD10;HIF3A;MARCHF1;UBA1;RNF20;UBE2L3;PEX13;ANAPC16;FBXW11;FBXW7;EPAS1;RNF217;RNF185;TSPAN17;RNF10;UBE2N;PEX5;RNF38;TRIM35;KLHL42;FBXL12;SH3RF1;FBXL7;BARD1
prerank,GO_Biological_Process_2021__mitochondrial transport (GO:0006839),-0.49688239535010387,-1.031094633825482,0.453125,0.9464444709126812,1.0,13/43,15.12%,TOMM7;DNAJC19;TIMM44;SLC25A5;FIS1;PITRM1;BCS1L;COX18;SPG7;TOMM40;MAIP1;OXA1L;STARD3
prerank,GO_Biological_Process_2021__morphogenesis of a polarized epithelium (GO:0001738),0.6092443511865344,1.0310582028473347,0.42857142857142855,0.8367284037733147,1.0,2/7,5.14%,SCRIB;RAB10
prerank,GO_Biological_Process_2021__TRIF-dependent toll-like receptor signaling pathway (GO:0035666),-0.5205397939674071,-1.0307833956177876,0.4583333333333333,0.9459166737505232,1.0,4/25,5.48%,UBC;RPS27A;CD14;CD300LF
prerank,GO_Biological_Process_2021__MyD88-independent toll-like receptor signaling pathway (GO:0002756),-0.5205397939674071,-1.0307833956177876,0.4583333333333333,0.9459166737505232,1.0,4/25,5.48%,UBC;RPS27A;CD14;CD300LF
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell migration (GO:0010595),0.4569297235223488,1.0304768694785094,0.38095238095238093,0.8375757421880253,1.0,6/60,6.25%,NRP1;SEMA5A;FGF2;SIRT1;WNT5A;RIN2
prerank,GO_Biological_Process_2021__positive regulation of cell population proliferation (GO:0008284),-0.40200716829701777,-1.0304303182834174,0.3493975903614458,0.9461466105677975,1.0,41/236,14.51%,NR4A3;RPS4X;TGFBR3;CCL5;IL7R;PID1;PDGFD;AIF1;DDRGK1;AQP11;TSPAN31;RPL23;IGF1;SLC25A5;TIPIN;IL12RB2;OSMR;PRLR;C5AR1;RPS6;NAMPT;RBPJ;S100A6;CHTOP;STAT1;MEIS1;PTN;NPM1;TRPM4;RPS9;VEGFA;TBC1D8;CD47;EFNB2;FLT1;PTPRC;ZNF16;TET1;NOD2;FGF20;CCAR1
prerank,GO_Biological_Process_2021__regulation of carbohydrate catabolic process (GO:0043470),0.40544924954638845,1.0302580013467983,0.3684210526315789,0.8373419432824901,1.0,4/36,7.20%,NUP153;NUP188;SCARB2;NUP42
prerank,GO_Biological_Process_2021__cellular response to growth factor stimulus (GO:0071363),0.390250697655631,1.030073084630241,0.4,0.8370782862575015,1.0,11/101,6.06%,KLF4;ANXA1;NRP1;ACVR2A;SPRY2;TGFBR2;SMAD7;RAP1A;WNT5A;SMAD3;CIB1
prerank,GO_Biological_Process_2021__pyrimidine nucleobase catabolic process (GO:0006208),0.6574277668854637,1.0300340512510882,0.5609756097560976,0.8364524003828898,1.0,1/6,1.43%,DPYSL5
prerank,PanglaoDB_Augmented_2021__Mesothelial Cells,0.4420065982914652,1.0299583940461619,0.40540540540540543,0.835887949396307,1.0,12/43,13.56%,COL16A1;FKBP9;SVEP1;COL5A2;FRAS1;TIMP3;CDH11;EPAS1;FAM114A1;TJP1;TWSG1;PCSK6
prerank,GO_Biological_Process_2021__polyol metabolic process (GO:0019751),0.4680891209198775,1.029758077221731,0.28125,0.8358071895146818,1.0,13/35,18.14%,INPP1;PLCB4;IPPK;IMPA1;NUDT3;PTEN;ISYNA1;PPIP5K1;PLD4;INPP5A;NUDT4;PLCB3;INPP4B
prerank,GO_Biological_Process_2021__odontogenesis (GO:0042476),0.5604665370943789,1.029456804236281,0.3888888888888889,0.835857200905494,1.0,3/10,19.59%,HDAC1;ANKRD11;FGFR2
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-serine phosphorylation (GO:0033137),-0.5676427102195201,-1.0293716099653507,0.43137254901960786,0.9483264010814162,1.0,3/15,4.24%,DDIT4;PAQR3;RACK1
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate catabolic process (GO:0009169),0.6503399005778576,1.0289377513744369,0.4888888888888889,0.8364493263627766,1.0,4/5,33.42%,PNP;PRTFDC1;HPRT1;AMPD3
prerank,GO_Biological_Process_2021__regulation of glial cell apoptotic process (GO:0034350),0.7005911993296322,1.0286873833909387,0.5609756097560976,0.8364686257743803,1.0,1/5,12.90%,PRKCI
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-lysine acetylation (GO:2000757),0.5829893850149792,1.0286172671295102,0.48717948717948717,0.8359265457831545,1.0,1/7,2.51%,SIRT1
prerank,GO_Biological_Process_2021__isocitrate metabolic process (GO:0006102),-0.6413476107083541,-1.0283087138992624,0.5102040816326531,0.9507471333228357,1.0,1/5,10.29%,IDH3B
prerank,GO_Biological_Process_2021__regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1903025),-0.6893594869953165,-1.0280703446360921,0.4444444444444444,0.9506167068786082,1.0,3/7,8.69%,DDRGK1;LAMTOR5;TMSB4X
prerank,GO_Biological_Process_2021__cardiac right ventricle morphogenesis (GO:0003215),0.6916011042446232,1.0280094717646768,0.46511627906976744,0.8366874126862389,1.0,3/5,12.30%,JAG1;SOX4;BMPR1A
prerank,GO_Biological_Process_2021__cell-matrix adhesion (GO:0007160),-0.4869192868346486,-1.0279772320419103,0.4594594594594595,0.9501657239385899,1.0,9/53,11.27%,CD96;SIGLEC1;CD63;ITGA4;FERMT3;CD44;SGCE;ITGB2;ITGAL
prerank,GO_Biological_Process_2021__glycerol metabolic process (GO:0006071),-0.6511104510756536,-1.0279714985750308,0.543859649122807,0.9494228278535608,1.0,5/6,34.91%,GK;GK5;TPI1;PGP;GOT1
prerank,GO_Biological_Process_2021__protein localization to microtubule cytoskeleton (GO:0072698),-0.6695261427225849,-1.027912608899769,0.484375,0.9488551746682827,1.0,3/6,32.16%,MID1;CHAMP1;MAPRE1
prerank,GO_Biological_Process_2021__regulation of granulocyte chemotaxis (GO:0071622),-0.5896506320960768,-1.0277990864675413,0.44642857142857145,0.9484414732729147,1.0,1/11,1.49%,CCL5
prerank,GO_Biological_Process_2021__positive regulation of helicase activity (GO:0051096),-0.6562457234502265,-1.02750555716478,0.49056603773584906,0.9485566972356632,1.0,4/7,26.23%,CHTOP;MSH6;SSBP1;MSH3
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization (GO:0070201),0.5802855785029728,1.0273501137226069,0.46153846153846156,0.8375170744084702,1.0,4/11,23.04%,CEP120;CEP135;DNAJA1;CEP290
prerank,GO_Biological_Process_2021__glycosaminoglycan metabolic process (GO:0030203),0.4644982847445688,1.0272704133823856,0.3888888888888889,0.837175456118184,1.0,6/31,6.07%,HS3ST5;GLB1;HS2ST1;UGDH;HPSE;B4GALT7
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor signaling pathway (GO:0034123),-0.5400572094583407,-1.0271485392756163,0.46774193548387094,0.9486439555679561,1.0,7/19,20.38%,RSAD2;TASL;CYBA;IFI35;FLOT1;PTPN22;TLR2
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle phase transition (GO:1901991),0.41955834721859553,1.0271128651143242,0.3333333333333333,0.836874365470043,1.0,2/68,1.00%,KLF4;PKD2
prerank,GO_Biological_Process_2021__endoplasmic reticulum calcium ion homeostasis (GO:0032469),-0.5394286602897997,-1.027065723556674,0.41935483870967744,0.9480648645568854,1.0,7/17,29.99%,FIS1;TMCO1;BCAP31;HERPUD1;WFS1;CCDC47;THADA
prerank,GO_Biological_Process_2021__JNK cascade (GO:0007254),-0.48571128264799457,-1.0270561251603147,0.3888888888888889,0.9473272150605698,1.0,2/36,1.30%,UBC;RPS27A
prerank,GO_Biological_Process_2021__regulation of MDA-5 signaling pathway (GO:0039533),-0.6936852732924348,-1.0268808996054535,0.62,0.9470549603166811,1.0,1/5,2.65%,DHX58
prerank,GO_Biological_Process_2021__R-loop disassembly (GO:0062176),-0.6690001038880481,-1.0268386183748033,0.5192307692307693,0.94639544941075,1.0,1/5,12.91%,DDX23
prerank,GO_Biological_Process_2021__entry of bacterium into host cell (GO:0035635),0.6269414608702704,1.0268271085855643,0.47368421052631576,0.8370828911194839,1.0,3/5,35.15%,CBL;CTNNB1;GRB2
prerank,GO_Biological_Process_2021__mRNA polyadenylation (GO:0006378),0.502642565329699,1.0265574926300503,0.3783783783783784,0.8362730565548592,1.0,6/21,16.20%,WDR33;SSU72;PCF11;SCAF8;AHCYL1;PAPOLA
prerank,GO_Biological_Process_2021__RNA polyadenylation (GO:0043631),0.502642565329699,1.0265574926300503,0.3783783783783784,0.8362730565548592,1.0,6/21,16.20%,WDR33;SSU72;PCF11;SCAF8;AHCYL1;PAPOLA
prerank,"GO_Biological_Process_2021__mRNA splicing, via spliceosome (GO:0000398)",-0.41607270545119684,-1.0264897810584306,0.40963855421686746,0.9466085999386837,1.0,50/226,19.10%,PPIE;FRG1;RAVER2;DHX16;ZCRB1;DHX38;CSTF2T;SNRNP27;SNRPD2;RNPC3;WDR83;RBM22;POLR2G;SRPK1;PNN;EIF4A3;LSM7;PDCD7;CRNKL1;ZRSR2;U2AF2;NCBP2;ZCCHC8;SMNDC1;PRPF3;BUD31;GCFC2;RBM4B;DDX23;SRSF2;DDX5;SRSF7;CWC25;SNRPA1;CWF19L2;CCAR1;PPWD1;EFTUD2;SLU7;SNRPA;SCNM1;LSM4;IK;SNRNP200;GTF2F1;HNRNPH2;RBM4;BCAS2;SF3A1;PRPF4
prerank,"GO_Biological_Process_2021__regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.5337992256282516,1.0261716841628399,0.3939393939393939,0.8364716041331997,1.0,5/16,10.28%,SIRT1;SPRED1;SPRED2;MDM2;DYRK1A
prerank,GO_Biological_Process_2021__positive regulation of protein import (GO:1904591),-0.537969402152354,-1.025908193900835,0.47540983606557374,0.9475402599003547,1.0,4/22,9.33%,FLNA;JUP;RBM22;PDCD5
prerank,GO_Biological_Process_2021__presynaptic active zone organization (GO:1990709),-0.7146397166784025,-1.0257985921856623,0.5357142857142857,0.9470891339942309,1.0,1/6,6.19%,RAB3A
prerank,GO_Biological_Process_2021__kidney development (GO:0001822),0.48515294008601034,1.0254167422165719,0.42857142857142855,0.8374260202022028,1.0,13/30,17.57%,LRP4;ZBTB16;PKD1;SALL1;SOX4;C1GALT1;NF1;BAG6;NIPBL;TGFBR1;ROBO2;CTSH;PRKX
prerank,GO_Biological_Process_2021__Arp2/3 complex-mediated actin nucleation (GO:0034314),-0.5828884541183647,-1.0251504713221178,0.42105263157894735,0.9481569479689889,1.0,2/11,20.30%,ARPC5L;IQGAP2
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.6222374405396037,1.0250593179705094,0.45454545454545453,0.836995757093066,1.0,3/8,7.81%,SIRT1;TAF9B;ZNF385A
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.6222374405396037,1.0250593179705094,0.45454545454545453,0.836995757093066,1.0,3/8,7.81%,SIRT1;TAF9B;ZNF385A
prerank,GO_Biological_Process_2021__glutathione derivative metabolic process (GO:1901685),-0.5833127217248539,-1.0250162054132563,0.44776119402985076,0.947000936049134,1.0,4/12,8.97%,GSTM4;GSTP1;GSTK1;GSTM3
prerank,GO_Biological_Process_2021__glutathione derivative biosynthetic process (GO:1901687),-0.5833127217248539,-1.0250162054132563,0.44776119402985076,0.947000936049134,1.0,4/12,8.97%,GSTM4;GSTP1;GSTK1;GSTM3
prerank,GO_Biological_Process_2021__peptidyl-glutamic acid modification (GO:0018200),0.5463040185976318,1.0248889772822307,0.40625,0.836726564496962,1.0,6/14,15.60%,TTLL11;PARP1;TTLL1;CEP41;TTLL7;VKORC1L1
prerank,PanglaoDB_Augmented_2021__Hepatocytes,0.41117974069807156,1.024755686117417,0.45454545454545453,0.8362495487970653,1.0,7/48,10.52%,LEPR;SAMD5;PRRG4;TM7SF2;MSMO1;HMGCS1;GPAT4
prerank,GO_Biological_Process_2021__regulation of interleukin-5 production (GO:0032674),-0.632363147587285,-1.0247388055407674,0.48,0.946916553636003,1.0,1/5,5.46%,LILRB4
prerank,GO_Biological_Process_2021__Golgi to plasma membrane transport (GO:0006893),-0.47925816374460556,-1.0246986483984672,0.421875,0.9462613399474753,1.0,5/39,12.09%,OSBPL5;BBS2;STXBP6;GOLGA4;STEAP2
prerank,GO_Biological_Process_2021__maturation of 5.8S rRNA (GO:0000460),0.5019749686353601,1.0245403316016173,0.47619047619047616,0.8360408627410901,1.0,2/15,2.35%,NOL9;RPF1
prerank,GO_Biological_Process_2021__endoplasmic reticulum organization (GO:0007029),0.4326323251547975,1.0245331489982397,0.39285714285714285,0.8353671654423852,1.0,13/55,18.23%,VAPB;LRRK2;TOR1AIP2;RAB10;LMAN2L;STX1A;REEP3;RTN4;SEC61G;UBE2J2;SEC31A;SHTN1;SEC31B
prerank,GO_Biological_Process_2021__regulation of cytoplasmic mRNA processing body assembly (GO:0010603),0.6590905430530735,1.0242223541166953,0.4418604651162791,0.8353672948687549,1.0,2/6,26.04%,CNOT2;ATXN2
prerank,GO_Biological_Process_2021__calcium ion transmembrane transport (GO:0070588),0.41749933115615095,1.0241706360458078,0.4166666666666667,0.8348138667615346,1.0,5/62,3.46%,CACNA1A;TRPC1;PKD2;MCU;PKD1
prerank,GO_Biological_Process_2021__protein polymerization (GO:0051258),-0.4990487011322472,-1.0241144931877872,0.43478260869565216,0.9470368833480061,1.0,6/41,11.71%,CATIP;AIF1;PSTPIP1;FGF13;TRPV4;GPX4
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.5682959999139405,-1.0241043978844264,0.45161290322580644,0.9463001943195541,1.0,2/15,8.36%,SRI;CALM1
prerank,GO_Biological_Process_2021__regulation of apoptotic process (GO:0042981),-0.3845839571641274,-1.0238811638823397,0.4,0.9461205553468751,1.0,61/482,10.76%,BCL2A1;FLNA;PLEKHG5;UBC;APIP;RPS27A;TFRC;MNDA;CARD14;RASGRF2;GADD45B;VAV3;IKZF3;IFIT3;ATF5;PRELID1;STIL;TNFRSF25;NAIP;USP36;CTSB;DDRGK1;RACK1;TNFSF10;ING3;PTMA;CLU;ING5;RPL10;BNIP2;ARHGEF1;RPS3;MTCH1;IGF1;RPS3A;RNF144B;TNFAIP8;PHB2;ARHGEF3;PRLR;GSTP1;OBSCN;RPS6;TPT1;IFIT2;NAA38;SGK1;CFL1;ITGA6;TMEM219;CD44;MTCH2;EGLN3;PDCD5;ITGB3BP;STAT1;CFLAR;BCL2L14;NPM1;CITED2;NCKAP1L
prerank,GO_Biological_Process_2021__regulation of nitrogen compound metabolic process (GO:0051171),0.6000157046966749,1.0232871395541276,0.42857142857142855,0.8362959806932585,1.0,2/7,7.30%,LDLR;TNF
prerank,GO_Biological_Process_2021__positive regulation of ATP biosynthetic process (GO:2001171),0.5614444312134025,1.0231846207698019,0.5,0.8351903160073147,1.0,1/8,0.24%,PPARGC1A
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.5614444312134025,1.0231846207698019,0.5,0.8351903160073147,1.0,1/8,0.24%,PPARGC1A
prerank,GO_Biological_Process_2021__phosphatidylinositol 3-kinase signaling (GO:0014065),0.46157500492642894,1.0229434601834306,0.45454545454545453,0.835042797106532,1.0,7/21,17.35%,IGF1R;NYAP2;PIK3C2B;PTEN;NF1;TYRO3;PIK3CA
prerank,GO_Biological_Process_2021__regulation of endothelial cell development (GO:1901550),0.5992132603416362,1.02279047016012,0.5238095238095238,0.8347576913015643,1.0,3/9,18.17%,TNF;VCL;TNFRSF1A
prerank,GO_Biological_Process_2021__iron ion homeostasis (GO:0055072),-0.5023956587510904,-1.0227394712150657,0.49230769230769234,0.9486018445305366,1.0,4/41,2.81%,FTH1;TFRC;HAMP;B2M
prerank,GO_Biological_Process_2021__regulation of acyl-CoA biosynthetic process (GO:0050812),0.6398998872868827,1.022643676991807,0.4888888888888889,0.8337957166866237,1.0,1/5,2.30%,PDK4
prerank,GO_Biological_Process_2021__regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510),0.6398998872868827,1.022643676991807,0.4888888888888889,0.8337957166866237,1.0,1/5,2.30%,PDK4
prerank,GO_Biological_Process_2021__establishment of epithelial cell polarity (GO:0090162),0.5232364947754499,1.0223591046101523,0.43902439024390244,0.8338265821090948,1.0,3/14,15.71%,MSN;CLASP1;PARD3
prerank,GO_Biological_Process_2021__nucleobase catabolic process (GO:0046113),0.6613342449871801,1.0223145189016745,0.5869565217391305,0.833249000328009,1.0,1/5,1.43%,DPYSL5
prerank,GO_Biological_Process_2021__ribose phosphate biosynthetic process (GO:0046390),-0.6434036281715074,-1.0222733534214488,0.5454545454545454,0.9489003037066246,1.0,2/5,31.02%,PRPSAP1;TKT
prerank,GO_Biological_Process_2021__mitochondrial translation (GO:0032543),-0.46179089992541256,-1.0222468645076686,0.47058823529411764,0.9481918563800985,1.0,21/75,17.46%,MRPL57;AURKAIP1;MRPS7;MRPL51;MRPL19;GADD45GIP1;MRPL52;MRPL50;MTIF3;MTRF1;MRPS11;MRPS10;MRPS15;MRPL16;MRPL32;CHCHD1;OXA1L;MRPL43;MRPS18C;MRPL45;MRPS25
prerank,GO_Biological_Process_2021__positive regulation of steroid metabolic process (GO:0045940),0.6336441761250952,1.0222068044242385,0.5106382978723404,0.8327998177591385,1.0,1/5,4.97%,STARD4
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 9 signaling pathway (GO:0034163),-0.63385173419072,-1.022130847195727,0.5409836065573771,0.9478402641918002,1.0,1/8,1.20%,RSAD2
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species biosynthetic process (GO:1903427),-0.6646274078845303,-1.022071541396128,0.5,0.9472704842379746,1.0,1/6,7.36%,FYN
prerank,GO_Biological_Process_2021__protein import (GO:0017038),0.36824762659712273,1.0216912243352152,0.3125,0.8333800448502624,1.0,12/67,13.09%,NUTF2;E2F3;GDAP1;TSC2;IPO13;NUP153;NUP188;PPP1R10;PEX13;PEX5;IPO8;PEX11B
prerank,GO_Biological_Process_2021__mitochondrial gene expression (GO:0140053),-0.5516148899895512,-1.0215866181937074,0.5,0.9479037370270705,1.0,6/28,12.07%,MRPL57;MRPS7;MRPL51;MRPS11;MRPS15;MRPL16
prerank,GO_Biological_Process_2021__negative regulation of osteoblast differentiation (GO:0045668),0.4899990924498352,1.0215659966740385,0.45454545454545453,0.8330097950639421,1.0,5/18,11.88%,PPARG;RANBP3L;TWIST2;PTCH1;CDK6
prerank,GO_Biological_Process_2021__nuclear DNA replication (GO:0033260),-0.6527833637801486,-1.0213490280679374,0.5423728813559322,0.9478398494168757,1.0,6/8,30.04%,MCM7;MCM6;DONSON;MCM5;MCM3;MCMDC2
prerank,GO_Biological_Process_2021__cardiac myofibril assembly (GO:0055003),-0.6347203593722162,-1.021332832341516,0.484375,0.9471350234050014,1.0,2/7,19.65%,TTN;MEF2A
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination at telomere (GO:0048239),0.5497388399564758,1.0213228713830638,0.46153846153846156,0.8322222221794322,1.0,1/15,0.68%,POLR2D
prerank,GO_Biological_Process_2021__regulation of DNA recombination at telomere (GO:0072695),0.5497388399564758,1.0213228713830638,0.46153846153846156,0.8322222221794322,1.0,1/15,0.68%,POLR2D
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.5672250597646996,1.0212828861883247,0.42857142857142855,0.8316487289875528,1.0,3/8,12.29%,ACADS;ACADVL;GCDH
prerank,GO_Biological_Process_2021__pre-replicative complex assembly involved in nuclear cell cycle DNA replication (GO:0006267),-0.6440026344222498,-1.0209776892386984,0.5,0.9473103376454909,1.0,5/6,30.04%,MCM7;MCM6;MCM5;MCM3;MCMDC2
prerank,GO_Biological_Process_2021__protein-containing complex assembly (GO:0065003),0.3487492531562011,1.0207334723253862,0.4074074074074074,0.8322763334239149,1.0,25/201,10.09%,PPARGC1A;COL16A1;TSPAN33;TGFA;MITF;TCF7L1;MCU;PICALM;TLE2;LRRK2;BET1;CTSC;PDE4DIP;RAB1B;SEC24B;LIN7A;TMED10;MAGI1;TNF;BOK;SLC9A1;GRIA1;MDM2;HDAC1;BCL9L
prerank,GO_Biological_Process_2021__regulation of axon extension (GO:0030516),0.4277218525942405,1.0206549756624388,0.38095238095238093,0.8318207159745784,1.0,11/28,22.75%,DIP2B;RTN4;RNF6;MAP3K13;KIAA0319;GSK3B;SHTN1;MAP2;ZFYVE27;CTTN;ABL1
prerank,GO_Biological_Process_2021__collagen fibril organization (GO:0030199),0.4204059313835922,1.02063582152537,0.4,0.8311904790877926,1.0,12/44,13.53%,COL5A3;COL16A1;COL5A2;COL24A1;BMP1;LOXL2;P3H2;COL11A1;NF1;COL6A1;COL25A1;COL15A1
prerank,GO_Biological_Process_2021__short-chain fatty acid catabolic process (GO:0019626),0.6214997741814101,1.0205077927041606,0.5319148936170213,0.8308046048492351,1.0,2/7,10.70%,ACADS;PCK2
prerank,GO_Biological_Process_2021__regulation of mitotic metaphase/anaphase transition (GO:0030071),-0.537841548663124,-1.0196494422309679,0.4918032786885246,0.9504063726532548,1.0,1/17,1.54%,DUSP1
prerank,GO_Biological_Process_2021__negative regulation of cellular protein localization (GO:1903828),-0.5015813519928469,-1.019315390768444,0.4153846153846154,0.9506128614195485,1.0,2/28,5.46%,RIPOR2;LILRB4
prerank,GO_Biological_Process_2021__negative regulation of fat cell differentiation (GO:0045599),0.47220151185134496,1.0192914837145621,0.48484848484848486,0.8331913054537109,1.0,7/21,14.62%,SIRT1;WNT5A;SMAD3;TNF;RUNX1T1;FERMT2;ENPP1
prerank,GO_Biological_Process_2021__positive regulation of stress fiber assembly (GO:0051496),0.4388770993514572,1.0189883052876436,0.3870967741935484,0.833300080741463,1.0,9/29,23.43%,NRP1;FERMT2;RAPGEF3;TGFBR1;PPM1F;PPM1E;LIMCH1;ABL1;ARHGEF10L
prerank,GO_Biological_Process_2021__nerve growth factor signaling pathway (GO:0038180),0.6237844655794496,1.0186793065769109,0.47058823529411764,0.8333504182191709,1.0,4/5,27.64%,RAP1A;RAPGEF2;MAGI2;KIDINS220
prerank,GO_Biological_Process_2021__regulation of lipid transport (GO:0032368),-0.6592085211515966,-1.0186666772219959,0.5357142857142857,0.9515736229752348,1.0,1/6,5.38%,NR1H2
prerank,GO_Biological_Process_2021__androgen metabolic process (GO:0008209),-0.6081668051115481,-1.018468189357737,0.5483870967741935,0.9513237529921964,1.0,3/8,28.53%,CYP19A1;MED1;HSD17B7
prerank,GO_Biological_Process_2021__respiratory chain complex III assembly (GO:0017062),-0.6238262366695435,-1.0182675939961645,0.5,0.9503165203546315,1.0,4/7,25.83%,BCS1L;TTC19;UQCC2;LYRM7
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex III assembly (GO:0034551),-0.6238262366695435,-1.0182675939961645,0.5,0.9503165203546315,1.0,4/7,25.83%,BCS1L;TTC19;UQCC2;LYRM7
prerank,GO_Biological_Process_2021__regulation of skeletal muscle cell differentiation (GO:2001014),-0.6663706992289731,-1.0182567977618195,0.5384615384615384,0.949627720352608,1.0,3/6,19.90%,DDX5;NR1D2;UQCC2
prerank,GO_Biological_Process_2021__cobalamin metabolic process (GO:0009235),-0.6166967074056644,-1.0182301645958791,0.43859649122807015,0.9481924496362459,1.0,4/9,30.78%,MMAA;MMAB;MTRR;LMBRD1
prerank,GO_Biological_Process_2021__tetrapyrrole metabolic process (GO:0033013),-0.6166967074056644,-1.0182301645958791,0.43859649122807015,0.9481924496362459,1.0,4/9,30.78%,MMAA;MMAB;MTRR;LMBRD1
prerank,GO_Biological_Process_2021__negative regulation of DNA replication (GO:0008156),0.6038339201028172,1.0179982596070651,0.5,0.8343030333431619,1.0,5/11,26.09%,SLFN11;GTPBP4;GMNN;RAD17;WAPL
prerank,GO_Biological_Process_2021__positive regulation of signal transduction (GO:0009967),0.34983445367354943,1.017839154301186,0.391304347826087,0.8339065167911637,1.0,25/156,9.91%,CD180;NRP1;PKD2;GRB10;MAML2;CDKN2AIP;SLC39A14;DLG5;SIRT1;SPRING1;NLGN1;LRRK2;STK36;RELN;JAG1;SALL1;ROBO1;MAML3;KANK1;SHANK3;CTBP2;NPTN;POGLUT1;ZRANB1;SASH1
prerank,MSigDB_Hallmark_2020__IL-6/JAK/STAT3 Signaling,-0.4710068648895138,-1.0175235798391509,0.4305555555555556,0.9493797288841327,1.0,15/55,12.47%,CD36;CD14;IL3RA;OSMR;CSF2RA;TNFRSF1B;ITGA4;CD44;STAT1;IRF1;CSF2RB;CSF3R;A2M;IFNGR2;IL18R1
prerank,GO_Biological_Process_2021__positive regulation of cellular protein catabolic process (GO:1903364),0.5186751377257187,1.0170226553437658,0.4897959183673469,0.8350121589023376,1.0,3/14,4.79%,MSN;ABCA2;CTSC
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 7 signaling pathway (GO:0034155),-0.6628848611187487,-1.0169905554248067,0.49122807017543857,0.9491970436572046,1.0,2/5,10.70%,RSAD2;TASL
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 7 signaling pathway (GO:0034157),-0.6628848611187487,-1.0169905554248067,0.49122807017543857,0.9491970436572046,1.0,2/5,10.70%,RSAD2;TASL
prerank,GO_Biological_Process_2021__Rho protein signal transduction (GO:0007266),-0.5040156727834504,-1.0168984332307405,0.43478260869565216,0.9487416700187737,1.0,6/32,8.34%,PLEKHG5;ARHGAP4;ARHGEF1;RHOU;ARHGEF3;CFL1
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 methylation (GO:0051570),0.5775070062520192,1.0165014478038832,0.45652173913043476,0.8356804554712705,1.0,1/8,2.51%,SIRT1
prerank,GO_Biological_Process_2021__unsaturated fatty acid biosynthetic process (GO:0006636),-0.6475142849409684,-1.016331305266253,0.5,0.9496821885611216,1.0,2/7,14.59%,FADS3;ALOX12
prerank,GO_Biological_Process_2021__positive regulation of fat cell differentiation (GO:0045600),-0.5216294511099602,-1.016261422508698,0.4423076923076923,0.9491328586649455,1.0,2/31,1.48%,SYAP1;ZFP36
prerank,GO_Biological_Process_2021__positive regulation of peptidase activity (GO:0010952),-0.535424708026561,-1.0162324515028514,0.5245901639344263,0.9484834384651826,1.0,6/16,19.69%,PRELID1;DDRGK1;PINK1;APH1B;PSME2;PSME1
prerank,GO_Biological_Process_2021__positive regulation of neuron death (GO:1901216),0.43506826695918055,1.0161992762512553,0.36363636363636365,0.8357480342195307,1.0,6/38,7.30%,EGR1;CDK5R1;PICALM;WNT5A;DDIT3;TNF
prerank,GO_Biological_Process_2021__negative regulation of toll-like receptor signaling pathway (GO:0034122),-0.5242344044608108,-1.015971240378308,0.4714285714285714,0.9485679781529032,1.0,3/23,8.14%,CD14;CD300LF;TNFAIP3
prerank,MSigDB_Hallmark_2020__Unfolded Protein Response,-0.44854493784788474,-1.0159533620753274,0.44285714285714284,0.9478998453382173,1.0,15/93,12.13%,SLC7A5;RPS14;DDIT4;IFIT1;DNAJB9;ERO1A;EXOSC10;EIF4A3;FKBP14;EXOSC1;NPM1;XPOT;VEGFA;NABP1;ATF3
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.5352580915211159,1.0153528755517889,0.4166666666666667,0.8371781374757047,1.0,4/14,3.94%,SPRY2;SMAD7;SPRED1;SPRED2
prerank,GO_Biological_Process_2021__regulation of biosynthetic process (GO:0009889),-0.6050172112181421,-1.0148400507798843,0.559322033898305,0.9501935842566841,1.0,1/7,6.85%,GSTP1
prerank,GO_Biological_Process_2021__cellular response to interleukin-18 (GO:0071351),-0.7122520265944688,-1.014792422162296,0.5106382978723404,0.9488512010093383,1.0,3/5,22.29%,IL18R1;IL18;PDGFB
prerank,GO_Biological_Process_2021__interleukin-18-mediated signaling pathway (GO:0035655),-0.7122520265944688,-1.014792422162296,0.5106382978723404,0.9488512010093383,1.0,3/5,22.29%,IL18R1;IL18;PDGFB
prerank,GO_Biological_Process_2021__homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.45109566132683815,1.0147398485013204,0.43333333333333335,0.8379493278742978,1.0,9/36,11.01%,CNTN2;IGSF11;PKD1;CADM1;PTPRM;PLXNB2;ROBO1;NPTN;CELSR2
prerank,GO_Biological_Process_2021__protein peptidyl-prolyl isomerization (GO:0000413),-0.5694614160801923,-1.0147349484011459,0.4852941176470588,0.9483188816435071,1.0,1/16,0.79%,PPIE
prerank,GO_Biological_Process_2021__mitochondrial membrane organization (GO:0007006),-0.5178121833449395,-1.0144996300738243,0.5,0.9481354296168367,1.0,9/26,26.37%,SLC25A5;MICOS13;APOO;SPG7;MAIP1;MTX3;GHITM;MICOS10;DNAJC11
prerank,GO_Biological_Process_2021__cardiac muscle tissue morphogenesis (GO:0055008),-0.6032737151075395,-1.0141111581625442,0.47540983606557374,0.9485541818563119,1.0,3/12,7.44%,TGFBR3;TTN;MYBPC3
prerank,GO_Biological_Process_2021__myeloid cell development (GO:0061515),-0.534712609696653,-1.0140169276910198,0.46875,0.9481369313243315,1.0,5/14,20.60%,ANXA2;NCKAP1L;EVI2B;TLR2;MED1
prerank,GO_Biological_Process_2021__postsynaptic membrane organization (GO:0001941),0.5141763080826173,1.0139731122233382,0.4883720930232558,0.8392017222095031,1.0,6/15,15.11%,LRP4;NLGN1;SHANK3;NRXN2;GPHN;NLGN4Y
prerank,GO_Biological_Process_2021__negative regulation of response to DNA damage stimulus (GO:2001021),-0.5381734250558373,-1.0139258742249284,0.4507042253521127,0.9476201580883847,1.0,5/18,8.71%,CLU;RPS3;PTTG1IP;TPT1;CD44
prerank,GO_Biological_Process_2021__negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.6378936404014927,1.0138671144480762,0.5714285714285714,0.8387745923833989,1.0,3/6,25.72%,TNF;ESR1;TGFB1
prerank,GO_Biological_Process_2021__positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),-0.5154291517381349,-1.0138206387126094,0.47368421052631576,0.9472443044102583,1.0,7/28,13.37%,RACK1;RPS3;FIS1;RPS7;EIF5A;BMF;SOD1
prerank,GO_Biological_Process_2021__negative regulation of smoothened signaling pathway (GO:0045879),0.48353341898021807,1.0136778564673312,0.48717948717948717,0.8385408082917024,1.0,8/20,14.62%,TULP3;PTCH2;GPR161;KCTD6;BTRC;PTCH1;MEGF8;ENPP1
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase II promoter (GO:0006367),0.373573045622912,1.0135836018961002,0.38461538461538464,0.838134134194072,1.0,12/97,7.63%,ESRRG;PPARGC1A;POLR2D;MAML2;DR1;HDAC9;E2F3;PPARG;CDK7;TAF2;MAML3;TAF9B
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization or depolymerization (GO:0031110),0.4827161187995622,1.0134847501561217,0.40540540540540543,0.8376992521130584,1.0,9/21,22.75%,MAP1S;CLASP1;FKBP4;CLASP2;CAMSAP2;MAP2;MAPRE2;STMN3;ABL1
prerank,GO_Biological_Process_2021__gene silencing by miRNA (GO:0035195),-0.496202927524674,-1.013035383831628,0.4262295081967213,0.9488025849447373,1.0,1/25,1.48%,ZFP36
prerank,GO_Biological_Process_2021__regulation of nitric oxide biosynthetic process (GO:0045428),0.4665495856647492,1.0129905997688116,0.4722222222222222,0.8380531106756991,1.0,5/26,7.30%,KLF4;PKD2;SIRPA;SMAD3;TNF
prerank,GO_Biological_Process_2021__cleavage furrow formation (GO:0036089),0.6110347737284332,1.0128572882723759,0.6,0.8376573935854704,1.0,2/5,12.03%,SPIRE2;SNX18
prerank,GO_Biological_Process_2021__negative regulation of interleukin-10 production (GO:0032693),-0.6109853369880573,-1.0128375574985147,0.5079365079365079,0.9485996202468112,1.0,2/10,11.20%,LILRB4;TYROBP
prerank,GO_Biological_Process_2021__cyclic purine nucleotide metabolic process (GO:0052652),0.5038074291281727,1.0128137500883594,0.45098039215686275,0.837099186245604,1.0,5/13,15.24%,ADCY9;GUCY1A1;NPR2;ADCY6;GUCY1B1
prerank,GO_Biological_Process_2021__nonribosomal peptide biosynthetic process (GO:0019184),0.5941539807895799,1.0127844763561114,0.5102040816326531,0.8358225620048076,1.0,1/6,1.41%,GCLC
prerank,GO_Biological_Process_2021__glutathione biosynthetic process (GO:0006750),0.5941539807895799,1.0127844763561114,0.5102040816326531,0.8358225620048076,1.0,1/6,1.41%,GCLC
prerank,GO_Biological_Process_2021__stress-activated MAPK cascade (GO:0051403),-0.46134220054085684,-1.0127115447361368,0.36619718309859156,0.94817727996794,1.0,3/57,1.48%,UBC;RPS27A;ZFP36
prerank,GO_Biological_Process_2021__energy derivation by oxidation of organic compounds (GO:0015980),-0.5601106948509544,-1.012509743323549,0.45454545454545453,0.9480682358689886,1.0,3/16,1.81%,NR4A3;CYCS;PID1
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),-0.5191437047388054,-1.0121817293988675,0.4745762711864407,0.948245179247945,1.0,6/25,14.82%,UBC;RPS27A;TNFAIP3;ALPK1;NOD2;UBA52
prerank,PanglaoDB_Augmented_2021__Neurons,0.34824617254511697,1.012017066944744,0.2727272727272727,0.8368465723832893,1.0,42/199,15.82%,KCNQ2;CNTN2;NCAN;LUZP2;NBEA;PNMA8A;CHODL;NOL4;SNAP91;SCN3B;CNRIP1;VGF;GNL3L;COPG1;GRIA3;GRIA4;CA10;DNM3;OLFM3;CTNNA2;CADM2;SCN8A;PSD2;GRM5;SNCB;STX1A;CLSTN3;PTPN5;FBXW7;RGS17;RBFOX1;SLC12A5;CSPP1;GRIA2;SGIP1;CACNG2;GAD1;CACNB4;CSRNP3;EML5;RNF220;PPFIA2
prerank,GO_Biological_Process_2021__zinc ion homeostasis (GO:0055069),-0.5535059031224965,-1.0119706308043355,0.4827586206896552,0.9480831151268874,1.0,1/16,0.25%,MT2A
prerank,GO_Biological_Process_2021__integrin-mediated signaling pathway (GO:0007229),0.4220900321577393,1.0116552350371721,0.2903225806451613,0.8370176957692164,1.0,2/49,0.61%,COL16A1;NRP1
prerank,GO_Biological_Process_2021__regulation of keratinocyte proliferation (GO:0010837),-0.6090027248915637,-1.0116496200956262,0.4909090909090909,0.9482730497488957,1.0,3/11,15.71%,ZFP36;NOTCH2;STXBP4
prerank,GO_Biological_Process_2021__protein autoprocessing (GO:0016540),0.5586923523210557,1.0110934026937486,0.4523809523809524,0.837723756387206,1.0,1/10,2.82%,MYRF
prerank,GO_Biological_Process_2021__glial cell differentiation (GO:0010001),0.5077735542771346,1.0109758235418076,0.3939393939393939,0.8374068814936017,1.0,6/14,11.35%,MYRF;TPPP;RELN;SOX4;NFIB;METRN
prerank,GO_Biological_Process_2021__cellular response to pH (GO:0071467),0.5936368780483307,1.0107351198230041,0.5121951219512195,0.8372527236047337,1.0,3/7,18.72%,SLC9A1;HVCN1;CHP1
prerank,GO_Biological_Process_2021__regulation of histone H3-K4 methylation (GO:0051569),-0.5473846669706107,-1.0107349878644472,0.46551724137931033,0.9496829311493145,1.0,3/15,14.26%,ZNF335;DNMT1;BRCA1
prerank,GO_Biological_Process_2021__regulation of mast cell activation involved in immune response (GO:0033006),0.5742075120355413,1.0104766646724115,0.45714285714285713,0.8372036901618907,1.0,1/9,1.04%,FER
prerank,GO_Biological_Process_2021__response to hexose (GO:0009746),-0.5856705566821436,-1.0104013932679952,0.47540983606557374,0.949685805910888,1.0,4/13,19.72%,EIF2B1;SELENOS;EIF2B2;PFKL
prerank,GO_Biological_Process_2021__phospholipid translocation (GO:0045332),-0.5079692586843927,-1.0100170978702634,0.47540983606557374,0.9500131343178368,1.0,5/24,14.37%,ABCB1;ATP10A;PLSCR1;ABCB4;ATP8B1
prerank,GO_Biological_Process_2021__negative regulation of protein tyrosine kinase activity (GO:0061099),-0.5704320068588382,-1.0095155662788091,0.453125,0.9505119929735844,1.0,6/16,12.82%,SNX6;CBLB;LILRB4;SH3BP5;SH3BP5L;PTPRC
prerank,GO_Biological_Process_2021__regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.5425350312756454,1.009279977609708,0.4864864864864865,0.839250717049784,1.0,1/11,0.08%,KLF4
prerank,GO_Biological_Process_2021__mitotic cell cycle phase transition (GO:0044772),0.3462665762850395,1.0091608949598971,0.4117647058823529,0.8388194017016299,1.0,34/152,19.38%,EPS8;CCNG2;BORA;E2F3;CDK7;TAF2;RCC1;CEP41;BRSK1;YWHAG;CCNG1;SPDYA;PLK2;CDC23;CEP131;BTRC;FBXW11;CHMP7;CDK6;CSNK1E;FBXL12;FBXL7;CLASP1;ANAPC1;DYNC1H1;CCND3;HINFP;CLASP2;ALMS1;TPD52L1;BRSK2;CEP135;ODF2;NDE1
prerank,GO_Biological_Process_2021__neutral amino acid transport (GO:0015804),-0.5485106840019704,-1.0087811613000623,0.5081967213114754,0.9519158648630754,1.0,4/16,10.63%,SLC7A5;SLC38A1;LLGL2;SLC36A4
prerank,GO_Biological_Process_2021__negative regulation of DNA repair (GO:0045738),-0.7264471798976948,-1.0087649166049606,0.5370370370370371,0.9512035321379065,1.0,1/5,5.49%,RPS3
prerank,GO_Biological_Process_2021__negative regulation of stem cell differentiation (GO:2000737),0.5538562009512862,1.0083732284040492,0.4772727272727273,0.8400914528269678,1.0,4/9,26.65%,JAG1;HNRNPU;YTHDF2;NOTCH1
prerank,GO_Biological_Process_2021__sphingosine-1-phosphate receptor signaling pathway (GO:0003376),-0.6924457451692604,-1.0082948975559576,0.5573770491803278,0.9518455755994959,1.0,3/5,17.60%,PIK3CB;RAC1;EZR
prerank,GO_Biological_Process_2021__cellular response to interleukin-9 (GO:0071355),-0.6647413611607247,-1.0082267844584516,0.5714285714285714,0.9505560948406367,1.0,1/6,9.56%,STAT1
prerank,GO_Biological_Process_2021__interleukin-9-mediated signaling pathway (GO:0038113),-0.6647413611607247,-1.0082267844584516,0.5714285714285714,0.9505560948406367,1.0,1/6,9.56%,STAT1
prerank,GO_Biological_Process_2021__regulation of lipid metabolic process (GO:0019216),0.38389296856243255,1.0080996044171868,0.32142857142857145,0.8399833165630884,1.0,13/69,12.66%,NFYC;IDI1;PPARG;PLPP1;FDFT1;ACACB;TM7SF2;ELOVL6;HMGCS1;TBL1XR1;MVD;RUBCNL;FASN
prerank,GO_Biological_Process_2021__positive regulation of vacuole organization (GO:0044090),-0.6092472268455384,-1.007815031757492,0.48936170212765956,0.9509139526821033,1.0,1/10,3.81%,ANXA2
prerank,GO_Biological_Process_2021__negative regulation of transcription regulatory region DNA binding (GO:2000678),-0.6270205957116615,-1.0077846716179615,0.5084745762711864,0.9502840615305536,1.0,2/7,8.69%,PER2;TMSB4X
prerank,GO_Biological_Process_2021__negative regulation of axon extension involved in axon guidance (GO:0048843),0.5735839023679191,1.0075416966464483,0.43478260869565216,0.8407775940897144,1.0,2/11,6.05%,SEMA5A;SEMA3B
prerank,"GO_Biological_Process_2021__mRNA cis splicing, via spliceosome (GO:0045292)",-0.5942776681580717,-1.0074499897999358,0.5,0.9503851040408486,1.0,4/14,17.33%,RBM22;NCBP2;DDX23;SNRNP200
prerank,GO_Biological_Process_2021__regulation of epidermis development (GO:0045682),0.605723508406122,1.0072738762972677,0.4444444444444444,0.8406975591820575,1.0,2/6,10.46%,TMEM79;KLF7
prerank,GO_Biological_Process_2021__positive regulation of p38MAPK cascade (GO:1900745),-0.53439841978805,-1.0068941223671155,0.4666666666666667,0.95109056131179,1.0,2/16,11.19%,GADD45B;VEGFA
prerank,GO_Biological_Process_2021__cellular glucan metabolic process (GO:0006073),0.6306471635868951,1.0063511105093337,0.5,0.8422770753270039,1.0,5/7,32.02%,GSK3B;PHKB;PRKAG2;PHKG2;UGP2
prerank,GO_Biological_Process_2021__maturation of LSU-rRNA (GO:0000470),-0.4975462230062089,-1.006147856132517,0.4603174603174603,0.9525566535774822,1.0,7/23,18.49%,RPL7A;RPL35;RPL10A;NSA2;NHP2;ZNHIT6;LAS1L
prerank,GO_Biological_Process_2021__receptor signaling pathway via STAT (GO:0097696),-0.5528445332571326,-1.0059968724548691,0.48214285714285715,0.9521505152376039,1.0,1/17,0.41%,STAT4
prerank,GO_Biological_Process_2021__regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.5284885143285104,1.005792357741116,0.47619047619047616,0.8428971433176422,1.0,6/11,25.72%,MAP2K1;TNF;MAP2K2;RIPK1;ESR1;TGFB1
prerank,GO_Biological_Process_2021__regulation of cell motility (GO:2000145),0.36709228535925087,1.0054365223308042,0.42105263157894735,0.8429197825977641,1.0,20/80,14.52%,PLXNB1;SRCIN1;AMOT;PLXNA2;FGF2;SERPINE2;PLXNA3;TBCCD1;NRG1;PLXNB2;CRK;PLXNC1;DOCK10;CCDC125;CDK6;MEMO1;PLXNA1;NRG2;ERBB4;FRMD5
prerank,GO_Biological_Process_2021__regulation of histone H4-K16 acetylation (GO:2000618),0.6614044275681186,1.0053069270858472,0.45454545454545453,0.8425923588026657,1.0,2/5,8.34%,SIRT1;AUTS2
prerank,GO_Biological_Process_2021__autophagosome membrane docking (GO:0016240),-0.6283794099445519,-1.0050666516946218,0.5283018867924528,0.9539873070120916,1.0,1/7,8.36%,CALM1
prerank,GO_Biological_Process_2021__response to leptin (GO:0044321),-0.6095554625742616,-1.004912028246695,0.5,0.9535938043129439,1.0,1/7,0.08%,NR4A3
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide metabolic process (GO:1904407),0.5017450210584095,1.00374648550837,0.42105263157894735,0.8456779153564997,1.0,4/18,7.30%,KLF4;PKD2;SMAD3;TNF
prerank,GO_Biological_Process_2021__lipoxygenase pathway (GO:0019372),-0.6128640269630559,-1.0037345504728943,0.49056603773584906,0.9561010285599525,1.0,4/8,14.59%,GPX4;PON2;GPX1;ALOX12
prerank,PanglaoDB_Augmented_2021__Urothelial Cells,-0.4845597030397727,-1.003253293286513,0.46153846153846156,0.9566485198258201,1.0,6/41,10.26%,CARD14;NBEAL2;PRKD2;LLGL2;SSH3;SLC14A1
prerank,GO_Biological_Process_2021__regulation of erythrocyte differentiation (GO:0045646),-0.4845962348837456,-1.0032128278084753,0.4603174603174603,0.9560316526430954,1.0,9/32,14.43%,ZFP36;ETS1;ANKRD54;STAT1;NCKAP1L;HIF1A;HSPA1B;ZNF16;HSPA1A
prerank,GO_Biological_Process_2021__glycerophospholipid biosynthetic process (GO:0046474),0.3626023913396411,1.0031587810362337,0.375,0.8465011957881333,1.0,32/132,18.14%,PLA2G4C;FGF2;ETNPPL;PIP5K1B;CHKA;PIK3C2B;ABHD8;SLC44A2;PTPN13;PI4KB;DDHD1;IMPA1;GPAT4;SELENOI;AGPAT5;SLC44A5;SLC44A1;PTEN;LCAT;GPAT3;PIP4K2A;CHPT1;SBF1;MTMR9;HDHD5;AGPAT2;RAB14;STARD7;PEMT;PIK3CA;PLEKHA8;INPP4B
prerank,GO_Biological_Process_2021__positive regulation of glycogen metabolic process (GO:0070875),-0.564970545246997,-1.0029268600802659,0.42857142857142855,0.9560688926242327,1.0,1/10,5.56%,IGF1
prerank,GO_Biological_Process_2021__regulation of fibroblast proliferation (GO:0048145),-0.49761146100841863,-1.0028672215295062,0.46875,0.9554468640686511,1.0,7/34,9.17%,FTH1;NLRC3;EMD;IGF1;MED25;GSTP1;S100A6
prerank,PanglaoDB_Augmented_2021__Interneurons,0.34490892347040364,1.0028500072858302,0.4,0.8465209554037262,1.0,73/199,21.61%,KCNQ2;CNTN2;NCAN;NBEA;KCNIP2;NOL4;SLC22A15;SNAP91;CDK17;RELN;PARM1;PLCB4;PCF11;CHST1;NPTXR;VGF;SHISA9;ELMO1;GRIA4;DNAJC6;CA10;DNM3;OLFM3;CTNNA2;KCNC2;CADM2;DEPTOR;SV2B;SCN8A;PSD2;GRM5;SNCB;PTPN5;FBXW11;RGS17;SLC35F1;LINGO1;CAMKV;RBFOX1;SLC12A5;OXR1;CXCL14;CACNA1E;GRIA2;CACNG2;GAD1;CSRNP3;FBXO11;EML5;PPFIA2;SPOCK3;ADGRB3;MAPK4;NXPH1;CDH4;DLGAP1;TMEM132D;HIVEP2;TRIM9;MAP2;PTPRO;PHYHIPL;SYT4;GRM3;KCNQ5;CELF5;HLF;AMER2;CACNA1B;GABRA4;GRM1;SYNPR;NRXN1
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial membrane potential (GO:0010917),0.5797692350973638,1.0025663265900129,0.475,0.8465878379265565,1.0,1/6,0.62%,RNF122
prerank,GO_Biological_Process_2021__tRNA transcription by RNA polymerase III (GO:0042797),-0.6577490381493026,-1.0024901581137033,0.5535714285714286,0.9550658625322839,1.0,1/6,3.40%,GTF3C6
prerank,GO_Biological_Process_2021__5S class rRNA transcription by RNA polymerase III (GO:0042791),-0.6577490381493026,-1.0024901581137033,0.5535714285714286,0.9550658625322839,1.0,1/6,3.40%,GTF3C6
prerank,GO_Biological_Process_2021__regulation of cholesterol metabolic process (GO:0090181),0.4955394397271431,1.0023170766764593,0.425531914893617,0.8465886525661029,1.0,5/15,23.19%,ABCA2;ACADVL;ARV1;DGKQ;KPNB1
prerank,GO_Biological_Process_2021__regulation of anion channel activity (GO:0010359),-0.6489217206690514,-1.002181041071115,0.4897959183673469,0.9550646433412662,1.0,1/5,4.97%,ABCB1
prerank,GO_Biological_Process_2021__myelin assembly (GO:0032288),0.5701745425453401,1.00206317001759,0.5681818181818182,0.8464199766730462,1.0,2/10,5.32%,ABCA2;TPPP
prerank,GO_Biological_Process_2021__UV protection (GO:0009650),-0.6215325704451325,-1.0020125967073936,0.5306122448979592,0.9547640922142314,1.0,1/5,1.76%,XPA
prerank,GO_Biological_Process_2021__negative regulation of protein K63-linked ubiquitination (GO:1900045),0.6085766883625569,1.0013618435933622,0.48,0.8474276571552031,1.0,2/6,29.00%,TRIP12;UBR5
prerank,GO_Biological_Process_2021__positive regulation of apoptotic signaling pathway (GO:2001235),-0.49235921954300715,-1.0010124826175555,0.4925373134328358,0.9564797280082026,1.0,9/40,16.09%,RACK1;TNFSF10;ING5;RPS3;FIS1;TRAF7;BMF;AGT;DEDD2
prerank,GO_Biological_Process_2021__negative regulation of response to reactive oxygen species (GO:1901032),0.6100350675441499,1.0007477429045044,0.4772727272727273,0.8482739482816243,1.0,1/6,3.81%,LRRK2
prerank,GO_Biological_Process_2021__regulation of myelination (GO:0031641),0.48157908817608663,1.0006808250074595,0.4878048780487805,0.8478037445424593,1.0,6/21,15.71%,LGI4;MYRF;TPPP;RNF10;JAM2;PARD3
prerank,GO_Biological_Process_2021__regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.498397357234472,1.0006425494947475,0.46153846153846156,0.8471840798301782,1.0,1/13,1.00%,PKD2
prerank,GO_Biological_Process_2021__protein stabilization (GO:0050821),-0.3946666699936797,-1.0005912335288556,0.47435897435897434,0.9568413116781005,1.0,21/137,12.87%,FLNA;GAPDH;PYHIN1;RPL5;PER3;CDC37;USP36;CLU;RPL11;RPL23;IGF1;IFT46;PHB2;RPS7;HPS4;DVL1;TYROBP;NOP53;PFN1;HSPA1B;ATP1B3
prerank,GO_Biological_Process_2021__heart morphogenesis (GO:0003007),-0.5280212325818803,-1.000589141511752,0.4406779661016949,0.9561375618786724,1.0,4/23,11.19%,TGFBR3;TTN;MYBPC3;VEGFA
prerank,GO_Biological_Process_2021__regulation of proton transport (GO:0010155),-0.6420152341847049,-1.0005568443758062,0.5272727272727272,0.9555386699648217,1.0,2/6,19.58%,PHB2;SLC30A5
prerank,GO_Biological_Process_2021__substantia nigra development (GO:0021762),-0.5071593252168164,-1.0004584416086553,0.4657534246575342,0.955135161540464,1.0,6/34,14.67%,PADI2;BASP1;CALM1;ACTB;CASP5;INA
prerank,GO_Biological_Process_2021__protein oxidation (GO:0018158),0.6560880529278609,1.0002869973447712,0.5365853658536586,0.8473251228714539,1.0,1/5,9.95%,LOXL2
prerank,GO_Biological_Process_2021__positive regulation of histone ubiquitination (GO:0033184),0.7064008555822123,1.0000059604298595,0.52,0.8473253624433364,1.0,2/5,20.63%,RNF20;CDK9
prerank,GO_Biological_Process_2021__regulation of T cell proliferation (GO:0042129),-0.4785706839351949,-0.9998411960397355,0.4264705882352941,0.955911265968149,1.0,8/39,10.76%,IL4I1;TFRC;CCL5;AIF1;LILRB4;TNFRSF1B;GLMN;NCKAP1L
prerank,GO_Biological_Process_2021__platelet-derived growth factor receptor signaling pathway (GO:0048008),-0.5827744115967791,-0.9996126633766262,0.5645161290322581,0.9557216988108796,1.0,2/12,2.35%,NR4A3;PDGFD
prerank,GO_Biological_Process_2021__negative regulation of secretion (GO:0051048),0.5833925637827961,0.9989027563382906,0.43902439024390244,0.8490394138300796,1.0,1/5,6.19%,NRG1
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue development (GO:0003229),-0.5964597460849014,-0.9985572973887807,0.4716981132075472,0.9577704832414534,1.0,2/10,7.44%,TGFBR3;MYBPC3
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, glutamatergic (GO:0051966)",0.47967943656269685,0.9984929746645376,0.5161290322580645,0.8493939267822126,1.0,17/31,23.83%,NLGN1;LRRK2;RELN;TNF;SHANK3;GRM5;CACNG8;CACNG2;ATAD1;HOMER1;GRM3;GRIK3;CACNG3;GRM1;NRXN1;TSHZ3;CDH2
prerank,GO_Biological_Process_2021__myelin maintenance (GO:0043217),-0.6343287733992241,-0.9982950058452819,0.5,0.9577220111929825,1.0,4/7,13.37%,CXCR4;CLU;EPB41L3;SOD1
prerank,GO_Biological_Process_2021__positive regulation of supramolecular fiber organization (GO:1902905),0.37831752422653037,0.9979668135276814,0.4444444444444444,0.8499162035719858,1.0,6/60,4.28%,FER;CDK5R1;SEMA5A;CDC42EP3;NCK2;VASP
prerank,GO_Biological_Process_2021__energy reserve metabolic process (GO:0006112),0.564328678198541,0.9977778513570168,0.3902439024390244,0.8497369182202098,1.0,2/11,6.70%,LEPR;GFPT1
prerank,PanglaoDB_Augmented_2021__Adipocytes,0.3796014338402502,0.9976396377468952,0.47058823529411764,0.849417866156275,1.0,9/72,5.20%,COL5A3;PPARGC1A;SVEP1;GSN;ZBTB16;ACTA2;GULP1;PPARG;TIMP3
prerank,"GO_Biological_Process_2021__neurotransmitter receptor transport, endosome to postsynaptic membrane (GO:0098887)",0.6600414414168899,0.9972289880165577,0.5294117647058824,0.8498549562221905,1.0,1/5,0.84%,SCRIB
prerank,GO_Biological_Process_2021__regulation of mitotic sister chromatid separation (GO:0010965),0.5669901945859791,0.9969935789416847,0.5,0.8497040975853336,1.0,3/11,14.97%,CDC23;CENPE;ANAPC1
prerank,GO_Biological_Process_2021__negative regulation of nucleocytoplasmic transport (GO:0046823),-0.5810523861297645,-0.996986288125082,0.5,0.9605348449682146,1.0,2/12,4.08%,MDFIC;APOD
prerank,GO_Biological_Process_2021__positive regulation of receptor-mediated endocytosis (GO:0048260),-0.4853327327314143,-0.9967464065403766,0.4626865671641791,0.9604004853106598,1.0,8/30,14.85%,B2M;ANXA2;CLU;CD63;VEGFA;DGKD;PICK1;C3
prerank,GO_Biological_Process_2021__regulation of protein secretion (GO:0050708),0.35678664066502663,0.9966466197006697,0.4722222222222222,0.8497490790347819,1.0,20/73,15.33%,CACNA1A;MYOM1;GOLPH3L;RAP1A;TMED10;UNC13B;TNF;RFX3;CLOCK;KCNC2;CD33;DISP1;STX1A;ARF6;ABCC8;CACNA1E;RAPGEF3;ATP13A2;STXBP5;SLC12A2
prerank,GO_Biological_Process_2021__negative regulation of purine nucleotide metabolic process (GO:1900543),0.6455740625335743,0.9965678931450409,0.5208333333333334,0.8486111873585753,1.0,2/6,8.31%,CBFA2T3;GIT1
prerank,GO_Biological_Process_2021__negative regulation of glycolytic process (GO:0045820),0.6455740625335743,0.9965678931450409,0.5208333333333334,0.8486111873585753,1.0,2/6,8.31%,CBFA2T3;GIT1
prerank,GO_Biological_Process_2021__cellular response to osmotic stress (GO:0071470),-0.5534494862598907,-0.9962278971530799,0.55,0.9610079784523654,1.0,3/16,9.02%,MYLK;STK39;TRPV4
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion (GO:0022409),-0.5114303886324996,-0.9959047170615598,0.5454545454545454,0.9612472397164735,1.0,2/26,1.49%,SKAP1;CCL5
prerank,GO_Biological_Process_2021__negative regulation of myotube differentiation (GO:0010832),0.596093637706178,0.9958130785233301,0.52,0.8498092633610299,1.0,4/8,26.65%,TMEM119;HDAC1;HDAC3;NOTCH1
prerank,GO_Biological_Process_2021__regulation of Ras protein signal transduction (GO:0046578),0.4002827316996559,0.9958130178922596,0.3870967741935484,0.849157569140661,1.0,10/64,16.28%,EPS8;SPRY2;KBTBD6;KANK1;ARF6;SHOC2;SYNGAP1;VAV1;LZTR1;STARD13
prerank,GO_Biological_Process_2021__transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),-0.4325460396549823,-0.9955960131182814,0.43661971830985913,0.9612285625620378,1.0,4/74,1.30%,UBC;TGFBR3;FOS;RPS27A
prerank,GO_Biological_Process_2021__mitochondrial RNA metabolic process (GO:0000959),0.48903402773238863,0.995572451847095,0.4473684210526316,0.8489801015686531,1.0,2/12,16.21%,TFB1M;FASTKD1
prerank,PanglaoDB_Augmented_2021__Olfactory Epithelial Cells,-0.4123241652679077,-0.9954704955036411,0.5180722891566265,0.9609203475025336,1.0,6/113,7.02%,PKIB;PDE4A;ATF5;SEZ6L2;SCN9A;H2BC21
prerank,GO_Biological_Process_2021__regulation of protein neddylation (GO:2000434),-0.6027802500448299,-0.9954694906264051,0.5490196078431373,0.9602074985800542,1.0,3/9,11.34%,RPL5;RPL11;HIF1A
prerank,GO_Biological_Process_2021__regulation of protein-containing complex disassembly (GO:0043244),0.5011089546501047,0.9949097763577284,0.4166666666666667,0.8498228118235088,1.0,3/15,10.79%,IGF1R;TNF;IRAK3
prerank,GO_Biological_Process_2021__ERBB signaling pathway (GO:0038127),0.4431677612641681,0.9943041398306571,0.41935483870967744,0.8507939394536053,1.0,16/47,21.66%,TGFA;GAB1;NCK2;NRG1;MAPK1;NRG2;PTK2;ERBB4;PTPRR;PIK3CA;ERBIN;PTPN12;GAREM1;PTPN18;CPNE3;CBL
prerank,GO_Biological_Process_2021__DNA strand elongation (GO:0022616),0.5460384490514705,0.9942201545855301,0.5306122448979592,0.8503934431646288,1.0,4/11,18.30%,GINS3;POLA1;GINS1;NBN
prerank,GO_Biological_Process_2021__endomembrane system organization (GO:0010256),0.35916827841800486,0.99418294123388,0.4090909090909091,0.849808546313452,1.0,14/144,11.11%,SYNGR1;VAPB;EXOC8;GOLPH3L;LRRK2;TOR1AIP2;TMED3;TMED10;TMED5;LEMD3;LMAN2L;COG1;REEP3;BLZF1
prerank,GO_Biological_Process_2021__respiratory chain complex IV assembly (GO:0008535),-0.5684728752575863,-0.9937606796938382,0.5357142857142857,0.9641218878316429,1.0,7/15,18.82%,TIMM21;BCS1L;COX18;COA6;OXA1L;SURF1;COX20
prerank,GO_Biological_Process_2021__positive regulation of histone phosphorylation (GO:0033129),0.6118815738019178,0.9936958827626634,0.5,0.8501304115258964,1.0,1/6,5.00%,RPS6KA4
prerank,MSigDB_Hallmark_2020__Epithelial Mesenchymal Transition,-0.41238465802676294,-0.9935774745454058,0.47435897435897434,0.9638443169525188,1.0,13/103,8.71%,FLNA;MYLK;COL5A1;SAT1;TGFBR3;TNFRSF11B;GADD45B;BASP1;RGS4;SNTB1;EMP3;TNFAIP3;CD44
prerank,GO_Biological_Process_2021__regulation of necroptotic process (GO:0060544),-0.5824726013915251,-0.9934531847757808,0.5333333333333333,0.9633618533055875,1.0,10/18,29.20%,CDC37;CFLAR;MLKL;FLOT1;SDCBP;OGT;ARHGEF2;HSP90AA1;BIRC2;YBX3
prerank,GO_Biological_Process_2021__Golgi inheritance (GO:0048313),0.5394925507626789,0.9934320822011002,0.46153846153846156,0.850026906192215,1.0,1/9,6.12%,STK25
prerank,GO_Biological_Process_2021__positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),-0.5255277911220959,-0.9933204313305044,0.5166666666666667,0.9622581279023569,1.0,1/18,3.32%,GZMB
prerank,GO_Biological_Process_2021__regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),-0.5255277911220959,-0.9933204313305044,0.5166666666666667,0.9622581279023569,1.0,1/18,3.32%,GZMB
prerank,GO_Biological_Process_2021__neurotransmitter receptor transport to postsynaptic membrane (GO:0098969),0.6355480130207926,0.9931484495369767,0.47619047619047616,0.8499604765264964,1.0,1/7,0.84%,SCRIB
prerank,GO_Biological_Process_2021__regulation of spindle organization (GO:0090224),0.5505502099366546,0.9930758702653095,0.5,0.8494699157136228,1.0,1/13,2.24%,BORA
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell periphery (GO:1904376),-0.5595699694342879,-0.9928923552300286,0.48333333333333334,0.9625780953263937,1.0,1/14,1.81%,PID1
prerank,GO_Biological_Process_2021__response to acidic pH (GO:0010447),0.6038313631309706,0.9928762755661634,0.5777777777777777,0.8493579339304653,1.0,2/8,18.72%,SLC9A1;CHP1
prerank,GO_Biological_Process_2021__regulation of neuron apoptotic process (GO:0043523),0.3853043734553975,0.9927431131214252,0.38095238095238093,0.8490619541511619,1.0,13/57,12.90%,PPARGC1A;CDK5R1;GRID2;DDIT3;PPT1;CPEB4;LIG4;TNF;UNC5B;SOD2;NF1;NTRK2;PRKCI
prerank,GO_Biological_Process_2021__IMP metabolic process (GO:0046040),-0.6366106877619648,-0.9925885543584877,0.5,0.96260333764932,1.0,1/6,8.61%,AMPD2
prerank,GO_Biological_Process_2021__proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.3314028684649486,0.9924394986805276,0.4117647058823529,0.8491436823376488,1.0,40/258,13.44%,UBE2D1;SPSB2;RNF122;KBTBD6;UBE2J1;SIRT1;FBXL14;SPOPL;FEM1B;DNAJB2;UBE3D;DDIT3;SEL1L;FZR1;CLOCK;DNAJC18;UBR3;NEDD4L;APPBP2;AUP1;RMND5A;FAM8A1;SHARPIN;CDC23;MDM2;BTRC;FBXO45;KCTD10;TBL1XR1;ANAPC16;FBXW11;FBXW7;FEM1C;RNF185;KLHL42;FBXL12;COP1;FBXL7;STT3B;BAG6
prerank,GO_Biological_Process_2021__liver development (GO:0001889),0.5017352349557063,0.9924074719092058,0.4878048780487805,0.8485540929042487,1.0,7/19,12.89%,ANXA1;PKD2;PRKCSH;PCK2;COBL;NF1;CCDC40
prerank,GO_Biological_Process_2021__cellular response to brain-derived neurotrophic factor stimulus (GO:1990416),0.6685664276766807,0.9923844021393932,0.4583333333333333,0.8480113354215245,1.0,4/5,33.13%,NTRK2;TMEM108;WASF1;MAPT
prerank,GO_Biological_Process_2021__mismatch repair (GO:0006298),0.4766119119893463,0.9921769924765655,0.4444444444444444,0.8477356351346215,1.0,7/19,22.75%,MSH4;TDG;SETD2;MLH3;ERCC1;PMS1;ABL1
prerank,GO_Biological_Process_2021__positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902961),0.6667561289427768,0.9921255050539978,0.5238095238095238,0.847249361266507,1.0,1/5,3.41%,PICALM
prerank,GO_Biological_Process_2021__regulation of vascular wound healing (GO:0061043),0.6016640727075617,0.9919747232529231,0.45652173913043476,0.8469929883888231,1.0,2/6,7.30%,SERPINE1;TNF
prerank,GO_Biological_Process_2021__cellular response to acidic pH (GO:0071468),0.614452910569262,0.991546681265189,0.5531914893617021,0.8472774231244715,1.0,2/5,18.72%,SLC9A1;CHP1
prerank,GO_Biological_Process_2021__response to amino acid (GO:0043200),0.48931245158842646,0.9910460689858632,0.4642857142857143,0.8476529552106699,1.0,3/25,6.73%,RRAGD;GLRA1;CPEB4
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.48462639436197896,0.9907560439538687,0.41379310344827586,0.8475431915380369,1.0,9/28,18.04%,WNT5A;FZD3;NLK;PPP3CA;TCF7L2;MAP3K7;PPP3CB;PLCB3;TNRC6C
prerank,GO_Biological_Process_2021__negative regulation of centrosome duplication (GO:0010826),-0.577143138808616,-0.9901101292664661,0.5,0.9680873817325072,1.0,5/9,24.71%,TMEM67;NPM1;BRCA1;CENATAC;MDM1
prerank,MSigDB_Hallmark_2020__Glycolysis,-0.41359702270829213,-0.9900928906594777,0.5,0.9674186907017872,1.0,28/127,15.40%,COL5A1;ME1;CXCR4;MDH2;DDIT4;ANKZF1;IER3;CYB5A;SLC16A3;ERO1A;HK2;XYLT2;CD44;EGLN3;GPC3;LDHA;CITED2;VEGFA;MXI1;SDC3;PGK1;SOD1;DSC2;VLDLR;STMN1;PPFIA4;GUSB;TALDO1
prerank,MSigDB_Hallmark_2020__KRAS Signaling Dn,-0.4472247829307432,-0.9898703622121654,0.44594594594594594,0.9672424500138972,1.0,11/64,7.98%,MX1;RSAD2;IFI44L;BTG2;STAG3;SIDT1;SELENOP;SLC16A7;MFSD6;PLAG1;SGK1
prerank,GO_Biological_Process_2021__negative regulation of natural killer cell mediated immunity (GO:0002716),-0.6219942631480426,-0.989376410319079,0.5740740740740741,0.9679274949909686,1.0,3/6,14.31%,HLA-F;KLRD1;HLA-E
prerank,GO_Biological_Process_2021__carbohydrate catabolic process (GO:0016052),-0.5044490422468031,-0.9893519913872183,0.4918032786885246,0.9672986362750713,1.0,5/25,13.22%,GAPDH;HK2;LDHA;ENOSF1;PGK1
prerank,GO_Biological_Process_2021__glycosphingolipid biosynthetic process (GO:0006688),0.528497598916251,0.9890314648570839,0.4782608695652174,0.8506322148662068,1.0,5/10,17.01%,LARGE1;ST6GALNAC3;ST6GALNAC5;ST8SIA4;ST8SIA5
prerank,GO_Biological_Process_2021__regulation of nervous system development (GO:0051960),-0.5224175712494039,-0.9888982295837219,0.5211267605633803,0.9678616298885058,1.0,6/22,10.30%,PER2;BHLHE40;TNFRSF1B;TYMP;PRUNE1;PTN
prerank,GO_Biological_Process_2021__endocardial cushion development (GO:0003197),0.6037500013049089,0.9888237509984746,0.5116279069767442,0.8504107856359501,1.0,3/7,26.65%,BMPR1A;ACVR1;NOTCH1
prerank,GO_Biological_Process_2021__ribosomal small subunit export from nucleus (GO:0000056),-0.6140949818672732,-0.9884371845954406,0.625,0.9684937999517945,1.0,3/6,17.60%,RPS15;NPM1;NUP88
prerank,GO_Biological_Process_2021__regulation of intracellular transport (GO:0032386),-0.5062499869800696,-0.9880422839828701,0.5223880597014925,0.9687434870925782,1.0,1/27,0.35%,MX2
prerank,GO_Biological_Process_2021__sensory organ morphogenesis (GO:0090596),-0.6421264859729809,-0.9880203278129163,0.55,0.9680650375592289,1.0,1/6,0.65%,COL5A1
prerank,GO_Biological_Process_2021__negative regulation of anoikis (GO:2000811),0.5684029041854227,0.9878942967417382,0.5142857142857142,0.8516862137923895,1.0,4/11,17.35%,PDK4;PTK2;TLE1;PIK3CA
prerank,GO_Biological_Process_2021__activation of GTPase activity (GO:0090630),0.3753972189260842,0.9875579272666503,0.46153846153846156,0.851856410101143,1.0,14/72,12.53%,SCRIB;RAP1GAP;SGSM1;TBC1D1;ARHGEF26;TBC1D5;TBC1D10B;TBC1D16;SGSM2;TBC1D12;TBC1D22B;CCDC125;ARHGAP42;RABGAP1
prerank,GO_Biological_Process_2021__protein-containing complex disassembly (GO:0032984),-0.46034978572733914,-0.987459290377387,0.4782608695652174,0.9688226679716428,1.0,5/36,12.28%,GABARAPL1;RPL23;GABARAPL2;DVL1;FZD2
prerank,GO_Biological_Process_2021__negative regulation of membrane potential (GO:0045837),0.5705540708269475,0.9873666270152024,0.475,0.8516801166305403,1.0,1/7,0.62%,RNF122
prerank,GO_Biological_Process_2021__negative regulation of multicellular organismal process (GO:0051241),0.3479082137043642,0.9873219916177536,0.4444444444444444,0.8512036377425838,1.0,26/116,11.81%,HS3ST5;LRP4;SPRY2;SMAD7;ZNF706;SPRED1;HDAC9;PLCL1;SPRED2;PTPN23;ARRDC3;RPS6KA4;USF3;DDIT3;HPN;TNF;ROBO1;NPTN;SFMBT1;NFIB;LOXL2;PTPRG;KLF7;PTCH1;RPS6KA6;PTEN
prerank,GO_Biological_Process_2021__negative regulation of stress-activated protein kinase signaling cascade (GO:0070303),0.6160347226518087,0.9872132808943151,0.5306122448979592,0.8507642657092295,1.0,1/5,1.26%,QARS1
prerank,GO_Biological_Process_2021__skeletal system development (GO:0001501),0.3845813783258914,0.9871285682920266,0.48,0.850325553393643,1.0,18/72,15.21%,RAB33B;NCAN;ZBTB16;PKD1;WNT5A;GDF11;HAPLN2;BMP1;SOX4;CDH11;MMP16;SOX5;BMPR1B;EXT1;ANKH;MMP14;ANKRD11;TGFBR1
prerank,GO_Biological_Process_2021__ATP transport (GO:0015867),-0.6402449580349973,-0.9870077466700313,0.5714285714285714,0.9693253775570749,1.0,3/8,18.29%,SLC25A5;CD47;SLC17A9
prerank,GO_Biological_Process_2021__cellular amino acid catabolic process (GO:0009063),-0.46238116266758444,-0.9867952402735573,0.47761194029850745,0.9692123088710454,1.0,4/50,6.60%,IL4I1;GLUL;KMO;CRYM
prerank,PanglaoDB_Augmented_2021__Hematopoietic Stem Cells,-0.4232926551667035,-0.9864011568719302,0.46835443037974683,0.9695492623579316,1.0,24/114,11.39%,CD36;PROCR;CXCR4;MNDA;CLEC12A;MS4A4A;AIF1;SIGLEC1;CD14;FCER1G;CD93;ABCB1;IL3RA;F13A1;CD300LF;PECAM1;ITGA4;ITGA6;CD44;MEIS1;MS4A6A;CSF2RB;TYROBP;CSF3R
prerank,GO_Biological_Process_2021__nucleotide biosynthetic process (GO:0009165),-0.5480441165961611,-0.9863801876843625,0.4915254237288136,0.9688727021397036,1.0,2/15,3.80%,ME1;MTHFD1
prerank,GO_Biological_Process_2021__organic cation transport (GO:0015695),0.5620940941184057,0.9858990530387193,0.5333333333333333,0.8525582161369872,1.0,3/9,18.82%,SLC44A2;SLC44A1;SLC25A26
prerank,GO_Biological_Process_2021__organelle disassembly (GO:1903008),-0.4871079888807667,-0.9857614540025307,0.4915254237288136,0.9698231075810969,1.0,5/29,11.42%,DDRGK1;EIF2D;ATG2A;MTIF3;STING1
prerank,GO_Biological_Process_2021__cardiac atrium morphogenesis (GO:0003209),-0.6226930293458183,-0.9854896001379402,0.5384615384615384,0.969905992323999,1.0,2/7,17.77%,NOTCH2;ZFPM1
prerank,GO_Biological_Process_2021__regulation of muscle system process (GO:0090257),-0.6530748721971071,-0.9851284141102782,0.6181818181818182,0.9700898368818037,1.0,2/5,20.20%,SRI;TPM1
prerank,GO_Biological_Process_2021__melanosome assembly (GO:1903232),-0.6655588770034641,-0.9850797267985995,0.5510204081632653,0.9695600515761231,1.0,2/5,14.35%,HPS4;TRAPPC6A
prerank,GO_Biological_Process_2021__response to epinephrine (GO:0071871),0.5535820019060772,0.9847165608284754,0.5,0.8540656071183903,1.0,4/8,28.58%,SLC9A1;SNCA;RYR2;SIRT2
prerank,GO_Biological_Process_2021__cellular response to epinephrine stimulus (GO:0071872),0.5535820019060772,0.9847165608284754,0.5,0.8540656071183903,1.0,4/8,28.58%,SLC9A1;SNCA;RYR2;SIRT2
prerank,GO_Biological_Process_2021__female gamete generation (GO:0007292),-0.5425450353980912,-0.9846467884022229,0.5185185185185185,0.9699962140673078,1.0,3/13,10.30%,MEI4;IHO1;PTN
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell proliferation (GO:0046642),0.5799604158399867,0.9844723723044259,0.4473684210526316,0.8539882841477511,1.0,4/6,23.17%,LGALS9;TWSG1;CD274;ZBTB7B
prerank,GO_Biological_Process_2021__cellular response to amyloid-beta (GO:1904646),-0.4802959673858924,-0.9842815828485065,0.5,0.9700598205268496,1.0,5/27,8.15%,CD36;SNX6;IGF1;FYN;ITGA4
prerank,GO_Biological_Process_2021__negative regulation of fatty acid oxidation (GO:0046322),0.6649246237083204,0.9842054959443456,0.5714285714285714,0.8540107026704667,1.0,3/5,25.41%,ACADVL;MFSD2A;SIRT4
prerank,GO_Biological_Process_2021__regulation of neuron death (GO:1901214),0.41185871000830954,0.9832093931476398,0.4230769230769231,0.8555897090766195,1.0,6/66,4.48%,EGR1;PPARGC1A;GRID2;PICALM;LRRK2;WNT5A
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.5088675357003124,-0.9830204061236862,0.46774193548387094,0.9726430045121174,1.0,4/31,7.11%,EPN1;SNX6;CBLB;RNF126
prerank,GO_Biological_Process_2021__adenine nucleotide transport (GO:0051503),-0.5920256173198092,-0.9826602513572235,0.5166666666666667,0.9727108910452663,1.0,2/11,18.29%,SLC25A5;SLC17A9
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor production (GO:0032720),-0.5075948239223176,-0.9825573539801304,0.5344827586206896,0.9722503163232531,1.0,7/23,13.66%,NLRC3;IGF1;GSTP1;TNFAIP3;SELENOS;C5AR2;HAVCR2
prerank,GO_Biological_Process_2021__positive regulation of activated T cell proliferation (GO:0042104),-0.6495913004516689,-0.9825233137166419,0.55,0.9716144163925826,1.0,2/8,5.56%,RPS3;IGF1
prerank,GO_Biological_Process_2021__protein insertion into membrane (GO:0051205),-0.5524083040298562,-0.982513561310261,0.5666666666666667,0.9709291907242998,1.0,6/22,17.24%,EMD;CYB5A;COX18;MAIP1;OXA1L;SERP1
prerank,GO_Biological_Process_2021__regulation of T cell mediated immunity (GO:0002709),0.5210152277326063,0.9822081019816585,0.44642857142857145,0.8575009615207925,1.0,1/7,1.16%,ZBTB1
prerank,GO_Biological_Process_2021__epiboly involved in wound healing (GO:0090505),-0.5365360409594001,-0.9818690560417639,0.532258064516129,0.9719144714043648,1.0,1/13,0.28%,FLNA
prerank,GO_Biological_Process_2021__negative regulation of leukocyte degranulation (GO:0043301),-0.5893105749715559,-0.9818477171305412,0.5357142857142857,0.9712676512242513,1.0,2/8,10.76%,HLA-F;NCKAP1L
prerank,GO_Biological_Process_2021__epidermis development (GO:0008544),0.49020805998574984,0.9815085695905612,0.4722222222222222,0.8584514799754667,1.0,3/16,9.84%,SVEP1;EDA2R;HDAC1
prerank,GO_Biological_Process_2021__membrane raft organization (GO:0031579),0.5396002048195718,0.9815016931743247,0.5526315789473685,0.8578113222722784,1.0,4/13,6.24%,YJEFN3;FA2H;PPT1;MYADM
prerank,GO_Biological_Process_2021__endothelial cell differentiation (GO:0045446),-0.6569707260039751,-0.9814827155345199,0.543859649122807,0.971436514380409,1.0,2/6,10.85%,EDF1;KDM6B
prerank,GO_Biological_Process_2021__positive regulation of protein secretion (GO:0050714),0.426317034901674,0.9813707491701796,0.5,0.8574157436368092,1.0,10/45,12.17%,MYOM1;MCU;GOLPH3L;PTPN23;TMED10;UNC13B;SOX4;CD33;TCF7L2;ARF6
prerank,GO_Biological_Process_2021__embryonic organ development (GO:0048568),0.46424568506917135,0.9810631111500526,0.5714285714285714,0.8573814113261852,1.0,9/30,13.16%,PDGFA;TGFBR2;PBX1;KITLG;SALL1;TNF;COBL;BMPR1A;RARB
prerank,GO_Biological_Process_2021__negative regulation of cell cycle process (GO:0010948),0.3916288406038002,0.9808976192936969,0.38461538461538464,0.857049809277912,1.0,8/43,16.85%,RNF2;RYBP;PPP1R10;NME6;ZFYVE19;APAF1;PHC1;YAF2
prerank,GO_Biological_Process_2021__cellular zinc ion homeostasis (GO:0006882),-0.5568344187292841,-0.980855403359781,0.5272727272727272,0.9725633363342328,1.0,1/14,0.25%,MT2A
prerank,GO_Biological_Process_2021__late nucleophagy (GO:0044805),-0.6017501523163835,-0.9805214559689552,0.543859649122807,0.9727059871652604,1.0,1/5,7.60%,ATG2A
prerank,GO_Biological_Process_2021__determination of bilateral symmetry (GO:0009855),-0.5622264770212154,-0.98028801011898,0.5192307692307693,0.9724607011172466,1.0,2/11,2.84%,DNAH11;STIL
prerank,GO_Biological_Process_2021__negative regulation of protein catabolic process (GO:0042177),-0.49575168556171445,-0.9799493179474068,0.49122807017543857,0.9726219679019275,1.0,1/27,0.28%,FLNA
prerank,GO_Biological_Process_2021__regulation of vasculature development (GO:1901342),-0.5641377104922785,-0.9797893151782603,0.5217391304347826,0.9723458722485504,1.0,2/14,4.35%,WARS1;ETS1
prerank,GO_Biological_Process_2021__mRNA pseudouridine synthesis (GO:1990481),0.5978668718757656,0.9795915751110708,0.5769230769230769,0.8596176738414731,1.0,3/5,19.27%,TRUB1;PUS1;PUS7
prerank,GO_Biological_Process_2021__dendritic spine maintenance (GO:0097062),0.5611022302911606,0.9795589601744935,0.5476190476190477,0.8590779874052417,1.0,1/7,1.37%,IGF1R
prerank,GO_Biological_Process_2021__T cell proliferation (GO:0042098),-0.6072235769481247,-0.9790976114303364,0.5555555555555556,0.9733431788949204,1.0,1/11,0.38%,BTN3A1
prerank,GO_Biological_Process_2021__regulation of cell migration (GO:0030334),0.32596947513606467,0.9789541697493009,0.5217391304347826,0.8599145196296516,1.0,61/252,14.68%,ANXA1;PLXNB1;PDPN;PDGFA;FER;IGF1R;SRCIN1;SEMA5A;SERPINE1;SRGAP2B;SPRY2;AMOT;PLXNA2;FGF2;DLG5;SMAD7;MITF;SERPINE2;DAG1;PLXNA3;SEMA3B;CIB1;TBCCD1;MYADM;DACH1;TMEFF2;PDGFC;JAG1;PLXNB2;RECK;VCL;ROBO1;PLXNC1;KANK1;DOCK10;CTNNA2;PPP3CA;TWIST2;SASH1;HGF;PTPRK;RNF20;RIPOR1;PTEN;SORL1;SOD2;NF1;ELP3;GTPBP4;AFDN;TJP1;PLXNA1;ZNF703;MGAT5;GPNMB;PTK2;MMP14;ERBB4;FERMT2;FRMD5;SRGAP2
prerank,GO_Biological_Process_2021__regulation of ERBB signaling pathway (GO:1901184),0.5044020893936345,0.978650072607455,0.5135135135135135,0.8600132057774357,1.0,1/11,1.04%,FER
prerank,GO_Biological_Process_2021__regulation of membrane tubulation (GO:1903525),-0.6280775549648215,-0.978563036936986,0.6122448979591837,0.974083385637085,1.0,1/6,5.64%,ATP10A
prerank,GO_Biological_Process_2021__leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.5515526790404063,-0.9785107765878809,0.5081967213114754,0.973520197454641,1.0,3/13,8.15%,GCNT1;SELL;ITGA4
prerank,GO_Biological_Process_2021__regulation of NIK/NF-kappaB signaling (GO:1901222),-0.44288624334424664,-0.9784669544151976,0.5352112676056338,0.9729266845974562,1.0,14/54,20.43%,NLRC3;CD14;RPS3;PHB2;EIF2AK2;NLRP12;TMSB4X;TERF2IP;NOD2;IFI35;EZR;PTPN22;TLR2;ILK
prerank,GO_Biological_Process_2021__maintenance of protein localization in organelle (GO:0072595),-0.5427576172794346,-0.9781523477523684,0.49122807017543857,0.972993587738921,1.0,2/17,7.80%,CHCHD10;HK2
prerank,GO_Biological_Process_2021__chemical synaptic transmission (GO:0007268),0.34812785394671747,0.9781256756297141,0.47368421052631576,0.8605156803735705,1.0,39/166,15.11%,CACNA1A;KCNQ2;GRID2;DOC2A;SLC1A3;KCNIP2;NLGN1;TSPOAP1;GRID1;GRIK2;GLRA1;LIN7A;SLC1A2;UNC13B;PDE7B;GABRR2;DTNA;GRIA3;SLC12A6;GRIA4;BRSK1;GRIA1;KCNMB4;GRM5;SNCB;STX1A;PPFIA3;NRXN2;MAPK1;PTEN;GRIN2B;NPTX1;SLC12A5;CACNA1E;GRIA2;STXBP2;GAD1;CACNB4;NLGN4Y
prerank,GO_Biological_Process_2021__mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.3668194006386568,0.977728154501044,0.38095238095238093,0.8606855324460656,1.0,8/81,7.20%,NXF1;U2AF1;CPSF4;FYTTD1;NUP153;NUP188;WDR33;NUP42
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in immune response (GO:0002718),-0.5813788871340371,-0.9776506309329307,0.5081967213114754,0.9735702575237306,1.0,5/12,14.09%,SLC7A5;BTK;TNFRSF1B;TRPM4;NOD2
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell apoptotic process (GO:1904037),0.5415465166535466,0.9774224437889231,0.5490196078431373,0.8606310570834994,1.0,3/10,12.90%,GSN;ANO6;PRKCI
prerank,GO_Biological_Process_2021__regulation of lysosomal lumen pH (GO:0035751),0.6117745624712145,0.9773901907802922,0.5490196078431373,0.8600661469313662,1.0,2/7,6.14%,LRRK2;PPT1
prerank,GO_Biological_Process_2021__regulation of cellular protein catabolic process (GO:1903362),0.5291636577086076,0.9771160509613536,0.5227272727272727,0.8600569588329272,1.0,2/15,1.49%,ATRAID;MSN
prerank,GO_Biological_Process_2021__aspartate family amino acid metabolic process (GO:0009066),-0.5476366246951996,-0.9771114968385027,0.5151515151515151,0.974320075174212,1.0,2/14,3.80%,NIT2;MTHFD1
prerank,GO_Biological_Process_2021__negative regulation of supramolecular fiber organization (GO:1902904),0.4100460387593946,0.9768779334553757,0.4864864864864865,0.8600298979452323,1.0,16/56,19.55%,HIP1R;LDLR;PFDN4;CIB1;MYADM;KANK1;SHANK3;DYRK1A;SSH2;CLASP1;CLASP2;PIK3CA;CAMSAP2;ATXN7;SNCA;MAP2
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential involved in regulation of contraction (GO:0098909),-0.6715222625684436,-0.9768038391558568,0.5471698113207547,0.9743920453391149,1.0,2/5,18.55%,FGF13;AKAP9
prerank,GO_Biological_Process_2021__positive regulation of heart rate (GO:0010460),0.5433807340870431,0.9767705282454273,0.5121951219512195,0.859636477203924,1.0,2/8,6.22%,SCN3B;ADRA1A
prerank,GO_Biological_Process_2021__protein localization to endosome (GO:0036010),0.5473871555047215,0.9764358007260278,0.5769230769230769,0.8596722762486616,1.0,1/9,0.61%,NRP1
prerank,GO_Biological_Process_2021__NAD biosynthetic process (GO:0009435),-0.5391732565774747,-0.9763479508474953,0.4918032786885246,0.9748175680800778,1.0,4/15,12.97%,NUDT12;PARP9;NAMPT;QPRT
prerank,GO_Biological_Process_2021__cellular response to metal ion (GO:0071248),-0.4275293678906183,-0.976236166682581,0.5352112676056338,0.9743992757655967,1.0,3/79,2.81%,MT2A;FOS;B2M
prerank,GO_Biological_Process_2021__regulation of canonical Wnt signaling pathway (GO:0060828),0.32740803238160093,0.9761792898029529,0.4117647058823529,0.8596455586662337,1.0,32/171,15.94%,LRP4;ZNRF3;RUVBL2;SEMA5A;CSNK1G1;ANKRD6;TLE2;LRRK2;GNAQ;WNT5A;INVS;TMEM170B;DDIT3;DVL3;KANK1;SOX4;BTRC;HDAC1;DKK2;TBL1XR1;WNK1;TCF7L2;CSNK1E;ZNF703;XIAP;GID8;CAPRIN2;TLE1;PPM1A;GSK3B;RNF220;KLHL12
prerank,GO_Biological_Process_2021__regulation of sequestering of calcium ion (GO:0051282),0.5701176567521617,0.9760196333778886,0.5681818181818182,0.859351375282935,1.0,3/7,35.90%,RYR2;PTK2B;ANXA6
prerank,GO_Biological_Process_2021__mitochondrial RNA processing (GO:0000963),0.6032256286884119,0.975930097118683,0.46938775510204084,0.8588883295778504,1.0,1/6,1.40%,TBRG4
prerank,GO_Biological_Process_2021__positive regulation of T cell chemotaxis (GO:0010820),-0.6304764375766528,-0.9758454091262647,0.5531914893617021,0.973917381595901,1.0,2/7,7.09%,CCL5;STK39
prerank,GO_Biological_Process_2021__regulation of T cell chemotaxis (GO:0010819),-0.6304764375766528,-0.9758454091262647,0.5531914893617021,0.973917381595901,1.0,2/7,7.09%,CCL5;STK39
prerank,GO_Biological_Process_2021__iron-sulfur cluster assembly (GO:0016226),-0.5232245271017194,-0.9756441029055891,0.5230769230769231,0.9737357247723679,1.0,4/19,15.50%,ISCA1;NFS1;NUBPL;CIAO2B
prerank,GO_Biological_Process_2021__negative regulation of neuron differentiation (GO:0045665),-0.6392804068970269,-0.9755556148499686,0.625,0.9732823033738933,1.0,1/7,2.81%,B2M
prerank,GO_Biological_Process_2021__response to progesterone (GO:0032570),0.5178840540218359,0.9753008191849346,0.4782608695652174,0.8597081012673228,1.0,1/11,8.61%,TRERF1
prerank,GO_Biological_Process_2021__positive regulation of neuroblast proliferation (GO:0002052),-0.5452466763952122,-0.9752544775780331,0.47540983606557374,0.9734287895454218,1.0,3/9,15.22%,ZNF335;VEGFA;SMARCD3
prerank,GO_Biological_Process_2021__negative regulation of phosphatase activity (GO:0010923),-0.550195298867503,-0.9752079988287704,0.5245901639344263,0.9728589352041613,1.0,1/19,1.16%,PPP1R15A
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via homologous recombination (GO:0010569),0.4194781725620162,0.9751535638491229,0.5517241379310345,0.8594323147542656,1.0,8/33,19.52%,PARP1;PPP4R2;MMS19;SIRT6;CGAS;SETD2;KLHL15;ARID2
prerank,GO_Biological_Process_2021__regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358),0.5983349394205967,0.9750816281535333,0.5957446808510638,0.8589435575942396,1.0,1/6,2.51%,SIRT1
prerank,GO_Biological_Process_2021__response to muscle stretch (GO:0035994),0.5469451937830285,0.9749952500567444,0.4666666666666667,0.8584555176127311,1.0,5/11,17.35%,GSN;SLC9A1;SLC8A1;PTK2;PIK3CA
prerank,MSigDB_Hallmark_2020__Cholesterol Homeostasis,0.42553581248840366,0.9749069328295735,0.5,0.858030336535136,1.0,14/53,12.66%,ABCA2;IDI1;LDLR;STARD4;PPARG;SEMA3B;JAG1;FDFT1;CHKA;TM7SF2;HMGCS1;ALCAM;MVD;FASN
prerank,GO_Biological_Process_2021__metal ion homeostasis (GO:0055065),0.5080189558297008,0.9747866504862289,0.475,0.8577033606537527,1.0,8/20,21.96%,SLC7A8;TMTC2;SLC12A6;SLC12A5;SLC8A1;SLC12A2;SNCA;GRIN1
prerank,GO_Biological_Process_2021__regulation of anoikis (GO:2000209),0.5107136461784024,0.9746356421839126,0.47058823529411764,0.8573857281238978,1.0,4/14,17.35%,PDK4;PTK2;TLE1;PIK3CA
prerank,GO_Biological_Process_2021__regulation of rhodopsin mediated signaling pathway (GO:0022400),-0.6258636529548656,-0.9744761293593305,0.6507936507936508,0.9737704895758361,1.0,1/9,8.36%,CALM1
prerank,MSigDB_Hallmark_2020__UV Response Dn,0.3502811316782411,0.974404655332801,0.5,0.8573431624003574,1.0,29/111,13.61%,CACNA1A;NRP1;ACVR2A;IGF1R;SERPINE1;COL5A2;TGFBR2;SMAD7;LDLR;PPARG;PTPRM;SMAD3;PLCB4;RUNX1;PDLIM5;SCAF8;SFMBT1;MMP16;NFIB;SCN8A;TOGARAM1;DYRK1A;CDK13;COL11A1;PTEN;BMPR1A;TJP1;NIPBL;MGMT
prerank,GO_Biological_Process_2021__regulation of protein kinase C signaling (GO:0090036),0.5392136845526747,0.9744010519245796,0.5,0.8567164495623453,1.0,3/11,6.24%,WNT5A;ADRA1A;MYADM
prerank,GO_Biological_Process_2021__mitotic nuclear division (GO:0140014),-0.4474219976761737,-0.9741756945379133,0.5,0.973799185367271,1.0,5/50,8.95%,FLNA;CTDP1;RAB11A;WRAP73;ABRAXAS1
prerank,GO_Biological_Process_2021__L-amino acid transport (GO:0015807),0.49558098317663574,0.9737441910049278,0.5121951219512195,0.8576120251470947,1.0,5/16,6.03%,SLC1A3;SLC25A18;SLC7A8;SLC3A2;SLC1A2
prerank,GO_Biological_Process_2021__cholesterol efflux (GO:0033344),-0.5721820572268249,-0.9736761158751494,0.5344827586206896,0.9745116433423768,1.0,5/12,24.24%,ABCA8;ABCA5;NPC1;STX12;ABCA7
prerank,GO_Biological_Process_2021__purine nucleoside monophosphate biosynthetic process (GO:0009127),0.515749366132232,0.9735714422612379,0.5483870967741935,0.8574544839028416,1.0,1/10,5.19%,PPAT
prerank,GO_Biological_Process_2021__regulation of natural killer cell mediated cytotoxicity (GO:0042269),-0.5449238006508454,-0.9734222438273409,0.5254237288135594,0.9744720558544948,1.0,5/14,14.31%,SLAMF6;HLA-F;KLRD1;CD226;HLA-E
prerank,GO_Biological_Process_2021__replication fork protection (GO:0048478),-0.6015290161350475,-0.9731581431525691,0.5333333333333333,0.9744448278445527,1.0,3/8,21.03%,TIPIN;ZRANB3;DONSON
prerank,MSigDB_Hallmark_2020__UV Response Up,-0.4110711873303568,-0.9729932423048675,0.5,0.974097979898822,1.0,23/105,16.34%,FOS;TFRC;JUNB;BTG2;POLE3;ATP6V1F;ABCB1;EPHX1;HLA-F;ACAA1;PARP2;IRF1;TAP1;BTG1;PRPF3;ATF3;CLTB;NR4A1;CCK;STARD3;RPN1;AP2S1;CDKN1C
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 4 signaling pathway (GO:0034143),-0.5425965206896195,-0.9724234222599412,0.5873015873015873,0.974838921004454,1.0,7/16,22.16%,TNFAIP3;APPL1;IFI35;FLOT1;PTPN22;NR1D1;LYN
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta clearance (GO:1900223),-0.5775384306094437,-0.9723131372940466,0.5344827586206896,0.9744738695237158,1.0,3/6,31.99%,LRPAP1;ABCA7;TREM2
prerank,GO_Biological_Process_2021__negative regulation of MAP kinase activity (GO:0043407),-0.485506753039759,-0.9722486927317742,0.5,0.9739743817224569,1.0,4/34,6.85%,DUSP1;RGS2;PAQR3;GSTP1
prerank,GO_Biological_Process_2021__negative regulation of cellular response to insulin stimulus (GO:1900077),-0.4889242024518076,-0.9721971663617024,0.4931506849315068,0.9734143015084641,1.0,2/21,1.81%,PRKCQ;PID1
prerank,GO_Biological_Process_2021__regulation of bone mineralization (GO:0030500),-0.46423060542014316,-0.9720626524620388,0.4925373134328358,0.9731061608096521,1.0,2/33,0.93%,CCL3;SRGN
prerank,GO_Biological_Process_2021__regulation of endothelial cell migration (GO:0010594),0.3876309242273711,0.9718400256442035,0.47368421052631576,0.8606976032392439,1.0,9/52,13.77%,NRP1;FGF2;WNT5A;PTPRM;RIN2;SASH1;DNAJA4;NF1;PTK2
prerank,GO_Biological_Process_2021__protein K11-linked ubiquitination (GO:0070979),0.4776378088864012,0.9718145432015569,0.42857142857142855,0.8601320535757856,1.0,10/20,25.93%,UBE2E2;FZR1;CDC23;UBE2L3;ANAPC1;ANAPC4;UBE2D4;UBE2D3;UBE2E3;RNF4
prerank,GO_Biological_Process_2021__positive regulation of lipid localization (GO:1905954),-0.5828689224281202,-0.9715236003778497,0.5645161290322581,0.9737166401599339,1.0,1/5,14.85%,C3
prerank,GO_Biological_Process_2021__oligosaccharide metabolic process (GO:0009311),0.4409368383593837,0.9714376301500667,0.5111111111111111,0.8602023261132887,1.0,7/25,17.01%,ST6GAL2;ST6GALNAC3;MPDU1;FUT9;ST6GALNAC5;ST8SIA4;ST8SIA5
prerank,GO_Biological_Process_2021__plasma membrane repair (GO:0001778),-0.6011655901758648,-0.9709193578110635,0.55,0.9744485961056394,1.0,1/7,6.19%,RAB3A
prerank,GO_Biological_Process_2021__peptidyl-proline modification (GO:0018208),-0.5271361144451051,-0.9708421883370882,0.5757575757575758,0.9739692251637505,1.0,1/19,0.79%,PPIE
prerank,GO_Biological_Process_2021__cellular iron ion homeostasis (GO:0006879),-0.4827504721031509,-0.9707672249666037,0.46875,0.9734722049954495,1.0,3/39,2.30%,FTH1;TFRC;HAMP
prerank,GO_Biological_Process_2021__ribosomal subunit export from nucleus (GO:0000054),-0.5596993879904593,-0.9704668813108148,0.5535714285714286,0.9735252438871542,1.0,4/10,21.82%,RPS15;NPM1;NUP88;NMD3
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization to telomere (GO:0070203),0.5485155869338045,0.9703783252163098,0.5434782608695652,0.861479877803003,1.0,2/10,13.21%,TCP1;CCT3
prerank,GO_Biological_Process_2021__regulation of RNA metabolic process (GO:0051252),-0.4489580897474603,-0.9702247236069621,0.4533333333333333,0.9734135163993765,1.0,6/50,8.28%,OAS3;OAS2;USP36;FAM50A;TNFRSF1B;OAS1
prerank,GO_Biological_Process_2021__phosphatidylcholine catabolic process (GO:0034638),0.6103226583414418,0.9696880776455908,0.625,0.8623152415475351,1.0,1/7,1.59%,PLA2G7
prerank,GO_Biological_Process_2021__positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.6192513063061088,0.9694255797729271,0.5277777777777778,0.8622869721255486,1.0,3/5,25.01%,AKT2;SNCA;PRKCE
prerank,GO_Biological_Process_2021__positive regulation of vasculature development (GO:1904018),0.41585495403910777,0.9693191645214055,0.4857142857142857,0.8618806102435567,1.0,9/54,9.91%,SEMA5A;SERPINE1;FGF2;SIRT1;GAB1;WNT5A;RUNX1;TMIGD2;SASH1
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO:0008635),-0.6166178842868135,-0.9690755097086998,0.5,0.9755389593810133,1.0,1/5,1.08%,CYCS
prerank,PanglaoDB_Augmented_2021__Motor Neurons,0.457160192278538,0.969000831414801,0.5384615384615384,0.8620020834190818,1.0,6/20,12.60%,ADGRB2;CSPG5;VGF;ENAH;LINGO1;CSNK1E
prerank,GO_Biological_Process_2021__positive regulation of cardiocyte differentiation (GO:1905209),-0.586833090412838,-0.968774359132145,0.5689655172413793,0.9755904340625562,1.0,2/5,25.54%,EFNB2;DHX36
prerank,GO_Biological_Process_2021__negative regulation of focal adhesion assembly (GO:0051895),-0.5404765548117375,-0.9687125775370542,0.5,0.9743914963390874,1.0,1/14,4.08%,APOD
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate junction organization (GO:0150118),-0.5404765548117375,-0.9687125775370542,0.5,0.9743914963390874,1.0,1/14,4.08%,APOD
prerank,GO_Biological_Process_2021__metaphase/anaphase transition of mitotic cell cycle (GO:0007091),0.6025034176265727,0.9685890249074851,0.5957446808510638,0.8616741470479059,1.0,2/6,14.97%,CDC23;ANAPC1
prerank,GO_Biological_Process_2021__metaphase/anaphase transition of cell cycle (GO:0044784),0.6025034176265727,0.9685890249074851,0.5957446808510638,0.8616741470479059,1.0,2/6,14.97%,CDC23;ANAPC1
prerank,GO_Biological_Process_2021__thyroid hormone generation (GO:0006590),-0.591625258700486,-0.9685625274411428,0.5185185185185185,0.9741032822510879,1.0,2/6,10.07%,DUOX1;DIO2
prerank,GO_Biological_Process_2021__adherens junction assembly (GO:0034333),0.53527828587549,0.9683123339938755,0.5319148936170213,0.8616113708742249,1.0,3/9,13.62%,SMAD7;VCL;ZNF703
prerank,GO_Biological_Process_2021__store-operated calcium entry (GO:0002115),-0.6840785597634554,-0.9680580243432897,0.6031746031746031,0.9746658386529883,1.0,3/5,19.28%,CRACR2A;STIM2;ORAI2
prerank,GO_Biological_Process_2021__cellular response to oxygen-containing compound (GO:1901701),0.3294149629557882,0.9677927577301678,0.5,0.8620218328621156,1.0,15/188,5.25%,EGR1;CD180;RRAGD;PKD2;FER;RUVBL2;AANAT;SERPINE1;PDK4;NCOA3;RAP1A;SIRPA;NRIP1;WNT5A;GLRA1
prerank,GO_Biological_Process_2021__regulation of protein binding (GO:0043393),-0.43045544916012096,-0.9666613880991172,0.5466666666666666,0.9775766171376232,1.0,11/88,11.42%,DDX11;CARD16;B2M;IFIT1;RACK1;RPL11;DTX3L;IFIT2;DVL1;ACTB;STING1
prerank,GO_Biological_Process_2021__positive regulation of small molecule metabolic process (GO:0062013),0.5855459350800841,0.966566692539486,0.53125,0.8640777638043862,1.0,4/9,26.76%,PPARG;AKT2;PRKCE;PPM1K
prerank,GO_Biological_Process_2021__acylglycerol metabolic process (GO:0006639),-0.487429047666533,-0.9664821225356518,0.4444444444444444,0.977268582564881,1.0,4/25,16.99%,MGLL;GK;DGKD;LMF1
prerank,GO_Biological_Process_2021__mitotic sister chromatid segregation (GO:0000070),0.37093028608527395,0.9663578894100009,0.28,0.8639521417107558,1.0,11/64,14.09%,NCAPH2;NSL1;TEX14;BOD1;CDC23;CHMP7;SMC4;CENPE;ZNF207;NIPBL;CHMP1A
prerank,GO_Biological_Process_2021__positive regulation of cell death (GO:0010942),-0.4300507792403714,-0.9663263584289382,0.546875,0.97692461098572,1.0,5/45,4.82%,CALCR;CD36;FOS;DDIT4;CLU
prerank,GO_Biological_Process_2021__regulation of gene expression (GO:0010468),-0.3628138610703305,-0.9658439402983966,0.648936170212766,0.9773564248904304,1.0,96/645,14.51%,CALCR;BTN3A1;CD36;MYBL1;CCL3;PPIE;RIMS1;RUNX3;SLC7A5;TFRC;PRKCQ;NFKBID;PID1;WARS1;TRIM5;AIF1;CHD3;PARP14;ATF5;TAF6L;RPL5;EDF1;RORA;USP36;PARP15;ZNF335;DDRGK1;OGG1;RACK1;BTN3A3;ETS1;CLU;BHLHE40;ZNF331;RPL11;RPS3;RPL23;IGF1;TXK;LAMTOR5;TRIM22;VPS35;MSL3;PARP9;MUSK;BTN3A2;BTN2A1;TTN;RPS7;PLSCR1;PLAG1;FAM50A;BRCA2;SNF8;ACTG1;BTN2A2;RBPJ;OVOL2;RPL6;PDCD5;DVL1;GLMN;HINT1;ZNF513;SLC11A1;HNRNPAB;CITED2;KDM6B;REXO4;MLX;VEGFA;TYROBP;HIF1A;BTG1;ANKRA2;TCF3;GLI4;GLRX2;GCFC2;HSPA1B;CREM;TERF2IP;PTPRC;PRDM1;DNMT1;HAVCR2;ZNF217;PIK3CB;ESR2;NOTCH2;GPX1;REL;BRCA1;HSPA1A;FGF20;CCAR1
prerank,GO_Biological_Process_2021__negative regulation of protein localization to plasma membrane (GO:1903077),-0.5459502735906526,-0.9657087127749494,0.5357142857142857,0.9770310308915733,1.0,1/16,1.81%,PID1
prerank,GO_Biological_Process_2021__delamination (GO:0060232),-0.6346659085950487,-0.9656635723689722,0.5964912280701754,0.9764278547649011,1.0,2/5,16.09%,TRPV4;AKNA
prerank,GO_Biological_Process_2021__regulation of establishment of planar polarity (GO:0090175),-0.4544268938020789,-0.9656137824413492,0.5194805194805194,0.9758073866982646,1.0,19/63,22.96%,PSMB3;PSMB6;PSMA7;PSMB9;DVL1;FZD2;PSMD12;PFN1;PSMD8;PSMA5;AP2S1;RAC1;PSMA3;PSMC4;PSME2;PSME1;PSMB5;PSMC3;PSME3
prerank,GO_Biological_Process_2021__somatic hypermutation of immunoglobulin genes (GO:0016446),-0.6361536766091256,-0.9651995472431815,0.609375,0.9762206549406102,1.0,6/7,36.38%,MSH6;POLQ;PMS2;SAMHD1;POLL;MCM3AP
prerank,GO_Biological_Process_2021__arachidonic acid metabolic process (GO:0019369),0.4456033032577968,0.9647701235082164,0.4634146341463415,0.8667730948007945,1.0,2/21,0.68%,FAAH;PLA2G4C
prerank,GO_Biological_Process_2021__RNA export from nucleus (GO:0006405),0.3620077417610529,0.9647267494327855,0.4,0.8662088742886541,1.0,8/83,7.20%,NXF1;U2AF1;CPSF4;FYTTD1;NUP153;NUP188;WDR33;NUP42
prerank,GO_Biological_Process_2021__negative regulation of insulin receptor signaling pathway (GO:0046627),-0.4889269461261115,-0.9645446815248655,0.4788732394366197,0.9770800099885643,1.0,2/20,1.81%,PRKCQ;PID1
prerank,GO_Biological_Process_2021__synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.5298900619106114,0.9643239525132291,0.4444444444444444,0.8665097770765069,1.0,4/10,10.74%,STX11;STX1A;STX2;SNAP23
prerank,GO_Biological_Process_2021__erythrocyte differentiation (GO:0030218),-0.47125610799085904,-0.9641394985873476,0.5081967213114754,0.9772807052142064,1.0,6/34,11.19%,TGFBR3;RPS14;SLC25A5;ATP5IF1;NCKAP1L;VEGFA
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transporter activity (GO:1901018),0.5676796357780627,0.9641028034340242,0.48936170212765956,0.8664263853915414,1.0,1/7,3.23%,KCNIP2
prerank,GO_Biological_Process_2021__RNA biosynthetic process (GO:0032774),-0.4938891265160932,-0.9640737115665922,0.5070422535211268,0.9767276734019134,1.0,1/21,3.69%,TCEA2
prerank,GO_Biological_Process_2021__regulation of signal transduction (GO:0009966),-0.4070421127799588,-0.9640385272675249,0.48148148148148145,0.976097106094314,1.0,19/127,9.33%,CD36;DYNLT1;CD55;MGLL;RGS2;MDFIC;TRIM5;RORA;RGS16;CLU;MTCH1;CD63;RGS4;FYN;PLSCR1;NLRP12;ANKRD54;OVOL2;LLGL2
prerank,GO_Biological_Process_2021__negative regulation of MAPK cascade (GO:0043409),0.374760517093311,0.9639572161788649,0.42424242424242425,0.8661164501906092,1.0,14/60,12.21%,DUSP6;QARS1;SPRY2;SPRED1;SPRED2;SIRPA;TIMP3;DAG1;DUSP7;IRAK3;RPS6KA6;PTEN;SORL1;NF1
prerank,GO_Biological_Process_2021__negative regulation of histone acetylation (GO:0035067),0.5193910508704559,0.9638135865090285,0.5333333333333333,0.8657634031467111,1.0,3/10,19.35%,SIRT1;ZNF451;SNCA
prerank,GO_Biological_Process_2021__response to cAMP (GO:0051591),0.4629747373765444,0.9636948192189109,0.5217391304347826,0.8653847478316506,1.0,4/25,6.96%,PKD2;AANAT;RAP1A;VGF
prerank,GO_Biological_Process_2021__positive regulation of protein localization to plasma membrane (GO:1903078),0.40010554168856216,0.9636305419191868,0.5405405405405406,0.8649196461418637,1.0,11/37,23.61%,PTPN9;CIB1;TNF;ARF6;PRKCI;DPP10;PLS1;SPTBN1;STX3;ATP2C1;PIK3R1
prerank,GO_Biological_Process_2021__positive regulation of RNA export from nucleus (GO:0046833),-0.6223755870143066,-0.9633681838525722,0.5714285714285714,0.9763243105421839,1.0,2/5,17.54%,NCBP2;NRDE2
prerank,GO_Biological_Process_2021__positive regulation of nucleobase-containing compound transport (GO:0032241),-0.6223755870143066,-0.9633681838525722,0.5714285714285714,0.9763243105421839,1.0,2/5,17.54%,NCBP2;NRDE2
prerank,GO_Biological_Process_2021__autophagosome maturation (GO:0097352),-0.47952207915850575,-0.9632092820728657,0.5454545454545454,0.9760920517896158,1.0,3/25,9.32%,GABARAPL1;CALM1;GABARAPL2
prerank,GO_Biological_Process_2021__macromolecule modification (GO:0043412),0.5836661831844066,0.9625184557423365,0.5102040816326531,0.8666371043056531,1.0,2/7,14.78%,PARP1;SETD5
prerank,GO_Biological_Process_2021__positive regulation by host of viral genome replication (GO:0044829),-0.6605829798310666,-0.9623173639549175,0.5964912280701754,0.9777041711290708,1.0,4/5,31.12%,TBC1D20;NUCKS1;YTHDC2;PPIB
prerank,GO_Biological_Process_2021__positive regulation of endopeptidase activity (GO:0010950),-0.477592498121567,-0.9618588984537845,0.4722222222222222,0.9782095906435221,1.0,3/21,7.36%,PRELID1;AIM2;FYN
prerank,MSigDB_Hallmark_2020__Estrogen Response Late,-0.39826365306115247,-0.9617772625507778,0.5789473684210527,0.9777245772735721,1.0,14/112,10.34%,CALCR;FOS;SLC7A5;ZFP36;STIL;GLA;PRLR;SGK1;CD44;OVOL2;ETFB;LLGL2;XRCC3;SLC2A8
prerank,GO_Biological_Process_2021__regulation of centriole elongation (GO:1903722),0.6125054566628407,0.9614973439377127,0.6,0.868360784958752,1.0,2/5,31.84%,CEP120;CCP110
prerank,GO_Biological_Process_2021__regulation of sequestering of triglyceride (GO:0010889),0.5450805409109096,0.9614722395797518,0.5365853658536586,0.8677903861154479,1.0,4/10,27.88%,PPARG;OSBPL8;LPL;ABHD5
prerank,"GO_Biological_Process_2021__negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",-0.6114105130728406,-0.9608613178755758,0.59375,0.9792303209672764,1.0,1/8,1.37%,RUNX3
prerank,GO_Biological_Process_2021__anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.44369215836866477,-0.9606711796943833,0.5428571428571428,0.9789669060016698,1.0,17/59,19.69%,UBC;RPS27A;PSMB3;PSMB6;PSMA7;PSMB9;PSMD12;ANAPC11;PSMD8;PSMA5;UBA52;CDC26;PSMA3;PSMC4;BUB3;PSME2;PSME1
prerank,GO_Biological_Process_2021__MAPK cascade (GO:0000165),-0.39316928964675,-0.9605453958803241,0.5833333333333334,0.9785482200051177,1.0,33/209,14.82%,CCL3;UBC;RPS27A;ZFP36;CCL5;PRKCQ;RASGRF2;PAQR3;PSMB3;IL3RA;IGF1;WDR83;FGF13;NEFL;PSMB6;PSMA7;FYN;PPP1CB;CSF2RA;CALM1;PSMB9;CSF2RB;RBX1;KARS1;PSMD12;PSMD8;PSMA5;PEBP1;PIK3CB;PEA15;FGF20;RASA2;UBA52
prerank,GO_Biological_Process_2021__cellular response to leptin stimulus (GO:0044320),-0.6034848052514417,-0.9604860511720776,0.5333333333333333,0.9779626207993254,1.0,1/7,0.08%,NR4A3
prerank,"GO_Biological_Process_2021__regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.4886656611343107,0.9599995751100802,0.4782608695652174,0.8707164733516031,1.0,1/12,2.48%,UBE2J1
prerank,GO_Biological_Process_2021__positive regulation of lipid metabolic process (GO:0045834),0.5276066325660478,0.9599924801589924,0.5217391304347826,0.8701105332367128,1.0,5/14,26.79%,PPARG;EEF1A2;ZBTB20;SIRT4;SORBS1
prerank,GO_Biological_Process_2021__regulation of centriole replication (GO:0046599),-0.5397259065328937,-0.9599663962892395,0.5245901639344263,0.9786869455744059,1.0,3/13,14.26%,STIL;NPM1;BRCA1
prerank,GO_Biological_Process_2021__positive regulation of macrophage chemotaxis (GO:0010759),-0.5939867657566051,-0.9598251905864921,0.6666666666666666,0.978454499153844,1.0,1/8,1.49%,CCL5
prerank,GO_Biological_Process_2021__regulation of receptor catabolic process (GO:2000644),-0.6064812628280106,-0.9596627848193835,0.6086956521739131,0.9781626782468035,1.0,1/5,5.72%,DTX3L
prerank,GO_Biological_Process_2021__cellular protein-containing complex assembly (GO:0034622),0.33573877107345185,0.9595729765932546,0.5,0.8703369838636114,1.0,12/118,6.90%,VAMP1;SMAD1;HIP1R;IMMP2L;PICALM;NCK2;NUP153;PDE4DIP;SMAD2;SMAD3;NRG1;TCP1
prerank,GO_Biological_Process_2021__mitotic intra-S DNA damage checkpoint signaling (GO:0031573),-0.5530220301730637,-0.9593958010421398,0.49019607843137253,0.9781337347585716,1.0,3/12,5.76%,HUS1;MUS81;TIPIN
prerank,GO_Biological_Process_2021__positive regulation of nervous system development (GO:0051962),0.4345499063158784,0.9593007240115485,0.48148148148148145,0.8703380673509094,1.0,8/31,11.05%,GRID2;DLG5;NLGN1;LIG4;CLSTN2;NUMBL;CLSTN3;PTPRD
prerank,GO_Biological_Process_2021__cellular response to cold (GO:0070417),0.605418981692236,0.958808983221707,0.5277777777777778,0.8709186546121319,1.0,3/5,26.72%,DNAJC3;FOXO1;EIF2AK4
prerank,GO_Biological_Process_2021__anterograde synaptic vesicle transport (GO:0048490),0.5573263505648531,0.9587877727993843,0.6,0.8697712668956196,1.0,2/8,9.74%,AP3B2;AP3S1
prerank,GO_Biological_Process_2021__synaptic vesicle transport along microtubule (GO:0099517),0.5573263505648531,0.9587877727993843,0.6,0.8697712668956196,1.0,2/8,9.74%,AP3B2;AP3S1
prerank,MSigDB_Hallmark_2020__IL-2/STAT5 Signaling,-0.4030476770262542,-0.9586708021901339,0.5681818181818182,0.978933445522862,1.0,21/128,8.71%,SLC2A3;GADD45B;GABARAPL1;SELL;RORA;RGS16;GLIPR2;IFITM3;COCH;SCN9A;TNFSF10;BHLHE40;ABCB1;IL3RA;IL10RA;ODC1;PLSCR1;HK2;TNFRSF1B;ITGA6;CD44
prerank,GO_Biological_Process_2021__dendritic cell differentiation (GO:0097028),0.5323340864355743,0.9583735278654347,0.5483870967741935,0.8700144139915537,1.0,2/12,10.07%,TGFBR2;LGALS9
prerank,GO_Biological_Process_2021__positive regulation of histone deacetylation (GO:0031065),-0.5632928373904201,-0.9582548853058573,0.5818181818181818,0.9792435700819054,1.0,5/10,23.03%,PRKD2;AKAP8;VEGFA;CTBP1;AKAP8L
prerank,GO_Biological_Process_2021__translational elongation (GO:0006414),-0.438684278024374,-0.9581601013946164,0.5875,0.9788150884084653,1.0,23/75,17.99%,RACK1;MRPL57;AURKAIP1;MRPS7;MRPL51;MRPL19;GADD45GIP1;MRPL52;MRPL50;MRPS11;GTPBP2;MRPS10;MRPS15;MRPL16;MRPL32;CHCHD1;EEF1B2;OXA1L;MRPL43;MRPS18C;MRPL45;MRPS25;EEF2
prerank,GO_Biological_Process_2021__vascular process in circulatory system (GO:0003018),0.599398020677861,0.9578160930191453,0.6388888888888888,0.8699911752285138,1.0,3/7,15.46%,GCLC;ADCY6;SCPEP1
prerank,GO_Biological_Process_2021__regulation of tube diameter (GO:0035296),0.599398020677861,0.9578160930191453,0.6388888888888888,0.8699911752285138,1.0,3/7,15.46%,GCLC;ADCY6;SCPEP1
prerank,GO_Biological_Process_2021__positive regulation of protein serine/threonine kinase activity (GO:0071902),0.3968487158285514,0.9576727101170546,0.5789473684210527,0.8697169017447072,1.0,16/74,9.13%,PDGFA;PKD2;FGF2;SIRT1;PKD1;LRRK2;NEK10;MAP2K1;WNT5A;CIB1;PDGFC;CAB39;TNF;ROBO1;IRAK1;SPDYA
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide biosynthetic process (GO:0045429),0.5040376327898615,0.9573719608384269,0.5588235294117647,0.8696667819737757,1.0,4/17,7.30%,KLF4;PKD2;SMAD3;TNF
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),-0.5704823464333966,-0.9573357129062323,0.5576923076923077,0.9800410115090318,1.0,2/10,13.82%,P2RY8;LPAR6
prerank,GO_Biological_Process_2021__regulation of protein autoubiquitination (GO:1902498),0.5634421821153689,0.9572174468792499,0.5238095238095238,0.8694533298004781,1.0,2/6,9.91%,LRRK2;SASH1
prerank,GO_Biological_Process_2021__response to metal ion (GO:0010038),-0.45164094843910657,-0.9571670038952274,0.5081967213114754,0.9798563115745983,1.0,5/43,8.36%,MT2A;HAMP;TTN;PLSCR1;CALM1
prerank,GO_Biological_Process_2021__negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.445547163828893,-0.9569741011398704,0.5588235294117647,0.9796540423500393,1.0,8/39,9.91%,UBXN1;RPL5;PER2;RPL11;RPS3;TNFAIP3;U2AF2;VPS28
prerank,GO_Biological_Process_2021__regulation of mitochondrial fission (GO:0090140),0.4575549088581974,0.9568226761860305,0.5555555555555556,0.8696269144571785,1.0,4/20,9.11%,MCU;MARCHF5;LRRK2;DDHD1
prerank,GO_Biological_Process_2021__cadmium ion transmembrane transport (GO:0070574),0.6445921640165527,0.9567816980600167,0.6666666666666666,0.8684457667389895,1.0,2/5,5.71%,SLC39A14;SLC39A8
prerank,GO_Biological_Process_2021__cadmium ion transport (GO:0015691),0.6445921640165527,0.9567816980600167,0.6666666666666666,0.8684457667389895,1.0,2/5,5.71%,SLC39A14;SLC39A8
prerank,GO_Biological_Process_2021__activation of NF-kappaB-inducing kinase activity (GO:0007250),-0.5240340968572377,-0.9563742164312895,0.5087719298245614,0.9803603739752959,1.0,3/12,12.38%,CARD14;CHI3L1;COPS8
prerank,GO_Biological_Process_2021__intracellular sterol transport (GO:0032366),0.512997563020437,0.9563390772322636,0.5652173913043478,0.8689970325088541,1.0,1/11,4.97%,STARD4
prerank,GO_Biological_Process_2021__DNA replication initiation (GO:0006270),-0.4993941773975008,-0.956034812755641,0.484375,0.9803656808912407,1.0,7/24,22.17%,POLE3;MCM7;RPA3;PRIM1;MCM6;CDC7;MCM5
prerank,GO_Biological_Process_2021__cellular response to growth hormone stimulus (GO:0071378),0.5827376250900727,0.9558731091171327,0.5652173913043478,0.8693589833509848,1.0,3/6,27.36%,PTK2;PIK3R1;PXN
prerank,GO_Biological_Process_2021__response to cytokine (GO:0034097),-0.42501250990332673,-0.9557417685171435,0.5921052631578947,0.9803591232769029,1.0,15/106,10.20%,MX2;SIGIRR;MX1;CXCR4;XAF1;PID1;IFITM3;SHFL;OSMR;EIF2AK2;PLSCR1;NLRP12;CHI3L1;STAT1;SLC11A1
prerank,GO_Biological_Process_2021__monocarboxylic acid catabolic process (GO:0072329),0.5398001539160555,0.9556056606422727,0.5769230769230769,0.8692836737338832,1.0,2/11,8.50%,FAAH;FAH
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta production (GO:0071635),-0.6458173149946125,-0.955582968920901,0.6666666666666666,0.9801570633928741,1.0,2/5,25.48%,TYROBP;LILRB1
prerank,GO_Biological_Process_2021__membrane organization (GO:0061024),-0.3910178029349926,-0.9551578703747444,0.573170731707317,0.9805414126120741,1.0,9/187,1.80%,MX2;UBC;EPN1;MX1;RPS27A;RIMS1;CHRM2;TFRC;IL7R
prerank,GO_Biological_Process_2021__L-serine biosynthetic process (GO:0006564),0.6031548536829083,0.9550785941818442,0.6346153846153846,0.8697903903613949,1.0,3/5,34.37%,PSPH;SRR;PSAT1
prerank,GO_Biological_Process_2021__import into cell (GO:0098657),-0.4867534286388775,-0.9550671475243993,0.5846153846153846,0.9801324268339873,1.0,4/27,5.41%,SLC7A5;SLC38A1;IL10RA;GLUL
prerank,GO_Biological_Process_2021__positive regulation of cell cycle process (GO:0090068),-0.46329026591314554,-0.9549269384532147,0.5606060606060606,0.9799427599960272,1.0,8/55,13.80%,DDX11;IGF1;RANBP1;CENPV;PLSCR1;XRCC3;ZNF16;NUDT16
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation to 4-hydroxy-L-proline (GO:0018401),-0.6447664554312403,-0.9548215080195528,0.5555555555555556,0.9794520218785274,1.0,2/5,12.90%,EGLN3;P4HA3
prerank,GO_Biological_Process_2021__protein modification process (GO:0036211),-0.4352211210457713,-0.9545247159175388,0.5,0.9793811650085833,1.0,11/58,17.24%,USP6;YES1;ERO1A;GGCX;ADPRH;SEPHS1;UBA52;RPN1;PARP4;PIGH;SERP1
prerank,GO_Biological_Process_2021__chromatin disassembly (GO:0031498),0.49525930448921807,0.9545238644206031,0.5348837209302325,0.8697420278955622,1.0,3/11,10.75%,ARID1A;HMGA1;SUPT16H
prerank,GO_Biological_Process_2021__nucleosome disassembly (GO:0006337),0.49525930448921807,0.9545238644206031,0.5348837209302325,0.8697420278955622,1.0,3/11,10.75%,ARID1A;HMGA1;SUPT16H
prerank,GO_Biological_Process_2021__negative regulation of cellular process (GO:0048523),0.30258765026355766,0.9544732221182282,0.5454545454545454,0.8692055254766119,1.0,40/332,8.92%,KLF4;IFNLR1;PLXNB1;SERTAD2;PDPN;PKD2;SEMA5A;CDKN2AIP;PLXNA2;FGF2;DLG5;SIRT1;RNF139;CDK10;CHD5;MARCHF5;CBFA2T3;SIRPA;NCK2;MAP2K1;TSC2;ANP32B;PLPP1;DNAJB2;PLXNA3;SMAD3;CIB1;PPT1;ADRA1A;TXNDC12;PLXNB2;HMGA1;PLXNC1;NACC2;SOX4;NDRG3;CNOT7;CTBP2;CD33;NME6
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.33923302933872185,0.9543692735220536,0.56,0.8688063155648049,1.0,14/83,10.29%,ACER2;GSN;HIP1R;SIRT1;CASP9;TNFRSF10A;ANP32B;PPARG;SMAD3;TNF;ROBO1;BOK;LGALS9;LAPTM5
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.45621144976241346,0.9543171479267293,0.5405405405405406,0.8683223928048112,1.0,1/23,0.46%,TRPC1
prerank,GO_Biological_Process_2021__negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.4964227627346399,-0.9537769288263356,0.5571428571428572,0.9805494853374866,1.0,3/27,5.31%,UBXN1;DDRGK1;RPL11
prerank,GO_Biological_Process_2021__regulation of catecholamine secretion (GO:0050433),0.488597653227656,0.9535276285228916,0.5555555555555556,0.8695860607996568,1.0,6/15,22.41%,STX1A;SYT17;KCNB1;SNCA;SYT4;DTNBP1
prerank,GO_Biological_Process_2021__DNA geometric change (GO:0032392),-0.4624569835503459,-0.9534161160868005,0.5245901639344263,0.9806784548966497,1.0,1/21,0.51%,DDX11
prerank,GO_Biological_Process_2021__positive regulation of apoptotic process (GO:0043065),-0.37922870445790147,-0.9532005822792872,0.5584415584415584,0.980477276825981,1.0,25/217,9.49%,PLEKHG5;CCL3;UBC;RPS27A;MNDA;RASGRF2;GADD45B;VAV3;RACK1;TNFSF10;ING3;CLU;ING5;ARHGEF1;RPS3;MTCH1;TNFAIP8;ARHGEF3;OBSCN;RPS6;IFIT2;ITGA6;MTCH2;PDCD5;ITGB3BP
prerank,GO_Biological_Process_2021__negative regulation of mRNA polyadenylation (GO:1900364),0.5492087558740282,0.953170678173934,0.5283018867924528,0.869706872087802,1.0,3/8,20.63%,RNF20;ZC3H14;CDK9
prerank,GO_Biological_Process_2021__positive regulation of cell migration (GO:0030335),-0.3902133914190895,-0.9531566190190746,0.5675675675675675,0.9799054054664068,1.0,19/166,8.60%,CCL3;MYLK;CCL5;SYNE2;PDGFD;AIF1;CEMIP;GLIPR2;PLET1;DDRGK1;RACK1;RAB11A;IGF1;PECAM1;SEMA6A;ACTG1;ENPP2;FERMT3;ITGA6
prerank,GO_Biological_Process_2021__peroxisome proliferator activated receptor signaling pathway (GO:0035357),0.608751487518119,0.9531441464506373,0.6326530612244898,0.8691297318162713,1.0,1/5,5.17%,PPARG
prerank,GO_Biological_Process_2021__inner dynein arm assembly (GO:0036159),-0.6273040953479039,-0.9529829157890604,0.5882352941176471,0.9796932566395467,1.0,2/5,12.06%,DNAH1;CCDC39
prerank,GO_Biological_Process_2021__regulation of mRNA stability (GO:0043488),-0.4065023601489696,-0.9528707343527476,0.6103896103896104,0.9792873434720265,1.0,16/120,14.82%,UBC;RPS27A;ZFP36;PSMB3;PSMB6;PSMA7;PSMB9;EXOSC1;SLC11A1;NPM1;PSMD12;PSMD8;PSMA5;APEX1;HSPA1A;UBA52
prerank,GO_Biological_Process_2021__protein complex oligomerization (GO:0051259),0.3693627853542277,0.9525772460917576,0.5555555555555556,0.8697439002385822,1.0,10/67,8.90%,TIFA;PKD2;ZBTB1;MCU;UGDH;TMEM120B;BOK;NACC2;KCNC2;SLC9A1
prerank,"GO_Biological_Process_2021__DNA-templated transcription, initiation (GO:0006352)",0.3436277462346816,0.9522492909209682,0.5652173913043478,0.8699408247369173,1.0,13/119,7.63%,ESRRG;PPARGC1A;POLR2D;MAML2;HDAC9;E2F3;PPARG;TFB1M;CDK7;TAF2;MAML3;RRN3;TAF9B
prerank,GO_Biological_Process_2021__regulation of translational initiation (GO:0006446),-0.4301463561013112,-0.9519985142153127,0.5454545454545454,0.980780052359525,1.0,7/58,12.13%,MIF4GD;CCL5;EIF1;POLR2G;NCBP2;NPM1;ATF3
prerank,GO_Biological_Process_2021__protein O-linked mannosylation (GO:0035269),0.482343492743328,0.9518115397589294,0.4883720930232558,0.8702648475153208,1.0,4/14,12.20%,LARGE1;TMTC2;FKRP;FKTN
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein kinase activity (GO:1904029),0.4256240909299897,0.9517239134743238,0.5116279069767442,0.8698247048951266,1.0,7/27,16.39%,CDK5R1;CCNG2;CDK7;CCNG1;GTPBP4;CCND3;BLM
prerank,MSigDB_Hallmark_2020__G2-M Checkpoint,-0.3901771619443912,-0.9514232367538834,0.5454545454545454,0.9815308160081375,1.0,19/140,14.70%,MT2A;SLC7A5;ATF5;STIL;SLC38A1;HUS1;ILF3;ODC1;BRCA2;MEIS1;NUP50;HIF1A;CKS2;HIRA;SRSF2;NOTCH2;CCND1;STMN1;SMC1A
prerank,GO_Biological_Process_2021__positive regulation of signaling (GO:0023056),0.46404381319614973,0.9513359728555231,0.5128205128205128,0.8700974767461739,1.0,7/25,10.53%,SCRIB;CDKN2AIP;PTPN23;GRIK2;TNF;CLSTN2;CLSTN3
prerank,GO_Biological_Process_2021__negative regulation of kinase activity (GO:0033673),0.35461775772733234,0.9511886467178569,0.5405405405405406,0.8698699123741478,1.0,7/51,9.33%,QARS1;SPRED1;TSC2;GNAQ;CEP85;YWHAG;DEPTOR
prerank,GO_Biological_Process_2021__glutathione metabolic process (GO:0006749),-0.4724233509976564,-0.9511325719218274,0.5909090909090909,0.9815000624359222,1.0,8/20,14.09%,GSTM4;GSTP1;GSTK1;GCLM;GSTM3;GLRX2;SOD1;GPX1
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase II (GO:0000122),0.2904183781085951,0.9505995660534822,0.8571428571428571,0.8706757474654665,1.0,50/426,9.99%,KLF4;UBE2D1;BAG3;ZNF175;ZBTB1;TFEC;RNF2;CBX6;GLIS3;DR1;SIRT1;SMAD7;ZBTB16;MITF;ZNF536;HDAC9;MTA2;NRIP1;MIER3;MXD4;JAZF1;FOXP4;MOSPD1;PPARG;PARP1;ZNF555;ZNF75A;CXXC5;SMAD2;DDIT3;SMAD3;DACH1;RUNX1;ZBTB2;SALL1;TNF;BCL11A;NFIX;TAF9B;ZNF3;NACC2;NEDD4L;HSF4;CTBP2;SIRT6;MDM2;HDAC1;NFIB;LOXL2;CNOT2
prerank,GO_Biological_Process_2021__axonemal dynein complex assembly (GO:0070286),-0.5497436931850683,-0.9505401220933082,0.625,0.9823021031109986,1.0,5/12,22.38%,DNAH17;DNAH1;CCDC39;TTC12;DNAI4
prerank,GO_Biological_Process_2021__negative regulation of protein localization to membrane (GO:1905476),-0.5100243929343007,-0.9505318051291655,0.5,0.9816555181827036,1.0,1/19,1.81%,PID1
prerank,GO_Biological_Process_2021__protein kinase C signaling (GO:0070528),-0.6113418690132342,-0.950399904569932,0.5818181818181818,0.9813904814819139,1.0,3/7,22.29%,PLEK;FLOT1;PDGFB
prerank,MSigDB_Hallmark_2020__p53 Pathway,-0.38866248028790756,-0.9500293638998484,0.5542168674698795,0.9815823036073388,1.0,16/145,6.95%,PROCR;H1-2;SAT1;PPP1R15A;FOS;DDIT4;BTG2;RPS12;RGS16;IER3;RACK1;H2AJ;WRAP73;FGF13;EPHX1;RPL36
prerank,GO_Biological_Process_2021__rRNA transcription (GO:0009303),-0.528318838980967,-0.9499966563932659,0.5714285714285714,0.9809843022634263,1.0,1/15,3.40%,GTF3C6
prerank,GO_Biological_Process_2021__lipid catabolic process (GO:0016042),-0.5527828352792474,-0.949831508369025,0.5254237288135594,0.9806910309047928,1.0,1/10,2.51%,LIPG
prerank,GO_Biological_Process_2021__bone cell development (GO:0098751),-0.6074467122377287,-0.9495783311185213,0.6610169491525424,0.980666829033945,1.0,1/6,3.81%,ANXA2
prerank,GO_Biological_Process_2021__cellular response to acid chemical (GO:0071229),0.4614701122053257,0.9495186501898174,0.45161290322580644,0.8722081849623474,1.0,3/23,6.73%,RRAGD;GLRA1;CPEB4
prerank,GO_Biological_Process_2021__glycosaminoglycan catabolic process (GO:0006027),0.435998623936393,0.9494892323935149,0.5882352941176471,0.8716667494500827,1.0,6/31,8.90%,NCAN;FGF2;GLB1;CSPG5;HPSE;SLC9A1
prerank,PanglaoDB_Augmented_2021__Pulmonary Vascular Smooth Muscle Cells,-0.482952280948417,-0.949437052467932,0.4794520547945205,0.9803508191952199,1.0,2/35,0.65%,MYLK;COL5A1
prerank,GO_Biological_Process_2021__negative regulation of G0 to G1 transition (GO:0070317),0.40996917767363583,0.949308303681664,0.5384615384615384,0.8708310273372659,1.0,5/30,16.85%,RNF2;RYBP;APAF1;PHC1;YAF2
prerank,GO_Biological_Process_2021__regulation of G0 to G1 transition (GO:0070316),0.40996917767363583,0.949308303681664,0.5384615384615384,0.8708310273372659,1.0,5/30,16.85%,RNF2;RYBP;APAF1;PHC1;YAF2
prerank,GO_Biological_Process_2021__regulation of phosphatase activity (GO:0010921),0.4948230744436195,0.9491810479448481,0.625,0.8705785881473768,1.0,4/16,18.72%,TIPRL;PTPA;MTMR9;CHP1
prerank,GO_Biological_Process_2021__positive regulation of receptor recycling (GO:0001921),0.569353161070441,0.9491761421372806,0.6666666666666666,0.8699723356486668,1.0,1/8,0.84%,SCRIB
prerank,GO_Biological_Process_2021__cardiac left ventricle morphogenesis (GO:0003214),0.5931405074728725,0.9491557492998245,0.58,0.869451193219022,1.0,1/6,1.95%,TGFBR2
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 beta production (GO:0032731),-0.45312363043521786,-0.949065836049316,0.5915492957746479,0.9806885176124884,1.0,5/38,4.19%,CD36;CCL3;MNDA;PYHIN1;AIM2
prerank,GO_Biological_Process_2021__regulation of fat cell differentiation (GO:0045598),-0.45467499915025095,-0.9488345437817609,0.5,0.980617734572265,1.0,3/49,3.27%,SYAP1;ZFP36;RORA
prerank,GO_Biological_Process_2021__parallel actin filament bundle assembly (GO:0030046),-0.6199400974633564,-0.9476801930181319,0.625,0.9825275614588905,1.0,1/5,2.67%,AIF1
prerank,GO_Biological_Process_2021__positive regulation of protein kinase C signaling (GO:0090037),0.592827104924253,0.9471903911141588,0.5777777777777777,0.8731411603146304,1.0,2/6,6.22%,WNT5A;ADRA1A
prerank,GO_Biological_Process_2021__phospholipid efflux (GO:0033700),-0.6105079298659433,-0.9471184108750238,0.5777777777777777,0.9832647756775151,1.0,3/5,38.78%,ABCA7;APOE;APOC1
prerank,GO_Biological_Process_2021__glycogen biosynthetic process (GO:0005978),-0.5859393658744054,-0.9470855628247137,0.59375,0.9820272289000076,1.0,1/9,3.13%,PER2
prerank,GO_Biological_Process_2021__glucan biosynthetic process (GO:0009250),-0.5859393658744054,-0.9470855628247137,0.59375,0.9820272289000076,1.0,1/9,3.13%,PER2
prerank,GO_Biological_Process_2021__protein localization to chromosome (GO:0034502),-0.4940164529506607,-0.946838260368422,0.5555555555555556,0.9820661649171627,1.0,1/25,1.79%,TPP1
prerank,GO_Biological_Process_2021__mRNA transcription by RNA polymerase II (GO:0042789),0.5633314015011751,0.9468244785693958,0.5365853658536586,0.8732580738325091,1.0,1/6,1.16%,ZBTB1
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.5568970141580641,0.9467824114587646,0.5813953488372093,0.8720796700282307,1.0,4/6,27.48%,GSK3B;CHP1;HOMER2;DYRK2
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-mediated signaling (GO:0106057),0.5568970141580641,0.9467824114587646,0.5813953488372093,0.8720796700282307,1.0,4/6,27.48%,GSK3B;CHP1;HOMER2;DYRK2
prerank,PanglaoDB_Augmented_2021__Juxtaglomerular Cells,0.41531804391338945,0.9464829341134817,0.5,0.8720879100968785,1.0,5/28,5.20%,COL16A1;SEMA5A;SVEP1;ACTA2;TIMP3
prerank,GO_Biological_Process_2021__regulation of hydrogen peroxide-induced cell death (GO:1903205),0.5120338353648178,0.9464355362945036,0.48,0.8716094264421845,1.0,1/8,3.81%,LRRK2
prerank,PanglaoDB_Augmented_2021__Cholangiocytes,-0.5380020388599219,-0.9460796347845464,0.5084745762711864,0.9831094064431346,1.0,3/13,10.61%,CLDN7;OVOL2;CFTR
prerank,GO_Biological_Process_2021__sequestering of extracellular ligand from receptor (GO:0035581),0.6049245136935766,0.9458456292150543,0.5777777777777777,0.8723140004974779,1.0,2/5,20.80%,FBN2;CD46
prerank,GO_Biological_Process_2021__RNA transport (GO:0050658),-0.4245309701558452,-0.9458453620479035,0.5352112676056338,0.9830141280438536,1.0,10/57,13.24%,ZFP36;SIDT2;DHX38;SIDT1;EIF4A3;CHTOP;U2AF2;NCBP2;SRSF2;SRSF7
prerank,GO_Biological_Process_2021__glutamine family amino acid catabolic process (GO:0009065),-0.6178538404454819,-0.9457087079442967,0.5689655172413793,0.9826638752693776,1.0,1/5,5.41%,GLUL
prerank,GO_Biological_Process_2021__positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),-0.4762441923536668,-0.9456582014660918,0.5454545454545454,0.982105510580196,1.0,4/25,10.09%,PYHIN1;DDRGK1;CLU;ATP5IF1
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to telomere (GO:1904851),0.5489596297360225,0.9455473553610425,0.6363636363636364,0.8723136813155375,1.0,2/9,13.21%,TCP1;CCT3
prerank,GO_Biological_Process_2021__regulation of receptor-mediated endocytosis (GO:0048259),0.43125038747737826,0.9454034963109887,0.4583333333333333,0.8720537629490822,1.0,5/29,6.14%,SERPINE1;HIP1R;PICALM;SNAP91;PPT1
prerank,GO_Biological_Process_2021__embryonic heart tube morphogenesis (GO:0003143),0.4598507255163155,0.9453870286374407,0.5227272727272727,0.8715180468249981,1.0,5/18,13.38%,PKD2;TGFBR2;CCDC40;SETDB2;MEGF8
prerank,GO_Biological_Process_2021__acetyl-CoA biosynthetic process from pyruvate (GO:0006086),-0.6169178921511964,-0.944699538458143,0.6326530612244898,0.9838291610074951,1.0,3/5,20.82%,PDHX;PDHB;PDHA1
prerank,GO_Biological_Process_2021__regulation of heart rate by cardiac conduction (GO:0086091),0.45824488705400607,0.9446466669745486,0.6296296296296297,0.8725134291732941,1.0,4/23,5.43%,KCNJ2;KCND3;SCN3B;KCNJ5
prerank,GO_Biological_Process_2021__mitral valve morphogenesis (GO:0003183),0.5201276665657795,0.9442061641294925,0.5531914893617021,0.8727051806440969,1.0,2/7,12.30%,SOX4;BMPR1A
prerank,GO_Biological_Process_2021__retinal ganglion cell axon guidance (GO:0031290),0.5998717181370264,0.9439466216354154,0.6190476190476191,0.8727212949439584,1.0,3/6,9.71%,NRP1;PTPRM;ALCAM
prerank,GO_Biological_Process_2021__regulation of dendrite development (GO:0050773),0.41704271794362485,0.9438499706834714,0.6129032258064516,0.8723535020872758,1.0,17/31,23.37%,BCL11A;NEDD4L;KNDC1;CSMD3;COBL;MARK1;DCC;KIAA0319;GSK3B;ADGRB3;CAMSAP2;NEDD4;SEMA4D;MFSD2A;RAP2A;TNIK;DAB2IP
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell activation (GO:0046635),-0.6333165969674579,-0.9437337792967491,0.6551724137931034,0.9854695039535222,1.0,4/10,18.79%,CD55;HLA-DRA;HLA-E;HLA-DRB1
prerank,GO_Biological_Process_2021__positive regulation of phagocytosis (GO:0050766),-0.475485041597566,-0.943459424464132,0.5303030303030303,0.9853729689128041,1.0,8/32,14.85%,FCER1G;CD300LF;SLC11A1;NCKAP1L;CD47;CYBA;PTPRC;C3
prerank,GO_Biological_Process_2021__cAMP-mediated signaling (GO:0019933),0.4927502796378875,0.9432727696157862,0.4878048780487805,0.8730203234333493,1.0,10/17,27.96%,PDE7B;RAPGEF3;RAPGEF2;KSR1;RIMS2;DGKQ;EPHA5;ADCY1;PDE2A;CAP1
prerank,GO_Biological_Process_2021__regulation of androgen receptor signaling pathway (GO:0060765),0.45637387038446053,0.9430088300445346,0.54,0.8729028461650847,1.0,5/23,21.18%,SIRT1;HDAC1;RNF6;NCOA2;SAFB2
prerank,GO_Biological_Process_2021__heart looping (GO:0001947),0.48835947297416793,0.9428935453723045,0.5581395348837209,0.8726772651079705,1.0,2/15,1.95%,PKD2;TGFBR2
prerank,GO_Biological_Process_2021__protein deacetylation (GO:0006476),-0.426922879223049,-0.9428444969913393,0.639344262295082,0.9862300057047613,1.0,2/38,6.30%,FLNA;MSL3
prerank,GO_Biological_Process_2021__regulation of non-motile cilium assembly (GO:1902855),-0.6673071554442894,-0.9427000667965169,0.6444444444444445,0.9859194326718118,1.0,1/5,6.35%,WRAP73
prerank,GO_Biological_Process_2021__regulation of carbohydrate biosynthetic process (GO:0043255),-0.591684625458835,-0.9420738051887968,0.5892857142857143,0.9866826324645177,1.0,2/8,11.31%,SELENOS;FBP1
prerank,GO_Biological_Process_2021__regulation of stem cell population maintenance (GO:2000036),0.47551464047433306,0.94175460170543,0.5681818181818182,0.8744410435269163,1.0,7/15,12.63%,ZNF706;NCOA3;TAF5L;LOXL2;CNOT2;KAT2A;WDR43
prerank,GO_Biological_Process_2021__positive regulation of viral process (GO:0048524),-0.4360001575279305,-0.941476577099397,0.5074626865671642,0.9874217490513229,1.0,7/52,7.76%,PPIE;CCL5;MDFIC;IFIT1;CTDP1;POLR2G;SRPK1
prerank,GO_Biological_Process_2021__phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),-0.44114801523588487,-0.9411143805859924,0.5396825396825397,0.9873761045774885,1.0,8/34,15.92%,CHRM2;TACR1;C5AR1;P2RY8;C5AR2;LPAR6;FPR1;AGT
prerank,GO_Biological_Process_2021__protein localization to organelle (GO:0033365),0.3637092775752812,0.9410933487411556,0.4642857142857143,0.8752792491917395,1.0,6/106,3.95%,TULP2;RAB33B;BBS9;MARCHF5;LRRK2;TULP3
prerank,GO_Biological_Process_2021__non-canonical Wnt signaling pathway (GO:0035567),-0.4163425882976554,-0.9410280872168021,0.5925925925925926,0.986910095827461,1.0,18/89,19.69%,CCDC88C;PSMB3;PSMB6;PSMA7;CALM1;PSMB9;DVL1;FZD2;PSMD12;PFN1;PSMD8;PSMA5;AP2S1;RAC1;PSMA3;PSMC4;PSME2;PSME1
prerank,GO_Biological_Process_2021__cellular response to misfolded protein (GO:0071218),0.42768208693522625,0.9409709520763108,0.5,0.8749943248780502,1.0,7/18,23.10%,DNAJC18;AUP1;RNF185;BAG6;KLHL15;TOR1A;DNAJB14
prerank,GO_Biological_Process_2021__positive regulation of nucleocytoplasmic transport (GO:0046824),-0.46071724503920974,-0.9409479994175507,0.5806451612903226,0.9863986625752647,1.0,4/38,6.41%,FLNA;EMD;JUP;RBM22
prerank,GO_Biological_Process_2021__purine nucleotide metabolic process (GO:0006163),-0.505283465318372,-0.9408475252815769,0.5,0.9859396724876283,1.0,2/16,4.95%,MTHFD1;NT5C
prerank,GO_Biological_Process_2021__positive regulation of DNA recombination (GO:0045911),-0.5067252334824727,-0.9406680266278784,0.5666666666666667,0.9856767159415584,1.0,4/22,14.63%,TFRC;WDR48;ZCWPW1;FANCB
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 production (GO:0032732),-0.4436244439436288,-0.9404067784895611,0.5694444444444444,0.9857242827937754,1.0,5/41,4.19%,CD36;CCL3;MNDA;PYHIN1;AIM2
prerank,GO_Biological_Process_2021__protein deneddylation (GO:0000338),-0.5561367370782229,-0.9402230080168712,0.6031746031746031,0.9855077385791969,1.0,2/10,12.38%,COPS6;COPS8
prerank,GO_Biological_Process_2021__regulation of epithelial cell differentiation (GO:0030856),0.5910596189002439,0.9399154618296139,0.6666666666666666,0.8765618639809468,1.0,2/8,17.57%,KLF7;PRKX
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell proliferation (GO:0048662),-0.4957093670746598,-0.9397668924562474,0.5625,0.9859339551436778,1.0,3/18,8.14%,AIF1;APOD;TNFAIP3
prerank,GO_Biological_Process_2021__negative regulation of cellular senescence (GO:2000773),0.5390879358810607,0.9396671775034487,0.5416666666666666,0.8765420372405512,1.0,2/9,11.88%,SIRT1;CDK6
prerank,GO_Biological_Process_2021__positive regulation of defense response (GO:0031349),-0.39850162378351395,-0.9394930536592013,0.5135135135135135,0.9859353968255739,1.0,11/62,16.01%,CCL3;CCL5;ETS1;PLSCR1;NLRP12;TASL;CD47;CYBA;IFI35;AGT;POLR3C
prerank,GO_Biological_Process_2021__pteridine-containing compound metabolic process (GO:0042558),-0.6053663294686641,-0.938845843469047,0.6129032258064516,0.9867904268485377,1.0,2/8,9.36%,CALM1;PTS
prerank,GO_Biological_Process_2021__positive regulation of cell differentiation (GO:0045597),0.3291679985832521,0.938527662207291,0.5833333333333334,0.8785376507705213,1.0,27/144,10.09%,PDPN;ATRAID;ACVR2A;TGFBR2;MSR1;MAPK11;ZBTB16;CTNNBIP1;RAP1A;AKIRIN1;PPARG;SMAD2;SMAD3;RIN2;KITLG;ZC4H2;ZNF385A;RANBP3L;BRINP3;CTNNA2;TMEM119;FBN2;SOX5;BMPR1B;LOXL2;HGF;BCL9L
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",-0.6196481607800612,-0.9380122708396099,0.640625,0.988027903024901,1.0,3/9,10.77%,RUNX3;NCKAP1L;HLA-DRA
prerank,GO_Biological_Process_2021__positive regulation of monocyte differentiation (GO:0045657),0.565388025075771,0.9379867282792314,0.6136363636363636,0.8790303674832642,1.0,1/7,3.13%,CTNNBIP1
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle phase transition (GO:1901992),0.38196450574794155,0.9378787400469226,0.5172413793103449,0.8786030487605827,1.0,5/41,9.82%,ANXA1;KLHL18;UBE2E2;CDC23;RAD51B
prerank,GO_Biological_Process_2021__detection of mechanical stimulus (GO:0050982),0.46026041058291534,0.9377881229781877,0.5405405405405406,0.8782425291963734,1.0,2/14,3.46%,PKD2;PKD1
prerank,GO_Biological_Process_2021__mitochondrial calcium ion transmembrane transport (GO:0006851),-0.49609965060479155,-0.9377696337158221,0.5483870967741935,0.9880050747848103,1.0,7/17,16.70%,PHB2;SMDT1;MICU2;SPG7;MAIP1;MCUR1;STOML2
prerank,GO_Biological_Process_2021__cellular response to UV (GO:0034644),0.3894550835430306,0.9375165004272201,0.5,0.8782216221748894,1.0,8/49,10.90%,ZBTB1;RUVBL2;SIRT1;CASP9;PARP1;EIF2S1;PTPRK;ERCC4
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway (GO:0038094),-0.4318942003559673,-0.9372854023273482,0.6029411764705882,0.9885483048981755,1.0,11/65,13.75%,MYO1G;VAV3;YES1;FCER1G;CD247;FYN;ACTG1;ACTB;NCKAP1L;CYFIP2;PIK3CB
prerank,GO_Biological_Process_2021__glucan catabolic process (GO:0009251),-0.5470129050791359,-0.93693645568051,0.6923076923076923,0.9886622922203168,1.0,2/12,8.36%,PHKG1;CALM1
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transporter activity (GO:2000649),0.4375371182531243,0.9369137281169709,0.5,0.878878520792235,1.0,9/26,18.87%,NETO1;SCN3B;NEDD4L;WNK1;SLMAP;FXYD5;FXYD7;NEDD4;SCN1B
prerank,GO_Biological_Process_2021__cellular divalent inorganic cation homeostasis (GO:0072503),-0.45090632315696044,-0.936772350368024,0.582089552238806,0.9884563736142573,1.0,7/54,10.20%,MT2A;CCL3;CCL5;ATP13A1;TPT1;TRPV4;SLC11A1
prerank,GO_Biological_Process_2021__regulation of generation of precursor metabolites and energy (GO:0043467),0.3569321171995035,0.9367013853591412,0.5609756097560976,0.8786424501250479,1.0,7/37,17.93%,NUP153;NUP188;NUP42;RUBCNL;NDC1;NUP133;NUP205
prerank,GO_Biological_Process_2021__vesicle organization (GO:0016050),-0.4741398325177877,-0.9366176241638714,0.5757575757575758,0.9882735507923291,1.0,1/31,0.93%,SRGN
prerank,GO_Biological_Process_2021__positive regulation of cell-matrix adhesion (GO:0001954),-0.4711081591797628,-0.9365853277662591,0.4918032786885246,0.987714609400711,1.0,2/26,0.52%,SKAP1;CD36
prerank,GO_Biological_Process_2021__regulation of mitochondrion organization (GO:0010821),0.39828650918065905,0.9365197843743657,0.5,0.878497498661684,1.0,3/35,3.81%,PPARGC1A;MARCHF5;LRRK2
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),-0.4970948155917016,-0.9363619329295667,0.5636363636363636,0.9876179945871123,1.0,7/24,13.66%,NLRC3;IGF1;GSTP1;TNFAIP3;SELENOS;C5AR2;HAVCR2
prerank,GO_Biological_Process_2021__DNA dealkylation involved in DNA repair (GO:0006307),0.5515891898943489,0.9363549581669792,0.525,0.8776723883769988,1.0,4/9,22.91%,MGMT;ASCC1;ALKBH5;FTO
prerank,GO_Biological_Process_2021__DNA dealkylation (GO:0035510),0.5515891898943489,0.9363549581669792,0.525,0.8776723883769988,1.0,4/9,22.91%,MGMT;ASCC1;ALKBH5;FTO
prerank,GO_Biological_Process_2021__regulation of cell population proliferation (GO:0042127),-0.36148292433145324,-0.9362769158363763,0.625,0.9871285574107623,1.0,57/400,12.64%,NR4A3;STAT4;RPS4X;COL18A1;FTH1;TFRC;JUNB;IL7R;WARS1;H2AC6;PDGFD;IFIT3;AIF1;BTG2;ATF5;DDRGK1;ETS1;AQP11;TSPAN31;CLU;ING5;JUP;RPL23;IGF1;SLC25A5;TIPIN;IL12RB2;OSMR;PRLR;EIF2AK2;RNF126;RPS6;SGK1;NAMPT;BEX4;KANK2;EGLN3;PDCD5;CHTOP;STAT1;MEIS1;GLMN;PTN;IRF1;NPM1;TRPM4;RPS9;VEGFA;BTG1;ING4;TBC1D8;CD47;EFNB2;FLT1;COPS8;HSPA1B;SST
prerank,GO_Biological_Process_2021__respiratory system development (GO:0060541),0.4637569543837129,0.9362421949209065,0.4117647058823529,0.877314218674921,1.0,5/18,13.44%,PDPN;FGF2;DISP1;CCDC40;BAG6
prerank,GO_Biological_Process_2021__modification-dependent protein catabolic process (GO:0019941),0.32797689098754135,0.9362406500409381,0.7142857142857143,0.8767178120000909,1.0,22/162,11.31%,UBE2D1;SPSB2;ZNRF3;FBXL14;UBE2D2;FZR1;UBR3;NEDD4L;CDC23;MDM2;KCTD6;BTRC;FBXO45;RNF19B;KCTD10;UBA1;RNF20;UBE2L3;ANAPC16;RNF217;FEM1C;RNF185
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell activation (GO:2000514)",-0.6467921765973318,-0.9362312656318865,0.6379310344827587,0.9865999247132743,1.0,2/6,10.77%,CD55;HLA-DRA
prerank,GO_Biological_Process_2021__regulation of Wnt signaling pathway (GO:0030111),0.3789733934723238,0.9355940818112618,0.4642857142857143,0.8774548710685931,1.0,12/62,9.77%,GRB10;TCF7L1;CTNNBIP1;LRRK2;TSC2;GNAQ;RUNX1;SALL1;NLK;KANK1;ZRANB1;BTRC
prerank,GO_Biological_Process_2021__regulation of neuron migration (GO:2001222),0.4616666411057395,0.9355257595321518,0.5294117647058824,0.8769989303069875,1.0,9/25,18.01%,PLXNB2;CTNNA2;NIPBL;SRGAP2;ZNF609;SHTN1;CX3CL1;RAPGEF2;PHACTR1
prerank,GO_Biological_Process_2021__positive regulation of blood coagulation (GO:0030194),-0.5412572230381648,-0.9355247201954437,0.6,0.9876075956509638,1.0,2/9,2.94%,ENPP4;USF1
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.5971200667275502,0.9349120579940357,0.62,0.8776772928345002,1.0,1/6,2.26%,FGF2
prerank,GO_Biological_Process_2021__nucleus localization (GO:0051647),-0.5752378483055833,-0.93468228156545,0.5333333333333333,0.9888753959232636,1.0,1/9,1.88%,SYNE2
prerank,GO_Biological_Process_2021__negative regulation of DNA binding (GO:0043392),-0.5114702784797354,-0.9342458479519605,0.5714285714285714,0.9891475363484573,1.0,1/17,3.13%,PER2
prerank,GO_Biological_Process_2021__negative regulation of apoptotic process (GO:0043066),-0.36714112724565706,-0.9340646116633363,0.6511627906976745,0.9888630458479873,1.0,31/294,8.71%,BCL2A1;FLNA;UBC;APIP;RPS27A;TFRC;CARD14;CARD16;SNX6;IFIT3;ATF5;PRELID1;STIL;NAIP;RNF213;DDRGK1;PTMA;RPL10;BNIP2;IGF1;LAMTOR5;RPS3A;RNF144B;TNFAIP8;PHB2;PRLR;GSTP1;TPT1;NAA38;CFL1;CD44
prerank,GO_Biological_Process_2021__positive regulation of translation (GO:0045727),-0.41888529564756244,-0.9337592331495655,0.5303030303030303,0.9888682280450054,1.0,13/75,15.93%,RPS4X;CCL5;RPL5;POLR2G;EIF4A3;EIF5A;NPM1;RPS9;PASK;RPS27L;ZCCHC4;RPUSD4;TRUB2
prerank,GO_Biological_Process_2021__DNA biosynthetic process (GO:0071897),0.5291591385312006,0.9336130173600209,0.5151515151515151,0.880226509883928,1.0,3/11,19.02%,SIRT1;POLA1;WRNIP1
prerank,GO_Biological_Process_2021__mitochondrial DNA metabolic process (GO:0032042),0.5484872433246613,0.93337479362985,0.574468085106383,0.8801470008560726,1.0,1/7,5.45%,PARP1
prerank,GO_Biological_Process_2021__negative regulation of translation (GO:0017148),-0.4237114858535842,-0.9332119874338035,0.5915492957746479,0.9896046845288701,1.0,9/73,8.47%,GAPDH;BTG2;GZMB;RPL13A;RACK1;RPS3;ILF3;EIF2AK2;EIF4A3
prerank,GO_Biological_Process_2021__positive regulation of programmed cell death (GO:0043068),-0.3689998228532504,-0.9331575673095506,0.5974025974025974,0.9891051777303159,1.0,24/204,9.49%,PLEKHG5;UBC;RPS27A;MNDA;RASGRF2;GADD45B;VAV3;PRF1;RACK1;TNFSF10;ING3;CLU;ING5;ARHGEF1;MTCH1;TNFAIP8;ARHGEF3;OBSCN;RPS6;IFIT2;ITGA6;MTCH2;PDCD5;ITGB3BP
prerank,GO_Biological_Process_2021__pentose-phosphate shunt (GO:0006098),-0.5490145350424728,-0.9329896293454791,0.6031746031746031,0.9888837340179247,1.0,5/10,31.02%,TALDO1;H6PD;RPE;PGLS;TKT
prerank,GO_Biological_Process_2021__regulation of phospholipase C activity (GO:1900274),0.5276094522560926,0.9328840903805253,0.5333333333333333,0.8807316715157413,1.0,1/10,2.26%,FGF2
prerank,GO_Biological_Process_2021__regulation of protein localization to cell periphery (GO:1904375),0.47990070002876306,0.9322786061360705,0.5217391304347826,0.8813565153762256,1.0,1/13,1.57%,ABCA2
prerank,GO_Biological_Process_2021__regulation of cell killing (GO:0031341),-0.5752865541698374,-0.931909674336254,0.5714285714285714,0.9907276561740165,1.0,3/9,16.58%,CD55;CYBA;RAC1
prerank,GO_Biological_Process_2021__negative regulation of cilium assembly (GO:1902018),0.5468401567372082,0.9318607988117631,0.6538461538461539,0.8816202716028917,1.0,1/9,3.28%,CDK10
prerank,GO_Biological_Process_2021__determination of heart left/right asymmetry (GO:0061371),0.4534855587015273,0.9318136593920076,0.5531914893617021,0.8811064002465717,1.0,5/17,13.38%,PKD2;TGFBR2;CCDC40;SETDB2;MEGF8
prerank,GO_Biological_Process_2021__membrane biogenesis (GO:0044091),0.6300045765726972,0.9318118607434034,0.6666666666666666,0.880519636347975,1.0,4/5,27.18%,PEX16;SPTBN1;SERINC1;CLIP3
prerank,GO_Biological_Process_2021__negative regulation of neuron apoptotic process (GO:0043524),0.412354532124444,0.9317363847793558,0.5,0.8800643964646251,1.0,9/40,14.52%,PPARGC1A;PPT1;CPEB4;LIG4;UNC5B;SOD2;NTRK2;PRKCI;TYRO3
prerank,GO_Biological_Process_2021__cytoskeleton organization (GO:0007010),-0.4084486098916035,-0.9317224086146986,0.5405405405405406,0.990465864618139,1.0,7/88,8.34%,CCL3;ARHGAP4;SEMA6A;RHOU;EPB41L3;TNFAIP3;CFL1
prerank,GO_Biological_Process_2021__cellular biogenic amine biosynthetic process (GO:0042401),-0.634054873326875,-0.9315769287554034,0.6885245901639344,0.990147910699748,1.0,2/5,7.79%,SAT1;SAT2
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-independent decay (GO:0031086)",-0.6112178079255726,-0.9315207106364172,0.5789473684210527,0.9896157969432112,1.0,2/6,8.16%,ZFP36;PNRC2
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.37990116168386606,0.9314211379139048,0.5625,0.8802058338090467,1.0,1/35,0.08%,KLF4
prerank,GO_Biological_Process_2021__determination of left/right symmetry (GO:0007368),-0.5124327310510567,-0.9313246991082593,0.603448275862069,0.9893439545438816,1.0,5/18,12.06%,DNAH11;STIL;ENKUR;CITED2;CCDC39
prerank,GO_Biological_Process_2021__2-oxoglutarate metabolic process (GO:0006103),0.5210644525577028,0.931100219987165,0.5128205128205128,0.880314441544042,1.0,1/9,4.39%,L2HGDH
prerank,GO_Biological_Process_2021__protein methylation (GO:0006479),0.4100400073123356,0.9306463058375074,0.47368421052631576,0.8806349135965984,1.0,6/27,17.32%,VCPKMT;NSD3;SETD3;RAB6A;SNRPB;PRMT7
prerank,GO_Biological_Process_2021__mRNA processing (GO:0006397),-0.3701239013386214,-0.9305884513502068,0.6707317073170732,0.9903920713049061,1.0,54/248,19.10%,PPIE;FRG1;RAVER2;DHX16;ZCRB1;DHX38;CSTF2T;SNRNP27;SNRPD2;RNPC3;GTF2H5;WDR83;RBM22;AURKAIP1;POLR2G;RNMT;PNN;EIF4A3;LSM7;PDCD7;CHTOP;CRNKL1;ZRSR2;U2AF2;NCBP2;ZCCHC8;SMNDC1;PRPF3;BUD31;GCFC2;RBM4B;DDX23;SRSF2;DDX5;SRSF7;CWC25;SNRPA1;CWF19L2;CCAR1;PPWD1;EFTUD2;SLU7;SNRPA;LSM4;IK;SNRNP200;PRPF18;GTF2F1;HNRNPH2;RBM4;BCAS2;SRRM4;SF3A1;PRPF4
prerank,GO_Biological_Process_2021__histone lysine methylation (GO:0034968),0.4352948929721128,0.9305312458246838,0.5853658536585366,0.8803030530393982,1.0,12/23,34.98%,SETD3;SETDB2;RBBP5;SUV39H2;SETD1B;KDM6A;CXXC1;WDR82;EZH2;SMYD2;DOT1L;DPY30
prerank,GO_Biological_Process_2021__amyloid-beta metabolic process (GO:0050435),0.5301980296746979,0.9304714894453586,0.5681818181818182,0.8798169163954737,1.0,3/10,17.77%,BACE2;DYRK1A;IDE
prerank,GO_Biological_Process_2021__regulation of peptide hormone secretion (GO:0090276),0.4007757485102394,0.9304681346299359,0.5609756097560976,0.8792337793995257,1.0,10/36,14.74%,CACNA1A;RAP1A;TNF;RFX3;CLOCK;KCNC2;STX1A;ABCC8;CACNA1E;RAPGEF3
prerank,GO_Biological_Process_2021__negative regulation of ATP metabolic process (GO:1903579),-0.5166380802053702,-0.9304269773919379,0.5645161290322581,0.9900862636403697,1.0,3/12,11.31%,PID1;FIS1;FBP1
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transport (GO:1901381),-0.4641294790895766,-0.930352499033268,0.5277777777777778,0.989606261049897,1.0,1/30,0.28%,FLNA
prerank,GO_Biological_Process_2021__regulation of feeding behavior (GO:0060259),-0.6626778011817469,-0.9302800483713539,0.6491228070175439,0.9891043684245527,1.0,1/5,0.08%,NR4A3
prerank,GO_Biological_Process_2021__internal protein amino acid acetylation (GO:0006475),0.5473688381640056,0.9301280842108284,0.6,0.8793264105615759,1.0,2/7,13.44%,KAT2A;BAG6
prerank,GO_Biological_Process_2021__regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.5187816922897013,0.9295729889919957,0.5384615384615384,0.8800040534821963,1.0,3/10,8.88%,SPRY2;FGF2;NPTN
prerank,GO_Biological_Process_2021__cellular response to histamine (GO:0071420),0.6007742961911291,0.9295675441019325,0.6086956521739131,0.8788244233836946,1.0,3/6,28.96%,GABRB2;GABRB1;GABRB3
prerank,GO_Biological_Process_2021__response to histamine (GO:0034776),0.6007742961911291,0.9295675441019325,0.6086956521739131,0.8788244233836946,1.0,3/6,28.96%,GABRB2;GABRB1;GABRB3
prerank,GO_Biological_Process_2021__positive regulation of lipid kinase activity (GO:0090218),0.4592403695335359,0.9294592674384867,0.5952380952380952,0.8784791103022235,1.0,4/18,13.77%,FGF2;P2RY12;EEF1A2;PTK2
prerank,GO_Biological_Process_2021__cell junction organization (GO:0034330),-0.4298474106916874,-0.9291251397839637,0.6231884057971014,0.9912467368011717,1.0,7/47,14.60%,FLNA;NLGN2;ACTG1;DVL1;ACTB;MYOT;PPFIA4
prerank,GO_Biological_Process_2021__post-Golgi vesicle-mediated transport (GO:0006892),-0.41728416569893556,-0.9287182416358964,0.6129032258064516,0.9915538630015694,1.0,7/73,13.62%,OSBPL5;FTH1;NAPA;STXBP6;STEAP2;AP4M1;FTL
prerank,GO_Biological_Process_2021__fat cell differentiation (GO:0045444),-0.4614234211128363,-0.9286433608274666,0.6197183098591549,0.9910460665597661,1.0,5/41,3.44%,NR4A3;PID1;ATF5;PER2;BBS2
prerank,GO_Biological_Process_2021__regulation of leukocyte activation (GO:0002694),-0.5779155613675713,-0.9285754208458572,0.6181818181818182,0.9905389278853746,1.0,5/10,15.81%,LILRB4;PLSCR1;GPR137B;CD74;CD200
prerank,PanglaoDB_Augmented_2021__Sebocytes,-0.44602064627124943,-0.9281445642664894,0.5454545454545454,0.990930067937634,1.0,9/32,11.31%,CEBPD;ZMYND15;CLDN7;ANKRD22;ABCC3;TNFAIP2;LLGL2;SSH3;FBP1
prerank,GO_Biological_Process_2021__regulation of phagocytosis (GO:0050764),-0.46302903362704895,-0.9281440953841529,0.6376811594202898,0.9902891041161996,1.0,7/37,12.82%,FCER1G;RACK1;PLSCR1;SLC11A1;CD47;CYBA;PTPRC
prerank,GO_Biological_Process_2021__positive regulation of vascular permeability (GO:0043117),-0.5819198106091896,-0.928128805254148,0.5714285714285714,0.9896825862650095,1.0,2/6,11.19%,TRPV4;VEGFA
prerank,GO_Biological_Process_2021__humoral immune response mediated by circulating immunoglobulin (GO:0002455),-0.5844219069221553,-0.9280878643870446,0.625,0.9891328446947688,1.0,4/6,29.52%,C1QB;C1QC;ZP3;C1QA
prerank,GO_Biological_Process_2021__histone exchange (GO:0043486),-0.475302453339425,-0.9277425159723897,0.5076923076923077,0.9892608868006787,1.0,3/25,10.59%,CENPU;ITGB3BP;NPM1
prerank,GO_Biological_Process_2021__protein-DNA complex subunit organization (GO:0071824),-0.6218241975122402,-0.927688324875443,0.6290322580645161,0.9887177186803257,1.0,2/5,17.91%,RPL23;SUPT6H
prerank,GO_Biological_Process_2021__negative regulation of homotypic cell-cell adhesion (GO:0034111),0.5101328128000888,0.9275316076241137,0.5833333333333334,0.8816518865477764,1.0,2/9,13.62%,SERPINE2;ZNF703
prerank,GO_Biological_Process_2021__toll-like receptor 4 signaling pathway (GO:0034142),-0.5297821540928311,-0.9275047317961654,0.5517241379310345,0.9884602612221268,1.0,3/13,10.55%,CD14;OAS1;ITGB2
prerank,GO_Biological_Process_2021__cellular polysaccharide catabolic process (GO:0044247),-0.5344001208390037,-0.927220536830704,0.6792452830188679,0.9883762654399985,1.0,2/13,8.36%,PHKG1;CALM1
prerank,GO_Biological_Process_2021__regulation of protein kinase B signaling (GO:0051896),0.33353099636138606,0.9272061865043589,0.7272727272727273,0.8817101296430573,1.0,33/114,14.29%,PDGFA;IGF1R;SEMA5A;SPRY2;TGFA;FGF2;SIRT1;GAB1;TSC2;RCN3;DAG1;HPSE;PHLPP1;DDIT3;CIB1;NRG1;KITLG;TNF;HGF;P2RY12;TCF7L2;MFHAS1;PTEN;RTN4;NTRK2;GAB2;MTDH;PIK3AP1;NRG2;VAV1;PTK2;ERBB4;FERMT2
prerank,GO_Biological_Process_2021__proteoglycan biosynthetic process (GO:0030166),0.4339766620300931,0.9271717159171275,0.5483870967741935,0.8812340713544916,1.0,6/23,10.88%,CSGALNACT1;UGDH;B4GALT7;CANT1;BMPR1B;EXT1
prerank,GO_Biological_Process_2021__regulation of T-helper 17 cell differentiation (GO:2000319),-0.6259644977092294,-0.9271327415735293,0.603448275862069,0.9879463409900497,1.0,1/6,1.70%,NFKBID
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),-0.4092646294272457,-0.926804345856557,0.6301369863013698,0.9881583993533515,1.0,4/68,2.43%,UBC;TGFBR3;RPS27A;SNX6
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization (GO:0031116),0.39272171755576285,0.9266574866397518,0.5555555555555556,0.8817050490634485,1.0,5/24,14.39%,CDK5R1;GIT1;TOGARAM1;SLAIN2;CLASP1
prerank,GO_Biological_Process_2021__neural tube development (GO:0021915),0.4909316259870191,0.9260783566106777,0.6153846153846154,0.8821834814526505,1.0,4/10,10.96%,PKD2;PKD1;SOX4;PTCH1
prerank,GO_Biological_Process_2021__regulation of myosin-light-chain-phosphatase activity (GO:0035507),0.5429757625650296,0.926033208586988,0.5853658536585366,0.8816838258483953,1.0,2/7,7.30%,NUAK1;TNF
prerank,GO_Biological_Process_2021__sensory perception of pain (GO:0019233),-0.6287471853585259,-0.9259930683090647,0.625,0.9891951459880045,1.0,1/7,4.57%,SCN9A
prerank,GO_Biological_Process_2021__purine nucleotide biosynthetic process (GO:0006164),-0.5572012372478088,-0.9258720657822239,0.5178571428571429,0.9888045175186773,1.0,2/9,8.61%,MTHFD1;AMPD2
prerank,PanglaoDB_Augmented_2021__Ependymal Cells,-0.46686624143536537,-0.9254942666939624,0.5588235294117647,0.9890935527313512,1.0,5/32,9.34%,CATIP;PLTP;ENKUR;NME9;EFHC1
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in inflammatory response (GO:1900015),-0.47835071281678265,-0.9252960781464911,0.603448275862069,0.9887925041630052,1.0,6/29,14.09%,NLRC3;APOD;LILRB4;HIF1A;APPL1;NOD2
prerank,GO_Biological_Process_2021__positive regulation of telomerase activity (GO:0051973),-0.45650313539773013,-0.9251618035306534,0.5873015873015873,0.9884195649312634,1.0,2/26,1.65%,PKIB;PRKCQ
prerank,GO_Biological_Process_2021__regulation of glycogen metabolic process (GO:0070873),-0.5783538267236907,-0.9251596307208293,0.6363636363636364,0.9877970750367185,1.0,2/6,17.44%,PPP1R3B;INPP5K
prerank,GO_Biological_Process_2021__regulation of cellular response to stress (GO:0080135),0.34222597500608426,0.925153279415296,0.5,0.8830173418372487,1.0,17/104,17.93%,BAG3;SIRT1;CASP9;NUP153;NUP188;NUAK1;NUP42;MAPK1;MAPKAPK2;BAG5;FKBP4;GSK3B;MANF;NDC1;NUP133;HSPH1;NUP205
prerank,GO_Biological_Process_2021__response to insulin (GO:0032868),-0.44016054623068024,-0.9249133403562239,0.5142857142857142,0.9877028831103126,1.0,3/59,2.94%,SYAP1;INSIG1;USF1
prerank,GO_Biological_Process_2021__modulation by symbiont of host apoptotic process (GO:0052150),-0.5977266963125984,-0.92487117798464,0.6470588235294118,0.9872148270281298,1.0,1/6,3.95%,RNF213
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.35348926122108,0.9248701081799626,0.68,0.8830018364237451,1.0,10/59,7.92%,ACER2;HIP1R;CASP9;TNFRSF10A;ANP32B;PPARG;SMAD3;TNF;ROBO1;BOK
prerank,GO_Biological_Process_2021__protein localization to presynapse (GO:1905383),0.5544958647044821,0.9248328502505384,0.6041666666666666,0.8813290932198907,1.0,3/8,31.01%,DLG2;KIF5B;HSPB1
prerank,GO_Biological_Process_2021__anterograde axonal protein transport (GO:0099641),0.5544958647044821,0.9248328502505384,0.6041666666666666,0.8813290932198907,1.0,3/8,31.01%,DLG2;KIF5B;HSPB1
prerank,GO_Biological_Process_2021__axo-dendritic protein transport (GO:0099640),0.5544958647044821,0.9248328502505384,0.6041666666666666,0.8813290932198907,1.0,3/8,31.01%,DLG2;KIF5B;HSPB1
prerank,GO_Biological_Process_2021__acylglycerol catabolic process (GO:0046464),-0.533645524227455,-0.9248258280679624,0.543859649122807,0.9866497580259682,1.0,2/11,2.51%,MGLL;LIPG
prerank,GO_Biological_Process_2021__protein homotrimerization (GO:0070207),0.5602283424238228,0.9247307632764468,0.56,0.8803757642736973,1.0,3/7,10.35%,SLC1A2;DISP1;ALOX5AP
prerank,GO_Biological_Process_2021__protein trimerization (GO:0070206),0.5602283424238228,0.9247307632764468,0.56,0.8803757642736973,1.0,3/7,10.35%,SLC1A2;DISP1;ALOX5AP
prerank,GO_Biological_Process_2021__receptor clustering (GO:0043113),-0.4953337343978531,-0.9247244845308874,0.5789473684210527,0.9862350452165599,1.0,7/22,11.27%,FLNA;MUSK;ITGA4;DVL1;PTN;ITGB2;ITGAL
prerank,GO_Biological_Process_2021__cellular response to starvation (GO:0009267),0.3259794352866675,0.9245527858401119,0.5909090909090909,0.8800728057870337,1.0,22/115,18.33%,RRAGD;PDK4;MAP1LC3A;SIRT1;XPR1;LRRK2;CPEB4;NUAK1;BRSK1;EIF2S1;ATP6V1B2;MAPK1;RIPOR1;SESN2;TBL2;MAP3K5;LAMTOR3;PRKAA1;SH3GLB1;BRSK2;SIK2;TCIRG1
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell chemotaxis (GO:2001028),0.54770273944126,0.9244812437952545,0.5714285714285714,0.8796899502531051,1.0,2/10,2.26%,SEMA5A;FGF2
prerank,GO_Biological_Process_2021__brain development (GO:0007420),0.3375598952674302,0.9242034732280757,0.6428571428571429,0.8798452479077365,1.0,21/93,13.48%,QARS1;CDK5R1;MAP1S;AATK;TGFBR2;ARNT2;PBX1;RELN;PPT1;PLXNB2;CA10;CTNNA2;SHANK3;NFIB;FBXW11;PTCH1;PTEN;GRIN2B;NF1;BAG6;NIPBL
prerank,GO_Biological_Process_2021__organic heteropentacyclic compound metabolic process (GO:1901376),0.5800374453383235,0.9241156059920197,0.6122448979591837,0.8782997392548922,1.0,1/5,5.24%,ACY3
prerank,GO_Biological_Process_2021__mycotoxin metabolic process (GO:0043385),0.5800374453383235,0.9241156059920197,0.6122448979591837,0.8782997392548922,1.0,1/5,5.24%,ACY3
prerank,GO_Biological_Process_2021__aflatoxin metabolic process (GO:0046222),0.5800374453383235,0.9241156059920197,0.6122448979591837,0.8782997392548922,1.0,1/5,5.24%,ACY3
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),-0.46785341556298776,-0.923930363590084,0.5666666666666667,0.9873550113549336,1.0,7/20,23.60%,RBPJ;VEGFA;HIF1A;ATF3;MT3;NFE2L2;KLF2
prerank,GO_Biological_Process_2021__leukocyte cell-cell adhesion (GO:0007159),-0.48357923116055884,-0.9239037675131717,0.6206896551724138,0.9867687957140724,1.0,7/17,11.27%,CCL5;PECAM1;OLR1;ITGA4;FERMT3;ITGB2;ITGAL
prerank,GO_Biological_Process_2021__negative regulation of complement activation (GO:0045916),-0.5819212229274959,-0.9237590046656327,0.6071428571428571,0.9864488342773464,1.0,3/7,13.78%,CD55;A2M;SERPING1
prerank,GO_Biological_Process_2021__cellular calcium ion homeostasis (GO:0006874),-0.4035800359662814,-0.9228545063774991,0.5974025974025974,0.987881608580012,1.0,8/76,9.96%,CCL3;PLN;CCL5;CDH23;ATP13A1;TPT1;TRPV4;SMDT1
prerank,GO_Biological_Process_2021__regulation of gene silencing by miRNA (GO:0060964),0.35411929731230973,0.9225997196008521,0.71875,0.8808645531119539,1.0,5/56,7.20%,POLR2D;NUP153;NUP188;PPARG;NUP42
prerank,GO_Biological_Process_2021__negative regulation of neuroinflammatory response (GO:0150079),-0.55215404531685,-0.9223377807791079,0.6271186440677966,0.9883844700581402,1.0,5/12,15.81%,CD200R1;IGF1;TNFRSF1B;PTPRC;CD200
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043619),-0.5588305149372577,-0.9223227735530534,0.6363636363636364,0.9877770090319142,1.0,2/7,16.40%,HIF1A;MT3
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transporter activity (GO:1901016),0.4648873938811964,0.9222668431737071,0.5526315789473685,0.8810425562541301,1.0,3/19,8.52%,NETO1;CAB39;NEDD4L
prerank,GO_Biological_Process_2021__positive regulation of macromolecule metabolic process (GO:0010604),-0.36644435253152063,-0.9221730006452112,0.6419753086419753,0.9874572204993443,1.0,34/215,11.34%,CALCR;CD36;CCL3;RIMS1;TFRC;PID1;WARS1;RPL5;ANXA2;DDRGK1;ETS1;CLU;RPL11;RPS3;RPL23;IGF1;CD63;DTX3L;LAMTOR5;VPS35;MUSK;TTN;RPS7;PLSCR1;SNF8;ACTG1;RBPJ;OVOL2;PDCD5;SLC11A1;CITED2;VEGFA;TYROBP;HIF1A
prerank,GO_Biological_Process_2021__regulation of stem cell differentiation (GO:2000736),-0.41466643756842125,-0.922172427558366,0.6056338028169014,0.9868290670511894,1.0,18/66,22.96%,PSMB3;EIF2AK2;PSMB6;PSMA7;PSMB9;PTN;TCF3;PSMD12;PSMD8;PSMA5;SETD1A;PSMA3;PSMC4;PSME2;PSME1;PSMB5;PSMC3;PSME3
prerank,GO_Biological_Process_2021__regulation of neutrophil migration (GO:1902622),-0.5476870070535528,-0.9221665988178452,0.5932203389830508,0.9862182431014827,1.0,3/8,23.99%,NCKAP1L;RAC1;RAC2
prerank,GO_Biological_Process_2021__regulation of platelet aggregation (GO:0090330),0.482046560928388,0.9219355776566907,0.5945945945945946,0.8812123316255409,1.0,2/14,2.96%,PDPN;SERPINE2
prerank,GO_Biological_Process_2021__chromatin organization (GO:0006325),0.3181187385329117,0.9219061423270671,0.5666666666666667,0.8807109321088018,1.0,16/98,13.32%,ZBTB1;RUVBL2;DR1;SIRT1;ARID1A;TCF7L1;SETD7;MTA2;HP1BP3;SATB2;HDAC1;LOXL2;KAT2A;HMGN4;SETD2;SETDB2
prerank,GO_Biological_Process_2021__striated muscle cell differentiation (GO:0051146),0.4498874948503543,0.9218860275248048,0.59375,0.8801782646509512,1.0,2/10,7.87%,NRG1;SORT1
prerank,GO_Biological_Process_2021__regulation of microtubule-based process (GO:0032886),0.41693148575126576,0.9218718473374704,0.5813953488372093,0.8796622529689672,1.0,10/29,18.25%,PHLDB1;TPPP;KLHL42;MEMO1;CLASP1;GSK3B;PRKAA1;CLASP2;MARK2;MAP6
prerank,GO_Biological_Process_2021__regulation of vascular endothelial cell proliferation (GO:1905562),0.514172204591644,0.9213026824944862,0.6363636363636364,0.8802789071564376,1.0,3/13,9.36%,FGF2;PPARG;SIRT6
prerank,GO_Biological_Process_2021__cellular response to DNA damage stimulus (GO:0006974),-0.3705277519865371,-0.9210710391203236,0.7,0.9878659732708519,1.0,32/274,15.71%,BCL2A1;DDX11;PPP1R15A;MNDA;XPA;VAV3;BTG2;POLE3;OGG1;HUS1;MUS81;RPS3;DTX3L;TNFRSF1B;PARP2;XRCC3;NPM1;REXO4;NABP1;NOP53;WDR48;APEX1;MCM7;RAD9A;CCND1;BRCA1;ERCC8;CBX3;SMC1A;PARP4;PIDD1;STXBP4
prerank,GO_Biological_Process_2021__placenta development (GO:0001890),0.5847348705381384,0.9205566672563297,0.6122448979591837,0.8810939122335446,1.0,2/5,13.77%,PPARG;PTK2
prerank,GO_Biological_Process_2021__negative regulation of cytokine production (GO:0001818),-0.389339581365356,-0.9204498396123816,0.6282051282051282,0.9884990077138942,1.0,21/117,13.66%,SIGIRR;SRGN;ZFP36;NLRC3;DHX58;CD200R1;APOD;LILRB4;NLRC5;NLRP12;TNFAIP3;BTN2A2;TMSB4X;SELENOS;SLC11A1;NCKAP1L;TYROBP;C5AR2;PTPRC;KAT5;HAVCR2
prerank,GO_Biological_Process_2021__negative regulation of extracellular matrix organization (GO:1903054),-0.5901371982642233,-0.9202694989778512,0.6491228070175439,0.9883337696611232,1.0,1/5,8.06%,TNFRSF1B
prerank,GO_Biological_Process_2021__Wnt signaling pathway (GO:0016055),-0.4130128006211035,-0.9199279047931516,0.5652173913043478,0.9885095117534346,1.0,8/55,12.28%,UBC;CCDC88C;RPS27A;VPS35;DVL1;RBX1;CSNK1G2;FZD2
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.3813329019385351,0.9187558185442667,0.5625,0.8841688416068516,1.0,7/45,12.18%,POLR2D;DCP1B;SAMD4A;EXOSC6;CNOT7;CNOT2;LSM6
prerank,GO_Biological_Process_2021__plus-end-directed vesicle transport along microtubule (GO:0072383),-0.5975258901638945,-0.9184277847853342,0.6111111111111112,0.9910194781943858,1.0,2/5,32.69%,KIFAP3;FYCO1
prerank,GO_Biological_Process_2021__negative regulation of autophagy (GO:0010507),0.40270003524837394,0.9180921196713029,0.7407407407407407,0.8848449675290123,1.0,4/47,9.97%,LEPR;LRRK2;TAB2;HGF
prerank,GO_Biological_Process_2021__detection of calcium ion (GO:0005513),0.5093559494873938,0.9180197083052128,0.5,0.8844547985379874,1.0,3/9,13.35%,KCNIP2;KCNMB4;KCNMB3
prerank,GO_Biological_Process_2021__regulation of peptidase activity (GO:0052547),0.5037483011098316,0.9175342343888055,0.5789473684210527,0.884772298346043,1.0,4/12,16.14%,RCN3;HDAC1;ATP13A2;CTSH
prerank,GO_Biological_Process_2021__negative regulation of translational initiation (GO:0045947),0.5481688977835564,0.9174782797118259,0.5945945945945946,0.8843668079611263,1.0,1/11,3.39%,EIF4EBP2
prerank,GO_Biological_Process_2021__sulfate transport (GO:0008272),0.5251912063089981,0.9172777296275006,0.5555555555555556,0.8841205523791374,1.0,1/8,14.12%,SLC25A14
prerank,GO_Biological_Process_2021__positive regulation of neural precursor cell proliferation (GO:2000179),-0.4944267497664475,-0.9172262747404052,0.5423728813559322,0.9930706503954967,1.0,4/13,20.59%,ZNF335;VEGFA;SMARCD3;TOX
prerank,GO_Biological_Process_2021__vascular transport (GO:0010232),-0.4331183243395306,-0.9172066331996194,0.5909090909090909,0.9924860115773769,1.0,7/50,6.91%,SLC2A3;SLC7A5;TFRC;SLC38A1;ABCC3;ABCB1;SLC16A7
prerank,GO_Biological_Process_2021__regulation of cholesterol storage (GO:0010885),0.4868722073364242,0.9167310500258538,0.5531914893617021,0.8847310562503603,1.0,2/13,5.17%,MSR1;PPARG
prerank,GO_Biological_Process_2021__positive regulation of T-helper cell differentiation (GO:0045624),0.5658741341990076,0.9162446746808464,0.6341463414634146,0.8851267919270706,1.0,1/8,0.34%,ANXA1
prerank,GO_Biological_Process_2021__lipid biosynthetic process (GO:0008610),-0.43129534383150386,-0.9154587481948917,0.5970149253731343,0.9956520697527178,1.0,4/45,6.83%,LIPG;LPCAT1;GNPAT;PRLR
prerank,GO_Biological_Process_2021__regulation of protein export from nucleus (GO:0046825),0.4729661415740075,0.9154330057368226,0.6046511627906976,0.8862189346502419,1.0,6/21,15.67%,BAG3;ANP32B;TCF7L2;BARD1;RAPGEF3;GSK3B
prerank,GO_Biological_Process_2021__sterol homeostasis (GO:0055092),-0.4651334552415409,-0.915120596072418,0.578125,0.9950949989660824,1.0,4/33,5.38%,INSIG1;LIPG;RORA;NR1H2
prerank,GO_Biological_Process_2021__cholesterol homeostasis (GO:0042632),-0.4651334552415409,-0.915120596072418,0.578125,0.9950949989660824,1.0,4/33,5.38%,INSIG1;LIPG;RORA;NR1H2
prerank,GO_Biological_Process_2021__negative regulation of amyloid-beta formation (GO:1902430),-0.4917947249497368,-0.9150951869494875,0.5737704918032787,0.9945050865002234,1.0,2/15,5.56%,CLU;IGF1
prerank,GO_Biological_Process_2021__positive regulation of cellular process (GO:0048522),-0.355460604771728,-0.9150380033693613,0.6823529411764706,0.9940143524507091,1.0,46/336,14.51%,CALCR;CD36;RPS4X;ZFP36;CCL5;IL7R;PDGFD;AIF1;FCER1G;DDRGK1;ETS1;AQP11;TSPAN31;RPL23;IGF1;SLC25A5;TIPIN;IL12RB2;OSMR;PRLR;RPS6;NAMPT;TNFRSF1B;PRKD2;CHTOP;MEIS1;TRIM13;SLC11A1;PTN;POFUT2;NPM1;CITED2;TRPM4;RPS9;VEGFA;TBC1D8;CD47;EFNB2;FLT1;CYBA;ZNF16;TET1;CCND1;COLEC12;FGF20;CCAR1
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle contraction (GO:0045986),-0.6156050934947466,-0.9143028804392255,0.68,0.9951255145117193,1.0,2/5,24.74%,SOD1;KCNMA1
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial cell proliferation (GO:1905564),0.5046997248081537,0.9141816029009082,0.6410256410256411,0.8880615198733609,1.0,2/10,9.36%,FGF2;SIRT6
prerank,GO_Biological_Process_2021__positive regulation of cellular component organization (GO:0051130),-0.4036144279059267,-0.914131528877012,0.6075949367088608,0.99482070462137,1.0,14/78,14.13%,PPP1R15A;TFRC;WARS1;MPP7;RACK1;CLU;RPS3;ATP10A;GPC3;ABCB4;VEGFA;BMF;GPX1;CAMK1
prerank,GO_Biological_Process_2021__alpha-amino acid metabolic process (GO:1901605),-0.46017722030938446,-0.9139936176543079,0.5846153846153846,0.9944726128053368,1.0,3/25,5.45%,MTHFD1;GLUL;KMO
prerank,GO_Biological_Process_2021__negative regulation of protein polymerization (GO:0032272),0.45988078570795843,0.9139388080336154,0.5609756097560976,0.888043023593998,1.0,7/22,19.55%,HIP1R;MYADM;KANK1;DYRK1A;SSH2;SNCA;MAP2
prerank,GO_Biological_Process_2021__natural killer cell mediated immunity (GO:0002228),-0.5370573685388228,-0.9138807335644696,0.5964912280701754,0.9940704111947308,1.0,3/9,13.99%,GZMB;KLRD1;TUBB4B
prerank,GO_Biological_Process_2021__neuromuscular process controlling balance (GO:0050885),-0.603093635575697,-0.9134407953447646,0.676923076923077,0.9943446843190935,1.0,2/6,5.06%,TPP1;CDH23
prerank,GO_Biological_Process_2021__positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968),0.5042621595638468,0.9133918781977385,0.6,0.8887517277739367,1.0,4/10,18.47%,SUPT16H;CDK13;CDK12;EAPP
prerank,GO_Biological_Process_2021__sodium ion homeostasis (GO:0055078),0.5040053818330987,0.9128922479945051,0.5909090909090909,0.888713907680579,1.0,4/9,15.33%,NEDD4L;SLC9A1;SLC8A1;SLC12A2
prerank,GO_Biological_Process_2021__cellular sodium ion homeostasis (GO:0006883),0.5040053818330987,0.9128922479945051,0.5909090909090909,0.888713907680579,1.0,4/9,15.33%,NEDD4L;SLC9A1;SLC8A1;SLC12A2
prerank,GO_Biological_Process_2021__regulation of actin filament-based movement (GO:1903115),-0.6134674046395117,-0.9123842682659705,0.6530612244897959,0.996045971655021,1.0,3/7,7.44%,PLN;SRI;MYBPC3
prerank,GO_Biological_Process_2021__response to DNA damage checkpoint signaling (GO:0072423),-0.6184785902892912,-0.9123768910724349,0.6984126984126984,0.9954420926897122,1.0,2/5,14.70%,MUS81;SMC1A
prerank,GO_Biological_Process_2021__positive regulation of viral release from host cell (GO:1902188),-0.5705122047774972,-0.9122462494209655,0.6190476190476191,0.9951055855569516,1.0,1/8,12.55%,VPS37B
prerank,GO_Biological_Process_2021__rRNA pseudouridine synthesis (GO:0031118),-0.5891681427830939,-0.9121813583899452,0.6808510638297872,0.9946118078704661,1.0,4/7,22.19%,NHP2;NOP10;RPUSD4;RPUSD3
prerank,GO_Biological_Process_2021__positive regulation of execution phase of apoptosis (GO:1900119),0.6148325770826382,0.9118978488412853,0.6170212765957447,0.8902254312603317,1.0,1/5,7.92%,BOK
prerank,GO_Biological_Process_2021__protein import into nucleus (GO:0006606),0.3590054429666814,0.9117340571466165,0.4375,0.8900400327512075,1.0,7/58,6.86%,NUTF2;E2F3;TSC2;IPO13;NUP153;NUP188;PPP1R10
prerank,GO_Biological_Process_2021__negative regulation of macromolecule biosynthetic process (GO:0010558),-0.5285776403284658,-0.9116898168820459,0.5892857142857143,0.9950913841278023,1.0,2/8,9.83%,GSTP1;SELENOS
prerank,GO_Biological_Process_2021__negative regulation of transport (GO:0051051),-0.4250345116523353,-0.9116199012508516,0.6231884057971014,0.9946308193142034,1.0,4/37,7.40%,HAMP;RACK1;NR1H2;PLSCR1
prerank,GO_Biological_Process_2021__response to misfolded protein (GO:0051788),-0.5786582252859509,-0.911577422424074,0.66,0.9940894192838323,1.0,1/7,4.82%,CLU
prerank,GO_Biological_Process_2021__negative regulation of neural precursor cell proliferation (GO:2000178),0.5137704449885758,0.9115666116288336,0.6097560975609756,0.8897603349577106,1.0,2/6,12.21%,WNT5A;NF1
prerank,GO_Biological_Process_2021__neurotrophin TRK receptor signaling pathway (GO:0048011),-0.5693112990805073,-0.9113890604588815,0.603448275862069,0.9940043187757442,1.0,1/8,2.37%,DDIT4
prerank,GO_Biological_Process_2021__negative regulation of protein phosphorylation (GO:0001933),0.3131332651001837,0.9107930208949554,0.6666666666666666,0.8908352007667308,1.0,16/112,9.33%,QARS1;SPRY2;SMAD7;SPRED1;LRRK2;SPRED2;SIRPA;NCK2;TSC2;GNAQ;CEP85;CIB1;MYADM;PTPN13;YWHAG;DEPTOR
prerank,PanglaoDB_Augmented_2021__Epsilon Cells,-0.4770108989983128,-0.9107262138648226,0.6166666666666667,0.994792053928109,1.0,7/33,11.65%,CALCR;CGNL1;SLC6A16;ITGA4;S100A6;ABCA8;A2M
prerank,GO_Biological_Process_2021__T cell homeostasis (GO:0043029),-0.5803050890078574,-0.9105028522167306,0.6610169491525424,0.9946795341967506,1.0,4/6,32.78%,NCKAP1L;PPP2R3C;AKT1;ZC3H8
prerank,GO_Biological_Process_2021__regulation of stem cell division (GO:2000035),0.5534929117558632,0.9104181745465976,0.5531914893617021,0.8910195699950931,1.0,2/6,10.26%,NCOA3;SMYD5
prerank,"GO_Biological_Process_2021__synaptic transmission, glutamatergic (GO:0035249)",0.478473021928553,0.9103020973208971,0.6666666666666666,0.8906690137329681,1.0,4/16,6.64%,GRID2;GRID1;GRIK2;UNC13B
prerank,GO_Biological_Process_2021__phospholipid metabolic process (GO:0006644),0.39567039027825895,0.9099144556834077,0.6333333333333333,0.8908532515197839,1.0,10/43,14.11%,PLA2G4C;ABCA2;PLPPR1;PLPP1;PLPPR4;FDFT1;AGPAT5;LCAT;PIP4K2A;AGPAT2
prerank,MSigDB_Hallmark_2020__Pancreas Beta Cells,-0.4741932645306362,-0.9098596723103519,0.6140350877192983,0.9954712774559206,1.0,3/18,15.26%,SRP14;SST;PCSK2
prerank,GO_Biological_Process_2021__nucleotide catabolic process (GO:0009166),-0.5596869485274125,-0.9094284692957689,0.5737704918032787,0.9957588532334721,1.0,2/10,14.09%,NT5C;GPX1
prerank,GO_Biological_Process_2021__low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.5471542602725064,-0.9094172223546031,0.6065573770491803,0.9945442775583707,1.0,5/9,27.39%,VLDLR;AP2S1;AP2M1;CLTA;AP2A1
prerank,GO_Biological_Process_2021__low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.5471542602725064,-0.9094172223546031,0.6065573770491803,0.9945442775583707,1.0,5/9,27.39%,VLDLR;AP2S1;AP2M1;CLTA;AP2A1
prerank,GO_Biological_Process_2021__glycolytic process (GO:0006096),-0.505276058905732,-0.9093817215294189,0.6129032258064516,0.9940326320860078,1.0,4/16,13.22%,GAPDH;HK2;LDHA;PGK1
prerank,GO_Biological_Process_2021__regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),-0.37454821186614123,-0.9092655033302922,0.6103896103896104,0.993705123532357,1.0,14/85,12.71%,UBXN1;DDRGK1;RACK1;ELOB;CLU;ARIH2;RPL11;RNF144B;DVL1;GLMN;RBX1;NOP53;HSPA1B;CSNK1D
prerank,GO_Biological_Process_2021__negative regulation of autophagosome maturation (GO:1901097),0.5671042764055427,0.909100171937896,0.5714285714285714,0.8920659712949847,1.0,1/5,4.89%,TMEM39A
prerank,GO_Biological_Process_2021__pyrimidine ribonucleotide metabolic process (GO:0009218),-0.6041654521195192,-0.9089398537171116,0.5967741935483871,0.9937987306385254,1.0,2/5,11.81%,ENTPD4;DHODH
prerank,GO_Biological_Process_2021__muscle contraction (GO:0006936),0.3505571438937007,0.9087426064551599,0.5555555555555556,0.8923353900912225,1.0,10/54,8.30%,TPM2;MYOM1;ACTA2;KCNIP2;GLRA1;ADRA1A;TMOD2;VCL;DTNA;TMOD3
prerank,GO_Biological_Process_2021__negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.30577307397772113,0.9086893198129015,0.7272727272727273,0.8918829352160331,1.0,50/369,11.06%,KLF4;SYNCRIP;QARS1;CDK5R1;GCLC;ZBTB33;SIRT1;ZBTB16;RNF139;DPF3;ZNF706;SPINDOC;SAMD4A;HDAC9;TLE2;CBFA2T3;WNT5A;SAMD1;FOXN3;ZNF12;PPARG;POU2F1;SMAD2;DDIT3;NRG1;DACH1;SALL1;HMGA1;TNF;RFX3;EIF4E2;CLOCK;NACC2;MAP3K10;TRERF1;CNOT7;CTBP2;IKZF1;SFMBT1;DBI;MDM2;BTRC;HDAC1;TWIST2;SLFN11;LOXL2;PTPRK;FBXW11;ZBTB38;TCF7L2
prerank,GO_Biological_Process_2021__protein exit from endoplasmic reticulum (GO:0032527),0.43503988074708977,0.9086610402990968,0.5789473684210527,0.8913683653753751,1.0,3/22,8.99%,TECPR2;SEL1L;AUP1
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host apoptotic process (GO:0033668),-0.5767470410935308,-0.9085264266891472,0.6415094339622641,0.9941240058844837,1.0,1/7,3.95%,RNF213
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair (GO:2000780),-0.4863049283696005,-0.9082561363274764,0.65625,0.9940664006172857,1.0,3/24,14.63%,OGG1;CYREN;FANCB
prerank,GO_Biological_Process_2021__intraciliary retrograde transport (GO:0035721),-0.5591531127398257,-0.9082259195953988,0.6206896551724138,0.9935297227105742,1.0,2/11,16.14%,DYNC2I1;IFT43
prerank,GO_Biological_Process_2021__UV-damage excision repair (GO:0070914),-0.5363373379649936,-0.9077933519039197,0.5740740740740741,0.9938491789108895,1.0,1/11,1.76%,XPA
prerank,GO_Biological_Process_2021__negative regulation of oxidoreductase activity (GO:0051354),-0.5999268692071287,-0.9077257599287801,0.625,0.9933724482060694,1.0,2/5,16.40%,OXA1L;MT3
prerank,GO_Biological_Process_2021__presynaptic endocytosis (GO:0140238),0.45897990530200633,0.9077146243547922,0.5882352941176471,0.8928909148168371,1.0,6/18,19.35%,NLGN1;SNCB;STX1A;NLGN4Y;STON2;SNCA
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen (GO:0002478),-0.39006168561887244,-0.9075770351446383,0.6285714285714286,0.9931058801705117,1.0,18/77,19.77%,FCER1G;HLA-DRB5;MFSD6;HLA-F;DCTN6;HLA-DRA;DCTN4;DYNC1LI2;HLA-E;HLA-DPA1;HLA-DMB;AP2S1;CD74;SEC13;HLA-DPB1;DCTN2;HLA-DRB1;DYNC1I2
prerank,GO_Biological_Process_2021__estrogen metabolic process (GO:0008210),-0.5829854742294153,-0.9074110853990475,0.6530612244897959,0.992834272154378,1.0,3/6,28.53%,CYP3A5;CYP19A1;HSD17B7
prerank,GO_Biological_Process_2021__epithelial cell differentiation (GO:0030855),0.3618532360999566,0.9073930598989189,0.7096774193548387,0.8929712449169506,1.0,10/43,11.26%,ANXA1;SCRIB;RAB10;PPARG;CPT1A;PTER;JAG1;HDAC1;PCK2;ACADVL
prerank,GO_Biological_Process_2021__endothelial cell migration (GO:0043542),-0.46895524436621566,-0.9072202393877657,0.6031746031746031,0.9926918078963446,1.0,5/21,13.60%,PLEKHG5;CORO1B;STAT1;VEGFA;NR4A1
prerank,GO_Biological_Process_2021__glucose metabolic process (GO:0006006),-0.42949735322202065,-0.9071519662823239,0.6216216216216216,0.9921740641816651,1.0,6/40,8.28%,GAPDH;MDH2;PER2;APOD;G6PC3;OAS1
prerank,GO_Biological_Process_2021__positive regulation of gene silencing by miRNA (GO:2000637),-0.48516598010849527,-0.9067777621026053,0.5806451612903226,0.9924502906995812,1.0,1/21,1.48%,ZFP36
prerank,GO_Biological_Process_2021__glial cell development (GO:0021782),0.4496642261642292,0.9066234154100452,0.5853658536585366,0.8940214481284907,1.0,6/16,12.21%,MYRF;TPPP;CSPG5;SOX4;CDK6;NF1
prerank,GO_Biological_Process_2021__negative regulation of autophagosome assembly (GO:1902902),0.4714033686500011,0.9061972045460077,0.660377358490566,0.8942963782719296,1.0,2/11,4.89%,LRRK2;TMEM39A
prerank,GO_Biological_Process_2021__positive regulation of I-kappaB phosphorylation (GO:1903721),-0.5683919490418363,-0.9059447474567173,0.5964912280701754,0.9938029375857572,1.0,1/6,4.19%,DDRGK1
prerank,GO_Biological_Process_2021__selenocysteine incorporation (GO:0001514),-0.5657407502941333,-0.9056587663033313,0.6140350877192983,0.9931431638729379,1.0,1/7,10.07%,DIO2
prerank,GO_Biological_Process_2021__translational readthrough (GO:0006451),-0.5657407502941333,-0.9056587663033313,0.6140350877192983,0.9931431638729379,1.0,1/7,10.07%,DIO2
prerank,GO_Biological_Process_2021__central nervous system myelination (GO:0022010),0.5409296261386523,0.9047204387533588,0.6097560975609756,0.8970083915536167,1.0,4/9,14.79%,ABCA2;MYRF;PTEN;CNTNAP1
prerank,GO_Biological_Process_2021__histone H3-K14 acetylation (GO:0044154),-0.570937943195621,-0.9046119266957118,0.6153846153846154,0.9947388470103938,1.0,1/6,4.84%,ING5
prerank,GO_Biological_Process_2021__deadenylation-dependent decapping of nuclear-transcribed mRNA (GO:0000290),0.5518732859416824,0.9045931170814424,0.6444444444444445,0.8966408457134611,1.0,2/7,14.32%,DCP1B;LSM1
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.5003874471699246,0.9044320513691547,0.6363636363636364,0.8962425645807676,1.0,4/12,9.60%,SIRT1;TAF9B;ZNF385A;MDM2
prerank,GO_Biological_Process_2021__regulation of cell growth (GO:0001558),0.32931613265672904,0.9043969872577738,0.5384615384615384,0.8957590270614617,1.0,28/142,17.55%,SERTAD2;RAB33B;CDKN2AIP;SIRT1;PTCH2;DNAJB2;SMAD3;CIB1;PPT1;HPN;TAF9B;NDRG3;NME6;NRG3;ATAD3A;RTN4;DCBLD2;CHPT1;MMP14;ENPP1;SESN2;CAPRIN2;TGFBR1;OSGIN2;ING1;MTPN;DDX3X;CGRRF1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-2 production (GO:0032743),0.42090387918925776,0.9042969175138901,0.5526315789473685,0.8953618259679685,1.0,2/22,6.90%,ANXA1;RUNX1
prerank,GO_Biological_Process_2021__fatty acid metabolic process (GO:0006631),0.3649501193839833,0.9035087124612416,0.56,0.8962889565107592,1.0,7/69,5.87%,PPARGC1A;FAAH;CPT1C;ADIPOR2;PPARG;CPT1A;FA2H
prerank,GO_Biological_Process_2021__regulation of regulated secretory pathway (GO:1903305),-0.44803107690157795,-0.9032678602863872,0.6440677966101694,0.9971020716728309,1.0,3/22,7.73%,RIMS1;RAB3A;RAB3D
prerank,GO_Biological_Process_2021__membrane protein ectodomain proteolysis (GO:0006509),-0.49668715881457026,-0.9031763147861457,0.5892857142857143,0.9967547402892,1.0,2/17,10.83%,PRKCQ;ERAP1
prerank,GO_Biological_Process_2021__intracellular protein transport (GO:0006886),0.2958179339170303,0.9024414226910901,0.7894736842105263,0.8980553704165349,1.0,41/257,12.53%,BAG3;NUTF2;ARL5A;SGSM1;PKD1;NLGN1;TBC1D1;E2F3;C17ORF75;TSC2;IPO13;NUP153;NUP188;TLK1;TMED3;RAB1B;TECPR2;TMED10;TBC1D5;PPP1R10;TBC1D10B;TBC1D16;TMED5;NUP42;XPO1;STX11;RANBP3L;SGSM2;TBC1D12;RAB7A;STX1A;LAPTM5;STX2;SNX27;TBC1D22B;SORL1;ARF6;RAB6A;AP4E1;IPO8;RABGAP1
prerank,GO_Biological_Process_2021__negative regulation of protein dephosphorylation (GO:0035308),-0.5193061499960725,-0.9024391193410333,0.6229508196721312,0.9977634935741954,1.0,1/18,1.16%,PPP1R15A
prerank,GO_Biological_Process_2021__positive regulation of response to external stimulus (GO:0032103),-0.3818513668681684,-0.9021749290761295,0.589041095890411,0.9977895589729162,1.0,16/87,16.01%,CCL3;CCL5;DHX58;AIF1;USF1;ETS1;PLSCR1;NLRP12;PTN;TASL;CD47;CYBA;LY86;IFI35;AGT;POLR3C
prerank,GO_Biological_Process_2021__regulation of mRNA export from nucleus (GO:0010793),0.5684828192582239,0.9019305200480993,0.6451612903225806,0.8979595567406394,1.0,3/6,17.17%,NSUN2;SETD2;IWS1
prerank,GO_Biological_Process_2021__regulation of ribonucleoprotein complex localization (GO:2000197),0.5684828192582239,0.9019305200480993,0.6451612903225806,0.8979595567406394,1.0,3/6,17.17%,NSUN2;SETD2;IWS1
prerank,PanglaoDB_Augmented_2021__Mesangial Cells,-0.4090999711219495,-0.9017780598330266,0.6619718309859155,0.9979861736583947,1.0,4/71,3.11%,FLNA;MYLK;COL5A1;PER3
prerank,GO_Biological_Process_2021__focal adhesion assembly (GO:0048041),0.48032111093987595,0.9013987563282926,0.5294117647058824,0.8984787477664068,1.0,5/17,21.51%,PTPRK;FERMT2;TAOK2;PEAK1;CTTN
prerank,GO_Biological_Process_2021__regulation of amyloid fibril formation (GO:1905906),0.47981835422397434,0.9013273717606689,0.5454545454545454,0.8980502820704497,1.0,2/12,4.68%,LDLR;PFDN4
prerank,GO_Biological_Process_2021__regulation of neuron projection arborization (GO:0150011),0.4794413423111052,0.9012638802120467,0.5526315789473685,0.8975990935891737,1.0,3/14,14.98%,WNT5A;DVL3;MAP3K13
prerank,GO_Biological_Process_2021__autophagy of mitochondrion (GO:0000422),-0.4347325565804283,-0.9010112316180193,0.6440677966101694,0.9987152857272223,1.0,5/32,9.32%,GABARAPL1;FIS1;PHB2;ATG2A;GABARAPL2
prerank,GO_Biological_Process_2021__lysosome organization (GO:0007040),-0.4537798454834456,-0.9008117995920859,0.6,0.9985171054830544,1.0,5/28,17.49%,TPP1;HPS4;TASL;ZKSCAN3;HOOK2
prerank,GO_Biological_Process_2021__regulation of blood coagulation (GO:0030193),0.5140495327387519,0.9007932697453249,0.5416666666666666,0.8980399953869163,1.0,3/9,5.59%,SERPINE1;SERPINE2;HPSE
prerank,GO_Biological_Process_2021__termination of RNA polymerase I transcription (GO:0006363),-0.4439211797366336,-0.9000216438960982,0.5735294117647058,0.9994525096133605,1.0,2/24,4.34%,TAF1D;GTF2H5
prerank,GO_Biological_Process_2021__regulation of JUN kinase activity (GO:0043506),0.4094527293703943,0.8998251818869191,0.6216216216216216,0.8993945171683722,1.0,9/25,16.34%,MAP3K11;TNF;DVL3;MAP3K10;SASH1;AIDA;TRAF6;MAP3K5;MAP3K7
prerank,GO_Biological_Process_2021__negative regulation of cellular protein metabolic process (GO:0032269),-0.3983792071633012,-0.899724784074942,0.5769230769230769,0.9994189654078105,1.0,9/69,8.47%,GAPDH;BTG2;GZMB;RPL13A;RACK1;RPS3;ILF3;EIF2AK2;EIF4A3
prerank,GO_Biological_Process_2021__SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),-0.3982251788407997,-0.8995838816013655,0.5972222222222222,0.999125060391158,1.0,17/69,22.96%,PSMB3;PSMB6;PSMA7;PSMB9;RBX1;PSMD12;PSMD8;PSMA5;PSMA3;PSMC4;FBXO4;PSME2;PSME1;PSMB5;PSMC3;CUL4A;PSME3
prerank,GO_Biological_Process_2021__glutamine family amino acid metabolic process (GO:0009064),-0.47342402427070013,-0.8995823244948647,0.5972222222222222,0.9985128514080753,1.0,3/20,8.63%,NIT2;GLUL;GCLM
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.519891211065256,0.8994772917579055,0.5510204081632653,0.899671117417459,1.0,1/8,1.03%,GRB10
prerank,GO_Biological_Process_2021__regulation of extracellular matrix constituent secretion (GO:0003330),-0.5541914969382139,-0.8992056972317699,0.6842105263157895,0.9986604100141169,1.0,2/5,21.23%,TNFRSF1B;RGCC
prerank,GO_Biological_Process_2021__ribonucleoside monophosphate biosynthetic process (GO:0009156),0.47450043322223,0.8985201449356414,0.6206896551724138,0.901193089228151,1.0,2/11,15.81%,PPAT;ADK
prerank,GO_Biological_Process_2021__positive regulation of mRNA 3'-end processing (GO:0031442),-0.540744338566515,-0.8984787760643762,0.6415094339622641,0.9994496407829515,1.0,3/8,25.54%,NCBP2;LEO1;DHX36
prerank,GO_Biological_Process_2021__negative regulation of transferase activity (GO:0051348),-0.44556555218306027,-0.8982082291776652,0.5689655172413793,0.9993896942937648,1.0,2/23,5.72%,ZFP36;DTX3L
prerank,GO_Biological_Process_2021__heart development (GO:0007507),0.3519149304915499,0.8980541480622388,0.8076923076923077,0.9015841749330586,1.0,25/83,15.68%,PKD2;TGFBR2;PKD1;HDAC9;TSC2;SALL1;ALPK3;SOX4;PDLIM5;TAB2;LDB3;HEG1;KAT2A;PTEN;SMYD4;NF1;PDLIM7;FLRT2;MEGF8;NIPBL;PTK2;ERBB4;TGFBR1;TBX19;CACYBP
prerank,GO_Biological_Process_2021__tetrahydrobiopterin metabolic process (GO:0046146),-0.6190821677139263,-0.8980425993373293,0.6949152542372882,0.9991020034952776,1.0,2/7,9.36%,CALM1;PTS
prerank,GO_Biological_Process_2021__cytoskeleton-dependent intracellular transport (GO:0030705),-0.46467645591416745,-0.8979257323596341,0.6231884057971014,0.998767010558189,1.0,1/21,0.86%,CCDC88C
prerank,GO_Biological_Process_2021__positive regulation of interleukin-8 production (GO:0032757),-0.4545776749842533,-0.8976954179837264,0.6176470588235294,0.998570008627581,1.0,9/35,15.77%,CD2;CD14;LAMTOR5;PRKD2;CHI3L1;HSPA1B;NOD2;HSPA1A;CD74
prerank,GO_Biological_Process_2021__central nervous system projection neuron axonogenesis (GO:0021952),-0.5184881259593316,-0.8976890433702428,0.5909090909090909,0.9979766181367542,1.0,1/9,3.87%,EPHB1
prerank,GO_Biological_Process_2021__cellular response to glucose starvation (GO:0042149),0.40238057922145076,0.8974016688883886,0.6176470588235294,0.9024770520522671,1.0,9/33,18.07%,CPEB4;NUAK1;BRSK1;SESN2;TBL2;PRKAA1;SH3GLB1;BRSK2;SIK2
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to membrane (GO:0090314),-0.45228764627020024,-0.8972145053738788,0.56,0.9983141397019284,1.0,4/18,10.55%,CEMIP;FIS1;FYN;ITGB2
prerank,GO_Biological_Process_2021__histone monoubiquitination (GO:0010390),0.4593395791203277,0.8970681679176491,0.6842105263157895,0.9025115796004277,1.0,3/21,10.42%,RNF2;RYBP;RNF20
prerank,GO_Biological_Process_2021__cellular protein complex disassembly (GO:0043624),0.5332303721998414,0.8968235119490168,0.6296296296296297,0.9024534507737026,1.0,3/5,30.34%,APEH;ETF1;PEX14
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced cell death (GO:1903202),0.4231000038762769,0.8966262208826888,0.6190476190476191,0.902218002029704,1.0,4/20,13.66%,SIRT1;LRRK2;SOD2;BAG5
prerank,GO_Biological_Process_2021__negative regulation of RNA splicing (GO:0033119),-0.4710866581610784,-0.8964507525403951,0.5932203389830508,0.9991160606895887,1.0,4/18,13.24%,RPS13;RPS26;U2AF2;SRSF7
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection assembly (GO:0120031),0.29132826013568136,0.8964404304876699,0.96,0.9020368081313214,1.0,29/189,12.64%,AVIL;NRP1;GSN;BBS9;EXOC8;PKD1;RAP1A;CFAP54;RP2;FGD4;PTPN23;STK36;VCL;RFX3;CEP83;CEP41;WDPCP;DNM3;CDC14B;RFX2;CEP131;P2RY12;POC1B;ANO6;FXYD5;FNBP1L;ARF6;CILK1;RAB3IP
prerank,GO_Biological_Process_2021__DNA modification (GO:0006304),-0.515707057160017,-0.8962406324461784,0.6071428571428571,0.9989298835379284,1.0,4/14,12.59%,SMUG1;OGG1;PARP2;TERF2IP
prerank,PanglaoDB_Augmented_2021__Myoepithelial Cells,0.4518787475363436,0.8961775859909482,0.6764705882352942,0.9020330130341916,1.0,3/21,3.17%,COL16A1;FKBP9;ACTA2
prerank,GO_Biological_Process_2021__wound healing (GO:0042060),-0.45526806073725445,-0.8961148438368068,0.6712328767123288,0.9985540146177684,1.0,6/36,10.20%,JAML;IGF1;RAB3A;CORO1B;CFLAR;SLC11A1
prerank,GO_Biological_Process_2021__regulation of MAPK cascade (GO:0043408),-0.3719716657841555,-0.8960601638717419,0.6285714285714286,0.9980731569162367,1.0,8/97,6.85%,APIP;TGFBR3;DUSP1;TRIM5;EPHB1;LILRB4;IGF1;GSTP1
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.28842438311986246,0.8955922493414271,0.9375,0.9024911070506594,1.0,45/256,13.77%,NRP1;POLR2D;PDGFA;GRB10;FER;CDK5R1;IGF1R;FGF2;PDK4;SLC39A14;GAB1;MAPK11;SPRED1;SPRED2;NCK2;TSC2;WASF2;NRG1;PDGFC;HPN;RYK;CRK;ELMO1;SORT1;GIT1;FLRT1;SHC2;ATP6V1B2;AP3S1;HGF;PTPRG;GIGYF1;MPZL1;MERTK;EPHA6;ITGAV;MAPK1;ANKS1A;GRIN2B;NTRK2;MAPKAPK2;FLRT2;SHOC2;VAV1;PTK2
prerank,GO_Biological_Process_2021__mitochondrial DNA repair (GO:0043504),0.5845951047698351,0.8951900159397117,0.6888888888888889,0.9027255167505099,1.0,1/5,5.45%,PARP1
prerank,GO_Biological_Process_2021__actin filament depolymerization (GO:0030042),0.5177454837705106,0.89517482488448,0.5952380952380952,0.9021907991729696,1.0,1/9,1.66%,GSN
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance (GO:0032205),0.4632722795414636,0.8948226014341127,0.5853658536585366,0.9024251019492655,1.0,5/12,24.03%,PARP1;ERCC4;NBN;ERCC1;TNKS2
prerank,GO_Biological_Process_2021__response to UV (GO:0009411),0.3093847764040783,0.8946513558361774,0.7692307692307693,0.9022444661126905,1.0,9/71,10.90%,ZBTB1;RUVBL2;CASP9;CAT;PARP1;BRSK1;EIF2S1;PTPRK;ERCC4
prerank,GO_Biological_Process_2021__histone H3 acetylation (GO:0043966),-0.44907041200437214,-0.8946075456794221,0.6181818181818182,1.0,1.0,5/34,11.60%,TAF6L;POLE3;ING5;BRCA2;ING4
prerank,GO_Biological_Process_2021__regulation of telomerase activity (GO:0051972),-0.43709421523151415,-0.8945221807742025,0.6615384615384615,1.0,1.0,2/33,1.65%,PKIB;PRKCQ
prerank,GO_Biological_Process_2021__response to organophosphorus (GO:0046683),-0.5289592587681938,-0.8944055711502615,0.6140350877192983,0.9996496136704349,1.0,2/10,9.56%,DUOX1;STAT1
prerank,GO_Biological_Process_2021__T cell activation involved in immune response (GO:0002286),-0.5734771698710125,-0.8941008420680588,0.6363636363636364,0.999705727833754,1.0,4/8,15.77%,FCER1G;SLC11A1;ITGAL;CD74
prerank,GO_Biological_Process_2021__regulation of protein catabolic process (GO:0042176),-0.3945776190490619,-0.8937126262348769,0.6212121212121212,0.9997722865702174,1.0,9/75,11.99%,FLNA;NKD1;ODC1;SNF8;TNFAIP3;GPC3;VPS28;AZIN2;AZIN1
prerank,GO_Biological_Process_2021__cellular response to drug (GO:0035690),-0.49680860987994113,-0.8936064299286607,0.6206896551724138,0.9993554766571134,1.0,4/17,11.31%,TFRC;AIM2;RBM22;FBP1
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",-0.4201633129125037,-0.893497818784952,0.631578947368421,0.9989391716621356,1.0,19/65,22.96%,PSMB3;PSMB6;PSMA7;PSMB9;DVL1;FZD2;PSMD12;PFN1;PSMD8;PSMA5;AP2S1;RAC1;PSMA3;PSMC4;PSME2;PSME1;PSMB5;PSMC3;PSME3
prerank,GO_Biological_Process_2021__negative regulation of response to cytokine stimulus (GO:0060761),0.5453740752772792,0.893241783365194,0.5714285714285714,0.9048189101989391,1.0,1/7,0.08%,KLF4
prerank,GO_Biological_Process_2021__protein destabilization (GO:0031648),-0.47284694369258506,-0.8932140414914933,0.6666666666666666,0.9990165670871001,1.0,2/25,1.60%,CCDC88C;PYHIN1
prerank,GO_Biological_Process_2021__heterochromatin organization (GO:0070828),0.5154775230917042,0.8931208454321871,0.525,0.9045602989343555,1.0,5/10,13.32%,SIRT1;SETD7;HP1BP3;LOXL2;SETDB2
prerank,GO_Biological_Process_2021__protein dephosphorylation (GO:0006470),0.33515698498882085,0.8930042303024666,0.782608695652174,0.9042253753648856,1.0,21/109,11.81%,DUSP6;PTPN9;DUSP18;PPM1L;PTPRM;SSU72;PPP4R2;PPP2R1B;PTPN13;ILKAP;CDC14B;PPP3CA;DUSP7;BTRC;PTPRG;PTPRK;PTPN5;FBXW11;PTPRD;PPP1R15B;PTEN
prerank,GO_Biological_Process_2021__cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),-0.3696587369912761,-0.8927322343725522,0.6153846153846154,0.999502869382828,1.0,7/86,5.65%,JAML;EMB;SELL;CLDN7;MMP24;CDH23;PECAM1
prerank,GO_Biological_Process_2021__cellular component assembly (GO:0022607),-0.3503682730435736,-0.892622328449544,0.6329113924050633,0.9991658367536731,1.0,17/165,11.06%,FLNA;SYCE2;RIMS1;AIF1;STAG3;CD247;ELOB;CHCHD10;RHOU;CORO1B;NLGN2;ACTG1;DVL1;BAIAP2L2;ACTB;NCKAP1L;TUBGCP2
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),-0.47430675683318524,-0.8924977364498747,0.603448275862069,0.9988501604533047,1.0,1/19,1.48%,ZFP36
prerank,GO_Biological_Process_2021__negative regulation of T cell receptor signaling pathway (GO:0050860),-0.5304142664813698,-0.8922196356317421,0.6379310344827587,0.9988436771306703,1.0,3/12,19.00%,LILRB4;EZR;PTPN22
prerank,GO_Biological_Process_2021__peptide cross-linking (GO:0018149),0.5505638573140337,0.8916888235988721,0.6739130434782609,0.906196270164193,1.0,1/8,0.34%,ANXA1
prerank,GO_Biological_Process_2021__negative regulation of Wnt signaling pathway (GO:0030178),0.34002442264398425,0.8914996629607406,0.6,0.906029129993748,1.0,14/118,7.68%,LRP4;GRB10;ZNRF3;RUVBL2;CTNNBIP1;ANKRD6;TLE2;TSC2;WNT5A;INVS;TMEM170B;DDIT3;NLK;DVL3
prerank,GO_Biological_Process_2021__positive regulation of cholesterol transport (GO:0032376),-0.47939981774135926,-0.8914241562665884,0.6515151515151515,0.99997231523897,1.0,5/22,11.64%,LIPG;PLTP;NR1H2;ABCB4;ABCA8
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.3747958763648034,0.8912104658358825,0.7083333333333334,0.9059922415033818,1.0,1/37,0.08%,KLF4
prerank,GO_Biological_Process_2021__protein ADP-ribosylation (GO:0006471),-0.4606957353294388,-0.8911456363747062,0.6231884057971014,0.9999547073580836,1.0,7/24,16.67%,PARP14;PARP15;PARP9;PARP2;PARP4;PARP11;PARP12
prerank,GO_Biological_Process_2021__cellular response to amino acid stimulus (GO:0071230),0.42458593128187994,0.8911075146177699,0.6551724137931034,0.9056343258584285,1.0,3/28,6.73%,RRAGD;GLRA1;CPEB4
prerank,GO_Biological_Process_2021__postsynaptic density organization (GO:0097106),0.4933292333812777,0.8905821853370885,0.5084745762711864,0.9060561203753873,1.0,4/8,11.81%,NLGN1;SHANK3;NRXN2;PTEN
prerank,GO_Biological_Process_2021__muscle cell development (GO:0055001),-0.4934552327486016,-0.8904104174482304,0.625,1.0,1.0,3/19,11.19%,IGF1;TTN;VEGFA
prerank,GO_Biological_Process_2021__negative regulation of transporter activity (GO:0032410),0.5010356591121903,0.8902065776784952,0.5,0.9062865086819699,1.0,4/6,35.88%,SNCA;CTTNBP2NL;NDFIP2;PPIF
prerank,GO_Biological_Process_2021__regulation of keratinocyte differentiation (GO:0045616),-0.46967332626394875,-0.8894840015770876,0.6060606060606061,1.0,1.0,1/17,1.48%,ZFP36
prerank,GO_Biological_Process_2021__endothelial cell chemotaxis (GO:0035767),-0.5639479112411856,-0.8885377616120612,0.640625,1.0,1.0,4/5,13.60%,PLEKHG5;CORO1B;VEGFA;NR4A1
prerank,GO_Biological_Process_2021__phosphatidylcholine metabolic process (GO:0046470),0.395098181995287,0.888371616171498,0.5666666666666667,0.9093931775591748,1.0,10/42,13.00%,PLA2G4C;PLA2G7;CHKA;SLC44A2;DBI;GPAT4;SLC44A5;SLC44A1;LCAT;CHPT1
prerank,GO_Biological_Process_2021__receptor catabolic process (GO:0032801),0.45093110400434694,0.8883300618235699,0.6666666666666666,0.9088738893270687,1.0,5/21,18.25%,ZNRF3;SMURF1;SH3GLB1;MYLIP;NEDD4
prerank,GO_Biological_Process_2021__positive regulation of protein export from nucleus (GO:0046827),0.4962124455773157,0.8882260200088318,0.6444444444444445,0.908530527529347,1.0,2/14,4.84%,BAG3;ANP32B
prerank,GO_Biological_Process_2021__negative regulation of cell cycle (GO:0045786),-0.40160438983492736,-0.8880644460243394,0.6333333333333333,1.0,1.0,3/49,2.69%,RUNX3;DUSP1;BTG2
prerank,"GO_Biological_Process_2021__retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.3791721703103804,0.8879978543953678,0.5925925925925926,0.908484612470095,1.0,12/66,17.41%,GOLPH3L;TMED3;RAB1B;TMED10;COPG1;CENPE;RAB6A;KIF15;SCYL1;COG3;COPB1;COPZ1
prerank,GO_Biological_Process_2021__maintenance of epithelial cell apical/basal polarity (GO:0045199),0.5249437351836816,0.8876358861730869,0.6739130434782609,0.9080582827081611,1.0,1/6,5.96%,LIN7A
prerank,GO_Biological_Process_2021__maintenance of apical/basal cell polarity (GO:0035090),0.5249437351836816,0.8876358861730869,0.6739130434782609,0.9080582827081611,1.0,1/6,5.96%,LIN7A
prerank,GO_Biological_Process_2021__positive regulation of cell division (GO:0051781),0.42025540442023424,0.8876217581353745,0.5161290322580645,0.9075110566670856,1.0,11/23,28.91%,PKP4;CDC14B;CSPP1;CDC14A;FGFR2;PRKCE;CIT;ECT2;GIPC1;SIRT2;RHOA
prerank,GO_Biological_Process_2021__membrane raft distribution (GO:0031580),-0.5661245359026923,-0.8875484070414448,0.6721311475409836,1.0,1.0,1/5,1.25%,CD2
prerank,GO_Biological_Process_2021__secondary alcohol biosynthetic process (GO:1902653),-0.4552465881221758,-0.8875283906371075,0.625,1.0,1.0,1/19,0.72%,INSIG1
prerank,GO_Biological_Process_2021__divalent inorganic cation homeostasis (GO:0072507),0.48012986396944135,0.8875141145453824,0.6097560975609756,0.9072455934301529,1.0,5/14,21.96%,TMTC2;SLC8A1;ATP13A2;SNCA;GRIN1
prerank,"GO_Biological_Process_2021__maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-0.4876113032302661,-0.8874177936042834,0.6363636363636364,1.0,1.0,2/17,7.08%,RPS21;EXOSC10
prerank,GO_Biological_Process_2021__negative regulation of actin filament polymerization (GO:0030837),0.48929367276414226,0.8870742107615874,0.6410256410256411,0.9077168765065056,1.0,4/16,7.80%,GSN;HIP1R;MYADM;KANK1
prerank,GO_Biological_Process_2021__positive regulation of Rho protein signal transduction (GO:0035025),-0.5068624259718398,-0.886625434629174,0.609375,1.0,1.0,4/15,16.58%,ARHGEF3;P2RY8;LPAR6;RAC1
prerank,GO_Biological_Process_2021__C21-steroid hormone metabolic process (GO:0008207),0.5196876065120873,0.886259093306586,0.6222222222222222,0.9087793654819748,1.0,2/8,9.07%,TSPOAP1;CYP46A1
prerank,GO_Biological_Process_2021__positive regulation of viral genome replication (GO:0045070),-0.4891857624276958,-0.8861537084066264,0.6727272727272727,1.0,1.0,3/25,2.82%,PPIE;CCL5;IFIT1
prerank,GO_Biological_Process_2021__regulation of purine nucleotide metabolic process (GO:1900542),0.3525378840095535,0.8858679496087438,0.6756756756756757,0.9090216264350013,1.0,6/35,17.93%,NUP153;NUP188;NUP42;NDC1;NUP133;NUP205
prerank,GO_Biological_Process_2021__negative regulation of metabolic process (GO:0009892),-0.44542425068772645,-0.8858345281008573,0.609375,1.0,1.0,7/38,12.47%,NR1H2;FIS1;GSTP1;BTN2A2;RBPJ;PCTP;IL18R1
prerank,GO_Biological_Process_2021__prostanoid metabolic process (GO:0006692),-0.5131001990243511,-0.8858272088002238,0.7,1.0,1.0,1/7,6.85%,GSTP1
prerank,GO_Biological_Process_2021__regulation of cilium assembly (GO:1902017),0.35960207574623027,0.88560160994995,0.6129032258064516,0.9090438326644807,1.0,8/50,13.99%,CDK10;TBC1D1;TBC1D5;TBC1D10B;TBC1D16;TBC1D22B;RABGAP1;EVI5
prerank,GO_Biological_Process_2021__ethanol metabolic process (GO:0006067),-0.5905357768499305,-0.8854912878845348,0.6530612244897959,1.0,1.0,3/5,30.36%,ALDH2;ACSS1;ADH5
prerank,GO_Biological_Process_2021__ethanol oxidation (GO:0006069),-0.5905357768499305,-0.8854912878845348,0.6530612244897959,1.0,1.0,3/5,30.36%,ALDH2;ACSS1;ADH5
prerank,GO_Biological_Process_2021__regulation of chemokine-mediated signaling pathway (GO:0070099),-0.5499421686984021,-0.8854449558551752,0.6065573770491803,1.0,1.0,2/6,11.34%,PADI2;HIF1A
prerank,GO_Biological_Process_2021__natural killer cell activation (GO:0030101),-0.5013105638701544,-0.8848875004406243,0.711864406779661,1.0,1.0,1/16,1.25%,CD2
prerank,GO_Biological_Process_2021__phosphate ion transport (GO:0006817),0.4868623518053854,0.8844229199901602,0.627906976744186,0.9102158186608984,1.0,4/11,14.12%,XPR1;SLC37A2;SLC37A4;SLC25A14
prerank,GO_Biological_Process_2021__phosphate ion transmembrane transport (GO:0035435),0.4868623518053854,0.8844229199901602,0.627906976744186,0.9102158186608984,1.0,4/11,14.12%,XPR1;SLC37A2;SLC37A4;SLC25A14
prerank,GO_Biological_Process_2021__negative regulation of myeloid cell differentiation (GO:0045638),-0.4612928434581482,-0.8843198027968483,0.6226415094339622,1.0,1.0,2/15,9.63%,ZFP36;MEIS1
prerank,PanglaoDB_Augmented_2021__Enterochromaffin Cells,0.37126589244872943,0.8840634774621128,0.6296296296296297,0.9103128717694124,1.0,16/44,17.64%,PPARGC1A;SEMA5A;NTM;GRIA3;CDH11;SLC4A4;PTPRD;PDE1C;SGIP1;SLC26A3;CNTN4;NFASC;KALRN;GRIN2A;SORBS2;CNTN3
prerank,GO_Biological_Process_2021__negative regulation of chemokine production (GO:0032682),-0.5223387484872098,-0.8840511152380123,0.5964912280701754,1.0,1.0,6/10,8.28%,SIGIRR;OAS3;APOD;LILRB4;GSTP1;OAS1
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization to mitochondrion (GO:1903747),-0.5353028985314022,-0.8836579598323773,0.7192982456140351,1.0,1.0,4/7,29.58%,ATP5IF1;PINK1;SREBF1;HAX1
prerank,GO_Biological_Process_2021__cellular modified amino acid biosynthetic process (GO:0042398),-0.452664639350656,-0.8834568439675836,0.6,1.0,1.0,3/14,8.63%,GATM;PLSCR1;GCLM
prerank,PanglaoDB_Augmented_2021__Trophoblast Cells,-0.43163663218134607,-0.8831997088825554,0.6716417910447762,1.0,1.0,6/26,4.96%,FOSL2;CD55;ANXA2;IER3;BHLHE40;ABCC3
prerank,GO_Biological_Process_2021__response to exogenous dsRNA (GO:0043330),-0.46072315130558966,-0.8831341393237148,0.6949152542372882,1.0,1.0,4/16,16.49%,IFIT1;STING1;COLEC12;FLOT1
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090267),-0.5546412970438318,-0.8828362742556929,0.6181818181818182,1.0,1.0,1/5,9.58%,XRCC3
prerank,GO_Biological_Process_2021__positive regulation of spindle checkpoint (GO:0090232),-0.5546412970438318,-0.8828362742556929,0.6181818181818182,1.0,1.0,1/5,9.58%,XRCC3
prerank,GO_Biological_Process_2021__positive regulation of cytokinesis (GO:0032467),0.4549325061596172,0.8827657575536177,0.5789473684210527,0.9125942732490764,1.0,4/18,15.48%,PKP4;CDC14B;CSPP1;CDC14A
prerank,GO_Biological_Process_2021__regulation of monocyte differentiation (GO:0045655),0.46643510728080984,0.8827653418820347,0.5227272727272727,0.9120249692732505,1.0,2/10,11.88%,CTNNBIP1;CDK6
prerank,GO_Biological_Process_2021__positive regulation of myelination (GO:0031643),0.5291541618671648,0.8826058431975572,0.6170212765957447,0.9116979525377915,1.0,4/10,15.71%,MYRF;TPPP;RNF10;PARD3
prerank,GO_Biological_Process_2021__regulation of insulin secretion (GO:0050796),0.3554309201051073,0.8825641002162933,0.696969696969697,0.9112129069166925,1.0,13/56,14.74%,CACNA1A;MCU;RAP1A;TNF;RFX3;CLOCK;SOX4;KCNC2;STX1A;TCF7L2;ABCC8;CACNA1E;RAPGEF3
prerank,GO_Biological_Process_2021__regulation of actin filament depolymerization (GO:0030834),0.47722599121342923,0.8823750282626273,0.6363636363636364,0.9109245025274053,1.0,1/8,1.58%,SEMA5A
prerank,GO_Biological_Process_2021__chromatin remodeling (GO:0006338),0.34492195464223785,0.8823727457009582,0.6764705882352942,0.91035765467269,1.0,6/79,3.74%,ZBTB1;RUVBL2;DR1;SIRT1;ARID1A;MTA2
prerank,GO_Biological_Process_2021__termination of RNA polymerase II transcription (GO:0006369),0.41602370240711173,0.8823633796578928,0.5405405405405406,0.9098216339084035,1.0,7/24,12.20%,CPSF4;WDR33;SSU72;PCF11;SCAF8;CPSF7;SNRPB
prerank,GO_Biological_Process_2021__monoacylglycerol metabolic process (GO:0046462),0.5127371705262751,0.8822389401386078,0.64,0.9093991669277726,1.0,1/7,0.63%,FAAH
prerank,GO_Biological_Process_2021__oxoacid metabolic process (GO:0043436),0.4502854299128273,0.8821829373243081,0.631578947368421,0.9089170554766832,1.0,2/12,14.62%,PPA2;ENPP1
prerank,GO_Biological_Process_2021__positive regulation of Arp2/3 complex-mediated actin nucleation (GO:2000601),0.5382059074349762,0.8821269802005468,0.5952380952380952,0.9084956744751914,1.0,1/8,5.63%,WASF2
prerank,GO_Biological_Process_2021__antifungal innate immune response (GO:0061760),-0.5542219404210351,-0.8816286044963052,0.6610169491525424,1.0,1.0,3/6,27.95%,CLEC7A;CARD9;BCL10
prerank,GO_Biological_Process_2021__sensory perception (GO:0007600),-0.4753679385154296,-0.8815980063607406,0.6865671641791045,1.0,1.0,3/18,6.88%,SCN9A;CDH23;C5AR1
prerank,GO_Biological_Process_2021__establishment of protein localization to organelle (GO:0072594),0.35310066468270784,0.8813255857291129,0.6206896551724138,0.9095846936681224,1.0,7/58,6.86%,NUTF2;E2F3;TSC2;IPO13;NUP153;NUP188;PPP1R10
prerank,"GO_Biological_Process_2021__positive regulation of transcription, DNA-templated (GO:0045893)",-0.3275417173411258,-0.8812559242628215,0.8602150537634409,1.0,1.0,73/739,11.42%,NR4A3;H1-4;IL4I1;SKAP1;H1-3;MYBL1;BCL11B;UBC;H1-2;FOSL2;FOS;RPS27A;RUNX3;JUNB;PYHIN1;PID1;MDFIC;ATF5;TAF6L;CSRNP1;USF1;EDF1;RORA;CHCHD2;H1-0;ZNF335;DDRGK1;BEX1;ETS1;PADI2;CHCHD10;ING5;NR1H2;JUP;IGF1;JMJD6;DTX3L;TXK;ILF3;MED25;NLRC5;PARP9;IER2;PLSCR1;ZNF76;MAP3K12;PLAG1;BRCA2;NAMPT;RNASEL;PRKD2;RBPJ;H1-10;ITGA6;VENTX;DVL1;STAT1;MEIS1;ZNF513;EIF5A;SMARCD1;SLC11A1;LITAF;IRF1;HNRNPAB;NPM1;CITED2;KDM6B;MLX;VEGFA;KARS1;HIF1A;STING1
prerank,"GO_Biological_Process_2021__regulation of mRNA splicing, via spliceosome (GO:0048024)",0.33171162546033484,0.8811507812667678,0.8181818181818182,0.90932857899345,1.0,26/73,27.66%,PCBP4;KHDRBS2;PRDX6;KHDRBS3;RBFOX1;SRSF12;TRA2B;RBFOX2;THRAP3;HNRNPU;WTAP;CELF2;CELF5;PUF60;NOVA1;NUP98;KHDRBS1;RNPS1;CELF1;MBNL1;RBM15;RBM5;MBNL3;METTL16;HNRNPL;RBM8A
prerank,GO_Biological_Process_2021__negative regulation of organelle assembly (GO:1902116),0.40512757464142646,0.8809336850544945,0.5789473684210527,0.9092753497108604,1.0,3/29,4.89%,CDK10;LRRK2;TMEM39A
prerank,GO_Biological_Process_2021__cell-cell adhesion mediated by cadherin (GO:0044331),-0.5804774376859743,-0.8808786131802128,0.6481481481481481,1.0,1.0,2/5,4.61%,PLEKHA7;MMP24
prerank,GO_Biological_Process_2021__positive regulation of organelle assembly (GO:1902117),0.3846698323925631,0.8808464575340595,0.6,0.9088772841453105,1.0,11/36,25.67%,LCP1;TNF;CNOT2;PIP4K2A;DYNC1H1;CEP120;SH3GLB1;ARHGAP35;G3BP1;RAB3GAP2;PIP4K2B
prerank,GO_Biological_Process_2021__positive regulation of cellular amide metabolic process (GO:0034250),-0.3883690827061026,-0.8807635962115522,0.6857142857142857,1.0,1.0,14/66,20.17%,RPS4X;RPL5;RACK1;CLU;EIF4A3;NPM1;PASK;RPS27L;ZCCHC4;GSAP;EEF2;VIM;NSMAF;NSUN5
prerank,PanglaoDB_Augmented_2021__Undefined Placental Cells,0.38607310200310274,0.8804251881872506,0.6129032258064516,0.9091765820133298,1.0,2/35,0.65%,TUBA1C;AHCY
prerank,GO_Biological_Process_2021__purine nucleobase biosynthetic process (GO:0009113),-0.5842944243844752,-0.8802605653033726,0.7419354838709677,1.0,1.0,2/5,23.50%,SHMT1;GART
prerank,GO_Biological_Process_2021__positive regulation of JNK cascade (GO:0046330),0.3729917948093201,0.8802076241915979,0.59375,0.9090112164836496,1.0,22/48,27.93%,MAP3K11;ANKRD6;EDA2R;MAP3K10;MFHAS1;SH3RF1;TRAF6;MAP3K5;ZNF622;TPD52L1;TAOK2;MTURN;MAP4K2;AGER;DAB2IP;RIPK1;TRAF2;SERPINF2;PTK2B;HIPK2;MAPK8IP1;DUSP22
prerank,GO_Biological_Process_2021__cellular macromolecule catabolic process (GO:0044265),-0.42796114156060244,-0.8801869699736259,0.6349206349206349,1.0,1.0,2/36,2.26%,RNASET2;SIDT2
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transport (GO:1901379),-0.430226591221201,-0.8799628682555588,0.6268656716417911,1.0,1.0,3/37,7.09%,FLNA;CD63;STK39
prerank,GO_Biological_Process_2021__regulation of endothelial cell differentiation (GO:0045601),0.5394469845491507,0.879919631170486,0.6938775510204082,0.9088909591922937,1.0,1/6,3.51%,VEZF1
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),-0.372854783715498,-0.8798574231246681,0.6388888888888888,1.0,1.0,12/64,12.71%,PYHIN1;DDRGK1;RACK1;ELOB;CLU;ARIH2;RNF144B;DVL1;RBX1;NOP53;HSPA1B;CSNK1D
prerank,GO_Biological_Process_2021__fatty acid transmembrane transport (GO:1902001),0.468309953369218,0.8796120399120644,0.5882352941176471,0.9090625450789204,1.0,3/14,7.76%,PRKAB2;CPT1A;ACACB
prerank,GO_Biological_Process_2021__cell-cell junction assembly (GO:0007043),0.36626543283418644,0.8793828499791291,0.65625,0.9088228088512612,1.0,10/39,15.66%,PKP4;SMAD7;CDH20;VCL;CDH11;TJP1;CDH19;ZNF703;CNTNAP1;CDH8
prerank,GO_Biological_Process_2021__positive regulation of response to wounding (GO:1903036),-0.47291658620140015,-0.878529267855433,0.5901639344262295,1.0,1.0,4/15,10.30%,MYLK;DUOX1;ACTG1;PTN
prerank,GO_Biological_Process_2021__exit from mitosis (GO:0010458),0.4947284209388756,0.8784200065542799,0.6341463414634146,0.9102342651913752,1.0,4/10,16.96%,EPS8;CHMP7;CLASP1;CLASP2
prerank,GO_Biological_Process_2021__regulation of axon regeneration (GO:0048679),-0.5286565784700423,-0.8782527891700558,0.6938775510204082,1.0,1.0,2/9,23.95%,PTN;SCARF1
prerank,GO_Biological_Process_2021__mRNA cleavage involved in gene silencing by miRNA (GO:0035279),0.5845302351352193,0.8778368871986335,0.7142857142857143,0.9106809296193479,1.0,2/5,29.29%,AGO1;MOV10
prerank,GO_Biological_Process_2021__positive regulation of granulocyte differentiation (GO:0030854),0.5448197948415295,0.8778309400333609,0.6730769230769231,0.9101347418209685,1.0,1/5,6.90%,RUNX1
prerank,GO_Biological_Process_2021__negative regulation of microglial cell activation (GO:1903979),0.5050373190944405,0.8771066450977762,0.6808510638297872,0.9110804910057043,1.0,1/7,3.01%,LDLR
prerank,GO_Biological_Process_2021__regulation of smoothened signaling pathway (GO:0008589),0.36242100345557177,0.8770984670800795,0.6774193548387096,0.9105272778213467,1.0,8/32,13.38%,DLG5;TULP3;PTCH2;STK36;KCTD6;BTRC;PTCH1;MEGF8
prerank,GO_Biological_Process_2021__positive regulation of developmental growth (GO:0048639),-0.4259918913943666,-0.8770816053040051,0.6229508196721312,1.0,1.0,1/30,1.34%,RIMS1
prerank,GO_Biological_Process_2021__regulation of RNA biosynthetic process (GO:2001141),0.5372793284584776,0.8770431168589503,0.7272727272727273,0.9100790052005302,1.0,2/7,6.74%,MITF;RALY
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor superfamily cytokine production (GO:1903555),-0.5575558172607064,-0.8770218688060891,0.6470588235294118,1.0,1.0,1/8,1.48%,ZFP36
prerank,"GO_Biological_Process_2021__DNA-templated transcription, elongation (GO:0006354)",-0.389018448945221,-0.8768565745647651,0.6666666666666666,1.0,1.0,7/58,9.87%,TCEA2;GTF2H5;CTDP1;ELOB;ADRM1;POLR2G;NCBP2
prerank,GO_Biological_Process_2021__positive regulation of cell morphogenesis involved in differentiation (GO:0010770),-0.4255158589421664,-0.8767674175858484,0.6119402985074627,1.0,1.0,1/37,0.28%,FLNA
prerank,GO_Biological_Process_2021__positive regulation of T cell proliferation (GO:0042102),-0.4437776175292701,-0.8766978267015806,0.6714285714285714,1.0,1.0,5/36,5.56%,TFRC;CCL5;AIF1;RPS3;IGF1
prerank,GO_Biological_Process_2021__regulation of protein autophosphorylation (GO:0031952),0.38242453283151673,0.8762351996176644,0.6333333333333333,0.9110156022172521,1.0,12/31,18.72%,PDGFA;NEK10;PDGFC;MOB1B;PPP2R5E;GPNMB;ENPP1;DDX3X;RAP2C;NBN;TAOK2;CHP1
prerank,GO_Biological_Process_2021__blood vessel morphogenesis (GO:0048514),0.40678595663503275,0.875895108151636,0.6875,0.9111700584669904,1.0,3/22,2.59%,NRP1;TGFBR2;SMAD7
prerank,GO_Biological_Process_2021__negative regulation of collateral sprouting (GO:0048671),-0.5767295321993664,-0.8757861536523651,0.6415094339622641,1.0,1.0,1/5,6.76%,FGF13
prerank,GO_Biological_Process_2021__positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),-0.461149990717315,-0.8757640177190853,0.6612903225806451,1.0,1.0,1/25,0.28%,FLNA
prerank,GO_Biological_Process_2021__regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),-0.469724300837039,-0.8756700583214905,0.5555555555555556,1.0,1.0,1/16,1.03%,TGFBR3
prerank,GO_Biological_Process_2021__regulation of epithelial cell migration (GO:0010632),-0.4264148400697876,-0.8755356877105159,0.6811594202898551,1.0,1.0,7/39,12.45%,GLIPR2;RAB11A;GLUL;ENPP2;PTN;HIF1A;PFN1
prerank,GO_Biological_Process_2021__cellular response to steroid hormone stimulus (GO:0071383),0.479689467316784,0.87536599370882,0.5609756097560976,0.9118446655683212,1.0,3/9,18.31%,TRERF1;UBE2L3;NR3C1
prerank,GO_Biological_Process_2021__regulation of DNA replication (GO:0006275),0.4211061797575131,0.8752043701844521,0.6176470588235294,0.9116492665433226,1.0,9/35,22.88%,SLFN11;ZBTB38;BRPF3;GTPBP4;ANKRD17;FAF1;BLM;GMNN;RAD17
prerank,GO_Biological_Process_2021__negative regulation of intracellular signal transduction (GO:1902532),-0.3571812107170582,-0.8751489039948932,0.725,1.0,1.0,22/142,13.97%,DUSP1;DDIT4;NLRC3;RORA;RACK1;CGNL1;PLEK;LILRB4;GSTP1;THEM4;NLRP12;TNFAIP3;TMSB4X;STAT1;BANK1;NOP53;DGKD;PLEKHA1;PEBP1;PRDM15;PIK3CB;OTUD3
prerank,GO_Biological_Process_2021__amino acid import across plasma membrane (GO:0089718),0.4836368677923453,0.8748788805908501,0.6862745098039216,0.9117659285777331,1.0,4/11,6.03%,SLC1A3;SLC7A8;SLC3A2;SLC1A2
prerank,GO_Biological_Process_2021__RNA processing (GO:0006396),0.3064862373318843,0.8748524869499316,0.7222222222222222,0.9112517671010001,1.0,6/151,2.54%,PPARGC1A;ADARB2;NUFIP1;SYNCRIP;NOL9;U2AF1
prerank,GO_Biological_Process_2021__regulation of T-helper 17 type immune response (GO:2000316),-0.6060755222131914,-0.8748426424176572,0.6923076923076923,1.0,1.0,1/5,1.65%,PRKCQ
prerank,GO_Biological_Process_2021__regulation of T cell differentiation (GO:0045580),-0.45058163162734344,-0.8746504399415647,0.6229508196721312,1.0,1.0,2/20,2.84%,CD2;PRELID1
prerank,GO_Biological_Process_2021__regulation of peptidyl-cysteine S-nitrosylation (GO:2000169),-0.5811687801533268,-0.8745977580729035,0.6470588235294118,1.0,1.0,2/5,25.69%,NOS1AP;ATP2B4
prerank,GO_Biological_Process_2021__regulation of exocytosis (GO:0017157),0.3809637415884772,0.8744948915125645,0.6666666666666666,0.9114204362636089,1.0,15/39,24.55%,ANXA1;RAB10;CLASP1;STXBP5;CLASP2;IL1RAPL1;RALA;RIMS2;SNCA;UNC13D;SEPTIN4;RAB3C;STXBP5L;CADPS2;CADPS
prerank,GO_Biological_Process_2021__regulation of chromosome separation (GO:1905818),-0.6075693298627316,-0.874474356567942,0.7551020408163265,1.0,1.0,2/5,18.08%,PLSCR1;CSNK2A2
prerank,MSigDB_Hallmark_2020__Reactive Oxygen Species Pathway,0.3622296788333814,0.8741690944551648,0.6551724137931034,0.9116778272492125,1.0,5/40,6.12%,PFKP;GCLC;CAT;PRDX6;STK25
prerank,MSigDB_Hallmark_2020__Mitotic Spindle,0.3156329970474397,0.8736807652842465,0.8947368421052632,0.912075620363319,1.0,39/163,18.90%,PKD2;CLIP2;GSN;MAP1S;MAP3K11;EPB41;NCK2;FGD4;RASAL2;TLK1;WASF2;PPP4R2;ARAP3;VCL;STK38L;SASS6;PDLIM5;SPTAN1;CEP131;SMC4;CENPE;ARF6;NF1;KIF15;RABGAP1;SSH2;CLASP1;TUBGCP6;DYNC1H1;ABI1;NIN;SORBS2;FARP1;ALMS1;MYO1E;PREX1;TAOK2;BIN1;DYNLL2
prerank,GO_Biological_Process_2021__regulation of retinoic acid receptor signaling pathway (GO:0048385),0.5097775284571805,0.8736612089913787,0.6,0.9115403218174213,1.0,1/9,8.76%,CTBP2
prerank,GO_Biological_Process_2021__regulation of receptor internalization (GO:0002090),-0.453330163332505,-0.8735715088693263,0.5967741935483871,1.0,1.0,6/23,17.17%,CD63;VEGFA;ANKRD13D;PICK1;FLOT1;LRPAP1
prerank,GO_Biological_Process_2021__protein localization to axon (GO:0099612),0.5779121107030992,0.8733324417250032,0.7450980392156863,0.9117157996758507,1.0,1/5,1.34%,CNTN2
prerank,GO_Biological_Process_2021__positive regulation of hormone secretion (GO:0046887),-0.5731961594275871,-0.8728782908414514,0.6615384615384615,1.0,1.0,1/6,19.59%,CYP19A1
prerank,GO_Biological_Process_2021__RNA 3'-end processing (GO:0031123),-0.38533665756525076,-0.8728413288848997,0.7123287671232876,1.0,1.0,8/53,13.24%,DHX38;CSTF2T;EIF4A3;CHTOP;U2AF2;NCBP2;SRSF2;SRSF7
prerank,GO_Biological_Process_2021__positive regulation of secretion by cell (GO:1903532),0.36218284173572934,0.8725061251711284,0.7272727272727273,0.9128964558481204,1.0,18/52,22.41%,MYOM1;GOLPH3L;BAIAP3;TMED10;UNC13B;CD33;STX1A;ARF6;CLASP1;ATP13A2;STXBP5;SLC12A2;CLASP2;KCNB1;SNCA;UNC13D;CD2AP;DTNBP1
prerank,GO_Biological_Process_2021__establishment of protein localization to chromosome (GO:0070199),0.5356394511068852,0.8724159125361924,0.65,0.912516786011848,1.0,1/7,1.43%,RUVBL2
prerank,GO_Biological_Process_2021__positive regulation of cell communication (GO:0010647),0.4557585978045116,0.8724157231150496,0.6041666666666666,0.9119603733374505,1.0,6/18,10.53%,CDKN2AIP;PTPN23;GRIK2;TNF;CLSTN2;CLSTN3
prerank,MSigDB_Hallmark_2020__KRAS Signaling Up,-0.36422579712973463,-0.8722926720380844,0.6626506024096386,1.0,1.0,19/116,8.14%,CD37;PPP1R15A;CXCR4;IL7R;FCER1G;PCSK1N;RGS16;APOD;ETS1;ABCB1;IL10RA;ERO1A;F13A1;JUP;PECAM1;EPB41L3;CSF2RA;TNFRSF1B;TNFAIP3
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",-0.5154016864863544,-0.8722268919145911,0.6346153846153846,1.0,1.0,1/8,1.52%,RPS21
prerank,PanglaoDB_Augmented_2021__Satellite Cells,-0.4000591429251912,-0.8721934673723174,0.6615384615384615,1.0,1.0,2/60,1.43%,CALCR;CXCR4
prerank,GO_Biological_Process_2021__membrane protein intracellular domain proteolysis (GO:0031293),0.3870204266373071,0.872072086968267,0.6744186046511628,0.9120613767125142,1.0,5/17,25.72%,TRAF6;SPPL2B;RHBDD1;ADAM10;TGFB1
prerank,GO_Biological_Process_2021__detection of muscle stretch (GO:0035995),-0.5731957614528854,-0.8719806013207976,0.6964285714285714,1.0,1.0,1/5,7.37%,TTN
prerank,GO_Biological_Process_2021__progesterone receptor signaling pathway (GO:0050847),0.5374954352689232,0.8719799072384469,0.64,0.9117271566248375,1.0,2/6,18.25%,TRERF1;NEDD4
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle tissue growth (GO:0055023),-0.5268670465232855,-0.871913036747181,0.6170212765957447,1.0,1.0,3/12,8.45%,TGFBR3;IGF1;RBPJ
prerank,GO_Biological_Process_2021__potassium ion import across plasma membrane (GO:1990573),0.4393022661270001,0.8716941280308445,0.6756756756756757,0.9116807770914801,1.0,5/18,15.33%,KCNJ2;KCNJ5;SLC12A6;SLC12A5;SLC12A2
prerank,GO_Biological_Process_2021__regulation of delayed rectifier potassium channel activity (GO:1902259),-0.557117224822637,-0.8716578721120054,0.6545454545454545,1.0,1.0,3/6,30.60%,NOS1AP;SUMO1;ANK3
prerank,GO_Biological_Process_2021__molybdopterin cofactor biosynthetic process (GO:0032324),-0.585165343144072,-0.8716039977268804,0.7142857142857143,1.0,1.0,2/5,17.37%,NFS1;MOCOS
prerank,GO_Biological_Process_2021__histone H3-K4 methylation (GO:0051568),-0.43482602163983053,-0.8714180167382086,0.6666666666666666,1.0,1.0,2/21,14.77%,ZNF335;SETD1A
prerank,GO_Biological_Process_2021__cellular response to alcohol (GO:0097306),0.36390319703985957,0.8712676893032613,0.6538461538461539,0.9119880033655817,1.0,6/30,16.39%,GRAMD1A;GLRA1;GRAMD1C;PTCH1;ADCY6;BLM
prerank,GO_Biological_Process_2021__calcium ion homeostasis (GO:0055074),-0.4176125118460829,-0.8707498360338426,0.7,1.0,1.0,5/45,9.02%,CCL3;CCL5;ATP13A1;TPT1;TRPV4
prerank,GO_Biological_Process_2021__RNA stabilization (GO:0043489),0.41606091802838246,0.8705846899044729,0.6756756756756757,0.9126334683041195,1.0,5/23,19.56%,NSUN2;TENT5A;NAF1;THRAP3;HNRNPU
prerank,GO_Biological_Process_2021__negative regulation of T cell proliferation (GO:0042130),-0.4732799971324275,-0.8705194930431102,0.6666666666666666,1.0,1.0,4/22,9.67%,IL4I1;LILRB4;BTN2A2;GLMN
prerank,GO_Biological_Process_2021__calcium ion transmembrane import into cytosol (GO:0097553),0.4080220130691238,0.8701679190092285,0.6388888888888888,0.9127116859494646,1.0,2/24,2.26%,PKD2;FGF2
prerank,GO_Biological_Process_2021__cellular response to organic cyclic compound (GO:0071407),-0.3817238237444057,-0.8701512866539163,0.68,1.0,1.0,5/99,3.27%,NR4A3;CCL3;INSIG1;CCL5;RORA
prerank,GO_Biological_Process_2021__negative regulation of protein modification process (GO:0031400),-0.3889268214955397,-0.8700349837674751,0.6794871794871795,1.0,1.0,4/65,2.98%,PPP1R15A;PID1;WARS1;PAQR3
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.44975068682142383,0.8699172189271208,0.5869565217391305,0.9126721734806087,1.0,1/15,1.03%,GRB10
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transport (GO:0010765),0.5091904051701399,0.8697707871711188,0.5853658536585366,0.9124416678672684,1.0,3/7,18.87%,SCN3B;AHCYL1;SCN1B
prerank,GO_Biological_Process_2021__spermatid development (GO:0007286),0.45558839358436276,0.8697298016241379,0.5483870967741935,0.9119397405156051,1.0,5/14,13.41%,SYCP3;CIB1;CDYL;RFX2;JAM2
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell differentiation (GO:0046638),-0.5234419299472114,-0.8696560297048188,0.6833333333333333,1.0,1.0,3/9,10.76%,RUNX3;LILRB4;NCKAP1L
prerank,GO_Biological_Process_2021__interleukin-1-mediated signaling pathway (GO:0070498),0.3408132668220484,0.8694491916370193,0.6551724137931034,0.9118493959363648,1.0,1/82,0.03%,EGR1
prerank,GO_Biological_Process_2021__positive regulation of neuron apoptotic process (GO:0043525),-0.4998629783015299,-0.8694159448713619,0.7017543859649122,1.0,1.0,1/19,0.62%,CCL3
prerank,GO_Biological_Process_2021__regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.40167010499586775,0.8692794467402521,0.6060606060606061,0.9116638138196532,1.0,7/35,7.80%,NRP1;PDPN;CSPG5;CIB1;MYADM;CRK;KANK1
prerank,GO_Biological_Process_2021__regulation of cell cycle phase transition (GO:1901987),0.3410982996575218,0.8692061391647216,0.5862068965517241,0.9112072484744379,1.0,7/70,10.80%,UBE2D1;NEK10;FZR1;CDC23;BTRC;ANAPC16;FBXW7
prerank,GO_Biological_Process_2021__nuclear migration (GO:0007097),-0.5123909423108135,-0.8687692839734842,0.6557377049180327,1.0,1.0,1/12,1.88%,SYNE2
prerank,PanglaoDB_Augmented_2021__Hepatoblasts,-0.5019528808568776,-0.8687096723961801,0.6666666666666666,1.0,1.0,5/14,24.18%,ADGRG6;PKP2;GPRC5C;TOM1L1;EPB41L4B
prerank,GO_Biological_Process_2021__mitotic chromosome condensation (GO:0007076),0.4545571004840748,0.8686186603641457,0.6,0.9119452935091079,1.0,3/18,14.09%,NCAPH2;SMC4;CHMP1A
prerank,GO_Biological_Process_2021__positive regulation of cellular catabolic process (GO:0031331),-0.3677989663788922,-0.8684247568459733,0.734375,1.0,1.0,20/98,18.39%,TRIM5;IGF1;DTX3L;TRIM22;VPS35;PTTG1IP;TNFRSF1B;PFKFB3;PFKFB4;PRR5L;HIF1A;ENTPD5;KAT5;PIK3CB;TP53INP1;SNX9;CNOT8;EZR;TPCN1;PNPT1
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),-0.4017351583467937,-0.8681683140926216,0.6764705882352942,1.0,1.0,10/64,13.75%,MYO1G;VAV3;YES1;CD247;FYN;ACTG1;ACTB;NCKAP1L;CYFIP2;PIK3CB
prerank,"GO_Biological_Process_2021__protein localization to chromosome, centromeric region (GO:0071459)",-0.4775847354728334,-0.8679688499886157,0.5818181818181818,1.0,1.0,6/11,25.39%,ZWILCH;MIS12;IK;BUB3;CHAMP1;RB1
prerank,GO_Biological_Process_2021__protein acetylation (GO:0006473),0.4222586110989827,0.8676626897749736,0.5625,0.9133559854730539,1.0,3/23,8.08%,AANAT;SIRT1;CLOCK
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),-0.39993452573782085,-0.8676344836505439,0.7746478873239436,1.0,1.0,12/56,14.43%,EYA2;TNFSF10;IGF1;GSTP1;TNFAIP3;ITGA6;CFLAR;HSPA1B;GPX1;PEA15;BRCA1;HSPA1A
prerank,GO_Biological_Process_2021__triglyceride biosynthetic process (GO:0019432),0.5113490133166876,0.8675212805402599,0.5625,0.9130894583462251,1.0,3/9,12.41%,GPAT4;PCK2;GPAT3
prerank,GO_Biological_Process_2021__negative regulation of apoptotic signaling pathway (GO:2001234),-0.38473327043981476,-0.8674490680939381,0.6818181818181818,1.0,1.0,9/56,14.43%,PRELID1;CLU;IGF1;SLC25A5;GSTP1;ITGA6;CFLAR;GPX1;HSPA1A
prerank,GO_Biological_Process_2021__regulation of small molecule metabolic process (GO:0062012),0.41288677120171835,0.8674184429254462,0.6190476190476191,0.912684320586655,1.0,2/19,2.51%,PDK4;SIRT1
prerank,MSigDB_Hallmark_2020__DNA Repair,-0.37161509576713436,-0.8668422012180453,0.7671232876712328,1.0,1.0,31/113,24.26%,CMPK2;EDF1;GTF2H5;NT5C;ADRM1;POLR2G;RNMT;NCBP2;VPS28;RBX1;DCTN4;GPX4;VPS37B;TAF1C;RPA3;ERCC8;POLR3C;NME3;GTF2F1;SURF1;NELFE;PRIM1;SF3A3;MPG;TK2;TYMS;NELFCD;SDCBP;SNAPC5;UPF3B;BCAP31
prerank,GO_Biological_Process_2021__ceramide biosynthetic process (GO:0046513),-0.4676346433976951,-0.8664547600972671,0.6296296296296297,1.0,1.0,1/22,0.87%,DEGS2
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic translation (GO:2000767),-0.5990137415368191,-0.8664505841043045,0.7954545454545454,1.0,1.0,3/5,31.65%,DHX36;YBX3;PKM
prerank,GO_Biological_Process_2021__aortic valve development (GO:0003176),0.41971564295873803,0.8663229985691993,0.6052631578947368,0.914238168993286,1.0,8/15,26.68%,JAG1;ROBO1;ROBO2;TNFRSF1A;SLIT3;TGFB1;NOTCH1;SLIT2
prerank,GO_Biological_Process_2021__positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),-0.5232636076706554,-0.8661995640156331,0.6909090909090909,1.0,1.0,2/12,14.20%,RAB11A;CCND1
prerank,GO_Biological_Process_2021__immune response-activating cell surface receptor signaling pathway (GO:0002429),-0.4748734366175878,-0.8661460737806908,0.6,1.0,1.0,5/14,15.16%,FCER1G;C5AR1;SPG21;C5AR2;FPR1
prerank,GO_Biological_Process_2021__positive regulation of nervous system process (GO:0031646),-0.456926584847424,-0.8658526625153103,0.6538461538461539,1.0,1.0,3/15,8.06%,RIMS1;NLGN2;TNFRSF1B
prerank,GO_Biological_Process_2021__neuron projection arborization (GO:0140058),0.5281764544164014,0.8657016513524934,0.6382978723404256,0.9147968782379138,1.0,1/5,3.53%,NLGN1
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway (GO:0097191),0.35885342509683404,0.8656717747331439,0.6538461538461539,0.9143038557262569,1.0,9/52,7.92%,BAG3;CASP9;TNFRSF10A;SMAD3;CIB1;SIVA1;TNF;SORT1;BOK
prerank,GO_Biological_Process_2021__negative regulation of chemokine-mediated signaling pathway (GO:0070100),-0.53641243915276,-0.8655075660707716,0.6271186440677966,1.0,1.0,1/5,4.71%,PADI2
prerank,PanglaoDB_Augmented_2021__Proximal Tubule Cells,0.43906738628216235,0.8650947988062522,0.631578947368421,0.9148691468752238,1.0,6/24,13.34%,HPN;FAH;SLC4A4;FUT9;GCDH;NME4
prerank,GO_Biological_Process_2021__pentose metabolic process (GO:0019321),0.5422851492565142,0.8650912994328256,0.6666666666666666,0.9143183526868582,1.0,1/5,9.49%,FGGY
prerank,GO_Biological_Process_2021__regulation of filopodium assembly (GO:0051489),0.37160363243135897,0.8650465063615527,0.5945945945945946,0.9138847947507039,1.0,5/31,12.17%,NRP1;NLGN1;GPM6A;FNBP1L;ARF6
prerank,GO_Biological_Process_2021__'de novo' posttranslational protein folding (GO:0051084),-0.43515736106631725,-0.864733447608663,0.6231884057971014,1.0,1.0,6/24,19.11%,ERO1A;ENTPD5;HSPA1B;HSPA1A;HSPA2;CCT2
prerank,GO_Biological_Process_2021__negative regulation of biomineralization (GO:0110150),0.5742658977159596,0.8643112176181358,0.7619047619047619,0.9147260135675453,1.0,4/5,37.07%,TGFB1;NOTCH1;ROCK2;ROCK1
prerank,GO_Biological_Process_2021__positive regulation of wound healing (GO:0090303),-0.4463751662090049,-0.864021519807616,0.6666666666666666,1.0,1.0,4/21,7.76%,MYLK;ENPP4;DUOX1;ACTG1
prerank,"GO_Biological_Process_2021__regulation of gene expression, epigenetic (GO:0040029)",-0.3857644364302184,-0.863820328760092,0.6833333333333333,1.0,1.0,9/67,16.76%,TAF1D;ZNF335;GLMN;ACTB;TAF1C;DNMT1;GPX1;CGGBP1;KDM1B
prerank,GO_Biological_Process_2021__protein modification by small protein removal (GO:0070646),-0.34322098007817103,-0.8636340401267385,0.7654320987654321,1.0,1.0,26/210,14.82%,UBC;USP6;RPS27A;COPS6;PSMB3;USP36;ADRM1;PSMB6;PSMA7;TNFAIP3;OTUD1;ABRAXAS1;PSMB9;JOSD1;CFTR;ACTB;HIF1A;WDR48;PSMD12;COPS8;PSMD8;PSMA5;OTUD6B;OTUD3;BRCA1;UBA52
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.39284890712924136,0.8634634748566182,0.7222222222222222,0.9158645817147877,1.0,4/19,11.89%,PARP1;GNL3L;ERCC4;HNRNPC
prerank,GO_Biological_Process_2021__cellular response to insulin stimulus (GO:0032869),0.3252106335366861,0.8632088457830328,0.6111111111111112,0.9158163300640993,1.0,10/90,5.45%,GRB10;FER;IGF1R;PDK4;SLC39A14;GAB1;HDAC9;RAB10;PPARG;PARP1
prerank,GO_Biological_Process_2021__aminoglycan catabolic process (GO:0006026),0.4231844358760604,0.8631188878156077,0.631578947368421,0.9154846707980028,1.0,3/17,5.59%,CTBS;GLB1;HPSE
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation (GO:0006635),0.3799699550258006,0.8627993169713352,0.7441860465116279,0.9155456647445503,1.0,7/36,16.90%,ACADS;ACOX3;ACADVL;GCDH;ECI1;ECHDC1;AUH
prerank,GO_Biological_Process_2021__positive regulation of glycoprotein biosynthetic process (GO:0010560),0.52525330617136,0.8627780101516246,0.6521739130434783,0.9150330746170802,1.0,2/8,8.66%,ABCA2;RAMP1
prerank,GO_Biological_Process_2021__regulation of phosphoprotein phosphatase activity (GO:0043666),-0.44779775303469527,-0.8626717197075054,0.6119402985074627,1.0,1.0,2/27,8.36%,PPP1R15A;CALM1
prerank,GO_Biological_Process_2021__regulation of protein targeting to membrane (GO:0090313),-0.42245430748279905,-0.8626630252100145,0.7346938775510204,1.0,1.0,4/22,10.55%,CEMIP;FIS1;FYN;ITGB2
prerank,GO_Biological_Process_2021__double-strand break repair via classical nonhomologous end joining (GO:0097680),0.5430915176664574,0.8624961056441411,0.6666666666666666,0.9151015213345757,1.0,1/6,7.13%,LIG4
prerank,GO_Biological_Process_2021__regulation of cellular pH (GO:0030641),0.404515574978062,0.8624841050885084,0.525,0.9145753091656776,1.0,7/17,18.72%,SLC9C2;SLC4A4;SLC9A1;CA2;SLC9A9;SLC9A7;CHP1
prerank,GO_Biological_Process_2021__macromolecule catabolic process (GO:0009057),-0.4689763674556098,-0.8623546428319806,0.6666666666666666,1.0,1.0,1/20,1.79%,TPP1
prerank,GO_Biological_Process_2021__positive regulation of monocyte chemotaxis (GO:0090026),-0.5032541644939613,-0.8621613777894541,0.6557377049180327,1.0,1.0,2/10,2.67%,CCL5;AIF1
prerank,GO_Biological_Process_2021__protein deubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0071947),0.5487372242452087,0.8620386277694716,0.6888888888888889,0.9149048254602608,1.0,2/5,9.29%,OTUD7A;ZRANB1
prerank,MSigDB_Hallmark_2020__Protein Secretion,-0.3749126716110022,-0.8617705845534992,0.6716417910447762,1.0,1.0,23/88,24.53%,TPD52;GLA;CD63;NAPA;GOLGA4;SOD1;COPE;IGF2R;SCAMP3;AP2S1;ATP1A1;YIPF6;STX12;GALC;ICA1;SSPN;RAB9A;M6PR;ERGIC3;TOM1L1;AP2M1;CLTA;PAM
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase III (GO:0006359),-0.44981369137459865,-0.861694157459166,0.7014925373134329,1.0,1.0,8/19,32.78%,ZNF76;POLR3C;DHX36;POLR3F;MAF1;ZNF345;PRDX5;ZC3H8
prerank,GO_Biological_Process_2021__cellular response to nitrogen levels (GO:0043562),-0.542007829658031,-0.861507624590812,0.6792452830188679,1.0,1.0,2/8,9.32%,GABARAPL1;GABARAPL2
prerank,GO_Biological_Process_2021__cellular response to nitrogen starvation (GO:0006995),-0.542007829658031,-0.861507624590812,0.6792452830188679,1.0,1.0,2/8,9.32%,GABARAPL1;GABARAPL2
prerank,GO_Biological_Process_2021__negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067),-0.49471108802003905,-0.8613730530290561,0.5862068965517241,1.0,1.0,2/8,11.92%,NLRC3;NOP53
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.4628162099105386,0.8596686838649799,0.6666666666666666,0.9187536881961818,1.0,2/12,6.68%,LRRK2;TXNDC12
prerank,GO_Biological_Process_2021__negative regulation of mast cell activation (GO:0033004),0.5008306778574908,0.8593223560809392,0.6521739130434783,0.9188269852818637,1.0,1/6,1.04%,FER
prerank,GO_Biological_Process_2021__protein processing (GO:0016485),-0.4005081624788764,-0.8593159464099034,0.6911764705882353,1.0,1.0,19/57,25.42%,SRGN;PITRM1;SPG7;XPNPEP3;TMEM208;PCSK2;PIDD1;PCSK5;STOML2;CASP4;APH1B;C1RL;LONP2;CASP2;SEC11A;AFG3L2;SPCS2;PCSK7;OGT
prerank,GO_Biological_Process_2021__regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),-0.4901999707608374,-0.8592093219248182,0.7,1.0,1.0,5/11,22.78%,DNMT1;TET1;RESF1;SETDB1;MORC2
prerank,GO_Biological_Process_2021__cellular response to corticosteroid stimulus (GO:0071384),0.5176405394938085,0.8588601172509682,0.6666666666666666,0.919175072050924,1.0,1/9,0.34%,ANXA1
prerank,GO_Biological_Process_2021__negative regulation of amyloid fibril formation (GO:1905907),0.4847469807183532,0.8583390666070472,0.6176470588235294,0.9195444310741553,1.0,2/10,4.68%,LDLR;PFDN4
prerank,GO_Biological_Process_2021__protein localization to plasma membrane (GO:0072659),-0.3786345979905716,-0.8580116806432061,0.704225352112676,1.0,1.0,9/101,7.98%,FLNA;TMEM150A;TSPAN32;RAB11A;JUP;RAB3A;FGF13;RAB3D;EPB41L3
prerank,GO_Biological_Process_2021__amino acid import (GO:0043090),-0.4933921434904991,-0.8576414593044358,0.68,1.0,1.0,1/12,1.42%,SLC7A5
prerank,PanglaoDB_Augmented_2021__Vascular Smooth Muscle Cells,-0.4242993802449882,-0.8575374473308497,0.631578947368421,1.0,1.0,2/37,0.65%,MYLK;COL5A1
prerank,GO_Biological_Process_2021__positive regulation of protein autophosphorylation (GO:0031954),0.40246073898217705,0.8573571491124581,0.5675675675675675,0.9207947968908191,1.0,3/17,6.42%,PDGFA;NEK10;PDGFC
prerank,GO_Biological_Process_2021__lipid homeostasis (GO:0055088),0.37134497752819406,0.857158398296055,0.6923076923076923,0.9205634338173577,1.0,7/33,10.80%,ABCA2;SIRT1;RCN3;PPARG;ABHD8;ACOX3;FBXW7
prerank,GO_Biological_Process_2021__response to alcohol (GO:0097305),-0.4741542229719159,-0.856973988221156,0.6507936507936508,1.0,1.0,2/18,1.03%,CCL3;TGFBR3
prerank,GO_Biological_Process_2021__eye development (GO:0001654),-0.44562760581487454,-0.8567259232373614,0.7384615384615385,1.0,1.0,1/26,0.65%,COL5A1
prerank,GO_Biological_Process_2021__neurotransmitter uptake (GO:0001504),-0.57982278529066,-0.85650920012496,0.7115384615384616,1.0,1.0,2/6,5.41%,SLC38A1;GLUL
prerank,GO_Biological_Process_2021__regulation of glucose import (GO:0046324),-0.4161893586427245,-0.8560812419570457,0.6470588235294118,1.0,1.0,5/24,14.20%,PID1;IGF1;SELENOS;APPL1;PEA15
prerank,GO_Biological_Process_2021__positive regulation of exocytosis (GO:0045921),-0.421149914003738,-0.856067926094408,0.7413793103448276,1.0,1.0,4/30,10.61%,RAB3A;RAB3D;SNF8;CFTR
prerank,GO_Biological_Process_2021__steroid catabolic process (GO:0006706),-0.5295551079500487,-0.8560647461137696,0.6440677966101694,1.0,1.0,1/6,19.59%,CYP19A1
prerank,GO_Biological_Process_2021__response to lipopolysaccharide (GO:0032496),0.3245254408626895,0.8557931792392092,0.7857142857142857,0.9226632335456798,1.0,11/84,10.79%,CD180;FER;SERPINE1;SIRPA;WNT5A;GIT1;IRAK1;TAB2;LGALS9;GCH1;IRAK3
prerank,GO_Biological_Process_2021__epithelial cell migration (GO:0010631),-0.4411528447253449,-0.8553991104881038,0.7090909090909091,1.0,1.0,3/22,9.56%,PLEKHG5;KANK2;STAT1
prerank,GO_Biological_Process_2021__nucleic acid metabolic process (GO:0090304),0.34992572448391646,0.8553338989853446,0.8,0.9229935747429956,1.0,11/57,20.03%,POLR2D;WDR74;MMS19;HNRNPC;LSM1;ENPP1;POLR2H;RBFOX2;HNRNPU;HNRNPD;WTAP
prerank,GO_Biological_Process_2021__positive regulation of receptor internalization (GO:0002092),-0.4883295205246201,-0.8553265272520962,0.6792452830188679,1.0,1.0,3/12,14.27%,CD63;VEGFA;PICK1
prerank,GO_Biological_Process_2021__mucosal immune response (GO:0002385),0.5788987338546168,0.8551602304145148,0.7619047619047619,0.9228189782426099,1.0,1/5,0.25%,IFNLR1
prerank,GO_Biological_Process_2021__negative regulation of protein ubiquitination (GO:0031397),-0.39240900179514865,-0.8548375691338237,0.7014925373134329,1.0,1.0,9/40,14.43%,UBXN1;PER2;RPS3;DTX3L;TNFAIP3;U2AF2;VPS28;HSPA1B;HSPA1A
prerank,GO_Biological_Process_2021__positive regulation of brown fat cell differentiation (GO:0090336),0.5060176344410323,0.8547807369622165,0.6190476190476191,0.9229255255754024,1.0,2/7,5.93%,PIM1;NAPEPLD
prerank,GO_Biological_Process_2021__mRNA transcription (GO:0009299),0.481520199681786,0.8545095562585909,0.6388888888888888,0.9228519660382256,1.0,1/10,1.16%,ZBTB1
prerank,GO_Biological_Process_2021__negative regulation of interferon-beta production (GO:0032688),-0.5344146398587043,-0.8543781316273089,0.7192982456140351,1.0,1.0,1/8,2.57%,NLRC3
prerank,GO_Biological_Process_2021__mitochondrion-endoplasmic reticulum membrane tethering (GO:1990456),-0.5612713426796991,-0.8543533987800711,0.6538461538461539,1.0,1.0,1/6,8.36%,CALM1
prerank,GO_Biological_Process_2021__protein hydroxylation (GO:0018126),-0.49374271839747513,-0.8543203035095542,0.7037037037037037,1.0,1.0,2/10,16.10%,EGLN3;VIPAS39
prerank,GO_Biological_Process_2021__histone H3 deacetylation (GO:0070932),0.4776780890060489,0.8538833646274748,0.6341463414634146,0.923555546306732,1.0,4/14,9.84%,SIRT1;HDAC9;SIRT6;HDAC1
prerank,GO_Biological_Process_2021__nucleoside phosphate catabolic process (GO:1901292),-0.5436380500825444,-0.8538220873748563,0.7017543859649122,1.0,1.0,3/8,11.98%,ENPP3;ENTPD4;ENTPD5
prerank,GO_Biological_Process_2021__negative regulation of actin nucleation (GO:0051126),-0.5645239672028228,-0.8537880041356009,0.7090909090909091,1.0,1.0,2/6,14.27%,CORO1B;PICK1
prerank,GO_Biological_Process_2021__regulation of intracellular pH (GO:0051453),0.39770428618621534,0.853542506853199,0.6052631578947368,0.9235967505232021,1.0,10/23,18.72%,SLC9C2;LRRK2;SLC4A4;SLC9A1;CA2;SLC9A9;SLC26A3;SLC9A7;TMEM165;CHP1
prerank,GO_Biological_Process_2021__protein autophosphorylation (GO:0046777),-0.34668885630570473,-0.8532895381788634,0.7380952380952381,1.0,1.0,9/125,8.41%,ITK;EPHB1;TXK;MAK;MUSK;EIF2AK2;STK39;MAP3K12;PRKD2
prerank,GO_Biological_Process_2021__regulation of striated muscle contraction (GO:0006942),-0.48099304120180275,-0.8531218281529386,0.6507936507936508,1.0,1.0,3/14,8.36%,SRI;MYBPC3;CALM1
prerank,GO_Biological_Process_2021__positive regulation of neuron projection arborization (GO:0150012),0.5395099234252947,0.8530348251385889,0.6486486486486487,0.9239541069736564,1.0,3/7,14.98%,WNT5A;DVL3;MAP3K13
prerank,GO_Biological_Process_2021__positive regulation of stem cell proliferation (GO:2000648),0.4860963755676746,0.8529791455079707,0.7368421052631579,0.9234994591424288,1.0,3/9,19.56%,LTBP3;FERMT2;HNRNPU
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),-0.43802537109198386,-0.8528844406704991,0.625,1.0,1.0,5/20,16.16%,RNF126;SNF8;VPS28;VPS37B;MVB12A
prerank,GO_Biological_Process_2021__dephosphorylation of RNA polymerase II C-terminal domain (GO:0070940),-0.5706025456856395,-0.8528816730105155,0.7258064516129032,1.0,1.0,1/5,4.48%,CTDP1
prerank,GO_Biological_Process_2021__myelination (GO:0042552),0.35767007849231364,0.8527431581234323,0.7666666666666667,0.9234042438049226,1.0,8/31,15.71%,LGI4;MYRF;TPPP;SCN8A;NF1;NFASC;CNTNAP1;PARD3
prerank,GO_Biological_Process_2021__very long-chain fatty acid metabolic process (GO:0000038),0.4289856767418523,0.8525245281233459,0.6,0.9231943634009921,1.0,2/16,8.59%,HACD2;ELOVL6
prerank,GO_Biological_Process_2021__negative regulation of DNA biosynthetic process (GO:2000279),0.4029788771066313,0.8524081447852909,0.8125,0.922913037820365,1.0,4/19,11.89%,DACH1;GNL3L;ERCC4;HNRNPC
prerank,GO_Biological_Process_2021__negative regulation of phosphoprotein phosphatase activity (GO:0032515),-0.4672613573719517,-0.8522785470438993,0.6811594202898551,1.0,1.0,1/17,1.16%,PPP1R15A
prerank,GO_Biological_Process_2021__regulation of histone exchange (GO:1900049),-0.5501247166415275,-0.8520633078777436,0.7,1.0,1.0,1/7,12.59%,TERF2IP
prerank,GO_Biological_Process_2021__positive regulation of histone exchange (GO:1900051),-0.5501247166415275,-0.8520633078777436,0.7,1.0,1.0,1/7,12.59%,TERF2IP
prerank,GO_Biological_Process_2021__receptor signaling pathway via JAK-STAT (GO:0007259),-0.4578881813793158,-0.8517496139039588,0.6290322580645161,1.0,1.0,1/20,0.41%,STAT4
prerank,GO_Biological_Process_2021__negative regulation of peptidase activity (GO:0010466),-0.424989954265591,-0.8513443682562452,0.6271186440677966,1.0,1.0,8/25,19.40%,GAPDH;UBXN1;SPOCK2;SERPING1;TIMP2;AGT;SERPINF1;SPOCK1
prerank,GO_Biological_Process_2021__positive regulation of receptor catabolic process (GO:2000646),0.5438604541878592,0.8512948241433985,0.6122448979591837,0.9243015200078829,1.0,2/6,10.29%,ABCA2;LAPTM5
prerank,GO_Biological_Process_2021__cholesterol biosynthetic process (GO:0006695),-0.44348312718577626,-0.8512333696878954,0.7377049180327869,1.0,1.0,1/20,0.72%,INSIG1
prerank,GO_Biological_Process_2021__calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.4881934980448303,-0.8507671692869386,0.6949152542372882,1.0,1.0,4/11,24.26%,FIS1;PTPRC;TRPM2;BCAP31
prerank,GO_Biological_Process_2021__protein transport (GO:0015031),-0.3370228740376814,-0.8506024433973919,0.8,1.0,1.0,37/272,16.10%,CD36;USP6;TFRC;ARL5C;SNX6;BBS2;ARL4C;CLU;ATP6V1F;IL10RA;RAB3A;VPS35;EIF2D;NAPA;ARL17A;RAB3D;GOLGA4;NPM1;ADPRH;TRIM23;IFT27;STX19;TBC1D8;DENND10;AP4M1;VLDLR;PICK1;TMEM167A;STX10;TBC1D2B;SNX9;SCAMP3;VPS26A;CD74;SLU7;SEC13;VIPAS39
prerank,"GO_Biological_Process_2021__transcription, DNA-templated (GO:0006351)",-0.3424282497878438,-0.8504377167044344,0.7654320987654321,1.0,1.0,10/168,7.21%,CEBPD;GTF3C6;BTF3;TCEA2;GTF2H5;CTDP1;ELOB;PTMA;POLR2G;RNMT
prerank,GO_Biological_Process_2021__B cell homeostasis (GO:0001782),-0.5096408050410611,-0.8504297214511448,0.6862745098039216,1.0,1.0,5/9,23.82%,TNFAIP3;NCKAP1L;LYN;CAMLG;PPP2R3C
prerank,GO_Biological_Process_2021__cellular response to glucocorticoid stimulus (GO:0071385),0.48857675875446394,0.8501596191600042,0.76,0.9260034391902683,1.0,1/11,0.34%,ANXA1
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-mediated signaling (GO:0106058),0.48753988003680704,0.8500875437356725,0.6470588235294118,0.9251169395139196,1.0,3/8,8.90%,CIB1;TNF;SLC9A1
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.48753988003680704,0.8500875437356725,0.6470588235294118,0.9251169395139196,1.0,3/8,8.90%,CIB1;TNF;SLC9A1
prerank,GO_Biological_Process_2021__regulation of inflammatory response (GO:0050727),-0.3693751562360777,-0.8499403374168061,0.7261904761904762,1.0,1.0,16/113,9.83%,CCL3;CCL5;MGLL;SNX6;NLRC3;CD200R1;RORA;ETS1;VPS35;NLRP12;TNFRSF1B;TNFAIP3;ENPP3;TMSB4X;METRNL;SELENOS
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity (GO:1990264),-0.5460922270234123,-0.8496088446266322,0.6885245901639344,1.0,1.0,1/6,10.98%,PTPRB
prerank,GO_Biological_Process_2021__negative regulation of protein kinase B signaling (GO:0051898),0.4041702810071399,0.8495017687661509,0.675,0.925607315955536,1.0,6/25,6.06%,SIRT1;TSC2;DAG1;PHLPP1;DDIT3;CIB1
prerank,GO_Biological_Process_2021__protein localization to lysosome (GO:0061462),0.40777328545570063,0.8493435550299508,0.7209302325581395,0.9253398506308256,1.0,8/24,18.25%,SCARB2;RAB7A;LAPTM5;NCOA4;SORL1;RTN4;ATP13A2;NEDD4
prerank,GO_Biological_Process_2021__protein localization to cell-cell junction (GO:0150105),-0.5092429261365514,-0.8491331698712361,0.6730769230769231,1.0,1.0,4/11,10.71%,MPP7;CGNL1;ACTG1;ACTB
prerank,GO_Biological_Process_2021__production of small RNA involved in gene silencing by RNA (GO:0070918),0.44006175264607084,0.8490753320460322,0.6666666666666666,0.9253868510215312,1.0,8/15,30.25%,DROSHA;AGO1;MRPL44;HENMT1;SNIP1;ZC3H7A;PUM1;TSN
prerank,GO_Biological_Process_2021__lymphocyte differentiation (GO:0030098),0.3689562727326978,0.8490040259865665,0.75,0.9249628482390927,1.0,6/44,9.31%,LEPR;KLF6;HDAC9;PBX1;SOX4;IKZF1
prerank,GO_Biological_Process_2021__vesicle cytoskeletal trafficking (GO:0099518),-0.4250267821158533,-0.8486448198096667,0.6825396825396826,1.0,1.0,1/28,0.94%,MYO1G
prerank,GO_Biological_Process_2021__negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.5229981055587486,0.8485785836697857,0.7111111111111111,0.9246152421247386,1.0,1/6,1.00%,PKD2
prerank,GO_Biological_Process_2021__negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.5229981055587486,0.8485785836697857,0.7111111111111111,0.9246152421247386,1.0,1/6,1.00%,PKD2
prerank,GO_Biological_Process_2021__lytic vacuole organization (GO:0080171),-0.4418481784785363,-0.8474123237173559,0.6721311475409836,1.0,1.0,4/24,17.49%,TPP1;HPS4;ZKSCAN3;HOOK2
prerank,GO_Biological_Process_2021__cellular response to radiation (GO:0071478),0.3949444067372102,0.8472400669831907,0.5882352941176471,0.9263578274660746,1.0,7/23,19.46%,SIRT1;LIG4;CLOCK;INTS7;BLM;OPN3;EEF1D
prerank,GO_Biological_Process_2021__regulation of defense response to virus by host (GO:0050691),0.38585180369263467,0.8471517660091679,0.6511627906976745,0.9259840824729717,1.0,2/24,4.27%,IFNLR1;TOMM70
prerank,GO_Biological_Process_2021__natural killer cell differentiation (GO:0001779),0.47778501755922087,0.846885371428504,0.6511627906976745,0.9258953610679901,1.0,1/8,4.87%,PBX1
prerank,GO_Biological_Process_2021__protein targeting to membrane (GO:0006612),-0.371673245474081,-0.8468311395894109,0.684931506849315,1.0,1.0,9/60,13.39%,SRP14;AQP11;FIS1;NACA;ACBD5;ZDHHC4;ZDHHC19;VPS37B;SEC62
prerank,GO_Biological_Process_2021__connective tissue development (GO:0061448),-0.4330687982419811,-0.8464298017791554,0.6461538461538462,1.0,1.0,5/20,9.28%,DDRGK1;SULF2;NAMPT;CD44;CHI3L1
prerank,GO_Biological_Process_2021__snRNA transcription (GO:0009301),0.3273665936259255,0.8463109364114717,0.7692307692307693,0.9265462288297731,1.0,4/62,6.76%,POLR2D;INTS6;POU2F1;CDK7
prerank,GO_Biological_Process_2021__cellular response to virus (GO:0098586),-0.4471102362440753,-0.8462786913105976,0.6666666666666666,1.0,1.0,4/22,11.34%,CCL5;OAS1;EIF5A;HIF1A
prerank,GO_Biological_Process_2021__synaptic vesicle cycle (GO:0099504),-0.48346985711471413,-0.8457655596778852,0.6825396825396826,1.0,1.0,2/16,6.19%,RIMS1;RAB3A
prerank,GO_Biological_Process_2021__sodium ion export across plasma membrane (GO:0036376),0.46251658540099466,0.8454783300566804,0.631578947368421,0.9275729644231271,1.0,2/7,8.90%,SLC4A4;SLC9A1
prerank,GO_Biological_Process_2021__reticulophagy (GO:0061709),-0.45956578478236526,-0.8451138135125112,0.7192982456140351,1.0,1.0,3/13,11.42%,DDRGK1;ATG2A;STING1
prerank,GO_Biological_Process_2021__positive regulation of catalytic activity (GO:0043085),-0.4019077224780187,-0.8450724635571705,0.6619718309859155,1.0,1.0,12/28,26.23%,CHTOP;AZIN2;SOD1;NOD2;MT3;WRN;MSH6;MAPK3;STX4;YWHAB;SSBP1;MSH3
prerank,GO_Biological_Process_2021__endothelial cell development (GO:0001885),-0.43545760128488276,-0.8449491977924025,0.6440677966101694,1.0,1.0,3/17,8.97%,COL18A1;PECAM1;GSTM3
prerank,GO_Biological_Process_2021__cellular potassium ion homeostasis (GO:0030007),0.4828201903246004,0.8447587251418491,0.6862745098039216,0.9284919642583811,1.0,1/8,2.68%,KCNJ2
prerank,GO_Biological_Process_2021__alpha-beta T cell activation (GO:0046631),0.49043771597629116,0.8446748141194695,0.6923076923076923,0.9281251616185011,1.0,1/6,0.34%,ANXA1
prerank,GO_Biological_Process_2021__filopodium assembly (GO:0046847),0.4818587906780648,0.8446117120828236,0.6458333333333334,0.927723319888495,1.0,3/9,14.68%,FGD4;DNM3;SRGAP2
prerank,GO_Biological_Process_2021__positive regulation of excitatory postsynaptic potential (GO:2000463),-0.45647640572104753,-0.8444080439269541,0.6984126984126984,1.0,1.0,2/14,7.64%,RIMS1;NLGN2
prerank,GO_Biological_Process_2021__regulation of cell development (GO:0060284),-0.4455195262377527,-0.844223018163376,0.6811594202898551,1.0,1.0,4/21,13.87%,PER2;BHLHE40;PRUNE1;NOTCH2
prerank,GO_Biological_Process_2021__establishment of protein localization to extracellular region (GO:0035592),0.39260086017533574,0.843548037881296,0.7105263157894737,0.9291439803567687,1.0,4/30,7.65%,RCN3;RAB10;SEL1L;COPG1
prerank,GO_Biological_Process_2021__positive regulation of TORC1 signaling (GO:1904263),0.4269579651149456,0.843528769651934,0.6153846153846154,0.928621559770998,1.0,2/15,5.75%,RRAGD;GPR137C
prerank,GO_Biological_Process_2021__muscle organ development (GO:0007517),-0.4298735877082998,-0.8433663321421804,0.7575757575757576,1.0,1.0,4/26,8.85%,EMD;IGF1;SRI;SGCE
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase II (GO:0042795),0.3281745750259218,0.8433434315871751,0.8148148148148148,0.9284467351477957,1.0,4/61,6.76%,POLR2D;INTS6;POU2F1;CDK7
prerank,GO_Biological_Process_2021__ceramide transport (GO:0035627),-0.49913843337277874,-0.8431398936639691,0.7321428571428571,1.0,1.0,3/10,10.11%,PLTP;ABCB1;ABCB4
prerank,GO_Biological_Process_2021__modulation by host of viral genome replication (GO:0044827),-0.5158502046930421,-0.8430963517757862,0.71875,1.0,1.0,6/10,34.05%,TBC1D20;NUCKS1;YTHDC2;CCNK;PPIB;FBXL2
prerank,GO_Biological_Process_2021__negative regulation of developmental growth (GO:0048640),-0.43609423327794117,-0.8429893746540501,0.7166666666666667,1.0,1.0,3/22,6.76%,NKD1;BBS2;FGF13
prerank,GO_Biological_Process_2021__positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),-0.593599523049877,-0.8429242278370896,0.7777777777777778,1.0,1.0,4/5,34.84%,IL18;CARD9;IL1B;RASGRP1
prerank,GO_Biological_Process_2021__induction of positive chemotaxis (GO:0050930),-0.5588087088567426,-0.8428437286053027,0.7,1.0,1.0,1/5,11.19%,VEGFA
prerank,GO_Biological_Process_2021__positive regulation of adenylate cyclase activity (GO:0045762),0.5361857707577482,0.8425905442233849,0.717391304347826,0.9293266156949958,1.0,2/5,23.24%,NF1;ORAI1
prerank,MSigDB_Hallmark_2020__Wnt-beta Catenin Signaling,-0.424883241249803,-0.8421333611321021,0.6833333333333333,1.0,1.0,2/26,8.45%,NKD1;RBPJ
prerank,GO_Biological_Process_2021__central nervous system neuron axonogenesis (GO:0021955),-0.5061424664471122,-0.8419609099378598,0.7230769230769231,1.0,1.0,1/11,3.87%,EPHB1
prerank,GO_Biological_Process_2021__telomere maintenance via telomere lengthening (GO:0010833),-0.43277681901883364,-0.841934976759849,0.7213114754098361,1.0,1.0,6/22,21.40%,TERF2IP;NHP2;NOP10;ANKRD28;RFC1;CTC1
prerank,GO_Biological_Process_2021__early endosome to Golgi transport (GO:0034498),0.45768980176955193,0.8418387590452313,0.696969696969697,0.9302832719253613,1.0,3/11,19.96%,RBSN;RAB6A;SNX1
prerank,GO_Biological_Process_2021__regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903995),-0.5553618513665819,-0.8405745329879188,0.7666666666666667,1.0,1.0,1/5,7.36%,FYN
prerank,GO_Biological_Process_2021__regulation of apoptotic signaling pathway (GO:2001233),0.41102268683408066,0.8405653025793788,0.7297297297297297,0.9320800131481982,1.0,9/29,19.22%,DAPK2;QARS1;TNF;DEPTOR;SGMS1;TGFBR1;CX3CL1;TPD52L1;CSNK2A1
prerank,GO_Biological_Process_2021__regulation of protein localization to centrosome (GO:1904779),-0.5076576975818177,-0.8405018836394863,0.6206896551724138,1.0,1.0,4/8,27.78%,CEP72;CEP250;UBXN2B;MARK4
prerank,GO_Biological_Process_2021__regulation of mononuclear cell migration (GO:0071675),-0.4721027838590346,-0.8403763276327751,0.7241379310344828,1.0,1.0,2/14,2.67%,CCL5;AIF1
prerank,GO_Biological_Process_2021__T cell differentiation in thymus (GO:0033077),0.4848483530745705,0.8403745827375346,0.6792452830188679,0.9318965139501364,1.0,1/7,7.13%,LIG4
prerank,GO_Biological_Process_2021__negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.4319971889631333,0.8399455215061636,0.6578947368421053,0.9320803841121279,1.0,2/17,10.29%,CD22;LAPTM5
prerank,GO_Biological_Process_2021__negative regulation of monooxygenase activity (GO:0032769),-0.535989919889147,-0.8398570101627524,0.6909090909090909,1.0,1.0,1/6,5.40%,GLA
prerank,GO_Biological_Process_2021__positive regulation of stress-activated MAPK cascade (GO:0032874),0.3361625093832629,0.8392839436053129,0.78125,0.9328003389524233,1.0,17/66,20.52%,MAP3K11;ANKRD6;EDA2R;STK25;MAP3K10;SASH1;KLHDC10;MFHAS1;SH3RF1;TRAF6;MAP3K5;ZNF622;TPD52L1;TAOK2;MTURN;MAP4K2;AGER
prerank,GO_Biological_Process_2021__protein localization to cell periphery (GO:1990778),-0.3746603220921992,-0.8389034349898924,0.704225352112676,1.0,1.0,9/103,7.98%,FLNA;TMEM150A;TSPAN32;RAB11A;JUP;RAB3A;FGF13;RAB3D;EPB41L3
prerank,GO_Biological_Process_2021__negative regulation of cell population proliferation (GO:0008285),-0.33590713510372494,-0.8385659385447808,0.7906976744186046,1.0,1.0,32/203,12.64%,COL18A1;FTH1;TGFBR3;RUNX3;WARS1;H2AC6;IFIT3;NLRC3;AIF1;BTG2;ATF5;B2M;PER2;APOD;EMD;ETS1;AQP11;ING5;MED25;GSTP1;EIF2AK2;TNFAIP3;KANK2;PDCD5;GLMN;IRF1;NPM1;BTG1;ING4;COPS8;HSPA1B;SST
prerank,GO_Biological_Process_2021__positive regulation of T cell activation (GO:0050870),-0.3982606298325807,-0.8384876472864001,0.7536231884057971,1.0,1.0,4/44,2.67%,TFRC;CCL5;PRKCQ;AIF1
prerank,GO_Biological_Process_2021__cyclic nucleotide transport (GO:0070729),0.5496589745838775,0.8384183304122332,0.7111111111111111,0.9337521862110887,1.0,3/5,35.29%,LRRC8D;ABCC5;ABCC4
prerank,GO_Biological_Process_2021__cellular response to ionizing radiation (GO:0071479),0.361228113180528,0.8377338446363283,0.7419354838709677,0.9345055715638083,1.0,9/36,20.87%,SIRT1;LIG4;CLOCK;MDM2;INTS7;NIPBL;BLM;EEF1D;TMEM109
prerank,GO_Biological_Process_2021__ear morphogenesis (GO:0042471),0.4950432673273254,0.8374605300270187,0.6666666666666666,0.9344902570846367,1.0,3/6,21.78%,NIPBL;FGFR2;CHD7
prerank,GO_Biological_Process_2021__ERAD pathway (GO:0036503),0.3271395692028707,0.8373925543877079,0.7777777777777778,0.9341088723582928,1.0,13/76,13.82%,UBE2J1;RNF139;RCN3;DNAJB2;SEL1L;UBXN6;DNAJC18;AUP1;FAM8A1;RNF185;STT3B;BAG6;FBXO27
prerank,GO_Biological_Process_2021__regulation of exit from mitosis (GO:0007096),-0.40601764537395985,-0.8372013718094646,0.7083333333333334,1.0,1.0,3/26,6.40%,UBC;RPS27A;PHB2
prerank,GO_Biological_Process_2021__regulation of developmental growth (GO:0048638),-0.4314002668591129,-0.8370180922434549,0.6909090909090909,1.0,1.0,3/23,13.37%,IGF1;MUSK;SOD1
prerank,GO_Biological_Process_2021__negative regulation of chemotaxis (GO:0050922),-0.4224248500597303,-0.836854432455259,0.6268656716417911,1.0,1.0,3/21,6.72%,AIF1;SEMA6A;CORO1B
prerank,GO_Biological_Process_2021__positive regulation of erythrocyte differentiation (GO:0045648),-0.42825440148353117,-0.836382621609144,0.7580645161290323,1.0,1.0,8/23,14.43%,ETS1;ANKRD54;STAT1;NCKAP1L;HIF1A;HSPA1B;ZNF16;HSPA1A
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue morphogenesis (GO:0055010),-0.47714186123020785,-0.8354319396967209,0.6875,1.0,1.0,3/19,8.45%,TGFBR3;MYBPC3;RBPJ
prerank,GO_Biological_Process_2021__negative regulation of immune effector process (GO:0002698),-0.4883806446635234,-0.8352858964865075,0.7704918032786885,1.0,1.0,5/13,13.66%,CD55;ENPP3;APPL1;CD47;HAVCR2
prerank,GO_Biological_Process_2021__positive regulation of immune system process (GO:0002684),0.43127421298200735,0.8351375401009069,0.6511627906976745,0.9379073529578343,1.0,1/12,0.34%,ANXA1
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 2 signaling pathway (GO:0034135),-0.508776485222714,-0.8348309293346623,0.746031746031746,1.0,1.0,2/8,12.67%,TNFAIP3;CYBA
prerank,GO_Biological_Process_2021__positive regulation of phosphate metabolic process (GO:0045937),-0.44508883821178113,-0.8348110862478187,0.6515151515151515,1.0,1.0,4/18,10.76%,CCL5;ITGA6;GLMN;NCKAP1L
prerank,GO_Biological_Process_2021__epithelium development (GO:0060429),-0.3825990785175213,-0.8341713008685337,0.6818181818181818,1.0,1.0,9/44,11.19%,TPP1;STIL;MTHFD1;CTSB;GSTK1;KANK2;DVL1;STAT1;VEGFA
prerank,GO_Biological_Process_2021__regulation of lymphocyte proliferation (GO:0050670),-0.49773423210584683,-0.834048420210501,0.7090909090909091,1.0,1.0,3/7,8.06%,IKZF3;ZNF335;TNFRSF1B
prerank,GO_Biological_Process_2021__nucleic acid-templated transcription (GO:0097659),0.3965697987690161,0.8340357874253458,0.7647058823529411,0.9393386771810873,1.0,2/27,7.93%,POLR2D;MMS19
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.49094442380176223,0.8340079871694017,0.7058823529411765,0.9388216125197516,1.0,1/9,5.85%,DDIT3
prerank,GO_Biological_Process_2021__cellular response to retinoic acid (GO:0071300),0.3945512979800092,0.833613843262509,0.7272727272727273,0.938951339181162,1.0,2/19,8.25%,WNT5A;BRINP3
prerank,GO_Biological_Process_2021__regulation of autophagosome assembly (GO:2000785),0.36969002652364225,0.8334585568051844,0.8,0.9386948292589824,1.0,4/32,8.16%,LRRK2;TMEM39A;RAB1B;TBC1D12
prerank,GO_Biological_Process_2021__protein K63-linked deubiquitination (GO:0070536),0.38562869349388806,0.8334112532618518,0.7714285714285715,0.9382421774827744,1.0,3/24,9.29%,STAMBPL1;OTUD7A;ZRANB1
prerank,GO_Biological_Process_2021__positive regulation of protein transport (GO:0051222),0.3518557967679972,0.8333512174679545,0.7692307692307693,0.9377970615316834,1.0,9/53,12.17%,MYOM1;GOLPH3L;TMED10;UNC13B;TNF;CD33;CEP131;RIPOR1;ARF6
prerank,GO_Biological_Process_2021__regulation of peptidyl-threonine phosphorylation (GO:0010799),0.3880794685299111,0.8333240117827205,0.625,0.9373174229531489,1.0,5/27,7.11%,SPRY2;SMAD7;SPRED1;SPRED2;CAB39
prerank,GO_Biological_Process_2021__regulation of supramolecular fiber organization (GO:1902903),0.3916663807324111,0.8329077369444194,0.6666666666666666,0.9374476444417771,1.0,1/18,1.80%,MAP1S
prerank,GO_Biological_Process_2021__purine nucleobase metabolic process (GO:0006144),-0.5027771068517363,-0.8326716845134713,0.703125,1.0,1.0,1/7,15.99%,SHMT1
prerank,GO_Biological_Process_2021__positive regulation of heart contraction (GO:0045823),-0.49959461835196906,-0.8326555492191896,0.7,1.0,1.0,2/10,10.69%,RGS2;TRPM4
prerank,GO_Biological_Process_2021__mitotic cytokinesis (GO:0000281),-0.40198730064213484,-0.8325558499327943,0.7361111111111112,1.0,1.0,8/34,21.61%,EFHC1;TTC19;CNTROB;STMN1;SNX9;MITD1;CKAP2;MYH10
prerank,GO_Biological_Process_2021__protein deubiquitination (GO:0016579),-0.33080509595411717,-0.8325274832775735,0.775,1.0,1.0,25/200,14.82%,UBC;USP6;RPS27A;PSMB3;USP36;ADRM1;PSMB6;PSMA7;TNFAIP3;OTUD1;ABRAXAS1;PSMB9;JOSD1;CFTR;ACTB;HIF1A;WDR48;PSMD12;PSMD8;PSMA5;OTUD6B;MINDY1;OTUD3;BRCA1;UBA52
prerank,GO_Biological_Process_2021__regulation of synapse structural plasticity (GO:0051823),0.573004294597483,0.8323328448184006,0.7441860465116279,0.9380116819277273,1.0,2/5,8.67%,CTNNA2;SHANK3
prerank,GO_Biological_Process_2021__positive regulation of NIK/NF-kappaB signaling (GO:1901224),-0.3965078535801433,-0.8320720251888792,0.7692307692307693,1.0,1.0,8/38,15.37%,CD14;RPS3;PHB2;EIF2AK2;NLRP12;TERF2IP;NOD2;IFI35
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.4188485168910602,0.8312625505999935,0.6904761904761905,0.9392186460665487,1.0,3/15,13.66%,SIRT1;SOD2;BAG5
prerank,GO_Biological_Process_2021__cellular response to molecule of bacterial origin (GO:0071219),-0.36560462638438035,-0.8311162522320523,0.75,1.0,1.0,7/60,9.83%,ZFP36;CARD16;CD14;GSTP1;TNFRSF1B;TNFAIP3;SELENOS
prerank,GO_Biological_Process_2021__response to molecule of bacterial origin (GO:0002237),0.3596026790129825,0.8304407496769893,0.7352941176470589,0.9402144751470414,1.0,11/38,20.08%,FER;IRAK1;TAB2;LGALS9;GCH1;IRAK3;MAPKAPK2;IRF5;ERBIN;SNCA;PELI1
prerank,GO_Biological_Process_2021__negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.37373403849321407,0.830059682419577,0.7142857142857143,0.9403147749946725,1.0,3/49,5.85%,KLF4;SIRT1;DDIT3
prerank,GO_Biological_Process_2021__regulation of mRNA metabolic process (GO:1903311),-0.5050848316162622,-0.8297368155792295,0.7321428571428571,1.0,1.0,3/11,21.90%,SRPK1;SUPT6H;CDK11B
prerank,PanglaoDB_Augmented_2021__Myocytes,-0.3708132595853906,-0.8297222010522375,0.7297297297297297,1.0,1.0,4/42,7.37%,CXCR4;PRKCQ;IQSEC1;TTN
prerank,GO_Biological_Process_2021__amino acid transport (GO:0006865),0.39913233182625,0.8294267915042626,0.7333333333333333,0.9408549079363486,1.0,4/27,4.23%,PDPN;SLC38A10;SLC7A8;SLC3A2
prerank,GO_Biological_Process_2021__exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.398131644557107,0.8293174930558065,0.6764705882352942,0.9405010692536605,1.0,6/24,17.25%,DCP1B;EXOSC6;CNOT7;LSM6;LSM1;EXOSC7
prerank,GO_Biological_Process_2021__macrophage activation involved in immune response (GO:0002281),-0.5061170640880546,-0.8288626077318295,0.6666666666666666,1.0,1.0,2/10,15.37%,TYROBP;IFI35
prerank,GO_Biological_Process_2021__positive regulation of transport (GO:0051050),0.3239232681779749,0.8288489680057137,0.8064516129032258,0.9407475113255275,1.0,6/59,8.52%,ANXA1;HIP1R;SIRPA;TNF;BOK;NEDD4L
prerank,GO_Biological_Process_2021__cellular response to organic substance (GO:0071310),-0.36247591787513983,-0.8286937061341743,0.8,1.0,1.0,7/81,4.25%,CCL3;SIGIRR;CXCR4;CCL5;PID1;RACK1;EMD
prerank,GO_Biological_Process_2021__transition metal ion homeostasis (GO:0055076),0.3965061965133865,0.8284645575019131,0.6486486486486487,0.9409588133765147,1.0,3/23,3.41%,SLC39A14;NEO1;PICALM
prerank,GO_Biological_Process_2021__hemopoiesis (GO:0030097),0.322980242471885,0.8282905925809846,0.8888888888888888,0.9407030670646876,1.0,10/60,7.17%,YJEFN3;TGFBR2;ZBTB16;WNT5A;ARMC6;SELPLG;WNT2B;JAG1;RUNX1;KITLG
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions (GO:0000375)",-0.42314952710676546,-0.8276947330898947,0.71875,1.0,1.0,8/24,20.36%,WDR83;SMNDC1;PRPF3;DDX23;SLU7;BCAS2;PRPF4;SF3A3
prerank,GO_Biological_Process_2021__regulation of hippocampal neuron apoptotic process (GO:0110089),-0.5256718243752103,-0.8276355230534668,0.75,1.0,1.0,1/5,11.20%,TYROBP
prerank,GO_Biological_Process_2021__cellular amide metabolic process (GO:0043603),-0.3670987747433691,-0.8274930741932933,0.7058823529411765,1.0,1.0,11/64,18.15%,VNN2;MTHFD1;NIT1;THEM4;ACOT9;ORMDL1;ABCB9;ACSM5;SHMT1;MCCC2;FOLR2
prerank,GO_Biological_Process_2021__positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),-0.45817423408840097,-0.8274560603459366,0.7121212121212122,1.0,1.0,6/18,25.54%,MED12;MED30;PSMC4;MED1;PSMC3;DHX36
prerank,GO_Biological_Process_2021__negative regulation of DNA-binding transcription factor activity (GO:0043433),-0.3567021955433338,-0.827385101299487,0.7532467532467533,1.0,1.0,10/86,8.69%,FLNA;SIGIRR;NLRC3;AIM2;BHLHE40;PHB2;NLRC5;NLRP12;TNFAIP3;TMSB4X
prerank,GO_Biological_Process_2021__transition metal ion transport (GO:0000041),-0.4416395543380901,-0.8273255974723861,0.71875,1.0,1.0,2/23,1.44%,FTH1;TFRC
prerank,GO_Biological_Process_2021__regulation of secretion by cell (GO:1903530),-0.4166897880353637,-0.8272711243638805,0.7391304347826086,1.0,1.0,5/41,9.33%,MCTP2;RIMS1;RAB3A;RAB3D;LLGL2
prerank,GO_Biological_Process_2021__negative regulation of bone remodeling (GO:0046851),-0.5400533751175265,-0.8271455597286572,0.6875,1.0,1.0,2/6,8.75%,TNFAIP3;GPR137B
prerank,GO_Biological_Process_2021__negative regulation of bone resorption (GO:0045779),-0.5400533751175265,-0.8271455597286572,0.6875,1.0,1.0,2/6,8.75%,TNFAIP3;GPR137B
prerank,GO_Biological_Process_2021__vasculogenesis (GO:0001570),-0.5081648340906757,-0.8270461961661477,0.7777777777777778,1.0,1.0,3/13,11.19%,TGFBR3;GLMN;VEGFA
prerank,GO_Biological_Process_2021__mesoderm formation (GO:0001707),0.4670154227972222,0.8267838194657642,0.65,0.9428290414026265,1.0,3/6,15.58%,SMAD2;ITGA2;TBX19
prerank,GO_Biological_Process_2021__regulation of cell size (GO:0008361),-0.43903339065004987,-0.8266545112177436,0.7090909090909091,1.0,1.0,4/20,10.33%,VAV3;PLEK;LAMTOR5;LARS1
prerank,GO_Biological_Process_2021__positive regulation of phospholipase activity (GO:0010518),-0.4658521839229888,-0.826473375362606,0.7719298245614035,1.0,1.0,1/15,1.49%,CCL5
prerank,GO_Biological_Process_2021__enzyme linked receptor protein signaling pathway (GO:0007167),0.32846912314782495,0.8263367857383994,0.625,0.9429274351208385,1.0,15/76,14.52%,FER;ACVR2A;IGF1R;RYK;SHC2;PTPRG;MPZL1;MERTK;EPHA6;PTPRD;NTRK2;NPR2;PTK2;ERBB4;TYRO3
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta production (GO:0071636),0.4946253021013354,0.8263230385163259,0.6818181818181818,0.9424136550120386,1.0,4/7,25.56%,LGALS9;BMPR1A;CD46;SERPINF2
prerank,GO_Biological_Process_2021__regulation of wound healing (GO:0061041),0.3997267308300101,0.8262394114531586,0.7428571428571429,0.9420533921372024,1.0,5/21,7.80%,ANXA1;SERPINE1;FGF2;CRK;KANK1
prerank,GO_Biological_Process_2021__protein K11-linked deubiquitination (GO:0035871),0.5317765529891141,0.8261966443559556,0.7209302325581395,0.9416101755782875,1.0,2/8,4.84%,OTUD7A;USP30
prerank,GO_Biological_Process_2021__Golgi organization (GO:0007030),0.32105357023164277,0.8261952837641572,0.8695652173913043,0.9410841480308515,1.0,22/98,18.97%,GOLPH3L;LRRK2;BET1;TMED3;STK25;TMED10;TMED5;LMAN2L;VTI1A;COG1;BLZF1;BAG5;CLASP1;STX6;COG3;UBXN2A;PLEKHM2;CLASP2;ATP8B2;TRAPPC12;HACE1;TRAPPC8
prerank,GO_Biological_Process_2021__regulation of Rho protein signal transduction (GO:0035023),0.3394457009074234,0.8261192189847751,0.7241379310344828,0.940711387828082,1.0,7/47,11.76%,NRP1;EPS8;ROBO1;KANK1;KCTD10;HEG1;CCDC125
prerank,GO_Biological_Process_2021__microtubule cytoskeleton organization involved in mitosis (GO:1902850),-0.3606039082295344,-0.8260125599032638,0.7534246575342466,1.0,1.0,17/85,19.89%,STIL;RPS27;CENPU;EFHC1;ITGB3BP;ZWILCH;DCTN6;MIS12;DYNC1LI2;STMN1;SEC13;SGO2;DCTN2;CENPF;BUB3;DYNC1I2;RMDN1
prerank,GO_Biological_Process_2021__mitochondrion disassembly (GO:0061726),-0.3986075140653454,-0.8257684849736509,0.7543859649122807,1.0,1.0,4/29,9.32%,GABARAPL1;FIS1;ATG2A;GABARAPL2
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),-0.38621751603252774,-0.8255812334868015,0.7638888888888888,1.0,1.0,10/58,11.19%,CYCS;CARD16;NAIP;TNFSF10;FIS1;LAMTOR5;NLRP12;CD44;PDCD5;VEGFA
prerank,GO_Biological_Process_2021__constitutive secretory pathway (GO:0045054),-0.5249063736069581,-0.8249970527578199,0.7192982456140351,1.0,1.0,2/5,14.42%,RAB3A;TMEM167A
prerank,GO_Biological_Process_2021__histone lysine demethylation (GO:0070076),-0.41336676024891766,-0.8246431244719257,0.6896551724137931,1.0,1.0,3/20,16.76%,KDM7A;KDM6B;KDM1B
prerank,GO_Biological_Process_2021__aminoglycan metabolic process (GO:0006022),-0.4954615127260046,-0.8244360547539233,0.6909090909090909,1.0,1.0,2/6,11.82%,XYLT2;B3GAT2
prerank,GO_Biological_Process_2021__regulation of protein deubiquitination (GO:0090085),-0.5289685147244747,-0.8241185283318692,0.7115384615384616,1.0,1.0,1/5,12.01%,WDR48
prerank,GO_Biological_Process_2021__sodium ion transport (GO:0006814),0.3606404080837675,0.8241059089007937,0.7647058823529411,0.9437928433183309,1.0,10/37,15.33%,PKD2;SCN3A;SCN3B;NEDD4L;SLC4A4;SCN8A;ANO6;SLC8A1;SLC24A2;SLC12A2
prerank,GO_Biological_Process_2021__RNA secondary structure unwinding (GO:0010501),0.48628126635207186,0.8233212479441503,0.7045454545454546,0.9446596708174371,1.0,2/7,22.24%,DDX3X;AGO1
prerank,GO_Biological_Process_2021__cardiac muscle tissue development (GO:0048738),0.37860660397196094,0.8232426170534491,0.75,0.944237013184946,1.0,3/17,12.30%,SMAD1;NRG1;BMPR1A
prerank,GO_Biological_Process_2021__regulation of maintenance of mitotic sister chromatid cohesion (GO:0034182),0.5124297845928397,0.8230294844912336,0.7272727272727273,0.9430341764893092,1.0,2/5,25.05%,NSMCE2;MACROH2A1
prerank,GO_Biological_Process_2021__positive regulation of maintenance of mitotic sister chromatid cohesion (GO:0034184),0.5124297845928397,0.8230294844912336,0.7272727272727273,0.9430341764893092,1.0,2/5,25.05%,NSMCE2;MACROH2A1
prerank,GO_Biological_Process_2021__positive regulation of maintenance of sister chromatid cohesion (GO:0034093),0.5124297845928397,0.8230294844912336,0.7272727272727273,0.9430341764893092,1.0,2/5,25.05%,NSMCE2;MACROH2A1
prerank,GO_Biological_Process_2021__response to glucose (GO:0009749),0.3618990497771544,0.8229865790722215,0.7857142857142857,0.9425512075138012,1.0,6/30,11.06%,IGF1R;SLC39A14;UNC13B;SOX4;PCK2;TCF7L2
prerank,GO_Biological_Process_2021__positive regulation of autophagosome maturation (GO:1901098),0.5438541237278687,0.8229818734342477,0.74,0.94202043618403,1.0,2/5,29.88%,SMCR8;CALCOCO2
prerank,GO_Biological_Process_2021__positive regulation of viral transcription (GO:0050434),-0.4245619444001999,-0.8226831736538789,0.7142857142857143,1.0,1.0,3/22,7.16%,MDFIC;CTDP1;POLR2G
prerank,"GO_Biological_Process_2021__retrograde transport, endosome to Golgi (GO:0042147)",0.30377660859569855,0.8225695806211946,0.9655172413793104,0.9421944461073947,1.0,13/77,14.60%,UBE2O;BAIAP3;TBC1D5;TBC1D10B;SGSM2;RAB7A;SNX12;RBSN;VTI1A;RAB6A;YKT6;EVI5;STX6
prerank,GO_Biological_Process_2021__regulation of dendritic cell apoptotic process (GO:2000668),0.4633226017465381,0.822263641675363,0.6304347826086957,0.9422302626698791,1.0,3/7,22.44%,LGALS9;RAPGEF2;CXCL12
prerank,GO_Biological_Process_2021__peptidyl-asparagine modification (GO:0018196),0.3739570435906262,0.8222479367615333,0.7647058823529411,0.941735060013774,1.0,8/23,22.09%,UBE2J1;OSTC;STT3B;MGAT5;ALG8;MAGT1;ALG5;RPN2
prerank,GO_Biological_Process_2021__white fat cell differentiation (GO:0050872),0.4914743231257298,0.8221665817075097,0.6410256410256411,0.9413300157349234,1.0,3/6,8.76%,SIRT1;PPARG;CTBP2
prerank,GO_Biological_Process_2021__cellular response to purine-containing compound (GO:0071415),0.495755022926444,0.8216883010770716,0.6595744680851063,0.9416762219275591,1.0,3/6,23.01%,SLC8A1;RYR1;RYR2
prerank,GO_Biological_Process_2021__renal system development (GO:0072001),0.39462272843273694,0.8216122287957304,0.7096774193548387,0.9413198600771441,1.0,6/23,15.21%,LRP4;PKD1;SALL1;C1GALT1;BAG6;TGFBR1
prerank,GO_Biological_Process_2021__response to cholesterol (GO:0070723),0.42991335906941486,0.821541768594102,0.6875,0.9409226222751107,1.0,6/13,10.96%,ABCA2;TGFBR2;GRAMD1A;SMAD2;GRAMD1C;PTCH1
prerank,GO_Biological_Process_2021__negative regulation of cellular component organization (GO:0051129),0.3289342717837708,0.8215355515916555,0.8214285714285714,0.9403951869793411,1.0,12/57,17.16%,SPRY2;DNAJB2;TMEFF2;TNF;DNAJA4;IRAK3;SORL1;PEX5;AIDA;RAPGEF3;GSK3B;DDX3X
prerank,GO_Biological_Process_2021__endosome organization (GO:0007032),0.37498108042155803,0.8214443720338306,0.7096774193548387,0.9400401589090053,1.0,1/28,2.76%,EXOC8
prerank,GO_Biological_Process_2021__positive regulation of response to biotic stimulus (GO:0002833),-0.39785004038304106,-0.8213477057499284,0.7049180327868853,1.0,1.0,9/30,17.22%,CCL5;DHX58;PLSCR1;TASL;CYBA;LY86;IFI35;POLR3C;DDX60
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction resulting in transcription (GO:0042772)",-0.5022652330905667,-0.8212358143583844,0.7192982456140351,1.0,1.0,3/8,15.14%,ING4;KAT5;RPS27L
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",-0.5022652330905667,-0.8212358143583844,0.7192982456140351,1.0,1.0,3/8,15.14%,ING4;KAT5;RPS27L
prerank,GO_Biological_Process_2021__homocysteine metabolic process (GO:0050667),0.5435539582390289,0.8211192726164704,0.6923076923076923,0.9401045086651357,1.0,2/5,26.96%,BLMH;MPST
prerank,GO_Biological_Process_2021__protein K63-linked ubiquitination (GO:0070534),-0.4141520529205194,-0.8208442258409938,0.7424242424242424,1.0,1.0,3/33,7.11%,TRIM5;ARIH2;RNF126
prerank,GO_Biological_Process_2021__regulation of pinocytosis (GO:0048548),-0.5303783878735833,-0.8206772360545374,0.625,1.0,1.0,1/6,5.38%,NR1H2
prerank,GO_Biological_Process_2021__regulation of lamellipodium morphogenesis (GO:2000392),0.4739358097393007,0.8201139033883051,0.6304347826086957,0.9411916034313565,1.0,2/9,7.80%,PDPN;KANK1
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.44565433279845434,-0.8198890786257024,0.7142857142857143,1.0,1.0,6/16,30.31%,CITED2;CDKN1C;RNF111;SDCBP;DAB2;SNW1
prerank,GO_Biological_Process_2021__positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.44565433279845434,-0.8198890786257024,0.7142857142857143,1.0,1.0,6/16,30.31%,CITED2;CDKN1C;RNF111;SDCBP;DAB2;SNW1
prerank,GO_Biological_Process_2021__carbohydrate derivative transport (GO:1901264),-0.49476603048765994,-0.8196206845708874,0.7096774193548387,1.0,1.0,4/12,15.59%,PLTP;VLDLR;SLC25A19;SLC15A3
prerank,GO_Biological_Process_2021__positive regulation of filopodium assembly (GO:0051491),0.3953664067309054,0.8195906029200256,0.7941176470588235,0.9415022116845195,1.0,4/18,12.11%,NRP1;NLGN1;GPM6A;FNBP1L
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol dephosphorylation (GO:0060304),0.5162311926702094,0.8195695732145966,0.7021276595744681,0.941017082156371,1.0,1/5,13.78%,MTMR9
prerank,GO_Biological_Process_2021__regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.38581415852658263,0.819267376134664,0.8222222222222222,0.940977939938169,1.0,2/20,4.79%,PKD1;CTSC
prerank,GO_Biological_Process_2021__organelle organization (GO:0006996),0.26989079350078476,0.8180053623697358,1.0,0.9428223223530476,1.0,63/304,18.97%,VAPB;PPARGC1A;PKD2;ATAD3B;GOLPH3L;LRRK2;FGD4;TOR1AIP2;SYNE3;PARP1;TMED3;TFB1M;CSPG5;TMED10;MAST2;ARAP3;LIG4;TMED5;SORT1;WDPCP;RAB7A;AUP1;MAST3;ZRANB1;LMAN2L;NCKIPSD;COG1;BLZF1;CHMP7;ATAD3A;FNBP1L;PRKCI;PEX11B;CLUH;STRIP1;MARK1;BAG5;CHMP1A;ESRRA;CLASP1;PPRC1;CNTNAP1;NRF1;COG3;PEX16;UBXN2A;RAB14;PLEKHM2;SEC31A;CLASP2;BRWD1;ALAS1;ATP8B2;TRAPPC12;NIPSNAP2;SEC31B;PCLO;HACE1;BIN1;GABPB1;YTHDF1;ODF2;TRAPPC8
prerank,GO_Biological_Process_2021__regulation of osteoclast development (GO:2001204),-0.4942541658162071,-0.8175430308723163,0.7169811320754716,1.0,1.0,2/6,13.87%,TYROBP;NOTCH2
prerank,GO_Biological_Process_2021__positive regulation of protein kinase B signaling (GO:0051897),-0.36019013821548124,-0.8170077204269076,0.8115942028985508,1.0,1.0,2/89,0.62%,CALCR;CCL3
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265),-0.508278477835719,-0.8168296386374244,0.7457627118644068,1.0,1.0,3/9,18.05%,HSPA1B;HSPA1A;CASP4
prerank,GO_Biological_Process_2021__cellular response to nitric oxide (GO:0071732),0.5249780266809249,0.8166914560672157,0.6976744186046512,0.9439393548642567,1.0,3/5,22.15%,KCNC2;GUCY1B1;FOXO1
prerank,GO_Biological_Process_2021__cellular response to reactive nitrogen species (GO:1902170),0.5249780266809249,0.8166914560672157,0.6976744186046512,0.9439393548642567,1.0,3/5,22.15%,KCNC2;GUCY1B1;FOXO1
prerank,GO_Biological_Process_2021__natural killer cell mediated cytotoxicity (GO:0042267),-0.4605291075504113,-0.8166638554452801,0.7272727272727273,1.0,1.0,2/10,13.99%,GZMB;TUBB4B
prerank,"GO_Biological_Process_2021__neurotransmitter receptor transport, endosome to plasma membrane (GO:0099639)",0.5130665735787543,0.8166259211950176,0.7037037037037037,0.9435020807677489,1.0,1/6,0.84%,SCRIB
prerank,GO_Biological_Process_2021__potassium ion homeostasis (GO:0055075),0.4429639922289608,0.8164650725301787,0.75,0.9431609700336234,1.0,4/14,15.33%,KCNJ2;SLC12A6;SLC12A5;SLC12A2
prerank,GO_Biological_Process_2021__gluconeogenesis (GO:0006094),-0.405701729217425,-0.816326843634266,0.7397260273972602,1.0,1.0,4/27,6.17%,GAPDH;MDH2;PER2;G6PC3
prerank,GO_Biological_Process_2021__cardiac muscle contraction (GO:0060048),0.3978118212993444,0.8162363161622896,0.6923076923076923,0.9430183055193461,1.0,2/16,5.10%,GSN;SCN3B
prerank,GO_Biological_Process_2021__regulation of focal adhesion disassembly (GO:0120182),-0.4991423669916515,-0.8161462360734967,0.7254901960784313,1.0,1.0,1/6,6.65%,IQSEC1
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion disassembly (GO:0120183),-0.4991423669916515,-0.8161462360734967,0.7254901960784313,1.0,1.0,1/6,6.65%,IQSEC1
prerank,GO_Biological_Process_2021__regulation of vasoconstriction (GO:0019229),-0.48763336329555884,-0.8157104268757791,0.6935483870967742,1.0,1.0,3/10,15.92%,PER2;TRPM4;AGT
prerank,GO_Biological_Process_2021__negative regulation of Arp2/3 complex-mediated actin nucleation (GO:0034316),-0.564536760414365,-0.8155625279365581,0.7719298245614035,1.0,1.0,2/5,14.27%,CORO1B;PICK1
prerank,GO_Biological_Process_2021__establishment of spindle localization (GO:0051293),-0.5223176673649855,-0.8154399526213598,0.6842105263157895,1.0,1.0,2/7,9.33%,CFL1;LLGL2
prerank,GO_Biological_Process_2021__response to thyroid hormone (GO:0097066),-0.46333270173731655,-0.815387812426316,0.7692307692307693,1.0,1.0,1/11,3.91%,CTSB
prerank,GO_Biological_Process_2021__L-alpha-amino acid transmembrane transport (GO:1902475),0.42525276934083367,0.8150820512254492,0.7105263157894737,0.9445754396909936,1.0,5/16,6.03%,SLC1A3;SLC25A18;SLC7A8;SLC3A2;SLC1A2
prerank,GO_Biological_Process_2021__cellular response to oxidative stress (GO:0034599),-0.3422933160631955,-0.814388232354195,0.8095238095238095,1.0,1.0,18/93,14.43%,CYCS;FOS;AIF1;CHCHD2;NCF4;ERO1A;RPS3;GSTP1;ERMP1;NCF2;SELENOS;PRR5L;HIF1A;HSPA1B;CYBA;SOD1;GPX1;HSPA1A
prerank,GO_Biological_Process_2021__negative regulation of biosynthetic process (GO:0009890),-0.4818086663948724,-0.8139945061733682,0.7636363636363637,1.0,1.0,3/9,22.45%,GSTP1;CIITA;PARK7
prerank,GO_Biological_Process_2021__cellular protein localization (GO:0034613),-0.3185444221497956,-0.813954301456676,0.9012345679012346,1.0,1.0,37/240,16.63%,FLNA;USP6;RIC3;ARL5C;SNX6;BBS2;ARL4C;CD63;VPS35;EIF2D;NAPA;CORO1B;ARL17A;EPB41L3;TM9SF2;NPM1;ADPRH;TRIM23;IFT27;COX18;STX19;TBC1D8;ARMCX3;AP4M1;OXA1L;PICK1;STX10;TBC1D2B;SNX9;WIPI1;VPS26A;CD74;SLU7;SEC13;VIPAS39;RRAGA;PIGK
prerank,GO_Biological_Process_2021__small GTPase mediated signal transduction (GO:0007264),0.3049345827563179,0.8136766014297675,0.875,0.9466220040115148,1.0,22/84,19.78%,ARHGAP31;FGF2;MAPK11;RIN2;RUNDC3A;RGL2;SHC2;PLK2;NF1;SHOC2;JUN;TIAM2;SHTN1;RAPGEF2;NUCB1;KSR1;CHP1;ARHGAP1;RALA;ARHGAP33;TRIM28;TIAM1
prerank,GO_Biological_Process_2021__negative regulation of viral life cycle (GO:1903901),-0.47283180666037733,-0.813498396169313,0.7142857142857143,1.0,1.0,3/10,8.41%,TRIM5;IFITM3;LY6E
prerank,GO_Biological_Process_2021__regulation of macrophage chemotaxis (GO:0010758),-0.46811330922630723,-0.8134559010527399,0.7272727272727273,1.0,1.0,1/12,1.49%,CCL5
prerank,GO_Biological_Process_2021__regulation of mitotic nuclear division (GO:0007088),-0.401205146627704,-0.8133909522469416,0.696969696969697,1.0,1.0,3/24,6.57%,DUSP1;IGF1;AURKAIP1
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte migration (GO:0051549),-0.5034317193056479,-0.8133817115745474,0.7058823529411765,1.0,1.0,1/7,6.65%,IQSEC1
prerank,GO_Biological_Process_2021__regulation of heterotypic cell-cell adhesion (GO:0034114),0.4227050171702863,0.8133314404607759,0.6571428571428571,0.9467026312492571,1.0,3/14,7.30%,KLF4;MYADM;TNF
prerank,GO_Biological_Process_2021__regulation of cell cycle G1/S phase transition (GO:1902806),-0.423898598926962,-0.813232376609884,0.7090909090909091,1.0,1.0,9/21,22.96%,DDRGK1;PHB2;APPL1;STXBP4;PSME2;PSME1;CDKN1B;TAF1;PSME3
prerank,GO_Biological_Process_2021__photoreceptor cell development (GO:0042461),-0.5012208441618027,-0.8131537669509806,0.7037037037037037,1.0,1.0,1/7,11.19%,VEGFA
prerank,GO_Biological_Process_2021__leucine transport (GO:0015820),-0.5383113829606211,-0.8130737167734085,0.75,1.0,1.0,2/5,9.33%,SLC7A5;LLGL2
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase II (GO:0045944),-0.3032736569092193,-0.8130133224814293,0.9347826086956522,1.0,1.0,54/564,11.42%,NR4A3;IL4I1;SKAP1;MYBL1;BCL11B;UBC;FOSL2;FOS;RPS27A;JUNB;PID1;ATF5;TAF6L;CSRNP1;USF1;RORA;CHCHD2;ZNF335;DDRGK1;BEX1;ETS1;NR1H2;JUP;IGF1;JMJD6;TXK;MED25;NLRC5;IER2;PLSCR1;ZNF76;PLAG1;NAMPT;RNASEL;PRKD2;RBPJ;ITGA6;VENTX;DVL1;STAT1;MEIS1;ZNF513;EIF5A;SMARCD1;SLC11A1;LITAF;IRF1;NPM1;CITED2;KDM6B;MLX;VEGFA;HIF1A;STING1
prerank,GO_Biological_Process_2021__generation of neurons (GO:0048699),0.3022052775574171,0.8129561512860335,0.8181818181818182,0.9467422817548524,1.0,22/95,13.54%,NRP1;CDK5R1;MAP2K1;WNT5A;FZD3;RELN;WNT2B;RUNX1;PLXNB2;RYK;AUTS2;BRSK1;FUT9;GPM6A;OLIG1;PEX13;PTPRD;CDK6;ELP3;NTRK2;SH3RF1;MARK1
prerank,GO_Biological_Process_2021__mitochondrial protein processing (GO:0034982),0.46210675129531287,0.8126084879974697,0.7142857142857143,0.946809129653411,1.0,1/9,2.93%,IMMP2L
prerank,GO_Biological_Process_2021__positive regulation of macromolecule biosynthetic process (GO:0010557),0.29180323207940767,0.8125271872799179,0.8918918918918919,0.946392628809999,1.0,4/89,3.55%,KLF4;FGF2;SIRT1;SAMD4A
prerank,GO_Biological_Process_2021__negative regulation of cellular protein catabolic process (GO:1903363),0.501002615548626,0.8121315070136794,0.723404255319149,0.9466024578052267,1.0,1/7,0.96%,ATRAID
prerank,GO_Biological_Process_2021__positive regulation of nuclear cell cycle DNA replication (GO:0010571),-0.5433174278243558,-0.8119014353857348,0.7647058823529411,1.0,1.0,2/6,31.29%,CDC7;DBF4B
prerank,GO_Biological_Process_2021__regulation of actin nucleation (GO:0051125),0.4854371323091903,0.811309369233577,0.7045454545454546,0.9475055518859963,1.0,1/9,1.66%,GSN
prerank,GO_Biological_Process_2021__regulation of autophagosome maturation (GO:1901096),0.44287052164187507,0.8110990127457496,0.6226415094339622,0.947266036905292,1.0,1/11,4.89%,TMEM39A
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Aorta),-0.374151341619851,-0.8109795220143619,0.8028169014084507,1.0,1.0,4/70,3.11%,COL5A1;PROCR;ENPP4;PER3
prerank,GO_Biological_Process_2021__negative regulation of secretion by cell (GO:1903531),0.3971016866574979,0.8104636524740121,0.725,0.9478010102041173,1.0,1/22,0.34%,ANXA1
prerank,GO_Biological_Process_2021__unsaturated fatty acid metabolic process (GO:0033559),0.39335070322020005,0.8103406991120901,0.7631578947368421,0.9474801470028663,1.0,2/30,0.68%,FAAH;PLA2G4C
prerank,GO_Biological_Process_2021__negative regulation of neuron death (GO:1901215),0.3215856892819632,0.80997419950998,0.8518518518518519,0.9476073734993444,1.0,15/59,16.55%,PPARGC1A;LRRK2;PPT1;CPEB4;LIG4;UNC5B;SORL1;SOD2;NTRK2;PRKCI;GPNMB;TYRO3;ATP13A2;GSK3B;INPP5A
prerank,GO_Biological_Process_2021__negative regulation of protein autophosphorylation (GO:0031953),-0.5033248793425604,-0.8099144695106287,0.7619047619047619,1.0,1.0,1/7,7.60%,NLRP12
prerank,GO_Biological_Process_2021__ERBB2 signaling pathway (GO:0038128),0.4208404649320656,0.8096425737643651,0.7073170731707317,0.9477954774565343,1.0,11/22,23.61%,GAB1;NRG1;NRG2;ERBB4;PTPRR;PIK3CA;ERBIN;PTPN12;PTPN18;CPNE3;PIK3R1
prerank,GO_Biological_Process_2021__mRNA transport (GO:0051028),0.3086596731950565,0.8094249241804133,0.95,0.9476310085754421,1.0,8/85,7.20%,NXF1;U2AF1;CPSF4;FYTTD1;NUP153;NUP188;WDR33;NUP42
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.365544849168821,0.8094195109962935,0.8076923076923077,0.9471010136042031,1.0,4/21,14.39%,CDK5R1;TOGARAM1;SLAIN2;CLASP1
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor-activated receptor activity (GO:0007176),-0.4421603554578236,-0.8092574194826592,0.765625,1.0,1.0,2/14,3.88%,SNX6;CBLB
prerank,GO_Biological_Process_2021__amino acid transmembrane transport (GO:0003333),-0.42549206142186663,-0.8092391433903153,0.7619047619047619,1.0,1.0,3/26,4.58%,SLC7A5;SLC38A4;SLC38A1
prerank,GO_Biological_Process_2021__NLS-bearing protein import into nucleus (GO:0006607),-0.43591808257975956,-0.809097785788146,0.6212121212121212,1.0,1.0,1/13,3.88%,CBLB
prerank,GO_Biological_Process_2021__renal water homeostasis (GO:0003091),-0.45536056881610715,-0.8088946780329642,0.7222222222222222,1.0,1.0,2/17,6.63%,RAB11A;PRKAR1B
prerank,GO_Biological_Process_2021__regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),-0.4170312808293163,-0.8086331625974615,0.7285714285714285,1.0,1.0,1/19,1.03%,TGFBR3
prerank,PanglaoDB_Augmented_2021__Chondrocytes,-0.3584259532604686,-0.808523353020707,0.7567567567567568,1.0,1.0,8/59,11.54%,COL5A1;RUNX3;GADD45B;IL10RA;STAT1;OLFML2B;VEGFA;SDC3
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta production (GO:0071634),0.4170677808249018,0.8083484746958252,0.7435897435897436,0.9484329824433567,1.0,3/13,10.85%,SMAD3;LGALS9;ITGAV
prerank,GO_Biological_Process_2021__protein monoubiquitination (GO:0006513),0.3719191346484747,0.8076760876465737,0.8285714285714286,0.9489449172182131,1.0,4/31,10.42%,ZNF598;UBE2O;UBE3D;RNF20
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.3400553937665224,0.8076051386696186,0.7941176470588235,0.9485367755534616,1.0,3/31,4.66%,SERPINE1;FEM1B;TNFRSF10A
prerank,GO_Biological_Process_2021__regulation of leukocyte chemotaxis (GO:0002688),0.4398245717756101,0.8074639182702832,0.675,0.948183147736215,1.0,1/9,4.07%,MTUS1
prerank,GO_Biological_Process_2021__phosphatidic acid metabolic process (GO:0046473),-0.38722002297778907,-0.8073866457279357,0.7352941176470589,1.0,1.0,3/32,5.77%,LPCAT1;DDHD2;GNPAT
prerank,GO_Biological_Process_2021__protein N-linked glycosylation via asparagine (GO:0018279),0.38035558554132576,0.8073009233449786,0.8387096774193549,0.9478974496010006,1.0,8/22,22.09%,UBE2J1;OSTC;STT3B;MGAT5;ALG8;MAGT1;ALG5;RPN2
prerank,GO_Biological_Process_2021__protein localization to Golgi apparatus (GO:0034067),0.3836639988847456,0.8072096588640585,0.7777777777777778,0.9475108235950485,1.0,6/26,12.19%,RAB33B;ARL5A;TMED10;RIPOR1;SORL1;RAB6A
prerank,GO_Biological_Process_2021__positive regulation of protein binding (GO:0032092),0.3354538774948353,0.8071192731648761,0.7428571428571429,0.94717185035622,1.0,4/42,3.81%,HIP1R;PKD1;EPB41;LRRK2
prerank,GO_Biological_Process_2021__cellular response to lipid (GO:0071396),-0.34680616502706857,-0.8067225265018083,0.7894736842105263,1.0,1.0,13/113,11.38%,INSIG1;ZFP36;CARD16;PID1;CD14;RORA;GSTP1;TNFRSF1B;TNFAIP3;SELENOS;ABCB4;CFTR;BRINP2
prerank,GO_Biological_Process_2021__piecemeal microautophagy of the nucleus (GO:0034727),-0.4944787799480118,-0.8062021659439594,0.7407407407407407,1.0,1.0,1/7,7.60%,ATG2A
prerank,GO_Biological_Process_2021__lysosomal microautophagy (GO:0016237),-0.4944787799480118,-0.8062021659439594,0.7407407407407407,1.0,1.0,1/7,7.60%,ATG2A
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.44431333401050976,-0.8060792171094986,0.7183098591549296,1.0,1.0,3/13,14.43%,EYA2;HSPA1B;HSPA1A
prerank,GO_Biological_Process_2021__negative regulation of signal transduction in absence of ligand (GO:1901099),-0.44431333401050976,-0.8060792171094986,0.7183098591549296,1.0,1.0,3/13,14.43%,EYA2;HSPA1B;HSPA1A
prerank,GO_Biological_Process_2021__Ras protein signal transduction (GO:0007265),-0.3531734797419287,-0.8059958016811072,0.7866666666666666,1.0,1.0,8/107,8.34%,PLEKHG5;ARHGAP4;GRAP2;AIF1;ARHGEF1;IGF1;ARHGEF3;CFL1
prerank,GO_Biological_Process_2021__monoubiquitinated protein deubiquitination (GO:0035520),0.4823626747085029,0.805934008831385,0.8043478260869565,0.9487682780140652,1.0,2/6,26.97%,USP7;BAP1
prerank,GO_Biological_Process_2021__positive regulation of phosphorylation (GO:0042327),0.2729453104582919,0.8058757118739811,1.0,0.9484020283291369,1.0,18/161,10.77%,LEPR;NRP1;ACVR2A;IGF1R;FGF2;SIRT1;LRRK2;CIB1;RYK;TNF;DVL3;TMEM119;SLC4A4;NPTN;KNDC1;HGF;MERTK;EPHA6
prerank,GO_Biological_Process_2021__N-acetylneuraminate catabolic process (GO:0019262),0.4899130090334374,0.8058630653067613,0.6944444444444444,0.9479149606818733,1.0,2/6,20.15%,RENBP;GNPDA1
prerank,GO_Biological_Process_2021__protein depolymerization (GO:0051261),0.4102681343194555,0.8052539542131256,0.6756756756756757,0.9483573123241775,1.0,1/17,1.66%,GSN
prerank,GO_Biological_Process_2021__regulation of DNA repair (GO:0006282),-0.40378790054713876,-0.8050422807825377,0.828125,1.0,1.0,6/34,14.44%,EYA2;RPS3;ABRAXAS1;PARG;BRCA1;ERCC8
prerank,"GO_Biological_Process_2021__regulation of CD8-positive, alpha-beta T cell proliferation (GO:2000564)",-0.5065441630698181,-0.8048777632011529,0.7777777777777778,1.0,1.0,3/7,19.00%,IRF1;HLA-E;PTPN22
prerank,GO_Biological_Process_2021__regulation of Rab protein signal transduction (GO:0032483),-0.5570686771450883,-0.8047459848336665,0.7924528301886793,1.0,1.0,1/6,15.84%,DENND3
prerank,GO_Biological_Process_2021__fatty acid derivative biosynthetic process (GO:1901570),0.3513736224662679,0.804588179654372,0.7419354838709677,0.9488126269829068,1.0,6/25,20.80%,PPT1;ALOX5AP;GCDH;FASN;ACACA;SCD5
prerank,GO_Biological_Process_2021__negative regulation of RNA catabolic process (GO:1902369),-0.4855715857843256,-0.804453565432293,0.7692307692307693,1.0,1.0,2/7,17.88%,NRDE2;SLIRP
prerank,GO_Biological_Process_2021__protein localization to membrane (GO:0072657),-0.340759613539887,-0.8043796476601889,0.7808219178082192,1.0,1.0,18/148,11.27%,FLNA;ARL5C;TMEM150A;TSPAN32;RAB11A;JUP;RAB3A;FGF13;NLGN2;RAB3D;EPB41L3;ITGA4;TM9SF2;DVL1;PTN;EFR3B;ITGB2;ITGAL
prerank,GO_Biological_Process_2021__ketone body metabolic process (GO:1902224),-0.47051834637031875,-0.8043484521545478,0.6607142857142857,1.0,1.0,4/8,27.15%,HMGCL;BDH1;AACS;SLC27A5
prerank,GO_Biological_Process_2021__organic acid transport (GO:0015849),-0.3837947467436158,-0.8043265652587114,0.7066666666666667,1.0,1.0,4/54,4.96%,SLC51A;SLC38A4;SLC38A1;ABCC3
prerank,GO_Biological_Process_2021__monoacylglycerol catabolic process (GO:0052651),0.5192302177055645,0.8042781060759535,0.7708333333333334,0.948695936491478,1.0,1/5,0.63%,FAAH
prerank,GO_Biological_Process_2021__negative regulation of macrophage activation (GO:0043031),0.40563914929665823,0.8040527343617317,0.7674418604651163,0.9486196942683799,1.0,1/11,3.01%,LDLR
prerank,GO_Biological_Process_2021__regulation of long-term synaptic potentiation (GO:1900271),0.37193191634202194,0.8037297327130152,0.6923076923076923,0.9486106972747302,1.0,10/20,26.72%,RELN;SHANK3;CYP46A1;GSK3B;YTHDF1;AGER;ABL1;EPHA4;ADCY1;EIF2AK4
prerank,GO_Biological_Process_2021__negative regulation of activated T cell proliferation (GO:0046007),0.4681181705271814,0.8036039196280051,0.775,0.9483063671720402,1.0,1/9,0.84%,SCRIB
prerank,GO_Biological_Process_2021__positive regulation of proteasomal protein catabolic process (GO:1901800),-0.33923504162756934,-0.8035260418685094,0.8055555555555556,1.0,1.0,11/69,12.71%,DDRGK1;RACK1;ELOB;CLU;ARIH2;RNF144B;DVL1;RBX1;NOP53;HSPA1B;CSNK1D
prerank,GO_Biological_Process_2021__response to nitric oxide (GO:0071731),0.4905596233579451,0.8034790648123161,0.7674418604651163,0.9479554139088135,1.0,3/6,22.15%,KCNC2;GUCY1B1;FOXO1
prerank,GO_Biological_Process_2021__regulation of protein tyrosine kinase activity (GO:0061097),0.3764591082477887,0.8031768435716373,0.7575757575757576,0.9478998653129301,1.0,4/26,10.03%,SRCIN1;NCK2;RELN;GRM5
prerank,GO_Biological_Process_2021__cell junction assembly (GO:0034329),-0.3696989442284895,-0.8029762070571894,0.7377049180327869,1.0,1.0,7/56,10.71%,FLNA;NLGN2;ACTG1;SPOCK2;ITGA6;TRPV4;ACTB
prerank,GO_Biological_Process_2021__regulation of interferon-alpha production (GO:0032647),-0.4423076929132732,-0.8028847987193958,0.8507462686567164,1.0,1.0,4/19,17.04%,NLRC3;STAT1;HAVCR2;IRF7
prerank,GO_Biological_Process_2021__negative regulation of glycogen biosynthetic process (GO:0045719),-0.5321127829531845,-0.8025252970654971,0.7924528301886793,1.0,1.0,3/5,17.44%,SELENOS;PASK;INPP5K
prerank,GO_Biological_Process_2021__negative regulation of glycogen metabolic process (GO:0070874),-0.5321127829531845,-0.8025252970654971,0.7924528301886793,1.0,1.0,3/5,17.44%,SELENOS;PASK;INPP5K
prerank,GO_Biological_Process_2021__regulation of cellular component biogenesis (GO:0044087),-0.3929675371839896,-0.8025252926040765,0.7352941176470589,1.0,1.0,1/31,0.52%,CD36
prerank,"GO_Biological_Process_2021__positive regulation of phagocytosis, engulfment (GO:0060100)",-0.49032398404596744,-0.8022207236708256,0.7627118644067796,1.0,1.0,4/7,24.91%,NCKAP1L;C3;ABCA7;RAB31
prerank,GO_Biological_Process_2021__carbohydrate derivative biosynthetic process (GO:1901137),-0.44115639158620196,-0.8019712136603079,0.7627118644067796,1.0,1.0,2/19,11.17%,GCNT1;GK
prerank,GO_Biological_Process_2021__protein localization to centrosome (GO:0071539),-0.436277101860917,-0.8018862088576376,0.7681159420289855,1.0,1.0,5/17,21.63%,STIL;CSNK1D;GOLGB1;DCTN2;SNX10
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.40282195260360765,0.8013996306590134,0.7567567567567568,0.9504511445734285,1.0,4/15,22.38%,MITF;JUN;MED24;MED13
prerank,GO_Biological_Process_2021__regulation of centrosome cycle (GO:0046605),-0.43116539729857095,-0.8012595592516982,0.7818181818181819,1.0,1.0,3/16,10.59%,ATF5;XRCC3;NPM1
prerank,GO_Biological_Process_2021__protein insertion into ER membrane (GO:0045048),-0.4127374494006995,-0.8012213646376564,0.7936507936507936,1.0,1.0,5/27,17.24%,EMD;CYB5A;EMC2;EMC1;SERP1
prerank,GO_Biological_Process_2021__regulation of cell cycle (GO:0051726),-0.31868929159142356,-0.8010633735977554,0.8846153846153846,1.0,1.0,25/190,15.42%,MX2;PPP1R15A;RUNX3;JUNB;DUSP1;GADD45B;PER2;RACK1;RPL23;MED25;GADD45GIP1;IRF1;CITED2;ING4;NOP53;PIM3;CKS2;PTPRC;NR4A1;NOTCH2;CCND1;BRCA1;CDC26;TP53INP1;NUDT6
prerank,MSigDB_Hallmark_2020__Myogenesis,-0.3578094336547167,-0.8010447017396652,0.8133333333333334,1.0,1.0,9/97,7.44%,CD36;MYLK;GADD45B;APOD;LSP1;CLU;BHLHE40;IGF1;MYBPC3
prerank,GO_Biological_Process_2021__vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.30102998826413696,0.8002730748983575,0.8125,0.9518342379288078,1.0,11/53,13.77%,NRP1;MAPK11;NCK2;WASF2;CRK;ELMO1;SHC2;ITGAV;MAPKAPK2;VAV1;PTK2
prerank,GO_Biological_Process_2021__regulation of microtubule depolymerization (GO:0031114),0.4046597138284786,0.8002203950799844,0.7857142857142857,0.9514352539731111,1.0,6/20,19.20%,MAP1S;CIB1;CLASP1;CLASP2;CAMSAP2;ATXN7
prerank,GO_Biological_Process_2021__cellular lipid catabolic process (GO:0044242),-0.41422060628055135,-0.7999116572406153,0.7931034482758621,1.0,1.0,3/18,8.11%,LIPG;ACBD5;ENPP2
prerank,GO_Biological_Process_2021__reelin-mediated signaling pathway (GO:0038026),0.48991314407994496,0.7998886926556714,0.7674418604651163,0.9513712154810369,1.0,1/5,5.60%,RELN
prerank,GO_Biological_Process_2021__regulation of interleukin-10 production (GO:0032653),-0.4220053558250121,-0.7998799094686759,0.7205882352941176,1.0,1.0,6/24,20.69%,LILRB4;TYROBP;CD47;NOD2;HLA-DRB1;CLEC7A
prerank,GO_Biological_Process_2021__regulation of transmembrane transporter activity (GO:0022898),0.49865204001863744,0.7997704266248992,0.7272727272727273,0.9510865965830885,1.0,4/6,21.35%,PIM1;AHCYL1;SNCA;CHRM3
prerank,GO_Biological_Process_2021__negative regulation of neurogenesis (GO:0050768),-0.4064465621140466,-0.7995249305779872,0.7391304347826086,1.0,1.0,2/27,2.81%,DYNLT1;B2M
prerank,GO_Biological_Process_2021__pathway-restricted SMAD protein phosphorylation (GO:0060389),-0.5032535223039231,-0.799467681726936,0.7818181818181819,1.0,1.0,1/8,1.03%,TGFBR3
prerank,GO_Biological_Process_2021__phosphatidic acid biosynthetic process (GO:0006654),-0.3874030275788685,-0.7991606387229121,0.7384615384615385,1.0,1.0,3/31,5.77%,LPCAT1;DDHD2;GNPAT
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G1/S phase transition (GO:1902808),0.3783567057426986,0.7989988608161775,0.7368421052631579,0.9517579190408565,1.0,2/24,5.15%,ANXA1;UBE2E2
prerank,PanglaoDB_Augmented_2021__Luminal Epithelial Cells,-0.4271124633205441,-0.7988745286750184,0.7368421052631579,1.0,1.0,7/21,13.66%,CEBPD;CLDN7;TNFSF10;OVOL2;HIF1A;BTG1;UXT
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),-0.36662768469250107,-0.7988082077054303,0.7205882352941176,1.0,1.0,3/46,2.43%,UBC;RPS27A;SNX6
prerank,PanglaoDB_Augmented_2021__Sertoli Cells,-0.36993672267530214,-0.7987126816551776,0.8059701492537313,1.0,1.0,21/69,17.39%,COL18A1;MRO;CD55;PADI2;CLU;SLC16A3;NR1H2;EPHX1;PRLR;PFKFB3;ABLIM3;TSPAN9;SERPING1;NOTCH2;C3;AGT;VASN;DOCK6;MATN2;CRYAB;GPRC5C
prerank,GO_Biological_Process_2021__regulation of gastrulation (GO:0010470),0.4796897948409498,0.7986067963030098,0.65,0.9518741421284188,1.0,5/8,16.96%,PHLDB1;DAG1;POGLUT1;CLASP1;CLASP2
prerank,GO_Biological_Process_2021__small RNA loading onto RISC (GO:0070922),-0.5015884375967494,-0.7984443732370673,0.7692307692307693,1.0,1.0,2/7,20.58%,ADAR;DICER1
prerank,GO_Biological_Process_2021__dosage compensation (GO:0007549),-0.46761991077484955,-0.7982736408458572,0.8,1.0,1.0,5/9,26.07%,BRCA1;LRIF1;SMCHD1;YTHDC1;METTL3
prerank,GO_Biological_Process_2021__regulation of viral release from host cell (GO:1902186),-0.46729254191625946,-0.7981719736015211,0.7910447761194029,1.0,1.0,3/16,12.55%,TRIM5;TRIM13;VPS37B
prerank,GO_Biological_Process_2021__endoplasmic reticulum to cytosol transport (GO:1903513),0.41323193217663406,0.7980351243195336,0.7631578947368421,0.9523440300860723,1.0,2/15,8.99%,SEL1L;AUP1
prerank,GO_Biological_Process_2021__mitochondrion transport along microtubule (GO:0047497),0.40469790297153807,0.7979404797096721,0.7878787878787878,0.9520194724897424,1.0,1/12,1.80%,MAP1S
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell activation (GO:0032816),0.46227887120460875,0.7976924327650632,0.7317073170731707,0.9518619720386852,1.0,1/10,1.16%,ZBTB1
prerank,GO_Biological_Process_2021__regulation of mitochondrial depolarization (GO:0051900),-0.5195256930980681,-0.7974863238852996,0.75,1.0,1.0,1/5,4.24%,RACK1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to early endosome (GO:1902966),0.47667773674369274,0.7972773766803853,0.7291666666666666,0.95095114832233,1.0,1/6,1.49%,MSN
prerank,GO_Biological_Process_2021__regulation of protein localization to early endosome (GO:1902965),0.47667773674369274,0.7972773766803853,0.7291666666666666,0.95095114832233,1.0,1/6,1.49%,MSN
prerank,GO_Biological_Process_2021__positive regulation of protein localization to endosome (GO:1905668),0.47667773674369274,0.7972773766803853,0.7291666666666666,0.95095114832233,1.0,1/6,1.49%,MSN
prerank,GO_Biological_Process_2021__stabilization of membrane potential (GO:0030322),-0.4968187685700267,-0.7971676554294856,0.7083333333333334,1.0,1.0,1/5,4.77%,CHCHD10
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell migration (GO:0014912),-0.4479701553387111,-0.7969589172339855,0.6909090909090909,1.0,1.0,2/11,6.72%,AIF1;CORO1B
prerank,GO_Biological_Process_2021__amino sugar catabolic process (GO:0046348),0.4664839925951875,0.7969346037692303,0.7435897435897436,0.9510207943462281,1.0,2/7,20.15%,RENBP;GNPDA1
prerank,GO_Biological_Process_2021__membrane protein proteolysis (GO:0033619),-0.3906893077509866,-0.7965520443314227,0.7377049180327869,1.0,1.0,1/27,1.65%,PRKCQ
prerank,GO_Biological_Process_2021__positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),-0.3382579468568983,-0.7964751667422612,0.835820895522388,1.0,1.0,11/63,12.71%,DDRGK1;RACK1;ELOB;CLU;ARIH2;RNF144B;DVL1;RBX1;NOP53;HSPA1B;CSNK1D
prerank,GO_Biological_Process_2021__protein polyubiquitination (GO:0000209),0.2991002998455797,0.7961427039448986,0.8888888888888888,0.9519681215760791,1.0,41/254,15.29%,UBE2D1;MKRN3;FBXO30;KBTBD6;UBE2J1;FBXL14;UBE2O;MARCHF5;FBXO32;DDA1;UBE2E2;UBE3D;UBE2D2;FZR1;NEDD4L;RMND5A;SHARPIN;CDC23;MDM2;BTRC;SASH1;RNF19B;MARCHF1;RNF20;UBE2L3;FBXW11;FBXW7;RNF217;UBE2N;KLHL42;FBXL12;FBXL7;BARD1;FBXO27;SMURF1;TRAF6;RNF6;ANAPC1;FBXO11;BLMH;UBE2J2
prerank,GO_Biological_Process_2021__mitotic spindle checkpoint signaling (GO:0071174),0.44665734102794563,0.7961362747368069,0.6578947368421053,0.9499015214188027,1.0,2/11,12.59%,TEX14;ZNF207
prerank,GO_Biological_Process_2021__negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.44665734102794563,0.7961362747368069,0.6578947368421053,0.9499015214188027,1.0,2/11,12.59%,TEX14;ZNF207
prerank,GO_Biological_Process_2021__mitotic spindle assembly checkpoint signaling (GO:0007094),0.44665734102794563,0.7961362747368069,0.6578947368421053,0.9499015214188027,1.0,2/11,12.59%,TEX14;ZNF207
prerank,GO_Biological_Process_2021__spindle assembly checkpoint signaling (GO:0071173),0.44665734102794563,0.7961362747368069,0.6578947368421053,0.9499015214188027,1.0,2/11,12.59%,TEX14;ZNF207
prerank,GO_Biological_Process_2021__pyrimidine nucleobase biosynthetic process (GO:0019856),-0.5579320436031353,-0.7959790761731285,0.7758620689655172,1.0,1.0,1/5,11.81%,DHODH
prerank,GO_Biological_Process_2021__modulation by symbiont of entry into host (GO:0052372),-0.4599609594480476,-0.7957890837650926,0.7428571428571429,1.0,1.0,2/12,5.98%,TRIM5;TRIM22
prerank,GO_Biological_Process_2021__negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.47727202634833255,0.7956858585602596,0.7441860465116279,0.9500908798996606,1.0,1/6,1.76%,SPRY2
prerank,GO_Biological_Process_2021__cellular component maintenance (GO:0043954),0.4109998741785444,0.7956181115339018,0.696969696969697,0.9497034088808312,1.0,1/10,1.37%,IGF1R
prerank,GO_Biological_Process_2021__regulation of hepatocyte proliferation (GO:2000345),0.5007392134990023,0.7955604564595657,0.7222222222222222,0.9492567438489893,1.0,2/5,10.80%,HPN;FBXW7
prerank,"GO_Biological_Process_2021__exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000467)",-0.48329376325517537,-0.7955151248923946,0.6949152542372882,1.0,1.0,3/8,25.53%,EXOSC10;ERI2;ERI3
prerank,GO_Biological_Process_2021__exonucleolytic trimming involved in rRNA processing (GO:0000459),-0.48329376325517537,-0.7955151248923946,0.6949152542372882,1.0,1.0,3/8,25.53%,EXOSC10;ERI2;ERI3
prerank,GO_Biological_Process_2021__response to purine-containing compound (GO:0014074),-0.4753522134018604,-0.7951229568396949,0.6896551724137931,1.0,1.0,2/11,9.56%,DUOX1;STAT1
prerank,GO_Biological_Process_2021__neurotransmitter transport (GO:0006836),-0.3851648309858322,-0.7950408344419835,0.7794117647058824,1.0,1.0,6/47,9.43%,RIMS1;SLC38A1;GLUL;RAB3A;SLC6A16;DVL1
prerank,GO_Biological_Process_2021__regulation of stress fiber assembly (GO:0051492),0.32850164375616886,0.794604051843932,0.7692307692307693,0.9502935802984178,1.0,18/54,23.61%,NRP1;WASF2;TMEFF2;SLC9A1;TJP1;FERMT2;CLASP1;RAPGEF3;TGFBR1;CLASP2;ALMS1;PPM1F;PPM1E;ARAP1;LIMCH1;ABL1;ARHGEF10L;PIK3R1
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),0.4944086169428473,0.794522259347407,0.7142857142857143,0.9499661864984309,1.0,1/5,1.76%,SPRY2
prerank,GO_Biological_Process_2021__protein homotetramerization (GO:0051289),-0.42111815992649604,-0.7944926007155289,0.78125,1.0,1.0,2/30,2.81%,APIP;B2M
prerank,GO_Biological_Process_2021__body fluid secretion (GO:0007589),-0.524651775318099,-0.7944421183686229,0.7358490566037735,1.0,1.0,2/5,11.19%,PRLR;VEGFA
prerank,GO_Biological_Process_2021__lactation (GO:0007595),-0.524651775318099,-0.7944421183686229,0.7358490566037735,1.0,1.0,2/5,11.19%,PRLR;VEGFA
prerank,GO_Biological_Process_2021__positive regulation of protein depolymerization (GO:1901881),0.4511275516736208,0.793872305531022,0.8260869565217391,0.950320326630375,1.0,1/6,1.58%,SEMA5A
prerank,GO_Biological_Process_2021__regulation of viral entry into host cell (GO:0046596),0.37280260035860846,0.7938417756077357,0.6363636363636364,0.9498676903517826,1.0,3/22,4.08%,HS3ST5;GSN;TRIM26
prerank,GO_Biological_Process_2021__regulation of dendritic cell chemotaxis (GO:2000508),0.4985778277207759,0.7937952175514853,0.7380952380952381,0.9494551848266579,1.0,2/5,23.45%,LGALS9;SLAMF8
prerank,GO_Biological_Process_2021__mitochondrial protein catabolic process (GO:0035694),-0.5282270072402966,-0.7937937424872817,0.7636363636363637,1.0,1.0,4/5,40.37%,BNIP3;PISD;AFG1L;BNIP3L
prerank,GO_Biological_Process_2021__microtubule polymerization or depolymerization (GO:0031109),-0.4375274893280836,-0.7937421614730408,0.765625,1.0,1.0,4/15,15.54%,FGF13;TRPV4;STMN1;MAP7D3
prerank,GO_Biological_Process_2021__response to estrogen (GO:0043627),-0.4225809431921952,-0.7936258333678587,0.7758620689655172,1.0,1.0,4/20,20.70%,GSTM3;CITED2;BRCA1;WBP2
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.4195528971008072,0.7934747179957112,0.7567567567567568,0.9494656919854183,1.0,3/16,13.77%,FGF2;P2RY12;PTK2
prerank,GO_Biological_Process_2021__stem cell development (GO:0048864),0.4961468446748549,0.7931784929880175,0.7272727272727273,0.9495025834773566,1.0,3/7,16.85%,NRG1;KLHL12;NOLC1
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity (GO:0006469),0.3025219115207857,0.7929603083758632,0.8484848484848485,0.9493415742199862,1.0,10/67,12.21%,QARS1;SRCIN1;SPRED1;TSC2;GNAQ;CEP85;YWHAG;DEPTOR;SORL1;NF1
prerank,GO_Biological_Process_2021__actin nucleation (GO:0045010),0.4043480041119837,0.7928527364133758,0.7727272727272727,0.948982987404514,1.0,1/14,4.43%,SPIRE2
prerank,GO_Biological_Process_2021__negative regulation of response to external stimulus (GO:0032102),-0.37683825733146714,-0.792845577618394,0.8028169014084507,1.0,1.0,11/67,9.83%,SIGIRR;CARD16;NLRC3;DHX58;RORA;VPS35;NLRP12;TNFAIP3;ENPP3;METRNL;SELENOS
prerank,GO_Biological_Process_2021__endodermal cell fate commitment (GO:0001711),-0.4901247819482361,-0.792620018617913,0.7142857142857143,1.0,1.0,2/5,32.34%,LEO1;CTR9
prerank,GO_Biological_Process_2021__phospholipid catabolic process (GO:0009395),-0.4317494439675868,-0.7924581941289921,0.7222222222222222,1.0,1.0,3/13,8.11%,LIPG;GDPD1;ENPP2
prerank,GO_Biological_Process_2021__positive regulation of rRNA processing (GO:2000234),-0.483490920751518,-0.7923337521258869,0.7818181818181819,1.0,1.0,1/8,7.38%,BUD23
prerank,GO_Biological_Process_2021__histone acetylation (GO:0016573),-0.36891518718933486,-0.7921710829573854,0.8032786885245902,1.0,1.0,8/59,12.89%,TAF6L;POLE3;ING3;ING5;MSL3;BRCA2;ING4;KAT5
prerank,GO_Biological_Process_2021__maintenance of DNA methylation (GO:0010216),0.4991033673755273,0.7921315956097321,0.7142857142857143,0.9494680772354073,1.0,1/6,2.05%,UHRF2
prerank,MSigDB_Hallmark_2020__Apical Surface,-0.41356098846337763,-0.7920846288420212,0.7878787878787878,1.0,1.0,5/24,14.37%,CRYBG1;SULF2;GSTM3;BRCA1;ATP8B1
prerank,GO_Biological_Process_2021__synaptic vesicle exocytosis (GO:0016079),-0.3934995105403055,-0.7920223572902992,0.765625,1.0,1.0,3/24,11.60%,RIMS1;RAB3A;STX19
prerank,GO_Biological_Process_2021__chordate embryonic development (GO:0043009),0.38170456539812414,0.7919226584137115,0.78125,0.9493271031783026,1.0,5/28,7.13%,PKD2;PKD1;ARNT2;WNT5A;LIG4
prerank,GO_Biological_Process_2021__regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.4143843967593517,0.7917689532764715,0.6666666666666666,0.9490085949661118,1.0,4/7,36.44%,ECT2;SIRT2;CDC42;APC
prerank,GO_Biological_Process_2021__ketone body biosynthetic process (GO:0046951),-0.4710845551818177,-0.7911476923707937,0.7017543859649122,1.0,1.0,4/7,27.15%,HMGCL;BDH1;AACS;SLC27A5
prerank,GO_Biological_Process_2021__establishment of vesicle localization (GO:0051650),-0.44320732187602596,-0.7910266563235854,0.75,1.0,1.0,1/14,5.18%,RAB11A
prerank,GO_Biological_Process_2021__histone H2B ubiquitination (GO:0033523),-0.4806179814871971,-0.7908565280148084,0.7924528301886793,1.0,1.0,1/9,5.72%,DTX3L
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase I promoter (GO:0006361),-0.3862564653651594,-0.7907863280668468,0.7903225806451613,1.0,1.0,2/26,4.34%,TAF1D;GTF2H5
prerank,GO_Biological_Process_2021__cytosolic transport (GO:0016482),0.2865523983692605,0.7906783193698107,1.0,0.9501966664539366,1.0,15/101,14.60%,UBE2O;MYO1D;PTPN23;BAIAP3;TBC1D5;TBC1D10B;SORT1;RAB7A;RBSN;VTI1A;LAPTM5;RAB6A;YKT6;EVI5;STX6
prerank,GO_Biological_Process_2021__negative regulation of protein polyubiquitination (GO:1902915),-0.48984233066716915,-0.7905272265798176,0.76,1.0,1.0,2/5,37.23%,PPIA;PARP10
prerank,GO_Biological_Process_2021__neuron maturation (GO:0042551),0.3938779967963934,0.79032855763417,0.7647058823529411,0.9501146912734751,1.0,1/14,0.85%,LGI4
prerank,GO_Biological_Process_2021__positive regulation of Ras protein signal transduction (GO:0046579),-0.36857456049691445,-0.7903244778434257,0.782608695652174,1.0,1.0,10/38,22.82%,IGF1;ARHGEF3;P2RY8;PIK3CB;LPAR6;NOTCH2;RAC1;RASGRP4;LYN;RAPGEF1
prerank,GO_Biological_Process_2021__endosomal vesicle fusion (GO:0034058),-0.4691296992911499,-0.7900441615074419,0.7450980392156863,1.0,1.0,1/8,9.09%,SAMD9
prerank,GO_Biological_Process_2021__protein import into mitochondrial matrix (GO:0030150),-0.4870121853576696,-0.7898895025310715,0.7017543859649122,1.0,1.0,3/10,7.54%,DNAJC19;TIMM44;TIMM21
prerank,GO_Biological_Process_2021__regulation of endopeptidase activity (GO:0052548),-0.3786215658655324,-0.7898531210973939,0.746268656716418,1.0,1.0,13/35,19.69%,GAPDH;PRELID1;SPOCK2;PSMB9;SERPING1;TIMP2;AGT;PSMA3;APH1B;SERPINF1;PSME2;SPOCK1;PSME1
prerank,GO_Biological_Process_2021__histone H4-K8 acetylation (GO:0043982),-0.43530416864246213,-0.7898172729521794,0.7931034482758621,1.0,1.0,4/15,25.42%,ING4;KAT8;KANSL1;OGT
prerank,GO_Biological_Process_2021__histone H4-K5 acetylation (GO:0043981),-0.43530416864246213,-0.7898172729521794,0.7931034482758621,1.0,1.0,4/15,25.42%,ING4;KAT8;KANSL1;OGT
prerank,GO_Biological_Process_2021__hexose biosynthetic process (GO:0019319),-0.38753658789508133,-0.7893041803603026,0.7702702702702703,1.0,1.0,4/30,6.17%,GAPDH;MDH2;PER2;G6PC3
prerank,GO_Biological_Process_2021__negative regulation of growth (GO:0045926),-0.3399481562237476,-0.7889315317279723,0.8133333333333334,1.0,1.0,14/77,16.40%,MT2A;RACK1;ING5;TP53TG5;FBP1;BTG1;ING4;HSPA1B;ESR2;NOTCH2;HSPA1A;TCHP;PSRC1;MT3
prerank,GO_Biological_Process_2021__regulation of protein localization to cell surface (GO:2000008),-0.3902254227708881,-0.7886700647038005,0.8095238095238095,1.0,1.0,1/25,0.78%,RIC3
prerank,GO_Biological_Process_2021__embryonic axis specification (GO:0000578),-0.5227814951980492,-0.7886414629384851,0.7457627118644068,1.0,1.0,1/6,2.84%,STIL
prerank,GO_Biological_Process_2021__regulation of glycoprotein biosynthetic process (GO:0010559),0.4809039401581962,0.7880727358071933,0.6590909090909091,0.9529894409120968,1.0,1/5,1.57%,ABCA2
prerank,GO_Biological_Process_2021__regulation of heart contraction (GO:0008016),0.3277901682015862,0.7874863093193306,0.875,0.9533460116244619,1.0,3/44,3.23%,TRPC1;SMAD7;KCNIP2
prerank,GO_Biological_Process_2021__negative regulation of hydrolase activity (GO:0051346),0.3749852298583302,0.7874686242449495,0.7619047619047619,0.952875235176413,1.0,4/28,10.86%,SLC39A14;LRRK2;LRCH1;WNK1
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell differentiation (GO:0045639),-0.38371714707886456,-0.7872563585870503,0.8285714285714286,1.0,1.0,8/30,14.43%,ETS1;ANKRD54;STAT1;NCKAP1L;HIF1A;HSPA1B;ZNF16;HSPA1A
prerank,PanglaoDB_Augmented_2021__Spermatozoa,-0.35532873546364685,-0.7872256879390753,0.7761194029850746,1.0,1.0,19/72,16.72%,CCDC170;MGLL;ANKUB1;CD14;SGK1;CFLAR;MS4A6A;HLA-DRA;SMIM14;DNAH12;RASSF4;APOL6;HLA-DPA1;C3;HLA-DMB;CD74;ALDH2;GSAP;HLA-DPB1
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via JAK-STAT (GO:0046425),-0.4049736564976232,-0.7871618558875315,0.7121212121212122,1.0,1.0,2/21,5.34%,CCL5;IL10RA
prerank,GO_Biological_Process_2021__pre-mRNA cleavage required for polyadenylation (GO:0098789),-0.49344885630131763,-0.7870766996989368,0.7796610169491526,1.0,1.0,2/9,9.87%,CSTF2T;NCBP2
prerank,GO_Biological_Process_2021__macroautophagy (GO:0016236),0.28134621277933763,0.7865451991030888,0.967741935483871,0.9538546457450494,1.0,24/97,21.01%,PRKAB2;MAP1LC3A;TOMM70;TBC1D5;UBXN6;MFN1;RUBCNL;PIP4K2A;PRKAB1;ILRUN;ATP13A2;HDAC10;PRKAA1;ATG16L1;ATG13;ARL8B;TCIRG1;DYNLL2;CSNK2A1;EI24;VTA1;MTERF3;SNAP29;ULK1
prerank,GO_Biological_Process_2021__late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),-0.4454793163599803,-0.7863920630634262,0.7333333333333333,1.0,1.0,5/12,24.43%,SNF8;VPS28;TMEM50B;CHMP6;VPS36
prerank,GO_Biological_Process_2021__ciliary basal body-plasma membrane docking (GO:0097711),-0.34655433496095767,-0.7861067599895091,0.8082191780821918,1.0,1.0,21/76,24.63%,RPGRIP1L;SSNA1;RAB11A;CEP72;CEP164;TMEM67;CSNK1D;TUBB4B;PRKAR2B;CC2D2A;DCTN2;AKAP9;DYNC1I2;NINL;SFI1;HAUS5;TUBB4A;SCLT1;CEP250;TCTN1;CEP162
prerank,GO_Biological_Process_2021__RNA splicing (GO:0008380),-0.3491678225236679,-0.7857890753285007,0.8589743589743589,1.0,1.0,24/84,19.10%,DHX16;ZCRB1;SNRPD2;RNPC3;WDR83;SRPK1;PDCD7;ZRSR2;NCBP2;SMNDC1;PRPF3;DDX23;SRSF2;USB1;SRSF7;SNRPA1;SLU7;SCNM1;LSM4;LUC7L3;PRPF18;NRDE2;BCAS2;PRPF4
prerank,GO_Biological_Process_2021__N-acetylneuraminate metabolic process (GO:0006054),0.42728193267334175,0.7854269077355482,0.6842105263157895,0.9550559022461763,1.0,2/9,20.15%,RENBP;GNPDA1
prerank,GO_Biological_Process_2021__protein-containing complex subunit organization (GO:0043933),0.2998988472868569,0.7852896212712946,0.9142857142857143,0.9547815405337712,1.0,5/83,6.51%,PPARGC1A;MITF;PICALM;LIN7A;MAGI1
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane potential (GO:0051881),0.34050832307325657,0.7852084136045892,0.8076923076923077,0.9544223388321293,1.0,4/28,7.54%,RNF122;LRRK2;SPART;PPA2
prerank,GO_Biological_Process_2021__telomeric loop disassembly (GO:0090657),-0.49011677100669954,-0.7851734109662366,0.7454545454545455,1.0,1.0,3/7,25.12%,XRCC3;WRN;SLX4
prerank,GO_Biological_Process_2021__negative regulation of canonical Wnt signaling pathway (GO:0090090),0.298039444009964,0.7846210072869356,0.9230769230769231,0.9547769785595244,1.0,13/104,11.06%,LRP4;ZNRF3;RUVBL2;ANKRD6;TLE2;WNT5A;INVS;TMEM170B;DDIT3;DVL3;HDAC1;DKK2;TCF7L2
prerank,GO_Biological_Process_2021__negative regulation of viral entry into host cell (GO:0046597),-0.4925024361353082,-0.7843493664495478,0.8076923076923077,1.0,1.0,3/8,8.41%,TRIM5;IFITM3;LY6E
prerank,GO_Biological_Process_2021__positive regulation of cell growth (GO:0030307),0.3056247590913908,0.783871093127162,0.8095238095238095,0.955477956072476,1.0,20/67,22.55%,CDKN2AIP;CIB1;HPN;TAF9B;NEDD4L;SYT17;MMP14;SMURF1;MAP3K13;TGFBR1;MTPN;DDX3X;SHTN1;SEMA4D;RIMS2;CSNK2A1;SYT4;ZFYVE27;MFSD2A;ADAM10
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle phase transition (GO:1901990),-0.3260654659206848,-0.7838395112319239,0.9,1.0,1.0,34/144,22.15%,UBC;RPS27A;PSMB3;SSNA1;PSMB6;PSMA7;CEP72;PSMB9;CEP164;APPL1;PSMD12;ANAPC11;CSNK1D;PSMD8;PSMA5;TUBB4B;UBA52;CDC26;PSMA3;PRKAR2B;PSMC4;DCTN2;CENPF;BUB3;AKAP9;PSME2;PSME1;DYNC1I2;NINL;PSMB5;RGCC;SFI1;PSMC3;HAUS5
prerank,GO_Biological_Process_2021__phosphatidylcholine acyl-chain remodeling (GO:0036151),0.39391014508717875,0.783781648257309,0.7058823529411765,0.9550731915871364,1.0,1/17,0.68%,PLA2G4C
prerank,GO_Biological_Process_2021__mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.38411751616119294,0.783709429470916,0.7878787878787878,0.9546884685093766,1.0,7/24,18.65%,FOXN3;FZR1;BRSK1;CDC14B;BLM;NBN;TAOK2
prerank,GO_Biological_Process_2021__IRE1-mediated unfolded protein response (GO:0036498),-0.38425198967107144,-0.7836088006048526,0.8088235294117647,1.0,1.0,4/42,6.27%,DDX11;TPP1;DNAJB9;HDGF
prerank,GO_Biological_Process_2021__establishment of protein localization to peroxisome (GO:0072663),0.47513886492741764,0.7834700838806476,0.74,0.9540312393175713,1.0,2/6,16.09%,ZFAND6;PEX16
prerank,GO_Biological_Process_2021__peroxisomal transport (GO:0043574),0.47513886492741764,0.7834700838806476,0.74,0.9540312393175713,1.0,2/6,16.09%,ZFAND6;PEX16
prerank,GO_Biological_Process_2021__negative regulation of cAMP-mediated signaling (GO:0043951),0.46494873657040015,0.783379673684149,0.7727272727272727,0.9536281266504947,1.0,1/7,10.95%,PDE3B
prerank,GO_Biological_Process_2021__positive regulation of ATP metabolic process (GO:1903580),-0.3859012505512759,-0.7831936827781355,0.7692307692307693,1.0,1.0,7/25,11.98%,PID1;IGF1;PFKFB3;TMSB4X;PFKFB4;HIF1A;ENTPD5
prerank,GO_Biological_Process_2021__glucosamine-containing compound catabolic process (GO:1901072),0.4939225090973093,0.7831834282630661,0.75,0.9533754258052313,1.0,1/6,0.62%,CTBS
prerank,GO_Biological_Process_2021__histone H4 acetylation (GO:0043967),0.3477809577446488,0.7828807174475358,0.7222222222222222,0.9532468248866437,1.0,3/43,3.65%,RUVBL2;MSL2;CHD5
prerank,GO_Biological_Process_2021__actin polymerization or depolymerization (GO:0008154),-0.3791667770651026,-0.782853632594376,0.8194444444444444,1.0,1.0,5/43,8.34%,CATIP;AIF1;PSTPIP1;VILL;CFL1
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.426817400988283,0.7827567613382606,0.8536585365853658,0.9529294634922709,1.0,2/11,7.93%,PARP1;MMS19
prerank,GO_Biological_Process_2021__regulation of nucleic acid-templated transcription (GO:1903506),-0.3023521111647663,-0.7826103570956576,0.9333333333333333,1.0,1.0,29/281,12.59%,MYBL1;PPIE;RUNX3;PRKCQ;CHD3;ATF5;TAF6L;EDF1;RORA;OGG1;BHLHE40;ZNF331;TRIM22;MSL3;PLAG1;BRCA2;RPL6;DVL1;HINT1;REXO4;MLX;HIF1A;BTG1;TCF3;GLI4;GLRX2;GCFC2;CREM;TERF2IP
prerank,GO_Biological_Process_2021__protein homooligomerization (GO:0051260),-0.33850467791117383,-0.7823503374079837,0.8108108108108109,1.0,1.0,6/77,5.68%,APIP;B2M;PRF1;RNF213;AQP11;JMJD6
prerank,GO_Biological_Process_2021__regulation of cation transmembrane transport (GO:1904062),0.4017376163842224,0.7820735712844438,0.7948717948717948,0.953504347701662,1.0,7/19,20.05%,KCNIP2;WNK1;SLMAP;KCNN2;DPP10;DPP6;HOMER1
prerank,GO_Biological_Process_2021__regulation of centrosome duplication (GO:0010824),-0.3848677104142789,-0.7819416331654984,0.7857142857142857,1.0,1.0,4/23,10.59%,STIL;XRCC3;TMEM67;NPM1
prerank,GO_Biological_Process_2021__insulin secretion involved in cellular response to glucose stimulus (GO:0035773),0.44704684189923405,0.7815677333584381,0.8292682926829268,0.9536947156899417,1.0,1/5,12.32%,PTPRN
prerank,PanglaoDB_Augmented_2021__Paneth Cells,-0.40498134497866156,-0.7815023853634674,0.8103448275862069,1.0,1.0,4/18,14.09%,TNFSF10;FBP1;CASP5;NOD2
prerank,GO_Biological_Process_2021__cellular response to decreased oxygen levels (GO:0036294),-0.37393671219639874,-0.7813729467508794,0.8135593220338984,1.0,1.0,11/39,18.04%,CARD16;RORA;EGLN3;VEGFA;HIF1A;NOP53;PGK1;PICK1;MT3;PINK1;FAM162A
prerank,GO_Biological_Process_2021__maintenance of blood-brain barrier (GO:0035633),-0.42136362523925247,-0.781282918987466,0.7333333333333333,1.0,1.0,5/17,19.27%,PECAM1;ACTG1;ACTB;ITGB1;LAMA2
prerank,GO_Biological_Process_2021__dendritic spine organization (GO:0097061),0.3767985665527272,0.7810466934895617,0.7931034482758621,0.9538458596532342,1.0,4/21,11.81%,IGF1R;DOCK10;SHANK3;PTEN
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),-0.4705394603760241,-0.7803267007638273,0.7543859649122807,1.0,1.0,3/9,22.54%,ACAA1;ECI2;SCP2
prerank,GO_Biological_Process_2021__regulation of collateral sprouting (GO:0048670),-0.4990099554029619,-0.780308868279481,0.7407407407407407,1.0,1.0,1/6,6.76%,FGF13
prerank,GO_Biological_Process_2021__chemical homeostasis (GO:0048878),0.32321165219383574,0.7798320116247991,0.8125,0.9551537999319897,1.0,8/35,10.86%,PPARG;VGF;ABHD8;NEDD4L;SLC4A4;ACOX3;FBXW7;WNK1
prerank,GO_Biological_Process_2021__L-serine metabolic process (GO:0006563),-0.4660071974276787,-0.7795776801949935,0.7142857142857143,1.0,1.0,1/6,15.99%,SHMT1
prerank,GO_Biological_Process_2021__signal release from synapse (GO:0099643),-0.4010700188139249,-0.7791166781447106,0.7727272727272727,1.0,1.0,3/31,9.43%,RIMS1;RAB3A;DVL1
prerank,GO_Biological_Process_2021__actin-mediated cell contraction (GO:0070252),0.4938483300960578,0.7790853732181073,0.8372093023255814,0.9557782274129057,1.0,2/7,1.66%,PDPN;GSN
prerank,GO_Biological_Process_2021__homeostasis of number of cells (GO:0048872),0.4529492657431455,0.7787351905738157,0.6530612244897959,0.9558695759116207,1.0,4/7,27.76%,NAPEPLD;OCIAD1;NOTCH1;UBAP2L
prerank,GO_Biological_Process_2021__regulation of cell cycle process (GO:0010564),-0.37389759592499594,-0.778622691244492,0.7857142857142857,1.0,1.0,7/64,9.53%,ATF5;RAB11A;TIPIN;KLHL13;ENTR1;CALM1;IHO1
prerank,GO_Biological_Process_2021__regulation of cell division (GO:0051302),-0.3728324397431408,-0.7786000878830598,0.7611940298507462,1.0,1.0,6/47,9.34%,RACK1;RAB11A;KLHL13;ENTR1;CALM1;EFHC1
prerank,GO_Biological_Process_2021__regulation of telomerase RNA localization to Cajal body (GO:1904872),0.3946936499332189,0.7785959954775065,0.8333333333333334,0.955610403357848,1.0,5/18,18.36%,RUVBL2;TCP1;CCT3;NAF1;SHQ1
prerank,GO_Biological_Process_2021__negative regulation of coagulation (GO:0050819),0.5020461718722137,0.7780790265420201,0.75,0.9560195501328769,1.0,3/6,2.96%,HS3ST5;SERPINE1;SERPINE2
prerank,GO_Biological_Process_2021__miRNA loading onto RISC involved in gene silencing by miRNA (GO:0035280),-0.5071053882051778,-0.7778872794763458,0.8695652173913043,1.0,1.0,2/6,20.58%,ADAR;DICER1
prerank,GO_Biological_Process_2021__midbody abscission (GO:0061952),0.40256951386963247,0.7777431861050383,0.7555555555555555,0.955993940085626,1.0,2/11,14.09%,CHMP7;CHMP1A
prerank,GO_Biological_Process_2021__regulation of helicase activity (GO:0051095),-0.48011224894811744,-0.7769649744874519,0.8148148148148148,1.0,1.0,2/9,9.47%,IFIT1;CHTOP
prerank,GO_Biological_Process_2021__positive regulation of histone methylation (GO:0031062),0.372169119658179,0.776563963711919,0.825,0.9572900532972174,1.0,2/18,8.34%,SIRT1;AUTS2
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta2 production (GO:0032909),0.5435080533130016,0.7765560936613581,0.875,0.9568040352289834,1.0,2/5,12.30%,SMAD3;BMPR1A
prerank,GO_Biological_Process_2021__cellular response to chemical stress (GO:0062197),-0.33441250662145006,-0.7765088882021242,0.8734177215189873,1.0,1.0,16/76,14.43%,CYCS;AIF1;CHCHD2;NCF4;ERO1A;GSTP1;ERMP1;TRPV4;NCF2;SELENOS;PRR5L;HSPA1B;CYBA;SOD1;GPX1;HSPA1A
prerank,GO_Biological_Process_2021__regulation of defense response (GO:0031347),-0.35669409790922274,-0.7764301621578408,0.7746478873239436,1.0,1.0,14/52,20.21%,MGLL;DHX58;TMSB4X;IRF1;ERAP1;APPL1;CASP5;NOD2;AKNA;CASP4;PTPN22;NR1D2;UFL1;HERC5
prerank,GO_Biological_Process_2021__nucleoside diphosphate catabolic process (GO:0009134),-0.500159632334477,-0.7762893994978152,0.7551020408163265,1.0,1.0,2/6,11.98%,ENTPD4;ENTPD5
prerank,GO_Biological_Process_2021__positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.4544443397237041,0.776214273817857,0.7391304347826086,0.9568168788127293,1.0,4/7,25.72%,MAP2K1;MAP2K2;RIPK1;TGFB1
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),-0.45873423213495734,-0.7761807454347694,0.7586206896551724,1.0,1.0,2/7,17.23%,NOS1AP;CACNB1
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),-0.35063598432122195,-0.7761594581945785,0.8732394366197183,1.0,1.0,15/70,18.87%,CCL5;PARP14;IGF1;PECAM1;PARP9;ENPP2;CD44;BANK1;VEGFA;PTPRC;CD74;AGT;IL18;NEDD9;TNFRSF14
prerank,GO_Biological_Process_2021__embryonic skeletal system development (GO:0048706),-0.46879058194709755,-0.7759077527796016,0.7540983606557377,1.0,1.0,3/9,15.68%,SULF2;DYNC2I1;PCSK5
prerank,GO_Biological_Process_2021__intermediate filament organization (GO:0045109),0.45268933849359894,0.7758310346334315,0.7906976744186046,0.9568685197850341,1.0,1/7,2.32%,GFAP
prerank,GO_Biological_Process_2021__regulation of cellular metabolic process (GO:0031323),0.32917210006196307,0.7756778887121715,0.8333333333333334,0.9565257366602411,1.0,4/36,7.76%,ABCA2;PDK4;TBC1D16;ACACB
prerank,GO_Biological_Process_2021__negative regulation of Ras protein signal transduction (GO:0046580),-0.3632190965313622,-0.7755968789686533,0.803030303030303,1.0,1.0,1/29,0.96%,RIPOR2
prerank,GO_Biological_Process_2021__regulation of macrophage migration (GO:1905521),-0.45809790777202447,-0.7753400174711998,0.746031746031746,1.0,1.0,1/7,3.15%,CD200R1
prerank,GO_Biological_Process_2021__positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),-0.4758310082912376,-0.7752673901016517,0.7272727272727273,1.0,1.0,2/7,10.20%,PRKCQ;SLC11A1
prerank,GO_Biological_Process_2021__positive regulation of pinocytosis (GO:0048549),0.4800610783538142,0.7750234654875673,0.7708333333333334,0.9569328667006235,1.0,1/6,6.14%,PPT1
prerank,GO_Biological_Process_2021__nuclear membrane organization (GO:0071763),-0.4507732898756962,-0.7745933712596982,0.7543859649122807,1.0,1.0,1/16,4.25%,EMD
prerank,GO_Biological_Process_2021__rescue of stalled ribosome (GO:0072344),0.49660694511549897,0.7742092273573121,0.7647058823529411,0.9575462238692816,1.0,1/5,1.81%,ZNF598
prerank,GO_Biological_Process_2021__hexose metabolic process (GO:0019318),-0.41414302858970287,-0.7741796932849359,0.78125,1.0,1.0,3/23,11.31%,APOD;OAS1;FBP1
prerank,GO_Biological_Process_2021__positive regulation of sphingolipid biosynthetic process (GO:0090154),-0.4711239739348956,-0.7741348866582188,0.7833333333333333,1.0,1.0,1/9,4.24%,RACK1
prerank,GO_Biological_Process_2021__positive regulation of ceramide biosynthetic process (GO:2000304),-0.4711239739348956,-0.7741348866582188,0.7833333333333333,1.0,1.0,1/9,4.24%,RACK1
prerank,GO_Biological_Process_2021__cellular response to X-ray (GO:0071481),0.48337244976459504,0.7740768086923308,0.7391304347826086,0.9571907182031453,1.0,1/5,13.48%,NIPBL
prerank,GO_Biological_Process_2021__signal peptide processing (GO:0006465),-0.4715299945227075,-0.7739502853591445,0.7413793103448276,1.0,1.0,3/8,23.96%,PCSK5;SEC11A;SPCS2
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway (GO:0060396),-0.43122708173575053,-0.7738312222967846,0.7192982456140351,1.0,1.0,1/13,6.83%,PRLR
prerank,GO_Biological_Process_2021__ncRNA 3'-end processing (GO:0043628),-0.44951759118674406,-0.773536761666248,0.7761194029850746,1.0,1.0,1/11,3.42%,SSB
prerank,GO_Biological_Process_2021__positive regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045899),-0.4918688753574123,-0.7735034545323851,0.7090909090909091,1.0,1.0,2/7,22.04%,PSMC4;PSMC3
prerank,GO_Biological_Process_2021__dopaminergic neuron differentiation (GO:0071542),0.44332760107954144,0.7731598839123123,0.6888888888888889,0.958035530792931,1.0,2/6,15.75%,RYK;MANF
prerank,GO_Biological_Process_2021__positive regulation of inflammatory response (GO:0050729),-0.35152142557711774,-0.7729557507532442,0.8055555555555556,1.0,1.0,6/53,12.25%,CCL3;ETS1;OSMR;NLRP12;KARS1;CD47
prerank,GO_Biological_Process_2021__ventricular trabecula myocardium morphogenesis (GO:0003222),0.441878600282008,0.7728213996608134,0.8055555555555556,0.9580928057208327,1.0,3/7,15.21%,NRG1;BMPR1A;TGFBR1
prerank,GO_Biological_Process_2021__chondrocyte differentiation (GO:0002062),-0.39973709698778054,-0.771847282568272,0.8275862068965517,1.0,1.0,2/18,6.07%,RUNX3;SULF2
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),-0.396878892025156,-0.771507774625226,0.8166666666666667,1.0,1.0,2/23,4.77%,GZMB;CHCHD10
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transporter activity (GO:0032412),0.3433570112143661,0.7714742262526643,0.8484848484848485,0.9597675692718297,1.0,10/26,21.45%,SCN3B;NEDD4L;FXYD5;AHCYL1;FXYD7;NEDD4;SCN1B;HOMER1;CHRM3;YWHAE
prerank,GO_Biological_Process_2021__regulation of protein localization to plasma membrane (GO:1903076),0.310917923184923,0.771272856657841,0.9285714285714286,0.9595984272246213,1.0,7/57,14.07%,PTPN9;PICALM;CIB1;TNF;ARF6;PRKCI;MMP14
prerank,GO_Biological_Process_2021__aspartate family amino acid catabolic process (GO:0009068),0.4025180460923852,0.7709705518160384,0.7111111111111111,0.9594938407055063,1.0,3/13,12.29%,ASPA;SLC25A21;GCDH
prerank,GO_Biological_Process_2021__response to organic cyclic compound (GO:0014070),-0.40973185777681187,-0.7703492095493099,0.8507462686567164,1.0,1.0,2/28,1.49%,CCL3;CCL5
prerank,GO_Biological_Process_2021__neurotransmitter secretion (GO:0007269),-0.39139425782033055,-0.7702441698898143,0.7761194029850746,1.0,1.0,3/32,9.43%,RIMS1;RAB3A;DVL1
prerank,GO_Biological_Process_2021__mRNA 3'-end processing (GO:0031124),0.3075803388496452,0.7701868308417602,0.92,0.9602258045627338,1.0,7/61,8.84%,POLR2D;U2AF1;CPSF4;WDR33;SSU72;PCF11;SCAF8
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity by regulation of protein phosphorylation (GO:0044387),-0.5066452675674208,-0.770007899887007,0.7843137254901961,1.0,1.0,3/5,25.76%,NPM1;ADAR;ADARB1
prerank,GO_Biological_Process_2021__monovalent inorganic anion homeostasis (GO:0055083),0.4759651247652672,0.7698817581305788,0.7272727272727273,0.9596178049035347,1.0,3/7,15.33%,SLC12A6;SLC12A5;SLC12A2
prerank,GO_Biological_Process_2021__chloride ion homeostasis (GO:0055064),0.4759651247652672,0.7698817581305788,0.7272727272727273,0.9596178049035347,1.0,3/7,15.33%,SLC12A6;SLC12A5;SLC12A2
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase activity (GO:0050999),-0.3804229074227372,-0.7695948020641388,0.7741935483870968,1.0,1.0,5/27,16.05%,GLA;CALM1;HIF1A;PIK3CB;NOS1AP
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle (GO:0045930),0.3737835608486078,0.7695914026278544,0.8666666666666667,0.9594427670516469,1.0,9/30,12.62%,SCRIB;FZD3;SMAD3;PRCC;BRINP3;NME6;PLK2;HECA;TRIM35
prerank,GO_Biological_Process_2021__coronary vasculature morphogenesis (GO:0060977),0.437546555274584,0.7695883623063359,0.7674418604651163,0.9589404692252276,1.0,2/7,3.63%,NRP1;SPRED1
prerank,GO_Biological_Process_2021__regulation of insulin receptor signaling pathway (GO:0046626),-0.38693109041746476,-0.7694585651190677,0.7714285714285715,1.0,1.0,2/30,1.81%,PRKCQ;PID1
prerank,GO_Biological_Process_2021__regulation of mitotic spindle organization (GO:0060236),0.34825569928389655,0.7693752476710537,0.8055555555555556,0.9586825535502653,1.0,4/26,19.56%,BORA;CHMP1A;DYNC1H1;HNRNPU
prerank,GO_Biological_Process_2021__mRNA cleavage involved in mRNA processing (GO:0098787),-0.46800953356432873,-0.768741958744814,0.8333333333333334,1.0,1.0,2/10,9.87%,CSTF2T;NCBP2
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host programmed cell death (GO:0052041),-0.47766029216563055,-0.768499549653969,0.8301886792452831,1.0,1.0,1/7,3.95%,RNF213
prerank,GO_Biological_Process_2021__positive regulation of mononuclear cell migration (GO:0071677),-0.417504443170647,-0.7683979409134127,0.71875,1.0,1.0,2/17,2.67%,CCL5;AIF1
prerank,GO_Biological_Process_2021__transcription by RNA polymerase II (GO:0006366),-0.30310981631051803,-0.76836320562275,0.9195402298850575,1.0,1.0,14/238,7.21%,NR4A3;CEBPD;SNAPC1;CSTF2T;RORA;BTF3;GTF2H5;CTDP1;ELOB;ADRM1;NR1H2;C5AR1;POLR2G;RNMT
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),-0.33386287475744836,-0.7680624481356906,0.8208955223880597,1.0,1.0,15/73,19.77%,FCER1G;HLA-DRB5;DCTN6;HLA-DRA;DCTN4;DYNC1LI2;HLA-DPA1;HLA-DMB;AP2S1;CD74;SEC13;HLA-DPB1;DCTN2;HLA-DRB1;DYNC1I2
prerank,GO_Biological_Process_2021__transcription by RNA polymerase I (GO:0006360),-0.37978717059371064,-0.7678508961061139,0.859375,1.0,1.0,2/28,4.34%,TAF1D;GTF2H5
prerank,GO_Biological_Process_2021__positive regulation of response to DNA damage stimulus (GO:2001022),0.33479028631488095,0.7675504371241056,0.8888888888888888,0.961028873468451,1.0,6/36,12.03%,SIRT1;SPRED1;SPRED2;NACC2;NSMCE1;UBE2N
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.30830855265401474,0.7673811964247576,0.8780487804878049,0.9608214077450536,1.0,7/45,13.66%,SIRT1;LRRK2;HYOU1;TXNDC12;MDM2;SOD2;BAG5
prerank,GO_Biological_Process_2021__cardiocyte differentiation (GO:0035051),0.42351595669045516,0.7672488194003279,0.8205128205128205,0.9604668025527007,1.0,1/5,6.19%,NRG1
prerank,GO_Biological_Process_2021__positive regulation of response to stimulus (GO:0048584),-0.39932025947818284,-0.7670337192716651,0.8947368421052632,1.0,1.0,2/28,2.81%,RSAD2;B2M
prerank,PanglaoDB_Augmented_2021__Beta Cells,-0.3258582799672298,-0.7667079067197876,0.9066666666666666,1.0,1.0,4/90,3.85%,TGFBR3;RIMS1;HAMP;RGS16
prerank,GO_Biological_Process_2021__regulation of ceramide biosynthetic process (GO:2000303),-0.4505898229627119,-0.7665276213216211,0.7936507936507936,1.0,1.0,2/12,9.50%,RACK1;ORMDL1
prerank,GO_Biological_Process_2021__regulation of necrotic cell death (GO:0010939),-0.4914277247457473,-0.7664291076937224,0.7818181818181819,1.0,1.0,3/5,27.45%,MT3;HEBP2;ASAH1
prerank,GO_Biological_Process_2021__regulation of macrophage apoptotic process (GO:2000109),0.4623716837466941,0.7663236187785751,0.75,0.9614060845249252,1.0,1/6,2.51%,SIRT1
prerank,GO_Biological_Process_2021__regulation of dopamine secretion (GO:0014059),0.41704424070301804,0.7662315873378044,0.7906976744186046,0.9610835458577991,1.0,4/11,22.41%,SYT17;SNCA;SYT4;DTNBP1
prerank,GO_Biological_Process_2021__purine ribonucleotide metabolic process (GO:0009150),0.332686556015553,0.7660330414441292,0.8888888888888888,0.9608828863979672,1.0,7/40,14.62%,EFL1;LRRK2;DBI;GPAT4;MFN1;AK3;ENPP1
prerank,GO_Biological_Process_2021__long-chain fatty acid metabolic process (GO:0001676),-0.37210493289378943,-0.766023113977097,0.8524590163934426,1.0,1.0,9/36,14.59%,MGLL;GSTM4;EPHX1;GSTP1;ACAA1;FAAH2;GPX4;GPX1;ALOX12
prerank,GO_Biological_Process_2021__negative regulation of protein targeting to membrane (GO:0090315),-0.5152363964490668,-0.7659388194034803,0.8571428571428571,1.0,1.0,2/5,30.75%,INPP5K;DMTN
prerank,GO_Biological_Process_2021__regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.49400260983675026,0.7656305162022261,0.7272727272727273,0.9608806336847516,1.0,5/7,22.89%,NPTXR;NPTX1;DLGAP4;DLGAP1;DLGAP2
prerank,GO_Biological_Process_2021__cytoplasmic microtubule organization (GO:0031122),-0.3551105748866317,-0.7653830691122883,0.90625,1.0,1.0,8/48,17.60%,CCDC88C;RAB11A;TRPV4;TUBGCP2;WDR73;TUBGCP5;HOOK2;EZR
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase II (GO:0006357),-0.2812291736757941,-0.7648112156429433,1.0,1.0,1.0,147/1260,14.39%,NR4A3;IL4I1;SKAP1;STAT4;MYBL1;BCL11B;UBC;CEBPD;FOSL2;FOS;RPS27A;RUNX3;ZFP36;JUNB;PID1;CTDSP1;RPS14;ZSCAN9;HAMP;IKZF3;CHD3;ATF5;TAF6L;CSRNP1;USF1;PER3;PER2;RORA;ZNF790;CHCHD2;PARP15;H1-0;ZNF335;ZNF689;DDRGK1;BEX1;GTF2H5;ETS1;CTDP1;BHLHE40;RPL10;SP110;HESX1;NR1H2;JUP;RPL23;IGF1;JMJD6;TXK;BRD9;HDGF;ZSCAN30;ZNF32;MED25;SP140;TCF25;NLRC5;PARP9;CRYM;BRD3;IER2;PLSCR1;ZNF76;PLAG1;ZNF805;SNF8;ZNF449;NAMPT;ZNF789;ZNF649;ZNF570;EID1;RNASEL;ZNF600;PRKD2;RBPJ;ITGA6;ZFP30;OVOL2;KANK2;ZNF394;VENTX;ZNF589;DVL1;STAT1;MEIS1;ZNF513;EIF5A;ZNF821;SMARCD1;SLC11A1;LITAF;IRF1;ZNF266;ZNF70;ZNF260;NPM1;CITED2;KDM7A;ZNF546;KDM6B;ZNF354A;MLX;VEGFA;ZNF528;FBP1;HIF1A;STING1;MXI1;ZSCAN29;TCF3;ZNF432;NOP53;BUD31;ATF3;TEF;GMEB1;ZNF586;HIRA;MAX;CREM;ATF1;ZNF674;PRDM1;KAT5;APEX1;DDX5;NRL;ZNF549;ZNF302;ZNF16;PRDM15;NR4A1;UXT;ZNF217;ZNF558;ZNF18;ESR2;TET1;ZNF681;NOD2;CAMK1;CCND1;REL;BRCA1;ZNF333;ZKSCAN3
prerank,GO_Biological_Process_2021__regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.409468854849052,0.7646399566955512,0.7948717948717948,0.9619582948138771,1.0,6/16,18.72%,CIB1;TNF;SLC9A1;GSK3B;CAMTA1;CHP1
prerank,GO_Biological_Process_2021__regulation of histone H2B ubiquitination (GO:2001166),0.5334354140054343,0.7643960088928324,0.8571428571428571,0.9618660643406731,1.0,2/5,20.63%,RNF20;CDK9
prerank,GO_Biological_Process_2021__long-term memory (GO:0007616),0.4434120428011269,0.7643149079253744,0.7555555555555555,0.9614866838789743,1.0,2/10,11.55%,LDLR;KAT2A
prerank,GO_Biological_Process_2021__negative regulation of cell death (GO:0060548),0.3100620093080497,0.7636912448670198,0.9629629629629629,0.96175207394933,1.0,13/60,17.34%,PPARGC1A;FGF2;LRRK2;TXNDC12;SOX4;SORL1;GPNMB;FERMT2;SRGAP2;ATP13A2;GSK3B;INPP5A;TM7SF3
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species metabolic process (GO:2000377),-0.377581923943745,-0.7635781789733932,0.78125,1.0,1.0,7/35,18.40%,PID1;BRCA1;AGT;MT3;RAC1;PINK1;PDK3
prerank,"GO_Biological_Process_2021__vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.31873549210601804,0.7633340423376808,0.9310344827586207,0.9607439040872284,1.0,7/50,9.45%,TGFA;BET1;CTSC;RAB1B;SEC24B;TMED10;GRIA1
prerank,GO_Biological_Process_2021__COPII vesicle coating (GO:0048208),0.31873549210601804,0.7633340423376808,0.9310344827586207,0.9607439040872284,1.0,7/50,9.45%,TGFA;BET1;CTSC;RAB1B;SEC24B;TMED10;GRIA1
prerank,GO_Biological_Process_2021__vesicle coating (GO:0006901),0.31873549210601804,0.7633340423376808,0.9310344827586207,0.9607439040872284,1.0,7/50,9.45%,TGFA;BET1;CTSC;RAB1B;SEC24B;TMED10;GRIA1
prerank,GO_Biological_Process_2021__protein transmembrane import into intracellular organelle (GO:0044743),-0.4093080730571386,-0.7627492899244079,0.7419354838709677,1.0,1.0,3/20,7.54%,DNAJC19;TIMM44;TIMM21
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.3570860004498087,0.7625454248423468,0.8333333333333334,0.9612892521713624,1.0,9/26,19.55%,CIB1;DYRK1A;CLASP1;FKBP4;CLASP2;CAMSAP2;ATXN7;SNCA;MAP2
prerank,GO_Biological_Process_2021__regulation of protein phosphorylation (GO:0001932),-0.3053592585784822,-0.76251372441113,0.9166666666666666,1.0,1.0,30/180,16.58%,CCDC88C;TFRC;CARD14;PID1;WARS1;MARCO;PAQR3;RACK1;PECAM1;MUSK;FYN;TTN;ANKRD54;ITGB2;NPM1;PRR5L;AKAP8;VEGFA;NOP53;ATF3;TERF2IP;CSNK1D;SOD1;CCND1;FGF20;C3;CD74;MT3;FLOT1;RAC1
prerank,GO_Biological_Process_2021__regulation of autophagy of mitochondrion (GO:1903146),-0.42945377759940684,-0.7624976758592515,0.8297872340425532,1.0,1.0,7/17,29.58%,USP36;PINK1;CSNK2A2;PARK7;SREBF1;HTRA2;HAX1
prerank,GO_Biological_Process_2021__histone H3-K4 demethylation (GO:0034720),-0.4899979725727217,-0.7623222573314787,0.7678571428571429,1.0,1.0,2/7,27.53%,KDM1B;KDM5C
prerank,GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis (GO:0090501),-0.4003773616460237,-0.7621374238421307,0.8688524590163934,1.0,1.0,8/21,21.97%,NYNRIN;NUDT16;NHP2;RNASE6;TRIR;DICER1;ERN1;PARN
prerank,GO_Biological_Process_2021__negative regulation of leukocyte apoptotic process (GO:2000107),-0.4700049696720683,-0.7621105570784337,0.7735849056603774,1.0,1.0,3/9,17.04%,SELENOS;NOD2;IRF7
prerank,GO_Biological_Process_2021__positive regulation of nuclear division (GO:0051785),0.43692968142554434,0.7617998703100364,0.7560975609756098,0.9619231111508094,1.0,1/9,2.15%,TGFA
prerank,GO_Biological_Process_2021__stress granule assembly (GO:0034063),-0.4144263241848738,-0.7612858908113781,0.7761194029850746,1.0,1.0,1/19,3.06%,RPS23
prerank,GO_Biological_Process_2021__regulation of cell adhesion (GO:0030155),-0.3268377261982124,-0.761037130167273,0.9,1.0,1.0,4/82,1.54%,RIPOR2;CXCR4;CCL5;DUSP1
prerank,GO_Biological_Process_2021__serine family amino acid metabolic process (GO:0009069),0.467166728585775,0.76069321574039,0.8,0.9629188131282924,1.0,1/7,1.41%,GCLC
prerank,GO_Biological_Process_2021__nucleus organization (GO:0006997),-0.3569550357638169,-0.760380806289111,0.8125,1.0,1.0,2/36,3.97%,USP36;SYNE1
prerank,GO_Biological_Process_2021__ncRNA catabolic process (GO:0034661),-0.39163824754756726,-0.7602600900880696,0.7794117647058824,1.0,1.0,7/21,21.97%,EXOSC10;ZCCHC8;NUDT16;DEDD2;TRIR;TENT4B;PARN
prerank,GO_Biological_Process_2021__transcription elongation from RNA polymerase II promoter (GO:0006368),-0.3380930246916371,-0.7598418327077451,0.8888888888888888,1.0,1.0,6/57,9.87%,GTF2H5;CTDP1;ELOB;ADRM1;POLR2G;NCBP2
prerank,GO_Biological_Process_2021__negative regulation of cation channel activity (GO:2001258),-0.4385970587901267,-0.7594966466820489,0.734375,1.0,1.0,3/11,8.36%,GNB5;SRI;CALM1
prerank,GO_Biological_Process_2021__regulation of programmed cell death (GO:0043067),-0.3203602720919077,-0.7590617875957699,0.88,1.0,1.0,19/122,15.92%,IKZF3;PRELID1;TNFRSF25;USP36;CTSB;CLU;RPS3;TPT1;SGK1;TMEM219;KANK2;STAT1;BCL2L14;NOP53;APEX1;TP53INP1;PIDD1;LGALS1;AGT
prerank,GO_Biological_Process_2021__regulation of nitric oxide metabolic process (GO:0080164),-0.45930682860479133,-0.7585777730688992,0.8333333333333334,1.0,1.0,4/8,16.58%,SELENOS;CD47;NOS1AP;RAC1
prerank,GO_Biological_Process_2021__regulation of cellular component organization (GO:0051128),-0.31841993536801816,-0.7585575493316461,0.9113924050632911,1.0,1.0,5/103,4.79%,CD36;TFRC;PRKCQ;ATF5;OGFR
prerank,GO_Biological_Process_2021__intracellular protein transmembrane transport (GO:0065002),-0.37023171094583884,-0.758552033048831,0.7384615384615385,1.0,1.0,5/32,13.88%,DNAJC19;TIMM44;TIMM21;SEC62;TOMM40
prerank,GO_Biological_Process_2021__regulation of cellular macromolecule biosynthetic process (GO:2000112),-0.29460007300444624,-0.7582865727667083,0.9655172413793104,1.0,1.0,32/310,12.59%,MYBL1;PPIE;RUNX3;PRKCQ;CHD3;ATF5;TAF6L;EDF1;RORA;OGG1;BHLHE40;RPL10;ZNF331;TRIM22;MSL3;PLAG1;BRCA2;RPL6;DVL1;HINT1;REXO4;MLX;HIF1A;EIF2A;BTG1;TCF3;GLI4;GLRX2;GCFC2;RBM4B;CREM;TERF2IP
prerank,GO_Biological_Process_2021__ephrin receptor signaling pathway (GO:0048013),-0.3531140474910855,-0.7582538757594883,0.8076923076923077,1.0,1.0,12/63,19.57%,VAV3;YES1;EPHB1;FYN;ACTG1;ACTB;EFNB2;AP2S1;RAC1;APH1B;ITSN1;EPHB2
prerank,GO_Biological_Process_2021__amide transport (GO:0042886),-0.4029159097346272,-0.758014361848501,0.78125,1.0,1.0,5/17,11.24%,PLTP;AQP11;SLC14A1;ABCB9;TAP1
prerank,GO_Biological_Process_2021__establishment of protein localization to plasma membrane (GO:0061951),0.3497729374405958,0.7573278099384141,0.9069767441860465,0.9673968127419411,1.0,6/29,12.69%,GOLPH3L;RAB10;GOLGA7;RAB7A;BLZF1;AFDN
prerank,GO_Biological_Process_2021__protein targeting to lysosome (GO:0006622),0.38336215418519076,0.7570860839747197,0.8292682926829268,0.9671497376688452,1.0,5/20,11.83%,SCARB2;RAB7A;LAPTM5;NCOA4;SORL1
prerank,GO_Biological_Process_2021__positive regulation of protein phosphorylation (GO:0001934),-0.29699843319629965,-0.7569460941219222,0.9647058823529412,1.0,1.0,32/226,16.58%,CALCR;TFRC;CARD14;PDGFD;MARCO;CEMIP;DDRGK1;RACK1;IGF1;PECAM1;MUSK;ENPP2;CALM1;PRKD2;CD44;CHI3L1;BANK1;VEGFA;MTCP1;TERF2IP;CSNK1D;PTPRC;CAMK1;CCND1;FGF20;C3;SNX9;CD74;AGT;MT3;FLOT1;RAC1
prerank,GO_Biological_Process_2021__regulation of interleukin-2 production (GO:0032663),-0.36472644143592897,-0.7568572305207397,0.8253968253968254,1.0,1.0,9/36,13.66%,ZFP36;LILRB4;RPS3;TNFAIP3;PRKD2;GLMN;PTPRC;KAT5;HAVCR2
prerank,GO_Biological_Process_2021__positive regulation of tissue remodeling (GO:0034105),-0.5054864011046853,-0.7564470044798811,0.7592592592592593,1.0,1.0,1/5,17.61%,IL18
prerank,GO_Biological_Process_2021__erythrocyte development (GO:0048821),-0.46432327758053715,-0.7564390829093782,0.78,1.0,1.0,2/8,20.60%,NCKAP1L;MED1
prerank,GO_Biological_Process_2021__regulation of oxidoreductase activity (GO:0051341),-0.4456622669872772,-0.7563254542761131,0.7241379310344828,1.0,1.0,4/10,23.53%,OXA1L;NOD2;MT3;SZT2
prerank,GO_Biological_Process_2021__positive regulation of ERBB signaling pathway (GO:1901186),0.35422355264771876,0.7562189978218798,0.7894736842105263,0.9678109429570018,1.0,1/16,2.09%,HIP1R
prerank,GO_Biological_Process_2021__positive regulation of glucose import (GO:0046326),-0.39285929599955116,-0.7562104214878601,0.8135593220338984,1.0,1.0,2/16,11.83%,IGF1;APPL1
prerank,GO_Biological_Process_2021__pulmonary valve development (GO:0003177),0.3680813334470534,0.7561578975176716,0.7948717948717948,0.967348129813405,1.0,4/12,18.17%,JAG1;ROBO1;ROBO2;TNFRSF1A
prerank,GO_Biological_Process_2021__regulation of extracellular matrix organization (GO:1903053),0.45416294718998973,0.7561464087753607,0.8461538461538461,0.9668540858129002,1.0,1/8,6.90%,RUNX1
prerank,GO_Biological_Process_2021__post-transcriptional gene silencing by RNA (GO:0035194),-0.4050114988665765,-0.7560711864475657,0.7540983606557377,1.0,1.0,3/17,17.54%,MOV10L1;CNOT8;NRDE2
prerank,GO_Biological_Process_2021__negative regulation of signal transduction by p53 class mediator (GO:1901797),0.4222965679870201,0.7559921621875343,0.8378378378378378,0.9665444140712035,1.0,3/13,10.28%,SIRT1;MDM2;DYRK1A
prerank,GO_Biological_Process_2021__negative regulation of B cell apoptotic process (GO:0002903),-0.492669748330291,-0.7557838375581081,0.7407407407407407,1.0,1.0,3/5,36.74%,BCL10;NOC2L;BCL6
prerank,GO_Biological_Process_2021__regulation of response to DNA damage stimulus (GO:2001020),0.3441141030435969,0.7557491123311647,0.7575757575757576,0.966342787056198,1.0,11/31,26.39%,CASP9;FEM1B;NSMCE1;UBE2N;RFWD3;WRNIP1;CDK9;ABL1;NEK4;UBE2V2;POLH
prerank,GO_Biological_Process_2021__regulation of granulocyte differentiation (GO:0030852),0.4473030219699438,0.7557048995745227,0.8181818181818182,0.9658817100048999,1.0,1/7,6.90%,RUNX1
prerank,GO_Biological_Process_2021__positive regulation of macrophage differentiation (GO:0045651),0.45614765093039134,0.7555559305415556,0.78,0.9656110114935131,1.0,2/6,25.72%,RIPK1;TGFB1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte degranulation (GO:0043302),-0.464734243666479,-0.7554042685026358,0.765625,1.0,1.0,2/10,10.55%,HLA-F;ITGB2
prerank,GO_Biological_Process_2021__peripheral nervous system development (GO:0007422),0.41550989471991584,0.7551336263619332,0.717948717948718,0.9657075372504998,1.0,4/12,14.53%,ADGRB2;SCN8A;NF1;NFASC
prerank,"GO_Biological_Process_2021__negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.43046925308548084,0.754853060229995,0.75,0.9655952942119066,1.0,3/9,10.28%,SIRT1;MDM2;DYRK1A
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell proliferation (GO:2000561)",-0.5011733498130467,-0.7546142604361478,0.8833333333333333,1.0,1.0,1/7,1.64%,CD55
prerank,GO_Biological_Process_2021__peroxisome organization (GO:0007031),-0.3932117029371995,-0.7545355146857381,0.7931034482758621,1.0,1.0,1/18,5.76%,FIS1
prerank,GO_Biological_Process_2021__granulocyte migration (GO:0097530),-0.49077749113896924,-0.7543244866581716,0.8571428571428571,1.0,1.0,1/6,0.62%,CCL3
prerank,GO_Biological_Process_2021__cell proliferation in forebrain (GO:0021846),0.43994675758121604,0.7540622920638266,0.7777777777777778,0.9661278054851181,1.0,4/7,25.45%,NUMBL;CEP120;HOOK3;PCM1
prerank,GO_Biological_Process_2021__regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.30094905153496865,0.75377225790502,0.96875,0.9660407270180126,1.0,5/58,9.97%,NRP1;PDGFA;RELN;CNOT7;HGF
prerank,GO_Biological_Process_2021__removal of superoxide radicals (GO:0019430),-0.49973115949362285,-0.7536689658525095,0.8135593220338984,1.0,1.0,2/5,16.40%,SOD1;MT3
prerank,GO_Biological_Process_2021__RNA modification (GO:0009451),0.3044166470336761,0.7533865087130787,0.8333333333333334,0.9661242006626939,1.0,4/44,5.52%,MEPCE;NSUN2;TRUB1;TFB1M
prerank,GO_Biological_Process_2021__COPII-coated vesicle cargo loading (GO:0090110),0.3758534900207533,0.7530438183157231,0.7636363636363637,0.9661192460232491,1.0,5/14,22.61%,SEC24B;SEC31A;SEC31B;SEC23B;SCAP
prerank,GO_Biological_Process_2021__ventricular septum development (GO:0003281),0.3510169506453699,0.7528965067863286,0.8421052631578947,0.9657863426625455,1.0,8/23,15.51%,TGFBR2;SMAD7;SALL1;ROBO1;SOX4;BMPR1A;TGFBR1;ROBO2
prerank,GO_Biological_Process_2021__regulation of interleukin-23 production (GO:0032667),-0.5067572251176143,-0.752885298088709,0.75,1.0,1.0,3/5,27.27%,RAC1;CLEC7A;MYD88
prerank,GO_Biological_Process_2021__negative regulation of inclusion body assembly (GO:0090084),0.4287205319169094,0.7527599073133757,0.75,0.965497910552074,1.0,3/9,11.83%,DNAJB2;DNAJA4;SORL1
prerank,GO_Biological_Process_2021__protein localization to nucleus (GO:0034504),-0.3313489074076451,-0.7525290259353281,0.8591549295774648,1.0,1.0,12/80,11.92%,XPA;RANBP6;CHCHD10;RPL11;PHB2;PTTG1IP;CNEP1R1;GBP2;DVL1;NUP50;APPL1;NOP53
prerank,GO_Biological_Process_2021__positive regulation of DNA biosynthetic process (GO:2000573),-0.3631274862966433,-0.7519117511420386,0.7936507936507936,1.0,1.0,4/45,8.41%,PKIB;PRKCQ;CHTF18;PRKD2
prerank,MSigDB_Hallmark_2020__TGF-beta Signaling,-0.3441463121517018,-0.7512570970288921,0.7746478873239436,1.0,1.0,2/45,1.53%,PPP1R15A;JUNB
prerank,MSigDB_Hallmark_2020__heme Metabolism,-0.31672510913629187,-0.7508814287182394,0.8860759493670886,1.0,1.0,10/144,9.00%,H4C3;TFRC;SIDT2;BTG2;H1-0;CTSB;ISCA1;HDGF;GCLM;UBAC1
prerank,GO_Biological_Process_2021__cartilage development (GO:0051216),-0.3875827724078899,-0.7507510657669245,0.8032786885245902,1.0,1.0,6/25,9.28%,RUNX3;DDRGK1;SULF2;CD44;TRPV4;CHI3L1
prerank,GO_Biological_Process_2021__nucleobase-containing compound biosynthetic process (GO:0034654),0.4188374274058482,0.7505923960029806,0.74,0.9680259870556273,1.0,1/11,2.67%,DGUOK
prerank,GO_Biological_Process_2021__neuronal action potential (GO:0019228),0.466897208626463,0.7505143202582544,0.7857142857142857,0.9676359388021655,1.0,4/9,13.35%,SCN3A;KCNMB4;SCN8A;KCNMB3
prerank,GO_Biological_Process_2021__protein localization to microtubule organizing center (GO:1905508),-0.41754301713626363,-0.7504469414835082,0.796875,1.0,1.0,4/15,21.63%,STIL;CSNK1D;DCTN2;SNX10
prerank,GO_Biological_Process_2021__positive regulation of actin filament bundle assembly (GO:0032233),0.33760897632452735,0.7502456989940991,0.8,0.9674791626662859,1.0,1/32,0.61%,NRP1
prerank,GO_Biological_Process_2021__oligodendrocyte differentiation (GO:0048709),0.4139834896653211,0.7497708224402674,0.8125,0.9676936844375968,1.0,2/10,5.32%,MYRF;TPPP
prerank,GO_Biological_Process_2021__secondary palate development (GO:0062009),-0.5034858858541836,-0.7496930041215779,0.7551020408163265,1.0,1.0,1/7,1.03%,TGFBR3
prerank,GO_Biological_Process_2021__regulation of viral life cycle (GO:1903900),-0.41771231646799645,-0.7492746630997165,0.7636363636363637,1.0,1.0,2/16,5.98%,TRIM5;TRIM22
prerank,GO_Biological_Process_2021__regulation of histone H3-K27 methylation (GO:0061085),-0.48485783558086626,-0.7491738529072569,0.7547169811320755,1.0,1.0,2/5,25.42%,SUPT6H;OGT
prerank,GO_Biological_Process_2021__protein targeting to peroxisome (GO:0006625),0.3478107694475639,0.7489693860936536,0.7674418604651163,0.9683669459832979,1.0,7/22,18.58%,GDAP1;ZFAND6;PEX13;PEX5;PEX11B;PEX16;ATAD1
prerank,GO_Biological_Process_2021__positive regulation of dendrite development (GO:1900006),-0.49005187861561167,-0.7489332351926248,0.8070175438596491,1.0,1.0,2/8,13.76%,PTN;VLDLR
prerank,"GO_Biological_Process_2021__negative regulation of DNA-templated transcription, elongation (GO:0032785)",-0.411509550198797,-0.748867759978151,0.7924528301886793,1.0,1.0,6/13,30.85%,RECQL5;NELFE;LARP7;NELFCD;RNF8;HEXIM1
prerank,"GO_Biological_Process_2021__regulation of phagocytosis, engulfment (GO:0060099)",-0.47835599843618515,-0.7485678638675183,0.7833333333333333,1.0,1.0,2/7,14.85%,NCKAP1L;C3
prerank,GO_Biological_Process_2021__C21-steroid hormone biosynthetic process (GO:0006700),0.45490495532112607,0.7484598090100109,0.7346938775510204,0.96880072073749,1.0,1/6,4.90%,TSPOAP1
prerank,GO_Biological_Process_2021__regulation of cell-substrate junction assembly (GO:0090109),0.36322734597526196,0.7481137228031521,0.7222222222222222,0.968800681626108,1.0,9/20,28.91%,VCL;SLC9A1;PTK2;CLASP1;PEAK1;LIMCH1;CORO1C;GPM6B;RHOA
prerank,GO_Biological_Process_2021__protein localization to perinuclear region of cytoplasm (GO:1905719),-0.466103678197104,-0.7477548051130677,0.7857142857142857,1.0,1.0,2/5,22.20%,HOOK2;AKTIP
prerank,GO_Biological_Process_2021__regulation of glucose metabolic process (GO:0010906),0.3506412384607776,0.7476441626122377,0.8823529411764706,0.9690580151438829,1.0,2/22,2.51%,PDK4;SIRT1
prerank,GO_Biological_Process_2021__purine ribonucleotide catabolic process (GO:0009154),-0.40755763101888,-0.7475374491833593,0.796875,1.0,1.0,3/15,13.80%,HINT1;ENTPD4;NUDT16
prerank,GO_Biological_Process_2021__positive regulation of membrane invagination (GO:1905155),-0.48117791682582445,-0.7473991550732576,0.7931034482758621,1.0,1.0,2/6,14.85%,NCKAP1L;C3
prerank,GO_Biological_Process_2021__purine-containing compound salvage (GO:0043101),0.45302839941644735,0.7471643776870609,0.7735849056603774,0.9693715491439319,1.0,1/8,2.67%,DGUOK
prerank,GO_Biological_Process_2021__positive regulation of membrane protein ectodomain proteolysis (GO:0051044),-0.4370829873566091,-0.7470442414913196,0.8125,1.0,1.0,3/8,21.94%,TNFRSF1B;SNX9;NRDC
prerank,GO_Biological_Process_2021__regulation of immunoglobulin production (GO:0002637),-0.4326369152101017,-0.7469851673698139,0.828125,1.0,1.0,7/15,22.02%,DNAJB9;PHB2;PTPRC;HLA-E;SUPT6H;EPHB2;STX4
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle exocytosis (GO:2000300),-0.3921480444494898,-0.7469704189733787,0.7966101694915254,1.0,1.0,1/15,1.34%,RIMS1
prerank,GO_Biological_Process_2021__mitotic DNA damage checkpoint signaling (GO:0044773),-0.3500199771633786,-0.746834986286999,0.8695652173913043,1.0,1.0,9/45,15.14%,HUS1;MUS81;TIPIN;ABRAXAS1;NOP53;RAD9A;CCND1;BRCA1;RPS27L
prerank,GO_Biological_Process_2021__positive regulation of protein modification process (GO:0031401),0.270880567559964,0.74666028910289,1.0,0.9696032369857601,1.0,24/141,16.10%,LEPR;ACVR2A;FGF2;SIRT1;LRRK2;CIB1;TNF;DVL3;TMEM119;RAMP1;NPTN;KNDC1;HGF;DYRK1A;UBE2N;NTRK2;PTPA;GPNMB;PTK2;ERBB4;RAPGEF3;AKT2;CCND3;WDFY2
prerank,GO_Biological_Process_2021__retinol metabolic process (GO:0042572),-0.46817999413654043,-0.7465848577968288,0.7586206896551724,1.0,1.0,3/5,35.62%,RDH11;RDH10;RETSAT
prerank,GO_Biological_Process_2021__negative regulation of macroautophagy (GO:0016242),0.36982686111690244,0.7464008763502631,0.9047619047619048,0.9694711622870458,1.0,3/23,4.89%,LRRK2;TSC2;TMEM39A
prerank,GO_Biological_Process_2021__cilium organization (GO:0044782),-0.30391676037102633,-0.7463325926211773,0.9418604651162791,1.0,1.0,13/144,11.48%,FLNA;CATIP;BBS2;RAB11A;IFT46;MAK;DYNC2I1;CEP164;TMEM138;DZIP1L;TMEM67;IFT81;ABLIM3
prerank,GO_Biological_Process_2021__DNA integrity checkpoint signaling (GO:0031570),-0.3898119301724658,-0.7463245276779249,0.8142857142857143,1.0,1.0,3/26,13.39%,HUS1;TIPIN;RAD9A
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation (GO:0019511),-0.4750782816895224,-0.7463000679343019,0.7962962962962963,1.0,1.0,2/8,12.90%,EGLN3;P4HA3
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway (GO:2001236),-0.33980602328231413,-0.7462907178179944,0.9,1.0,1.0,6/48,10.28%,TNFSF10;IGF1;GSTP1;ITGA6;CFLAR;BCL2L14
prerank,GO_Biological_Process_2021__lysine metabolic process (GO:0006553),-0.41036100533790965,-0.7462505417059356,0.75,1.0,1.0,3/10,20.62%,CRYM;DLST;PHYKPL
prerank,GO_Biological_Process_2021__lysine catabolic process (GO:0006554),-0.41036100533790965,-0.7462505417059356,0.75,1.0,1.0,3/10,20.62%,CRYM;DLST;PHYKPL
prerank,GO_Biological_Process_2021__endochondral bone morphogenesis (GO:0060350),0.44088744250841305,0.7459960283985334,0.8461538461538461,0.96942692570491,1.0,2/7,9.81%,TMEM119;BMPR1B
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via STAT (GO:1904892),-0.4379808514608976,-0.7454699790213237,0.7419354838709677,1.0,1.0,1/8,1.80%,IL7R
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization (GO:0031113),0.31822206698325795,0.7452904779097601,0.9090909090909091,0.9699086715699595,1.0,8/34,19.55%,CDK5R1;TOGARAM1;DYRK1A;SLAIN2;CLASP1;CAMSAP2;SNCA;MAP2
prerank,GO_Biological_Process_2021__ATP-dependent chromatin remodeling (GO:0043044),0.3049439407812369,0.745163722979122,0.9117647058823529,0.9695513588341471,1.0,7/37,16.76%,ARID1A;MTA2;HDAC1;HNRNPC;ARID1B;ACTL6A;VPS72
prerank,GO_Biological_Process_2021__positive regulation of cellular protein metabolic process (GO:0032270),-0.324029577475674,-0.7450709046651047,0.9117647058823529,1.0,1.0,18/76,18.50%,RPS4X;RPL5;NR1H2;VPS35;AURKAIP1;PTTG1IP;EIF4A3;NPM1;ATG10;CYFIP2;PASK;RPS27L;ZCCHC4;UHRF1;AGT;EZR;EEF2;VIM
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial fission (GO:0090141),0.39800605517736093,0.7447597892717231,0.8157894736842105,0.9696635164533655,1.0,3/14,9.11%,MCU;MARCHF5;DDHD1
prerank,GO_Biological_Process_2021__pyrimidine-containing compound metabolic process (GO:0072527),-0.4612967545827128,-0.744637227990072,0.7735849056603774,1.0,1.0,3/10,15.19%,TYMP;ENPP3;SLC25A19
prerank,PanglaoDB_Augmented_2021__Principal Cells,-0.39028590351751224,-0.7446007996019447,0.7966101694915254,1.0,1.0,3/26,8.80%,PLEKHA7;CLDN7;OVOL2
prerank,GO_Biological_Process_2021__positive regulation of cell killing (GO:0031343),-0.45614526655268683,-0.7442775424423189,0.819672131147541,1.0,1.0,4/9,20.69%,PRF1;CYBA;RAC1;CLEC7A
prerank,GO_Biological_Process_2021__positive regulation of stem cell differentiation (GO:2000738),0.4336079215803347,0.7440806921317883,0.7755102040816326,0.9702506687721476,1.0,4/7,21.47%,LTBP3;SOX5;NUDT21;SOX6
prerank,GO_Biological_Process_2021__negative regulation of cellular biosynthetic process (GO:0031327),0.3271683431564456,0.7440119207216491,0.8275862068965517,0.969825002171697,1.0,4/27,11.26%,ABCA2;SIRPA;FBXW7;ACADVL
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte differentiation (GO:0045621),0.3796277866163387,0.7440064701835258,0.813953488372093,0.9693373245701901,1.0,1/14,1.16%,ZBTB1
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle cell proliferation (GO:0060045),-0.4721844830274294,-0.7439486699733524,0.8888888888888888,1.0,1.0,2/10,8.45%,TGFBR3;RBPJ
prerank,GO_Biological_Process_2021__positive regulation of osteoclast differentiation (GO:0045672),0.4635963658502422,0.7437762768515751,0.8085106382978723,0.9691684808567623,1.0,2/5,14.94%,TNF;TRAF6
prerank,GO_Biological_Process_2021__histone H4-K16 acetylation (GO:0043984),0.37142180552065074,0.7436859664992767,0.7674418604651163,0.9688313697007556,1.0,1/19,1.75%,MSL2
prerank,GO_Biological_Process_2021__positive regulation of mast cell degranulation (GO:0043306),0.41349999019545125,0.7436374346311123,0.8333333333333334,0.9684135460621475,1.0,2/7,21.93%,GAB2;SYK
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),-0.4167899735643361,-0.7435872399482026,0.8513513513513513,1.0,1.0,1/19,2.37%,DDIT4
prerank,GO_Biological_Process_2021__regulation of water loss via skin (GO:0033561),0.42381101967603674,0.7433006090644553,0.8478260869565217,0.9679280092075787,1.0,2/7,10.18%,FA2H;TMEM79
prerank,GO_Biological_Process_2021__establishment of skin barrier (GO:0061436),0.42381101967603674,0.7433006090644553,0.8478260869565217,0.9679280092075787,1.0,2/7,10.18%,FA2H;TMEM79
prerank,GO_Biological_Process_2021__response to endoplasmic reticulum stress (GO:0034976),-0.3295655404029296,-0.7431680884661079,0.9066666666666666,1.0,1.0,10/91,13.27%,PPP1R15A;RASGRF2;DNAJB9;DDRGK1;ERO1A;SELENOS;CFTR;ATG10;ATF3;TMCO1
prerank,GO_Biological_Process_2021__ameboidal-type cell migration (GO:0001667),-0.3713189138030284,-0.7431551174685163,0.765625,1.0,1.0,5/28,8.87%,PDXDC1;SEMA6A;CENPV;ITGA4;GPC3
prerank,GO_Biological_Process_2021__regulation of actin filament bundle assembly (GO:0032231),-0.4085975309571021,-0.74265802665441,0.782608695652174,1.0,1.0,4/18,16.58%,PLEK;ACTG1;PFN1;RAC1
prerank,GO_Biological_Process_2021__negative regulation of cholesterol metabolic process (GO:0090206),-0.4960718900092655,-0.7426358540308335,0.7446808510638298,1.0,1.0,1/5,13.37%,SOD1
prerank,GO_Biological_Process_2021__negative regulation of sterol biosynthetic process (GO:0106119),-0.4960718900092655,-0.7426358540308335,0.7446808510638298,1.0,1.0,1/5,13.37%,SOD1
prerank,GO_Biological_Process_2021__negative regulation of cholesterol biosynthetic process (GO:0045541),-0.4960718900092655,-0.7426358540308335,0.7446808510638298,1.0,1.0,1/5,13.37%,SOD1
prerank,GO_Biological_Process_2021__glycerolipid catabolic process (GO:0046503),-0.4230561054344996,-0.742449675081778,0.7368421052631579,1.0,1.0,2/12,5.25%,MGLL;GDPD1
prerank,GO_Biological_Process_2021__protein localization to vacuole (GO:0072665),-0.43252444881727814,-0.7422185023595441,0.864406779661017,1.0,1.0,1/9,5.78%,LAMTOR5
prerank,"GO_Biological_Process_2021__negative regulation of transcription, DNA-templated (GO:0045892)",-0.2783523739118363,-0.7420880736768276,1.0,1.0,1.0,78/599,16.40%,NR4A3;FLNA;UBC;RPS27A;RUNX3;ZFP36;SCML4;RPS14;HAMP;MDFIC;SNX6;ZMYND15;CHD3;ATF5;PER3;PER2;PARP15;H1-0;L3MBTL3;BHLHE40;RPL10;HESX1;NR1H2;RPL23;BASP1;ILF3;HDGF;MED25;PHB2;TCF25;PARP9;CRYM;EID1;RBPJ;BTAF1;KANK2;ZNF589;STAT1;IRF1;ZNF266;CITED2;MLX;VEGFA;SCML1;FBP1;MXI1;ING4;TCF3;NOP53;GCFC2;ATF3;MAX;CREM;ZNF674;PRDM1;KAT5;DDX5;UXT;ZNF217;ZNF558;ESR2;CCND1;BRCA1;ATP8B1;ZKSCAN3;CBX3;UBA52;CIITA;ZFPM2;CGGBP1;UHRF1;SP2;ZNF20;DEDD2;KAT8;PRMT2;CDKN1C;MT3
prerank,GO_Biological_Process_2021__positive regulation of Wnt signaling pathway (GO:0030177),-0.30604699751026193,-0.7420336534125088,0.9764705882352941,1.0,1.0,15/109,13.53%,PSMB3;JUP;SULF2;PSMB6;PSMA7;TNFAIP3;GPC3;PSMB9;TRPM4;CSNK1G2;PSMD12;CSNK1D;PSMD8;PSMA5;PRDM15
prerank,GO_Biological_Process_2021__regulation of macromolecule metabolic process (GO:0060255),-0.311700880557966,-0.7411328558632451,0.9382716049382716,1.0,1.0,14/113,12.88%,NFKBID;TRIM5;AIF1;ZNF335;IGF1;TXK;TRIM22;ZNF513;HNRNPAB;KDM6B;HIF1A;ANKRA2;PTPRC;PRDM1
prerank,GO_Biological_Process_2021__organelle assembly (GO:0070925),-0.2872946028341275,-0.7411170617412911,0.9885057471264368,1.0,1.0,39/285,16.62%,FLNA;GOLGA8A;GABARAPL1;RPS23;BBS2;RAB11A;RPS3;IFT46;MAK;DYNC2I1;ATG2A;SNF8;GABARAPL2;HPS4;ZFYVE1;CEP164;TMEM138;DZIP1L;VPS28;TMEM67;NPM1;TUBGCP2;IFT81;EIF2A;STING1;ABLIM3;PATL2;VPS37B;CSNK1D;MIS12;IFT52;TRAPPC6A;TP53INP1;WIPI1;GOLGA8N;IFT43;MVB12A;TUBGCP5;LSM4
prerank,GO_Biological_Process_2021__triglyceride homeostasis (GO:0070328),-0.4041288326936314,-0.7410122112018468,0.7777777777777778,1.0,1.0,1/12,3.27%,RORA
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in inflammatory response (GO:1900017),-0.44557609472076953,-0.7407635270903559,0.7543859649122807,1.0,1.0,8/11,28.41%,HIF1A;APPL1;NOD2;CLEC7A;GBP5;CARD9;MYD88;STAT3
prerank,GO_Biological_Process_2021__DNA recombination (GO:0006310),-0.3552220189174678,-0.7406812922737012,0.847457627118644,1.0,1.0,4/25,18.09%,THAP9;XRCC3;RECQL5;WRN
prerank,GO_Biological_Process_2021__regulation of protein acetylation (GO:1901983),0.41010054794033235,0.7404725216018903,0.7608695652173914,0.9713712539570697,1.0,4/10,17.16%,SIRT1;RAPGEF3;GSK3B;DDX3X
prerank,GO_Biological_Process_2021__cilium assembly (GO:0060271),-0.30189597386471306,-0.74040230267267,0.9534883720930233,1.0,1.0,20/207,12.71%,FLNA;RPGRIP1L;BBOF1;BBS2;SSNA1;RAB11A;IFT46;MAK;DYNC2I1;TBC1D32;CEP72;CEP164;TMEM138;DZIP1L;TMEM67;IFT27;IFT81;ABLIM3;CCDC39;CSNK1D
prerank,GO_Biological_Process_2021__autophagy of nucleus (GO:0044804),-0.39751614614312036,-0.7401853263996494,0.75,1.0,1.0,2/13,15.41%,ATG2A;WIPI1
prerank,GO_Biological_Process_2021__regulation of RNA export from nucleus (GO:0046831),0.41467860082468494,0.7400956439792967,0.9166666666666666,0.9714819000288497,1.0,4/12,17.17%,NSUN2;NUP153;SETD2;IWS1
prerank,GO_Biological_Process_2021__chaperone cofactor-dependent protein refolding (GO:0051085),-0.38859199067104094,-0.7396208316655847,0.873015873015873,1.0,1.0,4/20,18.22%,ERO1A;HSPA1B;HSPA1A;HSPA2
prerank,GO_Biological_Process_2021__presynapse organization (GO:0099172),-0.4167291854234434,-0.7394366522167396,0.7213114754098361,1.0,1.0,3/9,9.43%,C5AR1;NLGN2;DVL1
prerank,GO_Biological_Process_2021__negative regulation of ERBB signaling pathway (GO:1901185),-0.38898997787710804,-0.7392437576477744,0.7868852459016393,1.0,1.0,2/29,7.11%,EPN1;RNF126
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, elongation (GO:0032784)",-0.3680185467391607,-0.7391982920643664,0.9122807017543859,1.0,1.0,1/22,3.69%,TCEA2
prerank,GO_Biological_Process_2021__regulation of DNA-dependent DNA replication (GO:0090329),-0.4301566213346274,-0.7390905667585018,0.8333333333333334,1.0,1.0,1/8,5.76%,TIPIN
prerank,"GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",-0.44505299633861356,-0.7390042934967539,0.8490566037735849,1.0,1.0,2/10,13.80%,NYNRIN;NUDT16
prerank,GO_Biological_Process_2021__anion transmembrane transport (GO:0098656),0.322200973608248,0.738807248106698,0.8387096774193549,0.9726559405877979,1.0,6/42,6.03%,SLC1A3;SLC25A18;SLC7A8;SLC3A2;SLC39A8;SLC1A2
prerank,GO_Biological_Process_2021__modulation of excitatory postsynaptic potential (GO:0098815),-0.3745210019375721,-0.7386613777901969,0.8245614035087719,1.0,1.0,2/20,7.64%,RIMS1;NLGN2
prerank,GO_Biological_Process_2021__ncRNA export from nucleus (GO:0097064),-0.361486200666383,-0.7386159396212835,0.8709677419354839,1.0,1.0,7/36,17.60%,SSB;NCBP2;NPM1;XPOT;NUP50;SEC13;NUP88
prerank,GO_Biological_Process_2021__histone deubiquitination (GO:0016578),-0.41618172271280307,-0.7382507912538754,0.8032786885245902,1.0,1.0,1/14,3.61%,USP36
prerank,GO_Biological_Process_2021__endocytic recycling (GO:0032456),-0.3663299299306437,-0.7380540142318842,0.8461538461538461,1.0,1.0,4/42,7.74%,ARL4C;VPS35;ENTR1;SNF8
prerank,"GO_Biological_Process_2021__retrograde protein transport, ER to cytosol (GO:0030970)",0.3834216138246711,0.7375936823535685,0.7941176470588235,0.9737168850087755,1.0,2/17,8.99%,SEL1L;AUP1
prerank,GO_Biological_Process_2021__neurogenesis (GO:0022008),0.37202775661689563,0.7374482890815593,0.8461538461538461,0.9733974627621431,1.0,4/23,11.88%,ANXA1;RYK;BTBD3;CDK6
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell apoptotic process (GO:0034391),0.45778648672683453,0.7370570889256565,0.8541666666666666,0.9733888570107615,1.0,2/5,12.51%,SIRT1;DIPK2A
prerank,GO_Biological_Process_2021__regulation of protein serine/threonine kinase activity (GO:0071900),-0.3086741763595727,-0.7364053710738425,0.9342105263157895,1.0,1.0,8/69,14.20%,SYAP1;CDC37;SNF8;CALM1;ACTB;MTCP1;CAMK1;CCND1
prerank,GO_Biological_Process_2021__double-strand break repair (GO:0006302),-0.3156764374989818,-0.7362995848288503,0.971830985915493,1.0,1.0,14/125,14.26%,UBXN1;HUS1;DTX3L;PARP9;BRCA2;POLM;CYREN;ABRAXAS1;PARP2;XRCC3;NABP1;KAT5;RPA3;BRCA1
prerank,GO_Biological_Process_2021__epithelial to mesenchymal transition (GO:0001837),-0.4058381538235324,-0.7359536172805876,0.8985507246376812,1.0,1.0,7/28,16.94%,TGFBR3;RBPJ;HNRNPAB;HIF1A;DDX5;AKNA;S100A4
prerank,GO_Biological_Process_2021__mitochondrial calcium ion homeostasis (GO:0051560),-0.4183103086679798,-0.7356166804644906,0.8360655737704918,1.0,1.0,5/17,14.94%,FIS1;SMDT1;MICU2;MAIP1;MCUR1
prerank,GO_Biological_Process_2021__ectoderm development (GO:0007398),0.475912156289356,0.7355492686591307,0.85,0.9749319087774373,1.0,5/7,23.17%,EDA2R;STX2;SMURF1;AMER2;ZBTB7B
prerank,GO_Biological_Process_2021__cellular metal ion homeostasis (GO:0006875),-0.3579435908853522,-0.7350791318263719,0.8805970149253731,1.0,1.0,11/52,16.90%,CCL3;CCL5;ATP13A1;TPT1;TRPV4;ATP1B3;TMCO1;ATP1A1;MT3;STOML2;STIM2
prerank,GO_Biological_Process_2021__pyrimidine ribonucleotide biosynthetic process (GO:0009220),-0.4893546369611823,-0.734857338084032,0.7903225806451613,1.0,1.0,1/7,11.81%,DHODH
prerank,GO_Biological_Process_2021__regulation of cell cycle G2/M phase transition (GO:1902749),-0.3359945488290971,-0.7346648154231049,0.9027777777777778,1.0,1.0,16/64,22.15%,ATF5;SSNA1;CEP72;CEP164;NPM1;CSNK1D;TUBB4B;PRKAR2B;ATAD5;DCTN2;CENPF;AKAP9;DYNC1I2;NINL;SFI1;HAUS5
prerank,GO_Biological_Process_2021__positive regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000343),0.4726777758006273,0.734476889397942,0.9117647058823529,0.9758344277852509,1.0,1/6,7.30%,TNF
prerank,GO_Biological_Process_2021__positive regulation of DNA methylation-dependent heterochromatin assembly (GO:0090309),-0.4181341321553827,-0.7343703326954264,0.8064516129032258,1.0,1.0,4/10,22.78%,DNMT1;RESF1;SETDB1;MORC2
prerank,GO_Biological_Process_2021__covalent chromatin modification (GO:0016569),0.3973339944949208,0.7341048840192368,0.8409090909090909,0.9758245874471979,1.0,3/12,14.78%,SIRT1;HDAC1;SETD5
prerank,GO_Biological_Process_2021__telomere organization (GO:0032200),-0.3710141035981165,-0.7340692372375583,0.8676470588235294,1.0,1.0,6/30,21.40%,HUS1;TERF2IP;APEX1;RPA3;WRN;CTC1
prerank,GO_Biological_Process_2021__response to muramyl dipeptide (GO:0032495),-0.4063744605048163,-0.7338910569894054,0.7931034482758621,1.0,1.0,5/11,25.45%,NOD2;VIM;PTPN22;TRIM41;ARHGEF2
prerank,GO_Biological_Process_2021__negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),-0.41515615032347974,-0.7334068082717121,0.8301886792452831,1.0,1.0,6/12,30.85%,RECQL5;NELFE;LARP7;NELFCD;RNF8;HEXIM1
prerank,GO_Biological_Process_2021__protein tetramerization (GO:0051262),-0.3537521258778798,-0.7333178048572735,0.8823529411764706,1.0,1.0,3/46,3.43%,APIP;B2M;KCNC3
prerank,GO_Biological_Process_2021__beta-catenin destruction complex disassembly (GO:1904886),-0.4180614156490119,-0.7328223578565162,0.8032786885245902,1.0,1.0,2/11,12.28%,DVL1;FZD2
prerank,GO_Biological_Process_2021__positive regulation of homotypic cell-cell adhesion (GO:0034112),0.4741321392099381,0.73261645984194,0.8958333333333334,0.9772586734948563,1.0,1/7,0.66%,PDPN
prerank,GO_Biological_Process_2021__positive regulation of coagulation (GO:0050820),-0.45903225323956875,-0.7325276004906102,0.7857142857142857,1.0,1.0,1/5,2.01%,ENPP4
prerank,GO_Biological_Process_2021__positive regulation of hemostasis (GO:1900048),-0.45903225323956875,-0.7325276004906102,0.7857142857142857,1.0,1.0,1/5,2.01%,ENPP4
prerank,GO_Biological_Process_2021__synapse pruning (GO:0098883),-0.4567786765056532,-0.7321540801375969,0.7575757575757576,1.0,1.0,6/8,34.67%,C3;C1QB;C1QC;C1QA;TREM2;ITGAM
prerank,GO_Biological_Process_2021__pancreas development (GO:0031016),0.43151019414627834,0.7319376876194299,0.7272727272727273,0.9775268400233443,1.0,2/6,12.89%,TCF7L2;CCDC40
prerank,GO_Biological_Process_2021__macrophage derived foam cell differentiation (GO:0010742),0.4311154375170929,0.7317639546421697,0.6888888888888889,0.9767134615423534,1.0,1/5,5.17%,PPARG
prerank,GO_Biological_Process_2021__foam cell differentiation (GO:0090077),0.4311154375170929,0.7317639546421697,0.6888888888888889,0.9767134615423534,1.0,1/5,5.17%,PPARG
prerank,GO_Biological_Process_2021__negative regulation of phosphorylation (GO:0042326),-0.32075661242164555,-0.7308963386902546,0.9027777777777778,1.0,1.0,3/61,2.98%,PID1;WARS1;PAQR3
prerank,GO_Biological_Process_2021__positive regulation of muscle cell differentiation (GO:0051149),0.3624872633315225,0.7301411898491343,0.8709677419354839,0.9783049584729341,1.0,3/18,8.54%,MAPK11;NRG1;CTNNA2
prerank,GO_Biological_Process_2021__microtubule-based transport (GO:0099111),0.41600969272636473,0.7300214494010894,0.8461538461538461,0.9779415559731254,1.0,4/8,26.62%,CCDC40;DNAAF2;CABYR;ADCY10
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell apoptotic process (GO:1905459),0.4507070900484916,0.7296258783549461,0.76,0.9780233471404562,1.0,3/7,12.13%,E2F3;PPARG;SOD2
prerank,GO_Biological_Process_2021__positive regulation of collagen metabolic process (GO:0010714),0.39784435332295065,0.729453087530281,0.8095238095238095,0.977722208322739,1.0,1/8,6.90%,RUNX1
prerank,GO_Biological_Process_2021__amide biosynthetic process (GO:0043604),-0.39191269643934434,-0.7293578395656038,0.8793103448275862,1.0,1.0,1/25,0.87%,DEGS2
prerank,GO_Biological_Process_2021__positive regulation of chromosome segregation (GO:0051984),0.4433029421627057,0.7293070576905765,0.8108108108108109,0.9774460636657432,1.0,2/6,28.58%,SMC6;SIRT2
prerank,GO_Biological_Process_2021__regulation of stress-activated MAPK cascade (GO:0032872),-0.33446612099442774,-0.7287916502191635,0.8548387096774194,1.0,1.0,4/42,6.90%,TGFBR3;EPHB1;GSTP1;EIF2AK2
prerank,GO_Biological_Process_2021__dendrite self-avoidance (GO:0070593),-0.45465789875279783,-0.7279523683630019,0.7777777777777778,1.0,1.0,1/10,1.68%,EMB
prerank,GO_Biological_Process_2021__positive regulation of positive chemotaxis (GO:0050927),-0.45260094644840365,-0.7278014501957909,0.8939393939393939,1.0,1.0,1/7,11.19%,VEGFA
prerank,GO_Biological_Process_2021__T-tubule organization (GO:0033292),0.45924509303052885,0.7277133047332217,0.8695652173913043,0.9788974232819457,1.0,2/5,31.67%,BIN1;MYOF
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate metabolic process (GO:0034032),-0.3923869040859988,-0.727693867569526,0.8688524590163934,1.0,1.0,3/16,14.80%,THEM4;ACOT9;ACSM5
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate metabolic process (GO:0033875),-0.3923869040859988,-0.727693867569526,0.8688524590163934,1.0,1.0,3/16,14.80%,THEM4;ACOT9;ACSM5
prerank,GO_Biological_Process_2021__regulation of neuroblast proliferation (GO:1902692),-0.3977738591531745,-0.7275975295640102,0.8275862068965517,1.0,1.0,4/13,15.22%,ZNF335;PTN;VEGFA;SMARCD3
prerank,GO_Biological_Process_2021__regulation of activated T cell proliferation (GO:0046006),-0.42230387159135707,-0.7272615139731144,0.8253968253968254,1.0,1.0,4/17,8.38%,LILRB4;RPS3;IGF1;BTN2A2
prerank,GO_Biological_Process_2021__positive regulation of cell migration by vascular endothelial growth factor signaling pathway (GO:0038089),0.4335649395238625,0.7270729058829379,0.7962962962962963,0.9792991678210266,1.0,1/7,2.61%,GAB1
prerank,GO_Biological_Process_2021__regulation of cellular component size (GO:0032535),-0.3562876575505317,-0.727017929734694,0.8857142857142857,1.0,1.0,3/26,5.78%,PPP1R15A;VAV3;LAMTOR5
prerank,GO_Biological_Process_2021__negative regulation of lipid storage (GO:0010888),0.34930233278678247,0.726688572538036,0.9090909090909091,0.979262974851076,1.0,3/16,10.85%,PPARG;TNF;ITGAV
prerank,GO_Biological_Process_2021__cytosolic calcium ion transport (GO:0060401),0.354717169122082,0.7266731549863312,0.8918918918918919,0.9787771941582981,1.0,4/22,13.70%,MCU;ADRA1A;MICU1;SLC8A1
prerank,GO_Biological_Process_2021__regulation of fibroblast migration (GO:0010762),0.3469082029030716,0.7264727929310426,0.8571428571428571,0.978593556737613,1.0,1/18,2.26%,FGF2
prerank,"GO_Biological_Process_2021__regulation of transcription, DNA-templated (GO:0006355)",-0.2681090139636466,-0.7262274383388541,1.0,1.0,1.0,168/1271,16.47%,NR4A3;SKAP1;STAT4;MYBL1;BCL11B;CEBPD;PPIE;FOSL2;FOS;RUNX3;SCML4;JUNB;PYHIN1;PRKCQ;CTDSP1;ZSCAN9;MDFIC;SNX6;IKZF3;ZMYND15;CHD3;ATF5;TAF6L;CSRNP1;USF1;EDF1;PER2;RORA;ZNF790;TCEA2;ZNF689;L3MBTL3;OGG1;ETS1;ING5;BHLHE40;ZNF331;SP110;HESX1;NR1H2;IGF1;BASP1;JMJD6;DTX3L;TRIM22;BRD9;ILF3;HDGF;MSL3;ZSCAN30;ZNF32;PHB2;SP140;PARP9;BRD3;ZNF76;MAP3K12;PLAG1;ZNF805;BRCA2;SNF8;ZNF449;ZNF789;ZNF649;ZNF570;EID1;ZNF600;RBPJ;BTAF1;ZFP30;OVOL2;ZNF394;RPL6;VENTX;ZNF589;DVL1;STAT1;MEIS1;HINT1;ZNF821;SMARCD1;LITAF;IRF1;ZNF266;ZNF70;ZNF260;HNRNPAB;NPM1;CITED2;KDM7A;ZNF546;ZNF354A;REXO4;MLX;VEGFA;ZNF528;SCML1;KARS1;HIF1A;MXI1;BTG1;ING4;ZSCAN29;TCF3;ZNF432;GLI4;GLRX2;GCFC2;ATF3;TEF;GMEB1;FZD2;ZNF586;HIRA;DNAJC2;MAX;CREM;TERF2IP;ATF1;ZNF674;PRDM1;KAT5;DDX5;NRL;ZNF549;ZNF302;ZNF16;PRDM15;NR4A1;UXT;ZNF217;ZNF558;ZNF18;ESR2;ZNF681;REL;BRCA1;ZNF333;ATP8B1;ZKSCAN3;CCAR1;ZFP82;CBX3;ZNF232;TP53INP1;HMGN5;GON4L;SMARCD3;CIITA;ZFPM2;ZNF461;ZNF484;PSRC1;ZNF445;CD74;MED12;SP2;AGT;POLR3C;ZNF20;DEDD2;KAT8;PRMT2;CDKN1C;MED30;CREBRF;MT3;ZNF35
prerank,GO_Biological_Process_2021__prostaglandin metabolic process (GO:0006693),-0.39219371428306793,-0.7261209983587874,0.8214285714285714,1.0,1.0,2/13,15.77%,GSTP1;CD74
prerank,GO_Biological_Process_2021__protein maturation (GO:0051604),0.2868281181348247,0.7260482273987304,1.0,0.9785085536348341,1.0,16/63,16.40%,AANAT;TSPAN33;TSPAN15;CPM;DNAJB11;MMS19;MMP16;PTCH1;TSPAN17;SORL1;PCSK6;NAA35;MMP14;GALNT2;GLRX3;HSPD1
prerank,GO_Biological_Process_2021__posttranscriptional regulation of gene expression (GO:0010608),-0.3483348850315113,-0.7259646754598328,0.863013698630137,1.0,1.0,5/35,15.70%,RPL10;PARP9;EIF2A;RBM4B;PUM3
prerank,GO_Biological_Process_2021__in utero embryonic development (GO:0001701),0.3808216506349655,0.724731020350846,0.7894736842105263,0.9798934524527049,1.0,9/14,22.55%,PKD1;ARNT2;LIG4;TGFBR1;HINFP;PTPRR;FGFR2;CHD7;ADAM10
prerank,GO_Biological_Process_2021__histone H2A acetylation (GO:0043968),-0.39420549568983365,-0.7242781768064854,0.8208955223880597,1.0,1.0,2/16,6.30%,ING3;MSL3
prerank,GO_Biological_Process_2021__histone H3-K9 demethylation (GO:0033169),-0.4166266135480782,-0.7242026122058027,0.803921568627451,1.0,1.0,1/8,10.73%,KDM7A
prerank,GO_Biological_Process_2021__cellular response to increased oxygen levels (GO:0036295),0.45213304353616507,0.7241642019553,0.7948717948717948,0.9800414517025337,1.0,5/8,34.82%,ATP6V0D1;FOXO1;ATP6V1G1;ATP6V1A;FAS
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),-0.3161948184880267,-0.7239733057688365,0.9076923076923077,1.0,1.0,15/75,19.77%,FCER1G;HLA-DRB5;DCTN6;HLA-DRA;DCTN4;DYNC1LI2;HLA-DPA1;HLA-DMB;AP2S1;CD74;SEC13;HLA-DPB1;DCTN2;HLA-DRB1;DYNC1I2
prerank,GO_Biological_Process_2021__nucleobase-containing small molecule interconversion (GO:0015949),0.3747386622731472,0.7236972816431886,0.8235294117647058,0.979998848690733,1.0,6/20,24.53%,AK6;NME4;NUDT13;DUT;GLRX;CTPS2
prerank,GO_Biological_Process_2021__Golgi to plasma membrane protein transport (GO:0043001),0.3413524534413715,0.7235980777920041,0.8863636363636364,0.9796185613750041,1.0,4/23,11.11%,GOLPH3L;RAB10;GOLGA7;BLZF1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-10 production (GO:0032733),0.39563239615363366,0.7228847127995777,0.9142857142857143,0.9800672069239452,1.0,5/13,21.93%,LGALS9;HSPD1;CD274;CD46;SYK
prerank,GO_Biological_Process_2021__Rac protein signal transduction (GO:0016601),0.35563397751147696,0.7226515474232703,0.8421052631578947,0.979816090130669,1.0,2/19,7.62%,EPS8;ELMO1
prerank,GO_Biological_Process_2021__nuclear envelope organization (GO:0006998),-0.4329417311887861,-0.7224232306843635,0.8771929824561403,1.0,1.0,1/14,4.25%,EMD
prerank,GO_Biological_Process_2021__pseudouridine synthesis (GO:0001522),0.38773434876482554,0.7221779474120716,0.8260869565217391,0.9798288680664343,1.0,4/10,19.27%,TRUB1;PUS7L;PUS1;PUS7
prerank,GO_Biological_Process_2021__hematopoietic progenitor cell differentiation (GO:0002244),-0.41976766222234824,-0.7217875626880998,0.847457627118644,1.0,1.0,3/15,12.82%,PLEK;FLT1;PTPRC
prerank,GO_Biological_Process_2021__regulation of monooxygenase activity (GO:0032768),-0.3827397151802535,-0.7216098241303123,0.8518518518518519,1.0,1.0,9/16,31.72%,CALM1;NOS1AP;ZDHHC21;EGFR;HSP90AA1;POR;IL1B;AKT1;IL1A
prerank,GO_Biological_Process_2021__response to reactive oxygen species (GO:0000302),-0.32102640968798174,-0.7213274140962993,0.88,1.0,1.0,9/45,14.09%,FOS;APOD;RPS3;GSTP1;FYN;HIF1A;GLRX2;SOD1;GPX1
prerank,GO_Biological_Process_2021__regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),-0.4327108082830218,-0.7213126554768512,0.8245614035087719,1.0,1.0,2/10,22.04%,PSMC4;PSMC3
prerank,GO_Biological_Process_2021__regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.3943202532035252,0.7212444752288927,0.8666666666666667,0.9805095927048534,1.0,4/10,8.84%,NFAT5;TNF;FUT9;IRAK1
prerank,GO_Biological_Process_2021__negative regulation of keratinocyte proliferation (GO:0010839),0.4964087310060361,0.7204579996479112,0.8666666666666667,0.9808956301213846,1.0,2/5,19.59%,PTPRK;FGFR2
prerank,GO_Biological_Process_2021__positive regulation of transferase activity (GO:0051347),-0.3110198379146475,-0.7202713203681803,0.8717948717948718,1.0,1.0,7/97,7.38%,PKIB;PRKCQ;EPHB1;DTX3L;CHTF18;MUSK;RPS2
prerank,GO_Biological_Process_2021__regulation of TOR signaling (GO:0032006),0.31851532955713924,0.72007960363214,0.9,0.9808833554082635,1.0,15/51,22.65%,RRAGD;SIRT1;TSC2;DEPTOR;GPAT3;LAMTOR3;PRKAA1;PIK3CA;TBCK;SMCR8;MIOS;DGKQ;HDAC3;UBR1;TBC1D7
prerank,GO_Biological_Process_2021__regulation of proteasomal protein catabolic process (GO:0061136),-0.3330940215057964,-0.7194550505863534,0.8823529411764706,1.0,1.0,12/44,22.96%,DDRGK1;GABARAPL2;GLMN;GPX1;PINK1;PSME2;UFL1;PSME1;RAD23A;USP19;PSMC3;PSME3
prerank,GO_Biological_Process_2021__positive regulation of cellular component movement (GO:0051272),-0.40667405483307884,-0.7191967158100635,0.8524590163934426,1.0,1.0,4/15,11.19%,DUOX1;ETS1;SPOCK2;VEGFA
prerank,GO_Biological_Process_2021__regulation of steroid metabolic process (GO:0019218),0.35333090008353346,0.7188274756288204,0.8,0.9819479984516913,1.0,1/13,1.57%,ABCA2
prerank,GO_Biological_Process_2021__cellular response to estrogen stimulus (GO:0071391),0.40869572064592585,0.7186849490444711,0.8163265306122449,0.9816171887522069,1.0,1/10,11.17%,NCOA4
prerank,GO_Biological_Process_2021__regulation of protein modification process (GO:0031399),-0.33290976464949296,-0.7180675048992196,0.9117647058823529,1.0,1.0,2/38,1.84%,CCDC88C;WARS1
prerank,GO_Biological_Process_2021__regulation of glycolytic process (GO:0006110),0.2755695598665562,0.7180130485138672,0.9736842105263158,0.9818735229175334,1.0,12/57,18.92%,CBFA2T3;NUP153;NUP188;NUP42;GIT1;SLC4A4;NDC1;PRKAA1;NUP133;P2RX7;NUP205;ZBTB20
prerank,GO_Biological_Process_2021__cilium-dependent cell motility (GO:0060285),-0.43690487418591845,-0.7176775431274597,0.8703703703703703,1.0,1.0,4/9,12.06%,DNAH17;EFHC1;DNAH1;CCDC39
prerank,GO_Biological_Process_2021__regulation of signal transduction by p53 class mediator (GO:1901796),0.283221353569075,0.7175279161517332,1.0,0.9819524223731458,1.0,17/120,13.71%,PRKAB2;CDK5R1;MAPK11;CHD5;MTA2;NUAK1;TAF2;TAF9B;ZNF385A;CCNG1;MDM2;HDAC1;SUPT16H;PIP4K2A;BARD1;PRKAB1;TAF3
prerank,GO_Biological_Process_2021__negative regulation of viral release from host cell (GO:1902187),-0.47683888658270956,-0.7175093273766889,0.8524590163934426,1.0,1.0,2/8,9.65%,TRIM5;TRIM13
prerank,GO_Biological_Process_2021__positive regulation of translational initiation (GO:0045948),-0.396965859034477,-0.7173686737378961,0.8208955223880597,1.0,1.0,2/16,7.16%,CCL5;POLR2G
prerank,GO_Biological_Process_2021__positive regulation of dephosphorylation (GO:0035306),-0.3820036851131647,-0.716878838728701,0.8904109589041096,1.0,1.0,6/21,26.56%,CALM1;CNEP1R1;PPP1R16B;SYMPK;ANKLE2;LILRB2
prerank,GO_Biological_Process_2021__cardiac ventricle morphogenesis (GO:0003208),-0.4056671133439906,-0.7165195807856632,0.8153846153846154,1.0,1.0,3/18,8.45%,TGFBR3;MYBPC3;RBPJ
prerank,GO_Biological_Process_2021__regulation of JNK cascade (GO:0046328),-0.30848557992728587,-0.7161964288867274,0.88,1.0,1.0,3/74,3.87%,TGFBR3;GADD45B;EPHB1
prerank,GO_Biological_Process_2021__negative regulation of stress-activated MAPK cascade (GO:0032873),-0.3462703501158828,-0.7161074854290729,0.90625,1.0,1.0,2/26,6.85%,DUSP1;GSTP1
prerank,GO_Biological_Process_2021__response to ATP (GO:0033198),0.452770007058111,0.7160144386660487,0.8604651162790697,0.9833929779123911,1.0,5/9,28.67%,P2RY12;P2RX7;DGKQ;HSP90B1;P2RX4
prerank,GO_Biological_Process_2021__hepaticobiliary system development (GO:0061008),-0.41415381575314536,-0.7159009148788336,0.8032786885245902,1.0,1.0,1/14,1.03%,TGFBR3
prerank,GO_Biological_Process_2021__bone development (GO:0060348),-0.3787118484032641,-0.7158586024871558,0.8493150684931506,1.0,1.0,3/21,15.82%,SULF2;PTPRC;RPL13
prerank,GO_Biological_Process_2021__regulation of neutrophil chemotaxis (GO:0090022),-0.3858723049443133,-0.7157736727142926,0.8245614035087719,1.0,1.0,5/17,16.58%,RIPOR2;NCKAP1L;C5AR2;CD74;RAC1
prerank,MSigDB_Hallmark_2020__E2F Targets,-0.3045742193643312,-0.715765012783917,0.972972972972973,1.0,1.0,21/132,17.36%,TFRC;ING3;HUS1;TIPIN;RANBP1;ILF3;BRCA2;NAA38;PNN;PRDX4;CKS2;DNMT1;SRSF2;MCM7;RPA3;BRCA1;STMN1;SMC1A;SHMT1;RFC1;LUC7L3
prerank,GO_Biological_Process_2021__mRNA destabilization (GO:0061157),-0.36976614110598804,-0.7157504357693801,0.8,1.0,1.0,1/32,1.48%,ZFP36
prerank,GO_Biological_Process_2021__negative regulation of endopeptidase activity (GO:0010951),0.3118974210860621,0.7156735060579831,0.9230769230769231,0.9833306546957863,1.0,4/26,7.10%,SERPINE1;SERPINE2;TIMP3;RECK
prerank,GO_Biological_Process_2021__negative regulation of interleukin-12 production (GO:0032695),0.4217105921419271,0.715270126279057,0.7916666666666666,0.9832378928465915,1.0,1/7,10.79%,IRAK3
prerank,GO_Biological_Process_2021__pyrimidine-containing compound biosynthetic process (GO:0072528),-0.46509937985073757,-0.7151845161608502,0.7931034482758621,1.0,1.0,1/7,11.81%,DHODH
prerank,GO_Biological_Process_2021__negative regulation of GTPase activity (GO:0034260),0.3804978440718558,0.7149011436462377,0.8571428571428571,0.9830598634212382,1.0,3/13,10.86%,LRRK2;LRCH1;WNK1
prerank,GO_Biological_Process_2021__organic cyclic compound biosynthetic process (GO:1901362),-0.40263833981495983,-0.7147846417757521,0.8524590163934426,1.0,1.0,5/14,22.54%,PRLR;NFS1;MOCOS;CYP19A1;SCP2
prerank,GO_Biological_Process_2021__actin filament bundle assembly (GO:0051017),-0.35913219094866744,-0.7147151607309236,0.7761194029850746,1.0,1.0,6/19,18.85%,AIF1;CORO1B;BAIAP2L2;CALD1;EZR;NEDD9
prerank,GO_Biological_Process_2021__regulation of systemic arterial blood pressure (GO:0003073),0.4617729841485617,0.7141587751959858,0.8095238095238095,0.9835523691572293,1.0,2/5,24.68%,PLCB3;PRCP
prerank,GO_Biological_Process_2021__regulation of interleukin-12 production (GO:0032655),-0.35767897169924967,-0.7141220111753326,0.8513513513513513,1.0,1.0,1/30,1.11%,HLA-B
prerank,GO_Biological_Process_2021__regulation of catabolic process (GO:0009894),-0.40788198934678394,-0.7134027864250899,0.8,1.0,1.0,5/13,20.58%,ODC1;SNF8;ITGB1;CENATAC;CHMP6
prerank,GO_Biological_Process_2021__negative regulation of cholesterol storage (GO:0010887),-0.42802264468877615,-0.7133798153389357,0.7692307692307693,1.0,1.0,2/9,16.68%,NR1H2;TTC39B
prerank,GO_Biological_Process_2021__diterpenoid metabolic process (GO:0016101),-0.367935956725141,-0.713167382802062,0.84375,1.0,1.0,3/22,11.54%,GPC3;PLB1;SDC3
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),-0.47795680329683315,-0.7129702629767691,0.8545454545454545,1.0,1.0,2/5,21.23%,VEGFA;RGCC
prerank,GO_Biological_Process_2021__cellular response to mechanical stimulus (GO:0071260),0.30776759688070326,0.7125714407108589,0.9615384615384616,0.9848240376150094,1.0,3/34,8.90%,TNFRSF10A;TLR7;SLC9A1
prerank,GO_Biological_Process_2021__negative regulation of defense response (GO:0031348),-0.3575756896022886,-0.7125506817053157,0.8507462686567164,1.0,1.0,9/48,9.83%,NLRC3;DHX58;RORA;VPS35;NLRP12;TNFAIP3;ENPP3;METRNL;SELENOS
prerank,GO_Biological_Process_2021__clathrin-dependent endocytosis (GO:0072583),0.3243791192919694,0.7122919490893229,0.8918918918918919,0.9847246234772536,1.0,6/25,14.26%,PICALM;SNAP91;DNAJC6;FNBP1L;GPR107;SGIP1
prerank,GO_Biological_Process_2021__G2/M transition of mitotic cell cycle (GO:0000086),0.2594903320576714,0.7119129923121859,1.0,0.9845887995051894,1.0,28/98,23.93%,BORA;CDK7;TAF2;CEP41;BRSK1;YWHAG;CEP131;BTRC;FBXW11;CSNK1E;FBXL12;FBXL7;CLASP1;DYNC1H1;ALMS1;TPD52L1;BRSK2;CEP135;ODF2;NDE1;NEDD1;YWHAE;CEP152;PAFAH1B1;CEP290;KHDRBS1;HAUS2;PPP1R12B
prerank,GO_Biological_Process_2021__intracellular estrogen receptor signaling pathway (GO:0030520),-0.4127834522921568,-0.7116752936709113,0.8307692307692308,1.0,1.0,4/13,13.87%,PADI2;DDX54;DDX5;ESR2
prerank,GO_Biological_Process_2021__regulation of cholesterol transport (GO:0032374),-0.3706398893579018,-0.7116234168361321,0.8615384615384616,1.0,1.0,6/18,16.98%,LIPG;NR1H2;ABCB4;ABCA8;TTC39B;ABCA5
prerank,GO_Biological_Process_2021__establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.3742287897083676,-0.711599323326054,0.8524590163934426,1.0,1.0,1/17,3.22%,SRP14
prerank,GO_Biological_Process_2021__regulation of muscle cell differentiation (GO:0051147),0.33963518490136474,0.7114809719296189,0.8387096774193549,0.984507849087002,1.0,3/23,8.54%,MAPK11;HDAC9;CTNNA2
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein catabolic process (GO:1902992),-0.37855992090112,-0.7109598408825624,0.8548387096774194,1.0,1.0,2/17,5.56%,CLU;IGF1
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),-0.41859722110665953,-0.7106807697569129,0.7538461538461538,1.0,1.0,2/10,18.55%,NOS1AP;AKAP9
prerank,GO_Biological_Process_2021__anterior/posterior pattern specification (GO:0009952),-0.41598267321941323,-0.7103663687723878,0.8333333333333334,1.0,1.0,2/14,5.60%,BHLHE40;BASP1
prerank,GO_Biological_Process_2021__double-strand break repair via homologous recombination (GO:0000724),-0.3184207459415185,-0.7100969495468137,0.9054054054054054,1.0,1.0,24/67,26.15%,HUS1;MUS81;BRCA2;XRCC3;NABP1;MCM7;RPA3;BRCA1;FANCB;RECQL5;ZSWIM7;WRN;MCM6;NUCKS1;CDC7;MCM5;FANCM;AP5Z1;EXD2;SLX4;RECQL;POLQ;LIG3;MMS22L
prerank,GO_Biological_Process_2021__regulation of mRNA polyadenylation (GO:1900363),0.3568252863979773,0.7097775361048217,0.875,0.9859527709446623,1.0,5/17,20.63%,RNF20;ZC3H14;CPSF7;NUDT21;CDK9
prerank,GO_Biological_Process_2021__glutamate metabolic process (GO:0006536),0.36920543125663285,0.709665736976727,0.9142857142857143,0.9856160338428575,1.0,2/13,7.83%,GCLC;ALDH5A1
prerank,GO_Biological_Process_2021__actin filament bundle organization (GO:0061572),-0.3642958225306892,-0.7094471782368489,0.8153846153846154,1.0,1.0,6/18,18.85%,AIF1;CORO1B;BAIAP2L2;CALD1;EZR;NEDD9
prerank,GO_Biological_Process_2021__response to light stimulus (GO:0009416),-0.360493044622568,-0.7089086718743794,0.9041095890410958,1.0,1.0,2/34,3.67%,USF1;UVSSA
prerank,GO_Biological_Process_2021__positive regulation of striated muscle cell differentiation (GO:0051155),-0.3918396319306213,-0.7084685407635051,0.7796610169491526,1.0,1.0,2/12,12.32%,IGF1;EFNB2
prerank,GO_Biological_Process_2021__negative regulation of TORC1 signaling (GO:1904262),-0.4340156744717355,-0.7082600388669621,0.8363636363636363,1.0,1.0,1/8,9.93%,ITFG2
prerank,GO_Biological_Process_2021__regulation of establishment of endothelial barrier (GO:1903140),0.40456679357136377,0.7080369501201225,0.8333333333333334,0.987101459931462,1.0,4/12,20.79%,TNF;VCL;TNFRSF1A;ADD1
prerank,GO_Biological_Process_2021__activation of protein kinase activity (GO:0032147),-0.296417571891042,-0.7078649206952198,0.9736842105263158,1.0,1.0,13/85,17.61%,CARD14;IGF1;PHB2;PRKAR1B;PRLR;CHI3L1;SLC11A1;VEGFA;COPS8;MT3;PRKAR2B;PINK1;IL18
prerank,GO_Biological_Process_2021__intracellular steroid hormone receptor signaling pathway (GO:0030518),0.3130787639537469,0.7078208122982906,0.8620689655172413,0.986861599946457,1.0,7/30,18.34%,ARID1A;PLPP1;TRERF1;NCOA4;NEDD4;NR3C1;RBFOX2
prerank,GO_Biological_Process_2021__positive regulation of microtubule nucleation (GO:0090063),-0.4277909684286551,-0.7077776477510104,0.8518518518518519,1.0,1.0,2/7,14.43%,HSPA1B;HSPA1A
prerank,GO_Biological_Process_2021__detection of visible light (GO:0009584),0.43028631238825193,0.7076131047791406,0.8205128205128205,0.9865491803035715,1.0,2/6,11.13%,GNAQ;GNA11
prerank,GO_Biological_Process_2021__postsynaptic density assembly (GO:0097107),0.4427838725778116,0.7072422405882147,0.7647058823529411,0.9864068551520149,1.0,3/5,11.81%,SHANK3;NRXN2;PTEN
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell proliferation (GO:0060043),-0.4139796759276704,-0.7060847743291242,0.9,1.0,1.0,2/13,8.45%,TGFBR3;RBPJ
prerank,GO_Biological_Process_2021__negative regulation of cytokine production involved in immune response (GO:0002719),0.3771939091352858,0.7058819294672863,0.8333333333333334,0.9874343670726856,1.0,3/11,10.79%,SMAD7;TNF;IRAK3
prerank,GO_Biological_Process_2021__negative regulation of protein depolymerization (GO:1901880),0.36537834776246386,0.7058628419188497,0.8837209302325582,0.9869525180310533,1.0,6/19,19.20%,CIB1;CLASP1;CLASP2;PIK3CA;CAMSAP2;ATXN7
prerank,GO_Biological_Process_2021__cellular biogenic amine catabolic process (GO:0042402),-0.41705647542161833,-0.7058580913640463,0.8301886792452831,1.0,1.0,1/7,9.85%,COMT
prerank,GO_Biological_Process_2021__mRNA stabilization (GO:0048255),-0.3480129336354894,-0.7053399890469109,0.875,1.0,1.0,1/27,1.48%,ZFP36
prerank,GO_Biological_Process_2021__negative regulation of macromolecule metabolic process (GO:0010605),-0.290948745021124,-0.7051800587865014,1.0,1.0,1.0,18/127,14.23%,CCL3;SLC7A5;PARP14;PARP15;DDRGK1;RACK1;IGF1;PARP9;OVOL2;CITED2;VEGFA;HIF1A;DNMT1;HAVCR2;NOTCH2;TET1;ANKRD13D;REL
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.38812216787865955,-0.7047945607253938,0.9019607843137255,1.0,1.0,3/14,8.71%,CLU;TPT1;CD44
prerank,GO_Biological_Process_2021__positive regulation of ATPase activity (GO:0032781),-0.3575779384192805,-0.7047634146894738,0.828125,1.0,1.0,9/31,20.20%,PLSCR1;MYBPC3;GABARAPL2;CHTOP;PFN1;ATP1B3;UHRF1;MSH6;TPM1
prerank,GO_Biological_Process_2021__ER overload response (GO:0006983),-0.4529364697971834,-0.7046933857373128,0.864406779661017,1.0,1.0,3/8,13.27%,SELENOS;ATG10;TMCO1
prerank,GO_Biological_Process_2021__cellular response to superoxide (GO:0071451),-0.4529289823520094,-0.7043728358296474,0.873015873015873,1.0,1.0,2/6,16.40%,SOD1;MT3
prerank,GO_Biological_Process_2021__sphingolipid catabolic process (GO:0030149),-0.41715445739082607,-0.7036746880861615,0.8813559322033898,1.0,1.0,3/10,8.11%,PDXDC1;GLA;ENPP2
prerank,GO_Biological_Process_2021__negative regulation of glucose transmembrane transport (GO:0010829),-0.4276952783224064,-0.703138655099757,0.8360655737704918,1.0,1.0,4/9,17.44%,PID1;SELENOS;PEA15;INPP5K
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transport (GO:0043267),0.39697875471570593,0.7031158297940737,0.7872340425531915,0.9895831809096645,1.0,2/7,8.52%,CAB39;NEDD4L
prerank,GO_Biological_Process_2021__regulation of lipoprotein lipase activity (GO:0051004),0.35078639994341926,0.7030282604217176,0.8,0.9891552031734148,1.0,3/10,13.56%,HDAC9;SORT1;PCSK6
prerank,GO_Biological_Process_2021__regulation of microtubule nucleation (GO:0010968),-0.3941634940398127,-0.702913440259548,0.8813559322033898,1.0,1.0,2/9,14.43%,HSPA1B;HSPA1A
prerank,GO_Biological_Process_2021__DNA topological change (GO:0006265),0.4120558208767313,0.7026378111572265,0.8627450980392157,0.9890784651015593,1.0,3/8,31.00%,TOP2B;TOP3A;TOP1
prerank,GO_Biological_Process_2021__positive regulation of triglyceride metabolic process (GO:0090208),-0.4215506920981872,-0.7023471768117,0.8169014084507042,1.0,1.0,2/11,8.91%,NR1H2;CNEP1R1
prerank,GO_Biological_Process_2021__tricarboxylic acid metabolic process (GO:0072350),-0.39131605700376676,-0.7019498236344778,0.896551724137931,1.0,1.0,2/11,20.66%,IDH3B;ACO2
prerank,GO_Biological_Process_2021__regulation of glutamate receptor signaling pathway (GO:1900449),-0.45513786431778025,-0.7018110336336809,0.7924528301886793,1.0,1.0,1/5,7.36%,FYN
prerank,GO_Biological_Process_2021__regulation of extent of cell growth (GO:0061387),0.3921508800269065,0.7015823592464555,0.82,0.9899751235202451,1.0,3/8,22.75%,GSK3B;CTTN;ABL1
prerank,GO_Biological_Process_2021__pore complex assembly (GO:0046931),-0.387700741673578,-0.7014650506214678,0.8709677419354839,1.0,1.0,1/16,1.24%,PLEKHA7
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection organization (GO:0120036),-0.30082380544161513,-0.7014389915339756,0.95,1.0,1.0,5/83,6.72%,CATIP;BTG2;RAB11A;PLEK;CORO1B
prerank,GO_Biological_Process_2021__positive regulation of collagen biosynthetic process (GO:0032967),0.40065875473337176,0.7011433201380545,0.813953488372093,0.9900249443060343,1.0,1/7,6.90%,RUNX1
prerank,GO_Biological_Process_2021__mesenchymal cell differentiation (GO:0048762),-0.3706650562526961,-0.7009965447822825,0.9210526315789473,1.0,1.0,7/32,16.94%,TGFBR3;RBPJ;HNRNPAB;HIF1A;DDX5;AKNA;S100A4
prerank,GO_Biological_Process_2021__regulation of skeletal muscle tissue development (GO:0048641),-0.43507458558489326,-0.7009515418252796,0.7540983606557377,1.0,1.0,2/5,21.55%,FLOT1;USP19
prerank,MSigDB_Hallmark_2020__Pperoxisome,-0.30711614149888494,-0.7008981771371697,0.9714285714285714,1.0,1.0,11/77,15.19%,ABCB1;FIS1;GNPAT;GSTK1;ACAA1;ABCB4;ABCB9;SOD1;ESR2;ECI2;SLC25A19
prerank,GO_Biological_Process_2021__methylguanosine-cap decapping (GO:0110156),0.3899531200045264,0.7005034936587619,0.8809523809523809,0.9903223322149405,1.0,1/9,2.41%,DCP1B
prerank,GO_Biological_Process_2021__regulation of intracellular signal transduction (GO:1902531),-0.2725197056132409,-0.7000854894442643,1.0,1.0,1.0,23/332,8.69%,PLEKHG5;ARHGAP4;RASGRF2;VAV3;DDIT4;CHD3;RPL5;GMIP;IER3;HUS1;ING5;ARHGEF1;RPL11;RHOU;PRKAR1B;ARHGEF3;OBSCN;NLRP12;SGK1;SRGAP3;ANKRD54;PRKD2;TMSB4X
prerank,GO_Biological_Process_2021__regulation of TORC1 signaling (GO:1903432),0.3339341365189001,0.6998752879454839,0.9487179487179487,0.9904745494508581,1.0,2/26,5.75%,RRAGD;GPR137C
prerank,GO_Biological_Process_2021__protein neddylation (GO:0045116),0.40866353475889317,0.6998625820942993,0.9019607843137255,0.9899870728773523,1.0,2/8,12.35%,DCUN1D4;DCUN1D1
prerank,GO_Biological_Process_2021__protein catabolic process (GO:0030163),-0.3425821061494926,-0.6998441723882549,0.9420289855072463,1.0,1.0,1/41,1.79%,TPP1
prerank,GO_Biological_Process_2021__organic substance transport (GO:0071702),-0.2999407680181575,-0.6997480111340423,0.9466666666666667,1.0,1.0,8/71,12.48%,ABCA9;ABCA6;PLTP;PCTP;ABCB9;TAP1;ABCA8;DENND10
prerank,GO_Biological_Process_2021__regulation of mitotic spindle assembly (GO:1901673),-0.3680080857263538,-0.6991818958144447,0.8676470588235294,1.0,1.0,2/15,14.43%,HSPA1B;HSPA1A
prerank,GO_Biological_Process_2021__hydrogen peroxide catabolic process (GO:0042744),0.38847759345904664,0.6991047956520272,0.8085106382978723,0.990314187399718,1.0,1/7,5.29%,CAT
prerank,"GO_Biological_Process_2021__positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",-0.45745544605386956,-0.6989212694786788,0.8833333333333333,1.0,1.0,1/7,1.60%,PYHIN1
prerank,GO_Biological_Process_2021__myoblast differentiation (GO:0045445),0.3975016406485957,0.6989088662238677,0.8974358974358975,0.9900201530565732,1.0,5/12,15.98%,NRG1;JAG1;EPAS1;TCF7L2;HINFP
prerank,GO_Biological_Process_2021__positive regulation of triglyceride biosynthetic process (GO:0010867),-0.4484298330628099,-0.6975303538874358,0.8615384615384616,1.0,1.0,2/8,8.91%,NR1H2;CNEP1R1
prerank,GO_Biological_Process_2021__autophagosome organization (GO:1905037),-0.32715204483724114,-0.6975141582331215,0.9354838709677419,1.0,1.0,6/40,15.41%,GABARAPL1;ATG2A;GABARAPL2;STING1;TP53INP1;WIPI1
prerank,GO_Biological_Process_2021__establishment of protein localization to membrane (GO:0090150),-0.315597421936169,-0.6968227664866239,0.9850746268656716,1.0,1.0,8/51,13.91%,AQP11;RAB11A;NACA;ZDHHC4;ZDHHC19;COX18;VPS37B;OXA1L
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transmembrane transport (GO:1901380),0.4145407736773825,0.6967525194973849,0.7659574468085106,0.9921241269252694,1.0,2/7,8.52%,CAB39;NEDD4L
prerank,GO_Biological_Process_2021__positive regulation of cellular senescence (GO:2000774),-0.4107922946564695,-0.6964868424405417,0.8909090909090909,1.0,1.0,1/8,2.81%,B2M
prerank,GO_Biological_Process_2021__positive regulation of cell aging (GO:0090343),-0.4107922946564695,-0.6964868424405417,0.8909090909090909,1.0,1.0,1/8,2.81%,B2M
prerank,GO_Biological_Process_2021__regulation of protein localization to chromatin (GO:1905634),0.44186917227299666,0.6963861344748138,0.868421052631579,0.9919920632050157,1.0,2/6,26.09%,SETD2;WAPL
prerank,GO_Biological_Process_2021__DNA strand elongation involved in DNA replication (GO:0006271),-0.3887439355705802,-0.6962214266056269,0.8727272727272727,1.0,1.0,2/13,13.28%,POLE3;MCM7
prerank,GO_Biological_Process_2021__rRNA modification (GO:0000154),-0.3659989202361521,-0.6960372784820981,0.8769230769230769,1.0,1.0,4/17,15.36%,BUD23;NHP2;NOP10;ZCCHC4
prerank,GO_Biological_Process_2021__sno(s)RNA 3'-end processing (GO:0031126),-0.44487560668200926,-0.6956801243190986,0.84,1.0,1.0,5/8,21.97%,EXOSC10;LARP7;FBL;TENT4B;PARN
prerank,GO_Biological_Process_2021__cytochrome complex assembly (GO:0017004),-0.4674127128717521,-0.6955897905655126,0.8775510204081632,1.0,1.0,4/5,18.64%,COX18;COA6;CYBA;SURF1
prerank,GO_Biological_Process_2021__regulation of mRNA processing (GO:0050684),0.3216464301963865,0.6946476101551866,0.972972972972973,0.9934670496154233,1.0,3/32,6.48%,KHDRBS2;CPSF4;KHDRBS3
prerank,GO_Biological_Process_2021__protein localization to synapse (GO:0035418),0.43273326335252715,0.6939985831324436,0.85,0.9936472524917146,1.0,4/8,21.61%,NLGN1;NRXN2;PCLO;NRXN1
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process (GO:0045732),-0.3062759171602939,-0.6937795702390723,0.9491525423728814,1.0,1.0,8/61,9.91%,NKD1;VPS35;PTTG1IP;SNF8;TNFRSF1B;TNFAIP3;GPC3;VPS28
prerank,GO_Biological_Process_2021__positive regulation of canonical Wnt signaling pathway (GO:0090263),-0.2939323108826054,-0.693389936232912,0.9759036144578314,1.0,1.0,13/96,13.53%,PSMB3;JUP;PSMB6;PSMA7;GPC3;PSMB9;TRPM4;CSNK1G2;PSMD12;CSNK1D;PSMD8;PSMA5;PRDM15
prerank,GO_Biological_Process_2021__regulation of MAP kinase activity (GO:0043405),-0.3145280704911448,-0.6933688513314522,0.9402985074626866,1.0,1.0,12/61,15.92%,DUSP1;RGS2;PDGFD;PAQR3;GSTP1;SNF8;VEGFA;FLT1;PIK3CB;NOD2;SPRY1;AGT
prerank,"GO_Biological_Process_2021__tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.39779608978634157,0.6931041758254304,0.8461538461538461,0.9941218862761828,1.0,2/12,6.43%,CPSF4;ZBTB8OS
prerank,GO_Biological_Process_2021__acetylcholine receptor signaling pathway (GO:0095500),-0.3949148838894242,-0.6930441184188376,0.8392857142857143,1.0,1.0,1/11,1.41%,CHRM2
prerank,GO_Biological_Process_2021__negative regulation of lipid metabolic process (GO:0045833),-0.39108005732159756,-0.6930346370831402,0.8571428571428571,1.0,1.0,1/12,4.08%,APOD
prerank,GO_Biological_Process_2021__camera-type eye morphogenesis (GO:0048593),-0.43979704063158886,-0.6922209843229626,0.864406779661017,1.0,1.0,1/7,11.19%,VEGFA
prerank,GO_Biological_Process_2021__defense response to Gram-negative bacterium (GO:0050829),-0.3674902844367,-0.6919747534113965,0.8636363636363636,1.0,1.0,7/17,19.56%,RPL30;SLC11A1;H2BC11;RPS19;RNASE6;TNFRSF14;MPEG1
prerank,GO_Biological_Process_2021__miRNA catabolic process (GO:0010587),-0.4586502388177554,-0.691935726343561,0.8367346938775511,1.0,1.0,2/5,21.97%,TENT4B;PARN
prerank,GO_Biological_Process_2021__negative regulation of cellular carbohydrate metabolic process (GO:0010677),-0.3903863378796481,-0.6918135807704602,0.8301886792452831,1.0,1.0,2/11,11.31%,PLEK;FBP1
prerank,GO_Biological_Process_2021__regulation of mitophagy (GO:1901524),-0.44991668601001095,-0.6917505221271053,0.8235294117647058,1.0,1.0,1/5,5.57%,SLC25A5
prerank,GO_Biological_Process_2021__sequestering of actin monomers (GO:0042989),0.4577344469147794,0.6912145560623825,0.8979591836734694,0.9954133358255236,1.0,1/5,1.66%,GSN
prerank,GO_Biological_Process_2021__cellular response to interleukin-6 (GO:0071354),-0.37363237413634953,-0.6911248462374814,0.8888888888888888,1.0,1.0,2/23,9.56%,PID1;STAT1
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced cell death (GO:1903201),-0.4112725428667909,-0.6909961506261317,0.8444444444444444,1.0,1.0,4/9,26.34%,FYN;PINK1;PARK7;REST
prerank,GO_Biological_Process_2021__dendritic spine morphogenesis (GO:0060997),-0.39356743118586335,-0.6909518219641725,0.8095238095238095,1.0,1.0,1/12,3.87%,EPHB1
prerank,GO_Biological_Process_2021__neuron migration (GO:0001764),0.3189732096126883,0.6907029034670499,0.9130434782608695,0.9954841884585177,1.0,10/39,13.54%,NRP1;CDK5R1;RELN;AUTS2;GPM6A;PEX13;ELP3;NTRK2;SH3RF1;MARK1
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.35378988436295417,0.6906561201817385,0.8918918918918919,0.9950506765476553,1.0,3/22,13.77%,FGF2;P2RY12;PTK2
prerank,GO_Biological_Process_2021__microtubule polymerization (GO:0046785),-0.36134881682068853,-0.6904967523820958,0.8870967741935484,1.0,1.0,7/25,18.55%,FGF13;TRPV4;TUBGCP2;CSNK1D;MAP7D3;TUBGCP5;AKAP9
prerank,GO_Biological_Process_2021__heterocycle biosynthetic process (GO:0018130),-0.4235185603337813,-0.6904802020964218,0.7903225806451613,1.0,1.0,2/8,17.37%,NFS1;MOCOS
prerank,GO_Biological_Process_2021__protein-DNA complex disassembly (GO:0032986),0.35691184386195374,0.690368411525921,0.813953488372093,0.9948996191193462,1.0,3/12,10.75%,ARID1A;HMGA1;SUPT16H
prerank,GO_Biological_Process_2021__defense response to protozoan (GO:0042832),-0.41493234885208957,-0.6901095643288928,0.7936507936507936,1.0,1.0,2/8,10.20%,GBP2;SLC11A1
prerank,GO_Biological_Process_2021__regulation of long-chain fatty acid import across plasma membrane (GO:0010746),0.4309079602537046,0.6896526765093911,0.8205128205128205,0.9951805353896255,1.0,1/6,15.47%,AKT2
prerank,MSigDB_Hallmark_2020__PI3K/AKT/mTOR  Signaling,-0.306102358649851,-0.6895680628378977,0.9315068493150684,1.0,1.0,6/85,12.75%,CXCR4;VAV3;THEM4;CFL1;PFN1;ATF1
prerank,GO_Biological_Process_2021__endoplasmic reticulum tubular network organization (GO:0071786),0.36548149945606745,0.6895530974856048,0.825,0.9947957743303476,1.0,3/13,12.26%,RAB10;REEP3;RTN4
prerank,GO_Biological_Process_2021__protein K6-linked ubiquitination (GO:0085020),0.41514068078647454,0.689475456225677,0.7837837837837838,0.9943874275493573,1.0,4/6,25.93%,BARD1;RNF6;UBE2D4;RNF4
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.3173046573444454,0.6894675097305332,0.8888888888888888,0.9938956434605594,1.0,3/37,7.92%,DAPK2;DDIT3;BOK
prerank,GO_Biological_Process_2021__pyrimidine-containing compound catabolic process (GO:0072529),-0.3985963712933114,-0.6894112052439878,0.8709677419354839,1.0,1.0,3/12,10.19%,NT5C;TYMP;DPYS
prerank,GO_Biological_Process_2021__production of siRNA involved in RNA interference (GO:0030422),0.4347846181306662,0.6889287578566148,0.8372093023255814,0.9940328438219805,1.0,4/7,30.25%,DROSHA;MRPL44;HENMT1;TSN
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transmembrane transporter activity (GO:1901017),0.4603655180576679,0.6887033981908562,0.8936170212765957,0.9937570995272544,1.0,2/6,8.52%,CAB39;NEDD4L
prerank,GO_Biological_Process_2021__glycoprotein metabolic process (GO:0009100),0.29994608706742854,0.6886106379914907,0.9714285714285714,0.9933799712124625,1.0,11/39,17.01%,LARGE1;ST6GALNAC3;HPSE;PRKCSH;B4GALT7;STT3B;PCSK6;FBXO27;ST8SIA4;ERP44;ST8SIA5
prerank,GO_Biological_Process_2021__positive regulation of catabolic process (GO:0009896),0.2899489094544136,0.688299548465957,0.9393939393939394,0.9931586128797422,1.0,15/46,19.22%,WNT5A;TNF;FZR1;RAB7A;NEDD4L;PLK2;SORL1;BARD1;SMURF1;GSK3B;IDE;NEDD4;HACE1;TIPARP;CSNK2A1
prerank,GO_Biological_Process_2021__myeloid cell differentiation (GO:0030099),0.32892903173058086,0.6875230970168449,0.8571428571428571,0.9934990182177701,1.0,5/38,11.63%,FLVCR1;ZBTB16;RUNX1;IKZF1;MFHAS1
prerank,GO_Biological_Process_2021__mitotic G1/S transition checkpoint signaling (GO:0044819),-0.40140471270016687,-0.6873960954821264,0.8833333333333333,1.0,1.0,2/10,15.14%,CCND1;RPS27L
prerank,GO_Biological_Process_2021__calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),-0.3824024498483541,-0.6870400954117486,0.8360655737704918,1.0,1.0,2/14,5.06%,SELL;CDH23
prerank,GO_Biological_Process_2021__nucleotide transport (GO:0006862),-0.458253274288342,-0.6870237087419109,0.8771929824561403,1.0,1.0,2/5,24.47%,SLC25A19;SLC25A36
prerank,GO_Biological_Process_2021__regulation of fibrinolysis (GO:0051917),-0.44496093210514687,-0.6865542682226995,0.8793103448275862,1.0,1.0,1/6,2.94%,USF1
prerank,GO_Biological_Process_2021__steroid hormone mediated signaling pathway (GO:0043401),0.39554318506788005,0.6864294060837254,0.875,0.9940659835723022,1.0,4/8,25.61%,PLPP1;NR3C1;NR3C2;ESR1
prerank,GO_Biological_Process_2021__endodermal cell differentiation (GO:0035987),0.34503946719742584,0.6863893098620816,0.9347826086956522,0.9936297665265909,1.0,5/17,14.07%,ITGAV;COL11A1;COL6A1;SETD2;MMP14
prerank,GO_Biological_Process_2021__early endosome to late endosome transport (GO:0045022),0.3160058135240189,0.6863766455195548,0.9148936170212766,0.993158188907255,1.0,2/19,8.42%,PTPN23;RAB7A
prerank,GO_Biological_Process_2021__histone modification (GO:0016570),0.27030400015130224,0.6862935941493926,0.96875,0.9927884317135529,1.0,13/86,12.90%,RUVBL2;SIRT1;HDAC9;MTA2;MIER3;RPS6KA4;TRERF1;HDAC1;TBL1XR1;NSD3;KAT2A;UBE2N;BRMS1L
prerank,"GO_Biological_Process_2021__negative regulation of gene expression, epigenetic (GO:0045814)",0.3224545519425167,0.6860288951618249,0.926829268292683,0.992585895668613,1.0,2/25,10.26%,AEBP2;SMYD5
prerank,GO_Biological_Process_2021__negative regulation of fibrinolysis (GO:0051918),-0.45289808500467305,-0.6859410336803533,0.8867924528301887,1.0,1.0,1/5,2.94%,USF1
prerank,GO_Biological_Process_2021__neurotrophin signaling pathway (GO:0038179),-0.38427109402114457,-0.6856456470757951,0.8852459016393442,1.0,1.0,1/13,2.37%,DDIT4
prerank,GO_Biological_Process_2021__cellular protein catabolic process (GO:0044257),0.28481976019356336,0.6849551858644063,0.9090909090909091,0.9931161782377183,1.0,5/46,9.60%,CTSF;CTSC;CTSK;RAB7A;MDM2
prerank,GO_Biological_Process_2021__organelle fusion (GO:0048284),0.33988119727104926,0.6849469564891741,0.8863636363636364,0.992633873856296,1.0,3/17,11.82%,GDAP1;USP30;MFN1
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translational elongation (GO:1900247),0.4437257581969243,0.6846870459024946,0.8571428571428571,0.9923781587293746,1.0,2/5,18.57%,DPH5;CPEB2
prerank,GO_Biological_Process_2021__cardiac muscle cell differentiation (GO:0055007),-0.3978084710480606,-0.6843962035605755,0.8787878787878788,1.0,1.0,3/12,11.19%,TTN;KDM6B;VEGFA
prerank,GO_Biological_Process_2021__regulation of cellular senescence (GO:2000772),0.36092651562539524,0.6837627137325388,0.868421052631579,0.9929196569281861,1.0,5/22,13.04%,SIRT1;NUAK1;HMGA1;CDK6;CGAS
prerank,GO_Biological_Process_2021__sulfur compound transport (GO:0072348),0.36016418638664166,0.6833726051470531,0.8518518518518519,0.99296722507807,1.0,4/18,18.82%,SLC19A2;SLC25A14;SLC35F3;SLC25A26
prerank,GO_Biological_Process_2021__negative regulation of nitric oxide metabolic process (GO:1904406),-0.4499185840739288,-0.6832118518514848,0.8333333333333334,1.0,1.0,1/5,5.40%,GLA
prerank,GO_Biological_Process_2021__negative regulation of nitric oxide biosynthetic process (GO:0045019),-0.4499185840739288,-0.6832118518514848,0.8333333333333334,1.0,1.0,1/5,5.40%,GLA
prerank,GO_Biological_Process_2021__regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070432),-0.4387698430540142,-0.6831570976371893,0.8448275862068966,1.0,1.0,4/6,19.00%,HSPA1B;HSPA1A;SLC15A3;PTPN22
prerank,GO_Biological_Process_2021__positive regulation of granulocyte chemotaxis (GO:0071624),-0.39372019360096266,-0.6829332854274686,0.9090909090909091,1.0,1.0,1/13,0.96%,RIPOR2
prerank,GO_Biological_Process_2021__positive regulation of neutrophil chemotaxis (GO:0090023),-0.39372019360096266,-0.6829332854274686,0.9090909090909091,1.0,1.0,1/13,0.96%,RIPOR2
prerank,GO_Biological_Process_2021__regulation of mitotic centrosome separation (GO:0046602),-0.4308930444169844,-0.6824768499720569,0.7931034482758621,1.0,1.0,1/6,5.97%,RANBP1
prerank,GO_Biological_Process_2021__calcium ion transport (GO:0006816),-0.3256496084761277,-0.6817868356492702,0.9726027397260274,1.0,1.0,10/69,10.69%,CCL3;CCL5;MCOLN2;CDH23;FYN;TPT1;TRPV4;TRPM3;CACNA2D4;TRPM4
prerank,GO_Biological_Process_2021__genitalia development (GO:0048806),0.46120988745016045,0.6812507046434704,0.8444444444444444,0.9944347989881374,1.0,2/5,4.48%,PKD1;WNT5A
prerank,GO_Biological_Process_2021__positive regulation of neuron migration (GO:2001224),-0.38175885991818287,-0.6812367154415961,0.8490566037735849,1.0,1.0,1/12,5.83%,SEMA6A
prerank,GO_Biological_Process_2021__G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),-0.38349799026240966,-0.6810238933499282,0.85,1.0,1.0,1/12,1.41%,CHRM2
prerank,GO_Biological_Process_2021__microtubule nucleation (GO:0007020),0.34335192056421127,0.6810074107243239,0.9024390243902439,0.9941668248139016,1.0,6/17,19.38%,TPPP;SLAIN2;CLASP1;TUBGCP6;CLASP2;NDE1
prerank,GO_Biological_Process_2021__embryonic organ morphogenesis (GO:0048562),0.36208082544432496,0.6808384367297927,0.8695652173913043,0.9938397551906951,1.0,6/10,25.10%,FBN2;MEGF8;NIPBL;FGFR2;RYR2;ACVR1
prerank,GO_Biological_Process_2021__regulation of cytokinesis (GO:0032465),-0.3319192503060932,-0.6808324835632966,0.9242424242424242,1.0,1.0,5/50,8.36%,RAB11A;KLHL13;CENPV;ENTR1;CALM1
prerank,GO_Biological_Process_2021__regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),-0.3913546587208221,-0.6803828312468662,0.8070175438596491,1.0,1.0,2/9,5.57%,CHCHD10;SLC25A5
prerank,GO_Biological_Process_2021__mitochondrial tRNA processing (GO:0090646),-0.4490264181338273,-0.6803812173812522,0.8431372549019608,1.0,1.0,1/5,10.63%,TRMT10B
prerank,GO_Biological_Process_2021__phosphatidylinositol dephosphorylation (GO:0046856),0.3094206342335685,0.6803045572856689,0.875,0.9938452489477146,1.0,8/21,33.18%,PTEN;MTMR9;PIP4P2;SYNJ2;OCRL;MTMR3;SYNJ1;INPP5F
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.34371615573965675,-0.6801232715819079,0.9242424242424242,1.0,1.0,6/26,14.26%,TNFSF10;TNFAIP3;CFLAR;GPX1;PEA15;BRCA1
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell differentiation (GO:0051151),0.4554572171987952,0.6800012197893494,0.8518518518518519,0.9936609772232889,1.0,2/5,18.52%,NFATC3;NFATC2
prerank,GO_Biological_Process_2021__telomere capping (GO:0016233),-0.40811867662839657,-0.6798667577985908,0.8421052631578947,1.0,1.0,2/11,21.40%,TERF2IP;CTC1
prerank,GO_Biological_Process_2021__camera-type eye development (GO:0043010),0.37538555796072526,0.6793045530973286,0.8367346938775511,0.993761386718562,1.0,2/10,12.21%,FBN2;NF1
prerank,GO_Biological_Process_2021__phosphatidylcholine biosynthetic process (GO:0006656),0.3244080131308587,0.6789301359263433,0.875,0.9936128815324079,1.0,10/21,19.22%,CHKA;SLC44A2;GPAT4;SLC44A5;SLC44A1;LCAT;CHPT1;STARD7;PEMT;CSNK2A1
prerank,GO_Biological_Process_2021__heart contraction (GO:0060047),-0.39476898918240766,-0.6788550084834412,0.8787878787878788,1.0,1.0,4/18,14.09%,TTN;MYBPC3;SOD1;GPX1
prerank,GO_Biological_Process_2021__response to forskolin (GO:1904321),-0.4098050917017843,-0.678556995315217,0.8571428571428571,1.0,1.0,1/7,10.61%,CFTR
prerank,GO_Biological_Process_2021__cellular response to forskolin (GO:1904322),-0.4098050917017843,-0.678556995315217,0.8571428571428571,1.0,1.0,1/7,10.61%,CFTR
prerank,GO_Biological_Process_2021__late endosome to lysosome transport (GO:1902774),0.48278433582690083,0.6782026121472579,0.9318181818181818,0.9937546654734876,1.0,1/5,17.89%,ARL8B
prerank,GO_Biological_Process_2021__megakaryocyte differentiation (GO:0030219),0.4418014085762555,0.6779712136856866,0.8837209302325582,0.9934938589528,1.0,1/6,7.81%,ZNF385A
prerank,GO_Biological_Process_2021__cellular response to ATP (GO:0071318),0.4128522924358082,0.6779572634703579,0.851063829787234,0.9930203485834287,1.0,4/8,28.67%,P2RY12;P2RX7;HSP90B1;P2RX4
prerank,GO_Biological_Process_2021__mitochondrial fusion (GO:0008053),0.3411221543042765,0.6776006811562912,0.875,0.9928488447611322,1.0,3/15,11.82%,GDAP1;USP30;MFN1
prerank,GO_Biological_Process_2021__mRNA metabolic process (GO:0016071),-0.2975722562518547,-0.6775368731103284,0.971830985915493,1.0,1.0,13/78,14.43%,ZFP36;NUDT12;SSB;AURKAIP1;U2AF2;NCBP2;PRPF3;HSPA1B;SRSF2;DDX5;SRSF7;NUDT16;HSPA1A
prerank,GO_Biological_Process_2021__complement receptor mediated signaling pathway (GO:0002430),0.4003508122239436,0.6773365191334371,0.8596491228070176,0.9925947719186775,1.0,1/7,2.10%,FPR3
prerank,GO_Biological_Process_2021__melanosome organization (GO:0032438),-0.3624426448320146,-0.6770876987423315,0.9047619047619048,1.0,1.0,3/15,14.35%,HPS4;BLOC1S2;TRAPPC6A
prerank,GO_Biological_Process_2021__tRNA wobble base modification (GO:0002097),-0.4140457258537425,-0.6770672291676502,0.8909090909090909,1.0,1.0,1/9,7.53%,GTPBP3
prerank,GO_Biological_Process_2021__positive regulation of actin filament depolymerization (GO:0030836),0.4003455222598597,0.6766866550419451,0.8409090909090909,0.9927012655140786,1.0,1/8,1.58%,SEMA5A
prerank,GO_Biological_Process_2021__regulation of I-kappaB phosphorylation (GO:1903719),0.4137801371412503,0.6766308435412739,0.8863636363636364,0.9922822008944591,1.0,2/7,7.30%,SIRPA;TNF
prerank,GO_Biological_Process_2021__positive regulation of regulated secretory pathway (GO:1903307),-0.378810591968538,-0.6760900209876118,0.8,1.0,1.0,2/11,7.73%,RAB3A;RAB3D
prerank,GO_Biological_Process_2021__RNA methylation (GO:0001510),0.2883476423898395,0.6757285244046122,0.9696969696969697,0.9925598750503648,1.0,3/47,5.52%,MEPCE;NSUN2;TFB1M
prerank,GO_Biological_Process_2021__positive regulation of acute inflammatory response (GO:0002675),-0.4352487117911569,-0.6755363213073826,0.84,1.0,1.0,1/5,6.67%,OSMR
prerank,GO_Biological_Process_2021__cell cycle checkpoint signaling (GO:0000075),-0.42618454347557294,-0.675507241912123,0.8333333333333334,1.0,1.0,3/6,16.30%,ZWILCH;NABP1;CHFR
prerank,GO_Biological_Process_2021__internal peptidyl-lysine acetylation (GO:0018393),-0.3773805486537958,-0.6753989407077883,0.8723404255319149,1.0,1.0,4/23,16.14%,TAF6L;MSL3;KAT5;KAT8
prerank,"GO_Biological_Process_2021__regulation of CD8-positive, alpha-beta T cell activation (GO:2001185)",-0.4125124162754704,-0.675128781340789,0.864406779661017,1.0,1.0,4/8,26.10%,IRF1;HLA-E;LILRB1;HLA-A
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell differentiation (GO:2000725),-0.4190034283947755,-0.6748231935754821,0.8275862068965517,1.0,1.0,1/5,12.32%,EFNB2
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K4 methylation (GO:0051571),-0.3903084315448112,-0.674375815324564,0.8490566037735849,1.0,1.0,2/11,14.26%,DNMT1;BRCA1
prerank,GO_Biological_Process_2021__Notch signaling involved in heart development (GO:0061314),-0.4460755921439792,-0.674208638578657,0.9019607843137255,1.0,1.0,2/5,13.87%,RBPJ;NOTCH2
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell differentiation (GO:1905063),0.4293475640048443,0.6741940655136875,0.8367346938775511,0.9934919822432182,1.0,2/6,18.52%,NFATC3;NFATC2
prerank,GO_Biological_Process_2021__mitotic nuclear membrane disassembly (GO:0007077),-0.4256277402892802,-0.6740437412783383,0.8793103448275862,1.0,1.0,1/7,8.91%,CNEP1R1
prerank,GO_Biological_Process_2021__positive regulation of neutrophil migration (GO:1902624),-0.38692927672373195,-0.6739228080469711,0.8928571428571429,1.0,1.0,1/14,0.96%,RIPOR2
prerank,GO_Biological_Process_2021__transepithelial transport (GO:0070633),0.39554479610114135,0.6736109571772047,0.8157894736842105,0.993491715186061,1.0,2/9,6.03%,SLC1A3;SLC1A2
prerank,GO_Biological_Process_2021__positive regulation of RNA metabolic process (GO:0051254),-0.33906598694144935,-0.6732455476134511,0.9130434782608695,1.0,1.0,9/35,22.88%,RBM22;BUD23;U2AF2;DDX5;HSPA1A;PNPT1;ERN1;NMD3;HEATR1
prerank,GO_Biological_Process_2021__regulation of non-canonical Wnt signaling pathway (GO:2000050),0.3820079212429889,0.6728885479814877,0.8409090909090909,0.9935916207144697,1.0,1/8,1.07%,ZNRF3
prerank,GO_Biological_Process_2021__positive regulation by host of viral transcription (GO:0043923),-0.3643827885214391,-0.672667425093394,0.8076923076923077,1.0,1.0,6/15,26.85%,CTDP1;TAF11;NUCKS1;TFAP4;CHD1;SMARCB1
prerank,"GO_Biological_Process_2021__RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",0.37390500392236603,0.6726048270483139,0.825,0.9933969478711362,1.0,2/13,6.43%,CPSF4;ZBTB8OS
prerank,GO_Biological_Process_2021__activation of protein kinase B activity (GO:0032148),0.2935121726739779,0.6725602596071714,0.9722222222222222,0.9929728806452626,1.0,2/23,6.19%,WNT5A;NRG1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte differentiation (GO:1902107),-0.4355249194950679,-0.671925562570953,0.8363636363636363,1.0,1.0,2/7,15.76%,NCKAP1L;LGALS1
prerank,GO_Biological_Process_2021__regulation of intracellular estrogen receptor signaling pathway (GO:0033146),-0.3622692715918413,-0.6716592138502913,0.9272727272727272,1.0,1.0,6/23,20.70%,DDRGK1;KANK2;BRCA1;UFSP2;UFL1;WBP2
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transport (GO:1902306),-0.41837902014422534,-0.6715417337425107,0.8333333333333334,1.0,1.0,2/8,15.13%,STK39;HECW1
prerank,GO_Biological_Process_2021__positive regulation of interferon-alpha production (GO:0032727),0.3489841360860152,0.671484306966349,0.9411764705882353,0.9934906495527404,1.0,5/16,17.16%,TLR7;SETD2;IRF5;HSPD1;DDX3X
prerank,GO_Biological_Process_2021__positive regulation of cell development (GO:0010720),-0.38555667462986964,-0.6710595027987261,0.9032258064516129,1.0,1.0,5/17,20.69%,ZNF335;TYROBP;SERPINF1;OPRM1;CLEC7A
prerank,GO_Biological_Process_2021__hemostasis (GO:0007599),-0.46064894608879847,-0.6709470240513841,0.9107142857142857,1.0,1.0,1/5,9.39%,HPS4
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.3974587939982646,0.6709441162987135,0.8936170212765957,0.9935903615131645,1.0,1/8,2.80%,CSGALNACT1
prerank,GO_Biological_Process_2021__regulation of extracellular matrix assembly (GO:1901201),0.44422867655331827,0.6708133557722961,0.8157894736842105,0.9932079652838977,1.0,1/5,5.98%,SMAD3
prerank,GO_Biological_Process_2021__tRNA wobble uridine modification (GO:0002098),-0.40969357933038486,-0.670365716851579,0.9107142857142857,1.0,1.0,1/9,7.53%,GTPBP3
prerank,GO_Biological_Process_2021__positive regulation of cholesterol efflux (GO:0010875),-0.3780745594357693,-0.6703238924820908,0.8769230769230769,1.0,1.0,3/17,11.64%,PLTP;NR1H2;ABCA8
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.37582647715534945,0.6699309773982275,0.9038461538461539,0.9937131157904969,1.0,2/8,7.38%,SPRY2;ROBO1
prerank,GO_Biological_Process_2021__regulation of cell communication (GO:0010646),-0.3431532622167414,-0.6699135186236126,0.8571428571428571,1.0,1.0,5/25,12.03%,MGLL;MTCH1;SRI;TYMP;GLRX2
prerank,GO_Biological_Process_2021__cell-cell junction maintenance (GO:0045217),0.444897764645676,0.6696969733584226,0.8478260869565217,0.9934602256230773,1.0,3/5,14.29%,MYADM;TJP1;FERMT2
prerank,GO_Biological_Process_2021__regulation of amyloid-beta clearance (GO:1900221),-0.37175886627827837,-0.6696626046152051,0.8431372549019608,1.0,1.0,1/11,4.82%,CLU
prerank,GO_Biological_Process_2021__autophagosome assembly (GO:0000045),-0.3177927898789422,-0.6693648345220161,0.9655172413793104,1.0,1.0,6/42,15.41%,GABARAPL1;ATG2A;GABARAPL2;STING1;TP53INP1;WIPI1
prerank,GO_Biological_Process_2021__hyaluronan catabolic process (GO:0030214),-0.38508150574245786,-0.6691897640568971,0.8771929824561403,1.0,1.0,3/10,15.24%,CEMIP;CD44;GUSB
prerank,GO_Biological_Process_2021__negative regulation of neuron projection regeneration (GO:0070571),0.4123383823766962,0.6689933483733265,0.8913043478260869,0.9936478035905114,1.0,3/6,36.97%,EPHA4;INPP5F;PTPRS
prerank,GO_Biological_Process_2021__nucleobase biosynthetic process (GO:0046112),-0.4072154893745527,-0.6689762173329425,0.8709677419354839,1.0,1.0,1/6,15.99%,SHMT1
prerank,GO_Biological_Process_2021__Notch signaling pathway (GO:0007219),-0.3075952829552612,-0.6682216577704458,0.9305555555555556,1.0,1.0,6/32,13.87%,DTX3;DTX3L;RBPJ;STAT1;TRAF7;NOTCH2
prerank,GO_Biological_Process_2021__negative regulation of JUN kinase activity (GO:0043508),-0.4012196376966852,-0.6681477927218118,0.9193548387096774,1.0,1.0,1/9,6.85%,GSTP1
prerank,GO_Biological_Process_2021__mitotic cell cycle checkpoint signaling (GO:0007093),0.3774978461919003,0.6679741661395396,0.8444444444444444,0.9941520067667683,1.0,3/11,10.22%,PRCC;PLK2;ZFYVE19
prerank,GO_Biological_Process_2021__regulation of DNA metabolic process (GO:0051052),0.28585827580954926,0.6675863101551677,0.8461538461538461,0.9940048226405955,1.0,4/34,12.48%,PDGFA;YLPM1;UBE2N;WDR18
prerank,GO_Biological_Process_2021__regulation of cellular response to oxidative stress (GO:1900407),0.4307733437138932,0.667229918995286,0.8888888888888888,0.9938108920656585,1.0,2/6,21.23%,GCH1;AIFM2
prerank,GO_Biological_Process_2021__positive regulation of ERAD pathway (GO:1904294),0.36432476889467963,0.6670435349884205,0.7906976744186046,0.9934999835190966,1.0,4/11,22.80%,RNF185;BAG6;SGTA;UBQLN1
prerank,GO_Biological_Process_2021__telomere maintenance (GO:0000723),-0.3496928716646319,-0.6659773475408155,0.967741935483871,1.0,1.0,8/35,21.40%,HUS1;XRCC3;TERF2IP;APEX1;RPA3;WRN;TEP1;CTC1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte chemotaxis (GO:0002690),-0.35022770419124744,-0.665682036349804,0.9523809523809523,1.0,1.0,4/26,11.19%,CCL5;AIF1;PTN;VEGFA
prerank,GO_Biological_Process_2021__hyaluronan metabolic process (GO:0030212),-0.36772990485817914,-0.6650589475792481,0.8771929824561403,1.0,1.0,3/12,15.24%,CEMIP;CD44;GUSB
prerank,GO_Biological_Process_2021__synaptic vesicle recycling (GO:0036465),0.3193277284420415,0.6650335731126328,0.9393939393939394,0.9948054793005657,1.0,6/21,19.35%,NLGN1;SNCB;STX1A;NLGN4Y;STON2;SNCA
prerank,GO_Biological_Process_2021__calcium ion transport into cytosol (GO:0060402),0.35107656981480734,0.6649168243490194,0.9032258064516129,0.9944300117879258,1.0,6/14,23.01%,ADRA1A;GRIN2B;SLC8A1;GRIN2A;GRIN1;RYR2
prerank,GO_Biological_Process_2021__smoothened signaling pathway (GO:0007224),0.3540593539009087,0.6648957860795128,0.8484848484848485,0.993955460606591,1.0,4/17,10.96%,PTCH2;STK36;MAP3K10;PTCH1
prerank,GO_Biological_Process_2021__chromatin organization involved in negative regulation of transcription (GO:0097549),-0.4676786203106256,-0.6644135714699436,0.8936170212765957,1.0,1.0,1/5,3.35%,POLE3
prerank,GO_Biological_Process_2021__mature B cell differentiation involved in immune response (GO:0002313),-0.4282260135425109,-0.6641062961120662,0.8571428571428571,1.0,1.0,1/7,1.61%,GPR183
prerank,GO_Biological_Process_2021__retrograde axonal transport (GO:0008090),-0.37202203534125655,-0.6636309325116561,0.9076923076923077,1.0,1.0,2/14,13.37%,NEFL;SOD1
prerank,GO_Biological_Process_2021__microtubule anchoring at centrosome (GO:0034454),0.3723095101418543,0.6634969755992843,0.8679245283018868,0.9946975366192417,1.0,3/7,25.45%,NIN;HOOK3;PCM1
prerank,GO_Biological_Process_2021__regulation of histone modification (GO:0031056),-0.39749758937115376,-0.6633040569942876,0.8936170212765957,1.0,1.0,5/9,25.13%,AKAP8;PARG;PARK7;AKAP8L;HPF1
prerank,GO_Biological_Process_2021__peptidyl-tyrosine modification (GO:0018212),0.2707200197244639,0.66312579443405,1.0,0.9945155215859652,1.0,12/39,24.63%,FER;RELN;DYRK1A;PTK2;ERBB4;ABI1;FGFR2;FGFR1;SYK;ABL1;FGFR3;EPHA4
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.3247657850846372,0.6630919167083248,0.967741935483871,0.9940532985650721,1.0,6/26,17.25%,DCP1B;EXOSC6;CNOT7;LSM6;LSM1;EXOSC7
prerank,GO_Biological_Process_2021__negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147),-0.4494649412492695,-0.6621726474654598,0.9411764705882353,1.0,1.0,2/7,14.26%,KANK2;BRCA1
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.42588296961766026,-0.661310762992353,0.9032258064516129,1.0,1.0,1/11,1.64%,CD55
prerank,GO_Biological_Process_2021__V(D)J recombination (GO:0033151),0.3714076340095986,0.6607126337132361,0.8666666666666667,0.9955649371148932,1.0,1/9,7.13%,LIG4
prerank,GO_Biological_Process_2021__positive regulation of endocytosis (GO:0045807),-0.31868341233148,-0.6604125539568174,0.921875,1.0,1.0,5/36,10.76%,B2M;CLU;GPC3;VPS28;NCKAP1L
prerank,GO_Biological_Process_2021__valine metabolic process (GO:0006573),-0.4422095913470421,-0.66034746566347,0.8688524590163934,1.0,1.0,1/5,23.10%,BCAT1
prerank,GO_Biological_Process_2021__ERK1 and ERK2 cascade (GO:0070371),0.35930845842589104,0.6592258596238476,0.875,0.9961764216856612,1.0,6/14,18.09%,MAP2K1;LGALS9;ITGAV;MAPK1;CTSH;MAP2K2
prerank,GO_Biological_Process_2021__detection of virus (GO:0009597),-0.41734211415062483,-0.6590582524193402,0.8666666666666667,1.0,1.0,5/5,58.29%,TLR3;IFIH1;SERINC3;ZCCHC3;SERINC5
prerank,GO_Biological_Process_2021__cation transmembrane transport (GO:0098655),-0.3464182982235362,-0.6588518776341301,0.8615384615384616,1.0,1.0,6/23,15.19%,SLC7A5;TRPM3;SLC36A4;TRPM4;SFXN3;SLC25A19
prerank,GO_Biological_Process_2021__regulation of ATP metabolic process (GO:1903578),-0.3057329802790452,-0.6584768459395915,0.873015873015873,1.0,1.0,9/43,19.90%,FIS1;ATP5IF1;NUP50;HIF1A;COX7A2;SEC13;PINK1;NUP88;UQCC2
prerank,GO_Biological_Process_2021__negative regulation of glucose import (GO:0046325),-0.45284973499496467,-0.658323271159496,0.9137931034482759,1.0,1.0,3/6,14.20%,PID1;SELENOS;PEA15
prerank,GO_Biological_Process_2021__regulation of keratinocyte migration (GO:0051547),-0.4013642806363999,-0.6582653106913965,0.8846153846153846,1.0,1.0,1/8,6.65%,IQSEC1
prerank,GO_Biological_Process_2021__phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092),0.39725106595998405,0.6581301091611037,0.9210526315789473,0.9965948319976796,1.0,2/7,17.35%,PIK3C2B;PIK3CA
prerank,GO_Biological_Process_2021__calcium ion import across plasma membrane (GO:0098703),-0.38248188936877653,-0.6581067985060567,0.8888888888888888,1.0,1.0,4/9,25.69%,TRPV4;TRPM2;TRPV2;ATP2B4
prerank,GO_Biological_Process_2021__calcium ion import into cytosol (GO:1902656),-0.38248188936877653,-0.6581067985060567,0.8888888888888888,1.0,1.0,4/9,25.69%,TRPV4;TRPM2;TRPV2;ATP2B4
prerank,GO_Biological_Process_2021__positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.36110842347026306,-0.6580631546639703,0.8636363636363636,1.0,1.0,3/17,16.09%,TNFSF10;AGT;DEDD2
prerank,GO_Biological_Process_2021__phosphorylation of RNA polymerase II C-terminal domain (GO:0070816),-0.38183390171704695,-0.6578156818122224,0.8653846153846154,1.0,1.0,1/8,4.34%,GTF2H5
prerank,GO_Biological_Process_2021__nucleoside metabolic process (GO:0009116),-0.40113869212690434,-0.6576748885719031,0.8387096774193549,1.0,1.0,1/8,8.20%,TYMP
prerank,GO_Biological_Process_2021__positive regulation of lipid biosynthetic process (GO:0046889),-0.3346868959985633,-0.6572278687225874,0.9076923076923077,1.0,1.0,2/22,8.91%,NR1H2;CNEP1R1
prerank,GO_Biological_Process_2021__regulation of kinase activity (GO:0043549),-0.3056569902298288,-0.6572236472589276,0.9577464788732394,1.0,1.0,20/65,25.87%,EPHB1;NLRC5;MUSK;TTN;ANKRD54;FLT1;SOD1;ZNF16;CD74;CDKN1C;HLA-DRB1;EPHB2;EMP2;CDKN1B;FGR;CD4;EEF1A1;NPRL2;RB1;EGFR
prerank,GO_Biological_Process_2021__adipose tissue development (GO:0060612),-0.41531990416672415,-0.6572074608959727,0.94,1.0,1.0,1/7,8.03%,NAMPT
prerank,GO_Biological_Process_2021__embryonic cranial skeleton morphogenesis (GO:0048701),-0.4059172890613793,-0.6572001964466186,0.7959183673469388,1.0,1.0,2/7,8.47%,MTHFD1;EIF4A3
prerank,GO_Biological_Process_2021__protein localization to cell junction (GO:1902414),-0.38506073315002765,-0.6568939803410593,0.9215686274509803,1.0,1.0,2/14,7.64%,CGNL1;NLGN2
prerank,GO_Biological_Process_2021__cell cycle G2/M phase transition (GO:0044839),0.24208146357210708,0.6560062518747992,1.0,0.9979106710091742,1.0,28/99,23.93%,BORA;CDK7;TAF2;CEP41;BRSK1;YWHAG;CEP131;BTRC;FBXW11;CSNK1E;FBXL12;FBXL7;CLASP1;DYNC1H1;ALMS1;TPD52L1;BRSK2;CEP135;ODF2;NDE1;NEDD1;YWHAE;CEP152;PAFAH1B1;CEP290;KHDRBS1;HAUS2;PPP1R12B
prerank,MSigDB_Hallmark_2020__Apical Junction,-0.2804587491521296,-0.6556760493747659,1.0,1.0,1.0,13/123,12.82%,INSIG1;TNFRSF11B;DHX16;CLDN7;JUP;PECAM1;NLGN2;ACTG1;SGCE;ACTB;SDC3;PFN1;PTPRC
prerank,GO_Biological_Process_2021__plus-end-directed organelle transport along microtubule (GO:0072386),-0.4263022726326432,-0.6556601170873313,0.8421052631578947,1.0,1.0,2/6,32.69%,KIFAP3;FYCO1
prerank,GO_Biological_Process_2021__carbohydrate derivative catabolic process (GO:1901136),0.3576674003917998,0.654583603256816,0.9142857142857143,0.9986133802552029,1.0,2/12,13.82%,STT3B;FBXO27
prerank,GO_Biological_Process_2021__myofibril assembly (GO:0030239),-0.37083011039051017,-0.6543428141634117,0.9054054054054054,1.0,1.0,3/14,9.94%,OBSCN;TTN;CFLAR
prerank,GO_Biological_Process_2021__regulation of cellular amide metabolic process (GO:0034248),0.3140886441388409,0.6543416981309538,0.8620689655172413,0.9983252541425366,1.0,6/25,17.10%,PICALM;TMED10;GRM5;SAMD8;NOLC1;MTPN
prerank,GO_Biological_Process_2021__negative regulation of phosphate metabolic process (GO:0045936),0.34422230357447714,0.654319354443403,0.9387755102040817,0.9978802200773477,1.0,1/12,2.51%,SIRT1
prerank,GO_Biological_Process_2021__positive regulation of peptide hormone secretion (GO:0090277),0.3041383278182711,0.6540507959313234,0.8837209302325582,0.9976218175324506,1.0,3/18,11.06%,MCU;SOX4;TCF7L2
prerank,GO_Biological_Process_2021__negative regulation of cellular metabolic process (GO:0031324),0.30864306498613775,0.6536766168359139,0.9666666666666667,0.9974043757320609,1.0,1/24,1.57%,ABCA2
prerank,GO_Biological_Process_2021__amyloid-beta formation (GO:0034205),0.3769108203124316,0.6534750042376368,0.7906976744186046,0.9971173833250948,1.0,1/7,10.28%,DYRK1A
prerank,GO_Biological_Process_2021__negative regulation of receptor internalization (GO:0002091),-0.38895280214928785,-0.6532467231881876,0.9508196721311475,1.0,1.0,3/9,23.34%,ANKRD13D;LRPAP1;SDCBP
prerank,GO_Biological_Process_2021__embryonic skeletal system morphogenesis (GO:0048704),0.38703424195645275,0.6532423225278419,0.8936170212765957,0.9968422873277564,1.0,4/7,19.59%,TGFBR2;MEGF8;TGFBR1;FGFR2
prerank,GO_Biological_Process_2021__protein retention in Golgi apparatus (GO:0045053),0.41506187526381766,0.6531555851600924,0.875,0.9964106471570473,1.0,1/5,11.83%,SORL1
prerank,GO_Biological_Process_2021__oligodendrocyte development (GO:0014003),0.3664601276796328,0.652807003607761,0.9534883720930233,0.9962812767535658,1.0,2/12,5.32%,MYRF;TPPP
prerank,GO_Biological_Process_2021__response to angiotensin (GO:1990776),0.40821099296126295,0.652530475166547,0.9166666666666666,0.9960243832448897,1.0,3/6,37.07%,SLC30A10;ROCK2;ROCK1
prerank,"GO_Biological_Process_2021__DNA-templated transcription, termination (GO:0006353)",-0.30464741101479575,-0.6523654338770966,0.9852941176470589,1.0,1.0,3/51,4.34%,CSTF2T;TAF1D;GTF2H5
prerank,GO_Biological_Process_2021__neuron remodeling (GO:0016322),0.37245333389334134,0.6523643755813134,0.8648648648648649,0.9956691466604444,1.0,3/8,17.58%,ANKS1A;ADGRB3;CX3CL1
prerank,GO_Biological_Process_2021__negative regulation of myosin-light-chain-phosphatase activity (GO:0035509),0.40498648785980423,0.6521900845826877,0.9069767441860465,0.9953722160297654,1.0,1/5,7.30%,TNF
prerank,GO_Biological_Process_2021__peroxisomal membrane transport (GO:0015919),-0.336847854995703,-0.6519833391033891,0.9375,1.0,1.0,2/20,6.99%,FIS1;ACBD5
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),-0.33031580275364825,-0.6518383921721486,0.935064935064935,1.0,1.0,4/30,15.14%,DDIT4;HINT1;DDX5;RPS27L
prerank,GO_Biological_Process_2021__negative regulation of vascular permeability (GO:0043116),-0.38851785307974507,-0.6514721436732772,0.8909090909090909,1.0,1.0,1/9,11.19%,VEGFA
prerank,GO_Biological_Process_2021__regulation of vacuole organization (GO:0044088),0.30511148843071406,0.6513999425145252,0.8717948717948718,0.9955101054197227,1.0,3/20,8.16%,RAB1B;SCARB2;TBC1D12
prerank,GO_Biological_Process_2021__mitotic sister chromatid cohesion (GO:0007064),0.39842772233343837,0.6512664744097908,0.8648648648648649,0.9951440423669506,1.0,2/10,13.48%,BOD1;NIPBL
prerank,GO_Biological_Process_2021__heterochromatin assembly (GO:0031507),-0.35393073893715626,-0.651078502249227,0.9454545454545454,1.0,1.0,2/17,6.97%,POLE3;CENPV
prerank,PanglaoDB_Augmented_2021__Goblet Cells,0.36575339527621803,0.6503783760987015,0.8867924528301887,0.9954844985445535,1.0,5/12,15.88%,FCGBP;BACE2;SLC26A3;MANF;OTOGL
prerank,GO_Biological_Process_2021__brain morphogenesis (GO:0048854),-0.38718081176633207,-0.6498828067884248,0.9104477611940298,1.0,1.0,1/10,3.44%,BBS2
prerank,GO_Biological_Process_2021__negative regulation of lipid localization (GO:1905953),-0.432133386631679,-0.6498285853408788,0.8771929824561403,1.0,1.0,1/6,5.38%,NR1H2
prerank,GO_Biological_Process_2021__positive regulation of TOR signaling (GO:0032008),0.31268569248568623,0.6496536607734952,0.9166666666666666,0.9957031337440014,1.0,2/33,5.75%,RRAGD;GPR137C
prerank,"GO_Biological_Process_2021__synaptic transmission, GABAergic (GO:0051932)",-0.3811409825306875,-0.6494349517634376,0.9,1.0,1.0,1/7,9.88%,GABRA3
prerank,GO_Biological_Process_2021__negative regulation of lipid kinase activity (GO:0090219),0.3962977604857172,0.6492640039038665,0.8863636363636364,0.9956035091899781,1.0,3/8,25.67%,PIP4K2A;DAB2IP;PIP4K2B
prerank,GO_Biological_Process_2021__regulation of ion transport (GO:0043269),-0.3219595195089381,-0.6491184476975411,0.9558823529411765,1.0,1.0,2/39,2.81%,SNX6;B2M
prerank,GO_Biological_Process_2021__protein import into peroxisome membrane (GO:0045046),-0.35525262544905056,-0.6489719013902192,0.9166666666666666,1.0,1.0,2/15,6.99%,FIS1;ACBD5
prerank,GO_Biological_Process_2021__regulation of membrane protein ectodomain proteolysis (GO:0051043),0.3667686510350092,0.6485457114443794,0.8775510204081632,0.9956947192140598,1.0,2/11,7.30%,TIMP3;TNF
prerank,GO_Biological_Process_2021__double-strand break repair via nonhomologous end joining (GO:0006303),-0.28699872627351464,-0.6483901517524491,0.9538461538461539,1.0,1.0,6/52,14.44%,POLM;CYREN;ABRAXAS1;KAT5;BRCA1;ERCC8
prerank,GO_Biological_Process_2021__regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),-0.4268003601818179,-0.6483073337546672,0.8837209302325582,1.0,1.0,4/6,34.84%,IL18;CARD9;IL1B;RASGRP1
prerank,GO_Biological_Process_2021__regulation of cellular component movement (GO:0051270),-0.31517472773084343,-0.6482926865190993,0.9545454545454546,1.0,1.0,2/43,4.35%,TGFBR3;ETS1
prerank,GO_Biological_Process_2021__peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.3271430860186491,0.6482773396844679,0.9473684210526315,0.9950222565292566,1.0,3/17,11.74%,ZDHHC3;GOLGA7;ZDHHC11B
prerank,GO_Biological_Process_2021__peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.3271430860186491,0.6482773396844679,0.9473684210526315,0.9950222565292566,1.0,3/17,11.74%,ZDHHC3;GOLGA7;ZDHHC11B
prerank,GO_Biological_Process_2021__negative regulation of microtubule depolymerization (GO:0007026),0.3463574344299529,0.6480842959328679,0.8837209302325582,0.9946576473803261,1.0,5/16,19.20%,CIB1;CLASP1;CLASP2;CAMSAP2;ATXN7
prerank,GO_Biological_Process_2021__regulation of protein localization (GO:0032880),-0.2970253717118157,-0.6478095655242704,0.9861111111111112,1.0,1.0,7/44,14.72%,TRIM5;RACK1;TRIM22;DVL1;DZIP1L;CAMK1;STX10
prerank,GO_Biological_Process_2021__protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),-0.38035596656761417,-0.6473522073770708,0.8703703703703703,1.0,1.0,2/8,14.65%,EMC2;EMC1
prerank,GO_Biological_Process_2021__ventricular septum morphogenesis (GO:0060412),-0.3399001262554764,-0.6472468599129302,0.890625,1.0,1.0,1/19,1.03%,TGFBR3
prerank,GO_Biological_Process_2021__macropinocytosis (GO:0044351),0.40168801326841286,0.6472418000209773,0.82,0.9948702825671694,1.0,1/5,12.49%,MAPKAPK2
prerank,GO_Biological_Process_2021__regulation of phosphorylation (GO:0042325),-0.28310623297429177,-0.6472028085424975,0.9863013698630136,1.0,1.0,10/90,13.28%,CCDC88C;CCL5;NLRC5;ITGA6;GLMN;NCKAP1L;NUP50;HIF1A;NOP53;MCM7
prerank,GO_Biological_Process_2021__nuclear membrane reassembly (GO:0031468),0.27968645206626686,0.6466201977427691,1.0,0.9949270272474191,1.0,8/46,17.93%,NUP188;RCC1;REEP3;CHMP7;UBXN2A;NDC1;NUP133;NUP205
prerank,GO_Biological_Process_2021__urate metabolic process (GO:0046415),-0.41444329943148694,-0.6460706446170891,0.9152542372881356,1.0,1.0,2/5,24.98%,CARMIL1;ABCG2
prerank,GO_Biological_Process_2021__organophosphate biosynthetic process (GO:0090407),-0.3390825175036857,-0.6460350536973193,0.9552238805970149,1.0,1.0,6/28,17.37%,LPCAT1;GNPAT;NFS1;GK;IPMK;MOCOS
prerank,GO_Biological_Process_2021__triglyceride metabolic process (GO:0006641),0.31683114000029056,0.6454807931092379,0.9117647058823529,0.9953468169992581,1.0,4/21,12.41%,SIRT1;SEL1L;GPAT4;GPAT3
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),-0.37579310315283054,-0.6454759674243732,0.9032258064516129,1.0,1.0,1/12,8.36%,CALM1
prerank,GO_Biological_Process_2021__lipoxin metabolic process (GO:2001300),0.40148919037883757,0.6453946210885935,0.8478260869565217,0.9949366613920624,1.0,1/5,10.35%,ALOX5AP
prerank,GO_Biological_Process_2021__tRNA processing (GO:0008033),-0.3070545982110272,-0.6453402152331618,0.9672131147540983,1.0,1.0,5/46,11.32%,SSB;C2ORF49;RTCB;TRMT10B;KARS1
prerank,GO_Biological_Process_2021__cellular response to fibroblast growth factor stimulus (GO:0044344),-0.30424349733614253,-0.6449090010598515,0.96875,1.0,1.0,5/52,9.87%,ZFP36;CCL5;POLR2G;CD44;NCBP2
prerank,GO_Biological_Process_2021__positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.37871460699165516,0.6446281079989966,0.8913043478260869,0.9950566315206281,1.0,3/10,23.61%,BOK;DAB2IP;PIK3R1
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial membrane (GO:0051204),-0.3584513335810888,-0.6443232125756935,0.9032258064516129,1.0,1.0,6/15,26.68%,COX18;BMF;MAIP1;TIMM29;TIMM9;HSP90AA1
prerank,GO_Biological_Process_2021__regulation of 3'-UTR-mediated mRNA stabilization (GO:1905868),-0.4513055464650834,-0.6438414637527348,0.8846153846153846,1.0,1.0,1/5,21.44%,TENT4B
prerank,GO_Biological_Process_2021__morphogenesis of an epithelium (GO:0002009),0.3286301388342624,0.6436279861543165,0.9024390243902439,0.9953721664392079,1.0,2/13,7.32%,DAG1;VCL
prerank,GO_Biological_Process_2021__rRNA-containing ribonucleoprotein complex export from nucleus (GO:0071428),0.387511543848764,0.6432606044311511,0.8627450980392157,0.9951754267821802,1.0,1/6,7.26%,XPO1
prerank,GO_Biological_Process_2021__autophagy of peroxisome (GO:0030242),0.35029002174928325,0.6431693255890334,0.9777777777777777,0.9947718813739734,1.0,3/12,18.97%,USP30;PEX5;TRAPPC8
prerank,GO_Biological_Process_2021__regulation of lipid kinase activity (GO:0043550),0.38348590069036526,0.6428371890592743,0.8913043478260869,0.9945411309745772,1.0,2/8,23.61%,EEF1A2;PIK3R1
prerank,GO_Biological_Process_2021__regulation of protein localization to membrane (GO:1905475),-0.34899010866693586,-0.6427161329244733,0.90625,1.0,1.0,4/20,11.83%,FYN;GPC3;ACTB;APPL1
prerank,"GO_Biological_Process_2021__maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.3516813069565406,0.6424456283736819,0.9523809523809523,0.9944427192984124,1.0,1/13,2.02%,NOL9
prerank,GO_Biological_Process_2021__positive regulation of mitotic nuclear division (GO:0045840),0.3198843439955392,0.6418741399548623,0.8888888888888888,0.9944420084058301,1.0,3/18,13.79%,TGFA;CDC23;NSMCE2
prerank,GO_Biological_Process_2021__negative regulation of cell junction assembly (GO:1901889),-0.34041294449850235,-0.6414598480700641,0.9821428571428571,1.0,1.0,1/22,4.08%,APOD
prerank,GO_Biological_Process_2021__anterograde axonal transport (GO:0008089),0.29262086790942526,0.6408701747368779,0.9743589743589743,0.9947339817831322,1.0,2/27,9.74%,AP3B2;AP3S1
prerank,GO_Biological_Process_2021__7-methylguanosine mRNA capping (GO:0006370),-0.3185229664172461,-0.6407021129691641,0.9310344827586207,1.0,1.0,4/27,9.87%,GTF2H5;POLR2G;RNMT;NCBP2
prerank,GO_Biological_Process_2021__7-methylguanosine RNA capping (GO:0009452),-0.3185229664172461,-0.6407021129691641,0.9310344827586207,1.0,1.0,4/27,9.87%,GTF2H5;POLR2G;RNMT;NCBP2
prerank,GO_Biological_Process_2021__attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.38922159125910594,0.6405508364087464,0.88,0.9945094227468877,1.0,2/8,11.55%,BOD1;CENPE
prerank,GO_Biological_Process_2021__negative regulation of DNA-dependent DNA replication (GO:2000104),-0.3847688675198211,-0.6400934909640374,0.9056603773584906,1.0,1.0,5/12,26.23%,TIPIN;ZRANB3;DONSON;LIG3;MSH3
prerank,GO_Biological_Process_2021__regulation of exosomal secretion (GO:1903541),-0.3486327272351881,-0.6395205170858909,0.9464285714285714,1.0,1.0,4/15,23.79%,SNF8;CHMP6;SDCBP;SMPD3
prerank,GO_Biological_Process_2021__negative regulation of histone modification (GO:0031057),-0.37346719681115215,-0.6394786311267797,0.9242424242424242,1.0,1.0,4/10,31.16%,BRCA1;CTBP1;SPHK2;NOC2L
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transporter activity (GO:2000650),-0.40668329239978135,-0.6391863531283902,0.8846153846153846,1.0,1.0,2/8,15.13%,STK39;HECW1
prerank,GO_Biological_Process_2021__positive regulation of mRNA metabolic process (GO:1903313),-0.3516289409115213,-0.6389912935075174,0.84375,1.0,1.0,4/12,23.44%,PRR5L;CNOT8;PNPT1;GTPBP1
prerank,GO_Biological_Process_2021__t-circle formation (GO:0090656),-0.36308578241259765,-0.6387798788703005,0.8867924528301887,1.0,1.0,3/9,25.12%,XRCC3;WRN;SLX4
prerank,GO_Biological_Process_2021__telomere maintenance via telomere trimming (GO:0090737),-0.36308578241259765,-0.6387798788703005,0.8867924528301887,1.0,1.0,3/9,25.12%,XRCC3;WRN;SLX4
prerank,GO_Biological_Process_2021__formation of extrachromosomal circular DNA (GO:0001325),-0.36308578241259765,-0.6387798788703005,0.8867924528301887,1.0,1.0,3/9,25.12%,XRCC3;WRN;SLX4
prerank,GO_Biological_Process_2021__negative regulation of TOR signaling (GO:0032007),0.29851555176987565,0.6383687137415489,0.9574468085106383,0.9957757758264335,1.0,3/24,9.33%,SIRT1;TSC2;DEPTOR
prerank,GO_Biological_Process_2021__positive regulation of circadian rhythm (GO:0042753),-0.40754919136857487,-0.638356687073933,0.8153846153846154,1.0,1.0,1/5,3.27%,RORA
prerank,GO_Biological_Process_2021__rRNA methylation (GO:0031167),-0.34092471180399375,-0.6377343635345809,0.9130434782608695,1.0,1.0,6/15,24.74%,BUD23;ZCCHC4;EMG1;NSUN5;FBL;METTL5
prerank,GO_Biological_Process_2021__ncRNA metabolic process (GO:0034660),-0.32293088869855713,-0.6375010581588849,0.9117647058823529,1.0,1.0,3/23,10.44%,MOV10L1;ZCCHC8;TDRKH
prerank,GO_Biological_Process_2021__anion transport (GO:0006820),0.3500136478817152,0.6365563211793288,0.9722222222222222,0.9965366246222351,1.0,6/17,24.86%,SLCO2B1;SLC26A3;SLC17A5;SLC13A3;SLC4A2;LRRC8D
prerank,GO_Biological_Process_2021__protein localization to mitochondrion (GO:0070585),0.35621562906198057,0.6364964678586392,0.9487179487179487,0.9960881381705216,1.0,2/11,3.81%,MARCHF5;LRRK2
prerank,GO_Biological_Process_2021__axonal transport (GO:0098930),0.2838443202197654,0.636093343349328,1.0,0.9958690888960656,1.0,3/26,10.79%,AP3B2;AP3S1;FBXW11
prerank,GO_Biological_Process_2021__postsynaptic density protein 95 clustering (GO:0097119),0.40694896426193417,0.6358411897906101,0.9649122807017544,0.9956216335565927,1.0,2/5,11.28%,NLGN1;NRXN2
prerank,GO_Biological_Process_2021__regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),-0.31931150574067696,-0.6354426097245972,0.9607843137254902,1.0,1.0,6/28,22.45%,DDRGK1;DDX5;PRMT2;UFSP2;UFL1;PARK7
prerank,GO_Biological_Process_2021__pyrimidine nucleoside biosynthetic process (GO:0046134),-0.3802481501815528,-0.6351284194595146,0.8939393939393939,1.0,1.0,2/11,11.81%,TYMP;DHODH
prerank,GO_Biological_Process_2021__embryo development ending in birth or egg hatching (GO:0009792),0.36072159448497537,0.6346018618316182,0.9523809523809523,0.9960722419934628,1.0,4/9,25.34%,UBR3;FGFR1;USP22;CELF1
prerank,GO_Biological_Process_2021__lamellipodium organization (GO:0097581),0.2791260208932024,0.6343663371552521,1.0,0.9957620350141917,1.0,7/23,22.19%,VCL;P2RY12;ARHGEF6;PTPRO;SNX1;CTTN;ABLIM1
prerank,GO_Biological_Process_2021__cortical actin cytoskeleton organization (GO:0030866),-0.35260516373299633,-0.6341499689345564,0.9558823529411765,1.0,1.0,3/18,10.76%,PLEK;LLGL2;NCKAP1L
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell migration (GO:0010634),-0.3056377582697721,-0.6339089182357703,1.0,1.0,1.0,12/63,16.58%,GLIPR2;ETS1;RAB11A;IQSEC1;ENPP2;PRKD2;VEGFA;HIF1A;PFN1;PIK3CB;AGT;RAC1
prerank,GO_Biological_Process_2021__regulation of chromatin organization (GO:1902275),0.3426241256545608,0.6337428758802653,0.8723404255319149,0.9958292790957997,1.0,4/12,20.63%,TLK1;SETD5;HNRNPU;CDK9
prerank,GO_Biological_Process_2021__positive regulation of autophagy (GO:0010508),-0.28053469178458257,-0.6337181197778277,0.9848484848484849,1.0,1.0,10/65,17.95%,TRIM5;TRIM22;PHB2;TRIM13;STING1;KAT5;PIK3CB;TP53INP1;PINK1;TPCN1
prerank,GO_Biological_Process_2021__SCF complex assembly (GO:0010265),-0.41062781879921717,-0.6334258280143529,0.9090909090909091,1.0,1.0,1/6,11.16%,RBX1
prerank,GO_Biological_Process_2021__vasodilation (GO:0042311),-0.41543172144115903,-0.6330373227736116,0.8421052631578947,1.0,1.0,3/5,24.74%,SOD1;KLF2;KCNMA1
prerank,GO_Biological_Process_2021__amyloid precursor protein metabolic process (GO:0042982),0.3398610090375417,0.632579809286592,0.9047619047619048,0.996153491809935,1.0,2/11,22.55%,TMCC2;ADAM10
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),-0.3383192533523774,-0.6324785938206033,0.9054054054054054,1.0,1.0,3/16,14.43%,EYA2;HSPA1B;HSPA1A
prerank,GO_Biological_Process_2021__regulation of actin polymerization or depolymerization (GO:0008064),-0.34430543650290024,-0.6322806385494987,0.890625,1.0,1.0,5/18,23.88%,PFN1;FCHSD1;WAS;BRK1;WDR1
prerank,GO_Biological_Process_2021__acylglycerol biosynthetic process (GO:0046463),0.3486310541273332,0.6321921084344448,0.8666666666666667,0.9959236131197116,1.0,2/12,12.41%,GPAT4;GPAT3
prerank,GO_Biological_Process_2021__positive regulation of protein localization to membrane (GO:1905477),-0.26599815614349787,-0.6314753802605341,1.0,1.0,1.0,6/71,10.55%,GZMB;CEMIP;FIS1;FYN;PDCD5;ITGB2
prerank,"GO_Biological_Process_2021__negative regulation of CD8-positive, alpha-beta T cell activation (GO:2001186)",0.45633380476294966,0.631190697274167,0.9375,0.9961162276777558,1.0,2/5,23.17%,CD274;ZBTB7B
prerank,GO_Biological_Process_2021__protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.3612057416698524,0.6306639265581905,0.9090909090909091,0.9960063619015388,1.0,3/8,17.62%,PLPP1;PARD3;PRKD3
prerank,GO_Biological_Process_2021__leukocyte aggregation (GO:0070486),-0.417696919084772,-0.6306094060234131,0.9285714285714286,1.0,1.0,1/5,8.71%,CD44
prerank,GO_Biological_Process_2021__medium-chain fatty acid metabolic process (GO:0051791),-0.4189816769399646,-0.6293865808934438,0.9090909090909091,1.0,1.0,6/6,58.13%,CROT;ACOT7;ABHD2;ABHD3;ACAD9;ACADM
prerank,GO_Biological_Process_2021__mitotic G2/M transition checkpoint (GO:0044818),-0.3157644490071092,-0.6285744575773446,0.9393939393939394,1.0,1.0,9/31,22.42%,HUS1;ABRAXAS1;NABP1;NOP53;BRCA1;CHFR;NAE1;DONSON;RINT1
prerank,GO_Biological_Process_2021__cholesterol catabolic process (GO:0006707),0.38418691691405743,0.6284520279768244,0.8297872340425532,0.996275433605781,1.0,1/6,9.07%,CYP46A1
prerank,GO_Biological_Process_2021__sterol catabolic process (GO:0016127),0.38418691691405743,0.6284520279768244,0.8297872340425532,0.996275433605781,1.0,1/6,9.07%,CYP46A1
prerank,GO_Biological_Process_2021__alcohol catabolic process (GO:0046164),0.38418691691405743,0.6284520279768244,0.8297872340425532,0.996275433605781,1.0,1/6,9.07%,CYP46A1
prerank,GO_Biological_Process_2021__negative regulation of programmed necrotic cell death (GO:0062099),0.34306224310087413,0.628217381599957,0.9024390243902439,0.995521175738481,1.0,3/7,23.66%,PELI1;SLC25A4;RIPK1
prerank,GO_Biological_Process_2021__negative regulation of necroptotic process (GO:0060546),0.34306224310087413,0.628217381599957,0.9024390243902439,0.995521175738481,1.0,3/7,23.66%,PELI1;SLC25A4;RIPK1
prerank,GO_Biological_Process_2021__regulation of striated muscle tissue development (GO:0016202),0.3986503871368541,0.6281551376117115,0.9347826086956522,0.9950933891199916,1.0,4/6,28.58%,MTPN;MEGF10;TGFB1;SIRT2
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell migration (GO:0043535),-0.3153635760066137,-0.6280052864399122,0.9841269841269841,1.0,1.0,6/41,11.34%,ETS1;JUP;PRKD2;TMSB4X;VEGFA;HIF1A
prerank,GO_Biological_Process_2021__endocrine system development (GO:0035270),-0.3973448965289671,-0.6279263831405756,0.9193548387096774,1.0,1.0,1/7,5.36%,HESX1
prerank,GO_Biological_Process_2021__regulation of inclusion body assembly (GO:0090083),0.37912703530324904,0.6270568182699978,0.9714285714285714,0.9953595751198475,1.0,3/10,13.66%,DNAJB2;DNAJA4;BAG5
prerank,GO_Biological_Process_2021__positive regulation of lipid catabolic process (GO:0050996),0.33931344073637526,0.626879503740937,0.9090909090909091,0.995000453903026,1.0,2/9,27.88%,AKT2;ABHD5
prerank,GO_Biological_Process_2021__telomere maintenance via recombination (GO:0000722),0.3199836428746632,0.6261335151750096,0.8695652173913043,0.9950392468007343,1.0,4/8,22.26%,ERCC4;NSMCE2;SMC6;ERCC1
prerank,GO_Biological_Process_2021__chromatin silencing at telomere (GO:0006348),0.3775844492299521,0.6251749036364603,0.8421052631578947,0.9953221148369683,1.0,4/6,34.98%,SIRT2;EZH2;DOT1L;DPY30
prerank,GO_Biological_Process_2021__nuclear membrane disassembly (GO:0051081),-0.3737723737725691,-0.6243600258624717,0.9298245614035088,1.0,1.0,1/9,8.91%,CNEP1R1
prerank,GO_Biological_Process_2021__positive regulation of CREB transcription factor activity (GO:0032793),0.33029119248217287,0.6236752915942021,0.9714285714285714,0.9958884353498534,1.0,2/16,5.60%,RPS6KA4;RELN
prerank,GO_Biological_Process_2021__regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell (GO:2001188),-0.41608651477120306,-0.6236684351146344,0.8545454545454545,1.0,1.0,2/5,15.55%,HAVCR2;HLA-DMB
prerank,GO_Biological_Process_2021__negative regulation of axon regeneration (GO:0048681),0.42218100265058867,0.6233298739026963,0.9148936170212766,0.9956431731274747,1.0,3/5,36.97%,EPHA4;INPP5F;PTPRS
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell activation (GO:0046636),0.3667232225770901,0.6231471077398747,0.8918918918918919,0.9952847597796028,1.0,2/6,20.47%,TWSG1;CD274
prerank,GO_Biological_Process_2021__negative regulation of toll-like receptor 4 signaling pathway (GO:0034144),-0.398645227928064,-0.6230727523580372,0.8928571428571429,1.0,1.0,3/8,22.16%,TNFAIP3;NR1D1;LYN
prerank,GO_Biological_Process_2021__left/right pattern formation (GO:0060972),0.37736773227960163,0.6230218302043367,0.875,0.9948870171672114,1.0,2/5,13.38%,SETDB2;MEGF8
prerank,GO_Biological_Process_2021__protein palmitoylation (GO:0018345),-0.322003288938404,-0.6229360827122614,0.9491525423728814,1.0,1.0,3/24,9.18%,GLUL;ZDHHC4;ZDHHC19
prerank,GO_Biological_Process_2021__calcium import into the mitochondrion (GO:0036444),-0.37505344815786407,-0.6226982568928883,0.9122807017543859,1.0,1.0,4/9,14.94%,SMDT1;MICU2;MAIP1;MCUR1
prerank,GO_Biological_Process_2021__neuron projection maintenance (GO:1990535),0.37693152072954506,0.6225968041591479,0.8222222222222222,0.9946935411013687,1.0,6/6,62.33%,INSR;PRNP;APP;DCTN1;MAP1A;PSEN1
prerank,GO_Biological_Process_2021__retinoid metabolic process (GO:0001523),-0.31669729542052755,-0.6222566463901889,0.9545454545454546,1.0,1.0,6/26,23.01%,GPC3;PLB1;SDC3;CYP3A5;AKR1B1;RDH11
prerank,GO_Biological_Process_2021__steroid metabolic process (GO:0008202),0.2768179955428466,0.6219640784596367,0.9761904761904762,0.9946870618303619,1.0,5/31,12.96%,DHCR24;FDFT1;MSMO1;CYP46A1;LIPA
prerank,"GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane, translocation (GO:0006616)",0.41419416453378594,0.6218763766215123,0.9318181818181818,0.9942844976569243,1.0,2/5,37.13%,SEC61A1;SEC61A2
prerank,GO_Biological_Process_2021__histone phosphorylation (GO:0016572),0.3871329031831738,0.6214048293819773,0.9130434782608695,0.994131164707701,1.0,1/7,5.00%,RPS6KA4
prerank,GO_Biological_Process_2021__mitotic nuclear membrane organization (GO:0101024),0.2677934399240534,0.6210522579170585,1.0,0.9935367515437505,1.0,7/43,17.93%,NUP188;RCC1;REEP3;CHMP7;NDC1;NUP133;NUP205
prerank,GO_Biological_Process_2021__mitotic nuclear membrane reassembly (GO:0007084),0.2677934399240534,0.6210522579170585,1.0,0.9935367515437505,1.0,7/43,17.93%,NUP188;RCC1;REEP3;CHMP7;NDC1;NUP133;NUP205
prerank,GO_Biological_Process_2021__resolution of meiotic recombination intermediates (GO:0000712),-0.3784367121865501,-0.6205821266759513,0.9642857142857143,1.0,1.0,2/11,5.13%,SHOC1;MUS81
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),-0.39256253080265285,-0.6205598189357473,0.9298245614035088,1.0,1.0,4/9,22.02%,CFTR;TRPM4;HLA-DRB1;STX4
prerank,GO_Biological_Process_2021__TORC1 signaling (GO:0038202),0.3574565107245399,0.6204493016145852,0.9142857142857143,0.9934856438466774,1.0,7/7,64.28%,NPRL3;LARP1;MTOR;CLEC16A;SMG1;CARD11;RPTOR
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.3211102088720095,0.6202235521715813,0.9230769230769231,0.9931579664342536,1.0,3/10,29.55%,ENPP1;PAPSS1;BPNT2
prerank,GO_Biological_Process_2021__self proteolysis (GO:0097264),0.3960663714246102,0.6195748584980386,0.8461538461538461,0.993090155009887,1.0,2/6,28.85%,ADGRV1;NLRP1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.37023752265079923,-0.6191029748247575,0.9636363636363636,1.0,1.0,2/9,10.55%,ETS1;ITGB2
prerank,GO_Biological_Process_2021__biotin metabolic process (GO:0006768),-0.3747427794978911,-0.6188620998685853,0.8888888888888888,1.0,1.0,2/8,24.48%,MCCC2;BTD
prerank,GO_Biological_Process_2021__RNA interference (GO:0016246),0.31868471998585357,0.6188162230132457,0.9545454545454546,0.9932423665074674,1.0,5/13,25.34%,DROSHA;AGO1;MRPL44;HENMT1;CELF1
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),-0.3221322905602316,-0.6181436265534714,0.9622641509433962,1.0,1.0,6/17,21.50%,RBPJ;VEGFA;HIF1A;MT3;CARF;NFE2L2
prerank,GO_Biological_Process_2021__positive regulation of leukocyte proliferation (GO:0070665),0.38507610178668683,0.6180907509507009,0.875,0.9933436999692847,1.0,2/6,13.77%,MAPK1;PTK2
prerank,GO_Biological_Process_2021__positive regulation of voltage-gated calcium channel activity (GO:1901387),0.3928222488765025,0.6177782696507881,0.9019607843137255,0.9930786807160985,1.0,2/5,29.78%,NIPSNAP2;CACNA2D1
prerank,GO_Biological_Process_2021__cyclooxygenase pathway (GO:0019371),0.35143141098894154,0.6172877783530124,0.8431372549019608,0.9928758613555542,1.0,2/6,17.76%,HPGDS;TBXAS1
prerank,GO_Biological_Process_2021__regulation of tubulin deacetylation (GO:0090043),0.364395141821645,0.6170267713387304,0.9767441860465116,0.9926113060154872,1.0,2/7,16.79%,TPPP;PRKAA1
prerank,GO_Biological_Process_2021__phosphatidylinositol phosphate biosynthetic process (GO:0046854),-0.3028624430764939,-0.6164647353514479,0.9545454545454546,1.0,1.0,3/28,13.75%,TMEM150A;EFR3B;PIK3CB
prerank,GO_Biological_Process_2021__striated muscle tissue development (GO:0014706),0.3371821110897006,0.6156715912204321,0.9166666666666666,0.9929209392841662,1.0,1/12,4.42%,PGM5
prerank,GO_Biological_Process_2021__sensory organ development (GO:0007423),0.2861012876454724,0.614730426098634,0.9722222222222222,0.9930390595361316,1.0,3/24,15.89%,PBX1;BMPR1B;PBX3
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.3102138250378257,0.6146960687887437,0.9117647058823529,0.9926061469421616,1.0,1/13,5.19%,PPAT
prerank,GO_Biological_Process_2021__mannose trimming involved in glycoprotein ERAD pathway (GO:1904382),-0.41052360836909474,-0.6145713285091886,0.9090909090909091,1.0,1.0,3/5,31.68%,EDEM1;MAN1B1;EDEM2
prerank,GO_Biological_Process_2021__ubiquitin-dependent glycoprotein ERAD pathway (GO:0097466),-0.41052360836909474,-0.6145713285091886,0.9090909090909091,1.0,1.0,3/5,31.68%,EDEM1;MAN1B1;EDEM2
prerank,GO_Biological_Process_2021__protein deglycosylation involved in glycoprotein catabolic process (GO:0035977),-0.41052360836909474,-0.6145713285091886,0.9090909090909091,1.0,1.0,3/5,31.68%,EDEM1;MAN1B1;EDEM2
prerank,GO_Biological_Process_2021__positive regulation of exosomal secretion (GO:1903543),-0.33390167892876443,-0.6145227508383742,0.9464285714285714,1.0,1.0,1/12,7.74%,SNF8
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell differentiation (GO:0072112),-0.4003903662043069,-0.6137414405991741,0.9344262295081968,1.0,1.0,1/6,5.60%,BASP1
prerank,GO_Biological_Process_2021__surfactant homeostasis (GO:0043129),-0.40214409859319306,-0.6131777569382478,0.9272727272727272,1.0,1.0,2/5,11.19%,OAS1;VEGFA
prerank,GO_Biological_Process_2021__chemical homeostasis within a tissue (GO:0048875),-0.40214409859319306,-0.6131777569382478,0.9272727272727272,1.0,1.0,2/5,11.19%,OAS1;VEGFA
prerank,GO_Biological_Process_2021__negative regulation of actin filament bundle assembly (GO:0032232),0.29707435625039025,0.6128952389552477,1.0,0.9932524949415884,1.0,6/21,16.96%,WASF2;TMEFF2;SHANK3;TJP1;CLASP1;CLASP2
prerank,GO_Biological_Process_2021__regulation of triglyceride biosynthetic process (GO:0010866),-0.37706606777575724,-0.6124792743099531,0.8852459016393442,1.0,1.0,3/10,14.85%,NR1H2;CNEP1R1;C3
prerank,GO_Biological_Process_2021__response to gamma radiation (GO:0010332),0.30885857206306633,0.6118708870824205,0.975609756097561,0.9934096122012352,1.0,4/17,20.87%,LIG4;MDM2;PRKAA1;TMEM109
prerank,GO_Biological_Process_2021__regulation of histone phosphorylation (GO:0033127),0.3547281364014653,0.611217852077198,0.9387755102040817,0.9932971191581862,1.0,1/9,5.00%,RPS6KA4
prerank,GO_Biological_Process_2021__toxin transport (GO:1901998),0.38556520922960447,0.610152993476977,0.9454545454545454,0.9935606837780449,1.0,3/5,23.39%,ANTXR1;ADAM10;RAB40B
prerank,GO_Biological_Process_2021__regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.284002853823061,0.6100640686848063,0.9761904761904762,0.9931509667396226,1.0,6/25,19.56%,SUPT16H;CDK13;WDR43;CDK12;EAPP;HNRNPU
prerank,GO_Biological_Process_2021__phospholipid biosynthetic process (GO:0008654),0.3046556009645335,0.6097725261354502,1.0,0.9927976895615362,1.0,6/24,13.86%,IDI1;AGPAT5;SAMD8;MVD;SGMS1;HDHD5
prerank,GO_Biological_Process_2021__phosphatidylglycerol biosynthetic process (GO:0006655),0.37482056911255607,0.6096930247977252,0.8292682926829268,0.9923774978796357,1.0,6/6,62.54%,CDS2;SLC27A1;PGS1;PLA2G6;GPAM;TAMM41
prerank,GO_Biological_Process_2021__cardiac muscle cell development (GO:0055013),0.3466298159744784,0.6095601422791289,0.8787878787878788,0.9919744974940526,1.0,4/10,17.01%,ALPK3;PDLIM5;SLC8A1;SORBS2
prerank,GO_Biological_Process_2021__DNA damage induced protein phosphorylation (GO:0006975),-0.36600052541670747,-0.6083530396004208,0.8867924528301887,1.0,1.0,3/6,32.49%,MAPK3;MAP2K6;CHEK2
prerank,GO_Biological_Process_2021__regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),-0.3564221101049503,-0.6080292410661584,0.9152542372881356,1.0,1.0,7/17,22.02%,CFTR;TRPM4;PIM3;STXBP4;HLA-DRB1;NR1D1;STX4
prerank,GO_Biological_Process_2021__lamellipodium assembly (GO:0030032),0.2846531626337055,0.6075497501433311,0.95,0.9927195158869613,1.0,6/20,22.19%,VCL;P2RY12;SRGAP2;ARHGEF6;PTPRO;ABLIM1
prerank,GO_Biological_Process_2021__microtubule anchoring at microtubule organizing center (GO:0072393),0.3496578422638574,0.6073745962550201,0.9574468085106383,0.9923670910931472,1.0,4/9,30.05%,NIN;HOOK3;PCM1;BICD2
prerank,GO_Biological_Process_2021__regulation of potassium ion transport (GO:0043266),0.31993832837783515,0.6072018481696406,0.975609756097561,0.9919590608422147,1.0,4/17,19.50%,KCNIP2;KCNN2;DPP10;DPP6
prerank,GO_Biological_Process_2021__response to hydroperoxide (GO:0033194),0.37622424856467407,0.6070149166816788,0.9318181818181818,0.9916073125510009,1.0,5/5,62.39%,PRKD1;SP1;PRKCD;DAPK1;XRCC1
prerank,"GO_Biological_Process_2021__Notch receptor processing, ligand-dependent (GO:0035333)",-0.37529422312658745,-0.6069839206709582,0.90625,1.0,1.0,1/5,18.14%,APH1B
prerank,GO_Biological_Process_2021__protein acylation (GO:0043543),-0.2942232882805633,-0.6069820909811035,0.9473684210526315,1.0,1.0,3/31,11.60%,ING5;GLUL;ING4
prerank,GO_Biological_Process_2021__negative regulation of small GTPase mediated signal transduction (GO:0051058),0.30457675695655406,0.6063776137194137,0.9487179487179487,0.9915129341500172,1.0,1/19,1.76%,SPRY2
prerank,GO_Biological_Process_2021__negative regulation of endocytosis (GO:0045806),0.295118560346764,0.6059148041513509,0.9444444444444444,0.9912957648336523,1.0,2/17,12.17%,PICALM;ARF6
prerank,GO_Biological_Process_2021__cellular amino acid biosynthetic process (GO:0008652),0.41173227509193766,0.6058470686854238,0.9210526315789473,0.9908778154100197,1.0,1/5,14.77%,GAD1
prerank,GO_Biological_Process_2021__cardiac cell development (GO:0055006),0.36279801764371405,0.6050075490353367,0.9210526315789473,0.9909680507529833,1.0,3/8,13.70%,JAG1;ALPK3;SLC8A1
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate metabolic process (GO:0009167),0.2955902518128041,0.6042342982691956,1.0,0.9910972464802346,1.0,2/16,13.57%,PPAT;AK3
prerank,GO_Biological_Process_2021__ubiquitin-dependent ERAD pathway (GO:0030433),-0.26369924741752826,-0.6042065202004385,0.9871794871794872,1.0,1.0,5/64,10.12%,DNAJB9;ANKZF1;TRIM13;SELENOS;TMEM67
prerank,GO_Biological_Process_2021__negative regulation of small molecule metabolic process (GO:0062014),-0.37512664640324217,-0.6039888671613737,0.8367346938775511,1.0,1.0,5/5,62.51%,PGP;NCOR1;CRY1;EP300;CLK2
prerank,GO_Biological_Process_2021__positive regulation of protein exit from endoplasmic reticulum (GO:0070863),0.30995485306990384,0.6039060596154214,0.8780487804878049,0.9908137675726342,1.0,1/10,11.83%,SORL1
prerank,GO_Biological_Process_2021__lipoxin biosynthetic process (GO:2001301),0.35974080153516597,0.6036193591636133,0.9387755102040817,0.9905138320421808,1.0,1/5,10.35%,ALOX5AP
prerank,GO_Biological_Process_2021__nuclear RNA surveillance (GO:0071027),-0.37699968857635496,-0.603601022494453,0.896551724137931,1.0,1.0,1/6,7.08%,EXOSC10
prerank,GO_Biological_Process_2021__cell-substrate junction assembly (GO:0007044),0.29178713089779984,0.6028092070802823,0.9444444444444444,0.9905929288888915,1.0,6/22,21.51%,PTPRK;FERMT2;TAOK2;PEAK1;CD151;CTTN
prerank,GO_Biological_Process_2021__stem cell differentiation (GO:0048863),0.2940753984083854,0.60099055467342,1.0,0.9912175569153483,1.0,4/22,19.59%,GPM6A;SETD2;BATF;FGFR2
prerank,GO_Biological_Process_2021__cellular response to gamma radiation (GO:0071480),0.30161075953932204,0.600921377700921,0.975,0.9908065527675928,1.0,2/13,20.87%,MDM2;TMEM109
prerank,GO_Biological_Process_2021__protein maturation by iron-sulfur cluster transfer (GO:0097428),-0.34408751234111024,-0.6008331471729913,0.9180327868852459,1.0,1.0,2/12,15.50%,ISCA1;CIAO2B
prerank,GO_Biological_Process_2021__ribosomal large subunit export from nucleus (GO:0000055),-0.393395578140897,-0.6007622344010723,0.8571428571428571,1.0,1.0,3/6,21.82%,NPM1;NUP88;NMD3
prerank,GO_Biological_Process_2021__activation of protein kinase A activity (GO:0034199),0.308138183939503,0.6005898601074813,0.9555555555555556,0.9904849225615433,1.0,3/14,13.60%,ADCY9;PRRC1;ADCY6
prerank,GO_Biological_Process_2021__protein K48-linked deubiquitination (GO:0071108),-0.32462324739195203,-0.6000086035918559,0.9482758620689655,1.0,1.0,3/20,13.97%,TNFAIP3;MINDY1;OTUD3
prerank,GO_Biological_Process_2021__regulation of fatty acid beta-oxidation (GO:0031998),0.35216123822444345,0.5996313644281912,0.9069767441860465,0.9905583276982765,1.0,2/8,21.70%,AKT2;MFSD2A
prerank,GO_Biological_Process_2021__mitochondrial tRNA modification (GO:0070900),0.4025787159489444,0.5989237889569015,0.9615384615384616,0.990464950456386,1.0,3/6,24.51%,PUS1;TRMT10C;TRIT1
prerank,GO_Biological_Process_2021__tRNA modification (GO:0006400),-0.28796700399376074,-0.5978775724565235,0.9565217391304348,1.0,1.0,10/49,22.80%,SSB;GTPBP3;OSGEP;TRMT44;THUMPD3;METTL2A;TYW5;FTSJ1;WDR6;URM1
prerank,GO_Biological_Process_2021__astral microtubule organization (GO:0030953),-0.3705111572845914,-0.5977307956678425,0.9555555555555556,1.0,1.0,1/8,5.18%,RAB11A
prerank,GO_Biological_Process_2021__positive regulation of bone resorption (GO:0045780),0.3490890139180213,0.5970182632139427,0.9,0.9909160114090484,1.0,2/7,31.40%,SYK;DEF8
prerank,GO_Biological_Process_2021__regulation of histone H4 acetylation (GO:0090239),-0.35490976581631395,-0.5970093616082589,0.9354838709677419,1.0,1.0,3/8,26.85%,CTBP1;PIH1D1;SMARCB1
prerank,GO_Biological_Process_2021__regulation of macrophage differentiation (GO:0045649),-0.3618178287345957,-0.5968416088731119,0.9629629629629629,1.0,1.0,5/7,38.41%,C1QC;PTPN2;ID2;CASP8;HSF1
prerank,GO_Biological_Process_2021__regulation of chromosome segregation (GO:0051983),-0.34941380005460776,-0.5967300109689385,0.9354838709677419,1.0,1.0,2/10,18.08%,IHO1;CSNK2A2
prerank,GO_Biological_Process_2021__DNA double-strand break processing (GO:0000729),0.29992755350302674,0.5965439162829288,0.9183673469387755,0.9906670978126764,1.0,5/17,19.93%,UBE2N;BARD1;BLM;NBN;RNF138
prerank,GO_Biological_Process_2021__dicarboxylic acid catabolic process (GO:0043649),-0.3429714285899059,-0.5961505538840739,0.9206349206349206,1.0,1.0,3/10,17.58%,GLUL;QPRT;GOT2
prerank,GO_Biological_Process_2021__glycerolipid metabolic process (GO:0046486),0.3427305810163903,0.5954292612257788,0.9555555555555556,0.9908013296839998,1.0,3/8,32.12%,DGKQ;DGKB;PLA2G15
prerank,GO_Biological_Process_2021__mRNA 5'-splice site recognition (GO:0000395),0.38789968628128346,0.5953264385136335,0.9038461538461539,0.9903862871440503,1.0,1/5,15.98%,SRSF12
prerank,GO_Biological_Process_2021__regulation of actomyosin structure organization (GO:0110020),-0.34353171253043785,-0.5938038641031613,0.9710144927536232,1.0,1.0,3/12,21.93%,ACTG1;RAC1;WAS
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by cadherin (GO:2000047),-0.3413454055529838,-0.5934191138163741,0.9152542372881356,1.0,1.0,4/10,21.23%,VEGFA;DENND6A;FLOT1;RGCC
prerank,GO_Biological_Process_2021__response to increased oxygen levels (GO:0036296),0.4080250621325894,0.5932143745669343,0.925,0.9911193246567732,1.0,3/5,31.45%,ATP6V0D1;ATP6V1G1;ATP6V1A
prerank,GO_Biological_Process_2021__transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery (GO:0000972),0.3614075029372602,0.5931104283839534,0.9512195121951219,0.9907045164830055,1.0,1/6,16.80%,NUP133
prerank,GO_Biological_Process_2021__purine-containing compound biosynthetic process (GO:0072522),0.3099635028051193,0.5930268757833175,0.972972972972973,0.9902956271943121,1.0,2/18,5.19%,DGUOK;PPAT
prerank,GO_Biological_Process_2021__negative regulation of cold-induced thermogenesis (GO:0120163),-0.2998252611911205,-0.592135335568003,0.9696969696969697,1.0,1.0,4/31,12.47%,NR1H2;RBPJ;PCTP;IL18R1
prerank,GO_Biological_Process_2021__regulation of mammary gland epithelial cell proliferation (GO:0033599),0.3503036353576773,0.5910058217662256,0.8837209302325582,0.9909391112020568,1.0,3/7,13.62%,ROBO1;RTN4;ZNF703
prerank,GO_Biological_Process_2021__peptidyl-lysine trimethylation (GO:0018023),0.2880141140494579,0.5901838622152186,0.9714285714285714,0.9909566301851077,1.0,6/22,15.35%,VCPKMT;SMYD5;SETD3;SETD2;SETD5;SETD4
prerank,GO_Biological_Process_2021__protein alkylation (GO:0008213),0.2897603305677402,0.590075758511558,1.0,0.9905703132216147,1.0,2/16,12.20%,VCPKMT;SNRPB
prerank,GO_Biological_Process_2021__skeletal muscle tissue development (GO:0007519),-0.35397065349703327,-0.5892834736976649,0.9824561403508771,1.0,1.0,5/11,31.47%,CFLAR;SVIL;MYL6B;MYH14;MYL6
prerank,GO_Biological_Process_2021__very-low-density lipoprotein particle assembly (GO:0034379),0.355077299306239,0.58897394632442,0.9285714285714286,0.9906930404339294,1.0,3/7,25.59%,P4HB;MFSD2A;SOAT1
prerank,GO_Biological_Process_2021__cortical cytoskeleton organization (GO:0030865),-0.30927602671799725,-0.5885662660417434,0.9565217391304348,1.0,1.0,5/33,10.76%,PLEK;EPB41L3;TRPV4;LLGL2;NCKAP1L
prerank,GO_Biological_Process_2021__embryonic heart tube development (GO:0035050),-0.38041662187445785,-0.5885411771736487,0.9215686274509803,1.0,1.0,1/6,10.60%,CITED2
prerank,GO_Biological_Process_2021__protein localization to microtubule (GO:0035372),-0.37328949297818914,-0.5884136333654765,0.90625,1.0,1.0,3/7,32.16%,MID1;CHAMP1;MAPRE1
prerank,GO_Biological_Process_2021__regulation of macrophage activation (GO:0043030),-0.33911407202643246,-0.587915647198079,0.9830508474576272,1.0,1.0,4/16,15.81%,GPR137B;KARS1;CD74;CD200
prerank,GO_Biological_Process_2021__positive regulation of proteolysis (GO:0045862),-0.2919387280826979,-0.5876518845133665,0.9642857142857143,1.0,1.0,7/30,17.55%,AURKAIP1;TNFRSF1B;ATP5IF1;WDR48;CYFIP2;SNX9;PINK1
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase III (GO:0045945),0.32787162162162153,0.5874937901062018,0.918918918918919,0.9910643584881865,1.0,9/9,67.24%,ICE2;ELL;ZNF143;CHD8;CEBPA;ICE1;MTOR;RPTOR;ZC3H8
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 acetylation (GO:2000615),-0.36564427036121616,-0.5874328732691433,0.9629629629629629,1.0,1.0,5/10,28.16%,CAMK1;BRCA1;PIH1D1;SMARCB1;SPHK2
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via STAT (GO:1904893),0.35161519611332614,0.5872031589252478,0.9512195121951219,0.9908055779071571,1.0,3/8,39.26%,ADIPOR1;SH2B3;HGS
prerank,GO_Biological_Process_2021__glycoprotein catabolic process (GO:0006516),0.36000505646435255,0.5865447341999767,0.9024390243902439,0.9907347707960819,1.0,2/9,13.82%,STT3B;FBXO27
prerank,GO_Biological_Process_2021__nuclear mRNA surveillance (GO:0071028),-0.3714825230247558,-0.5860295210056642,0.9821428571428571,1.0,1.0,1/7,7.08%,EXOSC10
prerank,GO_Biological_Process_2021__somatic recombination of immunoglobulin gene segments (GO:0016447),0.33543259120928937,0.5859601515478755,0.9555555555555556,0.990697143271502,1.0,1/7,7.13%,LIG4
prerank,GO_Biological_Process_2021__steroid hormone biosynthetic process (GO:0120178),0.3217102857863602,0.5856583444287999,0.9487179487179487,0.9904554336500327,1.0,1/12,4.90%,TSPOAP1
prerank,GO_Biological_Process_2021__myotube differentiation (GO:0014902),-0.36768645744187267,-0.5844948308207069,0.9322033898305084,1.0,1.0,1/9,5.56%,IGF1
prerank,GO_Biological_Process_2021__positive regulation of lyase activity (GO:0051349),0.33672904508386703,0.5843214222139226,0.9069767441860465,0.9906495617639054,1.0,2/7,23.24%,NF1;ORAI1
prerank,GO_Biological_Process_2021__regulation of potassium ion import (GO:1903286),-0.3543557671979046,-0.5839767143502395,0.9591836734693877,1.0,1.0,1/7,12.87%,ATP1B3
prerank,GO_Biological_Process_2021__positive regulation of DNA metabolic process (GO:0051054),-0.2646163297320464,-0.5835939845063403,1.0,1.0,1.0,12/45,22.29%,EYA2;RPS3;PRKD2;ABRAXAS1;BRCA1;ERCC8;ZCWPW1;WRN;TOX;SMCHD1;RGCC;PDGFB
prerank,GO_Biological_Process_2021__skeletal muscle organ development (GO:0060538),-0.32621211845803316,-0.582748417664788,0.9672131147540983,1.0,1.0,2/12,9.94%,BASP1;CFLAR
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell proliferation (GO:0001937),0.2929935575198799,0.5825032094012265,0.9459459459459459,0.991075001909466,1.0,3/19,12.21%,PPARG;PTPRM;NF1
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion (GO:0045785),-0.2901866456463308,-0.5824911168274868,0.9833333333333333,1.0,1.0,6/42,12.25%,CCL5;PRKD2;CITED2;NCKAP1L;VEGFA;CD47
prerank,GO_Biological_Process_2021__protein deglutamylation (GO:0035608),-0.3806824692329004,-0.5820645524724632,0.9107142857142857,1.0,1.0,2/6,14.71%,AGBL3;AGBL5
prerank,GO_Biological_Process_2021__tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),-0.2907490529787063,-0.5808746205447969,1.0,1.0,1.0,5/32,17.60%,SSB;XPOT;NUP50;SEC13;NUP88
prerank,GO_Biological_Process_2021__tRNA export from nucleus (GO:0006409),-0.2907490529787063,-0.5808746205447969,1.0,1.0,1.0,5/32,17.60%,SSB;XPOT;NUP50;SEC13;NUP88
prerank,GO_Biological_Process_2021__protein auto-ADP-ribosylation (GO:0070213),-0.3537045827686893,-0.5800550478847681,0.9193548387096774,1.0,1.0,4/11,20.56%,PARP2;PARP11;PARP12;PARP8
prerank,"GO_Biological_Process_2021__posttranslational protein targeting to membrane, translocation (GO:0031204)",-0.3793941931221168,-0.5797493627422982,0.9649122807017544,1.0,1.0,1/7,13.39%,SEC62
prerank,GO_Biological_Process_2021__peptidyl-serine autophosphorylation (GO:0036289),0.35549673569603435,0.5790679179021379,0.92,0.9922327691497592,1.0,4/8,27.25%,DYRK1A;MAP2K2;RIPK1;PIKFYVE
prerank,GO_Biological_Process_2021__regulation of chromosome organization (GO:0033044),-0.3184076098022458,-0.5774260688531108,0.9672131147540983,1.0,1.0,2/15,12.59%,CENPV;TERF2IP
prerank,GO_Biological_Process_2021__negative regulation of fatty acid metabolic process (GO:0045922),0.2894997729903398,0.577206111695538,0.9354838709677419,0.9926460891404645,1.0,4/11,29.71%,ACADVL;SIRT4;WDTC1;ERLIN1
prerank,GO_Biological_Process_2021__P-body assembly (GO:0033962),-0.3305620112147888,-0.5768423638791589,0.9298245614035088,1.0,1.0,2/12,16.62%,PATL2;LSM4
prerank,GO_Biological_Process_2021__negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.3355158226103183,0.5762773335287991,0.9811320754716981,0.9926462243030564,1.0,3/10,15.41%,PPARG;NFIB;NFATC3
prerank,GO_Biological_Process_2021__actomyosin structure organization (GO:0031032),0.2570949928231444,0.5757705536321283,0.9615384615384616,0.9924538026300294,1.0,6/46,14.52%,EPB41;PGM5;TMOD2;TMOD3;TJP1;FRMD5
prerank,GO_Biological_Process_2021__positive regulation of mitotic sister chromatid separation (GO:1901970),0.34160257394827975,0.5754211376689339,0.9722222222222222,0.9912512542568818,1.0,3/10,19.61%,CDC23;NSMCE2;ANAPC4
prerank,GO_Biological_Process_2021__positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.34160257394827975,0.5754211376689339,0.9722222222222222,0.9912512542568818,1.0,3/10,19.61%,CDC23;NSMCE2;ANAPC4
prerank,GO_Biological_Process_2021__positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.34160257394827975,0.5754211376689339,0.9722222222222222,0.9912512542568818,1.0,3/10,19.61%,CDC23;NSMCE2;ANAPC4
prerank,GO_Biological_Process_2021__positive regulation of potassium ion import across plasma membrane (GO:1903288),-0.36176010278970655,-0.574950659867008,0.9333333333333333,1.0,1.0,1/6,12.87%,ATP1B3
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion (GO:0032024),-0.29786094356935733,-0.5742673576358753,0.9696969696969697,1.0,1.0,5/23,14.38%,NNAT;NLGN2;CFTR;TRPM4;MYRIP
prerank,GO_Biological_Process_2021__organic anion transport (GO:0015711),-0.2903298790280023,-0.5740994272864355,1.0,1.0,1.0,6/32,18.29%,SLC35B1;SLC2A8;CFTR;SLC25A19;SLCO3A1;SLC17A9
prerank,GO_Biological_Process_2021__response to magnesium ion (GO:0032026),0.3436435813556697,0.5710905932401614,0.9183673469387755,0.9928006641999249,1.0,2/7,19.35%,SLC41A1;SNCA
prerank,GO_Biological_Process_2021__positive regulation of cyclase activity (GO:0031281),0.3495633581659562,0.5709373754903302,0.9767441860465116,0.9924055100748338,1.0,3/8,26.56%,NF1;ORAI1;MAPK14
prerank,GO_Biological_Process_2021__regulation of nervous system process (GO:0031644),0.31256130274855576,0.5698879806988054,0.9512195121951219,0.9924825671055164,1.0,6/12,22.89%,NPTXR;NPTX1;DLGAP4;DLGAP1;TMEM108;DLGAP2
prerank,GO_Biological_Process_2021__amyloid precursor protein catabolic process (GO:0042987),0.3084421276822775,0.5693047351248947,0.9285714285714286,0.9922634086919027,1.0,2/10,22.55%,DYRK1A;ADAM10
prerank,GO_Biological_Process_2021__regulation of protein polymerization (GO:0032271),-0.2872630501375143,-0.5692666345718393,0.971830985915493,1.0,1.0,3/22,13.08%,PRUNE1;PFN1;FCHSD1
prerank,GO_Biological_Process_2021__regulation of hyaluronan biosynthetic process (GO:1900125),-0.39272226147896566,-0.567615255227534,0.9302325581395349,1.0,1.0,2/5,27.39%,PDGFB;AP2A1
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome organization (GO:0034724),-0.3214165110092553,-0.5664656097066936,0.9433962264150944,1.0,1.0,2/10,17.45%,HIRA;HAT1
prerank,GO_Biological_Process_2021__phagosome acidification (GO:0090383),0.2699407267998706,0.5658157227708295,0.9743589743589743,0.9933929459131259,1.0,10/21,26.64%,RAB7A;ATP6V1B2;TCIRG1;ATP6V0B;ATP6V0D1;RAB38;ATP6V0E2;SLAMF8;RAB20;ATP6V1G1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial calcium ion concentration (GO:0051561),0.3475554518775002,0.5656553216694595,0.9333333333333333,0.9930146766450764,1.0,2/6,12.23%,MCU;MICU1
prerank,GO_Biological_Process_2021__tRNA transport (GO:0051031),-0.28170262734567003,-0.5649936180622339,0.9841269841269841,1.0,1.0,7/34,22.06%,SSB;XPOT;NUP50;SEC13;NUP88;YBX1;NUP155
prerank,GO_Biological_Process_2021__copper ion transport (GO:0006825),0.30895436747473864,0.5642625191745435,0.90625,0.9931679930765982,1.0,2/8,14.08%,SLC31A1;STEAP3
prerank,GO_Biological_Process_2021__cognition (GO:0050890),0.26181118273338805,0.563665973888933,1.0,0.9930036637190117,1.0,10/30,21.78%,TNF;GRM5;NF1;NIPBL;RP9;SETD5;MAGT1;LINS1;MFSD2A;CHD7
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell apoptotic process (GO:2000353),-0.34856559371325857,-0.563208874354841,0.9361702127659575,1.0,1.0,1/8,8.15%,ITGA4
prerank,GO_Biological_Process_2021__response to glucagon (GO:0033762),-0.2960658538090265,-0.5622189682964077,0.9821428571428571,1.0,1.0,1/15,6.63%,PRKAR1B
prerank,GO_Biological_Process_2021__positive regulation of RNA splicing (GO:0033120),-0.28823382307954165,-0.5621109029487648,1.0,1.0,1.0,5/25,21.12%,RBM22;U2AF2;HSPA1A;ERN1;NCL
prerank,GO_Biological_Process_2021__cellular biogenic amine metabolic process (GO:0006576),0.3604726773179531,0.5620612459437189,0.96,0.9932772258990249,1.0,2/6,14.33%,AMD1;SRM
prerank,GO_Biological_Process_2021__regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.3484545566266835,0.5616556972827882,0.9555555555555556,0.9929981400061944,1.0,3/9,18.09%,MAP2K1;MAPK1;MAP2K2
prerank,GO_Biological_Process_2021__visual system development (GO:0150063),0.28233146644827883,0.5611401456051133,1.0,0.9927521071925218,1.0,3/20,15.89%,PBX1;BMPR1B;PBX3
prerank,GO_Biological_Process_2021__positive regulation of protein acetylation (GO:1901985),-0.3181519452681359,-0.561131908058242,0.9818181818181818,1.0,1.0,3/11,14.13%,TERF2IP;KAT5;CAMK1
prerank,GO_Biological_Process_2021__positive regulation of B cell receptor signaling pathway (GO:0050861),-0.3233977877227054,-0.5609538736062868,0.9310344827586207,1.0,1.0,6/6,67.69%,SLC39A10;FOXP1;PRKCH;CD81;NFAM1;PRKCB
prerank,GO_Biological_Process_2021__regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),-0.26668580184992513,-0.560857589615079,1.0,1.0,1.0,5/49,16.35%,MED25;VENTX;CCND1;MED12;MED30
prerank,GO_Biological_Process_2021__DNA unwinding involved in DNA replication (GO:0006268),-0.31517650813510567,-0.5607457511036842,0.9777777777777777,1.0,1.0,6/11,25.28%,MCM7;RECQL5;WRN;MCM6;RECQL;SSBP1
prerank,GO_Biological_Process_2021__striated muscle contraction (GO:0006941),-0.3080308556118025,-0.5606130212991581,0.9558823529411765,1.0,1.0,2/19,7.44%,TTN;MYBPC3
prerank,GO_Biological_Process_2021__vacuolar acidification (GO:0007035),0.32844570768431336,0.5605633544201016,0.9705882352941176,0.9926374415538607,1.0,4/14,22.90%,PPT1;TCIRG1;ATP6V0D1;ATP6V0E2
prerank,GO_Biological_Process_2021__cell communication by electrical coupling involved in cardiac conduction (GO:0086064),-0.33955266269584017,-0.5604563015544624,0.9836065573770492,1.0,1.0,2/10,16.41%,ATP1A1;PKP2
prerank,GO_Biological_Process_2021__negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.36404540267028607,-0.5602327501035383,0.9607843137254902,1.0,1.0,1/9,5.38%,NR1H2
prerank,GO_Biological_Process_2021__inner ear morphogenesis (GO:0042472),-0.3368809981186587,-0.5589984971593782,0.9830508474576272,1.0,1.0,1/8,7.41%,MYO3B
prerank,GO_Biological_Process_2021__blood vessel diameter maintenance (GO:0097746),-0.3210759711688768,-0.5587340321213712,0.9696969696969697,1.0,1.0,2/14,8.63%,PER2;GCLM
prerank,GO_Biological_Process_2021__atrial septum morphogenesis (GO:0060413),0.32867093984040163,0.5582265773517527,0.9347826086956522,0.9933640143277902,1.0,1/6,8.29%,SOX4
prerank,GO_Biological_Process_2021__negative regulation of tubulin deacetylation (GO:1904428),0.36714932473234674,0.5564192658284146,0.9545454545454546,0.9935549055619591,1.0,2/5,16.79%,TPPP;PRKAA1
prerank,GO_Biological_Process_2021__positive regulation of mRNA processing (GO:0050685),0.25852924474874805,0.5559941858859601,1.0,0.993249038424278,1.0,4/17,22.40%,PRDX6;TRA2B;THRAP3;NUP98
prerank,GO_Biological_Process_2021__purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.33229855510895834,0.5554598412566375,0.8913043478260869,0.9930579920655151,1.0,1/6,14.62%,ENPP1
prerank,GO_Biological_Process_2021__proton transmembrane transport (GO:1902600),-0.29756779402434386,-0.5550154383199686,0.9523809523809523,1.0,1.0,1/18,4.87%,ATP6V1F
prerank,GO_Biological_Process_2021__response to UV-A (GO:0070141),-0.35239210584482566,-0.553837963985917,0.9807692307692307,1.0,1.0,3/6,31.45%,CCND1;EGFR;AKT1
prerank,PanglaoDB_Augmented_2021__Serotonergic Neurons,0.2904850050137548,0.553480001572925,0.9743589743589743,0.9934886546960171,1.0,4/15,14.36%,MMRN1;TMEM236;SLC40A1;SLC26A3
prerank,GO_Biological_Process_2021__mammary gland development (GO:0030879),-0.3542715083109485,-0.5528470597509787,0.9183673469387755,1.0,1.0,2/8,11.19%,PRLR;VEGFA
prerank,GO_Biological_Process_2021__regulation of dephosphorylation (GO:0035303),-0.30750135883875857,-0.5525105999749234,1.0,1.0,1.0,2/12,18.95%,INPP5K;PPP1R16B
prerank,GO_Biological_Process_2021__negative regulation of mRNA catabolic process (GO:1902373),0.28015888617224644,0.5514362612799709,0.9534883720930233,0.9938807823174123,1.0,3/17,19.56%,TENT5A;THRAP3;HNRNPU
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle contraction (GO:0003056),0.33525611262508026,0.5513000066956486,0.9259259259259259,0.9934881641806295,1.0,2/5,28.10%,CHRM3;DOCK4
prerank,GO_Biological_Process_2021__mRNA splice site selection (GO:0006376),-0.2828963234478741,-0.5498116705669828,0.9836065573770492,1.0,1.0,10/23,31.43%,SLU7;LUC7L3;SF3A1;SF3A3;YTHDC1;SRSF5;PSIP1;SRSF9;SNRPC;SRSF10
prerank,GO_Biological_Process_2021__sister chromatid segregation (GO:0000819),0.2716453840707769,0.5497486471624223,1.0,0.9936240373565669,1.0,3/21,12.59%,NSL1;SMC4;ZNF207
prerank,"GO_Biological_Process_2021__alternative mRNA splicing, via spliceosome (GO:0000380)",-0.3089747403668923,-0.5487945476533703,0.9848484848484849,1.0,1.0,3/14,16.52%,DDX5;SLU7;SCNM1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial translation (GO:0070131),-0.3329174562881803,-0.5486777167784914,0.9152542372881356,1.0,1.0,5/10,22.19%,RPUSD4;TRUB2;UQCC2;C1QBP;RPUSD3
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 2 signaling pathway (GO:0034137),-0.35355700782780275,-0.5482294583737602,0.8709677419354839,1.0,1.0,1/5,12.67%,CYBA
prerank,GO_Biological_Process_2021__negative regulation of interferon-gamma production (GO:0032689),0.28273444697780553,0.5481970272502353,0.975609756097561,0.9936999233518183,1.0,4/16,15.40%,DDIT3;LGALS9;LAPTM5;CR1
prerank,GO_Biological_Process_2021__heme catabolic process (GO:0042167),0.3365807013869396,0.5474754138244208,0.9545454545454546,0.9930739441906674,1.0,1/6,13.92%,SLCO2B1
prerank,GO_Biological_Process_2021__porphyrin-containing compound catabolic process (GO:0006787),0.3365807013869396,0.5474754138244208,0.9545454545454546,0.9930739441906674,1.0,1/6,13.92%,SLCO2B1
prerank,GO_Biological_Process_2021__negative regulation of peptide hormone secretion (GO:0090278),0.32028346915805117,0.5470764153677405,1.0,0.9927640935247932,1.0,2/8,25.41%,KCNB1;SIRT4
prerank,GO_Biological_Process_2021__dopamine metabolic process (GO:0042417),-0.35963812733751177,-0.5463488476532482,0.9629629629629629,1.0,1.0,1/6,9.85%,COMT
prerank,GO_Biological_Process_2021__cardiolipin metabolic process (GO:0032048),-0.33099662162162163,-0.5460647245887182,0.9682539682539683,1.0,1.0,9/9,66.93%,PLA2G4A;HADHB;PNPLA8;TAMM41;HADHA;PLA2G6;PGS1;LCLAT1;SLC27A1
prerank,GO_Biological_Process_2021__calcium ion export (GO:1901660),-0.3537110529426666,-0.5455775585927191,0.9387755102040817,1.0,1.0,6/6,64.66%,ATP2B4;SLC8B1;SLC8A2;ATP2B1;LETM1;SLC35G1
prerank,GO_Biological_Process_2021__acyl-CoA metabolic process (GO:0006637),-0.2982660934142672,-0.5454855300832898,0.9464285714285714,1.0,1.0,5/21,18.11%,THEM4;ACOT9;MCEE;ACSM5;DLST
prerank,GO_Biological_Process_2021__regulation of aerobic respiration (GO:1903715),0.31985326599995006,0.5450458363260416,0.9411764705882353,0.9931444497397154,1.0,1/9,3.96%,CBFA2T3
prerank,GO_Biological_Process_2021__regulation of histone deacetylation (GO:0031063),-0.34607628777071364,-0.5445732339076342,0.9827586206896551,1.0,1.0,4/8,28.16%,AKAP8;CTBP1;AKAP8L;SPHK2
prerank,GO_Biological_Process_2021__lipid phosphorylation (GO:0046834),-0.3174457063068927,-0.5436608025313043,0.9811320754716981,1.0,1.0,2/9,23.87%,DGKD;DGKH
prerank,GO_Biological_Process_2021__pre-miRNA processing (GO:0031054),0.2958785197268701,0.5433847759734319,1.0,0.9932692513203771,1.0,3/11,23.72%,DROSHA;AGO1;MRPL44
prerank,GO_Biological_Process_2021__regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.3025568293478392,0.54190314985789,0.9473684210526315,0.9933450922551466,1.0,1/9,6.90%,RUNX1
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, initiation (GO:2000142)",0.22549434920408898,0.5418217943362285,1.0,0.9929488720515486,1.0,10/49,22.38%,MITF;TCF7L2;PTEN;JUN;TNRC6C;CBFB;TRIM28;MED24;AGO1;MED13
prerank,GO_Biological_Process_2021__recombinational repair (GO:0000725),-0.2473337564527264,-0.5407940845233722,0.9855072463768116,1.0,1.0,17/56,26.15%,HUS1;BRCA2;XRCC3;NABP1;RPA3;BRCA1;RECQL5;ZSWIM7;WRN;NUCKS1;AP5Z1;EXD2;SLX4;RECQL;POLQ;LIG3;MMS22L
prerank,GO_Biological_Process_2021__cellular response to amino acid starvation (GO:0034198),-0.2523849109049943,-0.5397426894198846,1.0,1.0,1.0,5/58,10.33%,ATP6V1F;LAMTOR5;EIF2AK2;ITFG2;LARS1
prerank,GO_Biological_Process_2021__mitotic metaphase plate congression (GO:0007080),-0.26310441235583987,-0.5396566991722164,1.0,1.0,1.0,6/31,20.58%,RAB11A;MIS12;PSRC1;DCTN2;RMDN1;CHMP6
prerank,GO_Biological_Process_2021__regulation of gene expression by genetic imprinting (GO:0006349),-0.35338682866614746,-0.5394934385810226,0.9310344827586207,1.0,1.0,1/6,16.76%,KDM1B
prerank,GO_Biological_Process_2021__positive regulation of interleukin-13 production (GO:0032736),-0.3767039242933009,-0.5394299738862179,0.9649122807017544,1.0,1.0,2/5,17.61%,HLA-E;IL18
prerank,GO_Biological_Process_2021__response to amino acid starvation (GO:1990928),-0.2515205347854987,-0.5392124965894386,1.0,1.0,1.0,5/59,10.33%,ATP6V1F;LAMTOR5;EIF2AK2;ITFG2;LARS1
prerank,GO_Biological_Process_2021__regulation of mRNA 3'-end processing (GO:0031440),0.2885615626175605,0.5383360608698152,1.0,0.9936809448424818,1.0,3/10,16.20%,BARD1;AHCYL1;PAPOLA
prerank,GO_Biological_Process_2021__positive regulation by symbiont of entry into host (GO:0075294),-0.3384427800661617,-0.5379973779794728,0.9607843137254902,1.0,1.0,4/8,24.40%,LGALS1;CD74;HLA-DRB1;CD4
prerank,GO_Biological_Process_2021__positive regulation of viral entry into host cell (GO:0046598),-0.3384427800661617,-0.5379973779794728,0.9607843137254902,1.0,1.0,4/8,24.40%,LGALS1;CD74;HLA-DRB1;CD4
prerank,GO_Biological_Process_2021__positive regulation of small GTPase mediated signal transduction (GO:0051057),0.2689821628459477,0.5379022767215774,1.0,0.9933445528924619,1.0,4/20,13.55%,RELN;ITGAV;SHOC2;VAV1
prerank,GO_Biological_Process_2021__positive regulation of viral life cycle (GO:1903902),-0.28133136730409464,-0.5376427519537242,0.9841269841269841,1.0,1.0,4/19,18.79%,VPS37B;LGALS1;CD74;HLA-DRB1
prerank,GO_Biological_Process_2021__positive regulation of histone H4 acetylation (GO:0090240),0.3568263391726072,0.5367617351716623,1.0,0.9932739403781112,1.0,1/6,8.34%,AUTS2
prerank,GO_Biological_Process_2021__positive regulation of IRE1-mediated unfolded protein response (GO:1903896),-0.38521443804733324,-0.5367606714062039,0.9583333333333334,1.0,1.0,1/5,19.79%,TMEM33
prerank,GO_Biological_Process_2021__negative regulation of cell communication (GO:0010648),-0.32233695715307487,-0.5339790211057104,0.9649122807017544,1.0,1.0,1/9,7.60%,NLRP12
prerank,GO_Biological_Process_2021__phagosome maturation (GO:0090382),0.26248288293636757,0.5336928007738937,1.0,0.9938424204680396,1.0,12/28,27.25%,RAB7A;ATP6V1B2;RAB14;TCIRG1;ATP6V0B;ATP6V0D1;RAB38;ATP6V0E2;SLAMF8;RAB20;ATP6V1G1;PIKFYVE
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase III promoter (GO:0006384),0.3257345491388045,0.5313723387256863,0.9210526315789473,0.9941830428243847,1.0,5/5,67.44%,BDP1;CRCP;BRF1;POLR3H;GTF3C1
prerank,GO_Biological_Process_2021__negative regulation of defense response to virus (GO:0050687),0.35201915417279833,0.5310991853014015,1.0,0.9938307957673691,1.0,3/6,26.66%,ILRUN;MICB;TRAF3IP1
prerank,GO_Biological_Process_2021__oligosaccharide catabolic process (GO:0009313),-0.31519653046511953,-0.5301091609114044,1.0,1.0,1.0,2/7,27.10%,GBA3;MANBA
prerank,GO_Biological_Process_2021__rRNA catabolic process (GO:0016075),-0.30516433133015186,-0.5292654177547477,0.96875,1.0,1.0,3/11,19.17%,EXOSC10;DEDD2;TRIR
prerank,GO_Biological_Process_2021__regulation of protein K63-linked ubiquitination (GO:1900044),0.3040960416963316,0.5291181011168363,0.9512195121951219,0.99392774790972,1.0,2/8,17.16%,SASH1;DDX3X
prerank,GO_Biological_Process_2021__intracellular pH reduction (GO:0051452),-0.27129166983594816,-0.5290513080160296,0.9836065573770492,1.0,1.0,2/28,10.20%,ATP6V1F;SLC11A1
prerank,GO_Biological_Process_2021__cell junction disassembly (GO:0150146),-0.3711060838674958,-0.5290208590283512,0.9482758620689655,1.0,1.0,3/5,29.52%,C1QB;C1QC;C1QA
prerank,GO_Biological_Process_2021__kinetochore assembly (GO:0051382),-0.3372869990175374,-0.5288949347277266,0.9344262295081968,1.0,1.0,2/6,18.36%,MIS12;CENPF
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity (GO:0097202),-0.31149298695411554,-0.5288279012345883,1.0,1.0,1.0,1/10,12.39%,CYFIP2
prerank,GO_Biological_Process_2021__histone-threonine phosphorylation (GO:0035405),-0.3233704829449511,-0.5286900966928502,0.9791666666666666,1.0,1.0,5/5,67.69%,VRK1;PKN1;PRKCA;DCAF1;PRKCB
prerank,GO_Biological_Process_2021__pyrimidine-containing compound salvage (GO:0008655),-0.3209317564801434,-0.5278433265294179,0.9838709677419355,1.0,1.0,1/8,8.20%,TYMP
prerank,GO_Biological_Process_2021__pyrimidine nucleoside salvage (GO:0043097),-0.3209317564801434,-0.5278433265294179,0.9838709677419355,1.0,1.0,1/8,8.20%,TYMP
prerank,GO_Biological_Process_2021__regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903069),0.28727305756882515,0.5269108962332207,0.9787234042553191,0.9940678601534613,1.0,3/8,22.80%,USP14;SGTA;UBQLN1
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903376),-0.34619366515280536,-0.5266779175591387,0.9636363636363636,1.0,1.0,2/7,22.45%,HIF1A;PARK7
prerank,GO_Biological_Process_2021__regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.2967865377261933,0.5266052913084374,0.9666666666666667,0.9937431531481933,1.0,2/15,8.54%,WASF2;CTNNA2
prerank,GO_Biological_Process_2021__prostaglandin biosynthetic process (GO:0001516),-0.293517831908867,-0.5264267880366829,0.9814814814814815,1.0,1.0,2/10,15.77%,PTGES2;CD74
prerank,GO_Biological_Process_2021__negative regulation of signaling (GO:0023057),-0.30367576516201794,-0.5258302490526628,0.9821428571428571,1.0,1.0,1/11,7.60%,NLRP12
prerank,GO_Biological_Process_2021__positive regulation of DNA replication (GO:0045740),0.3142512569951169,0.5252337865012593,1.0,0.9936671823024062,1.0,2/10,16.29%,BRPF3;FAF1
prerank,GO_Biological_Process_2021__regulation of interleukin-13 production (GO:0032656),-0.35396024064840476,-0.5237979081177832,1.0,1.0,1.0,4/6,29.40%,HLA-E;IL18;SPHK2;TNFRSF21
prerank,GO_Biological_Process_2021__glucuronate catabolic process to xylulose 5-phosphate (GO:0019640),-0.34408536013613433,-0.5224462390331832,0.9629629629629629,1.0,1.0,3/5,29.14%,CRYL1;AKR1A1;SORD
prerank,GO_Biological_Process_2021__xylulose 5-phosphate biosynthetic process (GO:1901159),-0.34408536013613433,-0.5224462390331832,0.9629629629629629,1.0,1.0,3/5,29.14%,CRYL1;AKR1A1;SORD
prerank,GO_Biological_Process_2021__glucuronate catabolic process (GO:0006064),-0.34408536013613433,-0.5224462390331832,0.9629629629629629,1.0,1.0,3/5,29.14%,CRYL1;AKR1A1;SORD
prerank,GO_Biological_Process_2021__cellular response to glucagon stimulus (GO:0071377),-0.2981720663174363,-0.5218386645410538,1.0,1.0,1.0,1/13,6.63%,PRKAR1B
prerank,GO_Biological_Process_2021__zymogen activation (GO:0031638),0.26523046518334537,0.5208957185162156,0.972972972972973,0.9945306361109333,1.0,4/18,16.68%,MMP14;NLRC4;CTSH;GRIN2A
prerank,GO_Biological_Process_2021__regulation of collagen biosynthetic process (GO:0032965),0.3050341799019427,0.5205746080857511,0.9512195121951219,0.9941521950062041,1.0,1/8,6.90%,RUNX1
prerank,GO_Biological_Process_2021__DNA damage checkpoint signaling (GO:0000077),-0.2821980403733185,-0.520379732801818,1.0,1.0,1.0,2/23,13.39%,HUS1;RAD9A
prerank,GO_Biological_Process_2021__negative regulation of stress fiber assembly (GO:0051497),-0.26883241491176724,-0.5203552439257333,0.9814814814814815,1.0,1.0,4/19,17.44%,CGNL1;PFN1;STMN1;INPP5K
prerank,GO_Biological_Process_2021__cardiolipin acyl-chain remodeling (GO:0035965),-0.34211415062478895,-0.5200956819477585,0.9272727272727272,1.0,1.0,5/5,65.81%,PLA2G4A;HADHB;HADHA;PLA2G6;LCLAT1
prerank,GO_Biological_Process_2021__cellular response to potassium ion (GO:0035865),0.3499769161763598,0.5193441671978648,0.9019607843137255,0.993628153626176,1.0,2/5,22.06%,SLC12A2;DLG2
prerank,GO_Biological_Process_2021__response to potassium ion (GO:0035864),0.3499769161763598,0.5193441671978648,0.9019607843137255,0.993628153626176,1.0,2/5,22.06%,SLC12A2;DLG2
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell differentiation (GO:1905064),-0.3172539840698609,-0.5191261753189549,0.9622641509433962,1.0,1.0,3/6,28.21%,DNMT1;PDGFB;PDCD4
prerank,GO_Biological_Process_2021__negative regulation of JNK cascade (GO:0046329),0.27992690133717585,0.5189054634048633,1.0,0.9933422322967127,1.0,7/22,24.31%,SIRPA;FKTN;AIDA;HDAC3;DNAJA1;PER1;HIPK3
prerank,GO_Biological_Process_2021__histone ubiquitination (GO:0016574),-0.29430535848994044,-0.5170434990450518,0.9827586206896551,1.0,1.0,4/18,21.66%,DTX3L;UHRF1;LEO1;ATXN7L3
prerank,GO_Biological_Process_2021__spliceosomal snRNP assembly (GO:0000387),-0.2724991080932445,-0.5170242101881495,1.0,1.0,1.0,3/29,16.62%,SNRPD2;PRPF3;LSM4
prerank,GO_Biological_Process_2021__response to mitochondrial depolarisation (GO:0098780),-0.3389902060114826,-0.5166178819075087,0.9482758620689655,1.0,1.0,5/5,66.12%,BECN1;AMBRA1;ATG14;GPS2;SQSTM1
prerank,GO_Biological_Process_2021__diacylglycerol metabolic process (GO:0046339),-0.26910790362744036,-0.5145321211502033,0.9636363636363636,1.0,1.0,5/16,33.45%,DGKD;DGKH;PNPLA2;DGKG;LIPE
prerank,GO_Biological_Process_2021__tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.2920980491337743,0.5138778214783911,0.975,0.9943224152610719,1.0,4/11,21.12%,EMC8;BAG6;MMGT1;SGTA
prerank,GO_Biological_Process_2021__DNA replication-dependent nucleosome organization (GO:0034723),-0.31634221006641616,-0.5138005371359055,0.9807692307692307,1.0,1.0,1/5,17.45%,HAT1
prerank,GO_Biological_Process_2021__DNA replication-dependent nucleosome assembly (GO:0006335),-0.31634221006641616,-0.5138005371359055,0.9807692307692307,1.0,1.0,1/5,17.45%,HAT1
prerank,GO_Biological_Process_2021__Notch receptor processing (GO:0007220),-0.29200300409241176,-0.5136908443515168,0.9516129032258065,1.0,1.0,2/7,29.51%,APH1B;GALNT11
prerank,PanglaoDB_Augmented_2021__Keratinocytes,0.3197177573038956,0.5130744030292159,0.9523809523809523,0.9941225867034285,1.0,1/9,7.39%,IL13RA1
prerank,GO_Biological_Process_2021__positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),-0.29342991915959843,-0.5121362297657446,0.9655172413793104,1.0,1.0,6/16,27.18%,EIF2AK2;NOD2;MID1;LYN;CARD9;PDCD10
prerank,GO_Biological_Process_2021__cellular response to oxygen levels (GO:0071453),0.3307351538191105,0.5111312463683481,1.0,0.9941489716777678,1.0,1/8,6.73%,CPEB4
prerank,GO_Biological_Process_2021__nucleoside salvage (GO:0043174),-0.3091356051211043,-0.5106181368305592,1.0,1.0,1.0,1/9,8.20%,TYMP
prerank,GO_Biological_Process_2021__regulation of mitochondrial translation (GO:0070129),-0.28524830873939055,-0.5080994065359764,0.9672131147540983,1.0,1.0,5/15,22.19%,RPUSD4;TRUB2;UQCC2;C1QBP;RPUSD3
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion mediated by cadherin (GO:2000049),0.34802065726148373,0.5077480522097052,1.0,0.9945841688592794,1.0,2/5,12.87%,AFDN;TJP1
prerank,GO_Biological_Process_2021__regulation of alpha-beta T cell proliferation (GO:0046640),-0.33713133968104925,-0.5051799649670404,0.9629629629629629,1.0,1.0,2/6,18.87%,IRF1;TNFRSF14
prerank,GO_Biological_Process_2021__prostanoid biosynthetic process (GO:0046457),-0.3024296141271077,-0.5048897744513382,0.98,1.0,1.0,1/7,15.77%,CD74
prerank,GO_Biological_Process_2021__myoblast fusion (GO:0007520),0.33125124846137954,0.5045812846030758,0.9459459459459459,0.9948415376276536,1.0,2/6,16.74%,JAM2;ADGRB3
prerank,GO_Biological_Process_2021__axo-dendritic transport (GO:0008088),-0.32390441611078274,-0.5038991811602181,0.9682539682539683,1.0,1.0,6/6,67.63%,SPG11;APBA1;DCTN1;APP;MAPT;HSPA8
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.29467557917313497,0.5036602571270938,0.9512195121951219,0.9945827123816792,1.0,2/7,23.37%,NEDD4;DAB2IP
prerank,GO_Biological_Process_2021__microtubule depolymerization (GO:0007019),-0.3121064617556454,-0.502348008159614,0.9818181818181818,1.0,1.0,1/8,14.46%,STMN1
prerank,GO_Biological_Process_2021__kinetochore organization (GO:0051383),-0.306743337430191,-0.502034537149859,0.9365079365079365,1.0,1.0,2/7,18.36%,MIS12;CENPF
prerank,GO_Biological_Process_2021__cellular response to interleukin-15 (GO:0071350),-0.2903116817298758,-0.5017996902783267,0.9516129032258065,1.0,1.0,10/10,71.00%,CD4;STAT3;IL15RA;STAT5B;JAK1;PLCB1;GRB2;IL15;JAK3;STAT5A
prerank,GO_Biological_Process_2021__interleukin-15-mediated signaling pathway (GO:0035723),-0.2903116817298758,-0.5017996902783267,0.9516129032258065,1.0,1.0,10/10,71.00%,CD4;STAT3;IL15RA;STAT5B;JAK1;PLCB1;GRB2;IL15;JAK3;STAT5A
prerank,GO_Biological_Process_2021__dosage compensation by inactivation of X chromosome (GO:0009048),-0.2815045533936647,-0.5014451549837646,0.9827586206896551,1.0,1.0,5/11,26.07%,BRCA1;LRIF1;SMCHD1;YTHDC1;METTL3
prerank,GO_Biological_Process_2021__positive regulation of interleukin-6 production (GO:0032755),-0.24029603379750586,-0.5010415907462115,1.0,1.0,1.0,15/47,28.41%,AIF1;TYROBP;CYBA;NOD2;CD74;TLR2;CLEC7A;CARD9;ARHGEF2;PTPN11;LILRB2;MYD88;BCL10;SPHK2;STAT3
prerank,GO_Biological_Process_2021__positive regulation of fibroblast migration (GO:0010763),0.2859917878267755,0.5006561682105813,0.9795918367346939,0.9947700140938942,1.0,3/8,25.72%,PTK2;PRKCE;TGFB1
prerank,GO_Biological_Process_2021__mitotic cytokinetic process (GO:1902410),-0.2732156486401256,-0.5000623248477276,0.9836065573770492,1.0,1.0,3/13,20.58%,CNTROB;MITD1;CHMP6
prerank,GO_Biological_Process_2021__positive regulation of heterochromatin assembly (GO:0031453),0.2634470465256611,0.49919072718574553,1.0,0.9946081078588616,1.0,3/12,19.62%,SIRT6;SETDB2;TRIM28
prerank,GO_Biological_Process_2021__cell surface receptor signaling pathway involved in heart development (GO:0061311),-0.3191365397682776,-0.49911834687491036,0.9811320754716981,1.0,1.0,2/8,13.87%,RBPJ;NOTCH2
prerank,GO_Biological_Process_2021__branched-chain amino acid metabolic process (GO:0009081),0.26462884939811093,0.49878434941146743,0.9655172413793104,0.9938930723442202,1.0,2/17,16.90%,DBT;AUH
prerank,GO_Biological_Process_2021__branched-chain amino acid catabolic process (GO:0009083),0.26462884939811093,0.49878434941146743,0.9655172413793104,0.9938930723442202,1.0,2/17,16.90%,DBT;AUH
prerank,GO_Biological_Process_2021__negative regulation of chromosome organization (GO:2001251),0.28265373454351206,0.49785358277665337,0.9347826086956522,0.9936942304118803,1.0,3/7,26.09%,ERCC4;ERCC1;WAPL
prerank,GO_Biological_Process_2021__positive regulation of protein localization to centrosome (GO:1904781),0.33753339635123414,0.497424713916236,0.9285714285714286,0.993372276109506,1.0,1/5,15.67%,GSK3B
prerank,GO_Biological_Process_2021__neuron projection organization (GO:0106027),0.27249678153359136,0.4970087595347889,1.0,0.9930023847765034,1.0,2/11,19.43%,GSK3B;PLS1
prerank,GO_Biological_Process_2021__positive regulation of chromatin organization (GO:1905269),-0.29342084287145737,-0.4967262745783893,0.9814814814814815,1.0,1.0,1/11,12.59%,TERF2IP
prerank,GO_Biological_Process_2021__muscle cell migration (GO:0014812),-0.33525227339112695,-0.49522929038876035,1.0,1.0,1.0,3/7,29.93%,THBS4;PLAT;AAMP
prerank,GO_Biological_Process_2021__regulation of transferase activity (GO:0051338),-0.2832478293382935,-0.4945806474013133,0.9696969696969697,1.0,1.0,2/13,15.20%,NLRC5;PARP4
prerank,GO_Biological_Process_2021__tRNA methylation (GO:0030488),-0.26310415029068174,-0.49098405125399813,0.9855072463768116,1.0,1.0,13/24,32.31%,GTPBP3;TRMT44;THUMPD3;METTL2A;FTSJ1;WDR6;DALRD3;THUMPD2;ALKBH8;TARBP1;THADA;NSUN6;TRMT13
prerank,GO_Biological_Process_2021__positive regulation of oxidoreductase activity (GO:0051353),0.26069086949627296,0.4894064947974835,0.9772727272727273,0.9944430216320392,1.0,1/9,7.30%,TNF
prerank,GO_Biological_Process_2021__desensitization of G protein-coupled receptor signaling pathway (GO:0002029),-0.3109009541501309,-0.48930450157073574,0.98,1.0,1.0,6/6,68.93%,GRK2;GTF2H2;ADRB2;GRK3;ARRB1;ARRB2
prerank,GO_Biological_Process_2021__regulation of cAMP-mediated signaling (GO:0043949),-0.2725583860698977,-0.48775164737587634,0.9655172413793104,1.0,1.0,1/16,6.63%,PRKAR1B
prerank,GO_Biological_Process_2021__regulation of SMAD protein signal transduction (GO:0060390),0.259266581940564,0.48479976113814305,0.9545454545454546,0.9949562713234636,1.0,3/12,15.36%,BMPR1A;TGFBR1;KIAA0319
prerank,GO_Biological_Process_2021__regulation of melanin biosynthetic process (GO:0048021),0.2932598419877033,0.4833818419864157,0.975609756097561,0.9948162587067918,1.0,5/7,28.19%,RAPGEF2;OPN3;ZEB2;MFSD12;GIPC1
prerank,GO_Biological_Process_2021__mitochondrial genome maintenance (GO:0000002),-0.2766439720869081,-0.4827582404610358,0.9710144927536232,1.0,1.0,4/12,24.47%,TYMP;MGME1;MEF2A;SLC25A36
prerank,GO_Biological_Process_2021__leukotriene biosynthetic process (GO:0019370),0.27014334293375486,0.4816653046703906,1.0,0.9946870668313227,1.0,3/9,27.72%,ALOX5AP;MGST3;MGST2
prerank,GO_Biological_Process_2021__regulation of hemopoiesis (GO:1903706),-0.2915457678640065,-0.48019329778314546,0.9636363636363636,1.0,1.0,2/8,17.08%,PTN;PURB
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization (GO:0031115),0.275653103531694,0.4797639748063953,0.9787234042553191,0.9947451048492851,1.0,3/11,19.55%,DYRK1A;SNCA;MAP2
prerank,GO_Biological_Process_2021__regulation of lipase activity (GO:0060191),-0.270882488024562,-0.4793710446720048,0.9344262295081968,1.0,1.0,2/7,16.99%,PCSK5;LMF1
prerank,GO_Biological_Process_2021__positive regulation of protein polyubiquitination (GO:1902916),-0.31182426479048764,-0.47865050414608123,0.9846153846153847,1.0,1.0,2/7,19.00%,NOD2;PTPN22
prerank,GO_Biological_Process_2021__ribonucleoprotein complex disassembly (GO:0032988),-0.3046525373638436,-0.47755846793359985,0.9636363636363636,1.0,1.0,6/6,69.56%,KLC1;ZFAND1;TFIP11;DHX8;VCP;KIF5B
prerank,GO_Biological_Process_2021__positive regulation of nitric-oxide synthase activity (GO:0051000),-0.2854137521699323,-0.47727746247998964,0.9827586206896551,1.0,1.0,3/12,16.05%,HIF1A;PIK3CB;NOS1AP
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.2789979021923027,-0.4767903601582645,0.9841269841269841,1.0,1.0,4/14,25.75%,FANCB;SMCHD1;POLQ;PARPBP
prerank,GO_Biological_Process_2021__I-kappaB phosphorylation (GO:0007252),0.27025792435878504,0.47655216758868446,0.975,0.9949366868145499,1.0,2/8,16.34%,TLR7;MAP3K7
prerank,GO_Biological_Process_2021__engulfment of apoptotic cell (GO:0043652),0.2677025171520179,0.4748964760109171,1.0,0.9947969298815904,1.0,5/10,30.82%,RHOBTB1;XKR6;MEGF10;RHOH;XKR4
prerank,GO_Biological_Process_2021__protein desumoylation (GO:0016926),-0.3114075825382082,-0.4743381394248505,0.9821428571428571,1.0,1.0,6/6,68.88%,SENP1;SENP7;SENP5;SENP2;USPL1;SENP6
prerank,GO_Biological_Process_2021__acetyl-CoA biosynthetic process (GO:0006085),-0.28496246477648773,-0.47418332950900327,0.9807692307692307,1.0,1.0,4/9,26.15%,PDHB;PDHA1;ACSS1;MLYCD
prerank,GO_Biological_Process_2021__axoneme assembly (GO:0035082),-0.2611597234363893,-0.4738281872613785,1.0,1.0,1.0,4/11,22.38%,CCDC39;TTC12;CFAP74;DNAI4
prerank,GO_Biological_Process_2021__miRNA metabolic process (GO:0010586),0.23659602131155408,0.47232830365708445,1.0,0.9948655208782767,1.0,3/15,24.72%,DROSHA;XPO5;SND1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),-0.2565854016784242,-0.4711355393595593,1.0,1.0,1.0,1/15,8.36%,CALM1
prerank,GO_Biological_Process_2021__histone H3-K4 dimethylation (GO:0044648),-0.3050252659157785,-0.47073578516758663,1.0,1.0,1.0,1/6,14.77%,SETD1A
prerank,GO_Biological_Process_2021__motor neuron axon guidance (GO:0008045),-0.27577859996206056,-0.47065607645406976,0.9444444444444444,1.0,1.0,2/9,23.99%,RAC1;RAC2
prerank,GO_Biological_Process_2021__regulation of mitochondrial gene expression (GO:0062125),0.27273494891497085,0.46846150015271115,1.0,0.9952329089387806,1.0,6/6,72.74%,NSUN3;MTG1;MTG2;ALKBH1;METTL4;MTRES1
prerank,GO_Biological_Process_2021__N-glycan processing (GO:0006491),-0.26022209775858385,-0.46717659132023015,1.0,1.0,1.0,1/17,6.14%,ST8SIA1
prerank,GO_Biological_Process_2021__spliceosomal tri-snRNP complex assembly (GO:0000244),-0.2802537869024195,-0.46711039964822015,0.9807692307692307,1.0,1.0,1/12,11.55%,PRPF3
prerank,GO_Biological_Process_2021__mitotic recombination (GO:0006312),-0.26954863088220804,-0.4663695992914147,0.9821428571428571,1.0,1.0,1/11,9.58%,XRCC3
prerank,GO_Biological_Process_2021__purine ribonucleotide transport (GO:0015868),0.2534229639120373,0.4653730043049955,0.9761904761904762,0.9952799098796299,1.0,3/10,25.94%,SLC25A4;LRRC8D;ABCC5
prerank,GO_Biological_Process_2021__cellular response to arsenic-containing substance (GO:0071243),-0.2610426201012863,-0.46483910679602897,0.9841269841269841,1.0,1.0,1/12,12.13%,ATF3
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomerase (GO:0032211),-0.2604394782844659,-0.4630529504857283,1.0,1.0,1.0,1/14,7.08%,EXOSC10
prerank,GO_Biological_Process_2021__regulation of spindle assembly (GO:0090169),-0.24825060353123204,-0.46248845708852493,0.9848484848484849,1.0,1.0,2/20,14.43%,HSPA1B;HSPA1A
prerank,GO_Biological_Process_2021__negative regulation of insulin secretion (GO:0046676),0.26676025487403876,0.46136803340217114,0.9743589743589743,0.9955188229250211,1.0,3/8,25.41%,KLF7;KCNB1;SIRT4
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein kinase activity (GO:1904030),-0.24839613246108197,-0.4609576022652601,1.0,1.0,1.0,6/16,30.85%,CDKN1C;CDKN1B;TFAP4;CDKN1A;CDKN2A;HEXIM1
prerank,GO_Biological_Process_2021__negative regulation of centriole replication (GO:0046600),-0.3066410234713736,-0.46054914590788276,0.9833333333333333,1.0,1.0,2/6,24.71%,BRCA1;MDM1
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transport (GO:1902307),-0.2717835943998607,-0.45693265657482174,0.9591836734693877,1.0,1.0,1/9,12.87%,ATP1B3
prerank,GO_Biological_Process_2021__immune response-regulating cell surface receptor signaling pathway (GO:0002768),-0.2941460732314173,-0.4567017743211371,1.0,1.0,1.0,4/7,26.56%,LYN;FGR;LILRB1;LILRB2
prerank,GO_Biological_Process_2021__histone H3-K4 monomethylation (GO:0097692),0.25883230367512855,0.4562161165850279,0.9811320754716981,0.9960559885644726,1.0,3/7,25.99%,SETD4;SETD1B;KMT2C
prerank,GO_Biological_Process_2021__protein localization to phagophore assembly site (GO:0034497),0.2592589549915546,0.45534526216400517,0.9811320754716981,0.9957189961639046,1.0,2/8,18.97%,ATG13;TRAPPC8
prerank,GO_Biological_Process_2021__negative regulation by host of viral process (GO:0044793),-0.30677495339624344,-0.4524269903955275,0.984375,1.0,1.0,3/5,36.88%,PSMC3;CCNK;VAPA
prerank,GO_Biological_Process_2021__posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),-0.2737529676379927,-0.4513210033150228,1.0,1.0,1.0,1/10,13.39%,SEC62
prerank,PanglaoDB_Augmented_2021__Pluripotent Stem Cells,-0.20458822752766692,-0.4503498780138511,1.0,1.0,1.0,11/52,22.11%,HK2;NPM1;SEPHS1;ZGRF1;FANCI;ATAD5;CENPF;MSH6;PHF6;NCL;CDC7
prerank,GO_Biological_Process_2021__positive regulation of megakaryocyte differentiation (GO:0045654),-0.28489544856367954,-0.446493071555327,0.9482758620689655,1.0,1.0,2/8,20.77%,ZNF16;PITHD1
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced neuron death (GO:1903203),-0.28333679182729726,-0.44398272639881897,0.9795918367346939,1.0,1.0,3/6,31.99%,PINK1;REST;TREM2
prerank,GO_Biological_Process_2021__cytoskeleton-dependent cytokinesis (GO:0061640),-0.20651870465121178,-0.44108185091606605,1.0,1.0,1.0,8/49,22.36%,EFHC1;TTC19;STMN1;SNX9;MITD1;CKAP2;MYH10;SEPTIN9
prerank,GO_Biological_Process_2021__positive regulation of neuron differentiation (GO:0045666),-0.2265240252852435,-0.43639843510664755,1.0,1.0,1.0,3/24,14.45%,BRINP2;TCF3;FGF20
prerank,GO_Biological_Process_2021__Golgi disassembly (GO:0090166),0.2598784194528875,0.4353160021885778,0.9767441860465116,0.9986199045422045,1.0,5/5,74.02%,GBF1;PLK3;GOLGA2;VRK1;STX5
prerank,GO_Biological_Process_2021__regulation of response to oxidative stress (GO:1902882),-0.2600516142834637,-0.4352116376942389,1.0,1.0,1.0,2/8,27.12%,PINK1;HEBP2
prerank,GO_Biological_Process_2021__positive regulation of monooxygenase activity (GO:0032770),-0.24452265126115574,-0.4350003177000008,1.0,0.9998344805232959,1.0,9/15,32.20%,HIF1A;PIK3CB;NOS1AP;PARK7;HTR2B;POR;IL1B;AKT1;TERF2
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial membrane potential (GO:0010918),-0.2953089058333328,-0.43482832346265976,1.0,0.9994530755733417,1.0,1/5,16.70%,STOML2
prerank,GO_Biological_Process_2021__retinoic acid metabolic process (GO:0042573),0.26791916918294423,0.43217144263293195,1.0,0.9986280547290838,1.0,1/5,15.46%,SCPEP1
prerank,GO_Biological_Process_2021__regulation of phosphate metabolic process (GO:0019220),-0.25461820649427636,-0.43193096720310675,0.9850746268656716,0.999367952076756,1.0,1/11,13.28%,MCM7
prerank,GO_Biological_Process_2021__positive regulation of protein deacetylation (GO:0090312),0.2726621775406808,0.4311852095547517,1.0,0.998269095125237,1.0,2/8,13.48%,DYRK1A;NIPBL
prerank,GO_Biological_Process_2021__hematopoietic stem cell differentiation (GO:0060218),-0.28873223271001025,-0.431113507597078,1.0,0.9990710781416842,1.0,1/5,19.66%,UFL1
prerank,GO_Biological_Process_2021__Golgi to endosome transport (GO:0006895),-0.2296763867544651,-0.4286199656008802,1.0,0.9989458384247707,1.0,3/14,21.27%,AP4M1;WIPI1;VPS13A
prerank,GO_Biological_Process_2021__positive regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903071),-0.2591581781380621,-0.4249387512137355,1.0,0.9989046847921418,1.0,3/6,28.04%,NFE2L2;BCAP31;HERPUD1
prerank,GO_Biological_Process_2021__histone methylation (GO:0016571),0.2331359660835233,0.4208816208532163,1.0,0.9989740490937176,1.0,7/17,33.88%,NSD3;PRMT7;SUV39H2;CREBBP;EZH2;SMYD2;NSD1
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),-0.23120642040168093,-0.41624915356536096,1.0,0.99923297146426,1.0,5/14,30.85%,CDKN1C;CDKN1B;TFAP4;CDKN2A;HEXIM1
prerank,GO_Biological_Process_2021__regulation of cyclase activity (GO:0031279),-0.2656197230665316,-0.4157954509523575,1.0,0.998886255354727,1.0,5/5,73.46%,MAPK3;CAP2;MAPK8;CAP1;MAPK14
prerank,GO_Biological_Process_2021__genetic imprinting (GO:0071514),-0.2707090605364452,-0.4141859165177218,1.0,0.9985834312597462,1.0,1/5,16.76%,KDM1B
prerank,GO_Biological_Process_2021__positive regulation of mRNA binding (GO:1902416),0.2715029426553811,0.4110844398577336,0.9836065573770492,0.9995242300884233,1.0,1/5,20.63%,CDK9
prerank,GO_Biological_Process_2021__telomeric D-loop disassembly (GO:0061820),-0.2587132159076676,-0.41073893503352404,1.0,0.9984921661917008,1.0,2/6,25.12%,WRN;SLX4
prerank,GO_Biological_Process_2021__DNA conformation change (GO:0071103),-0.22769516728624534,-0.40643333355409483,1.0,0.9984479145999521,1.0,13/13,77.26%,HAT1;HMGB2;TOP3B;TOP2A;HMGB1;MTERF1;ERCC3;HHEX;TOP1;KAT6A;TOP3A;TOP2B;ABL1
prerank,GO_Biological_Process_2021__regulation of actin filament organization (GO:0110053),0.24864687119492787,0.40132642321929696,1.0,0.9999092151984593,1.0,3/7,22.44%,PIK3CA;ARHGAP35;CXCL12
prerank,GO_Biological_Process_2021__positive regulation of membrane potential (GO:0045838),0.2374266456582177,0.3986225819632523,1.0,0.9996459213286452,1.0,2/7,22.31%,AKT2;GLRX
prerank,GO_Biological_Process_2021__plasma membrane tubulation (GO:0097320),-0.24307499501231686,-0.39665612970094505,1.0,0.9987087078623317,1.0,2/7,22.98%,SNX9;BIN2
prerank,GO_Biological_Process_2021__stress fiber assembly (GO:0043149),0.20218322388230406,0.39122297692656094,1.0,0.9992579906837874,1.0,7/13,36.81%,PHACTR1;SORBS1;RHOA;KCTD13;ARRB1;TNFAIP1;ZYX
prerank,GO_Biological_Process_2021__contractile actin filament bundle assembly (GO:0030038),0.20218322388230406,0.39122297692656094,1.0,0.9992579906837874,1.0,7/13,36.81%,PHACTR1;SORBS1;RHOA;KCTD13;ARRB1;TNFAIP1;ZYX
prerank,GO_Biological_Process_2021__ncRNA transcription (GO:0098781),-0.21692853522554487,-0.3880998165971717,1.0,0.9987347666380548,1.0,11/11,78.34%,GTF3A;GTF3C1;SIRT7;POLR1G;NIFK;BRF1;SNAPC3;USPL1;SPIN1;MARS1;RPAP2
prerank,GO_Biological_Process_2021__negative regulation of transmembrane transport (GO:0034763),-0.19227359076884154,-0.3276949213326016,1.0,0.9999296673264542,1.0,3/8,31.45%,INPP5K;IL1B;AKT1
prerank,GO_Biological_Process_2021__regulation of DNA demethylation (GO:1901535),0.20584262073623777,0.3143074814175078,1.0,1.0,1.0,5/5,79.42%,USP7;STPG4;USP9X;OTUD4;TOX
prerank,GO_Biological_Process_2021__positive regulation of DNA demethylation (GO:1901537),0.20584262073623777,0.3143074814175078,1.0,1.0,1.0,5/5,79.42%,USP7;STPG4;USP9X;OTUD4;TOX
